"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34167582","10.1186/s40001-021-00528-4","Using the absolute advantage coefficient (AAC) to measure the strength of damage hit by COVID-19 in India on a growth-share matrix.","The COVID-19 pandemic occurred and rapidly spread around the world. Some online dashboards have included essential features on a world map. However, only transforming data into visualizations for countries/regions is insufficient for the public need. This study aims to (1) develop an algorithm for classifying countries/regions into four quadrants inn GSM and (2) design an app for a better understanding of the COVID-19 situation. We downloaded COVID-19 outbreak numbers daily from the Github websi","2021","07","05","Eur J Med Res","European journal of medical research","COVID-19; Dashboard; Four-quadrant diagram; Google maps; Multiply infection rate; Algorithms; COVID-19; Global Health; Humans; India; Models, Statistical; SARS-CoV-2","Yang","Daw-Hsin","Department of Gastrointestinal Hepatobiliary, Chiali Chi-Mei Hospital, Tainan, Taiwan",NA
"2","34167582","10.1186/s40001-021-00528-4","Using the absolute advantage coefficient (AAC) to measure the strength of damage hit by COVID-19 in India on a growth-share matrix.","The COVID-19 pandemic occurred and rapidly spread around the world. Some online dashboards have included essential features on a world map. However, only transforming data into visualizations for countries/regions is insufficient for the public need. This study aims to (1) develop an algorithm for classifying countries/regions into four quadrants inn GSM and (2) design an app for a better understanding of the COVID-19 situation. We downloaded COVID-19 outbreak numbers daily from the Github websi","2021","07","05","Eur J Med Res","European journal of medical research","COVID-19; Dashboard; Four-quadrant diagram; Google maps; Multiply infection rate; Algorithms; COVID-19; Global Health; Humans; India; Models, Statistical; SARS-CoV-2","Chien","Tsair-Wei","Department of Medical Research, Chi-Mei Medical Center, 901 Chung Hwa Road, Yung Kung Dist, Tainan, 710, Taiwan. rasch.smile@gmail","rasch.smile@gmail.com"
"3","34167582","10.1186/s40001-021-00528-4","Using the absolute advantage coefficient (AAC) to measure the strength of damage hit by COVID-19 in India on a growth-share matrix.","The COVID-19 pandemic occurred and rapidly spread around the world. Some online dashboards have included essential features on a world map. However, only transforming data into visualizations for countries/regions is insufficient for the public need. This study aims to (1) develop an algorithm for classifying countries/regions into four quadrants inn GSM and (2) design an app for a better understanding of the COVID-19 situation. We downloaded COVID-19 outbreak numbers daily from the Github websi","2021","07","05","Eur J Med Res","European journal of medical research","COVID-19; Dashboard; Four-quadrant diagram; Google maps; Multiply infection rate; Algorithms; COVID-19; Global Health; Humans; India; Models, Statistical; SARS-CoV-2","Yeh","Yu-Tsen","Medical School, St. George's University of London, London, UK",NA
"4","34167582","10.1186/s40001-021-00528-4","Using the absolute advantage coefficient (AAC) to measure the strength of damage hit by COVID-19 in India on a growth-share matrix.","The COVID-19 pandemic occurred and rapidly spread around the world. Some online dashboards have included essential features on a world map. However, only transforming data into visualizations for countries/regions is insufficient for the public need. This study aims to (1) develop an algorithm for classifying countries/regions into four quadrants inn GSM and (2) design an app for a better understanding of the COVID-19 situation. We downloaded COVID-19 outbreak numbers daily from the Github websi","2021","07","05","Eur J Med Res","European journal of medical research","COVID-19; Dashboard; Four-quadrant diagram; Google maps; Multiply infection rate; Algorithms; COVID-19; Global Health; Humans; India; Models, Statistical; SARS-CoV-2","Yang","Ting-Ya","Medical Education Center, Chi-Mei Medical Center, Tainan, Taiwan",NA
"5","34167582","10.1186/s40001-021-00528-4","Using the absolute advantage coefficient (AAC) to measure the strength of damage hit by COVID-19 in India on a growth-share matrix.","The COVID-19 pandemic occurred and rapidly spread around the world. Some online dashboards have included essential features on a world map. However, only transforming data into visualizations for countries/regions is insufficient for the public need. This study aims to (1) develop an algorithm for classifying countries/regions into four quadrants inn GSM and (2) design an app for a better understanding of the COVID-19 situation. We downloaded COVID-19 outbreak numbers daily from the Github websi","2021","07","05","Eur J Med Res","European journal of medical research","COVID-19; Dashboard; Four-quadrant diagram; Google maps; Multiply infection rate; Algorithms; COVID-19; Global Health; Humans; India; Models, Statistical; SARS-CoV-2","Chou","Willy","Department of Physical Medicine and Rehabilitation, Chi Mei medical center, Tainan, Taiwan",NA
"6","34167582","10.1186/s40001-021-00528-4","Using the absolute advantage coefficient (AAC) to measure the strength of damage hit by COVID-19 in India on a growth-share matrix.","The COVID-19 pandemic occurred and rapidly spread around the world. Some online dashboards have included essential features on a world map. However, only transforming data into visualizations for countries/regions is insufficient for the public need. This study aims to (1) develop an algorithm for classifying countries/regions into four quadrants inn GSM and (2) design an app for a better understanding of the COVID-19 situation. We downloaded COVID-19 outbreak numbers daily from the Github websi","2021","07","05","Eur J Med Res","European journal of medical research","COVID-19; Dashboard; Four-quadrant diagram; Google maps; Multiply infection rate; Algorithms; COVID-19; Global Health; Humans; India; Models, Statistical; SARS-CoV-2","Lin","Ju-Kuo","Department of Medical Research, Chi-Mei Medical Center, 901 Chung Hwa Road, Yung Kung Dist, Tainan, 710, Taiwan",NA
"7","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Marfella","Raffaele","Department of Advanced Medical and Surgical Sciences, University of Campania ""Luigi Vanvitelli"" Naples, Piazza Miraglia, 2, 80138, Naples, Italy. raffaele.marfella@unicampamia","raffaele.marfella@unicampamia.it"
"8","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Paolisso","Pasquale","Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy",NA
"9","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Sardu","Celestino","Department of Advanced Medical and Surgical Sciences, University of Campania ""Luigi Vanvitelli"" Naples, Piazza Miraglia, 2, 80138, Naples, Italy",NA
"10","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Palomba","Luciana","Department of Experimental Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"11","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","D'Onofrio","Nunzia","Department of Precision Medicine, University of Campania ""Luigi Vanvitelli"" Naples, Naples, Italy",NA
"12","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Cesaro","Arturo","Department of Cardio-Thoracic and Respiratory Sciences, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"13","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Barbieri","Michelangela","Department of Advanced Medical and Surgical Sciences, University of Campania ""Luigi Vanvitelli"" Naples, Piazza Miraglia, 2, 80138, Naples, Italy",NA
"14","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Rizzo","Maria Rosaria","Department of Advanced Medical and Surgical Sciences, University of Campania ""Luigi Vanvitelli"" Naples, Piazza Miraglia, 2, 80138, Naples, Italy",NA
"15","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Sasso","Ferdinando Carlo","Department of Advanced Medical and Surgical Sciences, University of Campania ""Luigi Vanvitelli"" Naples, Piazza Miraglia, 2, 80138, Naples, Italy",NA
"16","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Scisciola","Lucia","Department of Advanced Medical and Surgical Sciences, University of Campania ""Luigi Vanvitelli"" Naples, Piazza Miraglia, 2, 80138, Naples, Italy",NA
"17","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Turriziani","Fabrizio","Department of Advanced Medical and Surgical Sciences, University of Campania ""Luigi Vanvitelli"" Naples, Piazza Miraglia, 2, 80138, Naples, Italy",NA
"18","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Galdiero","Massimiliano","Department of Experimental Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"19","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Pignataro","Danilo","Department of Experimental Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"20","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Minicucci","Fabio","Department of Cardiology, Hospital Cardarelli, Naples, Italy",NA
"21","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Trotta","Maria Consiglia","Department of Experimental Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"22","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","D'Amico","Michele","Department of Experimental Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"23","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Mauro","Ciro","Department of Cardiology, Hospital Cardarelli, Naples, Italy",NA
"24","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Calabrò","Paolo","Department of Cardio-Thoracic and Respiratory Sciences, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"25","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Balestrieri","Maria Luisa","Department of Precision Medicine, University of Campania ""Luigi Vanvitelli"" Naples, Naples, Italy",NA
"26","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Signioriello","Giuseppe","Department of Mental Health and Preventive Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"27","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Barbato","Emanuele","Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy",NA
"28","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Galdiero","Marilena","Department of Experimental Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"29","34167575","10.1186/s13054-021-03643-0","SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.","The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients. This was an observational study of 46 ASAP, and 1","2021","07","07","Crit Care","Critical care (London, England)","Asymptomatic SARS-COV-2 patients; Intracoronary thrombus; SARS-COV-2; STEMI; Thrombus viral load; Aged; Analysis of Variance; Asymptomatic Infections; COVID-19; Cohort Studies; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Myocardial Infarction","Paolisso","Giuseppe","Department of Advanced Medical and Surgical Sciences, University of Campania ""Luigi Vanvitelli"" Naples, Piazza Miraglia, 2, 80138, Naples, Italy",NA
"30","34167560","10.1186/s12960-021-00622-y","A systematic mapping review of factors associated with willingness to work under emergency condition.","An effective response to an emergency situation relies on health care workers' preparedness. The main purpose of this study was to provide a comprehensive overview of relevant studies regarding the willingness to work in emergency and disaster situations, describe and classify the most important challenges and solutions, identifying knowledge gaps in the literature which could inform future research. In this Systematic Mapping Review required information was searched from PubMed, Scopus, the web","2021","07","09","Hum Resour Health","Human resources for health","Emergency condition; Health workforce; Mapping review; Retention; Willingness to work; Attitude of Health Personnel; COVID-19; Disasters; Health Personnel; Humans","Nafar","Hamideh","Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran",NA
"31","34167560","10.1186/s12960-021-00622-y","A systematic mapping review of factors associated with willingness to work under emergency condition.","An effective response to an emergency situation relies on health care workers' preparedness. The main purpose of this study was to provide a comprehensive overview of relevant studies regarding the willingness to work in emergency and disaster situations, describe and classify the most important challenges and solutions, identifying knowledge gaps in the literature which could inform future research. In this Systematic Mapping Review required information was searched from PubMed, Scopus, the web","2021","07","09","Hum Resour Health","Human resources for health","Emergency condition; Health workforce; Mapping review; Retention; Willingness to work; Attitude of Health Personnel; COVID-19; Disasters; Health Personnel; Humans","Tahmazi Aghdam","Emir","Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran",NA
"32","34167560","10.1186/s12960-021-00622-y","A systematic mapping review of factors associated with willingness to work under emergency condition.","An effective response to an emergency situation relies on health care workers' preparedness. The main purpose of this study was to provide a comprehensive overview of relevant studies regarding the willingness to work in emergency and disaster situations, describe and classify the most important challenges and solutions, identifying knowledge gaps in the literature which could inform future research. In this Systematic Mapping Review required information was searched from PubMed, Scopus, the web","2021","07","09","Hum Resour Health","Human resources for health","Emergency condition; Health workforce; Mapping review; Retention; Willingness to work; Attitude of Health Personnel; COVID-19; Disasters; Health Personnel; Humans","Derakhshani","Naser","Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran",NA
"33","34167560","10.1186/s12960-021-00622-y","A systematic mapping review of factors associated with willingness to work under emergency condition.","An effective response to an emergency situation relies on health care workers' preparedness. The main purpose of this study was to provide a comprehensive overview of relevant studies regarding the willingness to work in emergency and disaster situations, describe and classify the most important challenges and solutions, identifying knowledge gaps in the literature which could inform future research. In this Systematic Mapping Review required information was searched from PubMed, Scopus, the web","2021","07","09","Hum Resour Health","Human resources for health","Emergency condition; Health workforce; Mapping review; Retention; Willingness to work; Attitude of Health Personnel; COVID-19; Disasters; Health Personnel; Humans","Sani'ee","Nadia","Department of Medical Librarianship and Information Sciences, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran",NA
"34","34167560","10.1186/s12960-021-00622-y","A systematic mapping review of factors associated with willingness to work under emergency condition.","An effective response to an emergency situation relies on health care workers' preparedness. The main purpose of this study was to provide a comprehensive overview of relevant studies regarding the willingness to work in emergency and disaster situations, describe and classify the most important challenges and solutions, identifying knowledge gaps in the literature which could inform future research. In this Systematic Mapping Review required information was searched from PubMed, Scopus, the web","2021","07","09","Hum Resour Health","Human resources for health","Emergency condition; Health workforce; Mapping review; Retention; Willingness to work; Attitude of Health Personnel; COVID-19; Disasters; Health Personnel; Humans","Sharifian","Sakineh","Nursing Care Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"35","34167560","10.1186/s12960-021-00622-y","A systematic mapping review of factors associated with willingness to work under emergency condition.","An effective response to an emergency situation relies on health care workers' preparedness. The main purpose of this study was to provide a comprehensive overview of relevant studies regarding the willingness to work in emergency and disaster situations, describe and classify the most important challenges and solutions, identifying knowledge gaps in the literature which could inform future research. In this Systematic Mapping Review required information was searched from PubMed, Scopus, the web","2021","07","09","Hum Resour Health","Human resources for health","Emergency condition; Health workforce; Mapping review; Retention; Willingness to work; Attitude of Health Personnel; COVID-19; Disasters; Health Personnel; Humans","Goharinezhad","Salime","Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Iran University of Medical Sciences, P.O. Box: 1449614535, Tehran, Iran. goharinezhad@gmail","goharinezhad@gmail.com"
"36","34167559","10.1186/s13019-021-01517-8","Video-assisted minimal access surgery for complicated mitral valve endocarditis, tricuspid valve insufficiency and progressive coronary disease after previous CABG - in the time of COVID-19: a case report.","The timing for heart surgery following cerebral embolization after cardiac valve vegetation is vital to postoperative recovery being uneventful, additionally Covid-19 may negatively affect the outcome. Minimally invasive methods and upgraded surgical instruments maximize the benefits of surgery also in complex cardiac revision cases with substantial perioperative risk. A 68 y.o. patient, 10 years after previous sternotomy for OPCAB was referred to cardiac surgery on the 10th postoperative day af","2021","07","13","J Cardiothorac Surg","Journal of cardiothoracic surgery","Cerebral septic embolism; Coronary revascularization; Covid-19; Minimally invasive video-assisted cardiac surgery; Valve endocarditis; Aged; COVID-19; Coronary Artery Bypass; Coronary Stenosis; Endocarditis; Humans; Male; Minimally Invasive Surgical Procedures; Mitral Valve; Pandemics; Postoperative Complications; Reoperation; SARS-CoV-2; Thoracotomy; Tricuspid Valve Insufficiency; Video-Assisted Surgery","Andrási","Terézia B","Department of Cardiac Surgery, Philipps University of Marburg, Baldingerstrasse 1, 35039, Marburg, Germany. terezia.andrasi@med.uni-marburg","terezia.andrasi@med.uni"
"37","34167559","10.1186/s13019-021-01517-8","Video-assisted minimal access surgery for complicated mitral valve endocarditis, tricuspid valve insufficiency and progressive coronary disease after previous CABG - in the time of COVID-19: a case report.","The timing for heart surgery following cerebral embolization after cardiac valve vegetation is vital to postoperative recovery being uneventful, additionally Covid-19 may negatively affect the outcome. Minimally invasive methods and upgraded surgical instruments maximize the benefits of surgery also in complex cardiac revision cases with substantial perioperative risk. A 68 y.o. patient, 10 years after previous sternotomy for OPCAB was referred to cardiac surgery on the 10th postoperative day af","2021","07","13","J Cardiothorac Surg","Journal of cardiothoracic surgery","Cerebral septic embolism; Coronary revascularization; Covid-19; Minimally invasive video-assisted cardiac surgery; Valve endocarditis; Aged; COVID-19; Coronary Artery Bypass; Coronary Stenosis; Endocarditis; Humans; Male; Minimally Invasive Surgical Procedures; Mitral Valve; Pandemics; Postoperative Complications; Reoperation; SARS-CoV-2; Thoracotomy; Tricuspid Valve Insufficiency; Video-Assisted Surgery","Abudureheman","Nunijiati","Department of Cardiac Surgery, Philipps University of Marburg, Baldingerstrasse 1, 35039, Marburg, Germany",NA
"38","34167559","10.1186/s13019-021-01517-8","Video-assisted minimal access surgery for complicated mitral valve endocarditis, tricuspid valve insufficiency and progressive coronary disease after previous CABG - in the time of COVID-19: a case report.","The timing for heart surgery following cerebral embolization after cardiac valve vegetation is vital to postoperative recovery being uneventful, additionally Covid-19 may negatively affect the outcome. Minimally invasive methods and upgraded surgical instruments maximize the benefits of surgery also in complex cardiac revision cases with substantial perioperative risk. A 68 y.o. patient, 10 years after previous sternotomy for OPCAB was referred to cardiac surgery on the 10th postoperative day af","2021","07","13","J Cardiothorac Surg","Journal of cardiothoracic surgery","Cerebral septic embolism; Coronary revascularization; Covid-19; Minimally invasive video-assisted cardiac surgery; Valve endocarditis; Aged; COVID-19; Coronary Artery Bypass; Coronary Stenosis; Endocarditis; Humans; Male; Minimally Invasive Surgical Procedures; Mitral Valve; Pandemics; Postoperative Complications; Reoperation; SARS-CoV-2; Thoracotomy; Tricuspid Valve Insufficiency; Video-Assisted Surgery","Glück","Alannah","Department of Cardiac Surgery, Philipps University of Marburg, Baldingerstrasse 1, 35039, Marburg, Germany",NA
"39","34167559","10.1186/s13019-021-01517-8","Video-assisted minimal access surgery for complicated mitral valve endocarditis, tricuspid valve insufficiency and progressive coronary disease after previous CABG - in the time of COVID-19: a case report.","The timing for heart surgery following cerebral embolization after cardiac valve vegetation is vital to postoperative recovery being uneventful, additionally Covid-19 may negatively affect the outcome. Minimally invasive methods and upgraded surgical instruments maximize the benefits of surgery also in complex cardiac revision cases with substantial perioperative risk. A 68 y.o. patient, 10 years after previous sternotomy for OPCAB was referred to cardiac surgery on the 10th postoperative day af","2021","07","13","J Cardiothorac Surg","Journal of cardiothoracic surgery","Cerebral septic embolism; Coronary revascularization; Covid-19; Minimally invasive video-assisted cardiac surgery; Valve endocarditis; Aged; COVID-19; Coronary Artery Bypass; Coronary Stenosis; Endocarditis; Humans; Male; Minimally Invasive Surgical Procedures; Mitral Valve; Pandemics; Postoperative Complications; Reoperation; SARS-CoV-2; Thoracotomy; Tricuspid Valve Insufficiency; Video-Assisted Surgery","Vondran","Maximilian","Department of Cardiac Surgery, Philipps University of Marburg, Baldingerstrasse 1, 35039, Marburg, Germany",NA
"40","34167559","10.1186/s13019-021-01517-8","Video-assisted minimal access surgery for complicated mitral valve endocarditis, tricuspid valve insufficiency and progressive coronary disease after previous CABG - in the time of COVID-19: a case report.","The timing for heart surgery following cerebral embolization after cardiac valve vegetation is vital to postoperative recovery being uneventful, additionally Covid-19 may negatively affect the outcome. Minimally invasive methods and upgraded surgical instruments maximize the benefits of surgery also in complex cardiac revision cases with substantial perioperative risk. A 68 y.o. patient, 10 years after previous sternotomy for OPCAB was referred to cardiac surgery on the 10th postoperative day af","2021","07","13","J Cardiothorac Surg","Journal of cardiothoracic surgery","Cerebral septic embolism; Coronary revascularization; Covid-19; Minimally invasive video-assisted cardiac surgery; Valve endocarditis; Aged; COVID-19; Coronary Artery Bypass; Coronary Stenosis; Endocarditis; Humans; Male; Minimally Invasive Surgical Procedures; Mitral Valve; Pandemics; Postoperative Complications; Reoperation; SARS-CoV-2; Thoracotomy; Tricuspid Valve Insufficiency; Video-Assisted Surgery","Dinges","Gerhard","Department of Anesthesiology and Intensive Care Medicine, Philipps University of Marburg, Marburg, Germany",NA
"41","34167559","10.1186/s13019-021-01517-8","Video-assisted minimal access surgery for complicated mitral valve endocarditis, tricuspid valve insufficiency and progressive coronary disease after previous CABG - in the time of COVID-19: a case report.","The timing for heart surgery following cerebral embolization after cardiac valve vegetation is vital to postoperative recovery being uneventful, additionally Covid-19 may negatively affect the outcome. Minimally invasive methods and upgraded surgical instruments maximize the benefits of surgery also in complex cardiac revision cases with substantial perioperative risk. A 68 y.o. patient, 10 years after previous sternotomy for OPCAB was referred to cardiac surgery on the 10th postoperative day af","2021","07","13","J Cardiothorac Surg","Journal of cardiothoracic surgery","Cerebral septic embolism; Coronary revascularization; Covid-19; Minimally invasive video-assisted cardiac surgery; Valve endocarditis; Aged; COVID-19; Coronary Artery Bypass; Coronary Stenosis; Endocarditis; Humans; Male; Minimally Invasive Surgical Procedures; Mitral Valve; Pandemics; Postoperative Complications; Reoperation; SARS-CoV-2; Thoracotomy; Tricuspid Valve Insufficiency; Video-Assisted Surgery","Talipov","Ildar","Department of Cardiac Surgery, Philipps University of Marburg, Baldingerstrasse 1, 35039, Marburg, Germany",NA
"42","34167559","10.1186/s13019-021-01517-8","Video-assisted minimal access surgery for complicated mitral valve endocarditis, tricuspid valve insufficiency and progressive coronary disease after previous CABG - in the time of COVID-19: a case report.","The timing for heart surgery following cerebral embolization after cardiac valve vegetation is vital to postoperative recovery being uneventful, additionally Covid-19 may negatively affect the outcome. Minimally invasive methods and upgraded surgical instruments maximize the benefits of surgery also in complex cardiac revision cases with substantial perioperative risk. A 68 y.o. patient, 10 years after previous sternotomy for OPCAB was referred to cardiac surgery on the 10th postoperative day af","2021","07","13","J Cardiothorac Surg","Journal of cardiothoracic surgery","Cerebral septic embolism; Coronary revascularization; Covid-19; Minimally invasive video-assisted cardiac surgery; Valve endocarditis; Aged; COVID-19; Coronary Artery Bypass; Coronary Stenosis; Endocarditis; Humans; Male; Minimally Invasive Surgical Procedures; Mitral Valve; Pandemics; Postoperative Complications; Reoperation; SARS-CoV-2; Thoracotomy; Tricuspid Valve Insufficiency; Video-Assisted Surgery","Rastan","Ardawan J","Department of Cardiac Surgery, Philipps University of Marburg, Baldingerstrasse 1, 35039, Marburg, Germany",NA
"43","34167549","10.1186/s13054-021-03642-1","Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study.",NA,"2021","07","07","Crit Care","Critical care (London, England)","Aged; COVID-19; Critical Illness; Feasibility Studies; Female; Humans; Male; Middle Aged; Psychological Tests; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors","Prével","Renaud","Medical Intensive Care Unit, CHU Bordeaux, 33000, Bordeaux, France. renaud.prevel@hotmail","renaud.prevel@hotmail.fr"
"44","34167549","10.1186/s13054-021-03642-1","Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study.",NA,"2021","07","07","Crit Care","Critical care (London, England)","Aged; COVID-19; Critical Illness; Feasibility Studies; Female; Humans; Male; Middle Aged; Psychological Tests; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors","Coelho","Julien","Service Universitaire Médecine du Sommeil, CHU Bordeaux, 33000, Bordeaux, France",NA
"45","34167549","10.1186/s13054-021-03642-1","Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study.",NA,"2021","07","07","Crit Care","Critical care (London, England)","Aged; COVID-19; Critical Illness; Feasibility Studies; Female; Humans; Male; Middle Aged; Psychological Tests; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors","Orieux","Arthur","Medical Intensive Care Unit, CHU Bordeaux, 33000, Bordeaux, France",NA
"46","34167549","10.1186/s13054-021-03642-1","Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study.",NA,"2021","07","07","Crit Care","Critical care (London, England)","Aged; COVID-19; Critical Illness; Feasibility Studies; Female; Humans; Male; Middle Aged; Psychological Tests; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors","Philip","Pierre","Service Universitaire Médecine du Sommeil, CHU Bordeaux, 33000, Bordeaux, France",NA
"47","34167549","10.1186/s13054-021-03642-1","Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study.",NA,"2021","07","07","Crit Care","Critical care (London, England)","Aged; COVID-19; Critical Illness; Feasibility Studies; Female; Humans; Male; Middle Aged; Psychological Tests; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors","Gruson","Didier","Medical Intensive Care Unit, CHU Bordeaux, 33000, Bordeaux, France",NA
"48","34167549","10.1186/s13054-021-03642-1","Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study.",NA,"2021","07","07","Crit Care","Critical care (London, England)","Aged; COVID-19; Critical Illness; Feasibility Studies; Female; Humans; Male; Middle Aged; Psychological Tests; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors","Bioulac","Stéphanie","Service Universitaire Médecine du Sommeil, CHU Bordeaux, 33000, Bordeaux, France",NA
"49","34167522","10.1186/s12910-021-00643-1","Principles for pandemics: COVID-19 and professional ethical guidance in England and Wales.","During the arrival of the COVID-19 pandemic, various professional ethical guidance was issued to (and for) health and social care professionals in England and Wales. Guidance can help to inform and support such professionals and their patients, clients and service users, but a plethora of guidance risked information overload, confusion, and inconsistency. During the early months of the pandemic, we undertook a rapid review, asking: what are the principles adopted by professional ethical guidance","2021","07","01","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical ethics; Coronavirus; Ethical guidance; Professional guidance","Smith","Helen","Centre for Ethics in Medicine, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK",NA
"50","34167522","10.1186/s12910-021-00643-1","Principles for pandemics: COVID-19 and professional ethical guidance in England and Wales.","During the arrival of the COVID-19 pandemic, various professional ethical guidance was issued to (and for) health and social care professionals in England and Wales. Guidance can help to inform and support such professionals and their patients, clients and service users, but a plethora of guidance risked information overload, confusion, and inconsistency. During the early months of the pandemic, we undertook a rapid review, asking: what are the principles adopted by professional ethical guidance","2021","07","01","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical ethics; Coronavirus; Ethical guidance; Professional guidance","Coulson-Smith","Peta","Clinical Ethics and Law at Southampton (CELS), Faculty of Medicine, University of Southampton, MP127, Room 2013, Southampton, UK",NA
"51","34167522","10.1186/s12910-021-00643-1","Principles for pandemics: COVID-19 and professional ethical guidance in England and Wales.","During the arrival of the COVID-19 pandemic, various professional ethical guidance was issued to (and for) health and social care professionals in England and Wales. Guidance can help to inform and support such professionals and their patients, clients and service users, but a plethora of guidance risked information overload, confusion, and inconsistency. During the early months of the pandemic, we undertook a rapid review, asking: what are the principles adopted by professional ethical guidance","2021","07","01","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical ethics; Coronavirus; Ethical guidance; Professional guidance","Kennedy","Mari-Rose","Centre for Ethics in Medicine, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK",NA
"52","34167522","10.1186/s12910-021-00643-1","Principles for pandemics: COVID-19 and professional ethical guidance in England and Wales.","During the arrival of the COVID-19 pandemic, various professional ethical guidance was issued to (and for) health and social care professionals in England and Wales. Guidance can help to inform and support such professionals and their patients, clients and service users, but a plethora of guidance risked information overload, confusion, and inconsistency. During the early months of the pandemic, we undertook a rapid review, asking: what are the principles adopted by professional ethical guidance","2021","07","01","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical ethics; Coronavirus; Ethical guidance; Professional guidance","Birchley","Giles","Centre for Ethics in Medicine, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK",NA
"53","34167522","10.1186/s12910-021-00643-1","Principles for pandemics: COVID-19 and professional ethical guidance in England and Wales.","During the arrival of the COVID-19 pandemic, various professional ethical guidance was issued to (and for) health and social care professionals in England and Wales. Guidance can help to inform and support such professionals and their patients, clients and service users, but a plethora of guidance risked information overload, confusion, and inconsistency. During the early months of the pandemic, we undertook a rapid review, asking: what are the principles adopted by professional ethical guidance","2021","07","01","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical ethics; Coronavirus; Ethical guidance; Professional guidance","Ives","Jonathan","Centre for Ethics in Medicine, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK",NA
"54","34167522","10.1186/s12910-021-00643-1","Principles for pandemics: COVID-19 and professional ethical guidance in England and Wales.","During the arrival of the COVID-19 pandemic, various professional ethical guidance was issued to (and for) health and social care professionals in England and Wales. Guidance can help to inform and support such professionals and their patients, clients and service users, but a plethora of guidance risked information overload, confusion, and inconsistency. During the early months of the pandemic, we undertook a rapid review, asking: what are the principles adopted by professional ethical guidance","2021","07","01","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical ethics; Coronavirus; Ethical guidance; Professional guidance","Huxtable","Richard","Centre for Ethics in Medicine, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. r.huxtable@bristol.ac","r.huxtable@bristol.ac.uk"
"55","34167515","10.1186/s12889-021-11258-x","A pre-COVID-19 assessment of aspects of the school health programme in some selected Nigerian primary schools: implications for school re-opening during the COVID-19 pandemic in developing country contexts.","Following the COVID-19 pandemic, school closures were part of the global public health response to limit community spread of the virus. In recent times, there has been an emphasis on safe school re-opening. This concept is likely to differ between developed and developing country settings. There are however no published studies on barriers hindering safe school re-opening within developing country contexts. This study evaluates aspects of the school health program (SHP) in some selected Nigerian","2021","06","30","BMC Public Health","BMC public health","COVID-19; Developing countries; Nigeria; Pandemic; School health program; COVID-19; Cross-Sectional Studies; Developing Countries; Humans; Nigeria; Pandemics; SARS-CoV-2; Schools","Sanni","Usman A","Department of Paediatrics, Federal Medical Centre, Birnin-Kebbi, Kebbi, Nigeria",NA
"56","34167515","10.1186/s12889-021-11258-x","A pre-COVID-19 assessment of aspects of the school health programme in some selected Nigerian primary schools: implications for school re-opening during the COVID-19 pandemic in developing country contexts.","Following the COVID-19 pandemic, school closures were part of the global public health response to limit community spread of the virus. In recent times, there has been an emphasis on safe school re-opening. This concept is likely to differ between developed and developing country settings. There are however no published studies on barriers hindering safe school re-opening within developing country contexts. This study evaluates aspects of the school health program (SHP) in some selected Nigerian","2021","06","30","BMC Public Health","BMC public health","COVID-19; Developing countries; Nigeria; Pandemic; School health program; COVID-19; Cross-Sectional Studies; Developing Countries; Humans; Nigeria; Pandemics; SARS-CoV-2; Schools","Offiong","Uduak M","Department of Paediatrics, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria",NA
"57","34167515","10.1186/s12889-021-11258-x","A pre-COVID-19 assessment of aspects of the school health programme in some selected Nigerian primary schools: implications for school re-opening during the COVID-19 pandemic in developing country contexts.","Following the COVID-19 pandemic, school closures were part of the global public health response to limit community spread of the virus. In recent times, there has been an emphasis on safe school re-opening. This concept is likely to differ between developed and developing country settings. There are however no published studies on barriers hindering safe school re-opening within developing country contexts. This study evaluates aspects of the school health program (SHP) in some selected Nigerian","2021","06","30","BMC Public Health","BMC public health","COVID-19; Developing countries; Nigeria; Pandemic; School health program; COVID-19; Cross-Sectional Studies; Developing Countries; Humans; Nigeria; Pandemics; SARS-CoV-2; Schools","Anigilaje","Emmanuel A","Department of Paediatrics, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria",NA
"58","34167515","10.1186/s12889-021-11258-x","A pre-COVID-19 assessment of aspects of the school health programme in some selected Nigerian primary schools: implications for school re-opening during the COVID-19 pandemic in developing country contexts.","Following the COVID-19 pandemic, school closures were part of the global public health response to limit community spread of the virus. In recent times, there has been an emphasis on safe school re-opening. This concept is likely to differ between developed and developing country settings. There are however no published studies on barriers hindering safe school re-opening within developing country contexts. This study evaluates aspects of the school health program (SHP) in some selected Nigerian","2021","06","30","BMC Public Health","BMC public health","COVID-19; Developing countries; Nigeria; Pandemic; School health program; COVID-19; Cross-Sectional Studies; Developing Countries; Humans; Nigeria; Pandemics; SARS-CoV-2; Schools","Airede","Kareem I","Department of Paediatrics, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria",NA
"59","34167515","10.1186/s12889-021-11258-x","A pre-COVID-19 assessment of aspects of the school health programme in some selected Nigerian primary schools: implications for school re-opening during the COVID-19 pandemic in developing country contexts.","Following the COVID-19 pandemic, school closures were part of the global public health response to limit community spread of the virus. In recent times, there has been an emphasis on safe school re-opening. This concept is likely to differ between developed and developing country settings. There are however no published studies on barriers hindering safe school re-opening within developing country contexts. This study evaluates aspects of the school health program (SHP) in some selected Nigerian","2021","06","30","BMC Public Health","BMC public health","COVID-19; Developing countries; Nigeria; Pandemic; School health program; COVID-19; Cross-Sectional Studies; Developing Countries; Humans; Nigeria; Pandemics; SARS-CoV-2; Schools","Imam","Abdulazeez","Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, P.O. Box 273, Fajara, Gambia. abdulimam2001@yahoo","abdulimam2001@yahoo.com"
"60","34167499","10.1186/s12889-021-11054-7","Disparity in the quality of COVID-19 data reporting across India.","Transparent and accessible reporting of COVID-19 data is critical for public health efforts. Each Indian state has its own mechanism for reporting COVID-19 data, and the quality of their reporting has not been systematically evaluated. We present a comprehensive assessment of the quality of COVID-19 data reporting done by the Indian state governments between 19 May and 1 June, 2020. We designed a semi-quantitative framework with 45 indicators to assess the quality of COVID-19 data reporting. The","2021","06","30","BMC Public Health","BMC public health","COVID-19; Coronavirus; Data reporting quality framework; India; Pandemic data reporting; COVID-19; Humans; India; Pandemics; Research Design; SARS-CoV-2","Vasudevan","Varun","Institute for Computational &amp","devan@stanford.edu"
"61","34167499","10.1186/s12889-021-11054-7","Disparity in the quality of COVID-19 data reporting across India.","Transparent and accessible reporting of COVID-19 data is critical for public health efforts. Each Indian state has its own mechanism for reporting COVID-19 data, and the quality of their reporting has not been systematically evaluated. We present a comprehensive assessment of the quality of COVID-19 data reporting done by the Indian state governments between 19 May and 1 June, 2020. We designed a semi-quantitative framework with 45 indicators to assess the quality of COVID-19 data reporting. The","2021","06","30","BMC Public Health","BMC public health","COVID-19; Coronavirus; Data reporting quality framework; India; Pandemic data reporting; COVID-19; Humans; India; Pandemics; Research Design; SARS-CoV-2","Gnanasekaran","Abeynaya","Institute for Computational &amp",NA
"62","34167499","10.1186/s12889-021-11054-7","Disparity in the quality of COVID-19 data reporting across India.","Transparent and accessible reporting of COVID-19 data is critical for public health efforts. Each Indian state has its own mechanism for reporting COVID-19 data, and the quality of their reporting has not been systematically evaluated. We present a comprehensive assessment of the quality of COVID-19 data reporting done by the Indian state governments between 19 May and 1 June, 2020. We designed a semi-quantitative framework with 45 indicators to assess the quality of COVID-19 data reporting. The","2021","06","30","BMC Public Health","BMC public health","COVID-19; Coronavirus; Data reporting quality framework; India; Pandemic data reporting; COVID-19; Humans; India; Pandemics; Research Design; SARS-CoV-2","Sankar","Varsha","Independent Researcher, Palo Alto, California, USA",NA
"63","34167499","10.1186/s12889-021-11054-7","Disparity in the quality of COVID-19 data reporting across India.","Transparent and accessible reporting of COVID-19 data is critical for public health efforts. Each Indian state has its own mechanism for reporting COVID-19 data, and the quality of their reporting has not been systematically evaluated. We present a comprehensive assessment of the quality of COVID-19 data reporting done by the Indian state governments between 19 May and 1 June, 2020. We designed a semi-quantitative framework with 45 indicators to assess the quality of COVID-19 data reporting. The","2021","06","30","BMC Public Health","BMC public health","COVID-19; Coronavirus; Data reporting quality framework; India; Pandemic data reporting; COVID-19; Humans; India; Pandemics; Research Design; SARS-CoV-2","Vasudevan","Siddarth A","Independent Researcher, Neuchatel, Switzerland",NA
"64","34167499","10.1186/s12889-021-11054-7","Disparity in the quality of COVID-19 data reporting across India.","Transparent and accessible reporting of COVID-19 data is critical for public health efforts. Each Indian state has its own mechanism for reporting COVID-19 data, and the quality of their reporting has not been systematically evaluated. We present a comprehensive assessment of the quality of COVID-19 data reporting done by the Indian state governments between 19 May and 1 June, 2020. We designed a semi-quantitative framework with 45 indicators to assess the quality of COVID-19 data reporting. The","2021","06","30","BMC Public Health","BMC public health","COVID-19; Coronavirus; Data reporting quality framework; India; Pandemic data reporting; COVID-19; Humans; India; Pandemics; Research Design; SARS-CoV-2","Zou","James","Department of Biomedical Data Science, Stanford University, Palo Alto, California, USA",NA
"65","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Leal Filho","Walter","European School of Sustainability Science and Research, Hamburg University of Applied Sciences, Hamburg, Germany. walter.leal2@haw-hamburg",NA
"66","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Wall","Tony","International Centre for Thriving, University of Chester, Chester, CH1 4BJ, UK",NA
"67","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Rayman-Bacchus","Lez","University of Winchester Business School, Winchester, SO22 5HT, UK",NA
"68","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Mifsud","Mark","Centre for Environmental and Education Research, University of Malta, Msida, Malta",NA
"69","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Pritchard","Diana J","Centre for Learning Excellence, University of Bedfordshire, Luton, UK",NA
"70","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Lovren","Violeta Orlovic","Faculty of Philosophy, University of Belgrade, Cika Ljubina 18/20, Belgrade, 11 000, Serbia. violeta.orlovic@f.bg.ac","violeta.orlovic@f.bg.ac.rs"
"71","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Farinha","Carla","CENSE - Center for Environmental and Sustainability Research, School of Science and Technology, NOVA University Lisbon, Campus da Caparica, 2829-516, Caparica, Portugal",NA
"72","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Petrovic","Danijela S","Faculty of Philosophy, University of Belgrade, Cika Ljubina 18/20, Belgrade, 11 000, Serbia",NA
"73","34167494","10.1186/s12889-021-11040-z","Impacts of COVID-19 and social isolation on academic staff and students at universities: a cross-sectional study.","""The impacts of the Coronavirus Disease 2019 (COVID-19) pandemic and the shutdown it triggered at universities across the world, led to a great degree of social isolation among university staff and students. The aim of this study was to identify the perceived consequences of this on staff and their work and on students and their studies at universities. The study used a variety of methods, which involved an on-line survey on the influences of social isolation using a non-probability sampling. Mo","2021","06","30","BMC Public Health","BMC public health","Academic staff; COVID-19; Social isolation; Students; University; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; SARS-CoV-2; Social Isolation; Students; Surveys and Questionnaires; Universities","Balogun","Abdul-Lateef","Geospatial Analysis and Modelling (GAM) Research Laboratory, Universiti Teknologi PETRONAS (UTP), 32610, Seri Iskandar, Perak, Malaysia",NA
"74","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Martindale","Anne-Marie","Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England. a.martindale@liverpool.ac","a.martindale@liverpool.ac.uk"
"75","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Pilbeam","Caitlin","Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England",NA
"76","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Mableson","Hayley","Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England",NA
"77","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Tonkin-Crine","Sarah","Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England",NA
"78","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Atkinson","Paul","Institute of Population Health, University of Liverpool, Liverpool, England",NA
"79","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Borek","Aleksandra","Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England",NA
"80","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Lant","Suzannah","Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England",NA
"81","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Gobat","Nina","Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England",NA
"82","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Solomon","Tom","Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England",NA
"83","34167491","10.1186/s12889-021-11285-8","Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England.","As COVID-19 death rates have risen and health-care systems have experienced increased demand, national testing strategies have come under scrutiny. Utilising qualitative interview data from a larger COVID-19 study, this paper provides insights into influences on and the enactment of national COVID-19 testing strategies for health care workers (HCWs) in English NHS settings during wave one of the COVID-19 pandemic (March-August 2020). Through the findings we aim to inform learning about COVID-19 ","2021","06","30","BMC Public Health","BMC public health","COVID-19; Health care settings; Healthcare workers; NHS; Pandemic; Semi-structured interviews; Testing; UK health policy; COVID-19; COVID-19 Testing; England; Health Personnel; Humans; Pandemics; Policy; SARS-CoV-2; State Medicine","Sheard","Sally","Institute of Population Health, University of Liverpool, Liverpool, England",NA
"84","34167485","10.1186/s12879-021-06268-4","Archiving time series sewage samples as biological records of built environments.","This commentary encourages the regular archiving of nucleic-acid-stabilized serial samples of wastewaters and/or sewage. Stabilized samples would facilitate retrospective reconstitution of built environments' biological fluids. Biological time capsules would allow retrospective searches for nucleic acids from viruses such as SARS-CoV-2. Current resources for testing need not be diverted if samples are saved in case they become important in the future. Systematic storage would facilitate investig","2021","06","30","BMC Infect Dis","BMC infectious diseases","Biological diaries; Covid-19; Historical epidemiology; Public health; SARS-CoV-2; Sample archiving; Sewage; Virus; Wastewater; Built Environment; COVID-19; Humans; Retrospective Studies; SARS-CoV-2; Sewage; Waste Water","Thaler","David S","Biozentrum, University of Basel, CH-4056, Basel, Switzerland. david.thaler@unibas","david.thaler@unibas.ch"
"85","34167485","10.1186/s12879-021-06268-4","Archiving time series sewage samples as biological records of built environments.","This commentary encourages the regular archiving of nucleic-acid-stabilized serial samples of wastewaters and/or sewage. Stabilized samples would facilitate retrospective reconstitution of built environments' biological fluids. Biological time capsules would allow retrospective searches for nucleic acids from viruses such as SARS-CoV-2. Current resources for testing need not be diverted if samples are saved in case they become important in the future. Systematic storage would facilitate investig","2021","06","30","BMC Infect Dis","BMC infectious diseases","Biological diaries; Covid-19; Historical epidemiology; Public health; SARS-CoV-2; Sample archiving; Sewage; Virus; Wastewater; Built Environment; COVID-19; Humans; Retrospective Studies; SARS-CoV-2; Sewage; Waste Water","Sakmar","Thomas P","Laboratory of Chemical Biology and Signal Transduction, Rockefeller University, New York, NY, USA",NA
"86","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Zhang","Tangqin","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China",NA
"87","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Chen","Chu","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China",NA
"88","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Xu","Xiangjun","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China",NA
"89","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Xu","Junfeng","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China",NA
"90","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Yang","Ke","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China",NA
"91","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Xu","Youqing","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China",NA
"92","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Yuan","Lili","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China",NA
"93","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Yang","Qian","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China",NA
"94","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Huang","Xianjun","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China. doctorhuangxj@hotmail","doctorhuangxj@hotmail.com"
"95","34167467","10.1186/s12883-021-02262-0","Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.","The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods. Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April ","2021","07","05","BMC Neurol","BMC neurology","Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic; Aged; Aged, 80 and over; Brain Ischemia; COVID-19; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Reperfusion; Retrospective Studies; Treatment Outcome","Zhou","Zhiming","Department of Neurology, Yijishan Hospital, Wannan Medical College, 2# Zheshan West Road, Wuhu, 241001, Anhui Province, China. neuro_depar@hotmail","depar@hotmail.com"
"96","34167463","10.1186/s12879-021-06300-7","Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.","Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients. We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis","2021","06","30","BMC Infect Dis","BMC infectious diseases","COVID-19; Mortality; Risk factors; SARS-COV-2; APACHE; Adult; COVID-19; Case-Control Studies; Critical Illness; Hospital Mortality; Humans; Inflammation; Lymphopenia; Male; Middle Aged; Organ Dysfunction Scores; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; SARS-CoV-2","Gao","Jinghua","The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510010, China",NA
"97","34167463","10.1186/s12879-021-06300-7","Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.","Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients. We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis","2021","06","30","BMC Infect Dis","BMC infectious diseases","COVID-19; Mortality; Risk factors; SARS-COV-2; APACHE; Adult; COVID-19; Case-Control Studies; Critical Illness; Hospital Mortality; Humans; Inflammation; Lymphopenia; Male; Middle Aged; Organ Dysfunction Scores; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; SARS-CoV-2","Zhong","Li","Department of Critical Care Medicine, The First Affiliated Hospital, Guizhou University of Chinese Medicine, Guiyang, 550001, China",NA
"98","34167463","10.1186/s12879-021-06300-7","Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.","Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients. We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis","2021","06","30","BMC Infect Dis","BMC infectious diseases","COVID-19; Mortality; Risk factors; SARS-COV-2; APACHE; Adult; COVID-19; Case-Control Studies; Critical Illness; Hospital Mortality; Humans; Inflammation; Lymphopenia; Male; Middle Aged; Organ Dysfunction Scores; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; SARS-CoV-2","Wu","Ming","Department of Critical Care Medicine and Infection Prevention and Control, Health Science Center, The Second People's Hospital of Shenzhen &amp",NA
"99","34167463","10.1186/s12879-021-06300-7","Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.","Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients. We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis","2021","06","30","BMC Infect Dis","BMC infectious diseases","COVID-19; Mortality; Risk factors; SARS-COV-2; APACHE; Adult; COVID-19; Case-Control Studies; Critical Illness; Hospital Mortality; Humans; Inflammation; Lymphopenia; Male; Middle Aged; Organ Dysfunction Scores; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; SARS-CoV-2","Ji","Jingjing","Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China",NA
"100","34167463","10.1186/s12879-021-06300-7","Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.","Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients. We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis","2021","06","30","BMC Infect Dis","BMC infectious diseases","COVID-19; Mortality; Risk factors; SARS-COV-2; APACHE; Adult; COVID-19; Case-Control Studies; Critical Illness; Hospital Mortality; Humans; Inflammation; Lymphopenia; Male; Middle Aged; Organ Dysfunction Scores; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; SARS-CoV-2","Liu","Zheying","Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China",NA
"101","34167463","10.1186/s12879-021-06300-7","Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.","Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients. We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis","2021","06","30","BMC Infect Dis","BMC infectious diseases","COVID-19; Mortality; Risk factors; SARS-COV-2; APACHE; Adult; COVID-19; Case-Control Studies; Critical Illness; Hospital Mortality; Humans; Inflammation; Lymphopenia; Male; Middle Aged; Organ Dysfunction Scores; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; SARS-CoV-2","Wang","Conglin","Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China",NA
"102","34167463","10.1186/s12879-021-06300-7","Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.","Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients. We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis","2021","06","30","BMC Infect Dis","BMC infectious diseases","COVID-19; Mortality; Risk factors; SARS-COV-2; APACHE; Adult; COVID-19; Case-Control Studies; Critical Illness; Hospital Mortality; Humans; Inflammation; Lymphopenia; Male; Middle Aged; Organ Dysfunction Scores; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; SARS-CoV-2","Xie","Qifeng","Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China",NA
"103","34167463","10.1186/s12879-021-06300-7","Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.","Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients. We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis","2021","06","30","BMC Infect Dis","BMC infectious diseases","COVID-19; Mortality; Risk factors; SARS-COV-2; APACHE; Adult; COVID-19; Case-Control Studies; Critical Illness; Hospital Mortality; Humans; Inflammation; Lymphopenia; Male; Middle Aged; Organ Dysfunction Scores; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; SARS-CoV-2","Liu","Zhifeng","The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510010, China. Zhifengliu7797@163","Zhifengliu7797@163.com"
"104","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Sanjay","Srinivasan","Department of Uvea and Ocular Immunology, Narayana Nethralaya, Bengaluru, India",NA
"105","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Leo","Seo Wei","Dr Leo Adult &amp",NA
"106","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Au Eong","Kah-Guan","International Eye Cataract Retina Center, Mount Elizabeth Medical Center and Farrer Park Medical Center, Singapore",NA
"107","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Adriono","Gitalisa Andayani","Department of Ophthalmology, Faculty of Medicine Universitas Indonesia, Mangunkusumo Hospital, Jakarta, Indonesia",NA
"108","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Fong","Kenneth Cs","OasisEye Specialists, Kuala Lumpur, Malaysia",NA
"109","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Anand","Kartik","Great Plains Health Callahan Cancer Center, University of Nebraska, North Platte, Nebraska, USA",NA
"110","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Kadarisman","Rumita S","Aini Eye Clinic, Jakarta Hospital, Jakarta, Indonesia",NA
"111","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Granet","David B","Ratner Children's Eye Center, Shiley Eye Institute, University of California, San Diego, USA",NA
"112","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Mahendradas","Padmamalini","Department of Uvea and Ocular Immunology, Narayana Nethralaya, Bengaluru, India",NA
"113","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Shetty","Rohit","Department of Cornea and Refractive Services, Narayana Nethralaya, Bengaluru, India",NA
"114","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Souza","Sharon D","Department of Cornea and Refractive Services, Narayana Nethralaya, Bengaluru, India",NA
"115","34167454","10.1080/09286586.2021.1934037","Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.","Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs.Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp ListServ17.0 (for pediatric ophthalmologists), WeChat (China) and ophthalmology associations (","2021","06","25","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID19; PPE; ophthalmic surgery; outpatient consultations; telehealth","Iyer","Swaminathan P","Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA",NA
"116","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Richardson","Edward","Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut, USA",NA
"117","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","García-Bernal","David","Department of Medicine, Stem Cell Transplant and Cell Therapy Unit, IMIB-Arrixaca, Virgen De La Arrixaca University Hospital, University of Murcia, Murcia, Spain",NA
"118","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Calabretta","Eleonora","Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy",NA
"119","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Jara","Rubén","Intensive Care Unit, Virgen De La Arrixaca University Hospital, University of Murcia, Murcia, Spain",NA
"120","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Palomo","Marta","Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain",NA
"121","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Baron","Rebecca M","Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"122","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Yanik","Gregory","Department of Pediatrics, Blood and Marrow Transplantation Program, University of Michigan, Ann Arbor, MI, USA",NA
"123","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Fareed","Jawed","Department of Molecular Pharmacology and Therapeutics, Hemostasis and Thrombosis Research Laboratories, Loyola University Medical Center, Chicago, Illinois, USA",NA
"124","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Vlodavsky","Israel","Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel",NA
"125","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Iacobelli","Massimo","Techitra S.r.l., Milan, Italy",NA
"126","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Díaz-Ricart","Maribel","Barcelona Endothelium Team, Barcelona, Spain",NA
"127","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Richardson","Paul G","Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut, USA",NA
"128","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Carlo-Stella","Carmelo","Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut, USA",NA
"129","34167431","10.1080/14728222.2021.1944101","Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.","Defibrotide (DF) is a polyribonucleotide with antithrombotic, pro-fibrinolytic, and anti-inflammatory effects on endothelium. These effects and the established safety of DF present DF as a strong candidate to treat viral and post-infectious syndromes involving endothelial dysfunction. We discuss DF and other therapeutic agents that have the potential to target endothelial components of pathogenesis in viral and post-infectious syndromes. We introduce defibrotide (DF), describe its mechanisms of ","2021","06","25","Expert Opin Ther Targets","Expert opinion on therapeutic targets","COVID-19; Defibrotide; Ebola; complement cascade; coronavirus; endothelial dysfunction; influenza A; viral hemorrhagic fever","Moraleda","Jose M","Department of Medicine, Stem Cell Transplant and Cell Therapy Unit, IMIB-Arrixaca, Virgen De La Arrixaca University Hospital, University of Murcia, Murcia, Spain",NA
"130","34167429","10.1080/09540261.2021.1901669","Gun purchasing behaviours during the initial phase of the COVID-19 pandemic, March to mid-July 2020.","We sought to characterize gun and ammunition purchasing during the initial phase of the COVID-19 pandemic using a nationally representative sample of U.S. adults. We fielded a survey using NORC's Amerispeak Panel between 7 and 22 July 2020 (survey completion rate = 91.1%, N = 1337). We used survey-weighted data to calculate the proportion of adults who purchased a gun during this time period and types of guns and amount of ammunition purchased. Between March and mid-July 2020, 6% of adult","2021","06","25","Int Rev Psychiatry","International review of psychiatry (Abingdon, England)","COVID-19; firearms; public opinion","Crifasi","Cassandra K","Department of Health Policy and Management, Center for Gun Violence Prevention and Policy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"131","34167429","10.1080/09540261.2021.1901669","Gun purchasing behaviours during the initial phase of the COVID-19 pandemic, March to mid-July 2020.","We sought to characterize gun and ammunition purchasing during the initial phase of the COVID-19 pandemic using a nationally representative sample of U.S. adults. We fielded a survey using NORC's Amerispeak Panel between 7 and 22 July 2020 (survey completion rate = 91.1%, N = 1337). We used survey-weighted data to calculate the proportion of adults who purchased a gun during this time period and types of guns and amount of ammunition purchased. Between March and mid-July 2020, 6% of adult","2021","06","25","Int Rev Psychiatry","International review of psychiatry (Abingdon, England)","COVID-19; firearms; public opinion","Ward","Julie A","Department of Health Policy and Management, Center for Gun Violence Prevention and Policy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"132","34167429","10.1080/09540261.2021.1901669","Gun purchasing behaviours during the initial phase of the COVID-19 pandemic, March to mid-July 2020.","We sought to characterize gun and ammunition purchasing during the initial phase of the COVID-19 pandemic using a nationally representative sample of U.S. adults. We fielded a survey using NORC's Amerispeak Panel between 7 and 22 July 2020 (survey completion rate = 91.1%, N = 1337). We used survey-weighted data to calculate the proportion of adults who purchased a gun during this time period and types of guns and amount of ammunition purchased. Between March and mid-July 2020, 6% of adult","2021","06","25","Int Rev Psychiatry","International review of psychiatry (Abingdon, England)","COVID-19; firearms; public opinion","McGinty","Emma E","Department of Health Policy and Management, Center for Gun Violence Prevention and Policy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"133","34167429","10.1080/09540261.2021.1901669","Gun purchasing behaviours during the initial phase of the COVID-19 pandemic, March to mid-July 2020.","We sought to characterize gun and ammunition purchasing during the initial phase of the COVID-19 pandemic using a nationally representative sample of U.S. adults. We fielded a survey using NORC's Amerispeak Panel between 7 and 22 July 2020 (survey completion rate = 91.1%, N = 1337). We used survey-weighted data to calculate the proportion of adults who purchased a gun during this time period and types of guns and amount of ammunition purchased. Between March and mid-July 2020, 6% of adult","2021","06","25","Int Rev Psychiatry","International review of psychiatry (Abingdon, England)","COVID-19; firearms; public opinion","Webster","Daniel W","Department of Health Policy and Management, Center for Gun Violence Prevention and Policy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"134","34167429","10.1080/09540261.2021.1901669","Gun purchasing behaviours during the initial phase of the COVID-19 pandemic, March to mid-July 2020.","We sought to characterize gun and ammunition purchasing during the initial phase of the COVID-19 pandemic using a nationally representative sample of U.S. adults. We fielded a survey using NORC's Amerispeak Panel between 7 and 22 July 2020 (survey completion rate = 91.1%, N = 1337). We used survey-weighted data to calculate the proportion of adults who purchased a gun during this time period and types of guns and amount of ammunition purchased. Between March and mid-July 2020, 6% of adult","2021","06","25","Int Rev Psychiatry","International review of psychiatry (Abingdon, England)","COVID-19; firearms; public opinion","Barry","Colleen L","Department of Health Policy and Management, Center for Gun Violence Prevention and Policy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"135","34167400","10.1177/21650799211016906","A Quality Improvement Project to Improve Influenza Vaccination Rates Among Employees at an Onsite Employer-Based Health Clinic.","In the United States, millions of people contract the flu each year. Immunization has been shown to provide the best protection against the flu. Increasing flu vaccination rates can reduce the number of patients who get the flu and seek care for non-specific symptoms thus making detection of the coronavirus more efficient. A quality improvement project was implemented to increase the number of influenza vaccines received by employees at an onsite employer-based health clinic. Anonymous pre- and ","2021","06","25","Workplace Health Saf","Workplace health &amp; safety","coronavirus; employees; flu vaccine; influenza; workplace","Landwehr","Karen","University of Cincinnati",NA
"136","34167400","10.1177/21650799211016906","A Quality Improvement Project to Improve Influenza Vaccination Rates Among Employees at an Onsite Employer-Based Health Clinic.","In the United States, millions of people contract the flu each year. Immunization has been shown to provide the best protection against the flu. Increasing flu vaccination rates can reduce the number of patients who get the flu and seek care for non-specific symptoms thus making detection of the coronavirus more efficient. A quality improvement project was implemented to increase the number of influenza vaccines received by employees at an onsite employer-based health clinic. Anonymous pre- and ","2021","06","25","Workplace Health Saf","Workplace health &amp; safety","coronavirus; employees; flu vaccine; influenza; workplace","Trees","W Jeff","University of Cincinnati",NA
"137","34167400","10.1177/21650799211016906","A Quality Improvement Project to Improve Influenza Vaccination Rates Among Employees at an Onsite Employer-Based Health Clinic.","In the United States, millions of people contract the flu each year. Immunization has been shown to provide the best protection against the flu. Increasing flu vaccination rates can reduce the number of patients who get the flu and seek care for non-specific symptoms thus making detection of the coronavirus more efficient. A quality improvement project was implemented to increase the number of influenza vaccines received by employees at an onsite employer-based health clinic. Anonymous pre- and ","2021","06","25","Workplace Health Saf","Workplace health &amp; safety","coronavirus; employees; flu vaccine; influenza; workplace","Reutman","Susan","University of Cincinnati",NA
"138","34167378","10.1177/15569845211011459","Impact of the Coronavirus Disease 2019 Pandemic on Cardiac Surgical Education in North America.","We report the impact of the coronavirus disease 2019 (COVID-19) pandemic on cardiac surgery trainee education in North America. A survey was sent to participating academic adult cardiac surgery centers in North America. Data regarding the effect of COVID-19 on cardiac surgery training were analyzed. Responses were received from 53 academic institutions with diverse geographic distribution. Cardiac surgery trainee re-deployment to alternative clinical duties peaked at the height of the pandemic. ","2021","06","25","Innovations (Phila)","Innovations (Philadelphia, Pa.)","cardiac surgery; coronavirus disease 2019; education; training","Luc","Jessica G Y","66 Division of Cardiovascular Surgery, University of British Columbia, Vancouver, BC, Canada",NA
"139","34167378","10.1177/15569845211011459","Impact of the Coronavirus Disease 2019 Pandemic on Cardiac Surgical Education in North America.","We report the impact of the coronavirus disease 2019 (COVID-19) pandemic on cardiac surgery trainee education in North America. A survey was sent to participating academic adult cardiac surgery centers in North America. Data regarding the effect of COVID-19 on cardiac surgery training were analyzed. Responses were received from 53 academic institutions with diverse geographic distribution. Cardiac surgery trainee re-deployment to alternative clinical duties peaked at the height of the pandemic. ","2021","06","25","Innovations (Phila)","Innovations (Philadelphia, Pa.)","cardiac surgery; coronavirus disease 2019; education; training","Nguyen","Tom C","Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center Houston, McGovern Medical School, TX, USA",NA
"140","34167378","10.1177/15569845211011459","Impact of the Coronavirus Disease 2019 Pandemic on Cardiac Surgical Education in North America.","We report the impact of the coronavirus disease 2019 (COVID-19) pandemic on cardiac surgery trainee education in North America. A survey was sent to participating academic adult cardiac surgery centers in North America. Data regarding the effect of COVID-19 on cardiac surgery training were analyzed. Responses were received from 53 academic institutions with diverse geographic distribution. Cardiac surgery trainee re-deployment to alternative clinical duties peaked at the height of the pandemic. ","2021","06","25","Innovations (Phila)","Innovations (Philadelphia, Pa.)","cardiac surgery; coronavirus disease 2019; education; training","Ad","Niv","264 Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD, USA",NA
"141","34167356","10.1177/01455613211028091","ENT Telephone Clinics During the Coronavirus Pandemic: An Analysis of 400 Telephone Consultations at a District General Hospital.","The COVID-19 pandemic led to the introduction of telephone consultations in order to provide specialist health care remotely. This study analyses the outcomes of ear, nose, and throat (ENT) telephone consultations. Retrospective analysis was undertaken of 400 ENT telephone consultations. All 2-week-wait neck or face lump patients underwent imaging and 78% were successfully discharged. 80% of vertigo patients and 100% of 2-week-wait throat symptom patients were offered face-to-face consultations.","2021","06","25","Ear Nose Throat J","Ear, nose, &amp; throat journal","COVID-19; outcomes; telemedicine; teleotology; telephone","Sargsyan","Narek","Department of Otolaryngology, 7518Eastbourne District General Hospital, Eastbourne, East Sussex, United Kingdom",NA
"142","34167356","10.1177/01455613211028091","ENT Telephone Clinics During the Coronavirus Pandemic: An Analysis of 400 Telephone Consultations at a District General Hospital.","The COVID-19 pandemic led to the introduction of telephone consultations in order to provide specialist health care remotely. This study analyses the outcomes of ear, nose, and throat (ENT) telephone consultations. Retrospective analysis was undertaken of 400 ENT telephone consultations. All 2-week-wait neck or face lump patients underwent imaging and 78% were successfully discharged. 80% of vertigo patients and 100% of 2-week-wait throat symptom patients were offered face-to-face consultations.","2021","06","25","Ear Nose Throat J","Ear, nose, &amp; throat journal","COVID-19; outcomes; telemedicine; teleotology; telephone","Karunaratne","Dilhara","Department of Otolaryngology, 7518Eastbourne District General Hospital, Eastbourne, East Sussex, United Kingdom",NA
"143","34167356","10.1177/01455613211028091","ENT Telephone Clinics During the Coronavirus Pandemic: An Analysis of 400 Telephone Consultations at a District General Hospital.","The COVID-19 pandemic led to the introduction of telephone consultations in order to provide specialist health care remotely. This study analyses the outcomes of ear, nose, and throat (ENT) telephone consultations. Retrospective analysis was undertaken of 400 ENT telephone consultations. All 2-week-wait neck or face lump patients underwent imaging and 78% were successfully discharged. 80% of vertigo patients and 100% of 2-week-wait throat symptom patients were offered face-to-face consultations.","2021","06","25","Ear Nose Throat J","Ear, nose, &amp; throat journal","COVID-19; outcomes; telemedicine; teleotology; telephone","Masani","Alisha","Department of Otolaryngology, 7518Eastbourne District General Hospital, Eastbourne, East Sussex, United Kingdom",NA
"144","34167356","10.1177/01455613211028091","ENT Telephone Clinics During the Coronavirus Pandemic: An Analysis of 400 Telephone Consultations at a District General Hospital.","The COVID-19 pandemic led to the introduction of telephone consultations in order to provide specialist health care remotely. This study analyses the outcomes of ear, nose, and throat (ENT) telephone consultations. Retrospective analysis was undertaken of 400 ENT telephone consultations. All 2-week-wait neck or face lump patients underwent imaging and 78% were successfully discharged. 80% of vertigo patients and 100% of 2-week-wait throat symptom patients were offered face-to-face consultations.","2021","06","25","Ear Nose Throat J","Ear, nose, &amp; throat journal","COVID-19; outcomes; telemedicine; teleotology; telephone","Howell","Lauren","Department of Otolaryngology, 7518Eastbourne District General Hospital, Eastbourne, East Sussex, United Kingdom",NA
"145","34167356","10.1177/01455613211028091","ENT Telephone Clinics During the Coronavirus Pandemic: An Analysis of 400 Telephone Consultations at a District General Hospital.","The COVID-19 pandemic led to the introduction of telephone consultations in order to provide specialist health care remotely. This study analyses the outcomes of ear, nose, and throat (ENT) telephone consultations. Retrospective analysis was undertaken of 400 ENT telephone consultations. All 2-week-wait neck or face lump patients underwent imaging and 78% were successfully discharged. 80% of vertigo patients and 100% of 2-week-wait throat symptom patients were offered face-to-face consultations.","2021","06","25","Ear Nose Throat J","Ear, nose, &amp; throat journal","COVID-19; outcomes; telemedicine; teleotology; telephone","Yousif","Madi","Department of Otolaryngology, 7518Eastbourne District General Hospital, Eastbourne, East Sussex, United Kingdom",NA
"146","34167321","10.1177/00045632211030957","Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff.","SARS-CoV-2 serological testing has seen extensive academic and clinical use from investigating correlates of immunity to seroprevalence, convalescent plasma and vaccine trials. Interpretation of these studies will depend on robust validation of the longitudinal sensitivities of these assays, especially in the context of mild disease which makes up the majority of the Coronavirus Disease 2019 (COVID-19) caseload. Hospital staff (n = 94) returning to work following polymerase chain reaction confir","2021","07","14","Ann Clin Biochem","Annals of clinical biochemistry","Coronavirus disease 2019; hospital staff; immunoassay; longitudinal cohort; quality assurance and control; sensitivity; serology","Sim","Marcus","Manchester University NHS Foundation Trust, Cobbett House, Manchester Royal Infirmary, Manchester, UK",NA
"147","34167321","10.1177/00045632211030957","Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff.","SARS-CoV-2 serological testing has seen extensive academic and clinical use from investigating correlates of immunity to seroprevalence, convalescent plasma and vaccine trials. Interpretation of these studies will depend on robust validation of the longitudinal sensitivities of these assays, especially in the context of mild disease which makes up the majority of the Coronavirus Disease 2019 (COVID-19) caseload. Hospital staff (n = 94) returning to work following polymerase chain reaction confir","2021","07","14","Ann Clin Biochem","Annals of clinical biochemistry","Coronavirus disease 2019; hospital staff; immunoassay; longitudinal cohort; quality assurance and control; sensitivity; serology","Cockcroft","Christopher","Bolton NHS Foundation Trust, Bolton, UK",NA
"148","34167321","10.1177/00045632211030957","Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff.","SARS-CoV-2 serological testing has seen extensive academic and clinical use from investigating correlates of immunity to seroprevalence, convalescent plasma and vaccine trials. Interpretation of these studies will depend on robust validation of the longitudinal sensitivities of these assays, especially in the context of mild disease which makes up the majority of the Coronavirus Disease 2019 (COVID-19) caseload. Hospital staff (n = 94) returning to work following polymerase chain reaction confir","2021","07","14","Ann Clin Biochem","Annals of clinical biochemistry","Coronavirus disease 2019; hospital staff; immunoassay; longitudinal cohort; quality assurance and control; sensitivity; serology","Darby","Denise","47Salford Royal NHS Foundation Trust, Salford, UK",NA
"149","34167321","10.1177/00045632211030957","Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff.","SARS-CoV-2 serological testing has seen extensive academic and clinical use from investigating correlates of immunity to seroprevalence, convalescent plasma and vaccine trials. Interpretation of these studies will depend on robust validation of the longitudinal sensitivities of these assays, especially in the context of mild disease which makes up the majority of the Coronavirus Disease 2019 (COVID-19) caseload. Hospital staff (n = 94) returning to work following polymerase chain reaction confir","2021","07","14","Ann Clin Biochem","Annals of clinical biochemistry","Coronavirus disease 2019; hospital staff; immunoassay; longitudinal cohort; quality assurance and control; sensitivity; serology","Ellis","Clare R","Manchester University NHS Foundation Trust, Cobbett House, Manchester Royal Infirmary, Manchester, UK",NA
"150","34167321","10.1177/00045632211030957","Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff.","SARS-CoV-2 serological testing has seen extensive academic and clinical use from investigating correlates of immunity to seroprevalence, convalescent plasma and vaccine trials. Interpretation of these studies will depend on robust validation of the longitudinal sensitivities of these assays, especially in the context of mild disease which makes up the majority of the Coronavirus Disease 2019 (COVID-19) caseload. Hospital staff (n = 94) returning to work following polymerase chain reaction confir","2021","07","14","Ann Clin Biochem","Annals of clinical biochemistry","Coronavirus disease 2019; hospital staff; immunoassay; longitudinal cohort; quality assurance and control; sensitivity; serology","Heaps","Adrian","North Cumbria Integrated Care NHS Foundation Trust, Carlisle, UK",NA
"151","34167321","10.1177/00045632211030957","Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff.","SARS-CoV-2 serological testing has seen extensive academic and clinical use from investigating correlates of immunity to seroprevalence, convalescent plasma and vaccine trials. Interpretation of these studies will depend on robust validation of the longitudinal sensitivities of these assays, especially in the context of mild disease which makes up the majority of the Coronavirus Disease 2019 (COVID-19) caseload. Hospital staff (n = 94) returning to work following polymerase chain reaction confir","2021","07","14","Ann Clin Biochem","Annals of clinical biochemistry","Coronavirus disease 2019; hospital staff; immunoassay; longitudinal cohort; quality assurance and control; sensitivity; serology","Scargill","Jonathan","Northern Care Alliance Group, Oldham, UK",NA
"152","34167321","10.1177/00045632211030957","Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff.","SARS-CoV-2 serological testing has seen extensive academic and clinical use from investigating correlates of immunity to seroprevalence, convalescent plasma and vaccine trials. Interpretation of these studies will depend on robust validation of the longitudinal sensitivities of these assays, especially in the context of mild disease which makes up the majority of the Coronavirus Disease 2019 (COVID-19) caseload. Hospital staff (n = 94) returning to work following polymerase chain reaction confir","2021","07","14","Ann Clin Biochem","Annals of clinical biochemistry","Coronavirus disease 2019; hospital staff; immunoassay; longitudinal cohort; quality assurance and control; sensitivity; serology","Garcez","Tomaz","Manchester University NHS Foundation Trust, Cobbett House, Manchester Royal Infirmary, Manchester, UK",NA
"153","34167146","10.24875/BMHIM.20000140","How the COVID-19 contingency affects children.","Due to the pandemic, children are undergoing many changes in their daily lives. We analyzed how parents perceive the effects of the contingency on their children through an online survey shared by digital media for 7 days. We obtained 4000 responses. The most frequent difficulty of the children was online homeschooling (30.4%), followed by sleeping disorders (20.3%). The use of screens increased 30-80% in over 65% of children. Tantrum was detected in 34% and mood swings in 30% of children. The m","2021","07","05","Bol Med Hosp Infant Mex","Boletin medico del Hospital Infantil de Mexico","COVID-19; Children; Contingencia; Contingency; Coronavirus disease 2019; Encuesta; Niños; Survey; Adolescent; COVID-19; Child; Child, Preschool; Education, Distance; Humans; Internet; Mental Health; Parents; Schools; Screen Time; Sleep Wake Disorders; Students; Surveys and Questionnaires","Reséndiz-Aparicio","J Carlos","Departamento de Neurología Pediátrica, Hospital Psiquiátrico Infantil Dr. Juan N. Navarro. Mexico City, Mexico",NA
"154","34167114","10.1159/000517153","Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.","There are a limited number of studies about the clinical findings of coronavirus infection in pediatric patients with asthma. We aimed to evaluate the clinical and laboratory characteristics of pediatric patients with asthma and healthy children without chronic disease who infected with SARS-CoV-2. This is a retrospective, case-control study comparing the asthma diagnosed and healthy children who were diagnosed as COVID-19 in our hospital between March 11 and November 10, 2020. During the study ","2021","06","24","Int Arch Allergy Immunol","International archives of allergy and immunology","Asthma; Child; Coronavirus; Coronavirus disease 2019","Metbulut","Azize Pinar","Division of Pediatric Allergy and Immunology, Ankara City Hospital, Ankara, Turkey",NA
"155","34167114","10.1159/000517153","Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.","There are a limited number of studies about the clinical findings of coronavirus infection in pediatric patients with asthma. We aimed to evaluate the clinical and laboratory characteristics of pediatric patients with asthma and healthy children without chronic disease who infected with SARS-CoV-2. This is a retrospective, case-control study comparing the asthma diagnosed and healthy children who were diagnosed as COVID-19 in our hospital between March 11 and November 10, 2020. During the study ","2021","06","24","Int Arch Allergy Immunol","International archives of allergy and immunology","Asthma; Child; Coronavirus; Coronavirus disease 2019","Mustafaoglu","Özlem","Division of Pediatric Infectious Disease, Ankara City Hospital, Ankara, Turkey",NA
"156","34167114","10.1159/000517153","Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.","There are a limited number of studies about the clinical findings of coronavirus infection in pediatric patients with asthma. We aimed to evaluate the clinical and laboratory characteristics of pediatric patients with asthma and healthy children without chronic disease who infected with SARS-CoV-2. This is a retrospective, case-control study comparing the asthma diagnosed and healthy children who were diagnosed as COVID-19 in our hospital between March 11 and November 10, 2020. During the study ","2021","06","24","Int Arch Allergy Immunol","International archives of allergy and immunology","Asthma; Child; Coronavirus; Coronavirus disease 2019","Sen","Gülsah","Division of Pediatric Allergy and Immunology, Ankara City Hospital, Ankara, Turkey",NA
"157","34167114","10.1159/000517153","Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.","There are a limited number of studies about the clinical findings of coronavirus infection in pediatric patients with asthma. We aimed to evaluate the clinical and laboratory characteristics of pediatric patients with asthma and healthy children without chronic disease who infected with SARS-CoV-2. This is a retrospective, case-control study comparing the asthma diagnosed and healthy children who were diagnosed as COVID-19 in our hospital between March 11 and November 10, 2020. During the study ","2021","06","24","Int Arch Allergy Immunol","International archives of allergy and immunology","Asthma; Child; Coronavirus; Coronavirus disease 2019","Kanik Yüksek","Saliha","Division of Pediatric Infectious Disease, Ankara City Hospital, Ankara, Turkey",NA
"158","34167114","10.1159/000517153","Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.","There are a limited number of studies about the clinical findings of coronavirus infection in pediatric patients with asthma. We aimed to evaluate the clinical and laboratory characteristics of pediatric patients with asthma and healthy children without chronic disease who infected with SARS-CoV-2. This is a retrospective, case-control study comparing the asthma diagnosed and healthy children who were diagnosed as COVID-19 in our hospital between March 11 and November 10, 2020. During the study ","2021","06","24","Int Arch Allergy Immunol","International archives of allergy and immunology","Asthma; Child; Coronavirus; Coronavirus disease 2019","Külhas Çelik","Ilknur","Division of Pediatric Allergy and Immunology, Ankara City Hospital, Ankara, Turkey",NA
"159","34167114","10.1159/000517153","Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.","There are a limited number of studies about the clinical findings of coronavirus infection in pediatric patients with asthma. We aimed to evaluate the clinical and laboratory characteristics of pediatric patients with asthma and healthy children without chronic disease who infected with SARS-CoV-2. This is a retrospective, case-control study comparing the asthma diagnosed and healthy children who were diagnosed as COVID-19 in our hospital between March 11 and November 10, 2020. During the study ","2021","06","24","Int Arch Allergy Immunol","International archives of allergy and immunology","Asthma; Child; Coronavirus; Coronavirus disease 2019","Akça","Halise","Division of Pediatric, Emergency Care Department, Ankara City Hospital, Ankara, Turkey",NA
"160","34167114","10.1159/000517153","Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.","There are a limited number of studies about the clinical findings of coronavirus infection in pediatric patients with asthma. We aimed to evaluate the clinical and laboratory characteristics of pediatric patients with asthma and healthy children without chronic disease who infected with SARS-CoV-2. This is a retrospective, case-control study comparing the asthma diagnosed and healthy children who were diagnosed as COVID-19 in our hospital between March 11 and November 10, 2020. During the study ","2021","06","24","Int Arch Allergy Immunol","International archives of allergy and immunology","Asthma; Child; Coronavirus; Coronavirus disease 2019","Dibek Misirlioglu","Emine","Division of Pediatric Allergy and Immunology, Ankara City Hospital, Ankara, Turkey",NA
"161","34167111","10.1159/000516670","Characteristics, Management, and Case-Fatality of Patients Hospitalized for Stroke with a Diagnosis of COVID-19 in France.","COVID-19 was found to be associated with an increased risk of stroke. This study aimed to compare characteristics, management, and outcomes of hospitalized stroke patients with or without a hospital diagnosis of CO-VID-19 at a nationwide scale. This is a cross-sectional study on all French hospitals covering the entire French population using the French national hospital discharge databases (Programme de Médicalisation des Systèmes d'Information, included in the Système National des Données de S","2021","07","22","Neuroepidemiology","Neuroepidemiology","COVID-19; Epidemiology; Mortality; Stroke; Stroke management","Gabet","Amélie","Department of Non-Communicable Diseases, Cardiovascular Diseases and Stroke Program, Santé Publique France, Saint-Maurice, France",NA
"162","34167111","10.1159/000516670","Characteristics, Management, and Case-Fatality of Patients Hospitalized for Stroke with a Diagnosis of COVID-19 in France.","COVID-19 was found to be associated with an increased risk of stroke. This study aimed to compare characteristics, management, and outcomes of hospitalized stroke patients with or without a hospital diagnosis of CO-VID-19 at a nationwide scale. This is a cross-sectional study on all French hospitals covering the entire French population using the French national hospital discharge databases (Programme de Médicalisation des Systèmes d'Information, included in the Système National des Données de S","2021","07","22","Neuroepidemiology","Neuroepidemiology","COVID-19; Epidemiology; Mortality; Stroke; Stroke management","Grave","Clémence","Department of Non-Communicable Diseases, Cardiovascular Diseases and Stroke Program, Santé Publique France, Saint-Maurice, France",NA
"163","34167111","10.1159/000516670","Characteristics, Management, and Case-Fatality of Patients Hospitalized for Stroke with a Diagnosis of COVID-19 in France.","COVID-19 was found to be associated with an increased risk of stroke. This study aimed to compare characteristics, management, and outcomes of hospitalized stroke patients with or without a hospital diagnosis of CO-VID-19 at a nationwide scale. This is a cross-sectional study on all French hospitals covering the entire French population using the French national hospital discharge databases (Programme de Médicalisation des Systèmes d'Information, included in the Système National des Données de S","2021","07","22","Neuroepidemiology","Neuroepidemiology","COVID-19; Epidemiology; Mortality; Stroke; Stroke management","Chatignoux","Edouard","Department of Non-Communicable Diseases, Cardiovascular Diseases and Stroke Program, Santé Publique France, Saint-Maurice, France",NA
"164","34167111","10.1159/000516670","Characteristics, Management, and Case-Fatality of Patients Hospitalized for Stroke with a Diagnosis of COVID-19 in France.","COVID-19 was found to be associated with an increased risk of stroke. This study aimed to compare characteristics, management, and outcomes of hospitalized stroke patients with or without a hospital diagnosis of CO-VID-19 at a nationwide scale. This is a cross-sectional study on all French hospitals covering the entire French population using the French national hospital discharge databases (Programme de Médicalisation des Systèmes d'Information, included in the Système National des Données de S","2021","07","22","Neuroepidemiology","Neuroepidemiology","COVID-19; Epidemiology; Mortality; Stroke; Stroke management","Tuppin","Philippe","Department of strategy and statistical studies, Caisse Nationale d'Assurance Maladie, Paris, France",NA
"165","34167111","10.1159/000516670","Characteristics, Management, and Case-Fatality of Patients Hospitalized for Stroke with a Diagnosis of COVID-19 in France.","COVID-19 was found to be associated with an increased risk of stroke. This study aimed to compare characteristics, management, and outcomes of hospitalized stroke patients with or without a hospital diagnosis of CO-VID-19 at a nationwide scale. This is a cross-sectional study on all French hospitals covering the entire French population using the French national hospital discharge databases (Programme de Médicalisation des Systèmes d'Information, included in the Système National des Données de S","2021","07","22","Neuroepidemiology","Neuroepidemiology","COVID-19; Epidemiology; Mortality; Stroke; Stroke management","Béjot","Yannick","Neurology Department, Dijon University Hospital, Dijon, France",NA
"166","34167111","10.1159/000516670","Characteristics, Management, and Case-Fatality of Patients Hospitalized for Stroke with a Diagnosis of COVID-19 in France.","COVID-19 was found to be associated with an increased risk of stroke. This study aimed to compare characteristics, management, and outcomes of hospitalized stroke patients with or without a hospital diagnosis of CO-VID-19 at a nationwide scale. This is a cross-sectional study on all French hospitals covering the entire French population using the French national hospital discharge databases (Programme de Médicalisation des Systèmes d'Information, included in the Système National des Données de S","2021","07","22","Neuroepidemiology","Neuroepidemiology","COVID-19; Epidemiology; Mortality; Stroke; Stroke management","Olié","Valérie","Department of Non-Communicable Diseases, Cardiovascular Diseases and Stroke Program, Santé Publique France, Saint-Maurice, France",NA
"167","34167077","10.1136/thoraxjnl-2020-215042corr1","Correction: <i>Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection</i>.",NA,"2021","06","24","Thorax","Thorax",NA,NA,NA,NA,NA
"168","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Lee","Jeong Hoon","Department of Electrical Engineering, Kwangwoon University, Seoul, 01897, Republic of Korea",NA
"169","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Bae","Pan Kee","BioNano Health Guard Research Center, Daejeon, 34141, Republic of Korea",NA
"170","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Kim","Hyunho","School of Mechanical Engineering, Korea University, Seoul, 02841, Republic of Korea",NA
"171","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Song","Yoon Ji","KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea",NA
"172","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Yi","So Yeon","BioNano Health Guard Research Center, Daejeon, 34141, Republic of Korea",NA
"173","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Kwon","Jungsun","BioNano Health Guard Research Center, Daejeon, 34141, Republic of Korea",NA
"174","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Seo","Joon-Seok","Absology, Anyang, 14057, Republic of Korea",NA
"175","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Lee","Jeong-Min","Absology, Anyang, 14057, Republic of Korea",NA
"176","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Jo","Han-Sang","Absology, Anyang, 14057, Republic of Korea",NA
"177","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Park","Seon Mee","Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, 28644, Republic of Korea",NA
"178","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Park","Hee Sue","Department of Laboratory Medicine, Chungbuk National University College of Medicine, Cheongju, 28644, Republic of Korea","pheno27@naver.com"
"179","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Shin","Kyeong Seob","Department of Laboratory Medicine, Chungbuk National University College of Medicine, Cheongju, 28644, Republic of Korea","ksshin@chungbuk.ac.kr"
"180","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Chung","Seok","School of Mechanical Engineering, Korea University, Seoul, 02841, Republic of Korea","sidchung@korea.ac.kr"
"181","34167074","10.1016/j.bios.2021.113406","A rapid quantitative on-site coronavirus disease 19 serological test.","On-site severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) serological assays allow for timely in-field decisions to be made regarding patient status, also enabling population-wide screening to assist in controlling the coronavirus disease 2019 (COVID-19) pandemic. Here we propose a rapid microfluidic serological assay with two unique functions of nanointerstice filling and digitized flow control, which enable the fast/robust filling of the sample fluid as well as precise regulation of","2021","07","12","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Immunoassay; Microfluidics; POCT; SARS-CoV-2","Shin","Yong Beom","BioNano Health Guard Research Center, Daejeon, 34141, Republic of Korea","ybshin@kribb.re.kr"
"182","34167069","10.1016/j.clinimag.2021.06.018","Addressing ethnic disparities in imaging utilization and clinical outcomes for COVID-19.","Racial and ethnic disparities have exacerbated during the COVID-19 pandemic as the healthcare system is overwhelmed. While Hispanics are disproportionately affected by COVID-19, little is known about ethnic disparities in the hospital settings. This study investigates imaging utilization and clinical outcomes between Hispanic and non-Hispanic COVID-19 patients in the Emergency Department (ED) and during hospitalization. Through retrospective chart review, we included 331 symptomatic COVID-19 pat","2021","07","21","Clin Imaging","Clinical imaging","Clinical outcome; Ethnicity; Healthcare disparity; Imaging utilization; Length of stay; COVID-19; Diagnostic Imaging; Ethnic Groups; Humans; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2","Larsen","Linda H","Keck School of Medicine, University of Southern California, United States of America","lhlarsen@med.usc.edu"
"183","34167069","10.1016/j.clinimag.2021.06.018","Addressing ethnic disparities in imaging utilization and clinical outcomes for COVID-19.","Racial and ethnic disparities have exacerbated during the COVID-19 pandemic as the healthcare system is overwhelmed. While Hispanics are disproportionately affected by COVID-19, little is known about ethnic disparities in the hospital settings. This study investigates imaging utilization and clinical outcomes between Hispanic and non-Hispanic COVID-19 patients in the Emergency Department (ED) and during hospitalization. Through retrospective chart review, we included 331 symptomatic COVID-19 pat","2021","07","21","Clin Imaging","Clinical imaging","Clinical outcome; Ethnicity; Healthcare disparity; Imaging utilization; Length of stay; COVID-19; Diagnostic Imaging; Ethnic Groups; Humans; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2","Desai","Bhushan","Keck School of Medicine, University of Southern California, United States of America",NA
"184","34167069","10.1016/j.clinimag.2021.06.018","Addressing ethnic disparities in imaging utilization and clinical outcomes for COVID-19.","Racial and ethnic disparities have exacerbated during the COVID-19 pandemic as the healthcare system is overwhelmed. While Hispanics are disproportionately affected by COVID-19, little is known about ethnic disparities in the hospital settings. This study investigates imaging utilization and clinical outcomes between Hispanic and non-Hispanic COVID-19 patients in the Emergency Department (ED) and during hospitalization. Through retrospective chart review, we included 331 symptomatic COVID-19 pat","2021","07","21","Clin Imaging","Clinical imaging","Clinical outcome; Ethnicity; Healthcare disparity; Imaging utilization; Length of stay; COVID-19; Diagnostic Imaging; Ethnic Groups; Humans; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2","Cen","Steven Y","Keck School of Medicine, University of Southern California, United States of America",NA
"185","34167069","10.1016/j.clinimag.2021.06.018","Addressing ethnic disparities in imaging utilization and clinical outcomes for COVID-19.","Racial and ethnic disparities have exacerbated during the COVID-19 pandemic as the healthcare system is overwhelmed. While Hispanics are disproportionately affected by COVID-19, little is known about ethnic disparities in the hospital settings. This study investigates imaging utilization and clinical outcomes between Hispanic and non-Hispanic COVID-19 patients in the Emergency Department (ED) and during hospitalization. Through retrospective chart review, we included 331 symptomatic COVID-19 pat","2021","07","21","Clin Imaging","Clinical imaging","Clinical outcome; Ethnicity; Healthcare disparity; Imaging utilization; Length of stay; COVID-19; Diagnostic Imaging; Ethnic Groups; Humans; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2","Stahl","Daniel","Keck School of Medicine, University of Southern California, United States of America",NA
"186","34167069","10.1016/j.clinimag.2021.06.018","Addressing ethnic disparities in imaging utilization and clinical outcomes for COVID-19.","Racial and ethnic disparities have exacerbated during the COVID-19 pandemic as the healthcare system is overwhelmed. While Hispanics are disproportionately affected by COVID-19, little is known about ethnic disparities in the hospital settings. This study investigates imaging utilization and clinical outcomes between Hispanic and non-Hispanic COVID-19 patients in the Emergency Department (ED) and during hospitalization. Through retrospective chart review, we included 331 symptomatic COVID-19 pat","2021","07","21","Clin Imaging","Clinical imaging","Clinical outcome; Ethnicity; Healthcare disparity; Imaging utilization; Length of stay; COVID-19; Diagnostic Imaging; Ethnic Groups; Humans; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2","Lei","Xiaomeng","Keck School of Medicine, University of Southern California, United States of America",NA
"187","34167069","10.1016/j.clinimag.2021.06.018","Addressing ethnic disparities in imaging utilization and clinical outcomes for COVID-19.","Racial and ethnic disparities have exacerbated during the COVID-19 pandemic as the healthcare system is overwhelmed. While Hispanics are disproportionately affected by COVID-19, little is known about ethnic disparities in the hospital settings. This study investigates imaging utilization and clinical outcomes between Hispanic and non-Hispanic COVID-19 patients in the Emergency Department (ED) and during hospitalization. Through retrospective chart review, we included 331 symptomatic COVID-19 pat","2021","07","21","Clin Imaging","Clinical imaging","Clinical outcome; Ethnicity; Healthcare disparity; Imaging utilization; Length of stay; COVID-19; Diagnostic Imaging; Ethnic Groups; Humans; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2","Gholamrezanezhad","Ali","Keck School of Medicine, University of Southern California, United States of America",NA
"188","34167069","10.1016/j.clinimag.2021.06.018","Addressing ethnic disparities in imaging utilization and clinical outcomes for COVID-19.","Racial and ethnic disparities have exacerbated during the COVID-19 pandemic as the healthcare system is overwhelmed. While Hispanics are disproportionately affected by COVID-19, little is known about ethnic disparities in the hospital settings. This study investigates imaging utilization and clinical outcomes between Hispanic and non-Hispanic COVID-19 patients in the Emergency Department (ED) and during hospitalization. Through retrospective chart review, we included 331 symptomatic COVID-19 pat","2021","07","21","Clin Imaging","Clinical imaging","Clinical outcome; Ethnicity; Healthcare disparity; Imaging utilization; Length of stay; COVID-19; Diagnostic Imaging; Ethnic Groups; Humans; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2","Yamashita","Mary","Keck School of Medicine, University of Southern California, United States of America",NA
"189","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Bayramoglu","Zuhal","Istanbul University, Istanbul Medical Faculty, Radiology Department, Turkey. Electronic address: incezuhal@yahoo","incezuhal@yahoo.com"
"190","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Cingoz","Eda","Istanbul University, Istanbul Medical Faculty, Radiology Department, Turkey",NA
"191","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Comert","Rana G","Istanbul University, Istanbul Medical Faculty, Radiology Department, Turkey",NA
"192","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Gasimli","Nilufar","Istanbul University, Istanbul Medical Faculty, Radiology Department, Turkey",NA
"193","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Kaba","Ozge","Istanbul University, Istanbul Medical Faculty, Department of Pediatric Infectious Disease, Turkey",NA
"194","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Sari Yanartas","Mehpare","Istanbul University, Istanbul Medical Faculty, Department of Pediatric Infectious Disease, Turkey",NA
"195","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Hancerli Torun","Selda","Istanbul University, Istanbul Medical Faculty, Department of Pediatric Infectious Disease, Turkey",NA
"196","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Somer","Ayper","Istanbul University, Istanbul Medical Faculty, Department of Pediatric Infectious Disease, Turkey",NA
"197","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Erturk","Sukru Mehmet","Istanbul University, Istanbul Medical Faculty, Radiology Department, Turkey",NA
"198","34167068","10.1016/j.clinimag.2021.06.012","Correlation of laboratory parameters and Chest CT findings in young adults with COVID-19 and comparison of imaging findings with children.","We aimed to compare COVID-19 imaging findings of young adults (19-35 years of age) with those of children (0-18 years) and to correlate imaging findings of young adults with their laboratory tests. This retrospective study included Real Time-Polymerase Chain Reaction (RT-PCR) confirmed 130 young adults (mean age: 28.39 ± 4.77; 65 male, 65 female) and 36 children (mean age: 12.41 ± 4.51; 17 male, 19 female), between March and June 2020. COVID-19 related imaging findings on chest CT were examined ","2021","07","05","Clin Imaging","Clinical imaging","COVID-19; Children; Computed tomography; Young adults","Tunaci","Atadan","Istanbul University, Istanbul Medical Faculty, Radiology Department, Turkey",NA
"199","34167045","10.1016/j.diagmicrobio.2020.115070","Accelerating the global response against the exponentially growing COVID-19 outbreak through decent data sharing.","The novel coronavirus disease 2019 (COVID-19) is a novel and exponentially growing disease, and consequently, the accelerated development of knowledge from good data is possible quickly and globally. In order to combat the global pandemic of COVID-19, all humans on earth need to make difficult strategic decisions on three very different scales, all fueled by Analytical and Artificial Intelligence-based predictive Models.","2021","07","09","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Artificial intelligence; COVID-19; Coronavirus; Data share; Pandemic; Artificial Intelligence; COVID-19; Delivery of Health Care; Disease Outbreaks; Humans; Information Dissemination; Models, Theoretical","Galvin","Cooper J","Biophysics program, Stanford Medical School, Stanford, CA, USA",NA
"200","34167045","10.1016/j.diagmicrobio.2020.115070","Accelerating the global response against the exponentially growing COVID-19 outbreak through decent data sharing.","The novel coronavirus disease 2019 (COVID-19) is a novel and exponentially growing disease, and consequently, the accelerated development of knowledge from good data is possible quickly and globally. In order to combat the global pandemic of COVID-19, all humans on earth need to make difficult strategic decisions on three very different scales, all fueled by Analytical and Artificial Intelligence-based predictive Models.","2021","07","09","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Artificial intelligence; COVID-19; Coronavirus; Data share; Pandemic; Artificial Intelligence; COVID-19; Delivery of Health Care; Disease Outbreaks; Humans; Information Dissemination; Models, Theoretical","Fernandez-Luque","Luis","Working Groups and SIGs, International Medical Informatics Association",NA
"201","34167045","10.1016/j.diagmicrobio.2020.115070","Accelerating the global response against the exponentially growing COVID-19 outbreak through decent data sharing.","The novel coronavirus disease 2019 (COVID-19) is a novel and exponentially growing disease, and consequently, the accelerated development of knowledge from good data is possible quickly and globally. In order to combat the global pandemic of COVID-19, all humans on earth need to make difficult strategic decisions on three very different scales, all fueled by Analytical and Artificial Intelligence-based predictive Models.","2021","07","09","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Artificial intelligence; COVID-19; Coronavirus; Data share; Pandemic; Artificial Intelligence; COVID-19; Delivery of Health Care; Disease Outbreaks; Humans; Information Dissemination; Models, Theoretical","Li","Yu-Chuan Jack","International Medical Informatics Association","jack@tmu.edu.tw"
"202","34166950","10.1016/j.yebeh.2021.108160","COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.","Due to the high demand for information regarding COVID-19 vaccination in people with epilepsy (PWE), we assessed the symptoms and seizure control of PWE following their COVID-19 vaccination. All adult patients who were treated at our center were asked to report on their vaccination status and, if vaccinated, about their experiences following their first COVID-19 vaccination with regard to adverse effects and seizure control. Fifty-four PWE have already received their first vaccination against CO","2021","07","21","Epilepsy Behav","Epilepsy &amp; behavior : E&amp;B","Adverse effect; COVID-19 pandemic; Epilepsy; SARS-CoV-2; Vaccination","von Wrede","Randi","Department of Epileptology, University Hospital of Bonn, Bonn, Germany. Electronic address: randi.von.wrede@ukbonn","randi.von.wrede@ukbonn.de"
"203","34166950","10.1016/j.yebeh.2021.108160","COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.","Due to the high demand for information regarding COVID-19 vaccination in people with epilepsy (PWE), we assessed the symptoms and seizure control of PWE following their COVID-19 vaccination. All adult patients who were treated at our center were asked to report on their vaccination status and, if vaccinated, about their experiences following their first COVID-19 vaccination with regard to adverse effects and seizure control. Fifty-four PWE have already received their first vaccination against CO","2021","07","21","Epilepsy Behav","Epilepsy &amp; behavior : E&amp;B","Adverse effect; COVID-19 pandemic; Epilepsy; SARS-CoV-2; Vaccination","Pukropski","Jan","Department of Epileptology, University Hospital of Bonn, Bonn, Germany",NA
"204","34166950","10.1016/j.yebeh.2021.108160","COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.","Due to the high demand for information regarding COVID-19 vaccination in people with epilepsy (PWE), we assessed the symptoms and seizure control of PWE following their COVID-19 vaccination. All adult patients who were treated at our center were asked to report on their vaccination status and, if vaccinated, about their experiences following their first COVID-19 vaccination with regard to adverse effects and seizure control. Fifty-four PWE have already received their first vaccination against CO","2021","07","21","Epilepsy Behav","Epilepsy &amp; behavior : E&amp;B","Adverse effect; COVID-19 pandemic; Epilepsy; SARS-CoV-2; Vaccination","Moskau-Hartmann","Susanna","Department of Epileptology, University Hospital of Bonn, Bonn, Germany",NA
"205","34166950","10.1016/j.yebeh.2021.108160","COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.","Due to the high demand for information regarding COVID-19 vaccination in people with epilepsy (PWE), we assessed the symptoms and seizure control of PWE following their COVID-19 vaccination. All adult patients who were treated at our center were asked to report on their vaccination status and, if vaccinated, about their experiences following their first COVID-19 vaccination with regard to adverse effects and seizure control. Fifty-four PWE have already received their first vaccination against CO","2021","07","21","Epilepsy Behav","Epilepsy &amp; behavior : E&amp;B","Adverse effect; COVID-19 pandemic; Epilepsy; SARS-CoV-2; Vaccination","Surges","Rainer","Department of Epileptology, University Hospital of Bonn, Bonn, Germany",NA
"206","34166950","10.1016/j.yebeh.2021.108160","COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.","Due to the high demand for information regarding COVID-19 vaccination in people with epilepsy (PWE), we assessed the symptoms and seizure control of PWE following their COVID-19 vaccination. All adult patients who were treated at our center were asked to report on their vaccination status and, if vaccinated, about their experiences following their first COVID-19 vaccination with regard to adverse effects and seizure control. Fifty-four PWE have already received their first vaccination against CO","2021","07","21","Epilepsy Behav","Epilepsy &amp; behavior : E&amp;B","Adverse effect; COVID-19 pandemic; Epilepsy; SARS-CoV-2; Vaccination","Baumgartner","Tobias","Department of Epileptology, University Hospital of Bonn, Bonn, Germany",NA
"207","34166943","10.1016/j.bios.2021.113439","Microfabricated potentiometric sensor for personalized methacholine challenge tests during the COVID-19 pandemic.","The methacholine challenge test is considered to be the gold standard bronchoprovocation test used to diagnose asthma, and this test is always performed in pulmonary function labs or doctors' offices. Methacholine (MCH) acts by inducing airway tightening/bronchoconstriction, and more importantly, MCH is hydrolyzed by cholinesterase enzyme (ChE). Recently, the American Thoracic Society raised concerns about pulmonary function testing during the COVID-19 pandemic due to recently reported correlati","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Cholinesterase activity; Companion diagnostics; Methacholine challenge test; Potentiometric sensors; Biosensing Techniques; Bronchoconstrictor Agents; COVID-19; Humans; Methacholine Chloride; Pandemics; SARS-CoV-2","ElDin","Norhan Badr","Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr-El Aini Street, Cairo, 11562, Egypt. Electronic address: norhan.ibrahim@pharma.cu.edu","norhan.ibrahim@pharma.cu.edu.eg"
"208","34166943","10.1016/j.bios.2021.113439","Microfabricated potentiometric sensor for personalized methacholine challenge tests during the COVID-19 pandemic.","The methacholine challenge test is considered to be the gold standard bronchoprovocation test used to diagnose asthma, and this test is always performed in pulmonary function labs or doctors' offices. Methacholine (MCH) acts by inducing airway tightening/bronchoconstriction, and more importantly, MCH is hydrolyzed by cholinesterase enzyme (ChE). Recently, the American Thoracic Society raised concerns about pulmonary function testing during the COVID-19 pandemic due to recently reported correlati","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Cholinesterase activity; Companion diagnostics; Methacholine challenge test; Potentiometric sensors; Biosensing Techniques; Bronchoconstrictor Agents; COVID-19; Humans; Methacholine Chloride; Pandemics; SARS-CoV-2","El-Rahman","Mohamed K Abd","Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr-El Aini Street, Cairo, 11562, Egypt",NA
"209","34166943","10.1016/j.bios.2021.113439","Microfabricated potentiometric sensor for personalized methacholine challenge tests during the COVID-19 pandemic.","The methacholine challenge test is considered to be the gold standard bronchoprovocation test used to diagnose asthma, and this test is always performed in pulmonary function labs or doctors' offices. Methacholine (MCH) acts by inducing airway tightening/bronchoconstriction, and more importantly, MCH is hydrolyzed by cholinesterase enzyme (ChE). Recently, the American Thoracic Society raised concerns about pulmonary function testing during the COVID-19 pandemic due to recently reported correlati","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Cholinesterase activity; Companion diagnostics; Methacholine challenge test; Potentiometric sensors; Biosensing Techniques; Bronchoconstrictor Agents; COVID-19; Humans; Methacholine Chloride; Pandemics; SARS-CoV-2","Zaazaa","Hala E","Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr-El Aini Street, Cairo, 11562, Egypt",NA
"210","34166943","10.1016/j.bios.2021.113439","Microfabricated potentiometric sensor for personalized methacholine challenge tests during the COVID-19 pandemic.","The methacholine challenge test is considered to be the gold standard bronchoprovocation test used to diagnose asthma, and this test is always performed in pulmonary function labs or doctors' offices. Methacholine (MCH) acts by inducing airway tightening/bronchoconstriction, and more importantly, MCH is hydrolyzed by cholinesterase enzyme (ChE). Recently, the American Thoracic Society raised concerns about pulmonary function testing during the COVID-19 pandemic due to recently reported correlati","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Cholinesterase activity; Companion diagnostics; Methacholine challenge test; Potentiometric sensors; Biosensing Techniques; Bronchoconstrictor Agents; COVID-19; Humans; Methacholine Chloride; Pandemics; SARS-CoV-2","Moustafa","Azza A","Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr-El Aini Street, Cairo, 11562, Egypt",NA
"211","34166943","10.1016/j.bios.2021.113439","Microfabricated potentiometric sensor for personalized methacholine challenge tests during the COVID-19 pandemic.","The methacholine challenge test is considered to be the gold standard bronchoprovocation test used to diagnose asthma, and this test is always performed in pulmonary function labs or doctors' offices. Methacholine (MCH) acts by inducing airway tightening/bronchoconstriction, and more importantly, MCH is hydrolyzed by cholinesterase enzyme (ChE). Recently, the American Thoracic Society raised concerns about pulmonary function testing during the COVID-19 pandemic due to recently reported correlati","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","COVID-19; Cholinesterase activity; Companion diagnostics; Methacholine challenge test; Potentiometric sensors; Biosensing Techniques; Bronchoconstrictor Agents; COVID-19; Humans; Methacholine Chloride; Pandemics; SARS-CoV-2","Hassan","Said A","Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr-El Aini Street, Cairo, 11562, Egypt",NA
"212","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Juma","Kevin Maafu","Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 606-8502, Japan",NA
"213","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Takita","Teisuke","Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 606-8502, Japan",NA
"214","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Ito","Kenji","Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 606-8502, Japan",NA
"215","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Yamagata","Masaya","Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 606-8502, Japan",NA
"216","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Akagi","Shihomi","Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 606-8502, Japan",NA
"217","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Arikawa","Emi","Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 606-8502, Japan",NA
"218","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Kojima","Kenji","Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 606-8502, Japan",NA
"219","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Biyani","Manish","Department of Bioscience and Biotechnology, Japan Advanced Institute of Science and Technology, 1-1 Asahidai, Nomi City, Ishikawa, 923-1292, Japan",NA
"220","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Fujiwara","Shinsuke","Department of Biosciences, School of Biological and Environmental and Sciences, Kwansei-Gakuin University, 2-1 Gakuen, Sanda, Hyogo, 669-1337, Japan",NA
"221","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Nakura","Yukiko","Department of Developmental Medicine, Research Institute, Osaka Women's and Children's Hospital, Osaka, 594-1101, Japan",NA
"222","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Yanagihara","Itaru","Department of Developmental Medicine, Research Institute, Osaka Women's and Children's Hospital, Osaka, 594-1101, Japan",NA
"223","34166918","10.1016/j.bbrc.2021.06.023","Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method.","Recombinase polymerase amplification (RPA) is an isothermal reaction that amplifies a target DNA sequence with a recombinase, a single-stranded DNA-binding protein (SSB), and a strand-displacing DNA polymerase. In this study, we optimized the reaction conditions of RPA to detect SARS-CoV-2 DNA and RNA using a statistical method to enhance the sensitivity. In vitro synthesized SARS-CoV-2 DNA and RNA were used as targets. After evaluating the concentration of each component, the uvsY, gp32, and AT","2021","07","19","Biochem Biophys Res Commun","Biochemical and biophysical research communications","RPA; Recombinase; Recombinase polymerase amplification; SARS-CoV-2; Single strand DNA-Binding protein; Taguchi method; DNA Primers; DNA, Viral; DNA-Binding Proteins; DNA-Directed DNA Polymerase; Membrane Proteins; Nucleic Acid Amplification Techniques; RNA, Viral; Recombinases; SARS-CoV-2; Statistics as Topic; Viral Proteins","Yasukawa","Kiyoshi","Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 606-8502, Japan. Electronic address: yasukawa.kiyoshi.7v@kyoto-u.ac",NA
"224","34166886","10.1016/j.compbiolchem.2021.107533","Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.","Coronavirus disease 2019 (COVID-19) is the newly emerging viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The epidemic sparked in December 2019 at Wuhan city, China that causes a large global outbreak and a major public health catastrophe. Till now, more than 129 million positive cases have been reported in which more than 2.81 million were dead, surveyed by Johns Hopkins University, USA. The diverse symptoms of COVID-19 and an increased number of positive ","2021","07","19","Comput Biol Chem","Computational biology and chemistry","COVID-19; Nsp3; Nucleocapsid phosphoprotein; SARS-CoV-2; SNP; Spike glycoprotein","Das","Avizit","Department of Genetic Engineering and Biotechnology, Jashore University of Science and Technology, Jashore, 7408, Khulna, Bangladesh. Electronic address: avizitdbmb@just.edu","avizitdbmb@just.edu.bd"
"225","34166886","10.1016/j.compbiolchem.2021.107533","Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.","Coronavirus disease 2019 (COVID-19) is the newly emerging viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The epidemic sparked in December 2019 at Wuhan city, China that causes a large global outbreak and a major public health catastrophe. Till now, more than 129 million positive cases have been reported in which more than 2.81 million were dead, surveyed by Johns Hopkins University, USA. The diverse symptoms of COVID-19 and an increased number of positive ","2021","07","19","Comput Biol Chem","Computational biology and chemistry","COVID-19; Nsp3; Nucleocapsid phosphoprotein; SARS-CoV-2; SNP; Spike glycoprotein","Khurshid","Sarah","Laboratory of Gut-Brain Signaling, Laboratory Sciences and Services Division (LSSD), icddr,b, Dhaka, 1212, Bangladesh. Electronic address: sarah.khurshid99@gmail","sarah.khurshid99@gmail.com"
"226","34166886","10.1016/j.compbiolchem.2021.107533","Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.","Coronavirus disease 2019 (COVID-19) is the newly emerging viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The epidemic sparked in December 2019 at Wuhan city, China that causes a large global outbreak and a major public health catastrophe. Till now, more than 129 million positive cases have been reported in which more than 2.81 million were dead, surveyed by Johns Hopkins University, USA. The diverse symptoms of COVID-19 and an increased number of positive ","2021","07","19","Comput Biol Chem","Computational biology and chemistry","COVID-19; Nsp3; Nucleocapsid phosphoprotein; SARS-CoV-2; SNP; Spike glycoprotein","Ferdausi","Aleya","Department of Genetics and Plant Breeding, Bangladesh Agricultural University, Mymensingh, 2202, Mymensingh, Bangladesh. Electronic address: aferdausi.gpb@bau.edu","aferdausi.gpb@bau.edu.bd"
"227","34166886","10.1016/j.compbiolchem.2021.107533","Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.","Coronavirus disease 2019 (COVID-19) is the newly emerging viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The epidemic sparked in December 2019 at Wuhan city, China that causes a large global outbreak and a major public health catastrophe. Till now, more than 129 million positive cases have been reported in which more than 2.81 million were dead, surveyed by Johns Hopkins University, USA. The diverse symptoms of COVID-19 and an increased number of positive ","2021","07","19","Comput Biol Chem","Computational biology and chemistry","COVID-19; Nsp3; Nucleocapsid phosphoprotein; SARS-CoV-2; SNP; Spike glycoprotein","Nipu","Eshita Sadhak","Upazilla Health Complex, Nazirpur, Pirojpur, Barishal, 8540, Barishal, Bangladesh. Electronic address: eshita.nipu@gmail","eshita.nipu@gmail.com"
"228","34166886","10.1016/j.compbiolchem.2021.107533","Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.","Coronavirus disease 2019 (COVID-19) is the newly emerging viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The epidemic sparked in December 2019 at Wuhan city, China that causes a large global outbreak and a major public health catastrophe. Till now, more than 129 million positive cases have been reported in which more than 2.81 million were dead, surveyed by Johns Hopkins University, USA. The diverse symptoms of COVID-19 and an increased number of positive ","2021","07","19","Comput Biol Chem","Computational biology and chemistry","COVID-19; Nsp3; Nucleocapsid phosphoprotein; SARS-CoV-2; SNP; Spike glycoprotein","Das","Amit","Gafargaon Islamia Govt. High School, Gafargaon, Mymensingh, Dhaka, 2230, Dhaka, Bangladesh. Electronic address: amitbau007@yahoo","amitbau007@yahoo.com"
"229","34166886","10.1016/j.compbiolchem.2021.107533","Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.","Coronavirus disease 2019 (COVID-19) is the newly emerging viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The epidemic sparked in December 2019 at Wuhan city, China that causes a large global outbreak and a major public health catastrophe. Till now, more than 129 million positive cases have been reported in which more than 2.81 million were dead, surveyed by Johns Hopkins University, USA. The diverse symptoms of COVID-19 and an increased number of positive ","2021","07","19","Comput Biol Chem","Computational biology and chemistry","COVID-19; Nsp3; Nucleocapsid phosphoprotein; SARS-CoV-2; SNP; Spike glycoprotein","Ahmed","Fee Faysal","Department of Mathematics, Jashore University of Science and Technology, Jashore, 7408, Bangladesh. Electronic address: ffa.math@just.edu","ffa.math@just.edu.bd"
"230","34166884","10.1016/j.clinimag.2021.06.019","Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.","We report two cases of myocarditis, in two young and previously healthy individuals, temporally related to the second dose of the mRNA-COVID-19 vaccine. Both patients developed acute chest pain, changes on electrocardiogram (ECG), and elevated serum troponin within two days of receiving their second dose. Cardiac magnetic resonance (CMR) findings were consistent with acute myocarditis.","2021","07","01","Clin Imaging","Clinical imaging","Acute myocarditis; COVID-19 vaccination; Cardiac magnetic resonance; Myocarditis; mRNA-COVID-19 vaccine","Mansour","Joseph","Mallinckrodt Institute of Radiology, Washington University School of Medicine, United States. Electronic address: jmansou@iu",NA
"231","34166884","10.1016/j.clinimag.2021.06.019","Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.","We report two cases of myocarditis, in two young and previously healthy individuals, temporally related to the second dose of the mRNA-COVID-19 vaccine. Both patients developed acute chest pain, changes on electrocardiogram (ECG), and elevated serum troponin within two days of receiving their second dose. Cardiac magnetic resonance (CMR) findings were consistent with acute myocarditis.","2021","07","01","Clin Imaging","Clinical imaging","Acute myocarditis; COVID-19 vaccination; Cardiac magnetic resonance; Myocarditis; mRNA-COVID-19 vaccine","Short","Ryan G","Mallinckrodt Institute of Radiology, Washington University School of Medicine, United States",NA
"232","34166884","10.1016/j.clinimag.2021.06.019","Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.","We report two cases of myocarditis, in two young and previously healthy individuals, temporally related to the second dose of the mRNA-COVID-19 vaccine. Both patients developed acute chest pain, changes on electrocardiogram (ECG), and elevated serum troponin within two days of receiving their second dose. Cardiac magnetic resonance (CMR) findings were consistent with acute myocarditis.","2021","07","01","Clin Imaging","Clinical imaging","Acute myocarditis; COVID-19 vaccination; Cardiac magnetic resonance; Myocarditis; mRNA-COVID-19 vaccine","Bhalla","Sanjeev","Mallinckrodt Institute of Radiology, Washington University School of Medicine, United States",NA
"233","34166884","10.1016/j.clinimag.2021.06.019","Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.","We report two cases of myocarditis, in two young and previously healthy individuals, temporally related to the second dose of the mRNA-COVID-19 vaccine. Both patients developed acute chest pain, changes on electrocardiogram (ECG), and elevated serum troponin within two days of receiving their second dose. Cardiac magnetic resonance (CMR) findings were consistent with acute myocarditis.","2021","07","01","Clin Imaging","Clinical imaging","Acute myocarditis; COVID-19 vaccination; Cardiac magnetic resonance; Myocarditis; mRNA-COVID-19 vaccine","Woodard","Pamela K","Mallinckrodt Institute of Radiology, Washington University School of Medicine, United States",NA
"234","34166884","10.1016/j.clinimag.2021.06.019","Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.","We report two cases of myocarditis, in two young and previously healthy individuals, temporally related to the second dose of the mRNA-COVID-19 vaccine. Both patients developed acute chest pain, changes on electrocardiogram (ECG), and elevated serum troponin within two days of receiving their second dose. Cardiac magnetic resonance (CMR) findings were consistent with acute myocarditis.","2021","07","01","Clin Imaging","Clinical imaging","Acute myocarditis; COVID-19 vaccination; Cardiac magnetic resonance; Myocarditis; mRNA-COVID-19 vaccine","Verma","Amanda","Cardiovascular Division, Washington University School of Medicine, United States",NA
"235","34166884","10.1016/j.clinimag.2021.06.019","Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.","We report two cases of myocarditis, in two young and previously healthy individuals, temporally related to the second dose of the mRNA-COVID-19 vaccine. Both patients developed acute chest pain, changes on electrocardiogram (ECG), and elevated serum troponin within two days of receiving their second dose. Cardiac magnetic resonance (CMR) findings were consistent with acute myocarditis.","2021","07","01","Clin Imaging","Clinical imaging","Acute myocarditis; COVID-19 vaccination; Cardiac magnetic resonance; Myocarditis; mRNA-COVID-19 vaccine","Robinson","Xavier","Mallinckrodt Institute of Radiology, Washington University School of Medicine, United States",NA
"236","34166884","10.1016/j.clinimag.2021.06.019","Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.","We report two cases of myocarditis, in two young and previously healthy individuals, temporally related to the second dose of the mRNA-COVID-19 vaccine. Both patients developed acute chest pain, changes on electrocardiogram (ECG), and elevated serum troponin within two days of receiving their second dose. Cardiac magnetic resonance (CMR) findings were consistent with acute myocarditis.","2021","07","01","Clin Imaging","Clinical imaging","Acute myocarditis; COVID-19 vaccination; Cardiac magnetic resonance; Myocarditis; mRNA-COVID-19 vaccine","Raptis","Demetrios A","Mallinckrodt Institute of Radiology, Washington University School of Medicine, United States",NA
"237","34166874","10.1016/j.envint.2021.106719","COVID-19 pandemic and innovation activities in the global airline industry: A review.","Despite the valuable contributions of scholars to the COVID-19 pandemic, limited scholarly attention has been paid to the opportunities unleashed by the crisis. As many industries have been turned upside down and markets rendered uncertain, the crisis is also propelling waves of innovation activities. In this paper, we developed the concept of ""CoviNovation"" to denote the firm's innovation emerging from, rooted in or accelerated by the crisis. Our analysis yielded insights on innovations inspire","2021","07","21","Environ Int","Environment international","Business development; COVID-19; Innovations; Stimulated innovations","Amankwah-Amoah","Joseph","Kent Business School, University of Kent, Kent ME4 4TE, United Kingdom. Electronic address: J.Amankwah-Amoah@kent.ac","Amoah@kent.ac.uk"
"238","34166857","10.1016/j.puhe.2021.05.005","Does fact-checking habit promote COVID-19 knowledge during the pandemic? Evidence from China.","Promoting health knowledge during a public health crisis is essential. This study aims to examine how fact-checking habit influences COVID-19 knowledge in the COVID-19 infodemic. This study uses a cross-sectional survey. During the early outbreak of COVID-19 in China, we conducted an online survey and collected data from 3000 representative Chinese Internet users. The study measured COVID-19 knowledge as a dependent variable, fact-checking habit as an independent variable, and general science kn","2021","07","21","Public Health","Public health","COVID-19; Coronavirus; Emotion; Fact-checking; Knowledge","Yu","W","Department of Media and Communication, Run Run Shaw Creative Media Centre, City University of Hong Kong, Kowloon Tong, Kowloon, Hong Kong",NA
"239","34166857","10.1016/j.puhe.2021.05.005","Does fact-checking habit promote COVID-19 knowledge during the pandemic? Evidence from China.","Promoting health knowledge during a public health crisis is essential. This study aims to examine how fact-checking habit influences COVID-19 knowledge in the COVID-19 infodemic. This study uses a cross-sectional survey. During the early outbreak of COVID-19 in China, we conducted an online survey and collected data from 3000 representative Chinese Internet users. The study measured COVID-19 knowledge as a dependent variable, fact-checking habit as an independent variable, and general science kn","2021","07","21","Public Health","Public health","COVID-19; Coronavirus; Emotion; Fact-checking; Knowledge","Shen","F","Department of Media and Communication, Run Run Shaw Creative Media Centre, City University of Hong Kong, Kowloon Tong, Kowloon, Hong Kong. Electronic address: feishen@cityu.edu","feishen@cityu.edu.hk"
"240","34166856","10.1016/j.puhe.2021.05.016","Clowning during COVID-19 - A survey of European Healthcare Clowning Organisations highlights the role of humour and art in the healthcare system.","This paper presents the findings of a Europe-wide survey that investigates the impact of COVID-19 on Healthcare Clowning Organisations and encourages the healthcare community to reflect on the role of medical clowning within the healthcare system. Online survey. The survey was conducted in June 2020. Forty organisations from 21 countries across Europe responded through a mix of closed and open-ended answers. During the pandemic, 36 out of 39 of the surveyed organisations (with one non-response) ","2021","07","21","Public Health","Public health","COVID-19; Elderly; Humour; Medical clowning; Paediatrics","De Faveri","S","RED NOSES International, Wattgasse 48, 1170 Vienna, Austria. Electronic address: silvia.de-faveri@rednoses","faveri@rednoses.eu"
"241","34166856","10.1016/j.puhe.2021.05.016","Clowning during COVID-19 - A survey of European Healthcare Clowning Organisations highlights the role of humour and art in the healthcare system.","This paper presents the findings of a Europe-wide survey that investigates the impact of COVID-19 on Healthcare Clowning Organisations and encourages the healthcare community to reflect on the role of medical clowning within the healthcare system. Online survey. The survey was conducted in June 2020. Forty organisations from 21 countries across Europe responded through a mix of closed and open-ended answers. During the pandemic, 36 out of 39 of the surveyed organisations (with one non-response) ","2021","07","21","Public Health","Public health","COVID-19; Elderly; Humour; Medical clowning; Paediatrics","Roessler","M","RED NOSES International, Wattgasse 48, 1170 Vienna, Austria. Electronic address: maggie.roessler@rednoses","maggie.roessler@rednoses.eu"
"242","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Vera","Magdalena","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile",NA
"243","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Kattan","Eduardo","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile",NA
"244","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Born","Pablo","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile",NA
"245","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Rivas","Elizabeth","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile",NA
"246","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Amthauer","Macarena","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile",NA
"247","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Nesvadba","Annael","Escuela de Medicina, Pontificia Universidad Católica de Chile, Chile",NA
"248","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Lara","Barbara","Sección Medicina de Urgencia, Departamento de Medicina Interna, Pontificia Universidad Católica de Chile, Chile",NA
"249","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Rao","Isabel","Sección Medicina de Urgencia, Departamento de Medicina Interna, Pontificia Universidad Católica de Chile, Chile",NA
"250","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Espíndola","Eduardo","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile",NA
"251","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Rojas","Luis","Departamento de Medicina Interna, Pontificia Universidad Católica de Chile, Chile",NA
"252","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Hernández","Glenn","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile",NA
"253","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Bugedo","Guillermo","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile",NA
"254","34166852","10.1016/j.jcrc.2021.06.008","Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection.","To determine whether time-to-intubation was associated with higher ICU mortality in patients with COVID-19 on mechanical ventilation due to respiratory insufficiency. We conducted an observational, prospective, single-center study of patients with confirmed SARS-CoV-2 infection hospitalized with moderate to severe ARDS, connected to mechanical ventilation in the ICU between March 17 and July 31, 2020. We examined their general and clinical characteristics. Time-to-intubation was the time from ho","2021","07","21","J Crit Care","Journal of critical care","ARDS; COVID-19; Mechanical ventilation; SARS-CoV-2","Castro","Ricardo","Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile, Chile. Electronic address: rcastro@ucchristus","rcastro@ucchristus.cl"
"255","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Warren","Graham W","Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina. Electronic address: warrengw@musc","warrengw@musc.edu"
"256","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Lim","Vun-Sin","International Association for the Study of Lung Cancer, Denver, Colorado",NA
"257","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Chowdhary","Mudit","Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois",NA
"258","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Marwaha","Gaurav","Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois",NA
"259","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Abd Elbadee","Osama Mostafa","Radiotherapy Department, South Egypt Cancer Institute, Assuit, Egypt",NA
"260","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Kirakli","Esra Korkmaz","Department of Radiation Oncology, Dr. Suat Seren Chest Diseases and Surgery Research and Training Hospital, Ismir, Turkey",NA
"261","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Billiet","Charlotte","Department of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium",NA
"262","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Marin","Alexandra Giraldo","Department of Radiation Oncology, Vall d'Hebron University Hospital, Barcelona, Spain",NA
"263","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Ramos","Monica","Department of Radiation Oncology, Vall d'Hebron University Hospital, Barcelona, Spain",NA
"264","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Suppli","Morten Hiul","Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark",NA
"265","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","McGinnis","Gwendolyn J","Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas",NA
"266","34166850","10.1016/j.jtho.2021.06.005","New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.","Screening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there ","2021","07","17","J Thorac Oncol","Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","COVID-19; Computed tomography; Ground-glass opacities; Radiotherapy","Adjei","Alex A","Department of Oncology and Pharmacology, Mayo Clinic, Rochester, Minnesota",NA
"267","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Wolfson","Anna R","Harvard Medical School, Boston, Mass","awolfson@mgh.harvard.edu"
"268","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Robinson","Lacey B","Harvard Medical School, Boston, Mass",NA
"269","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Li","Lily","Harvard Medical School, Boston, Mass",NA
"270","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","McMahon","Aubree E","Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass",NA
"271","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Cogan","Amelia S","Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass",NA
"272","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Fu","Xiaoqing","Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass",NA
"273","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Wickner","Paige","Harvard Medical School, Boston, Mass",NA
"274","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Samarakoon","Upeka","Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass",NA
"275","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Saff","Rebecca R","Harvard Medical School, Boston, Mass",NA
"276","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Blumenthal","Kimberly G","Harvard Medical School, Boston, Mass",NA
"277","34166844","10.1016/j.jaip.2021.06.010","First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.","The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. To assess outcomes associated with excipient skin testing after a reported allergic reaction to the first dose of mRNA COVID-19 vaccine. We identified a consecutive sample of patients with reported allergic reactions after the first dose of mRNA COVID-19 vaccine who underwent allergy assessment with skin testing","2021","07","16","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Anaphylaxis; COVID-19; COVID-19 vaccine; Drug allergy; Excipient allergy; PEG allergy; Polysorbate allergy; Skin testing; Vaccine allergy","Banerji","Aleena","Harvard Medical School, Boston, Mass",NA
"278","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Butler","Tracy","Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA. Electronic address: Tab2006@med.cornell","Tab2006@med.cornell.edu"
"279","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Goldberg","Judith D","Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA",NA
"280","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Galvin","James E","Comprehensive Center for Brain Health, Departments of Neurology and Psychiatry, University of Miami, Miller School of Medicine, Boca Raton, FL 33433, USA",NA
"281","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Maloney","Thomas","Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA",NA
"282","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Ravdin","Lisa","Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA",NA
"283","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Glodzik","Lidia","Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA",NA
"284","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"de Leon","Mony J","Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA",NA
"285","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Hochman","Tsivia","Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA",NA
"286","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Bowen","Richard L","OTB Research, Charleston, SC, USA",NA
"287","34166841","10.1016/j.cct.2021.106488","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.","The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide acetate is a gonadotropin analogue commonly used for hormone-sensitive conditions such as prostate cancer and endometriosis. This repurposed drug demonstrated efficacy in a previous Phase II clinical trial in those women with AD who also received a stable dose","2021","07","22","Contemp Clin Trials","Contemporary clinical trials",NA,"Atwood","Craig S","Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, and Geriatric Research, Education and Clinical Center, Veterans Administration Hospital, Madison, WI 53705, USA",NA
"288","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Fiore","Giorgio","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy","giorgiofiore.doc@gmail.com"
"289","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Remore","Luigi Gianmaria","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"290","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Tariciotti","Leonardo","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"291","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Carrabba","Giorgio Giovanni","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"292","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Schisano","Luigi","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"293","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Pluderi","Mauro","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"294","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Bertani","Giulio Andrea","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"295","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Borsa","Stefano","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"296","34166828","10.1016/j.wneu.2021.06.071","Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.","To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological s","2021","07","14","World Neurosurg","World neurosurgery","COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery","Locatelli","Marco","Department of Neurosurgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"297","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Bruno","Alfredo","Instituto Nacional de Salud Pública e Investigación ""Leopoldo Izquieta Pérez"". Guayaquil. Ecuador",NA
"298","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"de Mora","Domenica","Instituto Nacional de Salud Pública e Investigación ""Leopoldo Izquieta Pérez"". Guayaquil. Ecuador",NA
"299","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Freire-Paspuel","Byron","One Health Research Group. Universidad de Las Americas. Quito. Ecuador",NA
"300","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Rodriguez","Angel S","One Health Research Group. Universidad de Las Americas. Quito. Ecuador",NA
"301","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Paredes-Espinosa","Maria Belen","One Health Research Group. Universidad de Las Americas. Quito. Ecuador",NA
"302","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Olmedo","Maritza","Instituto Nacional de Salud Pública e Investigación ""Leopoldo Izquieta Pérez"". Guayaquil. Ecuador",NA
"303","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Sanchez","Martha","Instituto Nacional de Salud Pública e Investigación ""Leopoldo Izquieta Pérez"". Guayaquil. Ecuador",NA
"304","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Romero","Jennifer","Instituto Nacional de Salud Pública e Investigación ""Leopoldo Izquieta Pérez"". Guayaquil. Ecuador",NA
"305","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Paez","Michelle","Instituto Nacional de Salud Pública e Investigación ""Leopoldo Izquieta Pérez"". Guayaquil. Ecuador",NA
"306","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Gonzalez","Manuel","Instituto Nacional de Salud Pública e Investigación ""Leopoldo Izquieta Pérez"". Guayaquil. Ecuador",NA
"307","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Orlando","Alberto","Instituto Nacional de Salud Pública e Investigación ""Leopoldo Izquieta Pérez"". Guayaquil. Ecuador",NA
"308","34166793","10.1016/j.ijid.2021.06.038","Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.","The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits. The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both ""CDC"" (N gene) and ""Charite"" (E gene) RT-qPCR protocols. 1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68,","2021","06","26","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Garcia-Bereguiain","Miguel Angel","One Health Research Group. Universidad de Las Americas. Quito. Ecuador. Electronic address: magbereguiain@gmail","magbereguiain@gmail.com"
"309","34166753","10.1016/j.bbi.2021.06.007","Tri-infection: Tuberculosis, HIV, COVID-19 and the already strained South African health system.",NA,"2021","07","23","Brain Behav Immun","Brain, behavior, and immunity",NA,"Matatiele","Motladi","Statistics and Population Studies Department, University of the Western Cape, Bellville, Cape-Town, South-Africa",NA
"310","34166753","10.1016/j.bbi.2021.06.007","Tri-infection: Tuberculosis, HIV, COVID-19 and the already strained South African health system.",NA,"2021","07","23","Brain Behav Immun","Brain, behavior, and immunity",NA,"Stiegler","Nancy","Statistics and Population Studies Department, University of the Western Cape, Bellville, Cape-Town, South-Africa. Electronic address: nstiegler@uwc.ac","nstiegler@uwc.ac.za"
"311","34166753","10.1016/j.bbi.2021.06.007","Tri-infection: Tuberculosis, HIV, COVID-19 and the already strained South African health system.",NA,"2021","07","23","Brain Behav Immun","Brain, behavior, and immunity",NA,"Bouchard","Jean-Pierre","Statistics and Population Studies Department, University of the Western Cape, Bellville, Cape-Town, South-Africa",NA
"312","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Dave","Joel A","Division of Endocrinology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa. Electronic address: joel.dave@uct.ac","joel.dave@uct.ac.za"
"313","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Tamuhla","Tsaone","Division of Computational Biology, Department of Integrative Biomedical Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa",NA
"314","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Tiffin","Nicki","Division of Computational Biology, Department of Integrative Biomedical Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa","nicki.tiffin@uct.ac.za"
"315","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Levitt","Naomi S","Division of Endocrinology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa",NA
"316","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Ross","Ian L","Division of Endocrinology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa",NA
"317","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Toet","William","Division of Endocrinology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa",NA
"318","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Davies","Mary-Ann","Centre for Infectious Disease Epidemiology Research, School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa",NA
"319","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Boulle","Andrew","Centre for Infectious Disease Epidemiology Research, School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa",NA
"320","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Coetzee","Ankia","Division of Endocrinology, Department of Medicine, Stellenbosch University Faculty of Health Sciences, Tygerberg Campus, Cape Town, South Africa",NA
"321","34166703","10.1016/j.diabres.2021.108925","Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.","COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. The Provincial Health Data Centre (Western Cape, South Africa) is a health information exchange collating patient-level routine health data for approximately 4 million public sector health care seekers. Data from COVID-19 patients diagnosed between March and July 2020, including PLWD, were analysed to describe risk fac","2021","07","12","Diabetes Res Clin Pract","Diabetes research and clinical practice","COVID-19; Diabetes; Sub-Saharan Africa","Raubenheimer","Peter J","Department of Medicine, Groote Schuur Hospital and University of Cape Town, South Africa",NA
"322","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","Brown","Julianne R","Microbiology, Virology and Infection Prevention and Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. Electronic address: julianne.brown@gosh.nhs","julianne.brown@gosh.nhs.uk"
"323","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","O'Sullivan","Denise M","National Measurement Laboratory at LGC, Teddington, United Kingdom",NA
"324","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","Shah","Divya","Microbiology, Virology and Infection Prevention and Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom",NA
"325","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","Atkinson","Laura","Microbiology, Virology and Infection Prevention and Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom",NA
"326","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","Pereira","Rui P A","National Measurement Laboratory at LGC, Teddington, United Kingdom",NA
"327","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","Whale","Alexandra S","National Measurement Laboratory at LGC, Teddington, United Kingdom",NA
"328","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","Busby","Eloise J","National Measurement Laboratory at LGC, Teddington, United Kingdom",NA
"329","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","Huggett","Jim F","National Measurement Laboratory at LGC, Teddington, United Kingdom",NA
"330","34166701","10.1016/j.jviromet.2021.114215","Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.","This study aimed to evaluate the impact of four different reverse transcription quantitative PCR (RT-qPCR) master mixes on the performance of SARS-CoV-2 diagnostic PCRs using three primer/probe assays targeting the N gene (A, B and C). The dynamic range and lowest detected quantity was determined using a SARS-CoV-2 partial N gene RNA transcript dilution series (100,000-1 copy/µl) and verified using 72 nose and throat swabs, 29 of which tested positive for SARS-CoV-2 RNA. Assay C consistently det","2021","07","23","J Virol Methods","Journal of virological methods","Mastermix; N gene; SARS-CoV-2 RT-PCR; COVID-19; COVID-19 Nucleic Acid Testing; Coronavirus Nucleocapsid Proteins; DNA Primers; Humans; Nose; Pharynx; Phosphoproteins; RNA, Viral; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity; Sequence Homology, Nucleic Acid","Harris","Kathryn","Microbiology, Virology and Infection Prevention and Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom",NA
"331","34166671","10.1016/j.jpeds.2021.06.035","Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent.",NA,"2021","07","12","J Pediatr","The Journal of pediatrics",NA,"Minocha","Prashant K","Division of Pediatric Cardiology, Hassenfeld Children's Hospital, NYU Langone, New York, NY. Electronic address: prashant.minocha@nyulangone","prashant.minocha@nyulangone.org"
"332","34166671","10.1016/j.jpeds.2021.06.035","Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent.",NA,"2021","07","12","J Pediatr","The Journal of pediatrics",NA,"Better","Donna","Division of Pediatric Cardiology, NYU Long Island School of Medicine, Mineola, NY",NA
"333","34166671","10.1016/j.jpeds.2021.06.035","Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent.",NA,"2021","07","12","J Pediatr","The Journal of pediatrics",NA,"Singh","Rakesh K","Division of Pediatric Cardiology, Hassenfeld Children's Hospital, NYU Langone, New York, NY",NA
"334","34166671","10.1016/j.jpeds.2021.06.035","Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent.",NA,"2021","07","12","J Pediatr","The Journal of pediatrics",NA,"Hoque","Tasneem","Division of Pediatric Cardiology, NYU Long Island School of Medicine, Mineola, NY",NA
"335","34166653","10.1016/j.amjms.2021.06.005","Low Serum Levels of 25-Hydroxyvitamin D Accompany Severe COVID-19 Because it is a Negative Acute Phase Reactant.",NA,"2021","07","20","Am J Med Sci","The American journal of the medical sciences",NA,"Antonelli","Maria","Division of Rheumatology, Department of Medicine, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, USA. Electronic address: mantonelli@metrohealth","mantonelli@metrohealth.org"
"336","34166653","10.1016/j.amjms.2021.06.005","Low Serum Levels of 25-Hydroxyvitamin D Accompany Severe COVID-19 Because it is a Negative Acute Phase Reactant.",NA,"2021","07","20","Am J Med Sci","The American journal of the medical sciences",NA,"Kushner","Irving","Division of Rheumatology, Department of Medicine, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, USA",NA
"337","34166652","10.1016/j.cbi.2021.109567","TRP channels in COVID-19 disease: Potential targets for prevention and treatment.","Coronavirus disease 2019 [COVID-19] is a global health threat caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV2] that requires two proteins for entry: angiotensin-converting enzyme 2 [ACE2] and -membrane protease serine 2 [TMPRSS2]. Many patients complain from pneumonia, cough, fever, and gastrointestinal (GI) problems. Notably, different TRP channels are expressed in various tissues infected by SARS-CoV-2. TRP channels are cation channels that show a common architecture with ","2021","07","23","Chem Biol Interact","Chemico-biological interactions","COVID-19; Prevention; SARS-CoV-2; Symptoms; TRP channels; Treatment","Jaffal","Sahar M","Department of Biological Sciences, Faculty of Science, The University of Jordan, 11942, Amman, Jordan. Electronic address: sjaff333@gmail","sjaff333@gmail.com"
"338","34166652","10.1016/j.cbi.2021.109567","TRP channels in COVID-19 disease: Potential targets for prevention and treatment.","Coronavirus disease 2019 [COVID-19] is a global health threat caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV2] that requires two proteins for entry: angiotensin-converting enzyme 2 [ACE2] and -membrane protease serine 2 [TMPRSS2]. Many patients complain from pneumonia, cough, fever, and gastrointestinal (GI) problems. Notably, different TRP channels are expressed in various tissues infected by SARS-CoV-2. TRP channels are cation channels that show a common architecture with ","2021","07","23","Chem Biol Interact","Chemico-biological interactions","COVID-19; Prevention; SARS-CoV-2; Symptoms; TRP channels; Treatment","Abbas","Manal A","Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, 19328, Amman, Jordan",NA
"339","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Wang","Ruoke","NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Disease Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing 100084, China",NA
"340","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Qi","NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Disease Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing 100084, China",NA
"341","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Ge","Jiwan","The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, Beijing 100084, China",NA
"342","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Ren","Wenlin","Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 100084, China",NA
"343","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Rui","NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Disease Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing 100084, China",NA
"344","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Lan","Jun","The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, Beijing 100084, China",NA
"345","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Ju","Bin","Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital",NA
"346","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Su","Bin","Beijing Youan Hospital, Capital Medical University, Beijing 100069, China",NA
"347","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Yu","Fengting","Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8, Jing Shun Dong Jie, Chaoyang, 100015 District Beijing, China",NA
"348","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Chen","Peng","NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Disease Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing 100084, China",NA
"349","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Liao","Huiyu","Beijing Youan Hospital, Capital Medical University, Beijing 100069, China",NA
"350","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Feng","Yingmei","Beijing Youan Hospital, Capital Medical University, Beijing 100069, China",NA
"351","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Li","Xuemei","Beijing Youan Hospital, Capital Medical University, Beijing 100069, China",NA
"352","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Shi","Xuanling","NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Disease Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing 100084, China",NA
"353","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Zheng","Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital",NA
"354","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Fujie","Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8, Jing Shun Dong Jie, Chaoyang, 100015 District Beijing, China",NA
"355","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Ding","Qiang","Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 100084, China",NA
"356","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Tong","Beijing Youan Hospital, Capital Medical University, Beijing 100069, China. Electronic address: zt_doc@ccmu.edu","doc@ccmu.edu.cn"
"357","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Wang","Xinquan","The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, Beijing 100084, China. Electronic address: xinquanwang@mail.tsinghua.edu","xinquanwang@mail.tsinghua.edu.cn"
"358","34166623","10.1016/j.immuni.2021.06.003","Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy c","2021","07","22","Immunity","Immunity","SARS-CoV-2; antibody; immune escape; neutralization; variant of concern; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigenic Variation; COVID-19; Host Specificity; Humans; Immune Evasion; Mice; Mink; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Linqi","NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Disease Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing 100084, China","zhanglinqi@tsinghua.edu.cn"
"359","34166621","10.1016/S1473-3099(21)00355-8","COVID-19 and SOS tweets in India.",NA,"2021","06","26","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Jena","Anuraag","Department of Gastroenterology, Post Graduate Institute of Medical Education &amp","anuraag2destiny@gmail.com"
"360","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Nagler","Adi","Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel",NA
"361","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Kalaora","Shelly","Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel",NA
"362","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Barbolin","Chaya","Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel",NA
"363","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Gangaev","Anastasia","Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, the Netherlands",NA
"364","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Ketelaars","Steven L C","Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, the Netherlands",NA
"365","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Alon","Michal","Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel",NA
"366","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Pai","Joy","Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA",NA
"367","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Benedek","Gil","Tissue Typing and Immunogenetics Unit, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel",NA
"368","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Yahalom-Ronen","Yfat","Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel",NA
"369","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Erez","Noam","Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel",NA
"370","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Greenberg","Polina","Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel",NA
"371","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Yagel","Gal","Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel",NA
"372","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Peri","Aviyah","Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel",NA
"373","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Levin","Yishai","The de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel",NA
"374","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Satpathy","Ansuman T","Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA",NA
"375","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Bar-Haim","Erez","Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel",NA
"376","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Paran","Nir","Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel",NA
"377","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Kvistborg","Pia","Tissue Typing and Immunogenetics Unit, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel",NA
"378","34166618","10.1016/j.celrep.2021.109305","Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.","The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes.","2021","07","12","Cell Rep","Cell reports","HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs; Antigen Presentation; Antigens, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Epitopes, T-Lymphocyte; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Peptides; Peptidomimetics; SARS-CoV-2; T-Lymphocytes","Samuels","Yardena","Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. Electronic address: yardena.samuels@weizmann.ac","yardena.samuels@weizmann.ac.il"
"379","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Meng","Bo","Cambridge Institute of Therapeutic Immunology &amp",NA
"380","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Kemp","Steven A","Cambridge Institute of Therapeutic Immunology &amp",NA
"381","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Papa","Guido","MRC - Laboratory of Molecular Biology, Cambridge, UK",NA
"382","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Datir","Rawlings","Cambridge Institute of Therapeutic Immunology &amp",NA
"383","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Ferreira","Isabella A T M","Cambridge Institute of Therapeutic Immunology &amp",NA
"384","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Marelli","Sara","Cambridge Institute of Therapeutic Immunology &amp",NA
"385","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Harvey","William T","Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK",NA
"386","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Lytras","Spyros","MRC - University of Glasgow Centre for Virus Research, Glasgow, UK",NA
"387","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Mohamed","Ahmed","Pirbright Institute, Woking, Surrey, UK",NA
"388","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Gallo","Giulia","Pirbright Institute, Woking, Surrey, UK",NA
"389","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Thakur","Nazia","Pirbright Institute, Woking, Surrey, UK",NA
"390","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Collier","Dami A","Cambridge Institute of Therapeutic Immunology &amp",NA
"391","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Mlcochova","Petra","Cambridge Institute of Therapeutic Immunology &amp",NA
"392","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Duncan","Lidia M","Cambridge Institute of Therapeutic Immunology &amp",NA
"393","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Carabelli","Alessandro M","Department of Medicine, University of Cambridge, Cambridge, UK",NA
"394","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Kenyon","Julia C","Department of Medicine, University of Cambridge, Cambridge, UK",NA
"395","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Lever","Andrew M","Department of Medicine, University of Cambridge, Cambridge, UK",NA
"396","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","De Marco","Anna","Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland",NA
"397","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Saliba","Christian","Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland",NA
"398","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Culap","Katja","Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland",NA
"399","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Cameroni","Elisabetta","Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland",NA
"400","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Matheson","Nicholas J","Cambridge Institute of Therapeutic Immunology &amp",NA
"401","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Piccoli","Luca","Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland",NA
"402","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Corti","Davide","Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland",NA
"403","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","James","Leo C","MRC - Laboratory of Molecular Biology, Cambridge, UK",NA
"404","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Robertson","David L","MRC - University of Glasgow Centre for Virus Research, Glasgow, UK",NA
"405","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Bailey","Dalan","Pirbright Institute, Woking, Surrey, UK. Electronic address: dalan.bailey@pirbright.ac","dalan.bailey@pirbright.ac.uk"
"406","34166617","10.1016/j.celrep.2021.109292","Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.","We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike <U+0394>H69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although <U+0394>H69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. <U+0394>H69/V70 is able","2021","07","12","Cell Rep","Cell reports","Alpha variant; B.1.1.7; COVID-19; SARS-CoV-2; antibody escape; deletion; infectivity; neutralizing antibodies; resistance; spike mutation; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Cell Line; Chlorocebus aethiops; HEK293 Cells; Humans; Immune Evasion; Mutation; Pandemics; Phylogeny; Protein Binding; Recurrence; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Gupta","Ravindra K","Cambridge Institute of Therapeutic Immunology &amp","rkg20@cam.ac.uk"
"407","34166583","10.1002/ar.24677","Withdrawn: A data-mining based analysis of traditional Chinese medicine in diagnosing and treating COVID-19.","Yongshen Fan, Ting Zhao, Yaxue Han, Zi Yang, Shan Fang, Mengqing Zhang, Zhijun Xie, A data-mining based analysis of traditional Chinese medicine in diagnosing and treating COVID-19, The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 2021, (https://doi.org/10.1002/ar.24677). The above article, published online on 24 June 2021 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the journal Editor-in-Chief, Heather F. Smith, Ph.D., ","2021","07","14","Anat Rec (Hoboken)","Anatomical record (Hoboken, N.J. : 2007)",NA,NA,NA,NA,NA
"408","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Margolis","Rebecca D","Department of Anesthesiology Critical Care Medicine, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA",NA
"409","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Berenstain","Laura K","Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA",NA
"410","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Janosy","Norah","Department of Anesthesiology, Children's Hospital Colorado, University of Colorado, Aurora, Colorado, USA",NA
"411","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Yanofsky","Samuel","Department of Anesthesiology Critical Care Medicine, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA",NA
"412","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Tackett","Sean","Department of Medicine and Biostatistics, Epidemiology, and Data Management Core, Johns Hopkins University, Baltimore, Maryland, USA",NA
"413","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Schwartz","Jamie McElrath","Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA",NA
"414","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Lee","Jennifer K","Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA",NA
"415","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Deutsch","Nina","Department of Anesthesiology, Pain and Perioperative Medicine, Children's National Hospital, Washington, District of Columbia, USA",NA
"416","34166544","10.1111/pan.14247","Grow and Advance through Intentional Networking: A pilot program to foster connections within the Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia.","The Women's Empowerment and Leadership Initiative in the Society for Pediatric Anesthesia was established to support women's efforts to achieve promotion, leadership positions, and equity in pediatric anesthesiology through coaching, mentoring, sponsorship, and networking. Career advancement relies on the establishment of mentoring relationships within institutions and at regional and national levels. Prior to the SARS-CoV-2 (COVID-19) pandemic, networking was primarily conducted at large nation","2021","07","16","Paediatr Anaesth","Paediatric anaesthesia","COVID-19; anesthesiology; female; leadership; mentoring; well-being","Sinskey","Jina L","Department of Anesthesia and Perioperative Care, University of California, San Francisco, California, USA",NA
"417","34166540","10.1111/jdv.17476","Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Kim","J E","Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea",NA
"418","34166540","10.1111/jdv.17476","Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Lee","H","Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea",NA
"419","34166540","10.1111/jdv.17476","Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Paik","S S","Department of Pathology, Hanyang University College of Medicine, Seoul, Korea",NA
"420","34166540","10.1111/jdv.17476","Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Moon","J-Y","Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea",NA
"421","34166540","10.1111/jdv.17476","Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Yoon","H J","Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea",NA
"422","34166540","10.1111/jdv.17476","Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Kim","S-H","Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea",NA
"423","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Verderese","John Paul","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"424","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Stepanova","Maria","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"425","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Lam","Brian","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"426","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Racila","Andrei","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"427","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Kolacevski","Andrej","Inova Office of Research, Inova Health System, Falls Church, VA, USA",NA
"428","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Allen","David","Department of Pharmacy, Inova Fairfax Medical Campus, Falls Church, VA, USA",NA
"429","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Hodson","Erin","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"430","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Aslani-Amoli","Bahareh","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"431","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Homeyer","Michael","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"432","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Stanmyre","Sarah","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"433","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Stevens","Helen","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"434","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Garofalo","Stephanie","Inova Office of Research, Inova Health System, Falls Church, VA, USA",NA
"435","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Henry","Linda","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"436","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Venkatesan","Chapy","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"437","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Gerber","Lynn H","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"438","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Motew","Steve","Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA",NA
"439","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Jones","J Stephen","Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA",NA
"440","34166513","10.1093/cid/ciab579","Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.","Neutralizing monoclonal antibody (NmAb) treatments have received emergency use authorization to treat patients with mild or moderate COVID-19 infection. To date, no real- world data about the efficacy of NmAb has been reported from clinical practice. We assessed the impact of NmAb treatment given in the outpatient clinical practice setting on hospital utilization. Electronic medical records were used to identify adult COVID-19 patients who received NmAbs [bamlanivimab (BAM) or casirivimab and im","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; immunotherapy; inpatient care; multimorbidity; resource utilization","Younossi","Zobair M","Inova Medicine, Inova Health System, Falls Church, VA, USA",NA
"441","34166510","10.1093/eurheartj/ehab240","The evolution of cardiovascular COVID-19 research.",NA,"2021","06","24","Eur Heart J","European heart journal",NA,"Kotecha","Tushar","Department of Cardiology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK",NA
"442","34166510","10.1093/eurheartj/ehab240","The evolution of cardiovascular COVID-19 research.",NA,"2021","06","24","Eur Heart J","European heart journal",NA,"Knight","Daniel S","Department of Cardiology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK",NA
"443","34166510","10.1093/eurheartj/ehab240","The evolution of cardiovascular COVID-19 research.",NA,"2021","06","24","Eur Heart J","European heart journal",NA,"Moon","James C","Institute of Cardiovascular Science, University College London, London WC1e 6DD, UK",NA
"444","34166510","10.1093/eurheartj/ehab240","The evolution of cardiovascular COVID-19 research.",NA,"2021","06","24","Eur Heart J","European heart journal",NA,"Cole","Graham D","Department of Cardiology, Imperial Healthcare NHS Trust, Du Cane Road, London W12 0HS, UK",NA
"445","34166510","10.1093/eurheartj/ehab240","The evolution of cardiovascular COVID-19 research.",NA,"2021","06","24","Eur Heart J","European heart journal",NA,"Fontana","Marianna","Department of Cardiology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK",NA
"446","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Choe","Pyoeng Gyun","Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea",NA
"447","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Kang","Chang Kyung","Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea",NA
"448","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Kim","Kye-Hyung","Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea",NA
"449","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Yi","Jongyoun","Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, Republic of Korea",NA
"450","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Kim","Eu Suk","Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea",NA
"451","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Park","San Won","Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea",NA
"452","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Kim","Nam Joong","Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea",NA
"453","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Park","Wan Beom","Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea",NA
"454","34166506","10.1093/infdis/jiab339","Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection.",NA,"2021","06","24","J Infect Dis","The Journal of infectious diseases",NA,"Oh","Myoung-Don","Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea",NA
"455","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Mazzola","Alessandra","Sorbonne Université, Unité médicale de transplantation hépatique, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris France",NA
"456","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Todesco","Eve","Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, F-75013 Paris, France",NA
"457","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Drouin","Sarah","Sorbonne Université, Chirurgie urologique, Transplantation rénale, AP-HP, Hôpital Pitié-Salpêtrière, 75013 Paris, France",NA
"458","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Hazan","Fanny","Sorbonne Université, Chirurgie cardiaque et thoracique, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France",NA
"459","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Marot","Stéphane","Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, F-75013 Paris, France",NA
"460","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Thabut","Dominique","Sorbonne Université, Service d'Hépato-gastroentérologie, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France",NA
"461","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Varnous","Sheida","Sorbonne Université, Chirurgie cardiaque et thoracique, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France",NA
"462","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Soulié","Cathia","Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, F-75013 Paris, France",NA
"463","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Barrou","Benoît","Sorbonne Université, Chirurgie urologique, Transplantation rénale, AP-HP, Hôpital Pitié-Salpêtrière, 75013 Paris, France",NA
"464","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Marcelin","Anne-Geneviève","Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, F-75013 Paris, France",NA
"465","34166499","10.1093/cid/ciab580","Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.","A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant-recipients without previous COVID-19. No serious adverse events were recorded. Four severe COVID-19 cases were reported between or after the two doses. Our data suggests to change the vaccine strategy.","2021","06","24","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19 disease; SARS-CoV-2 vaccination; SOT-recipients; anti-spike antibodies; humoral response","Conti","Filomena","Sorbonne Université, Unité médicale de transplantation hépatique, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris France",NA
"466","34166487","10.1093/eurheartj/ehab238","The Janus of COVID-19: from registry data to prospective studies.",NA,"2021","06","24","Eur Heart J","European heart journal",NA,"Sykes","Robert","West of Scotland Heart and Lung Centre, Beardmore Street, Clydebank, G81 4HX, UK",NA
"467","34166487","10.1093/eurheartj/ehab238","The Janus of COVID-19: from registry data to prospective studies.",NA,"2021","06","24","Eur Heart J","European heart journal",NA,"Morrow","Andrew","West of Scotland Heart and Lung Centre, Beardmore Street, Clydebank, G81 4HX, UK",NA
"468","34166487","10.1093/eurheartj/ehab238","The Janus of COVID-19: from registry data to prospective studies.",NA,"2021","06","24","Eur Heart J","European heart journal",NA,"Mangion","Kenneth","West of Scotland Heart and Lung Centre, Beardmore Street, Clydebank, G81 4HX, UK",NA
"469","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","McEwen","Abbye E","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"470","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Cohen","Seth","Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA",NA
"471","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Bryson-Cahn","Chloe","Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA",NA
"472","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Liu","Catherine","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA",NA
"473","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Pergam","Steven A","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA",NA
"474","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Lynch","John","Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA",NA
"475","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Schippers","Adrienne","Department of Infection Prevention and Employee Health, University of Washington Medical Center, Seattle, WA, USA",NA
"476","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Strand","Kathy","Department of Infection Prevention and Employee Health, University of Washington Medical Center, Seattle, WA, USA",NA
"477","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Whimbey","Estella","Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA",NA
"478","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Mani","Nandita S","Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA",NA
"479","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Zelikoff","Allison J","Harborview Medical Center, University of Washington, Seattle, WA, USA",NA
"480","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Makarewicz","Vanessa A","Harborview Medical Center, University of Washington, Seattle, WA, USA",NA
"481","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Brown","Elizabeth R","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA",NA
"482","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Bakhash","Shah A Mohamed","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"483","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Baker","Noah R","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"484","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Castor","Jared","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"485","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Livingston","Robert J","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"486","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Huang","Meei-Li","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"487","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Jerome","Keith R","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"488","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Greninger","Alexander L","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"489","34166484","10.1093/cid/ciab581","Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.","Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3). When compared to 5174 contemporaneous samples sequenced in our laboratory, VOC were significantly enriched among breakthrough infections (p &lt; .05).","2021","07","07","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; sequencing; vaccine breakthrough; variants of concern","Roychoudhury","Pavitra","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA",NA
"490","34166479","10.1371/journal.pone.0253803","Competition, capital growth and risk-taking in emerging markets: Policy implications for banking sector stability during COVID-19 pandemic.","This paper investigates how banking competition and capital level impact on the risk-taking behavior of banking institutions in the Middle East and North Africa (MENA) region. The topic is perceived to be of significant importance during the COVID-19 pandemic. We use data for more than 225 banks in 18 countries in the MENA region to test whether increased competition causes banks to hold higher capital ratios. Employing panel data techniques, and distinguishing between Islamic and conventional b","2021","07","05","PLoS One","PloS one","Africa, Northern; Banking, Personal; COVID-19; Employment; Humans; Models, Economic; Pandemics; Risk-Taking; SARS-CoV-2","Mateev","Miroslav","Abu Dhabi School of Management, Abu Dhabi, UAE",NA
"491","34166479","10.1371/journal.pone.0253803","Competition, capital growth and risk-taking in emerging markets: Policy implications for banking sector stability during COVID-19 pandemic.","This paper investigates how banking competition and capital level impact on the risk-taking behavior of banking institutions in the Middle East and North Africa (MENA) region. The topic is perceived to be of significant importance during the COVID-19 pandemic. We use data for more than 225 banks in 18 countries in the MENA region to test whether increased competition causes banks to hold higher capital ratios. Employing panel data techniques, and distinguishing between Islamic and conventional b","2021","07","05","PLoS One","PloS one","Africa, Northern; Banking, Personal; COVID-19; Employment; Humans; Models, Economic; Pandemics; Risk-Taking; SARS-CoV-2","Tariq","Muhammad Usman","Abu Dhabi School of Management, Abu Dhabi, UAE",NA
"492","34166479","10.1371/journal.pone.0253803","Competition, capital growth and risk-taking in emerging markets: Policy implications for banking sector stability during COVID-19 pandemic.","This paper investigates how banking competition and capital level impact on the risk-taking behavior of banking institutions in the Middle East and North Africa (MENA) region. The topic is perceived to be of significant importance during the COVID-19 pandemic. We use data for more than 225 banks in 18 countries in the MENA region to test whether increased competition causes banks to hold higher capital ratios. Employing panel data techniques, and distinguishing between Islamic and conventional b","2021","07","05","PLoS One","PloS one","Africa, Northern; Banking, Personal; COVID-19; Employment; Humans; Models, Economic; Pandemics; Risk-Taking; SARS-CoV-2","Sahyouni","Ahmad","Higher Institute for Administrative Development, Damascus University, Damascus, Syria",NA
"493","34166474","10.1371/journal.pone.0253753","The effect of mental health on sleep quality of front-line medical staff during the COVID-19 outbreak in China: A cross-sectional study.","The 2019 coronavirus disease (COVID-19) pandemic is a public health emergency of international concern and poses a challenge to the mental health and sleep quality of front-line medical staff (FMS). The aim of this study was to investigate the sleep quality of FMS during the COVID-19 outbreak in China and analyze the relationship between mental health and sleep quality of FMS. From February 24, 2020 to March 22, 2020, a cross-sectional study was performed with 543 FMS from a medical center in We","2021","07","05","PLoS One","PloS one","Adolescent; Adult; COVID-19; China; Cross-Sectional Studies; Female; Humans; Male; Medical Staff; Mental Health; Middle Aged; Pandemics; SARS-CoV-2; Sleep; Surveys and Questionnaires","Yue","Leiyu","West China School of Nursing, Sichuan University/Department of Mental Health Centre, West China Hospital, Sichuan University, Chengdu, PR China",NA
"494","34166474","10.1371/journal.pone.0253753","The effect of mental health on sleep quality of front-line medical staff during the COVID-19 outbreak in China: A cross-sectional study.","The 2019 coronavirus disease (COVID-19) pandemic is a public health emergency of international concern and poses a challenge to the mental health and sleep quality of front-line medical staff (FMS). The aim of this study was to investigate the sleep quality of FMS during the COVID-19 outbreak in China and analyze the relationship between mental health and sleep quality of FMS. From February 24, 2020 to March 22, 2020, a cross-sectional study was performed with 543 FMS from a medical center in We","2021","07","05","PLoS One","PloS one","Adolescent; Adult; COVID-19; China; Cross-Sectional Studies; Female; Humans; Male; Medical Staff; Mental Health; Middle Aged; Pandemics; SARS-CoV-2; Sleep; Surveys and Questionnaires","Zhao","Rui","Geriatric Psychiatric Ward 2, The Fourth People's Hospital of Chengdu, Chengdu, PR China",NA
"495","34166474","10.1371/journal.pone.0253753","The effect of mental health on sleep quality of front-line medical staff during the COVID-19 outbreak in China: A cross-sectional study.","The 2019 coronavirus disease (COVID-19) pandemic is a public health emergency of international concern and poses a challenge to the mental health and sleep quality of front-line medical staff (FMS). The aim of this study was to investigate the sleep quality of FMS during the COVID-19 outbreak in China and analyze the relationship between mental health and sleep quality of FMS. From February 24, 2020 to March 22, 2020, a cross-sectional study was performed with 543 FMS from a medical center in We","2021","07","05","PLoS One","PloS one","Adolescent; Adult; COVID-19; China; Cross-Sectional Studies; Female; Humans; Male; Medical Staff; Mental Health; Middle Aged; Pandemics; SARS-CoV-2; Sleep; Surveys and Questionnaires","Xiao","Qingqing","West China School of Nursing, Sichuan University/Department of Mental Health Centre, West China Hospital, Sichuan University, Chengdu, PR China",NA
"496","34166474","10.1371/journal.pone.0253753","The effect of mental health on sleep quality of front-line medical staff during the COVID-19 outbreak in China: A cross-sectional study.","The 2019 coronavirus disease (COVID-19) pandemic is a public health emergency of international concern and poses a challenge to the mental health and sleep quality of front-line medical staff (FMS). The aim of this study was to investigate the sleep quality of FMS during the COVID-19 outbreak in China and analyze the relationship between mental health and sleep quality of FMS. From February 24, 2020 to March 22, 2020, a cross-sectional study was performed with 543 FMS from a medical center in We","2021","07","05","PLoS One","PloS one","Adolescent; Adult; COVID-19; China; Cross-Sectional Studies; Female; Humans; Male; Medical Staff; Mental Health; Middle Aged; Pandemics; SARS-CoV-2; Sleep; Surveys and Questionnaires","Zhuo","Yu","West China School of Nursing, Sichuan University/Department of Mental Health Centre, West China Hospital, Sichuan University, Chengdu, PR China",NA
"497","34166474","10.1371/journal.pone.0253753","The effect of mental health on sleep quality of front-line medical staff during the COVID-19 outbreak in China: A cross-sectional study.","The 2019 coronavirus disease (COVID-19) pandemic is a public health emergency of international concern and poses a challenge to the mental health and sleep quality of front-line medical staff (FMS). The aim of this study was to investigate the sleep quality of FMS during the COVID-19 outbreak in China and analyze the relationship between mental health and sleep quality of FMS. From February 24, 2020 to March 22, 2020, a cross-sectional study was performed with 543 FMS from a medical center in We","2021","07","05","PLoS One","PloS one","Adolescent; Adult; COVID-19; China; Cross-Sectional Studies; Female; Humans; Male; Medical Staff; Mental Health; Middle Aged; Pandemics; SARS-CoV-2; Sleep; Surveys and Questionnaires","Yu","Jianying","West China School of Nursing, Sichuan University/Department of Mental Health Centre, West China Hospital, Sichuan University, Chengdu, PR China",NA
"498","34166474","10.1371/journal.pone.0253753","The effect of mental health on sleep quality of front-line medical staff during the COVID-19 outbreak in China: A cross-sectional study.","The 2019 coronavirus disease (COVID-19) pandemic is a public health emergency of international concern and poses a challenge to the mental health and sleep quality of front-line medical staff (FMS). The aim of this study was to investigate the sleep quality of FMS during the COVID-19 outbreak in China and analyze the relationship between mental health and sleep quality of FMS. From February 24, 2020 to March 22, 2020, a cross-sectional study was performed with 543 FMS from a medical center in We","2021","07","05","PLoS One","PloS one","Adolescent; Adult; COVID-19; China; Cross-Sectional Studies; Female; Humans; Male; Medical Staff; Mental Health; Middle Aged; Pandemics; SARS-CoV-2; Sleep; Surveys and Questionnaires","Meng","Xiandong","West China School of Nursing, Sichuan University/Department of Mental Health Centre, West China Hospital, Sichuan University, Chengdu, PR China",NA
"499","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Zhao","Min","Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"500","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Su","Pei-Yi","Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"501","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Castro","Danielle A","Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"502","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Tripler","Therese N","Department of Molecular Biophysics and Biochemistry, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"503","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Hu","Yingxia","Department of Molecular Biophysics and Biochemistry, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"504","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Cook","Matthew","Department of Molecular Biophysics and Biochemistry, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"505","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Ko","Albert I","Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"506","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Farhadian","Shelli F","Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"507","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Israelow","Benjamin","Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"508","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Dela Cruz","Charles S","Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"509","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Xiong","Yong","Department of Molecular Biophysics and Biochemistry, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"510","34166473","10.1371/journal.ppat.1009683","Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.","COVID-19 is a global crisis of unimagined dimensions. Currently, Remedesivir is only fully licensed FDA therapeutic. A major target of the vaccine effort is the SARS-CoV-2 spike-hACE2 interaction, and assessment of efficacy relies on time consuming neutralization assay. Here, we developed a cell fusion assay based upon spike-hACE2 interaction. The system was tested by transient co-transfection of 293T cells, which demonstrated good correlation with standard spike pseudotyping for inhibition by s","2021","07","19","PLoS Pathog","PLoS pathogens","Angiotensin-Converting Enzyme 2; Biological Assay; COVID-19; Cell Fusion; HEK293 Cells; Humans; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transfection; Virus Attachment","Sutton","Richard E","Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America",NA
"511","34166465","10.1371/journal.ppat.1009620","Dating first cases of COVID-19.","Questions persist as to the origin of the COVID-19 pandemic. Evidence is building that its origin as a zoonotic spillover occurred prior to the officially accepted timing of early December, 2019. Here we provide novel methods to date the origin of COVID-19 cases. We show that six countries had exceptionally early cases, unlikely to represent part of their main case series. The model suggests a likely timing of the first case of COVID-19 in China as November 17 (95% CI October 4). Origination dat","2021","07","05","PLoS Pathog","PLoS pathogens","Animals; COVID-19; China; History, 21st Century; Humans; Pandemics; SARS-CoV-2; Zoonoses","Roberts","David L","Durrell Institute of Conservation and Ecology, School of Anthropology &amp",NA
"512","34166465","10.1371/journal.ppat.1009620","Dating first cases of COVID-19.","Questions persist as to the origin of the COVID-19 pandemic. Evidence is building that its origin as a zoonotic spillover occurred prior to the officially accepted timing of early December, 2019. Here we provide novel methods to date the origin of COVID-19 cases. We show that six countries had exceptionally early cases, unlikely to represent part of their main case series. The model suggests a likely timing of the first case of COVID-19 in China as November 17 (95% CI October 4). Origination dat","2021","07","05","PLoS Pathog","PLoS pathogens","Animals; COVID-19; China; History, 21st Century; Humans; Pandemics; SARS-CoV-2; Zoonoses","Rossman","Jeremy S","School of Biosciences, University of Kent, Canterbury, Kent, United Kingdom",NA
"513","34166465","10.1371/journal.ppat.1009620","Dating first cases of COVID-19.","Questions persist as to the origin of the COVID-19 pandemic. Evidence is building that its origin as a zoonotic spillover occurred prior to the officially accepted timing of early December, 2019. Here we provide novel methods to date the origin of COVID-19 cases. We show that six countries had exceptionally early cases, unlikely to represent part of their main case series. The model suggests a likely timing of the first case of COVID-19 in China as November 17 (95% CI October 4). Origination dat","2021","07","05","PLoS Pathog","PLoS pathogens","Animals; COVID-19; China; History, 21st Century; Humans; Pandemics; SARS-CoV-2; Zoonoses","Jaric","Ivan","Biology Centre of the Czech Academy of Sciences, Institute of Hydrobiology, Ceské Budejovice, Czech Republic",NA
"514","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Chow","Ronald","Yale School of Public Health, Yale University, New Haven, Connecticut, United States of America",NA
"515","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Im","James","Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"516","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Chiu","Nicholas","Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts, United States of America",NA
"517","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Chiu","Leonard","Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York City, New York, United States of America",NA
"518","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Aggarwal","Rahul","Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts, United States of America",NA
"519","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Lee","Jihui","Weill Cornell Medicine, New York, New York, United States of America",NA
"520","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Choi","Young-Geun","Sookmyung Women's University, Seoul, Korea",NA
"521","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Prsic","Elizabeth Horn","Yale New Haven Health, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America",NA
"522","34166458","10.1371/journal.pone.0253576","The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.","Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. Literatures were searched from January 2019 to December 2020 to identify studies that reported the association between statin usage and adverse outcomes, including mortality, ICU admissions, and mechanical ventilation. Studies were met","2021","07","05","PLoS One","PloS one","COVID-19; Cytokine Release Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2","Shin","Hyun Joon","Hanyang Impact Science Research Center, Seoul, Korea",NA
"523","34166444","10.1371/journal.pone.0253651","Nursing students' attitude on the practice of e-learning: A cross-sectional survey amid COVID-19 in Nepal.","In present days, the use of information technology (IT) in education is unquestionable. The mounting advancement of IT has changed the scenario of education. With the emergence of the current COVID-19 situation, it has undoubtedly provided a solution to most of our educational needs when all educational institutions remained closed due to the pandemic. This study aims to identify the nursing students' attitude towards the practice of e-learning amidst COVID-19. A descriptive web-based cross-sect","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Attitude; COVID-19; Cross-Sectional Studies; Education, Distance; Education, Nursing; Female; Humans; Learning; Male; Nepal; SARS-CoV-2; Students, Nursing; Surveys and Questionnaires","Thapa","Pratima","Department of Nursing, Maternal Health Nursing, College of Medical Sciences, Kathmandu University, Chitwan, Nepal",NA
"524","34166444","10.1371/journal.pone.0253651","Nursing students' attitude on the practice of e-learning: A cross-sectional survey amid COVID-19 in Nepal.","In present days, the use of information technology (IT) in education is unquestionable. The mounting advancement of IT has changed the scenario of education. With the emergence of the current COVID-19 situation, it has undoubtedly provided a solution to most of our educational needs when all educational institutions remained closed due to the pandemic. This study aims to identify the nursing students' attitude towards the practice of e-learning amidst COVID-19. A descriptive web-based cross-sect","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Attitude; COVID-19; Cross-Sectional Studies; Education, Distance; Education, Nursing; Female; Humans; Learning; Male; Nepal; SARS-CoV-2; Students, Nursing; Surveys and Questionnaires","Bhandari","Suman Lata","Department of Nursing, Medical-Surgical Nursing, Manmohan Memorial Institute of Health Sciences, Tribhuvan University, Kathmandu, Nepal",NA
"525","34166444","10.1371/journal.pone.0253651","Nursing students' attitude on the practice of e-learning: A cross-sectional survey amid COVID-19 in Nepal.","In present days, the use of information technology (IT) in education is unquestionable. The mounting advancement of IT has changed the scenario of education. With the emergence of the current COVID-19 situation, it has undoubtedly provided a solution to most of our educational needs when all educational institutions remained closed due to the pandemic. This study aims to identify the nursing students' attitude towards the practice of e-learning amidst COVID-19. A descriptive web-based cross-sect","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Attitude; COVID-19; Cross-Sectional Studies; Education, Distance; Education, Nursing; Female; Humans; Learning; Male; Nepal; SARS-CoV-2; Students, Nursing; Surveys and Questionnaires","Pathak","Sharada","Department of Nursing, Medical-Surgical Nursing, Chitwan Medical College, Tribhuvan University, Chitwan, Nepal",NA
"526","34166441","10.1371/journal.pone.0253665","Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use.","The COVID-19 pandemic has rapidly transformed how healthcare is delivered to limit the transmission of the virus. This descriptive cross-sectional study explored the current use of virtual visits in providing care among primary care providers in southwestern Ontario during the first wave of the COVID-19 pandemic and the anticipated level of utilization post-pandemic. It also explored clinicians' perceptions of the available support tools and resources and challenges to incorporating virtual visi","2021","07","05","PLoS One","PloS one","COVID-19; Cross-Sectional Studies; Female; Health Personnel; Humans; Male; Ontario; Pandemics; Primary Health Care; SARS-CoV-2; Telemedicine","Mohammed","Heba Tallah","eHealth Centre of Excellence, Kitchener, Ontario, Canada",NA
"527","34166441","10.1371/journal.pone.0253665","Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use.","The COVID-19 pandemic has rapidly transformed how healthcare is delivered to limit the transmission of the virus. This descriptive cross-sectional study explored the current use of virtual visits in providing care among primary care providers in southwestern Ontario during the first wave of the COVID-19 pandemic and the anticipated level of utilization post-pandemic. It also explored clinicians' perceptions of the available support tools and resources and challenges to incorporating virtual visi","2021","07","05","PLoS One","PloS one","COVID-19; Cross-Sectional Studies; Female; Health Personnel; Humans; Male; Ontario; Pandemics; Primary Health Care; SARS-CoV-2; Telemedicine","Hyseni","Lirije","eHealth Centre of Excellence, Kitchener, Ontario, Canada",NA
"528","34166441","10.1371/journal.pone.0253665","Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use.","The COVID-19 pandemic has rapidly transformed how healthcare is delivered to limit the transmission of the virus. This descriptive cross-sectional study explored the current use of virtual visits in providing care among primary care providers in southwestern Ontario during the first wave of the COVID-19 pandemic and the anticipated level of utilization post-pandemic. It also explored clinicians' perceptions of the available support tools and resources and challenges to incorporating virtual visi","2021","07","05","PLoS One","PloS one","COVID-19; Cross-Sectional Studies; Female; Health Personnel; Humans; Male; Ontario; Pandemics; Primary Health Care; SARS-CoV-2; Telemedicine","Bui","Victoria","Hamilton Family Health Team, Hamilton, Ontario, Canada",NA
"529","34166441","10.1371/journal.pone.0253665","Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use.","The COVID-19 pandemic has rapidly transformed how healthcare is delivered to limit the transmission of the virus. This descriptive cross-sectional study explored the current use of virtual visits in providing care among primary care providers in southwestern Ontario during the first wave of the COVID-19 pandemic and the anticipated level of utilization post-pandemic. It also explored clinicians' perceptions of the available support tools and resources and challenges to incorporating virtual visi","2021","07","05","PLoS One","PloS one","COVID-19; Cross-Sectional Studies; Female; Health Personnel; Humans; Male; Ontario; Pandemics; Primary Health Care; SARS-CoV-2; Telemedicine","Gerritsen","Beth","eHealth Centre of Excellence, Kitchener, Ontario, Canada",NA
"530","34166441","10.1371/journal.pone.0253665","Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use.","The COVID-19 pandemic has rapidly transformed how healthcare is delivered to limit the transmission of the virus. This descriptive cross-sectional study explored the current use of virtual visits in providing care among primary care providers in southwestern Ontario during the first wave of the COVID-19 pandemic and the anticipated level of utilization post-pandemic. It also explored clinicians' perceptions of the available support tools and resources and challenges to incorporating virtual visi","2021","07","05","PLoS One","PloS one","COVID-19; Cross-Sectional Studies; Female; Health Personnel; Humans; Male; Ontario; Pandemics; Primary Health Care; SARS-CoV-2; Telemedicine","Fuller","Katherine","Department of Medicine, McMaster University, Hamilton, Ontario, Canada",NA
"531","34166441","10.1371/journal.pone.0253665","Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use.","The COVID-19 pandemic has rapidly transformed how healthcare is delivered to limit the transmission of the virus. This descriptive cross-sectional study explored the current use of virtual visits in providing care among primary care providers in southwestern Ontario during the first wave of the COVID-19 pandemic and the anticipated level of utilization post-pandemic. It also explored clinicians' perceptions of the available support tools and resources and challenges to incorporating virtual visi","2021","07","05","PLoS One","PloS one","COVID-19; Cross-Sectional Studies; Female; Health Personnel; Humans; Male; Ontario; Pandemics; Primary Health Care; SARS-CoV-2; Telemedicine","Sung","Jihyun","Department of Medicine, McMaster University, Hamilton, Ontario, Canada",NA
"532","34166441","10.1371/journal.pone.0253665","Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use.","The COVID-19 pandemic has rapidly transformed how healthcare is delivered to limit the transmission of the virus. This descriptive cross-sectional study explored the current use of virtual visits in providing care among primary care providers in southwestern Ontario during the first wave of the COVID-19 pandemic and the anticipated level of utilization post-pandemic. It also explored clinicians' perceptions of the available support tools and resources and challenges to incorporating virtual visi","2021","07","05","PLoS One","PloS one","COVID-19; Cross-Sectional Studies; Female; Health Personnel; Humans; Male; Ontario; Pandemics; Primary Health Care; SARS-CoV-2; Telemedicine","Alarakhia","Mohamed","eHealth Centre of Excellence, Kitchener, Ontario, Canada",NA
"533","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Nishida","Sachiyo","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"534","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Nagaishi","Kanna","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"535","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Motoya","Masayo","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"536","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Kumagai","Ayako","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"537","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Terada","Noriko","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"538","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Kasuga","Ai","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"539","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Kubota","Narumi","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"540","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Iesato","Kotoe","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"541","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Kimizuka","Motonobu","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"542","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Miyajima","Satsuki","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"543","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Koyama","Masayuki","Department of Public Health, Sapporo Medical University, Sapporo, Japan",NA
"544","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Ohnishi","Hirofumi","Department of Public Health, Sapporo Medical University, Sapporo, Japan",NA
"545","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Narimatsu","Eichi","Department of Emergency Medicine, Sapporo Medical University, Sapporo, Japan",NA
"546","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Masumori","Naoya","Department of Urology, Sapporo Medical University, Sapporo, Japan",NA
"547","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Tsuchihashi","Kazufumi","Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Sapporo, Japan",NA
"548","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Tsukamoto","Taiji","Department of University Administration, Sapporo Medical University, Sapporo, Japan",NA
"549","34166439","10.1371/journal.pone.0253646","Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic.","Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. T","2021","07","05","PLoS One","PloS one","Adult; Aged; COVID-19; Female; Humans; Japan; Middle Aged; Mothers; Pandemics; Physicians, Women; SARS-CoV-2; Surveys and Questionnaires; Women, Working","Tsuji","Yoshihisa","The Physicians' Career Support Committee, Sapporo Medical University, Sapporo, Japan",NA
"550","34166429","10.1371/journal.pone.0253087","Mechanisms of parental distress during and after the first COVID-19 lockdown phase: A two-wave longitudinal study.","In these unpredictable times of the global coronavirus disease 2019 (COVID-19) pandemic, parents worldwide are affected by the stress and strain caused by the physical distancing protocols that have been put in place. In a two-wave longitudinal survey, we investigated the levels of parental stress and symptoms of anxiety and depression in a sample of parents at two time points; during the implementation of the strictest physical distancing protocols following the onset of the COVID-19 pandemic (","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Anxiety; COVID-19; Child; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Parents; Quarantine; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Johnson","Miriam S","Oslo Metropolitan University, Oslo, Norway",NA
"551","34166429","10.1371/journal.pone.0253087","Mechanisms of parental distress during and after the first COVID-19 lockdown phase: A two-wave longitudinal study.","In these unpredictable times of the global coronavirus disease 2019 (COVID-19) pandemic, parents worldwide are affected by the stress and strain caused by the physical distancing protocols that have been put in place. In a two-wave longitudinal survey, we investigated the levels of parental stress and symptoms of anxiety and depression in a sample of parents at two time points; during the implementation of the strictest physical distancing protocols following the onset of the COVID-19 pandemic (","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Anxiety; COVID-19; Child; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Parents; Quarantine; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Skjerdingstad","Nora","Department of Psychology, University of Oslo, Oslo, Norway",NA
"552","34166429","10.1371/journal.pone.0253087","Mechanisms of parental distress during and after the first COVID-19 lockdown phase: A two-wave longitudinal study.","In these unpredictable times of the global coronavirus disease 2019 (COVID-19) pandemic, parents worldwide are affected by the stress and strain caused by the physical distancing protocols that have been put in place. In a two-wave longitudinal survey, we investigated the levels of parental stress and symptoms of anxiety and depression in a sample of parents at two time points; during the implementation of the strictest physical distancing protocols following the onset of the COVID-19 pandemic (","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Anxiety; COVID-19; Child; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Parents; Quarantine; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Ebrahimi","Omid V","Department of Psychology, University of Oslo, Oslo, Norway",NA
"553","34166429","10.1371/journal.pone.0253087","Mechanisms of parental distress during and after the first COVID-19 lockdown phase: A two-wave longitudinal study.","In these unpredictable times of the global coronavirus disease 2019 (COVID-19) pandemic, parents worldwide are affected by the stress and strain caused by the physical distancing protocols that have been put in place. In a two-wave longitudinal survey, we investigated the levels of parental stress and symptoms of anxiety and depression in a sample of parents at two time points; during the implementation of the strictest physical distancing protocols following the onset of the COVID-19 pandemic (","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Anxiety; COVID-19; Child; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Parents; Quarantine; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Hoffart","Asle","Department of Psychology, University of Oslo, Oslo, Norway",NA
"554","34166429","10.1371/journal.pone.0253087","Mechanisms of parental distress during and after the first COVID-19 lockdown phase: A two-wave longitudinal study.","In these unpredictable times of the global coronavirus disease 2019 (COVID-19) pandemic, parents worldwide are affected by the stress and strain caused by the physical distancing protocols that have been put in place. In a two-wave longitudinal survey, we investigated the levels of parental stress and symptoms of anxiety and depression in a sample of parents at two time points; during the implementation of the strictest physical distancing protocols following the onset of the COVID-19 pandemic (","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Anxiety; COVID-19; Child; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Parents; Quarantine; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Urnes Johnson","Sverre","Department of Psychology, University of Oslo, Oslo, Norway",NA
"555","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Wen","Feng","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"556","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Yang","Jing","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"557","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Li","Anqi","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"558","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Gong","Zhonggui","Center for Animal Disease Control and Prevention, Shaoguan, Guangdong, China",NA
"559","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Yang","Lulu","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"560","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Cheng","Qing","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"561","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Wang","Congying","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"562","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Zhao","Mengmeng","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"563","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Yuan","Sheng","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"564","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Chen","Yao","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"565","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","El-Ashram","Saeed","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"566","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Li","Yong","College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang, Jiangxi, China",NA
"567","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Yu","Hai","Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China",NA
"568","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Guo","Jinyue","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"569","34166425","10.1371/journal.pone.0253622","Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019.","Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis v","2021","07","05","PLoS One","PloS one","Alphacoronavirus; Animals; China; Coronavirus Infections; Disease Outbreaks; Phylogeny; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Transmissible gastroenteritis virus","Huang","Shujian","College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China",NA
"570","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Coil","David A","Genome Center, University of California, Davis, California, United States of America",NA
"571","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Albertson","Timothy","Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, California, United States of America",NA
"572","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Banerjee","Shefali","Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California, United States of America",NA
"573","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Brennan","Greg","Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California, United States of America",NA
"574","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Campbell","A J","Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, California, United States of America",NA
"575","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Cohen","Stuart H","Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, University of California, Davis, California, United States of America",NA
"576","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Dandekar","Satya","Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California, United States of America",NA
"577","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Díaz-Muñoz","Samuel L","Genome Center, University of California, Davis, California, United States of America",NA
"578","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Eisen","Jonathan A","Genome Center, University of California, Davis, California, United States of America",NA
"579","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Goldstein","Tracey","One Health Institute, University of California, Davis, California, United States of America",NA
"580","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Jose","Ivy R","Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, California, United States of America",NA
"581","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Juarez","Maya","Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, California, United States of America",NA
"582","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Robinson","Brandt A","Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, California, United States of America",NA
"583","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Rothenburg","Stefan","Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California, United States of America",NA
"584","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Sandrock","Christian","Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, California, United States of America",NA
"585","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Stoian","Ana M M","Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California, United States of America",NA
"586","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Tompkins","Daniel G","Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, California, United States of America",NA
"587","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Tremeau-Bravard","Alexandre","One Health Institute, University of California, Davis, California, United States of America",NA
"588","34166421","10.1371/journal.pone.0253578","SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.","There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and ","2021","07","05","PLoS One","PloS one","Animals; COVID-19; Chlorocebus aethiops; Genome, Viral; Hospitals, Teaching; Humans; Phylogeny; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells","Haczku","Angela","Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, California, United States of America",NA
"589","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Horn","Abigail L","Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America",NA
"590","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Jiang","Lai","Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America",NA
"591","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Washburn","Faith","Los Angeles County Department of Public Health, Los Angeles, CA, United States of America",NA
"592","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Hvitfeldt","Emil","Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America",NA
"593","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","de la Haye","Kayla","Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America",NA
"594","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Nicholas","William","Los Angeles County Department of Public Health, Los Angeles, CA, United States of America",NA
"595","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Simon","Paul","Los Angeles County Department of Public Health, Los Angeles, CA, United States of America",NA
"596","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Pentz","Maryann","Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America",NA
"597","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Cozen","Wendy","Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America",NA
"598","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Sood","Neeraj","Sol Price School of Public Policy, University of Southern California, Los Angeles, CA, United States of America",NA
"599","34166416","10.1371/journal.pone.0253549","An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021.","The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning t","2021","07","05","PLoS One","PloS one","COVID-19; California; Female; Humans; Male; Models, Biological; Risk Assessment; SARS-CoV-2","Conti","David V","Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America",NA
"600","34166411","10.1371/journal.pone.0253004","Characterizing two outbreak waves of COVID-19 in Spain using phenomenological epidemic modelling.","Since the first case reported of SARS-CoV-2 the end of December 2019 in China, the number of cases quickly climbed following an exponential growth trend, demonstrating that a global pandemic is possible. As of December 3, 2020, the total number of cases reported are around 65,527,000 contagions worldwide, and 1,524,000 deaths affecting 218 countries and territories. In this scenario, Spain is one of the countries that has suffered in a hard way, the ongoing epidemic caused by the novel coronavir","2021","07","05","PLoS One","PloS one","COVID-19; Humans; Models, Biological; Pandemics; SARS-CoV-2; Spain","López","Miguel","Department of Telecommunications Engineering, University of Malaga, Malaga, Spain",NA
"601","34166411","10.1371/journal.pone.0253004","Characterizing two outbreak waves of COVID-19 in Spain using phenomenological epidemic modelling.","Since the first case reported of SARS-CoV-2 the end of December 2019 in China, the number of cases quickly climbed following an exponential growth trend, demonstrating that a global pandemic is possible. As of December 3, 2020, the total number of cases reported are around 65,527,000 contagions worldwide, and 1,524,000 deaths affecting 218 countries and territories. In this scenario, Spain is one of the countries that has suffered in a hard way, the ongoing epidemic caused by the novel coronavir","2021","07","05","PLoS One","PloS one","COVID-19; Humans; Models, Biological; Pandemics; SARS-CoV-2; Spain","Peinado","Alberto","Department of Telecommunications Engineering, University of Malaga, Malaga, Spain",NA
"602","34166411","10.1371/journal.pone.0253004","Characterizing two outbreak waves of COVID-19 in Spain using phenomenological epidemic modelling.","Since the first case reported of SARS-CoV-2 the end of December 2019 in China, the number of cases quickly climbed following an exponential growth trend, demonstrating that a global pandemic is possible. As of December 3, 2020, the total number of cases reported are around 65,527,000 contagions worldwide, and 1,524,000 deaths affecting 218 countries and territories. In this scenario, Spain is one of the countries that has suffered in a hard way, the ongoing epidemic caused by the novel coronavir","2021","07","05","PLoS One","PloS one","COVID-19; Humans; Models, Biological; Pandemics; SARS-CoV-2; Spain","Ortiz","Andrés","Department of Telecommunications Engineering, University of Malaga, Malaga, Spain",NA
"603","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Ngo Nsoga","Marie Thérèse","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"604","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Kronig","Ilona","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"605","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Perez Rodriguez","Francisco Javier","Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland",NA
"606","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Sattonnet-Roche","Pascale","Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland",NA
"607","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Da Silva","Diogo","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"608","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Helbling","Javan","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"609","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Sacks","Jilian A","Foundation for Innovative New Diagnostics, Geneva, Switzerland",NA
"610","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","de Vos","Margaretha","Foundation for Innovative New Diagnostics, Geneva, Switzerland",NA
"611","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Boehm","Erik","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"612","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Gayet-Ageron","Angèle","CRC &amp",NA
"613","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Berger","Alice","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"614","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Jacquerioz-Bausch","Frédérique","Department of Primary Care, Geneva University Hospitals, Geneva, Switzerland",NA
"615","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Chappuis","François","Department of Primary Care, Geneva University Hospitals, Geneva, Switzerland",NA
"616","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Kaiser","Laurent","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"617","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Schibler","Manuel","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"618","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Renzoni","Adriana","Laboratory Medicine Division, Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland",NA
"619","34166410","10.1371/journal.pone.0253321","Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.","Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantita","2021","07","05","PLoS One","PloS one","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Humans; Nasopharynx; Prospective Studies; SARS-CoV-2; Switzerland","Eckerle","Isabella","Infectious Disease Division, Geneva University Hospitals, Geneva, Switzerland",NA
"620","34166399","10.1371/journal.pone.0253499","Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia.","Scientists across the world are working on innovating a successful vaccine that will save lives and end COVID-19 pandemic. World Health Organization (WHO) is working to make sure COVID-19 vaccines can be safely delivered to all those who need them. Indeed, the successful deployment and a sufficient uptake of vaccines is equally important. Acceptance and accessibility of such vaccine is a key indicator of vaccination coverage. This study aimed to assess the determinants of intention to receive CO","2021","07","05","PLoS One","PloS one","Adult; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Ethiopia; Female; Humans; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; School Teachers; Vaccination","Handebo","Simegnew","Department of Health Education and Behavioral Sciences, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia",NA
"621","34166399","10.1371/journal.pone.0253499","Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia.","Scientists across the world are working on innovating a successful vaccine that will save lives and end COVID-19 pandemic. World Health Organization (WHO) is working to make sure COVID-19 vaccines can be safely delivered to all those who need them. Indeed, the successful deployment and a sufficient uptake of vaccines is equally important. Acceptance and accessibility of such vaccine is a key indicator of vaccination coverage. This study aimed to assess the determinants of intention to receive CO","2021","07","05","PLoS One","PloS one","Adult; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Ethiopia; Female; Humans; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; School Teachers; Vaccination","Wolde","Maereg","Department of Health Education and Behavioral Sciences, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia",NA
"622","34166399","10.1371/journal.pone.0253499","Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia.","Scientists across the world are working on innovating a successful vaccine that will save lives and end COVID-19 pandemic. World Health Organization (WHO) is working to make sure COVID-19 vaccines can be safely delivered to all those who need them. Indeed, the successful deployment and a sufficient uptake of vaccines is equally important. Acceptance and accessibility of such vaccine is a key indicator of vaccination coverage. This study aimed to assess the determinants of intention to receive CO","2021","07","05","PLoS One","PloS one","Adult; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Ethiopia; Female; Humans; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; School Teachers; Vaccination","Shitu","Kegnie","Department of Health Education and Behavioral Sciences, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia",NA
"623","34166399","10.1371/journal.pone.0253499","Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia.","Scientists across the world are working on innovating a successful vaccine that will save lives and end COVID-19 pandemic. World Health Organization (WHO) is working to make sure COVID-19 vaccines can be safely delivered to all those who need them. Indeed, the successful deployment and a sufficient uptake of vaccines is equally important. Acceptance and accessibility of such vaccine is a key indicator of vaccination coverage. This study aimed to assess the determinants of intention to receive CO","2021","07","05","PLoS One","PloS one","Adult; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Ethiopia; Female; Humans; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; School Teachers; Vaccination","Kassie","Ayenew","Department of Health Education and Behavioral Sciences, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia",NA
"624","34166398","10.1371/journal.pone.0253089","SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-<U+03BA>B activation early during virus infection. We also identify that the SARS-CoV-2 viral protei","2021","07","05","PLoS One","PloS one","Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; COVID-19; Cell Nucleus; HeLa Cells; Humans; Interferon Regulatory Factor-3; NF-kappa B; Phosphorylation; Protein-Serine-Threonine Kinases; RNA-Binding Proteins; SARS-CoV-2; Signal Transduction; Viral Nonstructural Proteins","Vazquez","Christine","Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America",NA
"625","34166398","10.1371/journal.pone.0253089","SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-<U+03BA>B activation early during virus infection. We also identify that the SARS-CoV-2 viral protei","2021","07","05","PLoS One","PloS one","Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; COVID-19; Cell Nucleus; HeLa Cells; Humans; Interferon Regulatory Factor-3; NF-kappa B; Phosphorylation; Protein-Serine-Threonine Kinases; RNA-Binding Proteins; SARS-CoV-2; Signal Transduction; Viral Nonstructural Proteins","Swanson","Sydnie E","Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America",NA
"626","34166398","10.1371/journal.pone.0253089","SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-<U+03BA>B activation early during virus infection. We also identify that the SARS-CoV-2 viral protei","2021","07","05","PLoS One","PloS one","Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; COVID-19; Cell Nucleus; HeLa Cells; Humans; Interferon Regulatory Factor-3; NF-kappa B; Phosphorylation; Protein-Serine-Threonine Kinases; RNA-Binding Proteins; SARS-CoV-2; Signal Transduction; Viral Nonstructural Proteins","Negatu","Seble G","Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America",NA
"627","34166398","10.1371/journal.pone.0253089","SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-<U+03BA>B activation early during virus infection. We also identify that the SARS-CoV-2 viral protei","2021","07","05","PLoS One","PloS one","Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; COVID-19; Cell Nucleus; HeLa Cells; Humans; Interferon Regulatory Factor-3; NF-kappa B; Phosphorylation; Protein-Serine-Threonine Kinases; RNA-Binding Proteins; SARS-CoV-2; Signal Transduction; Viral Nonstructural Proteins","Dittmar","Mark","Department Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America",NA
"628","34166398","10.1371/journal.pone.0253089","SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-<U+03BA>B activation early during virus infection. We also identify that the SARS-CoV-2 viral protei","2021","07","05","PLoS One","PloS one","Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; COVID-19; Cell Nucleus; HeLa Cells; Humans; Interferon Regulatory Factor-3; NF-kappa B; Phosphorylation; Protein-Serine-Threonine Kinases; RNA-Binding Proteins; SARS-CoV-2; Signal Transduction; Viral Nonstructural Proteins","Miller","Jesse","Department Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America",NA
"629","34166398","10.1371/journal.pone.0253089","SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-<U+03BA>B activation early during virus infection. We also identify that the SARS-CoV-2 viral protei","2021","07","05","PLoS One","PloS one","Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; COVID-19; Cell Nucleus; HeLa Cells; Humans; Interferon Regulatory Factor-3; NF-kappa B; Phosphorylation; Protein-Serine-Threonine Kinases; RNA-Binding Proteins; SARS-CoV-2; Signal Transduction; Viral Nonstructural Proteins","Ramage","Holly R","Department of Microbiology and Immunology, Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, United States of America",NA
"630","34166398","10.1371/journal.pone.0253089","SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-<U+03BA>B activation early during virus infection. We also identify that the SARS-CoV-2 viral protei","2021","07","05","PLoS One","PloS one","Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; COVID-19; Cell Nucleus; HeLa Cells; Humans; Interferon Regulatory Factor-3; NF-kappa B; Phosphorylation; Protein-Serine-Threonine Kinases; RNA-Binding Proteins; SARS-CoV-2; Signal Transduction; Viral Nonstructural Proteins","Cherry","Sara","Department Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America",NA
"631","34166398","10.1371/journal.pone.0253089","SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-<U+03BA>B activation early during virus infection. We also identify that the SARS-CoV-2 viral protei","2021","07","05","PLoS One","PloS one","Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; COVID-19; Cell Nucleus; HeLa Cells; Humans; Interferon Regulatory Factor-3; NF-kappa B; Phosphorylation; Protein-Serine-Threonine Kinases; RNA-Binding Proteins; SARS-CoV-2; Signal Transduction; Viral Nonstructural Proteins","Jurado","Kellie A","Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America",NA
"632","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Mao","Wenhui","Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America",NA
"633","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Ogbuoji","Osondu","Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America",NA
"634","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Watkins","David","Department of Medicine, University of Washington, Seattle, Washington, United States of America",NA
"635","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Bharali","Ipchita","Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America",NA
"636","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Nsiah-Boateng","Eric","National Health Insurance Authority, Accra, Ghana",NA
"637","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Diab","Mohamed Mustafa","Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America",NA
"638","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Dwomoh","Duah","Department of Biostatistics, School of Public Health, College of Health Sciences, University of Ghana, Legon, Ghana",NA
"639","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Jamison","Dean T","Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, United States of America",NA
"640","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Kumar","Preeti","Public Health Foundation of India, New Delhi, India",NA
"641","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Kennedy McDade","Kaci","Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America",NA
"642","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Nonvignon","Justice","Department of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana",NA
"643","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Ogundeji","Yewande","Health Strategy and Delivery Foundation, Abuja, Nigeria",NA
"644","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Zeng","Fan-Gang","Center for Hearing Research, University of California Irvine, Irvine, California, United States of America",NA
"645","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Zimmerman","Armand","Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America",NA
"646","34166391","10.1371/journal.pmed.1003675","Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.","Wenhui Mao and coauthors discuss possible implications of the COVID-19 pandemic for health aspirations in low- and middle-income countries.","2021","07","20","PLoS Med","PLoS medicine","COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; Mortality; Universal Health Insurance","Yamey","Gavin","Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America",NA
"647","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","Deol","Arminder K","Department of Infectious Disease Epidemiology, TB Centre, The London School of Hygiene &amp",NA
"648","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","Scarponi","Danny","Department of Infectious Disease Epidemiology, TB Centre, The London School of Hygiene &amp",NA
"649","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","Beckwith","Peter","Department of Medicine, University of Cape Town, Cape Town, South Africa",NA
"650","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","Yates","Tom A","Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom",NA
"651","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","Karat","Aaron S","Department of Infectious Disease Epidemiology, TB Centre, The London School of Hygiene &amp",NA
"652","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","Yan","Ada W C","Section of Immunology of Infection, Department of Infectious Disease, Imperial College London, London, United Kingdom",NA
"653","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","Baisley","Kathy S","Department of Infectious Disease Epidemiology, The London School of Hygiene &amp",NA
"654","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","Grant","Alison D","Department of Infectious Disease Epidemiology, TB Centre, The London School of Hygiene &amp",NA
"655","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","White","Richard G","Department of Infectious Disease Epidemiology, TB Centre, The London School of Hygiene &amp",NA
"656","34166388","10.1371/journal.pone.0253096","Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.","In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches","2021","07","05","PLoS One","PloS one","Air Microbiology; Air Pollution, Indoor; COVID-19; Humans; Models, Biological; SARS-CoV-2; Ventilation","McCreesh","Nicky","Department of Infectious Disease Epidemiology, TB Centre, The London School of Hygiene &amp",NA
"657","34166369","10.1371/journal.pntd.0009478","Schistosomal appendicitis: Case series and systematic literature review.","Globally, schistosomiasis affects at least 240 million people each year with a high proportion of cases in sub-Saharan Africa. The infection presents a wide range of symptoms mainly at the gastrointestinal and urogenital level. Cases of schistosomiasis-related appendicitis are seldom reported. The aim of the present study is to identify the prevalence of schistosomiasis-related appendicitis in Beira, Mozambique and compare to global prevalence. We retrospectively reviewed all cases of appendicit","2021","07","05","PLoS Negl Trop Dis","PLoS neglected tropical diseases","Adult; Appendicitis; Female; Humans; Male; Prevalence; Retrospective Studies; Schistosomiasis","Zacarias","Mateus","Department of Surgery, Central Hospital of Beira, Beira, Mozambique",NA
"658","34166369","10.1371/journal.pntd.0009478","Schistosomal appendicitis: Case series and systematic literature review.","Globally, schistosomiasis affects at least 240 million people each year with a high proportion of cases in sub-Saharan Africa. The infection presents a wide range of symptoms mainly at the gastrointestinal and urogenital level. Cases of schistosomiasis-related appendicitis are seldom reported. The aim of the present study is to identify the prevalence of schistosomiasis-related appendicitis in Beira, Mozambique and compare to global prevalence. We retrospectively reviewed all cases of appendicit","2021","07","05","PLoS Negl Trop Dis","PLoS neglected tropical diseases","Adult; Appendicitis; Female; Humans; Male; Prevalence; Retrospective Studies; Schistosomiasis","Pizzol","Damiano","Italian Agency for Development Cooperation, Khartoum, Sudan",NA
"659","34166369","10.1371/journal.pntd.0009478","Schistosomal appendicitis: Case series and systematic literature review.","Globally, schistosomiasis affects at least 240 million people each year with a high proportion of cases in sub-Saharan Africa. The infection presents a wide range of symptoms mainly at the gastrointestinal and urogenital level. Cases of schistosomiasis-related appendicitis are seldom reported. The aim of the present study is to identify the prevalence of schistosomiasis-related appendicitis in Beira, Mozambique and compare to global prevalence. We retrospectively reviewed all cases of appendicit","2021","07","05","PLoS Negl Trop Dis","PLoS neglected tropical diseases","Adult; Appendicitis; Female; Humans; Male; Prevalence; Retrospective Studies; Schistosomiasis","de Miranda","Helder","Department of Surgery, Central Hospital of Beira, Beira, Mozambique",NA
"660","34166369","10.1371/journal.pntd.0009478","Schistosomal appendicitis: Case series and systematic literature review.","Globally, schistosomiasis affects at least 240 million people each year with a high proportion of cases in sub-Saharan Africa. The infection presents a wide range of symptoms mainly at the gastrointestinal and urogenital level. Cases of schistosomiasis-related appendicitis are seldom reported. The aim of the present study is to identify the prevalence of schistosomiasis-related appendicitis in Beira, Mozambique and compare to global prevalence. We retrospectively reviewed all cases of appendicit","2021","07","05","PLoS Negl Trop Dis","PLoS neglected tropical diseases","Adult; Appendicitis; Female; Humans; Male; Prevalence; Retrospective Studies; Schistosomiasis","Colangelo","Anna Claudia","Department of Surgery and Organ Transplantation, University of Padua, Padua, Italy",NA
"661","34166369","10.1371/journal.pntd.0009478","Schistosomal appendicitis: Case series and systematic literature review.","Globally, schistosomiasis affects at least 240 million people each year with a high proportion of cases in sub-Saharan Africa. The infection presents a wide range of symptoms mainly at the gastrointestinal and urogenital level. Cases of schistosomiasis-related appendicitis are seldom reported. The aim of the present study is to identify the prevalence of schistosomiasis-related appendicitis in Beira, Mozambique and compare to global prevalence. We retrospectively reviewed all cases of appendicit","2021","07","05","PLoS Negl Trop Dis","PLoS neglected tropical diseases","Adult; Appendicitis; Female; Humans; Male; Prevalence; Retrospective Studies; Schistosomiasis","Veronese","Nicola","Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy",NA
"662","34166369","10.1371/journal.pntd.0009478","Schistosomal appendicitis: Case series and systematic literature review.","Globally, schistosomiasis affects at least 240 million people each year with a high proportion of cases in sub-Saharan Africa. The infection presents a wide range of symptoms mainly at the gastrointestinal and urogenital level. Cases of schistosomiasis-related appendicitis are seldom reported. The aim of the present study is to identify the prevalence of schistosomiasis-related appendicitis in Beira, Mozambique and compare to global prevalence. We retrospectively reviewed all cases of appendicit","2021","07","05","PLoS Negl Trop Dis","PLoS neglected tropical diseases","Adult; Appendicitis; Female; Humans; Male; Prevalence; Retrospective Studies; Schistosomiasis","Smith","Lee","The Cambridge Centre for Sport &amp",NA
"663","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Dillon","Matthew R","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"664","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Bolyen","Evan","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"665","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Adamov","Anja","Laboratory of Food Systems Biotechnology, Institute of Food, Nutrition, and Health, ETH Zürich, Zürich, Switzerland",NA
"666","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Belk","Aeriel","Department of Animal Sciences, Cell and Molecular Biology Special Academic Unit, Colorado State University, Fort Collins, Colorado, United States of America",NA
"667","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Borsom","Emily","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"668","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Burcham","Zachary","Department of Animal Sciences, Cell and Molecular Biology Special Academic Unit, Colorado State University, Fort Collins, Colorado, United States of America",NA
"669","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Debelius","Justine W","Centre for Translational Microbiome Research, Department of Microbiology, Tumor, and Cancer Biology, Karolinska Institutet, Stockholm, Sweden",NA
"670","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Deel","Heather","Department of Animal Sciences, Cell and Molecular Biology Special Academic Unit, Colorado State University, Fort Collins, Colorado, United States of America",NA
"671","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Emmons","Alex","Department of Animal Sciences, Cell and Molecular Biology Special Academic Unit, Colorado State University, Fort Collins, Colorado, United States of America",NA
"672","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Estaki","Mehrbod","Department of Pediatrics, University of California San Diego, San Diego, California, United States of America",NA
"673","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Herman","Chloe","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"674","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Keefe","Christopher R","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"675","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Morton","Jamie T","Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, New York, United States of America",NA
"676","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Oliveira","Renato R M","Environmental Genomics, Instituto Tecnológico Vale, Belém, Pará, Brazil",NA
"677","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Sanchez","Andrew","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"678","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Simard","Anthony","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"679","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Vázquez-Baeza","Yoshiki","Center for Microbiome Innovation, Jacobs School of Engineering, University of California San Diego, San Diego, California, United States of America",NA
"680","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Ziemski","Michal","Laboratory of Food Systems Biotechnology, Institute of Food, Nutrition, and Health, ETH Zürich, Zürich, Switzerland",NA
"681","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Miwa","Hazuki E","Academic Programs, Foundation for Advanced Education in the Sciences at the National Institutes of Health, Bethesda, Maryland, United States of America",NA
"682","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Kerere","Terry A","Academic Programs, Foundation for Advanced Education in the Sciences at the National Institutes of Health, Bethesda, Maryland, United States of America",NA
"683","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Coote","Carline","Academic Programs, Foundation for Advanced Education in the Sciences at the National Institutes of Health, Bethesda, Maryland, United States of America",NA
"684","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Bonneau","Richard","Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, New York, United States of America",NA
"685","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Knight","Rob","Department of Pediatrics, University of California San Diego, San Diego, California, United States of America",NA
"686","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Oliveira","Guilherme","Environmental Genomics, Instituto Tecnológico Vale, Belém, Pará, Brazil",NA
"687","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Gopalasingam","Piraveen","European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridgeshire, United Kingdom",NA
"688","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Kaehler","Benjamin D","School of Science, University of New South Wales, Canberra, Australia",NA
"689","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Cope","Emily K","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"690","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Metcalf","Jessica L","Department of Animal Sciences, Cell and Molecular Biology Special Academic Unit, Colorado State University, Fort Collins, Colorado, United States of America",NA
"691","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Robeson Ii","Michael S","Department of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America",NA
"692","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Bokulich","Nicholas A","Laboratory of Food Systems Biotechnology, Institute of Food, Nutrition, and Health, ETH Zürich, Zürich, Switzerland",NA
"693","34166363","10.1371/journal.pcbi.1009056","Experiences and lessons learned from two virtual, hands-on microbiome bioinformatics workshops.","In October of 2020, in response to the Coronavirus Disease 2019 (COVID-19) pandemic, our team hosted our first fully online workshop teaching the QIIME 2 microbiome bioinformatics platform. We had 75 enrolled participants who joined from at least 25 different countries on 6 continents, and we had 22 instructors on 4 continents. In the 5-day workshop, participants worked hands-on with a cloud-based shared compute cluster that we deployed for this course. The event was well received, and participa","2021","07","09","PLoS Comput Biol","PLoS computational biology","COVID-19; Computational Biology; Feedback; Humans; Microbiota; SARS-CoV-2","Caporaso","J Gregory","Center for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America",NA
"694","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Baack","Brittney N",NA,NA
"695","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Abad","Neetu",NA,NA
"696","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Yankey","David",NA,NA
"697","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Kahn","Katherine E",NA,NA
"698","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Razzaghi","Hilda",NA,NA
"699","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Brookmeyer","Kathryn",NA,NA
"700","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Kolis","Jessica",NA,NA
"701","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Wilhelm","Elisabeth",NA,NA
"702","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Nguyen","Kimberly H",NA,NA
"703","34166337","10.15585/mmwr.mm7025e2","COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.","Since April 19, 2021, all persons aged =16 years in the United States have been eligible to receive a COVID-19 vaccine. As of May 30, 2021, approximately one half of U.S. adults were fully vaccinated, with the lowest coverage and lowest reported intent to get vaccinated among young adults aged 18-39 years (1-4). To examine attitudes toward COVID-19 vaccination and vaccination intent among adults in this age group, CDC conducted nationally representative household panel surveys during March-May 2","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Intention; Male; United States; Vaccination Coverage; Young Adult","Singleton","James A",NA,NA
"704","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Bonwitt","Jesse",NA,NA
"705","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Deya","Ruth W",NA,NA
"706","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Currie","Dustin W",NA,NA
"707","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Lipton","Beth",NA,NA
"708","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Huntington-Frazier","Melinda",NA,NA
"709","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Sanford","Sara Jaye",NA,NA
"710","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Pallickaparambil","Aley Joseph",NA,NA
"711","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Hood","Julia",NA,NA
"712","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Rao","Agam K",NA,NA
"713","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Kelly-Reif","Kaitlin",NA,NA
"714","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Luckhaupt","Sara E",NA,NA
"715","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Pogosjans","Sargis",NA,NA
"716","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Lindquist","Scott",NA,NA
"717","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Duchin","Jeff",NA,NA
"718","34166336","10.15585/mmwr.mm7025a3","COVID-19 Surveillance and Investigations in Workplaces - Seattle &amp; King County, Washington, June 15-November 15, 2020.","Workplace activities involving close contact with coworkers and customers can lead to transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). Information on the approach to and effectiveness of COVID-19 workplace investigations is limited. In May 2020, Public Health - Seattle &amp; King County (PHSKC), King County, Washington established a COVID-19 workplace surveillance and response system to enhance COVID-19 contact tracing and identify outbreaks in workplaces. During June 15-Novembe","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","COVID-19; Contact Tracing; Humans; Interprofessional Relations; Occupational Health; Public Health Surveillance; Washington; Workplace","Kawakami","Vance",NA,NA
"719","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Diesel","Jill",NA,NA
"720","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Sterrett","Natalie",NA,NA
"721","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Dasgupta","Sharoda",NA,NA
"722","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Kriss","Jennifer L",NA,NA
"723","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Barry","Vaughn",NA,NA
"724","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Vanden Esschert","Kayla",NA,NA
"725","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Whiteman","Ari",NA,NA
"726","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Cadwell","Betsy L",NA,NA
"727","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Weller","Daniel",NA,NA
"728","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Qualters","Judith R",NA,NA
"729","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Harris","LaTreace",NA,NA
"730","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Bhatt","Achal",NA,NA
"731","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Williams","Charnetta",NA,NA
"732","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Fox","LeAnne M",NA,NA
"733","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Meaney Delman","Dana",NA,NA
"734","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Black","Carla L",NA,NA
"735","34166331","10.15585/mmwr.mm7025e1","COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.","The U.S. COVID-19 vaccination program launched on December 14, 2020. The Advisory Committee on Immunization Practices recommended prioritizing COVID-19 vaccination for specific groups of the U.S. population who were at highest risk for COVID-19 hospitalization and death, including adults aged =75 years*; implementation varied by state, and eligibility was gradually expanded to persons aged =65 years beginning in January 2021. By April 19, 2021, eligibility was expanded to all adults aged =18 yea","2021","06","25","MMWR Morb Mortal Wkly Rep","MMWR. Morbidity and mortality weekly report","Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; United States; Vaccination Coverage; Young Adult","Barbour","Kamil E",NA,NA
"736","34166294","10.1097/CCM.0000000000005197","Higher Than Expected Severity-Adjusted Mortality in ICU Patients With Coronavirus Disease 2019: Time to Consider the Contributions of Pandemic-Related Transformations in Structure and Process.",NA,"2021","06","28","Crit Care Med","Critical care medicine",NA,"Oud","Lavi","Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX",NA
"737","34166250","10.1213/XAA.0000000000001491","Rocuronium-Induced Dilated Nonreactive Pupils in a Patient With Coronavirus Disease 2019: A Case Report.","We report the clinical case of a patient with coronavirus disease 2019 (COVID-19) who had recently undergone neurosurgery and presented with dilated nonreactive pupils during continuous rocuronium infusion, which was reversible with the suspension of the drug. Both the neurosurgical procedure and possible disruption of the blood-brain barrier due to COVID-19 infection may have led to the action of rocuronium in the central nervous system (CNS). Thus, clinicians must remember that neuromuscular b","2021","06","24","A A Pract","A&amp;A practice",NA,"Rodrigues","Elba da Paixão","From the Intensive Care Unit, Hospital Gloria D'or, Rio de Janeiro, Brazil",NA
"738","34166250","10.1213/XAA.0000000000001491","Rocuronium-Induced Dilated Nonreactive Pupils in a Patient With Coronavirus Disease 2019: A Case Report.","We report the clinical case of a patient with coronavirus disease 2019 (COVID-19) who had recently undergone neurosurgery and presented with dilated nonreactive pupils during continuous rocuronium infusion, which was reversible with the suspension of the drug. Both the neurosurgical procedure and possible disruption of the blood-brain barrier due to COVID-19 infection may have led to the action of rocuronium in the central nervous system (CNS). Thus, clinicians must remember that neuromuscular b","2021","06","24","A A Pract","A&amp;A practice",NA,"da Costa","Gustavo Caniné","From the Intensive Care Unit, Hospital Gloria D'or, Rio de Janeiro, Brazil",NA
"739","34166250","10.1213/XAA.0000000000001491","Rocuronium-Induced Dilated Nonreactive Pupils in a Patient With Coronavirus Disease 2019: A Case Report.","We report the clinical case of a patient with coronavirus disease 2019 (COVID-19) who had recently undergone neurosurgery and presented with dilated nonreactive pupils during continuous rocuronium infusion, which was reversible with the suspension of the drug. Both the neurosurgical procedure and possible disruption of the blood-brain barrier due to COVID-19 infection may have led to the action of rocuronium in the central nervous system (CNS). Thus, clinicians must remember that neuromuscular b","2021","06","24","A A Pract","A&amp;A practice",NA,"Braga","Douglas Quintanilha","From the Intensive Care Unit, Hospital Gloria D'or, Rio de Janeiro, Brazil",NA
"740","34166250","10.1213/XAA.0000000000001491","Rocuronium-Induced Dilated Nonreactive Pupils in a Patient With Coronavirus Disease 2019: A Case Report.","We report the clinical case of a patient with coronavirus disease 2019 (COVID-19) who had recently undergone neurosurgery and presented with dilated nonreactive pupils during continuous rocuronium infusion, which was reversible with the suspension of the drug. Both the neurosurgical procedure and possible disruption of the blood-brain barrier due to COVID-19 infection may have led to the action of rocuronium in the central nervous system (CNS). Thus, clinicians must remember that neuromuscular b","2021","06","24","A A Pract","A&amp;A practice",NA,"Pinto","Jorge Eduardo da Silva Soares","From the Intensive Care Unit, Hospital Gloria D'or, Rio de Janeiro, Brazil",NA
"741","34166250","10.1213/XAA.0000000000001491","Rocuronium-Induced Dilated Nonreactive Pupils in a Patient With Coronavirus Disease 2019: A Case Report.","We report the clinical case of a patient with coronavirus disease 2019 (COVID-19) who had recently undergone neurosurgery and presented with dilated nonreactive pupils during continuous rocuronium infusion, which was reversible with the suspension of the drug. Both the neurosurgical procedure and possible disruption of the blood-brain barrier due to COVID-19 infection may have led to the action of rocuronium in the central nervous system (CNS). Thus, clinicians must remember that neuromuscular b","2021","06","24","A A Pract","A&amp;A practice",NA,"Lessa","Marcos Adriano","Laboratory of Cardiovascular Investigation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil",NA
"742","34166243","10.1097/NMC.0000000000000732","The COVID-19 Pandemic and Breastfeeding: Concerns &amp; Positive Opportunities.",NA,"2021","07","07","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing","Breast Feeding; COVID-19; Humans; Mothers","Spatz","Diane L","Dr. Diane L. Spatz is a Professor of Perinatal Nursing &amp","spatz@nursing.upenn.edu"
"743","34166242","10.1097/NMC.0000000000000726","Impact of the Covid-19 Pandemic on Mental Health of Children, Adolescents, and Young Adults.",NA,"2021","07","01","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing","Adolescent; COVID-19; Child; Humans; Mental Disorders; Mental Health; Pandemics; SARS-CoV-2; Young Adult","Beal","Judy A","Dr. Judy A. Beal is a Professor and Dean Emerita, College of Natural, Behavioral, and Health Sciences, Simmons University, Boston, MA. Dr. Beal can be reached via email at judy.beal@simmons","judy.beal@simmons.edu"
"744","34166237","10.1097/NMC.0000000000000734","Impact of COVID-19 on Pregnant Women and Maternity Nurses.",NA,"2021","07","07","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing","COVID-19; Humans; Maternal Health Services; Nurses; Obstetric Nursing; Pregnant Women","Simpson","Kathleen Rice",NA,NA
"745","34166234","10.1097/ACM.0000000000004214","Evolution of Clinical Skills Assessment in the USMLE: Looking to the Future After Step 2 CS Discontinuation.","The COVID-19 pandemic interrupted administration of the United States Medical Licensing Examination (USMLE) Step 2 Clinical Skills (CS) exam in March 2020 due to public health concerns. As the scope and magnitude of the pandemic became clearer, the initial plans by the USMLE program's sponsoring organizations (NBME and Federation of State Medical Boards) to resume Step 2 CS in the short-term shifted to long-range plans to relaunch an exam that could harness technology and reduce infection risk. ","2021","06","25","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Katsufrakis","Peter J","P.J. Katsufrakis is president and CEO, NBME, Philadelphia, Pennsylvania",NA
"746","34166234","10.1097/ACM.0000000000004214","Evolution of Clinical Skills Assessment in the USMLE: Looking to the Future After Step 2 CS Discontinuation.","The COVID-19 pandemic interrupted administration of the United States Medical Licensing Examination (USMLE) Step 2 Clinical Skills (CS) exam in March 2020 due to public health concerns. As the scope and magnitude of the pandemic became clearer, the initial plans by the USMLE program's sponsoring organizations (NBME and Federation of State Medical Boards) to resume Step 2 CS in the short-term shifted to long-range plans to relaunch an exam that could harness technology and reduce infection risk. ","2021","06","25","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Chaudhry","Humayun J","P.J. Katsufrakis is president and CEO, NBME, Philadelphia, Pennsylvania",NA
"747","34166232","10.1172/JCI152474","Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.","To the Editor: Povysil G. et al. report that ""rare loss-of-function (LOF) variants in type I interferon (IFN) immunity genes are not associated with severe COVID-19"" (1). We disagree with the authors' interpretation of our data and their own (2), for six reasons: 1) Only predicted LOF (pLOF) variants are relevant for comparison between the two studies, because, unlike us, these authors did not test variants experimentally. The relevant proportion in our data is therefore not 24/659=3.5%, but 9/6","2021","06","24","J Clin Invest","The Journal of clinical investigation","Genetic variation; Infectious disease","Zhang","Qian","St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, United States of America",NA
"748","34166232","10.1172/JCI152474","Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.","To the Editor: Povysil G. et al. report that ""rare loss-of-function (LOF) variants in type I interferon (IFN) immunity genes are not associated with severe COVID-19"" (1). We disagree with the authors' interpretation of our data and their own (2), for six reasons: 1) Only predicted LOF (pLOF) variants are relevant for comparison between the two studies, because, unlike us, these authors did not test variants experimentally. The relevant proportion in our data is therefore not 24/659=3.5%, but 9/6","2021","06","24","J Clin Invest","The Journal of clinical investigation","Genetic variation; Infectious disease","Cobat","Aurélie","Laboratory of Human Genetics of Infectious Diseases, Necker Hospital for Sick Children, Paris, France",NA
"749","34166232","10.1172/JCI152474","Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.","To the Editor: Povysil G. et al. report that ""rare loss-of-function (LOF) variants in type I interferon (IFN) immunity genes are not associated with severe COVID-19"" (1). We disagree with the authors' interpretation of our data and their own (2), for six reasons: 1) Only predicted LOF (pLOF) variants are relevant for comparison between the two studies, because, unlike us, these authors did not test variants experimentally. The relevant proportion in our data is therefore not 24/659=3.5%, but 9/6","2021","06","24","J Clin Invest","The Journal of clinical investigation","Genetic variation; Infectious disease","Bastard","Paul","Imagine Institute, University of Paris, Paris, France",NA
"750","34166232","10.1172/JCI152474","Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.","To the Editor: Povysil G. et al. report that ""rare loss-of-function (LOF) variants in type I interferon (IFN) immunity genes are not associated with severe COVID-19"" (1). We disagree with the authors' interpretation of our data and their own (2), for six reasons: 1) Only predicted LOF (pLOF) variants are relevant for comparison between the two studies, because, unlike us, these authors did not test variants experimentally. The relevant proportion in our data is therefore not 24/659=3.5%, but 9/6","2021","06","24","J Clin Invest","The Journal of clinical investigation","Genetic variation; Infectious disease","Notarangelo","Luigi D","Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America",NA
"751","34166232","10.1172/JCI152474","Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.","To the Editor: Povysil G. et al. report that ""rare loss-of-function (LOF) variants in type I interferon (IFN) immunity genes are not associated with severe COVID-19"" (1). We disagree with the authors' interpretation of our data and their own (2), for six reasons: 1) Only predicted LOF (pLOF) variants are relevant for comparison between the two studies, because, unlike us, these authors did not test variants experimentally. The relevant proportion in our data is therefore not 24/659=3.5%, but 9/6","2021","06","24","J Clin Invest","The Journal of clinical investigation","Genetic variation; Infectious disease","Su","Helen C","Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America",NA
"752","34166232","10.1172/JCI152474","Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.","To the Editor: Povysil G. et al. report that ""rare loss-of-function (LOF) variants in type I interferon (IFN) immunity genes are not associated with severe COVID-19"" (1). We disagree with the authors' interpretation of our data and their own (2), for six reasons: 1) Only predicted LOF (pLOF) variants are relevant for comparison between the two studies, because, unlike us, these authors did not test variants experimentally. The relevant proportion in our data is therefore not 24/659=3.5%, but 9/6","2021","06","24","J Clin Invest","The Journal of clinical investigation","Genetic variation; Infectious disease","Abel","Laurent","Laboratory of Human Genetics of Infectious Diseases, Necker Hospital for Sick Children, Paris, France",NA
"753","34166232","10.1172/JCI152474","Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.","To the Editor: Povysil G. et al. report that ""rare loss-of-function (LOF) variants in type I interferon (IFN) immunity genes are not associated with severe COVID-19"" (1). We disagree with the authors' interpretation of our data and their own (2), for six reasons: 1) Only predicted LOF (pLOF) variants are relevant for comparison between the two studies, because, unlike us, these authors did not test variants experimentally. The relevant proportion in our data is therefore not 24/659=3.5%, but 9/6","2021","06","24","J Clin Invest","The Journal of clinical investigation","Genetic variation; Infectious disease","Casanova","Jean-Laurent","St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockfeller University, New York, United States of America",NA
"754","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Zuo","Yu","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"755","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Yalavarthi","Srilakshmi","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"756","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Navaz","Sherwin A","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"757","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Hoy","Claire K","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"758","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Harbaugh","Alyssa","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"759","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Gockman","Kelsey","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"760","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Zuo","Melanie","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"761","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Madison","Jacqueline A","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"762","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Shi","Hui","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"763","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Kanthi","Yogendra","Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, United States of America",NA
"764","34166229","10.1172/jci.insight.150111","Autoantibodies stabilize neutrophil extracellular traps in COVID-19.","The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe presentations of COVID-19. At the same time, a variety of functional autoantibodies have been observed in individuals with severe COVID-19 where they likely contribute to immunopathology. Here, we aimed to determine the extent to which autoantibodies might target NETs in COVID-19 and, if detected, to elucidate their potential","2021","06","29","JCI Insight","JCI insight","Adaptive immunity; Autoimmunity; COVID-19; Neutrophils","Knight","Jason S","Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America",NA
"765","34166137","10.1177/21501327211027432","Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic.","This study aimed to evaluate the interleukin-6 (IL-6) levels and its relationship to stress, anxiety, and depressive symptoms among healthcare workers (HCWs) compared to controls during the COVID-19 pandemic. A total of 80 HCWs in Suez Canal University Hospital in Ismailia, Egypt, and 80 controls were analyzed during the COVID-19 pandemic. The Depression, Anxiety and Stress Scale (DASS 21) questionnaire was used, and serum IL-6 level was determined in both groups. IL-6 levels were high in 81.2% ","2021","06","30","J Prim Care Community Health","Journal of primary care &amp; community health","IL-6; anxiety; depression; mental stress; shift; the COVID-19; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Egypt; Health Personnel; Humans; Pandemics; SARS-CoV-2","Amer","Shaimaa A A M","Department of Public health, Occupational and Environmental Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt",NA
"766","34166137","10.1177/21501327211027432","Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic.","This study aimed to evaluate the interleukin-6 (IL-6) levels and its relationship to stress, anxiety, and depressive symptoms among healthcare workers (HCWs) compared to controls during the COVID-19 pandemic. A total of 80 HCWs in Suez Canal University Hospital in Ismailia, Egypt, and 80 controls were analyzed during the COVID-19 pandemic. The Depression, Anxiety and Stress Scale (DASS 21) questionnaire was used, and serum IL-6 level was determined in both groups. IL-6 levels were high in 81.2% ","2021","06","30","J Prim Care Community Health","Journal of primary care &amp; community health","IL-6; anxiety; depression; mental stress; shift; the COVID-19; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Egypt; Health Personnel; Humans; Pandemics; SARS-CoV-2","Fouad","Ahmed Mahmoud","Department of Public health, Occupational and Environmental Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt",NA
"767","34166137","10.1177/21501327211027432","Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic.","This study aimed to evaluate the interleukin-6 (IL-6) levels and its relationship to stress, anxiety, and depressive symptoms among healthcare workers (HCWs) compared to controls during the COVID-19 pandemic. A total of 80 HCWs in Suez Canal University Hospital in Ismailia, Egypt, and 80 controls were analyzed during the COVID-19 pandemic. The Depression, Anxiety and Stress Scale (DASS 21) questionnaire was used, and serum IL-6 level was determined in both groups. IL-6 levels were high in 81.2% ","2021","06","30","J Prim Care Community Health","Journal of primary care &amp; community health","IL-6; anxiety; depression; mental stress; shift; the COVID-19; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Egypt; Health Personnel; Humans; Pandemics; SARS-CoV-2","El-Samahy","Mohamed","Department of Neurology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt",NA
"768","34166137","10.1177/21501327211027432","Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic.","This study aimed to evaluate the interleukin-6 (IL-6) levels and its relationship to stress, anxiety, and depressive symptoms among healthcare workers (HCWs) compared to controls during the COVID-19 pandemic. A total of 80 HCWs in Suez Canal University Hospital in Ismailia, Egypt, and 80 controls were analyzed during the COVID-19 pandemic. The Depression, Anxiety and Stress Scale (DASS 21) questionnaire was used, and serum IL-6 level was determined in both groups. IL-6 levels were high in 81.2% ","2021","06","30","J Prim Care Community Health","Journal of primary care &amp; community health","IL-6; anxiety; depression; mental stress; shift; the COVID-19; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Egypt; Health Personnel; Humans; Pandemics; SARS-CoV-2","Hashem","Asmaa A","Department of Medical Microbiology and Immunology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt",NA
"769","34166137","10.1177/21501327211027432","Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic.","This study aimed to evaluate the interleukin-6 (IL-6) levels and its relationship to stress, anxiety, and depressive symptoms among healthcare workers (HCWs) compared to controls during the COVID-19 pandemic. A total of 80 HCWs in Suez Canal University Hospital in Ismailia, Egypt, and 80 controls were analyzed during the COVID-19 pandemic. The Depression, Anxiety and Stress Scale (DASS 21) questionnaire was used, and serum IL-6 level was determined in both groups. IL-6 levels were high in 81.2% ","2021","06","30","J Prim Care Community Health","Journal of primary care &amp; community health","IL-6; anxiety; depression; mental stress; shift; the COVID-19; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Egypt; Health Personnel; Humans; Pandemics; SARS-CoV-2","Saati","Abdullah A","Department of Community Medicine and Pilgrims Healthcare, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia",NA
"770","34166137","10.1177/21501327211027432","Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic.","This study aimed to evaluate the interleukin-6 (IL-6) levels and its relationship to stress, anxiety, and depressive symptoms among healthcare workers (HCWs) compared to controls during the COVID-19 pandemic. A total of 80 HCWs in Suez Canal University Hospital in Ismailia, Egypt, and 80 controls were analyzed during the COVID-19 pandemic. The Depression, Anxiety and Stress Scale (DASS 21) questionnaire was used, and serum IL-6 level was determined in both groups. IL-6 levels were high in 81.2% ","2021","06","30","J Prim Care Community Health","Journal of primary care &amp; community health","IL-6; anxiety; depression; mental stress; shift; the COVID-19; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Egypt; Health Personnel; Humans; Pandemics; SARS-CoV-2","Sarhan","Anas A","Department of Medicine, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia",NA
"771","34166137","10.1177/21501327211027432","Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic.","This study aimed to evaluate the interleukin-6 (IL-6) levels and its relationship to stress, anxiety, and depressive symptoms among healthcare workers (HCWs) compared to controls during the COVID-19 pandemic. A total of 80 HCWs in Suez Canal University Hospital in Ismailia, Egypt, and 80 controls were analyzed during the COVID-19 pandemic. The Depression, Anxiety and Stress Scale (DASS 21) questionnaire was used, and serum IL-6 level was determined in both groups. IL-6 levels were high in 81.2% ","2021","06","30","J Prim Care Community Health","Journal of primary care &amp; community health","IL-6; anxiety; depression; mental stress; shift; the COVID-19; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Egypt; Health Personnel; Humans; Pandemics; SARS-CoV-2","Anani","Maha","Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt",NA
"772","34166135","10.1177/00469580211024906","Citizens' Opinion on Governmental Response to COVID-19 Outbreak: A Qualitative Study from Iran.","Studying the people's expectations of government measures to control and manage the coronavirus disease 2019 (COVID-19) can help to prepare for future crises. This study aimed to investigate the opinion of the Iranian people on authorities' management during a crisis, such as the COVID-19 pandemic. This qualitative study was conducted on 70 Iranian citizens in Shiraz to explore their opinion about the government response to the COVID-19 outbreak in February and March 2020. Based on saturation cr","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; crisis management; epidemics; preparedness; trust","Bagheri Lankarani","Kamran","Shiraz University of Medical Sciences, Shiraz, Iran",NA
"773","34166135","10.1177/00469580211024906","Citizens' Opinion on Governmental Response to COVID-19 Outbreak: A Qualitative Study from Iran.","Studying the people's expectations of government measures to control and manage the coronavirus disease 2019 (COVID-19) can help to prepare for future crises. This study aimed to investigate the opinion of the Iranian people on authorities' management during a crisis, such as the COVID-19 pandemic. This qualitative study was conducted on 70 Iranian citizens in Shiraz to explore their opinion about the government response to the COVID-19 outbreak in February and March 2020. Based on saturation cr","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; crisis management; epidemics; preparedness; trust","Honarvar","Behnam","Shiraz University of Medical Sciences, Shiraz, Iran",NA
"774","34166135","10.1177/00469580211024906","Citizens' Opinion on Governmental Response to COVID-19 Outbreak: A Qualitative Study from Iran.","Studying the people's expectations of government measures to control and manage the coronavirus disease 2019 (COVID-19) can help to prepare for future crises. This study aimed to investigate the opinion of the Iranian people on authorities' management during a crisis, such as the COVID-19 pandemic. This qualitative study was conducted on 70 Iranian citizens in Shiraz to explore their opinion about the government response to the COVID-19 outbreak in February and March 2020. Based on saturation cr","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; crisis management; epidemics; preparedness; trust","Kalateh Sadati","Ahmad","Shiraz University of Medical Sciences, Shiraz, Iran",NA
"775","34166135","10.1177/00469580211024906","Citizens' Opinion on Governmental Response to COVID-19 Outbreak: A Qualitative Study from Iran.","Studying the people's expectations of government measures to control and manage the coronavirus disease 2019 (COVID-19) can help to prepare for future crises. This study aimed to investigate the opinion of the Iranian people on authorities' management during a crisis, such as the COVID-19 pandemic. This qualitative study was conducted on 70 Iranian citizens in Shiraz to explore their opinion about the government response to the COVID-19 outbreak in February and March 2020. Based on saturation cr","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; crisis management; epidemics; preparedness; trust","Rahmanian Haghighi","Mohammad Reza","Shiraz University of Medical Sciences, Shiraz, Iran",NA
"776","34166134","10.1177/00469580211023464","COVID-19 Transmission due to Mass Mobility Before and After the Largest Festival in Bangladesh: An Epidemiologic Study.","Festivals traditionally result in mass public mobility from large cities to rural or semi-urban areas in low- and middle-Income Countries (LMIC), which are inadequately prepared for tackling the consequences of the COVID-19 pandemic. This study aimed to explore the trend of COVID-19 infection in a peripheral region of Bangladesh during one of the largest festivals to develop an evidence-based hypothesis for its influence on the transmission rate of COVID-19. This study conducted a quantitative a","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","Bangladesh; COVID-19 pandemic; communicable disease; epidemiology; folklore","Rahman","Farah Naz","Centre for Injury Prevention and Research, Bangladesh (CIPRB), Mohakhali, Dhaka, Bangladesh",NA
"777","34166134","10.1177/00469580211023464","COVID-19 Transmission due to Mass Mobility Before and After the Largest Festival in Bangladesh: An Epidemiologic Study.","Festivals traditionally result in mass public mobility from large cities to rural or semi-urban areas in low- and middle-Income Countries (LMIC), which are inadequately prepared for tackling the consequences of the COVID-19 pandemic. This study aimed to explore the trend of COVID-19 infection in a peripheral region of Bangladesh during one of the largest festivals to develop an evidence-based hypothesis for its influence on the transmission rate of COVID-19. This study conducted a quantitative a","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","Bangladesh; COVID-19 pandemic; communicable disease; epidemiology; folklore","Rahman","A K M Fazlur","Centre for Injury Prevention and Research, Bangladesh (CIPRB), Mohakhali, Dhaka, Bangladesh",NA
"778","34166134","10.1177/00469580211023464","COVID-19 Transmission due to Mass Mobility Before and After the Largest Festival in Bangladesh: An Epidemiologic Study.","Festivals traditionally result in mass public mobility from large cities to rural or semi-urban areas in low- and middle-Income Countries (LMIC), which are inadequately prepared for tackling the consequences of the COVID-19 pandemic. This study aimed to explore the trend of COVID-19 infection in a peripheral region of Bangladesh during one of the largest festivals to develop an evidence-based hypothesis for its influence on the transmission rate of COVID-19. This study conducted a quantitative a","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","Bangladesh; COVID-19 pandemic; communicable disease; epidemiology; folklore","Iwuagwu","Anthony Obinna","University of Nigeria, Nsukka, Nigeria",NA
"779","34166134","10.1177/00469580211023464","COVID-19 Transmission due to Mass Mobility Before and After the Largest Festival in Bangladesh: An Epidemiologic Study.","Festivals traditionally result in mass public mobility from large cities to rural or semi-urban areas in low- and middle-Income Countries (LMIC), which are inadequately prepared for tackling the consequences of the COVID-19 pandemic. This study aimed to explore the trend of COVID-19 infection in a peripheral region of Bangladesh during one of the largest festivals to develop an evidence-based hypothesis for its influence on the transmission rate of COVID-19. This study conducted a quantitative a","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","Bangladesh; COVID-19 pandemic; communicable disease; epidemiology; folklore","Dalal","Koustuv","Division of Public Health Science, School of Health Sciences,Mid Sweden University, Sundsvall, Sweden",NA
"780","34166132","10.1177/00368504211026409","Effect of COVID-19 pandemic on mental health among Bangladeshi healthcare professionals: A cross-sectional study.","The COVID-19 has been spreading across the world since December 2019. The pandemic has created tremendous fear of death from infection and awful psychological pressure on healthcare professionals (HCPs). The measures of psychological effects of the COVID-19 outbreak on the Bangladeshi HCPs are unknown. The present study aimed to assess the mental health outcomes of Bangladeshi HCPs and associated risk factors. We conducted this cross-sectional study from July 15 to September 20, 2020. A total of","2021","07","07","Sci Prog","Science progress","Bangladesh; COVID-19; anxiety; depression; healthcare professionals; loneliness; mental health; sleep disturbance; Adult; Anxiety; Bangladesh; COVID-19; Cross-Sectional Studies; Depression; Female; Health Personnel; Humans; Loneliness; Male; Mental Health; Middle Aged; Occupational Health; Pandemics; SARS-CoV-2; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Surveys and Questionnaires","Repon","Md Azim Uddin","Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh",NA
"781","34166132","10.1177/00368504211026409","Effect of COVID-19 pandemic on mental health among Bangladeshi healthcare professionals: A cross-sectional study.","The COVID-19 has been spreading across the world since December 2019. The pandemic has created tremendous fear of death from infection and awful psychological pressure on healthcare professionals (HCPs). The measures of psychological effects of the COVID-19 outbreak on the Bangladeshi HCPs are unknown. The present study aimed to assess the mental health outcomes of Bangladeshi HCPs and associated risk factors. We conducted this cross-sectional study from July 15 to September 20, 2020. A total of","2021","07","07","Sci Prog","Science progress","Bangladesh; COVID-19; anxiety; depression; healthcare professionals; loneliness; mental health; sleep disturbance; Adult; Anxiety; Bangladesh; COVID-19; Cross-Sectional Studies; Depression; Female; Health Personnel; Humans; Loneliness; Male; Mental Health; Middle Aged; Occupational Health; Pandemics; SARS-CoV-2; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Surveys and Questionnaires","Pakhe","Sajuti Akter","Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh",NA
"782","34166132","10.1177/00368504211026409","Effect of COVID-19 pandemic on mental health among Bangladeshi healthcare professionals: A cross-sectional study.","The COVID-19 has been spreading across the world since December 2019. The pandemic has created tremendous fear of death from infection and awful psychological pressure on healthcare professionals (HCPs). The measures of psychological effects of the COVID-19 outbreak on the Bangladeshi HCPs are unknown. The present study aimed to assess the mental health outcomes of Bangladeshi HCPs and associated risk factors. We conducted this cross-sectional study from July 15 to September 20, 2020. A total of","2021","07","07","Sci Prog","Science progress","Bangladesh; COVID-19; anxiety; depression; healthcare professionals; loneliness; mental health; sleep disturbance; Adult; Anxiety; Bangladesh; COVID-19; Cross-Sectional Studies; Depression; Female; Health Personnel; Humans; Loneliness; Male; Mental Health; Middle Aged; Occupational Health; Pandemics; SARS-CoV-2; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Surveys and Questionnaires","Quaiyum","Sumaiya","Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh",NA
"783","34166132","10.1177/00368504211026409","Effect of COVID-19 pandemic on mental health among Bangladeshi healthcare professionals: A cross-sectional study.","The COVID-19 has been spreading across the world since December 2019. The pandemic has created tremendous fear of death from infection and awful psychological pressure on healthcare professionals (HCPs). The measures of psychological effects of the COVID-19 outbreak on the Bangladeshi HCPs are unknown. The present study aimed to assess the mental health outcomes of Bangladeshi HCPs and associated risk factors. We conducted this cross-sectional study from July 15 to September 20, 2020. A total of","2021","07","07","Sci Prog","Science progress","Bangladesh; COVID-19; anxiety; depression; healthcare professionals; loneliness; mental health; sleep disturbance; Adult; Anxiety; Bangladesh; COVID-19; Cross-Sectional Studies; Depression; Female; Health Personnel; Humans; Loneliness; Male; Mental Health; Middle Aged; Occupational Health; Pandemics; SARS-CoV-2; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Surveys and Questionnaires","Das","Rajesh","Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh",NA
"784","34166132","10.1177/00368504211026409","Effect of COVID-19 pandemic on mental health among Bangladeshi healthcare professionals: A cross-sectional study.","The COVID-19 has been spreading across the world since December 2019. The pandemic has created tremendous fear of death from infection and awful psychological pressure on healthcare professionals (HCPs). The measures of psychological effects of the COVID-19 outbreak on the Bangladeshi HCPs are unknown. The present study aimed to assess the mental health outcomes of Bangladeshi HCPs and associated risk factors. We conducted this cross-sectional study from July 15 to September 20, 2020. A total of","2021","07","07","Sci Prog","Science progress","Bangladesh; COVID-19; anxiety; depression; healthcare professionals; loneliness; mental health; sleep disturbance; Adult; Anxiety; Bangladesh; COVID-19; Cross-Sectional Studies; Depression; Female; Health Personnel; Humans; Loneliness; Male; Mental Health; Middle Aged; Occupational Health; Pandemics; SARS-CoV-2; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Surveys and Questionnaires","Daria","Sohel","Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh",NA
"785","34166132","10.1177/00368504211026409","Effect of COVID-19 pandemic on mental health among Bangladeshi healthcare professionals: A cross-sectional study.","The COVID-19 has been spreading across the world since December 2019. The pandemic has created tremendous fear of death from infection and awful psychological pressure on healthcare professionals (HCPs). The measures of psychological effects of the COVID-19 outbreak on the Bangladeshi HCPs are unknown. The present study aimed to assess the mental health outcomes of Bangladeshi HCPs and associated risk factors. We conducted this cross-sectional study from July 15 to September 20, 2020. A total of","2021","07","07","Sci Prog","Science progress","Bangladesh; COVID-19; anxiety; depression; healthcare professionals; loneliness; mental health; sleep disturbance; Adult; Anxiety; Bangladesh; COVID-19; Cross-Sectional Studies; Depression; Female; Health Personnel; Humans; Loneliness; Male; Mental Health; Middle Aged; Occupational Health; Pandemics; SARS-CoV-2; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Surveys and Questionnaires","Islam","Md Rabiul","Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh",NA
"786","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Roy","Steven","Department of Critical Care Medicine, University of Calgary, Calgary, Canada",NA
"787","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Soteras","Inigo","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"788","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Sheets","Alison","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"789","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Price","Richard","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"790","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Oshiro","Kazue","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"791","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Rauch","Simon","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"792","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","McPhalen","Don","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"793","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Nerin","Maria Antonia","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"794","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Strapazzon","Giacomo","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"795","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Allen","Myron","National Ski Patrol, Lakewood, Colorado, USA",NA
"796","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Read","Alistair","Terrestrial Commission of the International Commission for Alpine Rescue (ICAR), Zurich, Switzerland",NA
"797","34166103","10.1089/ham.2021.0032","Guidelines for Mountain Rescue During the COVID-19 Pandemic: Official Guidelines of the International Commission for Alpine Rescue.","Roy, Steven, Inigo Soteras, Alison Sheets, Richard Price, Kazue Oshiro, Simon Rauch, Don McPhalen, Maria Antonia Nerin, Giacomo Strapazzon, Myron Allen, Alistair Read, and Peter Paal. Guidelines for mountain rescue during the COVID-19 pandemic: official guidelines of the International Commission for Alpine Rescue. High Alt Med Biol. 22: 128-141, 2021. Background: In mountain rescue, uncertainty exists on the best practice to prevent coronavirus disease 2019 (COVID-19) transm","2021","06","30","High Alt Med Biol","High altitude medicine &amp; biology","COVID-19; Emergency Medicine; SARS-CoV-2; infections; mountain rescue; technical rescue; COVID-19; Cardiopulmonary Resuscitation; Humans; Pandemics; Rescue Work; SARS-CoV-2","Paal","Peter","Medical Commission of the International Commission for Alpine Rescue (ICAR MEDCOM), Zurich, Switzerland",NA
"798","34166095","10.1089/jwh.2021.0100","Work Patterns of Women Physicians During Vacation: A Cross-Sectional Study.","Background: Burnout and poor work-life integration (WLI) are prevalent among women physicians. Vacation may help alleviate burnout and improve WLI but working while on vacation may negate these potential benefits. Little is known about the work patterns of women physicians on vacation, and we attempted to further characterize it in this study. Methods: In this online cross-sectional study of 498 members of the Physician Women in Leadership Facebook Group, we collected","2021","06","24","J Womens Health (Larchmt)","Journal of women's health (2002)","COVID-19; burnout; vacation; women physicians","Marshall","Ariela L","Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA",NA
"799","34166095","10.1089/jwh.2021.0100","Work Patterns of Women Physicians During Vacation: A Cross-Sectional Study.","Background: Burnout and poor work-life integration (WLI) are prevalent among women physicians. Vacation may help alleviate burnout and improve WLI but working while on vacation may negate these potential benefits. Little is known about the work patterns of women physicians on vacation, and we attempted to further characterize it in this study. Methods: In this online cross-sectional study of 498 members of the Physician Women in Leadership Facebook Group, we collected","2021","06","24","J Womens Health (Larchmt)","Journal of women's health (2002)","COVID-19; burnout; vacation; women physicians","Elafros","Melissa","Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA",NA
"800","34166095","10.1089/jwh.2021.0100","Work Patterns of Women Physicians During Vacation: A Cross-Sectional Study.","Background: Burnout and poor work-life integration (WLI) are prevalent among women physicians. Vacation may help alleviate burnout and improve WLI but working while on vacation may negate these potential benefits. Little is known about the work patterns of women physicians on vacation, and we attempted to further characterize it in this study. Methods: In this online cross-sectional study of 498 members of the Physician Women in Leadership Facebook Group, we collected","2021","06","24","J Womens Health (Larchmt)","Journal of women's health (2002)","COVID-19; burnout; vacation; women physicians","Duma","Narjust","Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA",NA
"801","34166081","10.1152/japplphysiol.00147.2021","Case Studies in Physiology: Temporal Variations of the Lung Parenchyma and Vasculature in Asymptomatic COVID-19 Pneumonia: A Multi-Spectral CT Assessment.","This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and Expiratory non-contrast along with contrast Dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (Day 0), and across a 90 day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corres","2021","06","24","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature","Nagpal","Prashant","Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, IA, United States",NA
"802","34166081","10.1152/japplphysiol.00147.2021","Case Studies in Physiology: Temporal Variations of the Lung Parenchyma and Vasculature in Asymptomatic COVID-19 Pneumonia: A Multi-Spectral CT Assessment.","This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and Expiratory non-contrast along with contrast Dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (Day 0), and across a 90 day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corres","2021","06","24","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature","Motahari","Amin","Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, IA, United States",NA
"803","34166081","10.1152/japplphysiol.00147.2021","Case Studies in Physiology: Temporal Variations of the Lung Parenchyma and Vasculature in Asymptomatic COVID-19 Pneumonia: A Multi-Spectral CT Assessment.","This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and Expiratory non-contrast along with contrast Dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (Day 0), and across a 90 day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corres","2021","06","24","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature","Gerard","Sarah E","Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, IA, United States",NA
"804","34166081","10.1152/japplphysiol.00147.2021","Case Studies in Physiology: Temporal Variations of the Lung Parenchyma and Vasculature in Asymptomatic COVID-19 Pneumonia: A Multi-Spectral CT Assessment.","This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and Expiratory non-contrast along with contrast Dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (Day 0), and across a 90 day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corres","2021","06","24","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature","Guo","Junfeng","Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, IA, United States",NA
"805","34166081","10.1152/japplphysiol.00147.2021","Case Studies in Physiology: Temporal Variations of the Lung Parenchyma and Vasculature in Asymptomatic COVID-19 Pneumonia: A Multi-Spectral CT Assessment.","This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and Expiratory non-contrast along with contrast Dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (Day 0), and across a 90 day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corres","2021","06","24","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature","Reinhardt","Joseph M","Roy J. Carver Department of Biomedical Engineering, University of Iowa College of Engineering, University of Iowa, Iowa City, IA, United States",NA
"806","34166081","10.1152/japplphysiol.00147.2021","Case Studies in Physiology: Temporal Variations of the Lung Parenchyma and Vasculature in Asymptomatic COVID-19 Pneumonia: A Multi-Spectral CT Assessment.","This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and Expiratory non-contrast along with contrast Dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (Day 0), and across a 90 day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corres","2021","06","24","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature","Comellas","Alejandro P","Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States",NA
"807","34166081","10.1152/japplphysiol.00147.2021","Case Studies in Physiology: Temporal Variations of the Lung Parenchyma and Vasculature in Asymptomatic COVID-19 Pneumonia: A Multi-Spectral CT Assessment.","This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and Expiratory non-contrast along with contrast Dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (Day 0), and across a 90 day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corres","2021","06","24","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature","Hoffman","Eric A","Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, IA, United States",NA
"808","34166081","10.1152/japplphysiol.00147.2021","Case Studies in Physiology: Temporal Variations of the Lung Parenchyma and Vasculature in Asymptomatic COVID-19 Pneumonia: A Multi-Spectral CT Assessment.","This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and Expiratory non-contrast along with contrast Dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (Day 0), and across a 90 day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corres","2021","06","24","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature","Kaczka","David W","Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, IA, United States",NA
"809","34166080","10.1161/CIRCRESAHA.121.319446","Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19.",NA,"2021","06","30","Circ Res","Circulation research","COVID-19; Editorials; macrophage; myocyte, cardiac; pluripotent stem cell; COVID-19; Humans; Macrophages; Myocardium; SARS-CoV-2","Nishiga","Masataka","Stanford Cardiovascular Institute (M.N., J.C.W.), Stanford University School of Medicine, CA",NA
"810","34166080","10.1161/CIRCRESAHA.121.319446","Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19.",NA,"2021","06","30","Circ Res","Circulation research","COVID-19; Editorials; macrophage; myocyte, cardiac; pluripotent stem cell; COVID-19; Humans; Macrophages; Myocardium; SARS-CoV-2","Wu","Joseph C","Stanford Cardiovascular Institute (M.N., J.C.W.), Stanford University School of Medicine, CA",NA
"811","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Theel","Elitza S","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"812","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Johnson","Patrick W","Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL",NA
"813","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Kunze","Katie L","Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ",NA
"814","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Wu","Liang","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"815","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Gorsh","Amy P","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"816","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Granger","Dane","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"817","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Roforth","Matthew M","Advanced Diagnostics Laboratory, Mayo Clinic, Rochester, MN",NA
"818","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Jerde","Calvin R","Advanced Diagnostics Laboratory, Mayo Clinic, Rochester, MN",NA
"819","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Lasho","Michael","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"820","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Andersen","Kylie J","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Rochester, MN",NA
"821","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Murphy","Brenna M","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Rochester, MN",NA
"822","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Harring","Julie","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"823","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Lake","Douglas F","School of Life Sciences, Arizona State University, Tempe AZ",NA
"824","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Svarovsky","Sergei A","Axim Biotechnologies Inc, San Diego, CA",NA
"825","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Senefeld","Jonathon W","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Rochester, MN",NA
"826","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Carter","Rickey E","Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL",NA
"827","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Joyner","Michael J","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Rochester, MN",NA
"828","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Baumann","Nikola A","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"829","34166066","10.1128/JCM.01231-21","SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.","Background: Longitudinal studies assessing durability of the anti-SARS-CoV-2 humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. Methods: SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symp","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Mills","John R","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"830","34166058","10.1037/ort0000573","Community social workers' perspectives on the challenges and opportunities presented by the COVID-19 pandemic.","The COVID-19 pandemic has required public social services departments to cope with an unexpected and unprecedented emergency situation. As community social workers work on the macrolevel and deal with entire communities in emergency situations, the present study investigated the challenges they face as well as the factors that promoted they are coping during the ""age of COVID."" Drawing on in-depth interviews with 20 managers of community social work departments in Israel, findings highlighted th","2021","07","12","Am J Orthopsychiatry","The American journal of orthopsychiatry",NA,"Itzhaki-Braun","Yael","School of Social Work, Tel Aviv University",NA
"831","34166043","10.1037/tra0001061","Association between daily rumination and posttraumatic growth during the COVID-19 pandemic: An experience sampling method.","The current intensive longitudinal study aimed at examining the association between daily rumination (i.e., intrusive rumination and deliberate rumination) and posttraumatic growth (PTG) associated with the pandemic of coronavirus disease 2019 (COVID-19). Final participants were 71 adults who were recruited from Amazon's Mechanical Turk. Participants responded to daily questions regarding ruminations they engaged in and PTG they experienced that day for a total of 29 days. As expected, there was","2021","07","12","Psychol Trauma","Psychological trauma : theory, research, practice and policy",NA,"Shigemoto","Yuki","Department of Psychology",NA
"832","34166035","10.1037/pha0000479","Chronic pain and COVID-19: The association of delay discounting with perceived stress and pain severity.","The coronavirus disease pandemic of 2019 (COVID-19) is a worldwide threat to public health that has significantly affected the United States. The pandemic poses a variety of health risks including stressful disruptions in social and economic activity. Understanding the pandemic's effects on already vulnerable populations, such as individuals with chronic pain, may inform healthcare preparation for future catastrophic events. Given the association between excessive discounting of delayed rewards ","2021","07","12","Exp Clin Psychopharmacol","Experimental and clinical psychopharmacology",NA,"Craft","William H","Graduate Program in Translational Biology, Medicine, and Health, Virginia Polytechnic and State University",NA
"833","34166035","10.1037/pha0000479","Chronic pain and COVID-19: The association of delay discounting with perceived stress and pain severity.","The coronavirus disease pandemic of 2019 (COVID-19) is a worldwide threat to public health that has significantly affected the United States. The pandemic poses a variety of health risks including stressful disruptions in social and economic activity. Understanding the pandemic's effects on already vulnerable populations, such as individuals with chronic pain, may inform healthcare preparation for future catastrophic events. Given the association between excessive discounting of delayed rewards ","2021","07","12","Exp Clin Psychopharmacol","Experimental and clinical psychopharmacology",NA,"Tegge","Allison N","Fralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Polytechnic and State University",NA
"834","34166035","10.1037/pha0000479","Chronic pain and COVID-19: The association of delay discounting with perceived stress and pain severity.","The coronavirus disease pandemic of 2019 (COVID-19) is a worldwide threat to public health that has significantly affected the United States. The pandemic poses a variety of health risks including stressful disruptions in social and economic activity. Understanding the pandemic's effects on already vulnerable populations, such as individuals with chronic pain, may inform healthcare preparation for future catastrophic events. Given the association between excessive discounting of delayed rewards ","2021","07","12","Exp Clin Psychopharmacol","Experimental and clinical psychopharmacology",NA,"Bickel","Warren K","Fralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Polytechnic and State University",NA
"835","34165849","10.1111/ijcp.14563","An emergency plan for management of COVID-19 patients in rural areas.","To describe the experience of six hospitals in the management of COVID-19 patients in rural areas through an assessment of proportions, types and clinical outcomes of remote clinical interventions. This was a prospective observational study conducted in six Egyptian hospitals over a period five months. An emergency response was implemented in each hospital in order to connect clinical pharmacists with COVID-19 patients living in rural areas. Pharmacists used phone calls and social media applicat","2021","07","05","Int J Clin Pract","International journal of clinical practice",NA,"Al Meslamani","Ahmad Z","College of Pharmacy, Al Ain University of Science and Technology, Abu Dhabi, UAE",NA
"836","34165849","10.1111/ijcp.14563","An emergency plan for management of COVID-19 patients in rural areas.","To describe the experience of six hospitals in the management of COVID-19 patients in rural areas through an assessment of proportions, types and clinical outcomes of remote clinical interventions. This was a prospective observational study conducted in six Egyptian hospitals over a period five months. An emergency response was implemented in each hospital in order to connect clinical pharmacists with COVID-19 patients living in rural areas. Pharmacists used phone calls and social media applicat","2021","07","05","Int J Clin Pract","International journal of clinical practice",NA,"Kassem","Amira B","Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt",NA
"837","34165849","10.1111/ijcp.14563","An emergency plan for management of COVID-19 patients in rural areas.","To describe the experience of six hospitals in the management of COVID-19 patients in rural areas through an assessment of proportions, types and clinical outcomes of remote clinical interventions. This was a prospective observational study conducted in six Egyptian hospitals over a period five months. An emergency response was implemented in each hospital in order to connect clinical pharmacists with COVID-19 patients living in rural areas. Pharmacists used phone calls and social media applicat","2021","07","05","Int J Clin Pract","International journal of clinical practice",NA,"El-Bassiouny","Noha A","Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt",NA
"838","34165849","10.1111/ijcp.14563","An emergency plan for management of COVID-19 patients in rural areas.","To describe the experience of six hospitals in the management of COVID-19 patients in rural areas through an assessment of proportions, types and clinical outcomes of remote clinical interventions. This was a prospective observational study conducted in six Egyptian hospitals over a period five months. An emergency response was implemented in each hospital in order to connect clinical pharmacists with COVID-19 patients living in rural areas. Pharmacists used phone calls and social media applicat","2021","07","05","Int J Clin Pract","International journal of clinical practice",NA,"Ibrahim","Osama Mohamed","Department of Pharmacy Practice and Pharmacotherapeutics, College of University of Sharjah, Sharjah, UAE",NA
"839","34165775","10.1007/s41999-021-00524-1","Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID-19 Pandemic.","Many institutionalized older people have died during the first wave of COVID-19. Other related consequences have not yet been described objectively. The aim of this study was to compare functional, cognitive, and nutritional status before and after the first wave among nursing home residents, in both COVID-19 and non-COVID-19 patients. Older adults institutionalized in four nursing homes were assessed from May to June 2020, by a geriatric multidisciplinary team in collaboration with the nursing ","2021","06","26","Eur Geriatr Med","European geriatric medicine","COVID; Decline; Elderly; Malnutrition; Nursing homes","Pérez-Rodríguez","Patricia","Geriatrics Department, Hospital Universitario Puerta de Hierro Majadahonda, C/ Joaquín Rodrigo, 2, Majadahonda, 28220, Madrid, Spain. ppr.patriciaperez@gmail","ppr.patriciaperez@gmail.com"
"840","34165775","10.1007/s41999-021-00524-1","Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID-19 Pandemic.","Many institutionalized older people have died during the first wave of COVID-19. Other related consequences have not yet been described objectively. The aim of this study was to compare functional, cognitive, and nutritional status before and after the first wave among nursing home residents, in both COVID-19 and non-COVID-19 patients. Older adults institutionalized in four nursing homes were assessed from May to June 2020, by a geriatric multidisciplinary team in collaboration with the nursing ","2021","06","26","Eur Geriatr Med","European geriatric medicine","COVID; Decline; Elderly; Malnutrition; Nursing homes","Díaz de Bustamante","Macarena","Geriatrics Department, Hospital Universitario Puerta de Hierro Majadahonda, C/ Joaquín Rodrigo, 2, Majadahonda, 28220, Madrid, Spain",NA
"841","34165775","10.1007/s41999-021-00524-1","Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID-19 Pandemic.","Many institutionalized older people have died during the first wave of COVID-19. Other related consequences have not yet been described objectively. The aim of this study was to compare functional, cognitive, and nutritional status before and after the first wave among nursing home residents, in both COVID-19 and non-COVID-19 patients. Older adults institutionalized in four nursing homes were assessed from May to June 2020, by a geriatric multidisciplinary team in collaboration with the nursing ","2021","06","26","Eur Geriatr Med","European geriatric medicine","COVID; Decline; Elderly; Malnutrition; Nursing homes","Aparicio Mollá","Salvador","Geriatrics Department, Hospital Universitario Puerta de Hierro Majadahonda, C/ Joaquín Rodrigo, 2, Majadahonda, 28220, Madrid, Spain",NA
"842","34165775","10.1007/s41999-021-00524-1","Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID-19 Pandemic.","Many institutionalized older people have died during the first wave of COVID-19. Other related consequences have not yet been described objectively. The aim of this study was to compare functional, cognitive, and nutritional status before and after the first wave among nursing home residents, in both COVID-19 and non-COVID-19 patients. Older adults institutionalized in four nursing homes were assessed from May to June 2020, by a geriatric multidisciplinary team in collaboration with the nursing ","2021","06","26","Eur Geriatr Med","European geriatric medicine","COVID; Decline; Elderly; Malnutrition; Nursing homes","Arenas","María Caridad","Geriatrics Department, Hospital Universitario Puerta de Hierro Majadahonda, C/ Joaquín Rodrigo, 2, Majadahonda, 28220, Madrid, Spain",NA
"843","34165775","10.1007/s41999-021-00524-1","Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID-19 Pandemic.","Many institutionalized older people have died during the first wave of COVID-19. Other related consequences have not yet been described objectively. The aim of this study was to compare functional, cognitive, and nutritional status before and after the first wave among nursing home residents, in both COVID-19 and non-COVID-19 patients. Older adults institutionalized in four nursing homes were assessed from May to June 2020, by a geriatric multidisciplinary team in collaboration with the nursing ","2021","06","26","Eur Geriatr Med","European geriatric medicine","COVID; Decline; Elderly; Malnutrition; Nursing homes","Jiménez-Armero","Susana","Geriatrics Department, Hospital Universitario Puerta de Hierro Majadahonda, C/ Joaquín Rodrigo, 2, Majadahonda, 28220, Madrid, Spain",NA
"844","34165775","10.1007/s41999-021-00524-1","Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID-19 Pandemic.","Many institutionalized older people have died during the first wave of COVID-19. Other related consequences have not yet been described objectively. The aim of this study was to compare functional, cognitive, and nutritional status before and after the first wave among nursing home residents, in both COVID-19 and non-COVID-19 patients. Older adults institutionalized in four nursing homes were assessed from May to June 2020, by a geriatric multidisciplinary team in collaboration with the nursing ","2021","06","26","Eur Geriatr Med","European geriatric medicine","COVID; Decline; Elderly; Malnutrition; Nursing homes","Lacosta Esclapez","Pilar","Grupo Sergesa, Madrid, Spain",NA
"845","34165775","10.1007/s41999-021-00524-1","Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID-19 Pandemic.","Many institutionalized older people have died during the first wave of COVID-19. Other related consequences have not yet been described objectively. The aim of this study was to compare functional, cognitive, and nutritional status before and after the first wave among nursing home residents, in both COVID-19 and non-COVID-19 patients. Older adults institutionalized in four nursing homes were assessed from May to June 2020, by a geriatric multidisciplinary team in collaboration with the nursing ","2021","06","26","Eur Geriatr Med","European geriatric medicine","COVID; Decline; Elderly; Malnutrition; Nursing homes","González-Espinoza","Liliana","Grupo Albertia, Madrid, Spain",NA
"846","34165775","10.1007/s41999-021-00524-1","Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID-19 Pandemic.","Many institutionalized older people have died during the first wave of COVID-19. Other related consequences have not yet been described objectively. The aim of this study was to compare functional, cognitive, and nutritional status before and after the first wave among nursing home residents, in both COVID-19 and non-COVID-19 patients. Older adults institutionalized in four nursing homes were assessed from May to June 2020, by a geriatric multidisciplinary team in collaboration with the nursing ","2021","06","26","Eur Geriatr Med","European geriatric medicine","COVID; Decline; Elderly; Malnutrition; Nursing homes","Bermejo Boixareu","Cristina","Geriatrics Department, Hospital Universitario Puerta de Hierro Majadahonda, C/ Joaquín Rodrigo, 2, Majadahonda, 28220, Madrid, Spain",NA
"847","34165771","10.1007/s43440-021-00300-9","Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.","SARS-CoV-2 is a newly emerged human coronavirus that severely affected human health and the economy. The viral RNA-dependent RNA polymerase (RdRp) is a crucial protein target to stop virus replication. The adenosine derivative, remdesivir, was authorized for emergency use 10 months ago by the United States FDA against COVID-19 despite its doubtful efficacy against SARS-CoV-2. A dozen modifications based on remdesivir are tested against SARS-CoV-2 RdRp using combined molecular docking and dynamic","2021","06","26","Pharmacol Rep","Pharmacological reports : PR","Computational drug design; Medicinal; Nucleotide inhibitors; RdRp; Remdesivir; SARS-CoV-2","Sonousi","Amr","Pharmaceutical Organic Department, Faculty of Pharmacy, Cairo University, Giza, Egypt",NA
"848","34165771","10.1007/s43440-021-00300-9","Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.","SARS-CoV-2 is a newly emerged human coronavirus that severely affected human health and the economy. The viral RNA-dependent RNA polymerase (RdRp) is a crucial protein target to stop virus replication. The adenosine derivative, remdesivir, was authorized for emergency use 10 months ago by the United States FDA against COVID-19 despite its doubtful efficacy against SARS-CoV-2. A dozen modifications based on remdesivir are tested against SARS-CoV-2 RdRp using combined molecular docking and dynamic","2021","06","26","Pharmacol Rep","Pharmacological reports : PR","Computational drug design; Medicinal; Nucleotide inhibitors; RdRp; Remdesivir; SARS-CoV-2","Mahran","Hanan A","Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt",NA
"849","34165771","10.1007/s43440-021-00300-9","Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.","SARS-CoV-2 is a newly emerged human coronavirus that severely affected human health and the economy. The viral RNA-dependent RNA polymerase (RdRp) is a crucial protein target to stop virus replication. The adenosine derivative, remdesivir, was authorized for emergency use 10 months ago by the United States FDA against COVID-19 despite its doubtful efficacy against SARS-CoV-2. A dozen modifications based on remdesivir are tested against SARS-CoV-2 RdRp using combined molecular docking and dynamic","2021","06","26","Pharmacol Rep","Pharmacological reports : PR","Computational drug design; Medicinal; Nucleotide inhibitors; RdRp; Remdesivir; SARS-CoV-2","Ibrahim","Ibrahim M","Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt",NA
"850","34165771","10.1007/s43440-021-00300-9","Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.","SARS-CoV-2 is a newly emerged human coronavirus that severely affected human health and the economy. The viral RNA-dependent RNA polymerase (RdRp) is a crucial protein target to stop virus replication. The adenosine derivative, remdesivir, was authorized for emergency use 10 months ago by the United States FDA against COVID-19 despite its doubtful efficacy against SARS-CoV-2. A dozen modifications based on remdesivir are tested against SARS-CoV-2 RdRp using combined molecular docking and dynamic","2021","06","26","Pharmacol Rep","Pharmacological reports : PR","Computational drug design; Medicinal; Nucleotide inhibitors; RdRp; Remdesivir; SARS-CoV-2","Ibrahim","Mohamed N","Clinical Laboratories Department, College of Applied Medical Sciences, Jouf University, Sakakah, Kingdom of Saudi Arabia",NA
"851","34165771","10.1007/s43440-021-00300-9","Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.","SARS-CoV-2 is a newly emerged human coronavirus that severely affected human health and the economy. The viral RNA-dependent RNA polymerase (RdRp) is a crucial protein target to stop virus replication. The adenosine derivative, remdesivir, was authorized for emergency use 10 months ago by the United States FDA against COVID-19 despite its doubtful efficacy against SARS-CoV-2. A dozen modifications based on remdesivir are tested against SARS-CoV-2 RdRp using combined molecular docking and dynamic","2021","06","26","Pharmacol Rep","Pharmacological reports : PR","Computational drug design; Medicinal; Nucleotide inhibitors; RdRp; Remdesivir; SARS-CoV-2","Elfiky","Abdo A","Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt. abdo@sci.cu.edu","abdo@sci.cu.edu.eg"
"852","34165771","10.1007/s43440-021-00300-9","Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.","SARS-CoV-2 is a newly emerged human coronavirus that severely affected human health and the economy. The viral RNA-dependent RNA polymerase (RdRp) is a crucial protein target to stop virus replication. The adenosine derivative, remdesivir, was authorized for emergency use 10 months ago by the United States FDA against COVID-19 despite its doubtful efficacy against SARS-CoV-2. A dozen modifications based on remdesivir are tested against SARS-CoV-2 RdRp using combined molecular docking and dynamic","2021","06","26","Pharmacol Rep","Pharmacological reports : PR","Computational drug design; Medicinal; Nucleotide inhibitors; RdRp; Remdesivir; SARS-CoV-2","Elshemey","Wael M","Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt",NA
"853","34165766","10.1007/s40618-021-01614-4","Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.","To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients. PubMed/MEDLINE, Scopus, and Web of Science databases were systematically searched using appropriate keywords till June 8, 2021, to identify observational studies and randomized controlled trials (RCTs) reporting adverse clinical outcomes (ICU admission and/or mortality) in COVID-19 patients receiving vitamin D supplementation vs. ","2021","06","26","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; ICU admission; Mortality; Vitamin D","Pal","R","Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India",NA
"854","34165766","10.1007/s40618-021-01614-4","Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.","To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients. PubMed/MEDLINE, Scopus, and Web of Science databases were systematically searched using appropriate keywords till June 8, 2021, to identify observational studies and randomized controlled trials (RCTs) reporting adverse clinical outcomes (ICU admission and/or mortality) in COVID-19 patients receiving vitamin D supplementation vs. ","2021","06","26","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; ICU admission; Mortality; Vitamin D","Banerjee","M","Department of Endocrinology, Institute of Postgraduate Medical Education and Research, Kolkata, 700020, India",NA
"855","34165766","10.1007/s40618-021-01614-4","Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.","To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients. PubMed/MEDLINE, Scopus, and Web of Science databases were systematically searched using appropriate keywords till June 8, 2021, to identify observational studies and randomized controlled trials (RCTs) reporting adverse clinical outcomes (ICU admission and/or mortality) in COVID-19 patients receiving vitamin D supplementation vs. ","2021","06","26","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; ICU admission; Mortality; Vitamin D","Bhadada","S K","Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India. bhadadask@rediffmail","bhadadask@rediffmail.com"
"856","34165766","10.1007/s40618-021-01614-4","Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.","To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients. PubMed/MEDLINE, Scopus, and Web of Science databases were systematically searched using appropriate keywords till June 8, 2021, to identify observational studies and randomized controlled trials (RCTs) reporting adverse clinical outcomes (ICU admission and/or mortality) in COVID-19 patients receiving vitamin D supplementation vs. ","2021","06","26","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; ICU admission; Mortality; Vitamin D","Shetty","A J","Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India",NA
"857","34165766","10.1007/s40618-021-01614-4","Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.","To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients. PubMed/MEDLINE, Scopus, and Web of Science databases were systematically searched using appropriate keywords till June 8, 2021, to identify observational studies and randomized controlled trials (RCTs) reporting adverse clinical outcomes (ICU admission and/or mortality) in COVID-19 patients receiving vitamin D supplementation vs. ","2021","06","26","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; ICU admission; Mortality; Vitamin D","Singh","B","Government Medical College, Patiala, 147001, India",NA
"858","34165766","10.1007/s40618-021-01614-4","Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.","To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients. PubMed/MEDLINE, Scopus, and Web of Science databases were systematically searched using appropriate keywords till June 8, 2021, to identify observational studies and randomized controlled trials (RCTs) reporting adverse clinical outcomes (ICU admission and/or mortality) in COVID-19 patients receiving vitamin D supplementation vs. ","2021","06","26","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; ICU admission; Mortality; Vitamin D","Vyas","A","Department of Medicine, Rabindranath Tagore Medical College, Udaipur, 313001, India",NA
"859","34165695","10.1007/s10597-021-00861-2","Use of Telehealth in Mental Health (MH) Services During and After COVID-19.","COVID-19 social distancing guidelines caused a rapid transition to telephone and video technologies for the delivery of mental health (MH) services. The study examined: (a) adoption of these technologies across the MH service continuum; (b) acceptance of these technologies; and (c) intention of providers to use these technologies following the pandemic based on a sample of 327 MH organizations from 22 states during May-August 2020. There was widespread use of technology, with greater than 69% of","2021","06","26","Community Ment Health J","Community mental health journal","Behavioral health; Mental health; Technology adoption; Telehealth","Molfenter","Todd","University of Wisconsin - Madison, 1513 University Ave., Madison, WI, USA. todd.molfenter@chess.wisc","todd.molfenter@chess.wisc.edu"
"860","34165695","10.1007/s10597-021-00861-2","Use of Telehealth in Mental Health (MH) Services During and After COVID-19.","COVID-19 social distancing guidelines caused a rapid transition to telephone and video technologies for the delivery of mental health (MH) services. The study examined: (a) adoption of these technologies across the MH service continuum; (b) acceptance of these technologies; and (c) intention of providers to use these technologies following the pandemic based on a sample of 327 MH organizations from 22 states during May-August 2020. There was widespread use of technology, with greater than 69% of","2021","06","26","Community Ment Health J","Community mental health journal","Behavioral health; Mental health; Technology adoption; Telehealth","Heitkamp","Thomasine","College of Nursing and Professional Disciplines, 400 Oxford Street, Grand Forks, ND, 58202, USA",NA
"861","34165695","10.1007/s10597-021-00861-2","Use of Telehealth in Mental Health (MH) Services During and After COVID-19.","COVID-19 social distancing guidelines caused a rapid transition to telephone and video technologies for the delivery of mental health (MH) services. The study examined: (a) adoption of these technologies across the MH service continuum; (b) acceptance of these technologies; and (c) intention of providers to use these technologies following the pandemic based on a sample of 327 MH organizations from 22 states during May-August 2020. There was widespread use of technology, with greater than 69% of","2021","06","26","Community Ment Health J","Community mental health journal","Behavioral health; Mental health; Technology adoption; Telehealth","Murphy","Ann A","Department of Psychiatric Rehabilitation and Counseling Professions, Rutgers, School of Health Professions, 675 Hoes Lane West, Piscataway, NJ, 08854, USA",NA
"862","34165695","10.1007/s10597-021-00861-2","Use of Telehealth in Mental Health (MH) Services During and After COVID-19.","COVID-19 social distancing guidelines caused a rapid transition to telephone and video technologies for the delivery of mental health (MH) services. The study examined: (a) adoption of these technologies across the MH service continuum; (b) acceptance of these technologies; and (c) intention of providers to use these technologies following the pandemic based on a sample of 327 MH organizations from 22 states during May-August 2020. There was widespread use of technology, with greater than 69% of","2021","06","26","Community Ment Health J","Community mental health journal","Behavioral health; Mental health; Technology adoption; Telehealth","Tapscott","Stephanie","Department of Health Policy and Management, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA, 30322, USA",NA
"863","34165695","10.1007/s10597-021-00861-2","Use of Telehealth in Mental Health (MH) Services During and After COVID-19.","COVID-19 social distancing guidelines caused a rapid transition to telephone and video technologies for the delivery of mental health (MH) services. The study examined: (a) adoption of these technologies across the MH service continuum; (b) acceptance of these technologies; and (c) intention of providers to use these technologies following the pandemic based on a sample of 327 MH organizations from 22 states during May-August 2020. There was widespread use of technology, with greater than 69% of","2021","06","26","Community Ment Health J","Community mental health journal","Behavioral health; Mental health; Technology adoption; Telehealth","Behlman","Stephanie","University of Wisconsin - Madison, 1513 University Ave., Madison, WI, USA",NA
"864","34165695","10.1007/s10597-021-00861-2","Use of Telehealth in Mental Health (MH) Services During and After COVID-19.","COVID-19 social distancing guidelines caused a rapid transition to telephone and video technologies for the delivery of mental health (MH) services. The study examined: (a) adoption of these technologies across the MH service continuum; (b) acceptance of these technologies; and (c) intention of providers to use these technologies following the pandemic based on a sample of 327 MH organizations from 22 states during May-August 2020. There was widespread use of technology, with greater than 69% of","2021","06","26","Community Ment Health J","Community mental health journal","Behavioral health; Mental health; Technology adoption; Telehealth","Cody","Olivia J","University of Wisconsin - Madison, 1513 University Ave., Madison, WI, USA",NA
"865","34165650","10.1007/s10072-021-05409-6","MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine.","The use of disease-modifying therapies (DMTs) in people with multiple sclerosis (pwMS) may affect COVID-19 infection outcomes due to DMTs' immunomodulatory and immunosuppressive effects on immune response. The yet unknown issues are both the early response to the infection, as well as the post-infection development of immunity against the virus under these treatments due to their interaction with the immune system. We report two asymptomatic cases of COVID-19 in patients with relapsing-remitting","2021","06","26","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Cladribine; Multiple sclerosis; SARS-CoV-2 antibody response","Seferoglu","Meral","Department of Neurology, Bursa Yüksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa, Turkey. meralbozseferoglu@gmail","meralbozseferoglu@gmail.com"
"866","34165650","10.1007/s10072-021-05409-6","MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine.","The use of disease-modifying therapies (DMTs) in people with multiple sclerosis (pwMS) may affect COVID-19 infection outcomes due to DMTs' immunomodulatory and immunosuppressive effects on immune response. The yet unknown issues are both the early response to the infection, as well as the post-infection development of immunity against the virus under these treatments due to their interaction with the immune system. We report two asymptomatic cases of COVID-19 in patients with relapsing-remitting","2021","06","26","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Cladribine; Multiple sclerosis; SARS-CoV-2 antibody response","Ethemoglu","Özlem","Department of Neurology, Harran University School of Medicine, Sanliurfa, Turkey",NA
"867","34165650","10.1007/s10072-021-05409-6","MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine.","The use of disease-modifying therapies (DMTs) in people with multiple sclerosis (pwMS) may affect COVID-19 infection outcomes due to DMTs' immunomodulatory and immunosuppressive effects on immune response. The yet unknown issues are both the early response to the infection, as well as the post-infection development of immunity against the virus under these treatments due to their interaction with the immune system. We report two asymptomatic cases of COVID-19 in patients with relapsing-remitting","2021","06","26","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Cladribine; Multiple sclerosis; SARS-CoV-2 antibody response","Turan","Ömer Faruk","Department of Neurology, Uludag University School of Medicine, Bursa, Turkey",NA
"868","34165650","10.1007/s10072-021-05409-6","MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine.","The use of disease-modifying therapies (DMTs) in people with multiple sclerosis (pwMS) may affect COVID-19 infection outcomes due to DMTs' immunomodulatory and immunosuppressive effects on immune response. The yet unknown issues are both the early response to the infection, as well as the post-infection development of immunity against the virus under these treatments due to their interaction with the immune system. We report two asymptomatic cases of COVID-19 in patients with relapsing-remitting","2021","06","26","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Cladribine; Multiple sclerosis; SARS-CoV-2 antibody response","Siva","Aksel","Department of Neurology and MS Clinic, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey",NA
"869","34165646","10.1186/s41687-021-00323-z","Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic has led to a deep reorganization of hospital services including inflammatory bowel disease (IBD) units. In this situation, conversion of in-person routine follow-up visits into phone consultations might be necessary. Here we explored the feasibility of using the validated Crohn's Disease (CD) or Ulcerative Colitis (UC) Patient-Reported Outcomes Signs and Symptoms (CD- and UC-PRO/SS) to collect data about abdominal symptoms (abdominal/S) and bowel signs and symptoms (bowel/S","2021","06","26","J Patient Rep Outcomes","Journal of patient-reported outcomes","COVID-19; Inflammatory bowel disease; Patient-reported outcome; Telemedicine","Pinto","Sergio","Department of Medical Science and Public Health, Cagliari, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy",NA
"870","34165646","10.1186/s41687-021-00323-z","Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic has led to a deep reorganization of hospital services including inflammatory bowel disease (IBD) units. In this situation, conversion of in-person routine follow-up visits into phone consultations might be necessary. Here we explored the feasibility of using the validated Crohn's Disease (CD) or Ulcerative Colitis (UC) Patient-Reported Outcomes Signs and Symptoms (CD- and UC-PRO/SS) to collect data about abdominal symptoms (abdominal/S) and bowel signs and symptoms (bowel/S","2021","06","26","J Patient Rep Outcomes","Journal of patient-reported outcomes","COVID-19; Inflammatory bowel disease; Patient-reported outcome; Telemedicine","Loddo","Erica","Department of Medical Science and Public Health, Cagliari, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy",NA
"871","34165646","10.1186/s41687-021-00323-z","Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic has led to a deep reorganization of hospital services including inflammatory bowel disease (IBD) units. In this situation, conversion of in-person routine follow-up visits into phone consultations might be necessary. Here we explored the feasibility of using the validated Crohn's Disease (CD) or Ulcerative Colitis (UC) Patient-Reported Outcomes Signs and Symptoms (CD- and UC-PRO/SS) to collect data about abdominal symptoms (abdominal/S) and bowel signs and symptoms (bowel/S","2021","06","26","J Patient Rep Outcomes","Journal of patient-reported outcomes","COVID-19; Inflammatory bowel disease; Patient-reported outcome; Telemedicine","Paba","Salvatore","Department of Medical Science and Public Health, Cagliari, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy",NA
"872","34165646","10.1186/s41687-021-00323-z","Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic has led to a deep reorganization of hospital services including inflammatory bowel disease (IBD) units. In this situation, conversion of in-person routine follow-up visits into phone consultations might be necessary. Here we explored the feasibility of using the validated Crohn's Disease (CD) or Ulcerative Colitis (UC) Patient-Reported Outcomes Signs and Symptoms (CD- and UC-PRO/SS) to collect data about abdominal symptoms (abdominal/S) and bowel signs and symptoms (bowel/S","2021","06","26","J Patient Rep Outcomes","Journal of patient-reported outcomes","COVID-19; Inflammatory bowel disease; Patient-reported outcome; Telemedicine","Favale","Agnese","Department of Medical Science and Public Health, Cagliari, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy",NA
"873","34165646","10.1186/s41687-021-00323-z","Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic has led to a deep reorganization of hospital services including inflammatory bowel disease (IBD) units. In this situation, conversion of in-person routine follow-up visits into phone consultations might be necessary. Here we explored the feasibility of using the validated Crohn's Disease (CD) or Ulcerative Colitis (UC) Patient-Reported Outcomes Signs and Symptoms (CD- and UC-PRO/SS) to collect data about abdominal symptoms (abdominal/S) and bowel signs and symptoms (bowel/S","2021","06","26","J Patient Rep Outcomes","Journal of patient-reported outcomes","COVID-19; Inflammatory bowel disease; Patient-reported outcome; Telemedicine","Chicco","Fabio","Department of Medical Science and Public Health, Cagliari, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy",NA
"874","34165646","10.1186/s41687-021-00323-z","Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic has led to a deep reorganization of hospital services including inflammatory bowel disease (IBD) units. In this situation, conversion of in-person routine follow-up visits into phone consultations might be necessary. Here we explored the feasibility of using the validated Crohn's Disease (CD) or Ulcerative Colitis (UC) Patient-Reported Outcomes Signs and Symptoms (CD- and UC-PRO/SS) to collect data about abdominal symptoms (abdominal/S) and bowel signs and symptoms (bowel/S","2021","06","26","J Patient Rep Outcomes","Journal of patient-reported outcomes","COVID-19; Inflammatory bowel disease; Patient-reported outcome; Telemedicine","Onali","Sara","Department of Medical Science and Public Health, Cagliari, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy",NA
"875","34165646","10.1186/s41687-021-00323-z","Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic has led to a deep reorganization of hospital services including inflammatory bowel disease (IBD) units. In this situation, conversion of in-person routine follow-up visits into phone consultations might be necessary. Here we explored the feasibility of using the validated Crohn's Disease (CD) or Ulcerative Colitis (UC) Patient-Reported Outcomes Signs and Symptoms (CD- and UC-PRO/SS) to collect data about abdominal symptoms (abdominal/S) and bowel signs and symptoms (bowel/S","2021","06","26","J Patient Rep Outcomes","Journal of patient-reported outcomes","COVID-19; Inflammatory bowel disease; Patient-reported outcome; Telemedicine","Usai","Paolo","Department of Medical Science and Public Health, Cagliari, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy",NA
"876","34165646","10.1186/s41687-021-00323-z","Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic has led to a deep reorganization of hospital services including inflammatory bowel disease (IBD) units. In this situation, conversion of in-person routine follow-up visits into phone consultations might be necessary. Here we explored the feasibility of using the validated Crohn's Disease (CD) or Ulcerative Colitis (UC) Patient-Reported Outcomes Signs and Symptoms (CD- and UC-PRO/SS) to collect data about abdominal symptoms (abdominal/S) and bowel signs and symptoms (bowel/S","2021","06","26","J Patient Rep Outcomes","Journal of patient-reported outcomes","COVID-19; Inflammatory bowel disease; Patient-reported outcome; Telemedicine","Fantini","Massimo Claudio","Department of Medical Science and Public Health, Cagliari, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy. massimoc.fantini@unica","massimoc.fantini@unica.it"
"877","34165644","10.1007/s00455-021-10325-0","Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results.","A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease-2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we ","2021","07","22","Dysphagia","Dysphagia","COVID-19; Dysphagia; Oropharyngeal dysphagia; Post-COVID-19; SARS-CoV-2","Marchese","Maria Raffaella","Department of Head and Neck Sciences, Catholic University of Sacred Heart, Policlinico ""A. Gemelli"" Foundation, L.go ""A. Gemelli"" 8, 00168, Rome, Italy. mariaraffaella.marchese@policlinicogemelli","mariaraffaella.marchese@policlinicogemelli.it"
"878","34165644","10.1007/s00455-021-10325-0","Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results.","A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease-2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we ","2021","07","22","Dysphagia","Dysphagia","COVID-19; Dysphagia; Oropharyngeal dysphagia; Post-COVID-19; SARS-CoV-2","Ausili Cefaro","Carolina","Division of Phonatrics, Department of Aging, Neuroscience, Orthopedics and Head and Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"879","34165644","10.1007/s00455-021-10325-0","Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results.","A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease-2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we ","2021","07","22","Dysphagia","Dysphagia","COVID-19; Dysphagia; Oropharyngeal dysphagia; Post-COVID-19; SARS-CoV-2","Mari","Giorgia","Division of Phonatrics, Department of Aging, Neuroscience, Orthopedics and Head and Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"880","34165644","10.1007/s00455-021-10325-0","Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results.","A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease-2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we ","2021","07","22","Dysphagia","Dysphagia","COVID-19; Dysphagia; Oropharyngeal dysphagia; Post-COVID-19; SARS-CoV-2","Proietti","Ilaria","Division of Phonatrics, Department of Aging, Neuroscience, Orthopedics and Head and Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"881","34165644","10.1007/s00455-021-10325-0","Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results.","A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease-2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we ","2021","07","22","Dysphagia","Dysphagia","COVID-19; Dysphagia; Oropharyngeal dysphagia; Post-COVID-19; SARS-CoV-2","Carfì","Angelo","Institute of Internal Medicine and Geriatrics, Università Cattolica del Sacro Cuore, Rome, Italy",NA
"882","34165644","10.1007/s00455-021-10325-0","Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results.","A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease-2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we ","2021","07","22","Dysphagia","Dysphagia","COVID-19; Dysphagia; Oropharyngeal dysphagia; Post-COVID-19; SARS-CoV-2","Tosato","Matteo","Institute of Internal Medicine and Geriatrics, Università Cattolica del Sacro Cuore, Rome, Italy",NA
"883","34165644","10.1007/s00455-021-10325-0","Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results.","A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease-2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we ","2021","07","22","Dysphagia","Dysphagia","COVID-19; Dysphagia; Oropharyngeal dysphagia; Post-COVID-19; SARS-CoV-2","Longobardi","Ylenia","Division of Phonatrics, Department of Aging, Neuroscience, Orthopedics and Head and Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"884","34165644","10.1007/s00455-021-10325-0","Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results.","A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease-2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we ","2021","07","22","Dysphagia","Dysphagia","COVID-19; Dysphagia; Oropharyngeal dysphagia; Post-COVID-19; SARS-CoV-2","Lucia","D'Alatri","Department of Head and Neck Sciences, Catholic University of Sacred Heart, Policlinico ""A. Gemelli"" Foundation, L.go ""A. Gemelli"" 8, 00168, Rome, Italy",NA
"885","34165612","10.1007/s00426-021-01550-1","Daily mindfulness training reduces negative impact of COVID-19 news exposure on affective well-being.","COVID-19 has led to mental health adversities worldwide. The current study examined whether daily practice of brief mindfulness training has a beneficial impact on affective well-being, and mitigates the negative impact of exposure to COVID-19 news during the pandemic. Participants were randomly assigned into a mindfulness training (MT) group or a waitlist control (WC) group. Participants in the MT group practiced guided mindfulness meditation for a minimum of 10 min each day for 10 days. Both g","2021","06","26","Psychol Res","Psychological research",NA,"Kam","Julia W Y","Department of Psychology, University of Calgary, 2500 University Drive NW, Calgary, AB, Canada. julia.kam@ucalgary","julia.kam@ucalgary.ca"
"886","34165612","10.1007/s00426-021-01550-1","Daily mindfulness training reduces negative impact of COVID-19 news exposure on affective well-being.","COVID-19 has led to mental health adversities worldwide. The current study examined whether daily practice of brief mindfulness training has a beneficial impact on affective well-being, and mitigates the negative impact of exposure to COVID-19 news during the pandemic. Participants were randomly assigned into a mindfulness training (MT) group or a waitlist control (WC) group. Participants in the MT group practiced guided mindfulness meditation for a minimum of 10 min each day for 10 days. Both g","2021","06","26","Psychol Res","Psychological research",NA,"Javed","Javeria","Department of Psychology, University of Calgary, 2500 University Drive NW, Calgary, AB, Canada",NA
"887","34165612","10.1007/s00426-021-01550-1","Daily mindfulness training reduces negative impact of COVID-19 news exposure on affective well-being.","COVID-19 has led to mental health adversities worldwide. The current study examined whether daily practice of brief mindfulness training has a beneficial impact on affective well-being, and mitigates the negative impact of exposure to COVID-19 news during the pandemic. Participants were randomly assigned into a mindfulness training (MT) group or a waitlist control (WC) group. Participants in the MT group practiced guided mindfulness meditation for a minimum of 10 min each day for 10 days. Both g","2021","06","26","Psychol Res","Psychological research",NA,"Hart","Chelsie M","Department of Psychology, University of Calgary, 2500 University Drive NW, Calgary, AB, Canada",NA
"888","34165612","10.1007/s00426-021-01550-1","Daily mindfulness training reduces negative impact of COVID-19 news exposure on affective well-being.","COVID-19 has led to mental health adversities worldwide. The current study examined whether daily practice of brief mindfulness training has a beneficial impact on affective well-being, and mitigates the negative impact of exposure to COVID-19 news during the pandemic. Participants were randomly assigned into a mindfulness training (MT) group or a waitlist control (WC) group. Participants in the MT group practiced guided mindfulness meditation for a minimum of 10 min each day for 10 days. Both g","2021","06","26","Psychol Res","Psychological research",NA,"Andrews-Hanna","Jessica R","Department of Psychology",NA
"889","34165612","10.1007/s00426-021-01550-1","Daily mindfulness training reduces negative impact of COVID-19 news exposure on affective well-being.","COVID-19 has led to mental health adversities worldwide. The current study examined whether daily practice of brief mindfulness training has a beneficial impact on affective well-being, and mitigates the negative impact of exposure to COVID-19 news during the pandemic. Participants were randomly assigned into a mindfulness training (MT) group or a waitlist control (WC) group. Participants in the MT group practiced guided mindfulness meditation for a minimum of 10 min each day for 10 days. Both g","2021","06","26","Psychol Res","Psychological research",NA,"Tomfohr-Madsen","Lianne M","Department of Psychology, University of Calgary, 2500 University Drive NW, Calgary, AB, Canada",NA
"890","34165612","10.1007/s00426-021-01550-1","Daily mindfulness training reduces negative impact of COVID-19 news exposure on affective well-being.","COVID-19 has led to mental health adversities worldwide. The current study examined whether daily practice of brief mindfulness training has a beneficial impact on affective well-being, and mitigates the negative impact of exposure to COVID-19 news during the pandemic. Participants were randomly assigned into a mindfulness training (MT) group or a waitlist control (WC) group. Participants in the MT group practiced guided mindfulness meditation for a minimum of 10 min each day for 10 days. Both g","2021","06","26","Psychol Res","Psychological research",NA,"Mills","Caitlin","Department of Psychology, University of New Hampshire, 105 Main St, Durham, NH, USA",NA
"891","34165582","10.1001/jamanetworkopen.2021.14520","Association of the COVID-19 Pandemic With Estimated Life Expectancy by Race/Ethnicity in the United States, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Continental Population Groups; Cross-Sectional Studies; Health Status Disparities; Hispanic Americans; Humans; Life Expectancy; United States","Andrasfay","Theresa","Leonard Davis School of Gerontology, University of Southern California, Los Angeles",NA
"892","34165582","10.1001/jamanetworkopen.2021.14520","Association of the COVID-19 Pandemic With Estimated Life Expectancy by Race/Ethnicity in the United States, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Continental Population Groups; Cross-Sectional Studies; Health Status Disparities; Hispanic Americans; Humans; Life Expectancy; United States","Goldman","Noreen","Office of Population Research and Princeton School of Public and International Affairs, Princeton University, Princeton, New Jersey",NA
"893","34165581","10.1001/jamanetworkopen.2021.15352","Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Anosmia; COVID-19; COVID-19 Testing; Cohort Studies; France; Humans; Treatment Outcome","Renaud","Marion","Otorhinolaryngology Department, University Hospitals of Strasbourg, Strasbourg, France",NA
"894","34165581","10.1001/jamanetworkopen.2021.15352","Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Anosmia; COVID-19; COVID-19 Testing; Cohort Studies; France; Humans; Treatment Outcome","Thibault","Claire","Otorhinolaryngology Department, University Hospitals of Strasbourg, Strasbourg, France",NA
"895","34165581","10.1001/jamanetworkopen.2021.15352","Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Anosmia; COVID-19; COVID-19 Testing; Cohort Studies; France; Humans; Treatment Outcome","Le Normand","Floriane","Otorhinolaryngology Department, University Hospitals of Strasbourg, Strasbourg, France",NA
"896","34165581","10.1001/jamanetworkopen.2021.15352","Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Anosmia; COVID-19; COVID-19 Testing; Cohort Studies; France; Humans; Treatment Outcome","Mcdonald","Emily G","Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada",NA
"897","34165581","10.1001/jamanetworkopen.2021.15352","Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Anosmia; COVID-19; COVID-19 Testing; Cohort Studies; France; Humans; Treatment Outcome","Gallix","Benoît","Institut Hospitalo-Universitaire-Strasbourg, Strasbourg, France",NA
"898","34165581","10.1001/jamanetworkopen.2021.15352","Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Anosmia; COVID-19; COVID-19 Testing; Cohort Studies; France; Humans; Treatment Outcome","Debry","Christian","Otorhinolaryngology Department, University Hospitals of Strasbourg, Strasbourg, France",NA
"899","34165581","10.1001/jamanetworkopen.2021.15352","Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Anosmia; COVID-19; COVID-19 Testing; Cohort Studies; France; Humans; Treatment Outcome","Venkatasamy","Aina","Institut Hospitalo-Universitaire-Strasbourg, Strasbourg, France",NA
"900","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Funabashi","Rikako","Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan",NA
"901","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Miyakawa","Kei","Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan",NA
"902","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Yamaoka","Yutaro","Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan",NA
"903","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Yoshimura","Seiko","Primary Care Testing Solution Development Department, Canon Medical Systems Corporation, Tochigi, Japan",NA
"904","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Yamane","Satoshi","Primary Care Testing Solution Development Department, Canon Medical Systems Corporation, Tochigi, Japan",NA
"905","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Jeremiah","Sundararaj Stanleyraj","Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan",NA
"906","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Shimizu","Kohei","Yokohama City Institute of Public Health, Kanagawa, Japan",NA
"907","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Ozawa","Hiroki","Yokohama City Institute of Public Health, Kanagawa, Japan",NA
"908","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Kawakami","Chiharu","Yokohama City Institute of Public Health, Kanagawa, Japan",NA
"909","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Usuku","Shuzo","Yokohama City Institute of Public Health, Kanagawa, Japan",NA
"910","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Tanaka","Nobuko","Yokohama City Institute of Public Health, Kanagawa, Japan",NA
"911","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Yamazaki","Etsuko","Clinical Laboratory Department, Yokohama City University Hospital, Kanagawa, Japan",NA
"912","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Kimura","Hirokazu","Department of Health Science, Gunma Paz University Graduate School, Gunma, Japan",NA
"913","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Hasegawa","Hideki","Influenza Research Center, National Institute of Infectious Diseases, Tokyo, Japan",NA
"914","34165565","10.1093/jmcb/mjab037","Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.",NA,"2021","06","24","J Mol Cell Biol","Journal of molecular cell biology",NA,"Ryo","Akihide","Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan",NA
"915","34165563","10.1093/labmed/lmab015","Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms.","This research aims to develop a laboratory model that can accurately distinguish pneumonia from nonpneumonia in patients with COVID-19 and to identify potential protective factors against lung infection. We recruited 50 patients diagnosed with COVID-19 infection with or without pneumonia. We selected candidate predictors through group comparison and punitive least absolute shrinkage and selection operator (LASSO) analysis. A stepwise logistic regression model was used to distinguish patients wit","2021","07","12","Lab Med","Laboratory medicine","COVID-19 infection; laboratory examination; non-pneumonia; pneumonia; predictive model; protective factor; Adult; Blood Cell Count; COVID-19; COVID-19 Testing; Creatinine; Decision Trees; Female; Humans; Laboratories; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Reticulocytes; Tomography, X-Ray Computed; Young Adult","Li","Jiaxia","Department of Neurology, the Second People's Hospital of Hefei, Affiliated Hefei Hospital of Anhui Medical University, Hefei, Anhui, China",NA
"916","34165563","10.1093/labmed/lmab015","Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms.","This research aims to develop a laboratory model that can accurately distinguish pneumonia from nonpneumonia in patients with COVID-19 and to identify potential protective factors against lung infection. We recruited 50 patients diagnosed with COVID-19 infection with or without pneumonia. We selected candidate predictors through group comparison and punitive least absolute shrinkage and selection operator (LASSO) analysis. A stepwise logistic regression model was used to distinguish patients wit","2021","07","12","Lab Med","Laboratory medicine","COVID-19 infection; laboratory examination; non-pneumonia; pneumonia; predictive model; protective factor; Adult; Blood Cell Count; COVID-19; COVID-19 Testing; Creatinine; Decision Trees; Female; Humans; Laboratories; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Reticulocytes; Tomography, X-Ray Computed; Young Adult","Wan","Li","Affiliated Psychological Hospital of Anhui Medical University, Hefei Fourth People's Hospital, Anhui Mental Health Center, Hefei, Anhui, China",NA
"917","34165563","10.1093/labmed/lmab015","Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms.","This research aims to develop a laboratory model that can accurately distinguish pneumonia from nonpneumonia in patients with COVID-19 and to identify potential protective factors against lung infection. We recruited 50 patients diagnosed with COVID-19 infection with or without pneumonia. We selected candidate predictors through group comparison and punitive least absolute shrinkage and selection operator (LASSO) analysis. A stepwise logistic regression model was used to distinguish patients wit","2021","07","12","Lab Med","Laboratory medicine","COVID-19 infection; laboratory examination; non-pneumonia; pneumonia; predictive model; protective factor; Adult; Blood Cell Count; COVID-19; COVID-19 Testing; Creatinine; Decision Trees; Female; Humans; Laboratories; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Reticulocytes; Tomography, X-Ray Computed; Young Adult","Feng","Yuan","Department of Neurology, the Second People's Hospital of Hefei, Affiliated Hefei Hospital of Anhui Medical University, Hefei, Anhui, China",NA
"918","34165563","10.1093/labmed/lmab015","Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms.","This research aims to develop a laboratory model that can accurately distinguish pneumonia from nonpneumonia in patients with COVID-19 and to identify potential protective factors against lung infection. We recruited 50 patients diagnosed with COVID-19 infection with or without pneumonia. We selected candidate predictors through group comparison and punitive least absolute shrinkage and selection operator (LASSO) analysis. A stepwise logistic regression model was used to distinguish patients wit","2021","07","12","Lab Med","Laboratory medicine","COVID-19 infection; laboratory examination; non-pneumonia; pneumonia; predictive model; protective factor; Adult; Blood Cell Count; COVID-19; COVID-19 Testing; Creatinine; Decision Trees; Female; Humans; Laboratories; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Reticulocytes; Tomography, X-Ray Computed; Young Adult","Zuo","Huilin","Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, China",NA
"919","34165563","10.1093/labmed/lmab015","Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms.","This research aims to develop a laboratory model that can accurately distinguish pneumonia from nonpneumonia in patients with COVID-19 and to identify potential protective factors against lung infection. We recruited 50 patients diagnosed with COVID-19 infection with or without pneumonia. We selected candidate predictors through group comparison and punitive least absolute shrinkage and selection operator (LASSO) analysis. A stepwise logistic regression model was used to distinguish patients wit","2021","07","12","Lab Med","Laboratory medicine","COVID-19 infection; laboratory examination; non-pneumonia; pneumonia; predictive model; protective factor; Adult; Blood Cell Count; COVID-19; COVID-19 Testing; Creatinine; Decision Trees; Female; Humans; Laboratories; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Reticulocytes; Tomography, X-Ray Computed; Young Adult","Zhao","Qian","Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, China",NA
"920","34165563","10.1093/labmed/lmab015","Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms.","This research aims to develop a laboratory model that can accurately distinguish pneumonia from nonpneumonia in patients with COVID-19 and to identify potential protective factors against lung infection. We recruited 50 patients diagnosed with COVID-19 infection with or without pneumonia. We selected candidate predictors through group comparison and punitive least absolute shrinkage and selection operator (LASSO) analysis. A stepwise logistic regression model was used to distinguish patients wit","2021","07","12","Lab Med","Laboratory medicine","COVID-19 infection; laboratory examination; non-pneumonia; pneumonia; predictive model; protective factor; Adult; Blood Cell Count; COVID-19; COVID-19 Testing; Creatinine; Decision Trees; Female; Humans; Laboratories; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Reticulocytes; Tomography, X-Ray Computed; Young Adult","Ren","Jiecheng","Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, China",NA
"921","34165563","10.1093/labmed/lmab015","Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms.","This research aims to develop a laboratory model that can accurately distinguish pneumonia from nonpneumonia in patients with COVID-19 and to identify potential protective factors against lung infection. We recruited 50 patients diagnosed with COVID-19 infection with or without pneumonia. We selected candidate predictors through group comparison and punitive least absolute shrinkage and selection operator (LASSO) analysis. A stepwise logistic regression model was used to distinguish patients wit","2021","07","12","Lab Med","Laboratory medicine","COVID-19 infection; laboratory examination; non-pneumonia; pneumonia; predictive model; protective factor; Adult; Blood Cell Count; COVID-19; COVID-19 Testing; Creatinine; Decision Trees; Female; Humans; Laboratories; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Reticulocytes; Tomography, X-Ray Computed; Young Adult","Zhang","Xiaochu","Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, China",NA
"922","34165563","10.1093/labmed/lmab015","Laboratory Predictors of COVID-19 Pneumonia in Patients with Mild to Moderate Symptoms.","This research aims to develop a laboratory model that can accurately distinguish pneumonia from nonpneumonia in patients with COVID-19 and to identify potential protective factors against lung infection. We recruited 50 patients diagnosed with COVID-19 infection with or without pneumonia. We selected candidate predictors through group comparison and punitive least absolute shrinkage and selection operator (LASSO) analysis. A stepwise logistic regression model was used to distinguish patients wit","2021","07","12","Lab Med","Laboratory medicine","COVID-19 infection; laboratory examination; non-pneumonia; pneumonia; predictive model; protective factor; Adult; Blood Cell Count; COVID-19; COVID-19 Testing; Creatinine; Decision Trees; Female; Humans; Laboratories; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Reticulocytes; Tomography, X-Ray Computed; Young Adult","Xia","Mingwu","Department of Neurology, the Second People's Hospital of Hefei, Affiliated Hefei Hospital of Anhui Medical University, Hefei, Anhui, China",NA
"923","34165551","10.1093/occmed/kqab076","Prevalence of SARS-CoV-2 among Belgian workers in long-term care facilities.","Healthcare workers (HCWs) can be a source of SARS-CoV-2 within long-term care facilities (LTCFs); therefore, we analysed the data from a testing programme among LTCF employees. The aim of this study was to investigate the prevalence of SARS-CoV-2 and its determinants among employees of LTCFs and the risk for fellow workers and residents. Testing started at week 15, the first wave's peak, using nasopharyngeal swabs for PCR up to week 23. At the start of the second wave (week 32), testing resumed.","2021","06","24","Occup Med (Lond)","Occupational medicine (Oxford, England)","Health care workers; PCR; SARS-CoV-2; long-term care facilities","Mylle","G","IDEWE, External Service for Prevention and Protection at Work, Interleuvenlaan 58, 3001 Heverlee, Belgium",NA
"924","34165551","10.1093/occmed/kqab076","Prevalence of SARS-CoV-2 among Belgian workers in long-term care facilities.","Healthcare workers (HCWs) can be a source of SARS-CoV-2 within long-term care facilities (LTCFs); therefore, we analysed the data from a testing programme among LTCF employees. The aim of this study was to investigate the prevalence of SARS-CoV-2 and its determinants among employees of LTCFs and the risk for fellow workers and residents. Testing started at week 15, the first wave's peak, using nasopharyngeal swabs for PCR up to week 23. At the start of the second wave (week 32), testing resumed.","2021","06","24","Occup Med (Lond)","Occupational medicine (Oxford, England)","Health care workers; PCR; SARS-CoV-2; long-term care facilities","Vanacker","H","IDEWE, External Service for Prevention and Protection at Work, Interleuvenlaan 58, 3001 Heverlee, Belgium",NA
"925","34165551","10.1093/occmed/kqab076","Prevalence of SARS-CoV-2 among Belgian workers in long-term care facilities.","Healthcare workers (HCWs) can be a source of SARS-CoV-2 within long-term care facilities (LTCFs); therefore, we analysed the data from a testing programme among LTCF employees. The aim of this study was to investigate the prevalence of SARS-CoV-2 and its determinants among employees of LTCFs and the risk for fellow workers and residents. Testing started at week 15, the first wave's peak, using nasopharyngeal swabs for PCR up to week 23. At the start of the second wave (week 32), testing resumed.","2021","06","24","Occup Med (Lond)","Occupational medicine (Oxford, England)","Health care workers; PCR; SARS-CoV-2; long-term care facilities","Verbeek","C","IDEWE, External Service for Prevention and Protection at Work, Interleuvenlaan 58, 3001 Heverlee, Belgium",NA
"926","34165551","10.1093/occmed/kqab076","Prevalence of SARS-CoV-2 among Belgian workers in long-term care facilities.","Healthcare workers (HCWs) can be a source of SARS-CoV-2 within long-term care facilities (LTCFs); therefore, we analysed the data from a testing programme among LTCF employees. The aim of this study was to investigate the prevalence of SARS-CoV-2 and its determinants among employees of LTCFs and the risk for fellow workers and residents. Testing started at week 15, the first wave's peak, using nasopharyngeal swabs for PCR up to week 23. At the start of the second wave (week 32), testing resumed.","2021","06","24","Occup Med (Lond)","Occupational medicine (Oxford, England)","Health care workers; PCR; SARS-CoV-2; long-term care facilities","Bulterys","S","IDEWE, External Service for Prevention and Protection at Work, Interleuvenlaan 58, 3001 Heverlee, Belgium",NA
"927","34165551","10.1093/occmed/kqab076","Prevalence of SARS-CoV-2 among Belgian workers in long-term care facilities.","Healthcare workers (HCWs) can be a source of SARS-CoV-2 within long-term care facilities (LTCFs); therefore, we analysed the data from a testing programme among LTCF employees. The aim of this study was to investigate the prevalence of SARS-CoV-2 and its determinants among employees of LTCFs and the risk for fellow workers and residents. Testing started at week 15, the first wave's peak, using nasopharyngeal swabs for PCR up to week 23. At the start of the second wave (week 32), testing resumed.","2021","06","24","Occup Med (Lond)","Occupational medicine (Oxford, England)","Health care workers; PCR; SARS-CoV-2; long-term care facilities","Godderis","L","IDEWE, External Service for Prevention and Protection at Work, Interleuvenlaan 58, 3001 Heverlee, Belgium",NA
"928","34165551","10.1093/occmed/kqab076","Prevalence of SARS-CoV-2 among Belgian workers in long-term care facilities.","Healthcare workers (HCWs) can be a source of SARS-CoV-2 within long-term care facilities (LTCFs); therefore, we analysed the data from a testing programme among LTCF employees. The aim of this study was to investigate the prevalence of SARS-CoV-2 and its determinants among employees of LTCFs and the risk for fellow workers and residents. Testing started at week 15, the first wave's peak, using nasopharyngeal swabs for PCR up to week 23. At the start of the second wave (week 32), testing resumed.","2021","06","24","Occup Med (Lond)","Occupational medicine (Oxford, England)","Health care workers; PCR; SARS-CoV-2; long-term care facilities","De Schryver","A","IDEWE, External Service for Prevention and Protection at Work, Interleuvenlaan 58, 3001 Heverlee, Belgium",NA
"929","34165549","10.1242/dmm.049163","Models and Mechanisms for COVID-19 Research.",NA,"2021","07","05","Dis Model Mech","Disease models &amp; mechanisms","Animals; Biomedical Research; COVID-19; Disease Models, Animal; Humans; SARS-CoV-2","Hooper","Kirsty M","The Company of Biologists, Station Road, Histon, Cambridge CB24 9LF, UK",NA
"930","34165549","10.1242/dmm.049163","Models and Mechanisms for COVID-19 Research.",NA,"2021","07","05","Dis Model Mech","Disease models &amp; mechanisms","Animals; Biomedical Research; COVID-19; Disease Models, Animal; Humans; SARS-CoV-2","Patton","E Elizabeth","MRC Human Genetics Unit and Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK",NA
"931","34165533","10.1093/jalm/jfab079","Implementation of an extraction-free COVID RT-PCR workflow in a pediatric hospital setting.","This study outlines the development, implementation, and impact of a laboratory-developed, extraction-free real-time polymerase chain reaction (RT-PCR) assay as the primary diagnostic test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric hospital. Clinical specimens from both upper and lower respiratory tract sources were validated, including nasopharyngeal aspirates, nasopharyngeal swabs, anterior nares swabs and tracheal aspirates (n = 333 clinical samples). Test","2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Dumm","Rebekah E","Infectious Disease Diagnostics Laboratory, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA",NA
"932","34165533","10.1093/jalm/jfab079","Implementation of an extraction-free COVID RT-PCR workflow in a pediatric hospital setting.","This study outlines the development, implementation, and impact of a laboratory-developed, extraction-free real-time polymerase chain reaction (RT-PCR) assay as the primary diagnostic test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric hospital. Clinical specimens from both upper and lower respiratory tract sources were validated, including nasopharyngeal aspirates, nasopharyngeal swabs, anterior nares swabs and tracheal aspirates (n = 333 clinical samples). Test","2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Elkan","Michael","Infectious Disease Diagnostics Laboratory, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA",NA
"933","34165533","10.1093/jalm/jfab079","Implementation of an extraction-free COVID RT-PCR workflow in a pediatric hospital setting.","This study outlines the development, implementation, and impact of a laboratory-developed, extraction-free real-time polymerase chain reaction (RT-PCR) assay as the primary diagnostic test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric hospital. Clinical specimens from both upper and lower respiratory tract sources were validated, including nasopharyngeal aspirates, nasopharyngeal swabs, anterior nares swabs and tracheal aspirates (n = 333 clinical samples). Test","2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Fink","Jeffrey","Infectious Disease Diagnostics Laboratory, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA",NA
"934","34165533","10.1093/jalm/jfab079","Implementation of an extraction-free COVID RT-PCR workflow in a pediatric hospital setting.","This study outlines the development, implementation, and impact of a laboratory-developed, extraction-free real-time polymerase chain reaction (RT-PCR) assay as the primary diagnostic test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric hospital. Clinical specimens from both upper and lower respiratory tract sources were validated, including nasopharyngeal aspirates, nasopharyngeal swabs, anterior nares swabs and tracheal aspirates (n = 333 clinical samples). Test","2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Richard-Greenblatt","Melissa","Infectious Disease Diagnostics Laboratory, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA",NA
"935","34165533","10.1093/jalm/jfab079","Implementation of an extraction-free COVID RT-PCR workflow in a pediatric hospital setting.","This study outlines the development, implementation, and impact of a laboratory-developed, extraction-free real-time polymerase chain reaction (RT-PCR) assay as the primary diagnostic test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric hospital. Clinical specimens from both upper and lower respiratory tract sources were validated, including nasopharyngeal aspirates, nasopharyngeal swabs, anterior nares swabs and tracheal aspirates (n = 333 clinical samples). Test","2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Obstfeld","Amrom E","Infectious Disease Diagnostics Laboratory, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA",NA
"936","34165533","10.1093/jalm/jfab079","Implementation of an extraction-free COVID RT-PCR workflow in a pediatric hospital setting.","This study outlines the development, implementation, and impact of a laboratory-developed, extraction-free real-time polymerase chain reaction (RT-PCR) assay as the primary diagnostic test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric hospital. Clinical specimens from both upper and lower respiratory tract sources were validated, including nasopharyngeal aspirates, nasopharyngeal swabs, anterior nares swabs and tracheal aspirates (n = 333 clinical samples). Test","2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Harris","Rebecca M","Infectious Disease Diagnostics Laboratory, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA",NA
"937","34165521","10.1001/jamaoto.2021.1261","Bell Palsy and COVID-19: Overcoming the Fear of ""Known Unknowns"".",NA,"2021","06","24","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Chang","C W David","Department of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, Columbia",NA
"938","34165518","10.1001/jamaoto.2021.1266","Incidence of Bell Palsy in Patients With COVID-19.",NA,"2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Tamaki","Akina","Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio",NA
"939","34165518","10.1001/jamaoto.2021.1266","Incidence of Bell Palsy in Patients With COVID-19.",NA,"2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Cabrera","Claudia I","Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio",NA
"940","34165518","10.1001/jamaoto.2021.1266","Incidence of Bell Palsy in Patients With COVID-19.",NA,"2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Li","Shawn","Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio",NA
"941","34165518","10.1001/jamaoto.2021.1266","Incidence of Bell Palsy in Patients With COVID-19.",NA,"2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Rabbani","Cyrus","Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio",NA
"942","34165518","10.1001/jamaoto.2021.1266","Incidence of Bell Palsy in Patients With COVID-19.",NA,"2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Thuener","Jason E","Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio",NA
"943","34165518","10.1001/jamaoto.2021.1266","Incidence of Bell Palsy in Patients With COVID-19.",NA,"2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Rezaee","Rod P","Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio",NA
"944","34165518","10.1001/jamaoto.2021.1266","Incidence of Bell Palsy in Patients With COVID-19.",NA,"2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Fowler","Nicole","Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio",NA
"945","34165512","10.1001/jamaoto.2021.1259","Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study.","Peripheral facial nerve (Bell) palsy has been reported and widely suggested as a possible adverse effect of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Israel is currently the leading country in vaccination rates per capita, exclusively using the BNT162b2 vaccine, and all residents of Israel are obligatory members of a national digital health registry system. These factors enable early analysis of adverse events. To examine whether the BNT162b2 vaccine is associated with an increased risk o","2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Shemer","Asaf","Department of Ophthalmology, Shamir Medical Center, Be'er Ya'akov, Israel",NA
"946","34165512","10.1001/jamaoto.2021.1259","Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study.","Peripheral facial nerve (Bell) palsy has been reported and widely suggested as a possible adverse effect of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Israel is currently the leading country in vaccination rates per capita, exclusively using the BNT162b2 vaccine, and all residents of Israel are obligatory members of a national digital health registry system. These factors enable early analysis of adverse events. To examine whether the BNT162b2 vaccine is associated with an increased risk o","2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Pras","Eran","Department of Ophthalmology, Shamir Medical Center, Be'er Ya'akov, Israel",NA
"947","34165512","10.1001/jamaoto.2021.1259","Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study.","Peripheral facial nerve (Bell) palsy has been reported and widely suggested as a possible adverse effect of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Israel is currently the leading country in vaccination rates per capita, exclusively using the BNT162b2 vaccine, and all residents of Israel are obligatory members of a national digital health registry system. These factors enable early analysis of adverse events. To examine whether the BNT162b2 vaccine is associated with an increased risk o","2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Einan-Lifshitz","Adi","Department of Ophthalmology, Shamir Medical Center, Be'er Ya'akov, Israel",NA
"948","34165512","10.1001/jamaoto.2021.1259","Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study.","Peripheral facial nerve (Bell) palsy has been reported and widely suggested as a possible adverse effect of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Israel is currently the leading country in vaccination rates per capita, exclusively using the BNT162b2 vaccine, and all residents of Israel are obligatory members of a national digital health registry system. These factors enable early analysis of adverse events. To examine whether the BNT162b2 vaccine is associated with an increased risk o","2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Dubinsky-Pertzov","Biana","Department of Ophthalmology, Shamir Medical Center, Be'er Ya'akov, Israel",NA
"949","34165512","10.1001/jamaoto.2021.1259","Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study.","Peripheral facial nerve (Bell) palsy has been reported and widely suggested as a possible adverse effect of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Israel is currently the leading country in vaccination rates per capita, exclusively using the BNT162b2 vaccine, and all residents of Israel are obligatory members of a national digital health registry system. These factors enable early analysis of adverse events. To examine whether the BNT162b2 vaccine is associated with an increased risk o","2021","07","10","JAMA Otolaryngol Head Neck Surg","JAMA otolaryngology-- head &amp; neck surgery",NA,"Hecht","Idan","Department of Ophthalmology, Shamir Medical Center, Be'er Ya'akov, Israel",NA
"950","34165509","10.1093/jalm/jfab078","Strategic Thinking in Test Selection for Mass SARS-CoV-2 Testing.",NA,"2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Morjaria","Sejal","Infectious Disease, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, NY",NA
"951","34165509","10.1093/jalm/jfab078","Strategic Thinking in Test Selection for Mass SARS-CoV-2 Testing.",NA,"2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Nouvini","Rosa","Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, NY",NA
"952","34165509","10.1093/jalm/jfab078","Strategic Thinking in Test Selection for Mass SARS-CoV-2 Testing.",NA,"2021","06","24","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Sirintrapun","S Joseph","Department of Pathology, Memorial Sloan Kettering Cancer Center, NY, NY",NA
"953","34165445","10.1097/GME.0000000000001808","Anxiety and hot flashes as predictors of mid-life palpitations: getting to the heart of the matter in the time of COVID-19.",NA,"2021","07","01","Menopause","Menopause (New York, N.Y.)","Anxiety; Anxiety Disorders; COVID-19; Hot Flashes; Humans; SARS-CoV-2","Reame","Nancy King","Columbia University School of Nursing, New York, NY",NA
"954","34165438","10.1684/mrh.2021.0481","Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes.","Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. In this retrospective study, we characterized 118 T2D and non-diabetic subjects","2021","06","30","Magnes Res","Magnesium research","SARS-CoV-2; glomerular filtration rate; serum magnesium levels; type 2 diabetes; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Hospital Mortality; Humans; Kidney; Magnesium; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; SARS-CoV-2; Survival Analysis","Pulido-Perez","Patricia","Doctorate in Biological Science, Autonomous University of Tlaxcala, Mexico. La Loma Xicohtencatl, C.P. 90070 Tlaxcala, Tlaxcala, Mexico",NA
"955","34165438","10.1684/mrh.2021.0481","Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes.","Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. In this retrospective study, we characterized 118 T2D and non-diabetic subjects","2021","06","30","Magnes Res","Magnesium research","SARS-CoV-2; glomerular filtration rate; serum magnesium levels; type 2 diabetes; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Hospital Mortality; Humans; Kidney; Magnesium; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; SARS-CoV-2; Survival Analysis","Pondigo-de Los Angeles","Jorge Alberto","Internal Medicine Department, University Hospital of Puebla, Puebla, Mexico. Av 27 Poniente, Los Volcanes, C.P. 72410 Puebla, Puebla, Mexico",NA
"956","34165438","10.1684/mrh.2021.0481","Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes.","Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. In this retrospective study, we characterized 118 T2D and non-diabetic subjects","2021","06","30","Magnes Res","Magnesium research","SARS-CoV-2; glomerular filtration rate; serum magnesium levels; type 2 diabetes; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Hospital Mortality; Humans; Kidney; Magnesium; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; SARS-CoV-2; Survival Analysis","Hernandez-Hernandez","Maria Elena","Doctorate in Biological Science, Autonomous University of Tlaxcala, Mexico. La Loma Xicohtencatl, C.P. 90070 Tlaxcala, Tlaxcala, Mexico, Faculty of Medicine, Autonomous University of Puebla, Mexico. 13 Sur 2901, Los Volcanes, C.P. 72420, Puebla, Puebla, Mexico",NA
"957","34165438","10.1684/mrh.2021.0481","Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes.","Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. In this retrospective study, we characterized 118 T2D and non-diabetic subjects","2021","06","30","Magnes Res","Magnesium research","SARS-CoV-2; glomerular filtration rate; serum magnesium levels; type 2 diabetes; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Hospital Mortality; Humans; Kidney; Magnesium; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; SARS-CoV-2; Survival Analysis","Torres-Rasgado","Enrique","Faculty of Medicine, Autonomous University of Puebla, Mexico. 13 Sur 2901, Los Volcanes, C.P. 72420, Puebla, Puebla, Mexico",NA
"958","34165438","10.1684/mrh.2021.0481","Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes.","Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. In this retrospective study, we characterized 118 T2D and non-diabetic subjects","2021","06","30","Magnes Res","Magnesium research","SARS-CoV-2; glomerular filtration rate; serum magnesium levels; type 2 diabetes; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Hospital Mortality; Humans; Kidney; Magnesium; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; SARS-CoV-2; Survival Analysis","Romero","Jose R","Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School. 75 Francis Street Boston, Massachusetts, United States",NA
"959","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Kamel","Said","Laboratoire de biochimie CHU d'Amiens, UR 7517 MP3CV, Université de Picardie Jules-Verne, Amiens, France",NA
"960","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Raynor","Alexandre","Service de biochimie métabolique et cellulaire, Hôpital Bichat, AP-HP, Paris, France",NA
"961","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Zozor","Samuel","Service de biochimie et d'hormonologie, CHU de Montpellier, France",NA
"962","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Lacape","Geneviève","Service de biochimie, CHU de Bordeaux, Université de Bordeaux, France",NA
"963","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Brunel","Valéry","Laboratoire de biochimie générale, CHU de Rouen, France",NA
"964","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Nivet-Antoine","Valérie","DMU BioPhyGen, Hôpital Necker - Enfants-malades, AP-HP, Laboratoire de biochimie générale, UMRS1140, Faculté de Pharmacie et Université de Paris, France",NA
"965","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Collin-Chavagnac","Delphine","Service de biochimie et biologie moléculaire, Groupement hospitalier Sud, Hospices Civils de Lyon, France",NA
"966","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Peoc'h","Katell","Université de Paris, UFR de Médecine, France, Service de biochimie métabolique et cellulaire, Hôpital Bichat, AP-HP, Paris, France",NA
"967","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Cohen","Ariel","Service de cardiologie, Hôpital Saint-Antoine, Hôpital Tenon, AP-HP, Paris ",NA
"968","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Lassoued","Amin Ben","Service de biochimie Timone, Hôpital de la Timone, AP-HM, Marseille, France",NA
"969","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Chévrier","Marc","Service de biochimie et biologie moléculaire, Groupement hospitalier Sud, Hospices Civils de Lyon, France",NA
"970","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Alemann","Mathieu","Laboratoire de biochimie et biologie moléculaire, Nouvel hôpital civil, Hôpitaux Universitaires de Strasbourg, France",NA
"971","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Lessinger","Jean-Marc","Laboratoire de biochimie et biologie moléculaire, Nouvel hôpital civil, Hôpitaux Universitaires de Strasbourg, France",NA
"972","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Bérard","Annie M","Service de biochimie, CHU de Bordeaux, Université de Bordeaux, France",NA
"973","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Sapin","Vincent","Biochimie et génétique moléculaire, CHU Clermont-Ferrand ",NA
"974","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Beauvieux","Marie-Christine","Service de biochimie, CHU de Bordeaux, Université de Bordeaux, France, UMR5536 CNRS-Université de Bordeaux, France",NA
"975","34165431","10.1684/abc.2021.1642","[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].","Covid-19 is responsible for myocardial injury in many infected patients, which is associated with severe disease and critical illness. The mechanisms by which SARS-CoV-2 may cause myocardial damage involve direct effect of the virus in cardiac cells and indirect effect due to the clinical consequences of Covid-19. Cardiomyocytes are well known to express Angiotensin-Converting Enzyme-2 receptors (ACE-2) to facilitate the virus cell entry, which could explain the occurrence of myocarditis, functi","2021","07","21","Ann Biol Clin (Paris)","Annales de biologie clinique","Covid-19; SARS-CoV-2; myocarditis; myocardium; natriuretic peptides; troponin; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Endocarditis; Female; France; Heart; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Pandemics; Predictive Value of Tests; Prognosis; SARS-CoV-2","Levy","Pacifique","Laboratoire de biochimie et hormonologie, Hôpital Tenon, AP-HP, Sorbonne-Université, Paris, France",NA
"976","34165410","10.2174/1573405617666210623124108","The feasibility of low dose chest CT acquisition protocol for the imaging of COVID-19 pneumonia.","To investigate the feasibility of low dose chest CT acquisition protocol for the imaging of either the confirmed case of COVID-19 disease or the suspected case of this disease in adults. In this retrospective case-control study, the study group consisted of 141 patients who were imaged with low dose chest CT acquisition protocol. The control group consisted of 92 patients who were imaged with the standard protocol. Anteroposterior and lateral diameters of chest, effective diameter and scan lengt","2021","06","24","Curr Med Imaging","Current medical imaging","COVID-19; CTDIvol; Chest CT; DLP; low dose; pneumonia; radiation protection","Atli","Eray","Istanbul Okan University Hospital, Department of Radiology, Tuzla/Istanbul, Turkey",NA
"977","34165410","10.2174/1573405617666210623124108","The feasibility of low dose chest CT acquisition protocol for the imaging of COVID-19 pneumonia.","To investigate the feasibility of low dose chest CT acquisition protocol for the imaging of either the confirmed case of COVID-19 disease or the suspected case of this disease in adults. In this retrospective case-control study, the study group consisted of 141 patients who were imaged with low dose chest CT acquisition protocol. The control group consisted of 92 patients who were imaged with the standard protocol. Anteroposterior and lateral diameters of chest, effective diameter and scan lengt","2021","06","24","Curr Med Imaging","Current medical imaging","COVID-19; CTDIvol; Chest CT; DLP; low dose; pneumonia; radiation protection","Uyanik","Sadik Ahmet","Istanbul Okan University Hospital, Department of Radiology, Tuzla/Istanbul, Turkey",NA
"978","34165410","10.2174/1573405617666210623124108","The feasibility of low dose chest CT acquisition protocol for the imaging of COVID-19 pneumonia.","To investigate the feasibility of low dose chest CT acquisition protocol for the imaging of either the confirmed case of COVID-19 disease or the suspected case of this disease in adults. In this retrospective case-control study, the study group consisted of 141 patients who were imaged with low dose chest CT acquisition protocol. The control group consisted of 92 patients who were imaged with the standard protocol. Anteroposterior and lateral diameters of chest, effective diameter and scan lengt","2021","06","24","Curr Med Imaging","Current medical imaging","COVID-19; CTDIvol; Chest CT; DLP; low dose; pneumonia; radiation protection","Ögüslü","Umut","Istanbul Okan University Hospital, Department of Radiology, Tuzla/Istanbul, Turkey",NA
"979","34165410","10.2174/1573405617666210623124108","The feasibility of low dose chest CT acquisition protocol for the imaging of COVID-19 pneumonia.","To investigate the feasibility of low dose chest CT acquisition protocol for the imaging of either the confirmed case of COVID-19 disease or the suspected case of this disease in adults. In this retrospective case-control study, the study group consisted of 141 patients who were imaged with low dose chest CT acquisition protocol. The control group consisted of 92 patients who were imaged with the standard protocol. Anteroposterior and lateral diameters of chest, effective diameter and scan lengt","2021","06","24","Curr Med Imaging","Current medical imaging","COVID-19; CTDIvol; Chest CT; DLP; low dose; pneumonia; radiation protection","Cenkeri","Halime Çevik","Istanbul Okan University Hospital, Department of Radiology, Tuzla/Istanbul, Turkey",NA
"980","34165410","10.2174/1573405617666210623124108","The feasibility of low dose chest CT acquisition protocol for the imaging of COVID-19 pneumonia.","To investigate the feasibility of low dose chest CT acquisition protocol for the imaging of either the confirmed case of COVID-19 disease or the suspected case of this disease in adults. In this retrospective case-control study, the study group consisted of 141 patients who were imaged with low dose chest CT acquisition protocol. The control group consisted of 92 patients who were imaged with the standard protocol. Anteroposterior and lateral diameters of chest, effective diameter and scan lengt","2021","06","24","Curr Med Imaging","Current medical imaging","COVID-19; CTDIvol; Chest CT; DLP; low dose; pneumonia; radiation protection","Yilmaz","Birnur","Istanbul Okan University Hospital, Department of Radiology, Tuzla/Istanbul, Turkey",NA
"981","34165410","10.2174/1573405617666210623124108","The feasibility of low dose chest CT acquisition protocol for the imaging of COVID-19 pneumonia.","To investigate the feasibility of low dose chest CT acquisition protocol for the imaging of either the confirmed case of COVID-19 disease or the suspected case of this disease in adults. In this retrospective case-control study, the study group consisted of 141 patients who were imaged with low dose chest CT acquisition protocol. The control group consisted of 92 patients who were imaged with the standard protocol. Anteroposterior and lateral diameters of chest, effective diameter and scan lengt","2021","06","24","Curr Med Imaging","Current medical imaging","COVID-19; CTDIvol; Chest CT; DLP; low dose; pneumonia; radiation protection","Gümüs","Burçak","Istanbul Okan University Hospital, Department of Radiology, Tuzla/Istanbul, Turkey",NA
"982","34165401","10.2174/0929867328666210623142811","Interfering Reactive Cysteine Proteome in Covid-19 Disease.","Although vaccination against SARS-CoV-2 infection has been initiated, effective therapies for severe Covid-19 disease are still needed. A promising therapeutic strategy is using FDA-approved drugs that have the biological potential to interfere with or modify some of the viral proteins capable of changing the disease's course. Recent studies highlight that some clinically safe drugs can suppress the viral life cycle while potentially promoting an adequate host inflammatory/immune response by int","2021","06","24","Curr Med Chem","Current medicinal chemistry","Covid-19; N-acetyl-cysteine; cysteine; ebselen; immunity; proteome; redox","Martinez-Banaclocha","Marcos","Department of Pathology, Lluis Alcanyis Hospital, Xátiva, Valencia. Spain",NA
"983","34165328","10.2217/fmb-2021-0128","Amuchina Gel Xgerm hand rub <i>in vitro</i> virucidal activity against SARS-CoV-2.","Aim: Ethanol is highly effective at inactivating enveloped viruses, including SARS-CoV-2. The aim of this study is to evaluate the virucidal activity of Amuchina Gel Xgerm (74% ethanol) against SARS-CoV-2, according to the European Standard EN14476:2013+A2:2019. Materials &amp; methods: Virucidal activity of the study product was evaluated against SARS-CoV-2 strain USAWA1/2020 in suspension, in the presence of 0.3 g/l of bovine serum albumin. Results: The log10 reduction of SARS-CoV-2 in the pre","2021","07","22","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; alcohol-based hand rub; alcohol-based hand sanitizer; hand hygiene; hand sanitizer; Antiviral Agents; COVID-19; Ethanol; Hand Hygiene; Hand Sanitizers; Humans; SARS-CoV-2","de Joannon","Alessandra Capezzone","Angelini Pharma S.p.A, Via Vecchia del Pinocchio, Ancona, 22 - 60131, Italy",NA
"984","34165328","10.2217/fmb-2021-0128","Amuchina Gel Xgerm hand rub <i>in vitro</i> virucidal activity against SARS-CoV-2.","Aim: Ethanol is highly effective at inactivating enveloped viruses, including SARS-CoV-2. The aim of this study is to evaluate the virucidal activity of Amuchina Gel Xgerm (74% ethanol) against SARS-CoV-2, according to the European Standard EN14476:2013+A2:2019. Materials &amp; methods: Virucidal activity of the study product was evaluated against SARS-CoV-2 strain USAWA1/2020 in suspension, in the presence of 0.3 g/l of bovine serum albumin. Results: The log10 reduction of SARS-CoV-2 in the pre","2021","07","22","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; alcohol-based hand rub; alcohol-based hand sanitizer; hand hygiene; hand sanitizer; Antiviral Agents; COVID-19; Ethanol; Hand Hygiene; Hand Sanitizers; Humans; SARS-CoV-2","Testa","Angela","Angelini Pharma S.p.A, Viale Amelia, Rome, 70 - 00181, Italy",NA
"985","34165328","10.2217/fmb-2021-0128","Amuchina Gel Xgerm hand rub <i>in vitro</i> virucidal activity against SARS-CoV-2.","Aim: Ethanol is highly effective at inactivating enveloped viruses, including SARS-CoV-2. The aim of this study is to evaluate the virucidal activity of Amuchina Gel Xgerm (74% ethanol) against SARS-CoV-2, according to the European Standard EN14476:2013+A2:2019. Materials &amp; methods: Virucidal activity of the study product was evaluated against SARS-CoV-2 strain USAWA1/2020 in suspension, in the presence of 0.3 g/l of bovine serum albumin. Results: The log10 reduction of SARS-CoV-2 in the pre","2021","07","22","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; alcohol-based hand rub; alcohol-based hand sanitizer; hand hygiene; hand sanitizer; Antiviral Agents; COVID-19; Ethanol; Hand Hygiene; Hand Sanitizers; Humans; SARS-CoV-2","Falsetto","Natalie","Angelini Pharma S.p.A, Viale Amelia, Rome, 70 - 00181, Italy",NA
"986","34165328","10.2217/fmb-2021-0128","Amuchina Gel Xgerm hand rub <i>in vitro</i> virucidal activity against SARS-CoV-2.","Aim: Ethanol is highly effective at inactivating enveloped viruses, including SARS-CoV-2. The aim of this study is to evaluate the virucidal activity of Amuchina Gel Xgerm (74% ethanol) against SARS-CoV-2, according to the European Standard EN14476:2013+A2:2019. Materials &amp; methods: Virucidal activity of the study product was evaluated against SARS-CoV-2 strain USAWA1/2020 in suspension, in the presence of 0.3 g/l of bovine serum albumin. Results: The log10 reduction of SARS-CoV-2 in the pre","2021","07","22","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; alcohol-based hand rub; alcohol-based hand sanitizer; hand hygiene; hand sanitizer; Antiviral Agents; COVID-19; Ethanol; Hand Hygiene; Hand Sanitizers; Humans; SARS-CoV-2","Procaccini","Michela","Angelini Pharma S.p.A, Viale Amelia, Rome, 70 - 00181, Italy",NA
"987","34165328","10.2217/fmb-2021-0128","Amuchina Gel Xgerm hand rub <i>in vitro</i> virucidal activity against SARS-CoV-2.","Aim: Ethanol is highly effective at inactivating enveloped viruses, including SARS-CoV-2. The aim of this study is to evaluate the virucidal activity of Amuchina Gel Xgerm (74% ethanol) against SARS-CoV-2, according to the European Standard EN14476:2013+A2:2019. Materials &amp; methods: Virucidal activity of the study product was evaluated against SARS-CoV-2 strain USAWA1/2020 in suspension, in the presence of 0.3 g/l of bovine serum albumin. Results: The log10 reduction of SARS-CoV-2 in the pre","2021","07","22","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; alcohol-based hand rub; alcohol-based hand sanitizer; hand hygiene; hand sanitizer; Antiviral Agents; COVID-19; Ethanol; Hand Hygiene; Hand Sanitizers; Humans; SARS-CoV-2","Ragni","Lorella","Angelini Pharma S.p.A, Via Vecchia del Pinocchio, Ancona, 22 - 60131, Italy",NA
"988","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Bradley","Benjamin T","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"989","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Bryan","Andrew","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"990","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Fink","Susan L","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"991","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Goecker","Erin A","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"992","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Roychoudhury","Pavitra","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"993","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Huang","Meei-Li","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"994","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Zhu","Haiying","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"995","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Chaudhary","Anu","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"996","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Madarampalli","Bhanupriya","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"997","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Lu","Joyce Y C","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"998","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Strand","Kathy","Division of Infectious Diseases, Department of Medicine, University of Washington Medical Center, Seattle, WA",NA
"999","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Whimbey","Estella","Division of Infectious Diseases, Department of Medicine, University of Washington Medical Center, Seattle, WA",NA
"1000","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Bryson-Cahn","Chloe","Division of Infectious Diseases, Department of Medicine, University of Washington Medical Center, Seattle, WA",NA
"1001","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Schippers","Adrienne","Division of Infectious Diseases, Department of Medicine, University of Washington Medical Center, Seattle, WA",NA
"1002","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Mani","Nandita S","Division of Infectious Diseases, Department of Medicine, University of Washington Medical Center, Seattle, WA",NA
"1003","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Pepper","Gregory","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"1004","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Jerome","Keith R","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"1005","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Morishima","Chihiro","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"1006","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Coombs","Robert W","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"1007","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Wener","Mark","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"1008","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Cohen","Seth","Division of Infectious Diseases, Department of Medicine, University of Washington Medical Center, Seattle, WA",NA
"1009","34165323","10.1128/JCM.00989-21","Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity.","With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS-CoV-2 IgG, Roche elecsys Anti-SARS-CoV-2-S, EuroImmun Anti-SARS-CoV-2 ELISA, and GenScript surrogate virus neutralizati","2021","06","24","J Clin Microbiol","Journal of clinical microbiology",NA,"Greninger","Alexander L","Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA",NA
"1010","34165273","10.3906/sag-2101-146","Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19.","Due to the importance of early outpatient treatment to prevent hospitalization and disease progression, we examined the effects of hydroxychloroquine and favipiravir, which were initiated in early period, on the clinical course of COVID-19 outpatients. Data of confirmed COVID-19 outpatients over a 4-month period were analyzed retrospectively. Public Health Management System (HSYS) was used for the case-based follow-up. Patients on antiviral therapy for at least five days, including hydroxychloro","2021","06","24","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; favipiravir; hydroxychloroquine; outpatients; treatment","Kayhan Omeroglu","Seyda",NA,NA
"1011","34165273","10.3906/sag-2101-146","Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19.","Due to the importance of early outpatient treatment to prevent hospitalization and disease progression, we examined the effects of hydroxychloroquine and favipiravir, which were initiated in early period, on the clinical course of COVID-19 outpatients. Data of confirmed COVID-19 outpatients over a 4-month period were analyzed retrospectively. Public Health Management System (HSYS) was used for the case-based follow-up. Patients on antiviral therapy for at least five days, including hydroxychloro","2021","06","24","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; favipiravir; hydroxychloroquine; outpatients; treatment","Temel","Fehminaz",NA,NA
"1012","34165273","10.3906/sag-2101-146","Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19.","Due to the importance of early outpatient treatment to prevent hospitalization and disease progression, we examined the effects of hydroxychloroquine and favipiravir, which were initiated in early period, on the clinical course of COVID-19 outpatients. Data of confirmed COVID-19 outpatients over a 4-month period were analyzed retrospectively. Public Health Management System (HSYS) was used for the case-based follow-up. Patients on antiviral therapy for at least five days, including hydroxychloro","2021","06","24","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; favipiravir; hydroxychloroquine; outpatients; treatment","Altun","Dilek",NA,NA
"1013","34165273","10.3906/sag-2101-146","Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19.","Due to the importance of early outpatient treatment to prevent hospitalization and disease progression, we examined the effects of hydroxychloroquine and favipiravir, which were initiated in early period, on the clinical course of COVID-19 outpatients. Data of confirmed COVID-19 outpatients over a 4-month period were analyzed retrospectively. Public Health Management System (HSYS) was used for the case-based follow-up. Patients on antiviral therapy for at least five days, including hydroxychloro","2021","06","24","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; favipiravir; hydroxychloroquine; outpatients; treatment","Öztop","Mehmet Burak",NA,NA
"1014","34165269","10.20452/pamw.16037","Obesity pandemic triggered by the period of COVID-19 Pandemic: Experience from Turkey.",NA,"2021","06","24","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Unubol","Mustafa",NA,NA
"1015","34165269","10.20452/pamw.16037","Obesity pandemic triggered by the period of COVID-19 Pandemic: Experience from Turkey.",NA,"2021","06","24","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Erdemir","Zehra",NA,NA
"1016","34165269","10.20452/pamw.16037","Obesity pandemic triggered by the period of COVID-19 Pandemic: Experience from Turkey.",NA,"2021","06","24","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Colak","Gokhan",NA,NA
"1017","34165269","10.20452/pamw.16037","Obesity pandemic triggered by the period of COVID-19 Pandemic: Experience from Turkey.",NA,"2021","06","24","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Guney","Engin",NA,NA
"1018","34165269","10.20452/pamw.16037","Obesity pandemic triggered by the period of COVID-19 Pandemic: Experience from Turkey.",NA,"2021","06","24","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Omurlu","Imran K",NA,NA
"1019","34165257","10.1111/tan.14349","HLA-A homozygosis is associated with susceptibility to COVID-19.","The purpose of this single center retrospective study was to investigate the relationship between HLA and ABO polymorphisms and COVID-19 susceptibility and severity in kidney transplant recipients. It included 720 recipients who had COVID-19 and 1680 controls composed by recipients in follow-up who did not contact the transplantation center for COVID-19 symptoms, up to the moment of their inclusion in the study. HLA-A, -B, and -DRB1 allele groups and ABO frequencies were compared between recipie","2021","07","15","HLA","HLA","ABO blood groups; COVID-19; HLA; HLA homozygosis; Aged; Alleles; COVID-19; Gene Frequency; Genetic Predisposition to Disease; HLA-A Antigens; HLA-DRB1 Chains; Humans; Retrospective Studies; SARS-CoV-2","De Marco","Renato","Instituto de Imunogenética, Associação Fundo de Incentivo à Pesquisa, São Paulo, Brazil",NA
"1020","34165257","10.1111/tan.14349","HLA-A homozygosis is associated with susceptibility to COVID-19.","The purpose of this single center retrospective study was to investigate the relationship between HLA and ABO polymorphisms and COVID-19 susceptibility and severity in kidney transplant recipients. It included 720 recipients who had COVID-19 and 1680 controls composed by recipients in follow-up who did not contact the transplantation center for COVID-19 symptoms, up to the moment of their inclusion in the study. HLA-A, -B, and -DRB1 allele groups and ABO frequencies were compared between recipie","2021","07","15","HLA","HLA","ABO blood groups; COVID-19; HLA; HLA homozygosis; Aged; Alleles; COVID-19; Gene Frequency; Genetic Predisposition to Disease; HLA-A Antigens; HLA-DRB1 Chains; Humans; Retrospective Studies; SARS-CoV-2","Faria","Tathyane C","Instituto de Imunogenética, Associação Fundo de Incentivo à Pesquisa, São Paulo, Brazil",NA
"1021","34165257","10.1111/tan.14349","HLA-A homozygosis is associated with susceptibility to COVID-19.","The purpose of this single center retrospective study was to investigate the relationship between HLA and ABO polymorphisms and COVID-19 susceptibility and severity in kidney transplant recipients. It included 720 recipients who had COVID-19 and 1680 controls composed by recipients in follow-up who did not contact the transplantation center for COVID-19 symptoms, up to the moment of their inclusion in the study. HLA-A, -B, and -DRB1 allele groups and ABO frequencies were compared between recipie","2021","07","15","HLA","HLA","ABO blood groups; COVID-19; HLA; HLA homozygosis; Aged; Alleles; COVID-19; Gene Frequency; Genetic Predisposition to Disease; HLA-A Antigens; HLA-DRB1 Chains; Humans; Retrospective Studies; SARS-CoV-2","Mine","Karina L","Instituto de Imunogenética, Associação Fundo de Incentivo à Pesquisa, São Paulo, Brazil",NA
"1022","34165257","10.1111/tan.14349","HLA-A homozygosis is associated with susceptibility to COVID-19.","The purpose of this single center retrospective study was to investigate the relationship between HLA and ABO polymorphisms and COVID-19 susceptibility and severity in kidney transplant recipients. It included 720 recipients who had COVID-19 and 1680 controls composed by recipients in follow-up who did not contact the transplantation center for COVID-19 symptoms, up to the moment of their inclusion in the study. HLA-A, -B, and -DRB1 allele groups and ABO frequencies were compared between recipie","2021","07","15","HLA","HLA","ABO blood groups; COVID-19; HLA; HLA homozygosis; Aged; Alleles; COVID-19; Gene Frequency; Genetic Predisposition to Disease; HLA-A Antigens; HLA-DRB1 Chains; Humans; Retrospective Studies; SARS-CoV-2","Cristelli","Marina","Nephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil",NA
"1023","34165257","10.1111/tan.14349","HLA-A homozygosis is associated with susceptibility to COVID-19.","The purpose of this single center retrospective study was to investigate the relationship between HLA and ABO polymorphisms and COVID-19 susceptibility and severity in kidney transplant recipients. It included 720 recipients who had COVID-19 and 1680 controls composed by recipients in follow-up who did not contact the transplantation center for COVID-19 symptoms, up to the moment of their inclusion in the study. HLA-A, -B, and -DRB1 allele groups and ABO frequencies were compared between recipie","2021","07","15","HLA","HLA","ABO blood groups; COVID-19; HLA; HLA homozygosis; Aged; Alleles; COVID-19; Gene Frequency; Genetic Predisposition to Disease; HLA-A Antigens; HLA-DRB1 Chains; Humans; Retrospective Studies; SARS-CoV-2","Medina-Pestana","José O","Nephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil",NA
"1024","34165257","10.1111/tan.14349","HLA-A homozygosis is associated with susceptibility to COVID-19.","The purpose of this single center retrospective study was to investigate the relationship between HLA and ABO polymorphisms and COVID-19 susceptibility and severity in kidney transplant recipients. It included 720 recipients who had COVID-19 and 1680 controls composed by recipients in follow-up who did not contact the transplantation center for COVID-19 symptoms, up to the moment of their inclusion in the study. HLA-A, -B, and -DRB1 allele groups and ABO frequencies were compared between recipie","2021","07","15","HLA","HLA","ABO blood groups; COVID-19; HLA; HLA homozygosis; Aged; Alleles; COVID-19; Gene Frequency; Genetic Predisposition to Disease; HLA-A Antigens; HLA-DRB1 Chains; Humans; Retrospective Studies; SARS-CoV-2","Tedesco-Silva","Hélio","Nephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil",NA
"1025","34165257","10.1111/tan.14349","HLA-A homozygosis is associated with susceptibility to COVID-19.","The purpose of this single center retrospective study was to investigate the relationship between HLA and ABO polymorphisms and COVID-19 susceptibility and severity in kidney transplant recipients. It included 720 recipients who had COVID-19 and 1680 controls composed by recipients in follow-up who did not contact the transplantation center for COVID-19 symptoms, up to the moment of their inclusion in the study. HLA-A, -B, and -DRB1 allele groups and ABO frequencies were compared between recipie","2021","07","15","HLA","HLA","ABO blood groups; COVID-19; HLA; HLA homozygosis; Aged; Alleles; COVID-19; Gene Frequency; Genetic Predisposition to Disease; HLA-A Antigens; HLA-DRB1 Chains; Humans; Retrospective Studies; SARS-CoV-2","Gerbase-DeLima","Maria","Instituto de Imunogenética, Associação Fundo de Incentivo à Pesquisa, São Paulo, Brazil",NA
"1026","34165239","10.1111/jth.15433","Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme.",NA,"2021","07","09","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH",NA,"Kahn","Fredrik","Clinical Sciences, Lund University, Lund, Sweden",NA
"1027","34165239","10.1111/jth.15433","Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme.",NA,"2021","07","09","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH",NA,"Shannon","Oonagh","Clinical Sciences, Lund University, Lund, Sweden",NA
"1028","34165239","10.1111/jth.15433","Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme.",NA,"2021","07","09","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH",NA,"Björck","Lars","Clinical Sciences, Lund University, Lund, Sweden",NA
"1029","34165237","10.1111/dth.15040","Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.",NA,"2021","06","29","Dermatol Ther","Dermatologic therapy",NA,"Adya","Keshavmurthy A","Department of Dermatology, Venereology and Leprosy, Shri B M Patil Medical College, Hospital and Research Center, BLDE (Deemed to be University), Vijayapur, Karnataka, India",NA
"1030","34165237","10.1111/dth.15040","Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.",NA,"2021","06","29","Dermatol Ther","Dermatologic therapy",NA,"Inamadar","Arun C","Department of Dermatology, Venereology and Leprosy, Shri B M Patil Medical College, Hospital and Research Center, BLDE (Deemed to be University), Vijayapur, Karnataka, India",NA
"1031","34165237","10.1111/dth.15040","Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.",NA,"2021","06","29","Dermatol Ther","Dermatologic therapy",NA,"Albadri","Warood","Department of Dermatology, Venereology and Leprosy, Shri B M Patil Medical College, Hospital and Research Center, BLDE (Deemed to be University), Vijayapur, Karnataka, India",NA
"1032","34165228","10.1111/jir.12862","The impact of COVID-19 on the social inclusion of older adults with an intellectual disability during the first wave of the pandemic in Ireland.","Social restrictions and service closures from COVID-19 have negatively impacted social inclusion and well-being for some people with intellectual disabilities (IDs). The fourth wave of a national longitudinal study on ageing in people with ID in Ireland was interrupted during the COVID-19 outbreak. Social inclusion data for pre-existing participants interviewed before COVID-19 (n = 444) were compared with data for pre-existing participants interviewed during/after lockdown (n = 62). More people ","2021","06","24","J Intellect Disabil Res","Journal of intellectual disability research : JIDR","COVID-19; ageing; digital inclusion; intellectual disability; social inclusion; technology","McCausland","Darren","Trinity Centre for Ageing and Intellectual Disability, School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland",NA
"1033","34165228","10.1111/jir.12862","The impact of COVID-19 on the social inclusion of older adults with an intellectual disability during the first wave of the pandemic in Ireland.","Social restrictions and service closures from COVID-19 have negatively impacted social inclusion and well-being for some people with intellectual disabilities (IDs). The fourth wave of a national longitudinal study on ageing in people with ID in Ireland was interrupted during the COVID-19 outbreak. Social inclusion data for pre-existing participants interviewed before COVID-19 (n = 444) were compared with data for pre-existing participants interviewed during/after lockdown (n = 62). More people ","2021","06","24","J Intellect Disabil Res","Journal of intellectual disability research : JIDR","COVID-19; ageing; digital inclusion; intellectual disability; social inclusion; technology","Luus","Retha","Trinity Centre for Ageing and Intellectual Disability, School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland",NA
"1034","34165228","10.1111/jir.12862","The impact of COVID-19 on the social inclusion of older adults with an intellectual disability during the first wave of the pandemic in Ireland.","Social restrictions and service closures from COVID-19 have negatively impacted social inclusion and well-being for some people with intellectual disabilities (IDs). The fourth wave of a national longitudinal study on ageing in people with ID in Ireland was interrupted during the COVID-19 outbreak. Social inclusion data for pre-existing participants interviewed before COVID-19 (n = 444) were compared with data for pre-existing participants interviewed during/after lockdown (n = 62). More people ","2021","06","24","J Intellect Disabil Res","Journal of intellectual disability research : JIDR","COVID-19; ageing; digital inclusion; intellectual disability; social inclusion; technology","McCallion","Philip","Temple University, Philadelphia, PA, USA",NA
"1035","34165228","10.1111/jir.12862","The impact of COVID-19 on the social inclusion of older adults with an intellectual disability during the first wave of the pandemic in Ireland.","Social restrictions and service closures from COVID-19 have negatively impacted social inclusion and well-being for some people with intellectual disabilities (IDs). The fourth wave of a national longitudinal study on ageing in people with ID in Ireland was interrupted during the COVID-19 outbreak. Social inclusion data for pre-existing participants interviewed before COVID-19 (n = 444) were compared with data for pre-existing participants interviewed during/after lockdown (n = 62). More people ","2021","06","24","J Intellect Disabil Res","Journal of intellectual disability research : JIDR","COVID-19; ageing; digital inclusion; intellectual disability; social inclusion; technology","Murphy","Esther","Trinity Centre for Ageing and Intellectual Disability, School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland",NA
"1036","34165228","10.1111/jir.12862","The impact of COVID-19 on the social inclusion of older adults with an intellectual disability during the first wave of the pandemic in Ireland.","Social restrictions and service closures from COVID-19 have negatively impacted social inclusion and well-being for some people with intellectual disabilities (IDs). The fourth wave of a national longitudinal study on ageing in people with ID in Ireland was interrupted during the COVID-19 outbreak. Social inclusion data for pre-existing participants interviewed before COVID-19 (n = 444) were compared with data for pre-existing participants interviewed during/after lockdown (n = 62). More people ","2021","06","24","J Intellect Disabil Res","Journal of intellectual disability research : JIDR","COVID-19; ageing; digital inclusion; intellectual disability; social inclusion; technology","McCarron","Mary","Trinity Centre for Ageing and Intellectual Disability, School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland",NA
"1037","34165207","10.1002/prot.26163","Characterization of glucose-binding proteins isolated from health volunteers and human type 2 diabetes mellitus patients.","Glucose is one of the most important monosaccharides. Although hyperglycemia in type 2 diabetes mellitus (T2DM) lead to a series of changes; however, little is known about the alterations of serum proteins in T2DM, especially those proteins with glucose affinity. In this study, the glucose-binding proteins (GlcBPs) of serum were isolated from 30 health volunteer (HV) and 30 T2DM patients by glucose-magnetic particle conjugates (GMPC) and identified by mass spectrum analysis. Gene ontology (GO) e","2021","07","21","Proteins","Proteins","LC-MS/MS; T2DM; glucose; glycan-binding proteins; molecular docking","Chen","Wentian","Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China",NA
"1038","34165207","10.1002/prot.26163","Characterization of glucose-binding proteins isolated from health volunteers and human type 2 diabetes mellitus patients.","Glucose is one of the most important monosaccharides. Although hyperglycemia in type 2 diabetes mellitus (T2DM) lead to a series of changes; however, little is known about the alterations of serum proteins in T2DM, especially those proteins with glucose affinity. In this study, the glucose-binding proteins (GlcBPs) of serum were isolated from 30 health volunteer (HV) and 30 T2DM patients by glucose-magnetic particle conjugates (GMPC) and identified by mass spectrum analysis. Gene ontology (GO) e","2021","07","21","Proteins","Proteins","LC-MS/MS; T2DM; glucose; glycan-binding proteins; molecular docking","Zhong","Yaogang","Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China",NA
"1039","34165207","10.1002/prot.26163","Characterization of glucose-binding proteins isolated from health volunteers and human type 2 diabetes mellitus patients.","Glucose is one of the most important monosaccharides. Although hyperglycemia in type 2 diabetes mellitus (T2DM) lead to a series of changes; however, little is known about the alterations of serum proteins in T2DM, especially those proteins with glucose affinity. In this study, the glucose-binding proteins (GlcBPs) of serum were isolated from 30 health volunteer (HV) and 30 T2DM patients by glucose-magnetic particle conjugates (GMPC) and identified by mass spectrum analysis. Gene ontology (GO) e","2021","07","21","Proteins","Proteins","LC-MS/MS; T2DM; glucose; glycan-binding proteins; molecular docking","Shu","Jian","Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China",NA
"1040","34165207","10.1002/prot.26163","Characterization of glucose-binding proteins isolated from health volunteers and human type 2 diabetes mellitus patients.","Glucose is one of the most important monosaccharides. Although hyperglycemia in type 2 diabetes mellitus (T2DM) lead to a series of changes; however, little is known about the alterations of serum proteins in T2DM, especially those proteins with glucose affinity. In this study, the glucose-binding proteins (GlcBPs) of serum were isolated from 30 health volunteer (HV) and 30 T2DM patients by glucose-magnetic particle conjugates (GMPC) and identified by mass spectrum analysis. Gene ontology (GO) e","2021","07","21","Proteins","Proteins","LC-MS/MS; T2DM; glucose; glycan-binding proteins; molecular docking","Yu","Hanjie","Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China",NA
"1041","34165207","10.1002/prot.26163","Characterization of glucose-binding proteins isolated from health volunteers and human type 2 diabetes mellitus patients.","Glucose is one of the most important monosaccharides. Although hyperglycemia in type 2 diabetes mellitus (T2DM) lead to a series of changes; however, little is known about the alterations of serum proteins in T2DM, especially those proteins with glucose affinity. In this study, the glucose-binding proteins (GlcBPs) of serum were isolated from 30 health volunteer (HV) and 30 T2DM patients by glucose-magnetic particle conjugates (GMPC) and identified by mass spectrum analysis. Gene ontology (GO) e","2021","07","21","Proteins","Proteins","LC-MS/MS; T2DM; glucose; glycan-binding proteins; molecular docking","Chen","Zhuo","Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China",NA
"1042","34165207","10.1002/prot.26163","Characterization of glucose-binding proteins isolated from health volunteers and human type 2 diabetes mellitus patients.","Glucose is one of the most important monosaccharides. Although hyperglycemia in type 2 diabetes mellitus (T2DM) lead to a series of changes; however, little is known about the alterations of serum proteins in T2DM, especially those proteins with glucose affinity. In this study, the glucose-binding proteins (GlcBPs) of serum were isolated from 30 health volunteer (HV) and 30 T2DM patients by glucose-magnetic particle conjugates (GMPC) and identified by mass spectrum analysis. Gene ontology (GO) e","2021","07","21","Proteins","Proteins","LC-MS/MS; T2DM; glucose; glycan-binding proteins; molecular docking","Ren","Xiameng","Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China",NA
"1043","34165207","10.1002/prot.26163","Characterization of glucose-binding proteins isolated from health volunteers and human type 2 diabetes mellitus patients.","Glucose is one of the most important monosaccharides. Although hyperglycemia in type 2 diabetes mellitus (T2DM) lead to a series of changes; however, little is known about the alterations of serum proteins in T2DM, especially those proteins with glucose affinity. In this study, the glucose-binding proteins (GlcBPs) of serum were isolated from 30 health volunteer (HV) and 30 T2DM patients by glucose-magnetic particle conjugates (GMPC) and identified by mass spectrum analysis. Gene ontology (GO) e","2021","07","21","Proteins","Proteins","LC-MS/MS; T2DM; glucose; glycan-binding proteins; molecular docking","Hui","Ziye","Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China",NA
"1044","34165207","10.1002/prot.26163","Characterization of glucose-binding proteins isolated from health volunteers and human type 2 diabetes mellitus patients.","Glucose is one of the most important monosaccharides. Although hyperglycemia in type 2 diabetes mellitus (T2DM) lead to a series of changes; however, little is known about the alterations of serum proteins in T2DM, especially those proteins with glucose affinity. In this study, the glucose-binding proteins (GlcBPs) of serum were isolated from 30 health volunteer (HV) and 30 T2DM patients by glucose-magnetic particle conjugates (GMPC) and identified by mass spectrum analysis. Gene ontology (GO) e","2021","07","21","Proteins","Proteins","LC-MS/MS; T2DM; glucose; glycan-binding proteins; molecular docking","Li","Zheng","Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China",NA
"1045","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Gerlovin","Hanna","Massachusetts Veterans Epidemiology, Research and Information Center, VA Boston Healthcare System, U.S. Department of Veterans Affairs, Boston, Massachusetts, USA",NA
"1046","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Posner","Daniel C","Massachusetts Veterans Epidemiology, Research and Information Center, VA Boston Healthcare System, U.S. Department of Veterans Affairs, Boston, Massachusetts, USA",NA
"1047","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Ho","Yuk-Lam","Massachusetts Veterans Epidemiology, Research and Information Center, VA Boston Healthcare System, U.S. Department of Veterans Affairs, Boston, Massachusetts, USA",NA
"1048","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Rentsch","Christopher T","VA Connecticut Healthcare System, U.S. Department of Veterans Affairs, West Haven, Connecticut, USA",NA
"1049","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Tate","Janet P","VA Connecticut Healthcare System, U.S. Department of Veterans Affairs, West Haven, Connecticut, USA",NA
"1050","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","King","Joseph T","VA Connecticut Healthcare System, U.S. Department of Veterans Affairs, West Haven, Connecticut, USA",NA
"1051","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Kurgansky","Katherine E","Massachusetts Veterans Epidemiology, Research and Information Center, VA Boston Healthcare System, U.S. Department of Veterans Affairs, Boston, Massachusetts, USA",NA
"1052","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Danciu","Ioana","Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA",NA
"1053","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Costa","Lauren","Massachusetts Veterans Epidemiology, Research and Information Center, VA Boston Healthcare System, U.S. Department of Veterans Affairs, Boston, Massachusetts, USA",NA
"1054","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Linares","Franciel A","Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA",NA
"1055","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Goethert","Ian D","Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA",NA
"1056","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Jacobson","Daniel A","Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA",NA
"1057","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Freiberg","Matthew S","Geriatric Research Education and Clinical Center, Tennessee Valley Healthcare System, U.S. Department of Veterans Affairs, Nashville, Tennessee, USA",NA
"1058","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Begoli","Edmon","Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA",NA
"1059","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Muralidhar","Sumitra","Office of Research and Development, U.S. Department of Veterans Affairs, Washington, DC, USA",NA
"1060","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Ramoni","Rachel B","Office of Research and Development, U.S. Department of Veterans Affairs, Washington, DC, USA",NA
"1061","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Tourassi","Georgia","Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA",NA
"1062","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Gaziano","J Michael","Massachusetts Veterans Epidemiology, Research and Information Center, VA Boston Healthcare System, U.S. Department of Veterans Affairs, Boston, Massachusetts, USA",NA
"1063","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Justice","Amy C","VA Connecticut Healthcare System, U.S. Department of Veterans Affairs, West Haven, Connecticut, USA",NA
"1064","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Gagnon","David R","Massachusetts Veterans Epidemiology, Research and Information Center, VA Boston Healthcare System, U.S. Department of Veterans Affairs, Boston, Massachusetts, USA",NA
"1065","34165150","10.1093/aje/kwab183","Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans.","Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) after in vitro studies indicated possible benefit. Previous in vivo observational studies have presented conflicting results, though recent randomized clinical trials have reported no benefit from HCQ amongst hospitalized COVID-19 patients. We examined the effects of HCQ alone, and in combination with azithromycin, in a hospitalized COVID-19 positive, United States (US) Veteran population using a pr","2021","06","24","Am J Epidemiol","American journal of epidemiology","covid-19; gradient boosting; hydroxychloroquine; pharmacoepidemiology; propensity score; survival analysis; treatment outcome","Cho","Kelly","Massachusetts Veterans Epidemiology, Research and Information Center, VA Boston Healthcare System, U.S. Department of Veterans Affairs, Boston, Massachusetts, USA",NA
"1066","34165148","10.1093/milmed/usab241","Recovering Coronavirus Disease Patients in the Active Duty Military Population: A Review of Current Evidence and Special Considerations for Uniformed Providers.","Patients acutely infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) may continue to have symptoms well beyond 2 weeks. The range of symptoms and physiological sequelae can impact medical readiness even in a relatively young and healthy cohort of service members. It is important to monitor, document, and investigate symptoms from all service members recovering from COVID-19. Military medicine must be prepared to support and manage cases of pati","2021","06","24","Mil Med","Military medicine",NA,"Adams","Nehkonti","U.S. Naval Hospital Okinawa FPO AP 96382, Okinawa, Japan",NA
"1067","34165148","10.1093/milmed/usab241","Recovering Coronavirus Disease Patients in the Active Duty Military Population: A Review of Current Evidence and Special Considerations for Uniformed Providers.","Patients acutely infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) may continue to have symptoms well beyond 2 weeks. The range of symptoms and physiological sequelae can impact medical readiness even in a relatively young and healthy cohort of service members. It is important to monitor, document, and investigate symptoms from all service members recovering from COVID-19. Military medicine must be prepared to support and manage cases of pati","2021","06","24","Mil Med","Military medicine",NA,"Sanou","Aliye Z","U.S. Naval Hospital Okinawa FPO AP 96382, Okinawa, Japan",NA
"1068","34165148","10.1093/milmed/usab241","Recovering Coronavirus Disease Patients in the Active Duty Military Population: A Review of Current Evidence and Special Considerations for Uniformed Providers.","Patients acutely infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) may continue to have symptoms well beyond 2 weeks. The range of symptoms and physiological sequelae can impact medical readiness even in a relatively young and healthy cohort of service members. It is important to monitor, document, and investigate symptoms from all service members recovering from COVID-19. Military medicine must be prepared to support and manage cases of pati","2021","06","24","Mil Med","Military medicine",NA,"Lewis","Paul R","U.S. Naval Hospital Okinawa FPO AP 96382, Okinawa, Japan",NA
"1069","34165148","10.1093/milmed/usab241","Recovering Coronavirus Disease Patients in the Active Duty Military Population: A Review of Current Evidence and Special Considerations for Uniformed Providers.","Patients acutely infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) may continue to have symptoms well beyond 2 weeks. The range of symptoms and physiological sequelae can impact medical readiness even in a relatively young and healthy cohort of service members. It is important to monitor, document, and investigate symptoms from all service members recovering from COVID-19. Military medicine must be prepared to support and manage cases of pati","2021","06","24","Mil Med","Military medicine",NA,"Wilson","Cardia M","U.S. Naval Hospital Okinawa FPO AP 96382, Okinawa, Japan",NA
"1070","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Coifman","Karin G","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1071","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Disabato","David J","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1072","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Aurora","Pallavi","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1073","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Seah","T H Stanley","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1074","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Mitchell","Benjamin","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1075","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Simonovic","Nicolle","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1076","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Foust","Jeremy L","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1077","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Sidney","Pooja Gupta","Department of Psychology, University of Kentucky, Lexington, Kentucky, USA",NA
"1078","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Thompson","Clarissa A","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1079","34165145","10.1093/abm/kaab048","What Drives Preventive Health Behavior During a Global Pandemic? Emotion and Worry.","Primary prevention of COVID-19 has focused on encouraging compliance with specific behaviors that restrict contagion. This investigation sought to characterize engagement in these behaviors in U.S. adults early during the pandemic and to build explanatory models of the psychological processes that drive them. US adults were recruited through Qualtrics Research Panels (N = 324; 55% female; Mage = 50.91, SD = 15.98) and completed 10 days of online reports of emotion, COVID-19 perceived susceptibil","2021","06","24","Ann Behav Med","Annals of behavioral medicine : a publication of the Society of Behavioral Medicine","COVID-19; Emotion; Health Behavior; Health Cognition; Prevention","Taber","Jennifer M","Department of Psychological Sciences, Kent State University, Kent, Ohio, USA",NA
"1080","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Thakur","Amrit Kumar","Department of Mechanical Engineering, KPR Institute of Engineering and Technology, Arasur, Coimbatore, Tamil Nadu 641407, India. amritt1@gmail","amritt1@gmail.com"
"1081","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Sathyamurthy","Ravishankar","Department of Mechanical Engineering, KPR Institute of Engineering and Technology, Arasur, Coimbatore, Tamil Nadu 641407, India. amritt1@gmail","amritt1@gmail.com"
"1082","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Ramalingam","Velraj","Institute for Energy Studies, Anna University, Chennai-600025, Tamil Nadu, India",NA
"1083","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Lynch","Iseult","School of Geography, Earth and Environmental Sciences, University of Birmingham, Edgbaston, B15 2TT Birmingham, UK",NA
"1084","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Sharshir","Swellam Wafa","Mechanical Engineering Department, Faculty of Engineering, Kafrelsheikh University, Kafrelsheikh33516, Egypt",NA
"1085","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Ma","Zhenjun","Sustainable Buildings Research Centre (SBRC), University of Wollongong, Australia",NA
"1086","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Poongavanam","Ganeshkumar","School of Mechanical Engineering, Yeungnam University, 280 Daehak-Ro, Gyeongsan, Gyeongbuk 712-749, Republic of Korea",NA
"1087","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Lee","Suyeong","Department of Materials Science and Engineering, Chonnam National University, Gwangju 61186, Republic of Korea. hjy@jnu.ac","hjy@jnu.ac.kr"
"1088","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Jeong","Yeseul","Department of Materials Science and Engineering, Chonnam National University, Gwangju 61186, Republic of Korea. hjy@jnu.ac","hjy@jnu.ac.kr"
"1089","34165129","10.1039/d1em00034a","A case study of SARS-CoV-2 transmission behavior in a severely air-polluted city (Delhi, India) and the potential usage of graphene based materials for filtering air-pollutants and controlling/monitoring the COVID-19 pandemic.","Globally, humanity is facing its most significant challenge in 100 years due to the novel coronavirus, SARS-CoV-2, which is responsible for COVID-19. Under the enormous pressure created by the pandemic, scientists are studying virus transmission mechanisms in order to develop effective mitigation strategies. However, no established methods have been developed to control the spread of this deadly virus. In addition, the ease in lockdown has escalated air pollution which may affect SARS-CoV-2 tran","2021","07","23","Environ Sci Process Impacts","Environmental science. Processes &amp; impacts","Air Pollutants; COVID-19; Cities; Communicable Disease Control; Graphite; Humans; India; Pandemics; SARS-CoV-2","Hwang","Jang-Yeon","Department of Materials Science and Engineering, Chonnam National University, Gwangju 61186, Republic of Korea. hjy@jnu.ac","hjy@jnu.ac.kr"
"1090","34165103","","Research during COVID-19 Pandemic: Perspectives from the Ethics Committees of a Lower Middle Income Country.","The pandemic of Coronavirus Disease 2019 (COVID-19) has created paradoxically a good opportunity globally to conduct research in the field of health and social science, and a Lower Middle-Income Country (LMIC) like Nepal is not an exception in this regard. During this ongoing pandemic, the Ethical Review Board (ERB) of Nepal Health Research Council (NHRC) has received numerous research proposals regarding COVID-19. As its main responsibility is to ensure participants' safety, at the same time ma","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","COVID-19; Ethics Committees; Humans; Nepal; Pandemics; SARS-CoV-2","Ghimire","N","Nepal Health Research Council, Ram Shah Path, Kathmandu, Nepal",NA
"1091","34165103","","Research during COVID-19 Pandemic: Perspectives from the Ethics Committees of a Lower Middle Income Country.","The pandemic of Coronavirus Disease 2019 (COVID-19) has created paradoxically a good opportunity globally to conduct research in the field of health and social science, and a Lower Middle-Income Country (LMIC) like Nepal is not an exception in this regard. During this ongoing pandemic, the Ethical Review Board (ERB) of Nepal Health Research Council (NHRC) has received numerous research proposals regarding COVID-19. As its main responsibility is to ensure participants' safety, at the same time ma","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","COVID-19; Ethics Committees; Humans; Nepal; Pandemics; SARS-CoV-2","Panthee","A","Nepal Health Research Council, Ram Shah Path, Kathmandu, Nepal",NA
"1092","34165103","","Research during COVID-19 Pandemic: Perspectives from the Ethics Committees of a Lower Middle Income Country.","The pandemic of Coronavirus Disease 2019 (COVID-19) has created paradoxically a good opportunity globally to conduct research in the field of health and social science, and a Lower Middle-Income Country (LMIC) like Nepal is not an exception in this regard. During this ongoing pandemic, the Ethical Review Board (ERB) of Nepal Health Research Council (NHRC) has received numerous research proposals regarding COVID-19. As its main responsibility is to ensure participants' safety, at the same time ma","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","COVID-19; Ethics Committees; Humans; Nepal; Pandemics; SARS-CoV-2","Sharma","M R","Nepal Health Research Council, Ram Shah Path, Kathmandu, Nepal",NA
"1093","34165103","","Research during COVID-19 Pandemic: Perspectives from the Ethics Committees of a Lower Middle Income Country.","The pandemic of Coronavirus Disease 2019 (COVID-19) has created paradoxically a good opportunity globally to conduct research in the field of health and social science, and a Lower Middle-Income Country (LMIC) like Nepal is not an exception in this regard. During this ongoing pandemic, the Ethical Review Board (ERB) of Nepal Health Research Council (NHRC) has received numerous research proposals regarding COVID-19. As its main responsibility is to ensure participants' safety, at the same time ma","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","COVID-19; Ethics Committees; Humans; Nepal; Pandemics; SARS-CoV-2","Adhikari","R K","Nepal Health Research Council, Ram Shah Path, Kathmandu, Nepal",NA
"1094","34165103","","Research during COVID-19 Pandemic: Perspectives from the Ethics Committees of a Lower Middle Income Country.","The pandemic of Coronavirus Disease 2019 (COVID-19) has created paradoxically a good opportunity globally to conduct research in the field of health and social science, and a Lower Middle-Income Country (LMIC) like Nepal is not an exception in this regard. During this ongoing pandemic, the Ethical Review Board (ERB) of Nepal Health Research Council (NHRC) has received numerous research proposals regarding COVID-19. As its main responsibility is to ensure participants' safety, at the same time ma","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","COVID-19; Ethics Committees; Humans; Nepal; Pandemics; SARS-CoV-2","Gyanwali","P","Nepal Health Research Council, Ram Shah Path, Kathmandu, Nepal",NA
"1095","34165087","","Anxiety and Depression during COVID-19 Pandemic among Medical Students in Nepal.","Background Medical students' psychological response to societal lockdown during the COVID-19 pandemic has not been studied much. Objective To assess levels of anxiety and depression among medical students during initial stages of COVID-19 pandemic in Nepal and relate their distress to relevant variables. Method A cross-sectional study with online questionnaire was conducted among medical students at different colleges in Nepal. Hospital Anxiety and Depression Scale (HADS) detected 'anxiety' and ","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; Anxiety; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Depression; Female; Humans; Male; Nepal; Pandemics; SARS-CoV-2; Students, Medical; Young Adult","Risal","A","Department of Psychiatry, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal",NA
"1096","34165087","","Anxiety and Depression during COVID-19 Pandemic among Medical Students in Nepal.","Background Medical students' psychological response to societal lockdown during the COVID-19 pandemic has not been studied much. Objective To assess levels of anxiety and depression among medical students during initial stages of COVID-19 pandemic in Nepal and relate their distress to relevant variables. Method A cross-sectional study with online questionnaire was conducted among medical students at different colleges in Nepal. Hospital Anxiety and Depression Scale (HADS) detected 'anxiety' and ","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; Anxiety; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Depression; Female; Humans; Male; Nepal; Pandemics; SARS-CoV-2; Students, Medical; Young Adult","Shikhrakar","S","Department of Psychiatry, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal",NA
"1097","34165087","","Anxiety and Depression during COVID-19 Pandemic among Medical Students in Nepal.","Background Medical students' psychological response to societal lockdown during the COVID-19 pandemic has not been studied much. Objective To assess levels of anxiety and depression among medical students during initial stages of COVID-19 pandemic in Nepal and relate their distress to relevant variables. Method A cross-sectional study with online questionnaire was conducted among medical students at different colleges in Nepal. Hospital Anxiety and Depression Scale (HADS) detected 'anxiety' and ","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; Anxiety; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Depression; Female; Humans; Male; Nepal; Pandemics; SARS-CoV-2; Students, Medical; Young Adult","Mishra","S","Department of Psychiatry, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal",NA
"1098","34165087","","Anxiety and Depression during COVID-19 Pandemic among Medical Students in Nepal.","Background Medical students' psychological response to societal lockdown during the COVID-19 pandemic has not been studied much. Objective To assess levels of anxiety and depression among medical students during initial stages of COVID-19 pandemic in Nepal and relate their distress to relevant variables. Method A cross-sectional study with online questionnaire was conducted among medical students at different colleges in Nepal. Hospital Anxiety and Depression Scale (HADS) detected 'anxiety' and ","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; Anxiety; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Depression; Female; Humans; Male; Nepal; Pandemics; SARS-CoV-2; Students, Medical; Young Adult","Kunwar","D","Department of Psychiatry, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal",NA
"1099","34165087","","Anxiety and Depression during COVID-19 Pandemic among Medical Students in Nepal.","Background Medical students' psychological response to societal lockdown during the COVID-19 pandemic has not been studied much. Objective To assess levels of anxiety and depression among medical students during initial stages of COVID-19 pandemic in Nepal and relate their distress to relevant variables. Method A cross-sectional study with online questionnaire was conducted among medical students at different colleges in Nepal. Hospital Anxiety and Depression Scale (HADS) detected 'anxiety' and ","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; Anxiety; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Depression; Female; Humans; Male; Nepal; Pandemics; SARS-CoV-2; Students, Medical; Young Adult","Karki","E","Department of Psychiatry, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal",NA
"1100","34165087","","Anxiety and Depression during COVID-19 Pandemic among Medical Students in Nepal.","Background Medical students' psychological response to societal lockdown during the COVID-19 pandemic has not been studied much. Objective To assess levels of anxiety and depression among medical students during initial stages of COVID-19 pandemic in Nepal and relate their distress to relevant variables. Method A cross-sectional study with online questionnaire was conducted among medical students at different colleges in Nepal. Hospital Anxiety and Depression Scale (HADS) detected 'anxiety' and ","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; Anxiety; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Depression; Female; Humans; Male; Nepal; Pandemics; SARS-CoV-2; Students, Medical; Young Adult","Shrestha","B","Department of Psychiatry, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal",NA
"1101","34165087","","Anxiety and Depression during COVID-19 Pandemic among Medical Students in Nepal.","Background Medical students' psychological response to societal lockdown during the COVID-19 pandemic has not been studied much. Objective To assess levels of anxiety and depression among medical students during initial stages of COVID-19 pandemic in Nepal and relate their distress to relevant variables. Method A cross-sectional study with online questionnaire was conducted among medical students at different colleges in Nepal. Hospital Anxiety and Depression Scale (HADS) detected 'anxiety' and ","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; Anxiety; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Depression; Female; Humans; Male; Nepal; Pandemics; SARS-CoV-2; Students, Medical; Young Adult","Khadka","S","Department of Psychiatry, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal",NA
"1102","34165087","","Anxiety and Depression during COVID-19 Pandemic among Medical Students in Nepal.","Background Medical students' psychological response to societal lockdown during the COVID-19 pandemic has not been studied much. Objective To assess levels of anxiety and depression among medical students during initial stages of COVID-19 pandemic in Nepal and relate their distress to relevant variables. Method A cross-sectional study with online questionnaire was conducted among medical students at different colleges in Nepal. Hospital Anxiety and Depression Scale (HADS) detected 'anxiety' and ","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; Anxiety; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Depression; Female; Humans; Male; Nepal; Pandemics; SARS-CoV-2; Students, Medical; Young Adult","Holen","A","Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway",NA
"1103","34165086","","Age and Gender Differences in COVID 19 Morbidity and Mortality in Nepal.","Background The global health community has emphasized the importance of reporting epidemiological data by age and sex groups in the COVID-19 pandemic. However, age and sex disaggregated data of COVID-19 cases and deaths are rarely reported. Such data are very crucial for public to make truly informed choices about their own diseases risk and also for governments for public policy response. Objective To assess age and gender difference among COVID-19 cases and deaths in Nepal. Method This is a re","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; COVID-19; Female; Humans; Male; Middle Aged; Morbidity; Nepal; Pandemics; Retrospective Studies; SARS-CoV-2; Sex Characteristics; Young Adult","Dhimal","M L","Global Institute for Interdisciplinary Studies, Kathmandu, Nepal",NA
"1104","34165086","","Age and Gender Differences in COVID 19 Morbidity and Mortality in Nepal.","Background The global health community has emphasized the importance of reporting epidemiological data by age and sex groups in the COVID-19 pandemic. However, age and sex disaggregated data of COVID-19 cases and deaths are rarely reported. Such data are very crucial for public to make truly informed choices about their own diseases risk and also for governments for public policy response. Objective To assess age and gender difference among COVID-19 cases and deaths in Nepal. Method This is a re","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; COVID-19; Female; Humans; Male; Middle Aged; Morbidity; Nepal; Pandemics; Retrospective Studies; SARS-CoV-2; Sex Characteristics; Young Adult","Rana","N","Nepal Health Research Council, Ramshah Path, Kathmandu, Nepal",NA
"1105","34165086","","Age and Gender Differences in COVID 19 Morbidity and Mortality in Nepal.","Background The global health community has emphasized the importance of reporting epidemiological data by age and sex groups in the COVID-19 pandemic. However, age and sex disaggregated data of COVID-19 cases and deaths are rarely reported. Such data are very crucial for public to make truly informed choices about their own diseases risk and also for governments for public policy response. Objective To assess age and gender difference among COVID-19 cases and deaths in Nepal. Method This is a re","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; COVID-19; Female; Humans; Male; Middle Aged; Morbidity; Nepal; Pandemics; Retrospective Studies; SARS-CoV-2; Sex Characteristics; Young Adult","Aryal","B","Nepal Health Research Council, Ramshah Path, Kathmandu, Nepal",NA
"1106","34165086","","Age and Gender Differences in COVID 19 Morbidity and Mortality in Nepal.","Background The global health community has emphasized the importance of reporting epidemiological data by age and sex groups in the COVID-19 pandemic. However, age and sex disaggregated data of COVID-19 cases and deaths are rarely reported. Such data are very crucial for public to make truly informed choices about their own diseases risk and also for governments for public policy response. Objective To assess age and gender difference among COVID-19 cases and deaths in Nepal. Method This is a re","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; COVID-19; Female; Humans; Male; Middle Aged; Morbidity; Nepal; Pandemics; Retrospective Studies; SARS-CoV-2; Sex Characteristics; Young Adult","Adhikari","S K","Ministry of Health and Population, Ramshah Path, Kathmandu, Nepal",NA
"1107","34165086","","Age and Gender Differences in COVID 19 Morbidity and Mortality in Nepal.","Background The global health community has emphasized the importance of reporting epidemiological data by age and sex groups in the COVID-19 pandemic. However, age and sex disaggregated data of COVID-19 cases and deaths are rarely reported. Such data are very crucial for public to make truly informed choices about their own diseases risk and also for governments for public policy response. Objective To assess age and gender difference among COVID-19 cases and deaths in Nepal. Method This is a re","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; COVID-19; Female; Humans; Male; Middle Aged; Morbidity; Nepal; Pandemics; Retrospective Studies; SARS-CoV-2; Sex Characteristics; Young Adult","Shrestha","R","Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Kavre, Nepal",NA
"1108","34165086","","Age and Gender Differences in COVID 19 Morbidity and Mortality in Nepal.","Background The global health community has emphasized the importance of reporting epidemiological data by age and sex groups in the COVID-19 pandemic. However, age and sex disaggregated data of COVID-19 cases and deaths are rarely reported. Such data are very crucial for public to make truly informed choices about their own diseases risk and also for governments for public policy response. Objective To assess age and gender difference among COVID-19 cases and deaths in Nepal. Method This is a re","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; COVID-19; Female; Humans; Male; Middle Aged; Morbidity; Nepal; Pandemics; Retrospective Studies; SARS-CoV-2; Sex Characteristics; Young Adult","Gyanwali","P","Nepal Health Research Council, Ramshah Path, Kathmandu, Nepal",NA
"1109","34165086","","Age and Gender Differences in COVID 19 Morbidity and Mortality in Nepal.","Background The global health community has emphasized the importance of reporting epidemiological data by age and sex groups in the COVID-19 pandemic. However, age and sex disaggregated data of COVID-19 cases and deaths are rarely reported. Such data are very crucial for public to make truly informed choices about their own diseases risk and also for governments for public policy response. Objective To assess age and gender difference among COVID-19 cases and deaths in Nepal. Method This is a re","2021","06","25","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","Adult; COVID-19; Female; Humans; Male; Middle Aged; Morbidity; Nepal; Pandemics; Retrospective Studies; SARS-CoV-2; Sex Characteristics; Young Adult","Dhimal","M","Nepal Health Research Council, Ramshah Path, Kathmandu, Nepal",NA
"1110","34165085","","COVID-19: Mental Health Matters.",NA,"2021","06","28","Kathmandu Univ Med J (KUMJ)","Kathmandu University medical journal (KUMJ)","COVID-19; Humans; Mental Health; SARS-CoV-2","Risal","A","Department of Psychiatry, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal",NA
"1111","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Gaythorpe","Katy Am","MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College London, London, United Kingdom",NA
"1112","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Abbas","Kaja","Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene &amp",NA
"1113","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Huber","John","Department of Biological Sciences, University of Notre Dame, South Bend, United States",NA
"1114","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Karachaliou","Andromachi","Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom",NA
"1115","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Thakkar","Niket","Institute for Disease Modeling, Bill &amp",NA
"1116","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Woodruff","Kim","MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College London, London, United Kingdom",NA
"1117","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Li","Xiang","MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College London, London, United Kingdom",NA
"1118","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Echeverria-Londono","Susy","MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College London, London, United Kingdom",NA
"1119","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Ferrari","Matthew","Pennsylvania State University, University Park, United States",NA
"1120","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Jackson","Michael L","Kaiser Permanante Washington, Seattle, United States",NA
"1121","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","McCarthy","Kevin","Institute for Disease Modeling, Bill &amp",NA
"1122","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Perkins","T Alex","Department of Biological Sciences, University of Notre Dame, South Bend, United States",NA
"1123","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Trotter","Caroline","Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom",NA
"1124","34165077","10.7554/eLife.67023","Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.","Childhood immunisation services have been disrupted by the COVID-19 pandemic. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. We used two to three models per infection to estimate the health impact of 50% reduced routine vaccination coverage in 2020 and delay of campaign vaccination from 2020 to 2021 for measles vaccination in Bangladesh, Chad, Ethiopia, Kenya, Nigeria, and South Sudan,","2021","07","14","Elife","eLife","COVID-19; epidemiology; global health; human; mathematical modelling; measles; medicine; meningococcal disease; vaccination; yellow fever; Adolescent; Adult; Africa; Bangladesh; COVID-19; Child; Child, Preschool; Disease Outbreaks; Humans; Immunization Programs; Infant; Measles; Measles Vaccine; Meningococcal Infections; Meningococcal Vaccines; Pandemics; Risk Assessment; SARS-CoV-2; Vaccination; Yellow Fever; Yellow Fever Vaccine; Young Adult","Jit","Mark","Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene &amp",NA
"1125","34165071","10.1017/S0950268821001357","Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling.",NA,"2021","06","24","Epidemiol Infect","Epidemiology and infection",NA,"Wu","Yue","School of Public Health, University of Sydney, Camperdown, New South Wales, Australia",NA
"1126","34165071","10.1017/S0950268821001357","Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling.",NA,"2021","06","24","Epidemiol Infect","Epidemiology and infection",NA,"Foley","David","Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia",NA
"1127","34165071","10.1017/S0950268821001357","Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling.",NA,"2021","06","24","Epidemiol Infect","Epidemiology and infection",NA,"Ramsay","Jessica","Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia",NA
"1128","34165071","10.1017/S0950268821001357","Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling.",NA,"2021","06","24","Epidemiol Infect","Epidemiology and infection",NA,"Woodberry","Owen","Department of Data Science &amp",NA
"1129","34165071","10.1017/S0950268821001357","Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling.",NA,"2021","06","24","Epidemiol Infect","Epidemiology and infection",NA,"Mascaro","Steven","Department of Data Science &amp",NA
"1130","34165071","10.1017/S0950268821001357","Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling.",NA,"2021","06","24","Epidemiol Infect","Epidemiology and infection",NA,"Nicholson","Ann E","Department of Data Science &amp",NA
"1131","34165071","10.1017/S0950268821001357","Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling.",NA,"2021","06","24","Epidemiol Infect","Epidemiology and infection",NA,"Snelling","Tom","School of Public Health, University of Sydney, Camperdown, New South Wales, Australia",NA
"1132","34165070","10.1017/cjn.2021.139","A Novel COVID Era-Related Oromandibular Dyskinesia: Surgical Mask-Induced Dyskinesia?",NA,"2021","07","21","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","COVID-19; Orolingual dyskinesia; Oromandibular dystonia/dyskinesia; Respiratory protective devices; Surgical mask","Akhoundi","Fahimeh H","Division of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran",NA
"1133","34165070","10.1017/cjn.2021.139","A Novel COVID Era-Related Oromandibular Dyskinesia: Surgical Mask-Induced Dyskinesia?",NA,"2021","07","21","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","COVID-19; Orolingual dyskinesia; Oromandibular dystonia/dyskinesia; Respiratory protective devices; Surgical mask","Lang","Anthony E","Edmond J Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada",NA
"1134","34165070","10.1017/cjn.2021.139","A Novel COVID Era-Related Oromandibular Dyskinesia: Surgical Mask-Induced Dyskinesia?",NA,"2021","07","21","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","COVID-19; Orolingual dyskinesia; Oromandibular dystonia/dyskinesia; Respiratory protective devices; Surgical mask","Ghazvinian","Saeed","Division of Neurology, Atieh Hospital, Tehran, Iran",NA
"1135","34165070","10.1017/cjn.2021.139","A Novel COVID Era-Related Oromandibular Dyskinesia: Surgical Mask-Induced Dyskinesia?",NA,"2021","07","21","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","COVID-19; Orolingual dyskinesia; Oromandibular dystonia/dyskinesia; Respiratory protective devices; Surgical mask","Chitsaz","Ahmad","Department of Neurology, School of Medicine, Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1136","34165070","10.1017/cjn.2021.139","A Novel COVID Era-Related Oromandibular Dyskinesia: Surgical Mask-Induced Dyskinesia?",NA,"2021","07","21","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","COVID-19; Orolingual dyskinesia; Oromandibular dystonia/dyskinesia; Respiratory protective devices; Surgical mask","Emamikhah","Maziar","Division of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran",NA
"1137","34165070","10.1017/cjn.2021.139","A Novel COVID Era-Related Oromandibular Dyskinesia: Surgical Mask-Induced Dyskinesia?",NA,"2021","07","21","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","COVID-19; Orolingual dyskinesia; Oromandibular dystonia/dyskinesia; Respiratory protective devices; Surgical mask","Rohani","Mohammad","Division of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran",NA
"1138","34165057","10.1017/S0033291721002762","Increase in youth suicides during the COVID-19 pandemic: concerns over implications for the future.",NA,"2021","07","03","Psychol Med","Psychological medicine",NA,"Fushimi","Masahito","Akita University Health Center, Akita University, 1-1 Tegatagakuen-machi, Akita City, Akita 010-8502, Japan",NA
"1139","34165056","10.1017/ice.2021.291","The challenges of education in a continental country in the face of new severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variant circulation.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Zalona Fernandes","Henry Marcel","Institute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1140","34165056","10.1017/ice.2021.291","The challenges of education in a continental country in the face of new severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variant circulation.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Miranda","Karla Rodrigues","Institute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1141","34165056","10.1017/ice.2021.291","The challenges of education in a continental country in the face of new severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variant circulation.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"da Silva Dias","Rubens Clayton","Biomedical Institute, Federal University of State of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1142","34165056","10.1017/ice.2021.291","The challenges of education in a continental country in the face of new severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variant circulation.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Alviano","Daniela Sales","Institute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1143","34165056","10.1017/ice.2021.291","The challenges of education in a continental country in the face of new severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variant circulation.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Duarte","Rafael Silva","Institute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1144","34165056","10.1017/ice.2021.291","The challenges of education in a continental country in the face of new severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variant circulation.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"da Silva Carvalho","Ana Carolina","Institute of Chemistry, Federal University of Rio de Janeiro, Campus Macaé, Macaé, Rio de Janeiro, Brazil",NA
"1145","34165032","10.1080/0167482X.2021.1929162","Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a meta-analysis.","Coronavirus disease (COVID-19) is a newly emerged respiratory illness, which has spread around the world. Pregnant women are exposed to additional pressure due to the indirect adverse effects of this pandemic on their physical and mental health. Since the psychological wellness framework is weak in developing countries, it is likely that geographical factors affect the prevalence. Therefore, the goal of this meta-analysis is to investigate the prevalence of anxiety and depression among pregnant ","2021","06","24","J Psychosom Obstet Gynaecol","Journal of psychosomatic obstetrics and gynaecology","Anxiety; COVID-19; childbirth; depression; mental health; pregnancy","Ghazanfarpour","Masumeh","Department of Gynecology, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran",NA
"1146","34165032","10.1080/0167482X.2021.1929162","Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a meta-analysis.","Coronavirus disease (COVID-19) is a newly emerged respiratory illness, which has spread around the world. Pregnant women are exposed to additional pressure due to the indirect adverse effects of this pandemic on their physical and mental health. Since the psychological wellness framework is weak in developing countries, it is likely that geographical factors affect the prevalence. Therefore, the goal of this meta-analysis is to investigate the prevalence of anxiety and depression among pregnant ","2021","06","24","J Psychosom Obstet Gynaecol","Journal of psychosomatic obstetrics and gynaecology","Anxiety; COVID-19; childbirth; depression; mental health; pregnancy","Bahrami","Fereshteh","Shiraz University of Medical Science, Shiraz, Iran",NA
"1147","34165032","10.1080/0167482X.2021.1929162","Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a meta-analysis.","Coronavirus disease (COVID-19) is a newly emerged respiratory illness, which has spread around the world. Pregnant women are exposed to additional pressure due to the indirect adverse effects of this pandemic on their physical and mental health. Since the psychological wellness framework is weak in developing countries, it is likely that geographical factors affect the prevalence. Therefore, the goal of this meta-analysis is to investigate the prevalence of anxiety and depression among pregnant ","2021","06","24","J Psychosom Obstet Gynaecol","Journal of psychosomatic obstetrics and gynaecology","Anxiety; COVID-19; childbirth; depression; mental health; pregnancy","Rashidi Fakari","Farzaneh","Department of Midwifery, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran",NA
"1148","34165032","10.1080/0167482X.2021.1929162","Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a meta-analysis.","Coronavirus disease (COVID-19) is a newly emerged respiratory illness, which has spread around the world. Pregnant women are exposed to additional pressure due to the indirect adverse effects of this pandemic on their physical and mental health. Since the psychological wellness framework is weak in developing countries, it is likely that geographical factors affect the prevalence. Therefore, the goal of this meta-analysis is to investigate the prevalence of anxiety and depression among pregnant ","2021","06","24","J Psychosom Obstet Gynaecol","Journal of psychosomatic obstetrics and gynaecology","Anxiety; COVID-19; childbirth; depression; mental health; pregnancy","Ashrafinia","Farzane","Department of Gynecology, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran",NA
"1149","34165032","10.1080/0167482X.2021.1929162","Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a meta-analysis.","Coronavirus disease (COVID-19) is a newly emerged respiratory illness, which has spread around the world. Pregnant women are exposed to additional pressure due to the indirect adverse effects of this pandemic on their physical and mental health. Since the psychological wellness framework is weak in developing countries, it is likely that geographical factors affect the prevalence. Therefore, the goal of this meta-analysis is to investigate the prevalence of anxiety and depression among pregnant ","2021","06","24","J Psychosom Obstet Gynaecol","Journal of psychosomatic obstetrics and gynaecology","Anxiety; COVID-19; childbirth; depression; mental health; pregnancy","Babakhanian","Masoudeh","Abnormal Uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, Iran",NA
"1150","34165032","10.1080/0167482X.2021.1929162","Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a meta-analysis.","Coronavirus disease (COVID-19) is a newly emerged respiratory illness, which has spread around the world. Pregnant women are exposed to additional pressure due to the indirect adverse effects of this pandemic on their physical and mental health. Since the psychological wellness framework is weak in developing countries, it is likely that geographical factors affect the prevalence. Therefore, the goal of this meta-analysis is to investigate the prevalence of anxiety and depression among pregnant ","2021","06","24","J Psychosom Obstet Gynaecol","Journal of psychosomatic obstetrics and gynaecology","Anxiety; COVID-19; childbirth; depression; mental health; pregnancy","Dordeh","Mohammad","Department of Psychology, Bandar Abbas Branch, Islamic Azad University, Bandar Abbas, Iran",NA
"1151","34165032","10.1080/0167482X.2021.1929162","Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a meta-analysis.","Coronavirus disease (COVID-19) is a newly emerged respiratory illness, which has spread around the world. Pregnant women are exposed to additional pressure due to the indirect adverse effects of this pandemic on their physical and mental health. Since the psychological wellness framework is weak in developing countries, it is likely that geographical factors affect the prevalence. Therefore, the goal of this meta-analysis is to investigate the prevalence of anxiety and depression among pregnant ","2021","06","24","J Psychosom Obstet Gynaecol","Journal of psychosomatic obstetrics and gynaecology","Anxiety; COVID-19; childbirth; depression; mental health; pregnancy","Abdi","Fatemeh","School of Nursing and Midwifery, Alborz University of Medical Sciences, Karaj, Iran",NA
"1152","34165030","10.1080/15504263.2021.1940413","Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey.","The COVID-19 pandemic has posed a great challenge for the existing health systems. The restrictions imposed across countries on the movement of people and the realignment of health care services in response to the pandemic are likely to negatively affect the health status and delivery of mental health services to persons with dual disorders (PWDD). Methods: An online survey was conducted among mental health professionals involved in providing care to PWDD to better understand the problems","2021","06","24","J Dual Diagn","Journal of dual diagnosis","COVID-19; service delivery; Dual disorders; barriers; health care delivery","Singh Balhara","Yatan Pal","Department of Psychiatry, National Drug Dependence Treatment Center, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"1153","34165030","10.1080/15504263.2021.1940413","Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey.","The COVID-19 pandemic has posed a great challenge for the existing health systems. The restrictions imposed across countries on the movement of people and the realignment of health care services in response to the pandemic are likely to negatively affect the health status and delivery of mental health services to persons with dual disorders (PWDD). Methods: An online survey was conducted among mental health professionals involved in providing care to PWDD to better understand the problems","2021","06","24","J Dual Diagn","Journal of dual diagnosis","COVID-19; service delivery; Dual disorders; barriers; health care delivery","Szerman","Nestor","Mental Health Unit ""Retiro"", University Hospital Gregorio Marañon, Madrid, Spain",NA
"1154","34165030","10.1080/15504263.2021.1940413","Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey.","The COVID-19 pandemic has posed a great challenge for the existing health systems. The restrictions imposed across countries on the movement of people and the realignment of health care services in response to the pandemic are likely to negatively affect the health status and delivery of mental health services to persons with dual disorders (PWDD). Methods: An online survey was conducted among mental health professionals involved in providing care to PWDD to better understand the problems","2021","06","24","J Dual Diagn","Journal of dual diagnosis","COVID-19; service delivery; Dual disorders; barriers; health care delivery","Singh","Swarndeep","National Drug Dependence Treatment Center and Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"1155","34165030","10.1080/15504263.2021.1940413","Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey.","The COVID-19 pandemic has posed a great challenge for the existing health systems. The restrictions imposed across countries on the movement of people and the realignment of health care services in response to the pandemic are likely to negatively affect the health status and delivery of mental health services to persons with dual disorders (PWDD). Methods: An online survey was conducted among mental health professionals involved in providing care to PWDD to better understand the problems","2021","06","24","J Dual Diagn","Journal of dual diagnosis","COVID-19; service delivery; Dual disorders; barriers; health care delivery","Martinez Raga","Jose","Department of Psychiatry, University of Valencia, Valencia, Spain",NA
"1156","34165030","10.1080/15504263.2021.1940413","Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey.","The COVID-19 pandemic has posed a great challenge for the existing health systems. The restrictions imposed across countries on the movement of people and the realignment of health care services in response to the pandemic are likely to negatively affect the health status and delivery of mental health services to persons with dual disorders (PWDD). Methods: An online survey was conducted among mental health professionals involved in providing care to PWDD to better understand the problems","2021","06","24","J Dual Diagn","Journal of dual diagnosis","COVID-19; service delivery; Dual disorders; barriers; health care delivery","Salom","Caroline","Institute for Social Science Research, The University of Queensland, Brisbane, Australia",NA
"1157","34165030","10.1080/15504263.2021.1940413","Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey.","The COVID-19 pandemic has posed a great challenge for the existing health systems. The restrictions imposed across countries on the movement of people and the realignment of health care services in response to the pandemic are likely to negatively affect the health status and delivery of mental health services to persons with dual disorders (PWDD). Methods: An online survey was conducted among mental health professionals involved in providing care to PWDD to better understand the problems","2021","06","24","J Dual Diagn","Journal of dual diagnosis","COVID-19; service delivery; Dual disorders; barriers; health care delivery","Peris","Lola","CNP-Centre Neuchâtelois de Psychiatrie, Neuchâtel, Switzerland",NA
"1158","34165030","10.1080/15504263.2021.1940413","Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey.","The COVID-19 pandemic has posed a great challenge for the existing health systems. The restrictions imposed across countries on the movement of people and the realignment of health care services in response to the pandemic are likely to negatively affect the health status and delivery of mental health services to persons with dual disorders (PWDD). Methods: An online survey was conducted among mental health professionals involved in providing care to PWDD to better understand the problems","2021","06","24","J Dual Diagn","Journal of dual diagnosis","COVID-19; service delivery; Dual disorders; barriers; health care delivery","Ganesh","Ragul","National Drug Dependence Treatment Center and Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"1159","34165015","10.1177/17579759211018417","The COVID-19 and lifestyle nexus: settling the debate.","A recent debate that has gained our attention is that of coronavirus disease 2019 (COVID-19) being referred to as a lifestyle disease by the Royal College of General Practitioners (in the title of an online event) for which they later apologized and withdrew the reference. In this commentary, we demystify diseases related to 'lifestyle' and put this in the context of the age-old public health way of classifying diseases as communicable and non-communicable (NCDs). Evidence indicates that unhealt","2021","06","24","Glob Health Promot","Global health promotion","COVID-19; communicable diseases; lifestyle factors; lifestyle-related diseases; non-communicable diseases","Doraiswamy","Sathyanarayanan","Institute for Population Health, Weill Cornell Medicine - Qatar, Qatar",NA
"1160","34165015","10.1177/17579759211018417","The COVID-19 and lifestyle nexus: settling the debate.","A recent debate that has gained our attention is that of coronavirus disease 2019 (COVID-19) being referred to as a lifestyle disease by the Royal College of General Practitioners (in the title of an online event) for which they later apologized and withdrew the reference. In this commentary, we demystify diseases related to 'lifestyle' and put this in the context of the age-old public health way of classifying diseases as communicable and non-communicable (NCDs). Evidence indicates that unhealt","2021","06","24","Glob Health Promot","Global health promotion","COVID-19; communicable diseases; lifestyle factors; lifestyle-related diseases; non-communicable diseases","Cheema","Sohaila","Institute for Population Health, Weill Cornell Medicine - Qatar, Qatar",NA
"1161","34165015","10.1177/17579759211018417","The COVID-19 and lifestyle nexus: settling the debate.","A recent debate that has gained our attention is that of coronavirus disease 2019 (COVID-19) being referred to as a lifestyle disease by the Royal College of General Practitioners (in the title of an online event) for which they later apologized and withdrew the reference. In this commentary, we demystify diseases related to 'lifestyle' and put this in the context of the age-old public health way of classifying diseases as communicable and non-communicable (NCDs). Evidence indicates that unhealt","2021","06","24","Glob Health Promot","Global health promotion","COVID-19; communicable diseases; lifestyle factors; lifestyle-related diseases; non-communicable diseases","Mamtani","Ravinder","Institute for Population Health, Weill Cornell Medicine - Qatar, Qatar",NA
"1162","34164998","10.1177/08901171211028407","Risk Exposures, Risk Perceptions, Negative Attitudes Toward General Vaccination, and COVID-19 Vaccine Acceptance Among College Students in south Carolina.","The current study investigated how risk exposures, risk perceptions of COVID-19, and negative attitudes toward general vaccination were related to COVID vaccine acceptance among college students. Cross-sectional study. Data was collected by online survey using RedCap among college students in South Carolina between September 2020 and October 2020. 1062 college students in South Carolina. risk exposures to COVID-19, perceived severity of COVID-19, perceived susceptibility of COVID-19, negative at","2021","06","29","Am J Health Promot","American journal of health promotion : AJHP","COVID-19; college students; risk exposures; risk perceptions; vaccine acceptance","Qiao","Shan","Department of Health Promotion Education and Behavior, 2629University of South Carolina, SC SmartState Center for Healthcare Quality, Columbia, SC, USA",NA
"1163","34164998","10.1177/08901171211028407","Risk Exposures, Risk Perceptions, Negative Attitudes Toward General Vaccination, and COVID-19 Vaccine Acceptance Among College Students in south Carolina.","The current study investigated how risk exposures, risk perceptions of COVID-19, and negative attitudes toward general vaccination were related to COVID vaccine acceptance among college students. Cross-sectional study. Data was collected by online survey using RedCap among college students in South Carolina between September 2020 and October 2020. 1062 college students in South Carolina. risk exposures to COVID-19, perceived severity of COVID-19, perceived susceptibility of COVID-19, negative at","2021","06","29","Am J Health Promot","American journal of health promotion : AJHP","COVID-19; college students; risk exposures; risk perceptions; vaccine acceptance","Tam","Cheuk Chi","Department of Health Promotion Education and Behavior, 2629University of South Carolina, SC SmartState Center for Healthcare Quality, Columbia, SC, USA",NA
"1164","34164998","10.1177/08901171211028407","Risk Exposures, Risk Perceptions, Negative Attitudes Toward General Vaccination, and COVID-19 Vaccine Acceptance Among College Students in south Carolina.","The current study investigated how risk exposures, risk perceptions of COVID-19, and negative attitudes toward general vaccination were related to COVID vaccine acceptance among college students. Cross-sectional study. Data was collected by online survey using RedCap among college students in South Carolina between September 2020 and October 2020. 1062 college students in South Carolina. risk exposures to COVID-19, perceived severity of COVID-19, perceived susceptibility of COVID-19, negative at","2021","06","29","Am J Health Promot","American journal of health promotion : AJHP","COVID-19; college students; risk exposures; risk perceptions; vaccine acceptance","Li","Xiaoming","Department of Health Promotion Education and Behavior, 2629University of South Carolina, SC SmartState Center for Healthcare Quality, Columbia, SC, USA",NA
"1165","34164973","10.24095/hpcdp.41.10.02","Protecting vulnerable groups from tobacco-related harm during and following the COVID-19 pandemic.","Marginalized populations are being disproportionally affected by the current pandemic. Direct effects include higher infection rates with greater morbidity and mortality; indirect effects stem from the societal response to limit the spread of the virus. These same groups also have smoking rates that are significantly higher than the general population. In this commentary, we discuss how the pandemic has been acting to further increase the harm from tobacco endured by these groups by applying the","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19; health disparities; pandemic; policy; smoking; socioeconomic status; tobacco; tobacco control; vulnerable groups","Melamed","Osnat C","Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada",NA
"1166","34164973","10.24095/hpcdp.41.10.02","Protecting vulnerable groups from tobacco-related harm during and following the COVID-19 pandemic.","Marginalized populations are being disproportionally affected by the current pandemic. Direct effects include higher infection rates with greater morbidity and mortality; indirect effects stem from the societal response to limit the spread of the virus. These same groups also have smoking rates that are significantly higher than the general population. In this commentary, we discuss how the pandemic has been acting to further increase the harm from tobacco endured by these groups by applying the","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19; health disparities; pandemic; policy; smoking; socioeconomic status; tobacco; tobacco control; vulnerable groups","Zawertailo","Laurie","Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada",NA
"1167","34164973","10.24095/hpcdp.41.10.02","Protecting vulnerable groups from tobacco-related harm during and following the COVID-19 pandemic.","Marginalized populations are being disproportionally affected by the current pandemic. Direct effects include higher infection rates with greater morbidity and mortality; indirect effects stem from the societal response to limit the spread of the virus. These same groups also have smoking rates that are significantly higher than the general population. In this commentary, we discuss how the pandemic has been acting to further increase the harm from tobacco endured by these groups by applying the","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19; health disparities; pandemic; policy; smoking; socioeconomic status; tobacco; tobacco control; vulnerable groups","Schwartz","Robert","Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada",NA
"1168","34164973","10.24095/hpcdp.41.10.02","Protecting vulnerable groups from tobacco-related harm during and following the COVID-19 pandemic.","Marginalized populations are being disproportionally affected by the current pandemic. Direct effects include higher infection rates with greater morbidity and mortality; indirect effects stem from the societal response to limit the spread of the virus. These same groups also have smoking rates that are significantly higher than the general population. In this commentary, we discuss how the pandemic has been acting to further increase the harm from tobacco endured by these groups by applying the","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19; health disparities; pandemic; policy; smoking; socioeconomic status; tobacco; tobacco control; vulnerable groups","Buckley","Leslie","Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada",NA
"1169","34164973","10.24095/hpcdp.41.10.02","Protecting vulnerable groups from tobacco-related harm during and following the COVID-19 pandemic.","Marginalized populations are being disproportionally affected by the current pandemic. Direct effects include higher infection rates with greater morbidity and mortality; indirect effects stem from the societal response to limit the spread of the virus. These same groups also have smoking rates that are significantly higher than the general population. In this commentary, we discuss how the pandemic has been acting to further increase the harm from tobacco endured by these groups by applying the","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19; health disparities; pandemic; policy; smoking; socioeconomic status; tobacco; tobacco control; vulnerable groups","Selby","Peter","Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada",NA
"1170","34164972","10.24095/hpcdp.41.9.02","Changes in alcohol consumption during the COVID-19 pandemic: exploring gender differences and the role of emotional distress.","Restrictions to do with the COVID-19 pandemic have had substantial unintended consequences on Canadians' alcohol consumption patterns, including increased emotional distress and its potential impact on alcohol use. This study examines 1) changes in adults' alcohol consumption during the COVID-19 pandemic in New Brunswick and Nova Scotia; 2) whether drinking more frequently during the pandemic is associated with increased feelings of stress, loneliness and hopelessness; and 3) whether gender mode","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19 pandemic; alcohol drinking; emotions; gender; self-medication","Thompson","Kara","Department of Psychology, Faculty of Arts, St. Francis Xavier University, Antigonish, Nova Scotia, Canada",NA
"1171","34164972","10.24095/hpcdp.41.9.02","Changes in alcohol consumption during the COVID-19 pandemic: exploring gender differences and the role of emotional distress.","Restrictions to do with the COVID-19 pandemic have had substantial unintended consequences on Canadians' alcohol consumption patterns, including increased emotional distress and its potential impact on alcohol use. This study examines 1) changes in adults' alcohol consumption during the COVID-19 pandemic in New Brunswick and Nova Scotia; 2) whether drinking more frequently during the pandemic is associated with increased feelings of stress, loneliness and hopelessness; and 3) whether gender mode","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19 pandemic; alcohol drinking; emotions; gender; self-medication","Dutton","Daniel J","Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada",NA
"1172","34164972","10.24095/hpcdp.41.9.02","Changes in alcohol consumption during the COVID-19 pandemic: exploring gender differences and the role of emotional distress.","Restrictions to do with the COVID-19 pandemic have had substantial unintended consequences on Canadians' alcohol consumption patterns, including increased emotional distress and its potential impact on alcohol use. This study examines 1) changes in adults' alcohol consumption during the COVID-19 pandemic in New Brunswick and Nova Scotia; 2) whether drinking more frequently during the pandemic is associated with increased feelings of stress, loneliness and hopelessness; and 3) whether gender mode","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19 pandemic; alcohol drinking; emotions; gender; self-medication","MacNabb","Kathleen","Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada",NA
"1173","34164972","10.24095/hpcdp.41.9.02","Changes in alcohol consumption during the COVID-19 pandemic: exploring gender differences and the role of emotional distress.","Restrictions to do with the COVID-19 pandemic have had substantial unintended consequences on Canadians' alcohol consumption patterns, including increased emotional distress and its potential impact on alcohol use. This study examines 1) changes in adults' alcohol consumption during the COVID-19 pandemic in New Brunswick and Nova Scotia; 2) whether drinking more frequently during the pandemic is associated with increased feelings of stress, loneliness and hopelessness; and 3) whether gender mode","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19 pandemic; alcohol drinking; emotions; gender; self-medication","Liu","Tong","Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada",NA
"1174","34164972","10.24095/hpcdp.41.9.02","Changes in alcohol consumption during the COVID-19 pandemic: exploring gender differences and the role of emotional distress.","Restrictions to do with the COVID-19 pandemic have had substantial unintended consequences on Canadians' alcohol consumption patterns, including increased emotional distress and its potential impact on alcohol use. This study examines 1) changes in adults' alcohol consumption during the COVID-19 pandemic in New Brunswick and Nova Scotia; 2) whether drinking more frequently during the pandemic is associated with increased feelings of stress, loneliness and hopelessness; and 3) whether gender mode","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19 pandemic; alcohol drinking; emotions; gender; self-medication","Blades","Sarah","Health Promotion Team, Mental Health and Addictions, IWK Health, Halifax, Nova Scotia, Canada",NA
"1175","34164972","10.24095/hpcdp.41.9.02","Changes in alcohol consumption during the COVID-19 pandemic: exploring gender differences and the role of emotional distress.","Restrictions to do with the COVID-19 pandemic have had substantial unintended consequences on Canadians' alcohol consumption patterns, including increased emotional distress and its potential impact on alcohol use. This study examines 1) changes in adults' alcohol consumption during the COVID-19 pandemic in New Brunswick and Nova Scotia; 2) whether drinking more frequently during the pandemic is associated with increased feelings of stress, loneliness and hopelessness; and 3) whether gender mode","2021","06","24","Health Promot Chronic Dis Prev Can","Health promotion and chronic disease prevention in Canada : research, policy and practice","COVID-19 pandemic; alcohol drinking; emotions; gender; self-medication","Asbridge","Mark","Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada",NA
"1176","34164964","10.3349/ymj.2021.62.7.660","Role of Primary Care and Challenges for Public-Private Cooperation during the Coronavirus Disease 2019 Pandemic: An Expert Delphi Study in South Korea.","The aim of this study was to explore the role of primary care facilities and their support measures in response to coronavirus disease 2019 (COVID-19) and to identify challenges to achieving public-private cooperation in South Korea. Twenty-four leading experts were selected and recruited to participate in this iterative web-based Delphi study. An open-ended questionnaire was administered to collect the expert panel's views in the first round. In the second round, the panel was asked to rate on ","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; Delphi technique; Primary care; pandemics; COVID-19; Delphi Technique; Humans; Pandemics; Primary Health Care; Public-Private Sector Partnerships; Republic of Korea; SARS-CoV-2","Shin","Woo Young","Department of Family Medicine, Chung-Ang University Medical Center, Seoul, Korea",NA
"1177","34164964","10.3349/ymj.2021.62.7.660","Role of Primary Care and Challenges for Public-Private Cooperation during the Coronavirus Disease 2019 Pandemic: An Expert Delphi Study in South Korea.","The aim of this study was to explore the role of primary care facilities and their support measures in response to coronavirus disease 2019 (COVID-19) and to identify challenges to achieving public-private cooperation in South Korea. Twenty-four leading experts were selected and recruited to participate in this iterative web-based Delphi study. An open-ended questionnaire was administered to collect the expert panel's views in the first round. In the second round, the panel was asked to rate on ","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; Delphi technique; Primary care; pandemics; COVID-19; Delphi Technique; Humans; Pandemics; Primary Health Care; Public-Private Sector Partnerships; Republic of Korea; SARS-CoV-2","Kim","Changsoo","Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea",NA
"1178","34164964","10.3349/ymj.2021.62.7.660","Role of Primary Care and Challenges for Public-Private Cooperation during the Coronavirus Disease 2019 Pandemic: An Expert Delphi Study in South Korea.","The aim of this study was to explore the role of primary care facilities and their support measures in response to coronavirus disease 2019 (COVID-19) and to identify challenges to achieving public-private cooperation in South Korea. Twenty-four leading experts were selected and recruited to participate in this iterative web-based Delphi study. An open-ended questionnaire was administered to collect the expert panel's views in the first round. In the second round, the panel was asked to rate on ","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; Delphi technique; Primary care; pandemics; COVID-19; Delphi Technique; Humans; Pandemics; Primary Health Care; Public-Private Sector Partnerships; Republic of Korea; SARS-CoV-2","Lee","Sei Young","Department of Otorhinolaryngology-Head and Neck Surgery, Chung-Ang University College of Medicine, Seoul, Korea",NA
"1179","34164964","10.3349/ymj.2021.62.7.660","Role of Primary Care and Challenges for Public-Private Cooperation during the Coronavirus Disease 2019 Pandemic: An Expert Delphi Study in South Korea.","The aim of this study was to explore the role of primary care facilities and their support measures in response to coronavirus disease 2019 (COVID-19) and to identify challenges to achieving public-private cooperation in South Korea. Twenty-four leading experts were selected and recruited to participate in this iterative web-based Delphi study. An open-ended questionnaire was administered to collect the expert panel's views in the first round. In the second round, the panel was asked to rate on ","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; Delphi technique; Primary care; pandemics; COVID-19; Delphi Technique; Humans; Pandemics; Primary Health Care; Public-Private Sector Partnerships; Republic of Korea; SARS-CoV-2","Lee","Won","Department of Nursing, Chung-Ang University, Seoul, Korea",NA
"1180","34164964","10.3349/ymj.2021.62.7.660","Role of Primary Care and Challenges for Public-Private Cooperation during the Coronavirus Disease 2019 Pandemic: An Expert Delphi Study in South Korea.","The aim of this study was to explore the role of primary care facilities and their support measures in response to coronavirus disease 2019 (COVID-19) and to identify challenges to achieving public-private cooperation in South Korea. Twenty-four leading experts were selected and recruited to participate in this iterative web-based Delphi study. An open-ended questionnaire was administered to collect the expert panel's views in the first round. In the second round, the panel was asked to rate on ","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; Delphi technique; Primary care; pandemics; COVID-19; Delphi Technique; Humans; Pandemics; Primary Health Care; Public-Private Sector Partnerships; Republic of Korea; SARS-CoV-2","Kim","Jung Ha","Department of Family Medicine, Chung-Ang University College of Medicine, Seoul, Korea. girlpower219@cau.ac","girlpower219@cau.ac.kr"
"1181","34164961","10.3349/ymj.2021.62.7.631","Analysis of the Impact of the Coronavirus Disease Epidemic on the Emergency Medical System in South Korea Using the Korean Triage and Acuity Scale.","Severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19), has spread worldwide. Global health systems, including emergency medical systems, are suffering from a lack of medical resources. Using a method for classifying patients visiting the emergency department (ED), we aimed to investigate trends in emergency medical system usage during the COVID-19 epidemic in Korea. This retrospective observational study included patients who visited emergency medical ","2021","06","25","Yonsei Med J","Yonsei medical journal","Coronavirus disease 2019; emergency department; emergency medical system; COVID-19; Emergency Service, Hospital; Epidemics; Humans; Republic of Korea; Retrospective Studies; SARS-CoV-2; Triage","Kim","Sun Ju","Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea",NA
"1182","34164961","10.3349/ymj.2021.62.7.631","Analysis of the Impact of the Coronavirus Disease Epidemic on the Emergency Medical System in South Korea Using the Korean Triage and Acuity Scale.","Severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19), has spread worldwide. Global health systems, including emergency medical systems, are suffering from a lack of medical resources. Using a method for classifying patients visiting the emergency department (ED), we aimed to investigate trends in emergency medical system usage during the COVID-19 epidemic in Korea. This retrospective observational study included patients who visited emergency medical ","2021","06","25","Yonsei Med J","Yonsei medical journal","Coronavirus disease 2019; emergency department; emergency medical system; COVID-19; Emergency Service, Hospital; Epidemics; Humans; Republic of Korea; Retrospective Studies; SARS-CoV-2; Triage","Kim","Hyun","Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea",NA
"1183","34164961","10.3349/ymj.2021.62.7.631","Analysis of the Impact of the Coronavirus Disease Epidemic on the Emergency Medical System in South Korea Using the Korean Triage and Acuity Scale.","Severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19), has spread worldwide. Global health systems, including emergency medical systems, are suffering from a lack of medical resources. Using a method for classifying patients visiting the emergency department (ED), we aimed to investigate trends in emergency medical system usage during the COVID-19 epidemic in Korea. This retrospective observational study included patients who visited emergency medical ","2021","06","25","Yonsei Med J","Yonsei medical journal","Coronavirus disease 2019; emergency department; emergency medical system; COVID-19; Emergency Service, Hospital; Epidemics; Humans; Republic of Korea; Retrospective Studies; SARS-CoV-2; Triage","Park","Yu Hyun","Department of Center of Biomedical Data Science, Yonsei University Wonju College of Medicine, Wonju, Korea",NA
"1184","34164961","10.3349/ymj.2021.62.7.631","Analysis of the Impact of the Coronavirus Disease Epidemic on the Emergency Medical System in South Korea Using the Korean Triage and Acuity Scale.","Severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19), has spread worldwide. Global health systems, including emergency medical systems, are suffering from a lack of medical resources. Using a method for classifying patients visiting the emergency department (ED), we aimed to investigate trends in emergency medical system usage during the COVID-19 epidemic in Korea. This retrospective observational study included patients who visited emergency medical ","2021","06","25","Yonsei Med J","Yonsei medical journal","Coronavirus disease 2019; emergency department; emergency medical system; COVID-19; Emergency Service, Hospital; Epidemics; Humans; Republic of Korea; Retrospective Studies; SARS-CoV-2; Triage","Kang","Chan Young","Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea",NA
"1185","34164961","10.3349/ymj.2021.62.7.631","Analysis of the Impact of the Coronavirus Disease Epidemic on the Emergency Medical System in South Korea Using the Korean Triage and Acuity Scale.","Severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19), has spread worldwide. Global health systems, including emergency medical systems, are suffering from a lack of medical resources. Using a method for classifying patients visiting the emergency department (ED), we aimed to investigate trends in emergency medical system usage during the COVID-19 epidemic in Korea. This retrospective observational study included patients who visited emergency medical ","2021","06","25","Yonsei Med J","Yonsei medical journal","Coronavirus disease 2019; emergency department; emergency medical system; COVID-19; Emergency Service, Hospital; Epidemics; Humans; Republic of Korea; Retrospective Studies; SARS-CoV-2; Triage","Ro","Young Sun","Department of Emergency Medicine, Seoul National University Hospital, Seoul, Korea","ro.youngsun@gmail.com"
"1186","34164961","10.3349/ymj.2021.62.7.631","Analysis of the Impact of the Coronavirus Disease Epidemic on the Emergency Medical System in South Korea Using the Korean Triage and Acuity Scale.","Severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19), has spread worldwide. Global health systems, including emergency medical systems, are suffering from a lack of medical resources. Using a method for classifying patients visiting the emergency department (ED), we aimed to investigate trends in emergency medical system usage during the COVID-19 epidemic in Korea. This retrospective observational study included patients who visited emergency medical ","2021","06","25","Yonsei Med J","Yonsei medical journal","Coronavirus disease 2019; emergency department; emergency medical system; COVID-19; Emergency Service, Hospital; Epidemics; Humans; Republic of Korea; Retrospective Studies; SARS-CoV-2; Triage","Kim","Oh Hyun","Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea. ohkim@yonsei.ac","ohkim@yonsei.ac.kr"
"1187","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Kim","Yoon Jung","Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea",NA
"1188","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Bae","Joon Yong","Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University, Seoul, Korea",NA
"1189","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Bae","Sohyun","Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea",NA
"1190","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Hwang","Soyoon","Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea",NA
"1191","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Kwon","Ki Tae","Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea",NA
"1192","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Chang","Hyun Ha","Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea",NA
"1193","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Lee","Won Kee","Department of Medical Informatics, School of Medicine, Kyungpook National University, Daegu, Korea",NA
"1194","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Cui","Chunguang","Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University, Seoul, Korea",NA
"1195","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Lee","Gee Eun","Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University, Seoul, Korea",NA
"1196","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Kim","Shin Woo","Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea. ksw2kms@knu.ac","ksw2kms@knu.ac.kr"
"1197","34164955","10.3349/ymj.2021.62.7.584","Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.","Neutralizing antibodies (NAbs) have been considered effective in preventing and treating viral infections. However, until now, the duration and clinical implications of antibody-mediated nature immunity in Koreans have remained unknown. Therefore, we examined NAbs levels and clinical characteristics in recovered coronavirus disease 2019 (COVID-19) patients. Blood samples were collected from 143 adult patients who had been diagnosed with and had recovered from COVID-19 from February to March in 2","2021","06","25","Yonsei Med J","Yonsei medical journal","COVID-19; SARS-CoV-2; immunity; neutralization assay; neutralizing antibodies; Adult; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Middle Aged; Republic of Korea; SARS-CoV-2","Park","Man Seong","Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University, Seoul, Korea. ms0392@korea.ac","ms0392@korea.ac.kr"
"1198","34164954","10.3349/ymj.2021.62.7.577","Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea.","We aimed to investigate whether the use of cardiovascular drugs in coronavirus disease 2019 (COVID-19) patients with hypertension as a comorbidity has a significant effect on the incidence and associated mortality rate of COVID-19. Data covering the period between January 1, 2020 and June 4, 2020 were extracted from The National Health Insurance Service-COVID-19 (NHIS-COVID-19) database in South Korea and analyzed as a population-based cohort study. A total of 101657 hypertensive adults aged 20 ","2021","06","25","Yonsei Med J","Yonsei medical journal","Hypertension; aspirin; clopidogrel; cohort studies; viruses; Adult; Antihypertensive Agents; COVID-19; Calcium Channel Blockers; Cohort Studies; Humans; Hypertension; Incidence; Republic of Korea; SARS-CoV-2","Oh","Tak Kyu","Department of Anesthesiology and Pain Medicine Center, Seoul National University Bundang Hospital, Seongnam, Korea",NA
"1199","34164954","10.3349/ymj.2021.62.7.577","Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea.","We aimed to investigate whether the use of cardiovascular drugs in coronavirus disease 2019 (COVID-19) patients with hypertension as a comorbidity has a significant effect on the incidence and associated mortality rate of COVID-19. Data covering the period between January 1, 2020 and June 4, 2020 were extracted from The National Health Insurance Service-COVID-19 (NHIS-COVID-19) database in South Korea and analyzed as a population-based cohort study. A total of 101657 hypertensive adults aged 20 ","2021","06","25","Yonsei Med J","Yonsei medical journal","Hypertension; aspirin; clopidogrel; cohort studies; viruses; Adult; Antihypertensive Agents; COVID-19; Calcium Channel Blockers; Cohort Studies; Humans; Hypertension; Incidence; Republic of Korea; SARS-CoV-2","Cho","Hyoung Won","Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea",NA
"1200","34164954","10.3349/ymj.2021.62.7.577","Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea.","We aimed to investigate whether the use of cardiovascular drugs in coronavirus disease 2019 (COVID-19) patients with hypertension as a comorbidity has a significant effect on the incidence and associated mortality rate of COVID-19. Data covering the period between January 1, 2020 and June 4, 2020 were extracted from The National Health Insurance Service-COVID-19 (NHIS-COVID-19) database in South Korea and analyzed as a population-based cohort study. A total of 101657 hypertensive adults aged 20 ","2021","06","25","Yonsei Med J","Yonsei medical journal","Hypertension; aspirin; clopidogrel; cohort studies; viruses; Adult; Antihypertensive Agents; COVID-19; Calcium Channel Blockers; Cohort Studies; Humans; Hypertension; Incidence; Republic of Korea; SARS-CoV-2","Suh","Jung Won","Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea",NA
"1201","34164954","10.3349/ymj.2021.62.7.577","Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea.","We aimed to investigate whether the use of cardiovascular drugs in coronavirus disease 2019 (COVID-19) patients with hypertension as a comorbidity has a significant effect on the incidence and associated mortality rate of COVID-19. Data covering the period between January 1, 2020 and June 4, 2020 were extracted from The National Health Insurance Service-COVID-19 (NHIS-COVID-19) database in South Korea and analyzed as a population-based cohort study. A total of 101657 hypertensive adults aged 20 ","2021","06","25","Yonsei Med J","Yonsei medical journal","Hypertension; aspirin; clopidogrel; cohort studies; viruses; Adult; Antihypertensive Agents; COVID-19; Calcium Channel Blockers; Cohort Studies; Humans; Hypertension; Incidence; Republic of Korea; SARS-CoV-2","Song","In Ae","Department of Anesthesiology and Pain Medicine Center, Seoul National University Bundang Hospital, Seongnam, Korea. songoficu@outlook","songoficu@outlook.kr"
"1202","34164903","10.1111/hdi.12958","Lung ultrasound may help in the differential diagnosis of suspected oligosymptomatic COVID-19 patients on hemodialysis: A case report.","Considering that patients on dialysis showed a poor outcome during COVID-19 pandemic, and that COVID-19 symptoms in dialysis patients are often mild or absent, each dialysis unit should implement local strategies to early recognize patients affected by COVID-19. However, many available SARS-CoV-2 diagnostic tests demonstrated a moderate sensitivity, 70%-80% is probably a reasonable estimate. Consequently, having useful tools for differential diagnosis becomes essential. In this scenario, lung ul","2021","06","24","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; SARS-CoV-2; dialysis; lung ultrasound","Allinovi","Marco","Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, Italy",NA
"1203","34164903","10.1111/hdi.12958","Lung ultrasound may help in the differential diagnosis of suspected oligosymptomatic COVID-19 patients on hemodialysis: A case report.","Considering that patients on dialysis showed a poor outcome during COVID-19 pandemic, and that COVID-19 symptoms in dialysis patients are often mild or absent, each dialysis unit should implement local strategies to early recognize patients affected by COVID-19. However, many available SARS-CoV-2 diagnostic tests demonstrated a moderate sensitivity, 70%-80% is probably a reasonable estimate. Consequently, having useful tools for differential diagnosis becomes essential. In this scenario, lung ul","2021","06","24","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; SARS-CoV-2; dialysis; lung ultrasound","Laudicina","Selene","Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, Italy",NA
"1204","34164903","10.1111/hdi.12958","Lung ultrasound may help in the differential diagnosis of suspected oligosymptomatic COVID-19 patients on hemodialysis: A case report.","Considering that patients on dialysis showed a poor outcome during COVID-19 pandemic, and that COVID-19 symptoms in dialysis patients are often mild or absent, each dialysis unit should implement local strategies to early recognize patients affected by COVID-19. However, many available SARS-CoV-2 diagnostic tests demonstrated a moderate sensitivity, 70%-80% is probably a reasonable estimate. Consequently, having useful tools for differential diagnosis becomes essential. In this scenario, lung ul","2021","06","24","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; SARS-CoV-2; dialysis; lung ultrasound","Dallari","Lorenzo","Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, Italy",NA
"1205","34164903","10.1111/hdi.12958","Lung ultrasound may help in the differential diagnosis of suspected oligosymptomatic COVID-19 patients on hemodialysis: A case report.","Considering that patients on dialysis showed a poor outcome during COVID-19 pandemic, and that COVID-19 symptoms in dialysis patients are often mild or absent, each dialysis unit should implement local strategies to early recognize patients affected by COVID-19. However, many available SARS-CoV-2 diagnostic tests demonstrated a moderate sensitivity, 70%-80% is probably a reasonable estimate. Consequently, having useful tools for differential diagnosis becomes essential. In this scenario, lung ul","2021","06","24","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; SARS-CoV-2; dialysis; lung ultrasound","Gianassi","Iacopo","Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, Italy",NA
"1206","34164903","10.1111/hdi.12958","Lung ultrasound may help in the differential diagnosis of suspected oligosymptomatic COVID-19 patients on hemodialysis: A case report.","Considering that patients on dialysis showed a poor outcome during COVID-19 pandemic, and that COVID-19 symptoms in dialysis patients are often mild or absent, each dialysis unit should implement local strategies to early recognize patients affected by COVID-19. However, many available SARS-CoV-2 diagnostic tests demonstrated a moderate sensitivity, 70%-80% is probably a reasonable estimate. Consequently, having useful tools for differential diagnosis becomes essential. In this scenario, lung ul","2021","06","24","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; SARS-CoV-2; dialysis; lung ultrasound","Dervishi","Egrina","Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, Italy",NA
"1207","34164903","10.1111/hdi.12958","Lung ultrasound may help in the differential diagnosis of suspected oligosymptomatic COVID-19 patients on hemodialysis: A case report.","Considering that patients on dialysis showed a poor outcome during COVID-19 pandemic, and that COVID-19 symptoms in dialysis patients are often mild or absent, each dialysis unit should implement local strategies to early recognize patients affected by COVID-19. However, many available SARS-CoV-2 diagnostic tests demonstrated a moderate sensitivity, 70%-80% is probably a reasonable estimate. Consequently, having useful tools for differential diagnosis becomes essential. In this scenario, lung ul","2021","06","24","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; SARS-CoV-2; dialysis; lung ultrasound","Biagini","Maria","Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, Italy",NA
"1208","34164903","10.1111/hdi.12958","Lung ultrasound may help in the differential diagnosis of suspected oligosymptomatic COVID-19 patients on hemodialysis: A case report.","Considering that patients on dialysis showed a poor outcome during COVID-19 pandemic, and that COVID-19 symptoms in dialysis patients are often mild or absent, each dialysis unit should implement local strategies to early recognize patients affected by COVID-19. However, many available SARS-CoV-2 diagnostic tests demonstrated a moderate sensitivity, 70%-80% is probably a reasonable estimate. Consequently, having useful tools for differential diagnosis becomes essential. In this scenario, lung ul","2021","06","24","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; SARS-CoV-2; dialysis; lung ultrasound","Cirami","Lino","Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, Italy",NA
"1209","34164877","10.1111/resp.14099","Contemporary Concise Review 2020: Asthma.","Bushfires and coronavirus 2019 (COVID-19) were dominate features of 2020. Patients with asthma were significantly affected by the 2019/2020 bushfire season with an increased burden compared to the general population. Patients with controlled asthma do not appear to be at higher risk of severe COVID-19 infection or death than the general population. Personalized medicine is proposed as the next era for asthma management, with treatable traits as a strategy to implement personalized medicine into ","2021","07","22","Respirology","Respirology (Carlton, Vic.)","asthma; epithelial; microbiota; personalized medicine; treatable traits","Wang","Gang","Department of Respiratory and Critical Care Medicine, Clinical Research Centre for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, China",NA
"1210","34164877","10.1111/resp.14099","Contemporary Concise Review 2020: Asthma.","Bushfires and coronavirus 2019 (COVID-19) were dominate features of 2020. Patients with asthma were significantly affected by the 2019/2020 bushfire season with an increased burden compared to the general population. Patients with controlled asthma do not appear to be at higher risk of severe COVID-19 infection or death than the general population. Personalized medicine is proposed as the next era for asthma management, with treatable traits as a strategy to implement personalized medicine into ","2021","07","22","Respirology","Respirology (Carlton, Vic.)","asthma; epithelial; microbiota; personalized medicine; treatable traits","McDonald","Vanessa M","Priority Research Centre of Healthy Lungs, School of Nursing and Midwifery, The University of Newcastle, New Lambton Heights, New South Wales, Australia",NA
"1211","34164874","10.1111/resp.14107","Letter from Turkey.",NA,"2021","06","24","Respirology","Respirology (Carlton, Vic.)","COVID-19; Turkey; pandemic","Turan","Onur","Chest Diseases Department, Izmir Katip Celebi University Atatürk Research and Training Hospital, Izmir, Turkey",NA
"1212","34164867","10.1002/rmv.2267","Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19.","The rapid propagation of novel human coronavirus 2019 and its emergence as a pandemic raising morbidity calls for taking more appropriate measures for rapid improvement of present diagnostic techniques which are time-consuming, labour-intensive and non-portable. In this scenario, biosensors can be considered as a means to outmatch customary techniques and deliver point-of-care diagnostics for many diseases in a much better way owing to their speed, cost-effectiveness, accuracy, sensitivity and s","2021","06","24","Rev Med Virol","Reviews in medical virology","Covid-19; biosensors; nanobiosensors; nanotechnology; virus","Misra","Ranjita","Centre for Molecular and Nanomedical Sciences, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India",NA
"1213","34164867","10.1002/rmv.2267","Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19.","The rapid propagation of novel human coronavirus 2019 and its emergence as a pandemic raising morbidity calls for taking more appropriate measures for rapid improvement of present diagnostic techniques which are time-consuming, labour-intensive and non-portable. In this scenario, biosensors can be considered as a means to outmatch customary techniques and deliver point-of-care diagnostics for many diseases in a much better way owing to their speed, cost-effectiveness, accuracy, sensitivity and s","2021","06","24","Rev Med Virol","Reviews in medical virology","Covid-19; biosensors; nanobiosensors; nanotechnology; virus","Acharya","Sarbari","Department of Life Science, School of Applied Sciences, Kalinga Institute of Industrial Technology, Bhubaneswar, Odisha, India",NA
"1214","34164867","10.1002/rmv.2267","Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19.","The rapid propagation of novel human coronavirus 2019 and its emergence as a pandemic raising morbidity calls for taking more appropriate measures for rapid improvement of present diagnostic techniques which are time-consuming, labour-intensive and non-portable. In this scenario, biosensors can be considered as a means to outmatch customary techniques and deliver point-of-care diagnostics for many diseases in a much better way owing to their speed, cost-effectiveness, accuracy, sensitivity and s","2021","06","24","Rev Med Virol","Reviews in medical virology","Covid-19; biosensors; nanobiosensors; nanotechnology; virus","Sushmitha","Nehru","Centre for Molecular and Nanomedical Sciences, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India",NA
"1215","34164838","10.1002/sim.9115","Prospective individual patient data meta-analysis: Evaluating convalescent plasma for COVID-19.","As the world faced the devastation of the COVID-19 pandemic in late 2019 and early 2020, numerous clinical trials were initiated in many locations in an effort to establish the efficacy (or lack thereof) of potential treatments. As the pandemic has been shifting locations rapidly, individual studies have been at risk of failing to meet recruitment targets because of declining numbers of eligible patients with COVID-19 encountered at participating sites. It has become clear that it might take sev","2021","06","24","Stat Med","Statistics in medicine","Bayesian data and safety monitoring; International consortium for data sharing from ongoing RCTs; statistical analysis plan; stopping rules","Goldfeld","Keith S","Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA",NA
"1216","34164838","10.1002/sim.9115","Prospective individual patient data meta-analysis: Evaluating convalescent plasma for COVID-19.","As the world faced the devastation of the COVID-19 pandemic in late 2019 and early 2020, numerous clinical trials were initiated in many locations in an effort to establish the efficacy (or lack thereof) of potential treatments. As the pandemic has been shifting locations rapidly, individual studies have been at risk of failing to meet recruitment targets because of declining numbers of eligible patients with COVID-19 encountered at participating sites. It has become clear that it might take sev","2021","06","24","Stat Med","Statistics in medicine","Bayesian data and safety monitoring; International consortium for data sharing from ongoing RCTs; statistical analysis plan; stopping rules","Wu","Danni","Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA",NA
"1217","34164838","10.1002/sim.9115","Prospective individual patient data meta-analysis: Evaluating convalescent plasma for COVID-19.","As the world faced the devastation of the COVID-19 pandemic in late 2019 and early 2020, numerous clinical trials were initiated in many locations in an effort to establish the efficacy (or lack thereof) of potential treatments. As the pandemic has been shifting locations rapidly, individual studies have been at risk of failing to meet recruitment targets because of declining numbers of eligible patients with COVID-19 encountered at participating sites. It has become clear that it might take sev","2021","06","24","Stat Med","Statistics in medicine","Bayesian data and safety monitoring; International consortium for data sharing from ongoing RCTs; statistical analysis plan; stopping rules","Tarpey","Thaddeus","Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA",NA
"1218","34164838","10.1002/sim.9115","Prospective individual patient data meta-analysis: Evaluating convalescent plasma for COVID-19.","As the world faced the devastation of the COVID-19 pandemic in late 2019 and early 2020, numerous clinical trials were initiated in many locations in an effort to establish the efficacy (or lack thereof) of potential treatments. As the pandemic has been shifting locations rapidly, individual studies have been at risk of failing to meet recruitment targets because of declining numbers of eligible patients with COVID-19 encountered at participating sites. It has become clear that it might take sev","2021","06","24","Stat Med","Statistics in medicine","Bayesian data and safety monitoring; International consortium for data sharing from ongoing RCTs; statistical analysis plan; stopping rules","Liu","Mengling","Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA",NA
"1219","34164838","10.1002/sim.9115","Prospective individual patient data meta-analysis: Evaluating convalescent plasma for COVID-19.","As the world faced the devastation of the COVID-19 pandemic in late 2019 and early 2020, numerous clinical trials were initiated in many locations in an effort to establish the efficacy (or lack thereof) of potential treatments. As the pandemic has been shifting locations rapidly, individual studies have been at risk of failing to meet recruitment targets because of declining numbers of eligible patients with COVID-19 encountered at participating sites. It has become clear that it might take sev","2021","06","24","Stat Med","Statistics in medicine","Bayesian data and safety monitoring; International consortium for data sharing from ongoing RCTs; statistical analysis plan; stopping rules","Wu","Yinxiang","Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA",NA
"1220","34164838","10.1002/sim.9115","Prospective individual patient data meta-analysis: Evaluating convalescent plasma for COVID-19.","As the world faced the devastation of the COVID-19 pandemic in late 2019 and early 2020, numerous clinical trials were initiated in many locations in an effort to establish the efficacy (or lack thereof) of potential treatments. As the pandemic has been shifting locations rapidly, individual studies have been at risk of failing to meet recruitment targets because of declining numbers of eligible patients with COVID-19 encountered at participating sites. It has become clear that it might take sev","2021","06","24","Stat Med","Statistics in medicine","Bayesian data and safety monitoring; International consortium for data sharing from ongoing RCTs; statistical analysis plan; stopping rules","Troxel","Andrea B","Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA",NA
"1221","34164838","10.1002/sim.9115","Prospective individual patient data meta-analysis: Evaluating convalescent plasma for COVID-19.","As the world faced the devastation of the COVID-19 pandemic in late 2019 and early 2020, numerous clinical trials were initiated in many locations in an effort to establish the efficacy (or lack thereof) of potential treatments. As the pandemic has been shifting locations rapidly, individual studies have been at risk of failing to meet recruitment targets because of declining numbers of eligible patients with COVID-19 encountered at participating sites. It has become clear that it might take sev","2021","06","24","Stat Med","Statistics in medicine","Bayesian data and safety monitoring; International consortium for data sharing from ongoing RCTs; statistical analysis plan; stopping rules","Petkova","Eva","Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA",NA
"1222","34164811","10.1111/eci.13636","IFN-<U+03B3><sup>+</sup> cell response and IFN-<U+03B3> release concordance after in vitro SARS-CoV-2 stimulation.","Healthcare workers (HCWs) are at increased risk since they are directly exposed to SARS-CoV-2-infected patients, and nevertheless, some remain without the development of anti-SARS-CoV-2 antibodies or related symptoms, suggesting less susceptibility to the infection. This cross-sectional, case-control study aimed to compare SARS-CoV-2 T-cell response by two different technologies, the analysis of IFN-<U+03B3><sup>+</sup> CD8<sup>+</sup> /CD4<sup>+</sup> T cells by flow cytometry and the quantification o","2021","06","24","Eur J Clin Invest","European journal of clinical investigation","COVID-19; SARS-CoV-2; cellular immune response; exposed healthcare workers","Vallejo","Alejandro","Laboratory of Immunovirology, Department of Infectious Diseases, Ramon y Cajal Health Research Institute (IRyCIS), University Hospital Ramon y Cajal, Madrid, Spain",NA
"1223","34164811","10.1111/eci.13636","IFN-<U+03B3><sup>+</sup> cell response and IFN-<U+03B3> release concordance after in vitro SARS-CoV-2 stimulation.","Healthcare workers (HCWs) are at increased risk since they are directly exposed to SARS-CoV-2-infected patients, and nevertheless, some remain without the development of anti-SARS-CoV-2 antibodies or related symptoms, suggesting less susceptibility to the infection. This cross-sectional, case-control study aimed to compare SARS-CoV-2 T-cell response by two different technologies, the analysis of IFN-<U+03B3><sup>+</sup> CD8<sup>+</sup> /CD4<sup>+</sup> T cells by flow cytometry and the quantification o","2021","06","24","Eur J Clin Invest","European journal of clinical investigation","COVID-19; SARS-CoV-2; cellular immune response; exposed healthcare workers","Vizcarra","Pilar","Department of Infectious Diseases, Ramon y Cajal Health Research Institute (IRyCIS), University Hospital Ramon y Cajal, Madrid, Spain",NA
"1224","34164811","10.1111/eci.13636","IFN-<U+03B3><sup>+</sup> cell response and IFN-<U+03B3> release concordance after in vitro SARS-CoV-2 stimulation.","Healthcare workers (HCWs) are at increased risk since they are directly exposed to SARS-CoV-2-infected patients, and nevertheless, some remain without the development of anti-SARS-CoV-2 antibodies or related symptoms, suggesting less susceptibility to the infection. This cross-sectional, case-control study aimed to compare SARS-CoV-2 T-cell response by two different technologies, the analysis of IFN-<U+03B3><sup>+</sup> CD8<sup>+</sup> /CD4<sup>+</sup> T cells by flow cytometry and the quantification o","2021","06","24","Eur J Clin Invest","European journal of clinical investigation","COVID-19; SARS-CoV-2; cellular immune response; exposed healthcare workers","Quereda","Carmen","Department of Infectious Diseases, Ramon y Cajal Health Research Institute (IRyCIS), University Hospital Ramon y Cajal, Madrid, Spain",NA
"1225","34164811","10.1111/eci.13636","IFN-<U+03B3><sup>+</sup> cell response and IFN-<U+03B3> release concordance after in vitro SARS-CoV-2 stimulation.","Healthcare workers (HCWs) are at increased risk since they are directly exposed to SARS-CoV-2-infected patients, and nevertheless, some remain without the development of anti-SARS-CoV-2 antibodies or related symptoms, suggesting less susceptibility to the infection. This cross-sectional, case-control study aimed to compare SARS-CoV-2 T-cell response by two different technologies, the analysis of IFN-<U+03B3><sup>+</sup> CD8<sup>+</sup> /CD4<sup>+</sup> T cells by flow cytometry and the quantification o","2021","06","24","Eur J Clin Invest","European journal of clinical investigation","COVID-19; SARS-CoV-2; cellular immune response; exposed healthcare workers","Moreno","Ana","Department of Infectious Diseases, Ramon y Cajal Health Research Institute (IRyCIS), University Hospital Ramon y Cajal, Madrid, Spain",NA
"1226","34164811","10.1111/eci.13636","IFN-<U+03B3><sup>+</sup> cell response and IFN-<U+03B3> release concordance after in vitro SARS-CoV-2 stimulation.","Healthcare workers (HCWs) are at increased risk since they are directly exposed to SARS-CoV-2-infected patients, and nevertheless, some remain without the development of anti-SARS-CoV-2 antibodies or related symptoms, suggesting less susceptibility to the infection. This cross-sectional, case-control study aimed to compare SARS-CoV-2 T-cell response by two different technologies, the analysis of IFN-<U+03B3><sup>+</sup> CD8<sup>+</sup> /CD4<sup>+</sup> T cells by flow cytometry and the quantification o","2021","06","24","Eur J Clin Invest","European journal of clinical investigation","COVID-19; SARS-CoV-2; cellular immune response; exposed healthcare workers","Casado","José Luis","Department of Infectious Diseases, Ramon y Cajal Health Research Institute (IRyCIS), University Hospital Ramon y Cajal, Madrid, Spain",NA
"1227","34164809","10.1111/avj.13102","Pet ownership and mental health during COVID-19 lockdown.","Owning a pet has often been associated with improved mental health among owners, including enhanced quality of life, and decreased levels of depression and loneliness. The aim of this study was to identify whether owning a cat and/or dog was associated with better psychological wellbeing during a strict lockdown period in Victoria, Australia, during the COVID-19 pandemic. Data were analysed from a large-scale mental health study: the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLA","2021","06","24","Aust Vet J","Australian veterinary journal","cat; dog; loneliness; pandemic; quality of life; resilience","Phillipou","A","Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"1228","34164809","10.1111/avj.13102","Pet ownership and mental health during COVID-19 lockdown.","Owning a pet has often been associated with improved mental health among owners, including enhanced quality of life, and decreased levels of depression and loneliness. The aim of this study was to identify whether owning a cat and/or dog was associated with better psychological wellbeing during a strict lockdown period in Victoria, Australia, during the COVID-19 pandemic. Data were analysed from a large-scale mental health study: the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLA","2021","06","24","Aust Vet J","Australian veterinary journal","cat; dog; loneliness; pandemic; quality of life; resilience","Tan","E J","Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"1229","34164809","10.1111/avj.13102","Pet ownership and mental health during COVID-19 lockdown.","Owning a pet has often been associated with improved mental health among owners, including enhanced quality of life, and decreased levels of depression and loneliness. The aim of this study was to identify whether owning a cat and/or dog was associated with better psychological wellbeing during a strict lockdown period in Victoria, Australia, during the COVID-19 pandemic. Data were analysed from a large-scale mental health study: the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLA","2021","06","24","Aust Vet J","Australian veterinary journal","cat; dog; loneliness; pandemic; quality of life; resilience","Toh","W L","Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"1230","34164809","10.1111/avj.13102","Pet ownership and mental health during COVID-19 lockdown.","Owning a pet has often been associated with improved mental health among owners, including enhanced quality of life, and decreased levels of depression and loneliness. The aim of this study was to identify whether owning a cat and/or dog was associated with better psychological wellbeing during a strict lockdown period in Victoria, Australia, during the COVID-19 pandemic. Data were analysed from a large-scale mental health study: the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLA","2021","06","24","Aust Vet J","Australian veterinary journal","cat; dog; loneliness; pandemic; quality of life; resilience","Van Rheenen","T E","Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"1231","34164809","10.1111/avj.13102","Pet ownership and mental health during COVID-19 lockdown.","Owning a pet has often been associated with improved mental health among owners, including enhanced quality of life, and decreased levels of depression and loneliness. The aim of this study was to identify whether owning a cat and/or dog was associated with better psychological wellbeing during a strict lockdown period in Victoria, Australia, during the COVID-19 pandemic. Data were analysed from a large-scale mental health study: the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLA","2021","06","24","Aust Vet J","Australian veterinary journal","cat; dog; loneliness; pandemic; quality of life; resilience","Meyer","D","Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"1232","34164809","10.1111/avj.13102","Pet ownership and mental health during COVID-19 lockdown.","Owning a pet has often been associated with improved mental health among owners, including enhanced quality of life, and decreased levels of depression and loneliness. The aim of this study was to identify whether owning a cat and/or dog was associated with better psychological wellbeing during a strict lockdown period in Victoria, Australia, during the COVID-19 pandemic. Data were analysed from a large-scale mental health study: the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLA","2021","06","24","Aust Vet J","Australian veterinary journal","cat; dog; loneliness; pandemic; quality of life; resilience","Neill","E","Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"1233","34164809","10.1111/avj.13102","Pet ownership and mental health during COVID-19 lockdown.","Owning a pet has often been associated with improved mental health among owners, including enhanced quality of life, and decreased levels of depression and loneliness. The aim of this study was to identify whether owning a cat and/or dog was associated with better psychological wellbeing during a strict lockdown period in Victoria, Australia, during the COVID-19 pandemic. Data were analysed from a large-scale mental health study: the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLA","2021","06","24","Aust Vet J","Australian veterinary journal","cat; dog; loneliness; pandemic; quality of life; resilience","Sumner","P J","Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"1234","34164809","10.1111/avj.13102","Pet ownership and mental health during COVID-19 lockdown.","Owning a pet has often been associated with improved mental health among owners, including enhanced quality of life, and decreased levels of depression and loneliness. The aim of this study was to identify whether owning a cat and/or dog was associated with better psychological wellbeing during a strict lockdown period in Victoria, Australia, during the COVID-19 pandemic. Data were analysed from a large-scale mental health study: the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLA","2021","06","24","Aust Vet J","Australian veterinary journal","cat; dog; loneliness; pandemic; quality of life; resilience","Rossell","S L","Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"1235","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Calafat","Margalida","Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain",NA
"1236","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","González-Muñoza","Carlos","Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",NA
"1237","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Fortuny","Marta","Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain",NA
"1238","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Roig","Cristina","Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",NA
"1239","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Calm","Anna","Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain",NA
"1240","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Mombiela","Antonio","Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",NA
"1241","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Cañete","Fiorella","Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain",NA
"1242","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Bertoletti","Federico","Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",NA
"1243","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","González-González","Laura","Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain",NA
"1244","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Teller-Martín","Marta","Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",NA
"1245","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Gordillo","Jordi","Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",NA
"1246","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Mañosa","Míriam","Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain",NA
"1247","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Garcia-Planella","Esther","Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",NA
"1248","34164799","10.1007/s40520-021-01917-9","Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.","Older age has been reported as a risk factor for severe SARS-CoV-2 disease (COVID-19). The impact of immunosuppressants (IMS) on COVID-19 is still under debate. To describe the incidence and severity of COVID-19 in elderly patients with inflammatory bowel disease (IBD) in relation to the use of IMS. IBD patients over 65 years of age were selected and grouped in terms of IMS use. Confirmed COVID-19, adherence to IST, comorbidities and concomitant non-IBD-related treatments between 1st of March 20","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Elderly; Immunosuppressants; Inflammatory bowel disease; Thiopurines","Domènech","Eugeni","Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain. eugenidomenech@gmail","eugenidomenech@gmail.com"
"1249","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Goudouris","Ekaterini Simões","IPPMG-Universidade Federal Do Rio de Janeiro (UFRJ), Rua Professor Luis Cantanhede, 77 ap 101, Rio de Janeiro, RJ, 22245-040, Brazil. egoudouris@gmail","egoudouris@gmail.com"
"1250","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Pinto-Mariz","Fernanda","IPPMG-Universidade Federal Do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil",NA
"1251","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Mendonça","Leonardo Oliveira","Clinica Croce and Center for Rare Diseases At ""Hospital 9 de Julho"", Sao Paulo, SP, Brazil",NA
"1252","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Aranda","Carolina Sanchez","Universidade Federal de São Paulo (UNIFESP), Sao Paulo, SP, Brazil",NA
"1253","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Guimarães","Rafaela Rolla","Universidade Federal de São Paulo (UNIFESP), Sao Paulo, SP, Brazil",NA
"1254","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Kokron","Cristina","Division of Clinical Immunology and Allergy-Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), Sao Paulo, SP, Brazil",NA
"1255","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Barros","Myrthes Toledo","Division of Clinical Immunology and Allergy-Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), Sao Paulo, SP, Brazil",NA
"1256","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Anísio","Flávia","Instituto Fernandes Figueira (IFF-Fiocruz), Rio de Janeiro, RJ, Brazil",NA
"1257","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Alonso","Maria Luiza Oliva","Serviço de Imunologia, Hospital Universitário Clementino Fraga Filho (HUCFF-UFRJ), Rio de Janeiro, RJ, Brazil",NA
"1258","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Marcelino","Fernanda","Departamento de Alergia E Imunologia-Hospital Regional da Asa Norte (HRAN), Brasília, DF, Brazil",NA
"1259","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Valle","Solange Oliveira Rodrigues","Serviço de Imunologia, Hospital Universitário Clementino Fraga Filho (HUCFF-UFRJ), Rio de Janeiro, RJ, Brazil",NA
"1260","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Junior","Sergio Dortas","Serviço de Imunologia, Hospital Universitário Clementino Fraga Filho (HUCFF-UFRJ), Rio de Janeiro, RJ, Brazil",NA
"1261","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Barreto","Irma Douglas Paes","Universidade Estadual Do Pará, Belem, PA, Brazil",NA
"1262","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Ferreira","Janáira Fernandes Severo","Hospital Infantil Albert Sabin/Universidade Estadual Do Ceará, Fortaleza, CE, Brazil",NA
"1263","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Roxo-Junior","Pérsio","Serviço de Alergia E Imunologia Pediátrica Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP RP), Ribeirao Preto, SP, Brazil",NA
"1264","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","do Rego Silva","Almerinda Maria","Universidade Federal de Pernambuco, Recife, PE, Brazil",NA
"1265","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Campinhos","Fernanda Lugão","Asthma, Allergy and Immunology Reference Center, Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória, Vitoria, ES, Brazil",NA
"1266","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Bonfim","Carmem","Pediatric Bone Marrow Transplantation Unit, Hospital Pequeno Príncipe, Curitiba, PR, Brazil",NA
"1267","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Loth","Gisele","Pediatric Bone Marrow Transplantation Unit, Hospital de Clinicas, Universidade Federal do Parana, Curitiba, PR, Brazil",NA
"1268","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Fernandes","Juliana Folloni","Instituto Do Tratamento Do Cancer Infantil Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (USP) and Hospital Israelita Albert Einstein, São Paulo, SP, Brazil",NA
"1269","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Garcia","Julia Lopes","Instituto Do Tratamento Do Cancer Infantil Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (USP) and Hospital Israelita Albert Einstein, São Paulo, SP, Brazil",NA
"1270","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Capelo","Albertina","Universidade Federal Do Estado Do Rio de Janeiro (UNIRIO), Rio de Janeiro, RJ, Brazil",NA
"1271","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Takano","Olga Akiko","Hospital Universitário Júlio Müller, Universidade Federal Do Mato Grosso (UFMT), Cuiaba, MT, Brazil",NA
"1272","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Nadaf","Maria Isabel Valdomir","Hospital Universitário Júlio Müller, Universidade Federal Do Mato Grosso (UFMT), Cuiaba, MT, Brazil",NA
"1273","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Toledo","Eliana C","Division of Allergy and Clinical Immunology, FAMERP, Faculdade de Medicina de São José Do Rio Preto , São José Do Rio Preto, SP, Brazil",NA
"1274","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Cunha","Luciana Araújo Oliveira","Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil",NA
"1275","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Di Gesu","Regina Sumiko Watanabe","Division of Allergy and Clinical Immunology, Department of Pediatrics, Hospital Criança Conceição, Porto Alegre, RS, Brazil",NA
"1276","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Schidlowski","Laire","Faculdades Pequeno Príncipe, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, PR, Brasil",NA
"1277","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Fillipo","Priscila","Hospital Municipal Jesus, Rio de Janeiro, RJ, Brazil",NA
"1278","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Bichuetti-Silva","Daniélli C","Universidade Federal de Goias (UFG), Goiânia, GO, Brazil",NA
"1279","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Soldateli","Gustavo","Hospital Infantil Joana de Gusmão, Florianópolis, SC, Brazil",NA
"1280","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Ferraroni","Natasha Rebouças","Clínica Ferraroni, Brasília, DF, Brazil",NA
"1281","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","de Oliveira Dantas","Ellen","Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil",NA
"1282","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Pestana","Simone","Universidade Federal Fluminense (UFF), Rio de Janeiro, RJ, Brazil",NA
"1283","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Mansour","Eli","Alergia E Imunologia, Departamento de Clínica Médica, Universidade de Campinas (UNICAMP), Campinas, SP, Brazil",NA
"1284","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Ulaf","Raisa Gusso","Alergia E Imunologia, Departamento de Clínica Médica, Universidade de Campinas (UNICAMP), Campinas, SP, Brazil",NA
"1285","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Prando","Carolina","Hospital Pequeno Príncipe, Curitiba, Brazil",NA
"1286","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Condino-Neto","Antonio","Department of Immunology, Institute of Biomedical Sciences, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil",NA
"1287","34164762","10.1007/s10875-021-01066-8","Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.","There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of SARS-CoV-2 infection in Brazilian IEI patients and identify factors influencing the infection. We did a cross-sectional, multicenter study that included patients of any age affected by IEI and SARS-CoV-2 infection. The variables studied were sex, age, type of IEI, comorbidities (number and type), treatment in use for IEI, ","2021","06","26","J Clin Immunol","Journal of clinical immunology","COVID-19; Coronavirus; Immunodeficiency; Inborn errors of immunity; Primary immunodeficiency; SARS-CoV-2","Grumach","Anete Sevciovic","Faculdade de Medicina, Centro Universitario Saude ABC, Santo Andre, SP, Brazil",NA
"1288","34164740","10.1007/s00520-021-06369-5","Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic.","The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions. Three hundred and ninety-four respondents volunteered their participation in response to a study advertisement","2021","06","26","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","COVID-19 pandemic; Haematology patients; Psycho-oncology; Psychological distress; Supportive care","Zomerdijk","Nienke","Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, 3000, Australia. nienke.zomerdijk@unimelb.edu","nienke.zomerdijk@unimelb.edu.au"
"1289","34164740","10.1007/s00520-021-06369-5","Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic.","The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions. Three hundred and ninety-four respondents volunteered their participation in response to a study advertisement","2021","06","26","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","COVID-19 pandemic; Haematology patients; Psycho-oncology; Psychological distress; Supportive care","Jongenelis","Michelle","Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, 3000, Australia",NA
"1290","34164740","10.1007/s00520-021-06369-5","Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic.","The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions. Three hundred and ninety-four respondents volunteered their participation in response to a study advertisement","2021","06","26","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","COVID-19 pandemic; Haematology patients; Psycho-oncology; Psychological distress; Supportive care","Short","Camille E","Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, 3000, Australia",NA
"1291","34164740","10.1007/s00520-021-06369-5","Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic.","The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions. Three hundred and ninety-four respondents volunteered their participation in response to a study advertisement","2021","06","26","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","COVID-19 pandemic; Haematology patients; Psycho-oncology; Psychological distress; Supportive care","Smith","Andrew","Leukaemia Foundation, Brisbane, QLD, Australia",NA
"1292","34164740","10.1007/s00520-021-06369-5","Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic.","The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions. Three hundred and ninety-four respondents volunteered their participation in response to a study advertisement","2021","06","26","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","COVID-19 pandemic; Haematology patients; Psycho-oncology; Psychological distress; Supportive care","Turner","Jane","Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia",NA
"1293","34164740","10.1007/s00520-021-06369-5","Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic.","The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions. Three hundred and ninety-four respondents volunteered their participation in response to a study advertisement","2021","06","26","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","COVID-19 pandemic; Haematology patients; Psycho-oncology; Psychological distress; Supportive care","Huntley","Kathryn","Leukaemia Foundation, Brisbane, QLD, Australia",NA
"1294","34164727","10.1007/s00259-021-05468-z","Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?",NA,"2021","06","26","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Immuno-oncology; RNA vaccination; [18F]-FDG PET/CT","Seban","Romain-David","Department of Nuclear Medicine, Institut Curie, 92210, Saint-Cloud, France. romain.seban@gmail","romain.seban@gmail.com"
"1295","34164727","10.1007/s00259-021-05468-z","Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?",NA,"2021","06","26","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Immuno-oncology; RNA vaccination; [18F]-FDG PET/CT","Champion","Laurence","Department of Nuclear Medicine, Institut Curie, 92210, Saint-Cloud, France",NA
"1296","34164727","10.1007/s00259-021-05468-z","Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?",NA,"2021","06","26","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Immuno-oncology; RNA vaccination; [18F]-FDG PET/CT","Yeh","Randy","Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"1297","34164727","10.1007/s00259-021-05468-z","Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?",NA,"2021","06","26","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Immuno-oncology; RNA vaccination; [18F]-FDG PET/CT","Schwartz","Lawrence H","Department of Radiology, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA",NA
"1298","34164727","10.1007/s00259-021-05468-z","Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?",NA,"2021","06","26","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Immuno-oncology; RNA vaccination; [18F]-FDG PET/CT","Dercle","Laurent","Department of Radiology, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA",NA
"1299","34164684","10.1093/pubmed/fdab247","COVID-19 infodemic: the role of social media and other digital platforms.",NA,"2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Lacsa","Jose Eric M","Theology and Religious Education Department, De La Salle University, 2401 Taft Avenue, Manila 1004, Philippines",NA
"1300","34164680","10.1093/pubmed/fdab215","New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.","Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept' and 'non-inferiority' against PCR. We are calling this method, Dognosis (DN). Four hundred and fifty-nine subjects were included, 256 (Group 'P') were known cases of COVID-19 (PCR positive, some with and some without symptoms) and 203 (Group 'C') were PCR negative and asymptomatic (contr","2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; PCR; airport; axillary sweat; sniffer dogs","Sarkis","Riad","Faculty of Medicine, Hotel Dieu de France Hospital, University of Saint Joseph, 17-5208 Beirut, Lebanon",NA
"1301","34164680","10.1093/pubmed/fdab215","New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.","Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept' and 'non-inferiority' against PCR. We are calling this method, Dognosis (DN). Four hundred and fifty-nine subjects were included, 256 (Group 'P') were known cases of COVID-19 (PCR positive, some with and some without symptoms) and 203 (Group 'C') were PCR negative and asymptomatic (contr","2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; PCR; airport; axillary sweat; sniffer dogs","Lichaa","Anthony","Faculty of Medicine, Hotel Dieu de France Hospital, University of Saint Joseph, 17-5208 Beirut, Lebanon",NA
"1302","34164680","10.1093/pubmed/fdab215","New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.","Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept' and 'non-inferiority' against PCR. We are calling this method, Dognosis (DN). Four hundred and fifty-nine subjects were included, 256 (Group 'P') were known cases of COVID-19 (PCR positive, some with and some without symptoms) and 203 (Group 'C') were PCR negative and asymptomatic (contr","2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; PCR; airport; axillary sweat; sniffer dogs","Mjaess","Georges","Faculty of Medicine, Hotel Dieu de France Hospital, University of Saint Joseph, 17-5208 Beirut, Lebanon",NA
"1303","34164680","10.1093/pubmed/fdab215","New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.","Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept' and 'non-inferiority' against PCR. We are calling this method, Dognosis (DN). Four hundred and fifty-nine subjects were included, 256 (Group 'P') were known cases of COVID-19 (PCR positive, some with and some without symptoms) and 203 (Group 'C') were PCR negative and asymptomatic (contr","2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; PCR; airport; axillary sweat; sniffer dogs","Saliba","Michele","Faculty of Medicine, Rafiq Hariri Hospital, Lebanese University, 65-7314 Beirut, Lebanon",NA
"1304","34164680","10.1093/pubmed/fdab215","New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.","Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept' and 'non-inferiority' against PCR. We are calling this method, Dognosis (DN). Four hundred and fifty-nine subjects were included, 256 (Group 'P') were known cases of COVID-19 (PCR positive, some with and some without symptoms) and 203 (Group 'C') were PCR negative and asymptomatic (contr","2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; PCR; airport; axillary sweat; sniffer dogs","Selman","Carlo","Faculty of Medicine, Hotel Dieu de France Hospital, University of Saint Joseph, 17-5208 Beirut, Lebanon",NA
"1305","34164680","10.1093/pubmed/fdab215","New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.","Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept' and 'non-inferiority' against PCR. We are calling this method, Dognosis (DN). Four hundred and fifty-nine subjects were included, 256 (Group 'P') were known cases of COVID-19 (PCR positive, some with and some without symptoms) and 203 (Group 'C') were PCR negative and asymptomatic (contr","2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; PCR; airport; axillary sweat; sniffer dogs","Lecoq-Julien","Clothilde","National Veterinary School of Alfort, Paris 94704, France",NA
"1306","34164680","10.1093/pubmed/fdab215","New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.","Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept' and 'non-inferiority' against PCR. We are calling this method, Dognosis (DN). Four hundred and fifty-nine subjects were included, 256 (Group 'P') were known cases of COVID-19 (PCR positive, some with and some without symptoms) and 203 (Group 'C') were PCR negative and asymptomatic (contr","2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; PCR; airport; axillary sweat; sniffer dogs","Grandjean","Dominique","National Veterinary School of Alfort, Paris 94704, France",NA
"1307","34164680","10.1093/pubmed/fdab215","New method of screening for COVID-19 disease using sniffer dogs and scents from axillary sweat samples.","Early screening for COVID-19 is needed to limit the spread of the virus. The aim of this study is to test if the sniffer dogs can be successfully trained to identify subjects with COVID-19 for 'proof of concept' and 'non-inferiority' against PCR. We are calling this method, Dognosis (DN). Four hundred and fifty-nine subjects were included, 256 (Group 'P') were known cases of COVID-19 (PCR positive, some with and some without symptoms) and 203 (Group 'C') were PCR negative and asymptomatic (contr","2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; PCR; airport; axillary sweat; sniffer dogs","Jabbour","Nabil M","Vitreous &amp",NA
"1308","34164670","10.1093/pubmed/fdab245","Waiver of Intellectual Property Rights on COVID-19 vaccine roll out.",NA,"2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Cabatbat","Katherine Pia M","De La Salle University, Theology and Religious Education Department, Manila 1004, Philippines",NA
"1309","34164669","10.1093/pubmed/fdab234","Who is the 'pasaway'? Duterte's pandemic (COVID-19) blame game narrative.",NA,"2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Lacsa","Jose Eric M","Theology and Religious Education Department, De La Salle University, 2401 Taft Avenue, Manila, Philippines",NA
"1310","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Miró","Òscar","Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel 170, Barcelona 08036, Catalonia, Spain",NA
"1311","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Jiménez","Sònia","Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel 170, Barcelona 08036, Catalonia, Spain",NA
"1312","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Mebazaa","Alexandre","Department of Anesthesiology, Burn and Critical Care, University Hospitals Saint-Louis-Lariboisière, AP-HP Rue Ambroise Paré, 75010 Paris, France",NA
"1313","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Freund","Yonathan","Emergency Department, HôpitalPitié-Salpêtrière, Assistance Publique-Hôpitaux 18 de Paris (APHP), Sorbonne Université, 47-83 Boulevard de l'Hôpital, 75013 Paris, France",NA
"1314","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Burillo-Putze","Guillermo","Emergency Department, Hospital Universitario de Canarias, Carretera Ofra S/N, 38320 San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain",NA
"1315","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Martín","Alfonso","Emergency Department, Hospital Severo Ochoa, M-402, 8, 28914 Leganés, Madrid, Spain",NA
"1316","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Martín-Sánchez","Francisco Javier","Emergency Department, Hospital Clínico San Carlos, IDISSC, UnivesdadComplutenseCalle del Prof Martín Lagos, s/n, 28040 Madrid, Spain",NA
"1317","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","García-Lamberechts","Eric Jorge","Emergency Department, Hospital Clínico San Carlos, IDISSC, UnivesdadComplutenseCalle del Prof Martín Lagos, s/n, 28040 Madrid, Spain",NA
"1318","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Alquézar-Arbé","Aitor","Emergency Department, Hospital de la Santa Creu I Sant Pau, Carrer de Sant Quintí, 89, 08041 Barcelona, Spain",NA
"1319","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Jacob","Javier","Emergency Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain",NA
"1320","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Llorens","Pere","Emergency Department, Hospital General de Alicante, University Miguel Hernández, Calle Pintor Baeza, 11, 03010 Alicante, Spain",NA
"1321","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Piñera","Pascual","Emergency Department, Hospital General Universitario Reina Sofía. Av. Intendente Jorge Palacios, 1, 30003 Murcia, Spain",NA
"1322","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Gil","Víctor","Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel 170, Barcelona 08036, Catalonia, Spain",NA
"1323","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Guardiola","Josep","Emergency Department, Hospital de la Santa Creu I Sant Pau, Carrer de Sant Quintí, 89, 08041 Barcelona, Spain",NA
"1324","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Cardozo","Carlos","Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel 170, Barcelona 08036, Catalonia, Spain",NA
"1325","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Mòdol Deltell","Josep Maria","Emergency Department, Hospital Universitari Germans Trias i Pujol de Badalona, Carretera de Canyet, s/n, 08916 Badalona, Barcelona, Spain",NA
"1326","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Tost","Josep","Emergency Department, Hospital de Terrassa, Carretera Torrebonica, s/n, 08227 Terrassa, Barcelona, Spain",NA
"1327","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Aguirre Tejedo","Alfons","Emergency Department, Hospital del Mar, Passeig Marítim de la Barceloneta, 25, 29, 08003 Barcelona, Spain",NA
"1328","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Palau-Vendrell","Anna","Emergency Department, Hospital Universitari Joan XXIII, Carrer Dr. Mallafrè Guasch, 4, 43005 Tarragona, Spain",NA
"1329","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","LLauger García","Lluís","Emergency Department, Hospital Universitari de Vic, Carrer de Francesc Pla el Vigatà, 1, 08500 Vic Barcelona, Spain",NA
"1330","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Adroher Muñoz","Maria","Emergency Department, Hospital Universitari de Girona Dr JosepTrueta, Avinguda de França, S/N, 17007 Girona, Spain",NA
"1331","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Del Arco Galán","Carmen","Emergency Department, Hospital Universitario de la Princesa, Calle de Diego de León, 62, 28006 Madrid, Spain",NA
"1332","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Agudo Villa","Teresa","Emergency Department, Hospital Universitario Severo Ochoa, M-402, 8, 28914 Leganés, Madrid, Spain",NA
"1333","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","López-Laguna","Nieves","Emergency Department, Clínica Universidad Navarra, Calle Marquesado de Sta. Marta, 1, 28027 Madrid, Spain",NA
"1334","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","López Díez","María Pilar","Emergency Department, Hospital Universitario de Burgos. Av. Islas Baleares, 3, 09006 Burgos, Spain",NA
"1335","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Beddar Chaib","Fahd","Emergency Department, Complejo Asistencial de Soria, Paseo Sta. Bárbara, 42005 Soria, Spain",NA
"1336","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Quero Motto","Eva","Emergency Department, Hospital Clínico Universitario Virgen de la Arrixaca, Ctra. Madrid-Cartagena, s/n, 30120 El Palmar, Murcia, Spain",NA
"1337","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","González Tejera","Matilde","Emergency Department, Hospital General Universitario de Elche. Carrer Almazara, 11, 03203 Elche, Alicante, Spain",NA
"1338","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","Ponce","María Carmen","Emergency Department, Hospital de la Vega Baja Orihuela. Carretera Orihuela - Almoradí, S/N, Orihuela, Alicante, Spain",NA
"1339","34164664","10.1093/eurheartj/ehab314","Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.","We investigated the incidence, risk factors, clinical characteristics, and outcomes of pulmonary embolism (PE) in patients with COVID-19 attending emergency departments (EDs), before hospitalization. We retrospectively reviewed all COVID-19 patients diagnosed with PE in 62 Spanish EDs (20% of Spanish EDs, case group) during the first COVID-19 outbreak. COVID-19 patients without PE and non-COVID-19 patients with PE were included as control groups. Adjusted comparisons for baseline characteristics","2021","07","13","Eur Heart J","European heart journal","COVID-19; Clinical characteristics; Incidence; Outcome; Pulmonary embolism; Risk factors; SARS-CoV-2","González Del Castillo","Juan","Emergency Department, Hospital Clínico San Carlos, IDISSC, UnivesdadComplutenseCalle del Prof Martín Lagos, s/n, 28040 Madrid, Spain",NA
"1340","34164656","10.1093/pubmed/fdab243","Self-actualization through religious coping is needed in the time of COVID-19 pandemic.",NA,"2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Cabatbat","Katherine Pia M","De La Salle University, Theology and Religious Education Department, 2401 Taft Ave, Malate, Manila, 1004, Philippines",NA
"1341","34164656","10.1093/pubmed/fdab243","Self-actualization through religious coping is needed in the time of COVID-19 pandemic.",NA,"2021","06","24","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Camarines","Teresa M","De La Salle University, Theology and Religious Education Department, 2401 Taft Ave, Malate, Manila, 1004, Philippines",NA
"1342","34164619","10.3389/fspor.2021.637516","Changes in Training, Lifestyle, Psychological and Demographic Factors, and Associations With Running-Related Injuries During COVID-19.","The primary purpose of this study was to examine how the type and magnitude of changes in running behavior, as a consequence of COVID-19 pandemic restrictions, influence running-related injuries. Secondarily, we aimed to examine how lifestyle and psychosocial well-being measures may influence running behavior change. An online survey was advertised to individuals over the age of 18 that currently run or have previously participated in running for exercise. The survey questions examined injury hi","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; cross-country (XC); environment; injury; intensity; surface; track and field","Holmes","Hillary H","School of Kinesiology, Auburn University, Auburn, AL, United States",NA
"1343","34164619","10.3389/fspor.2021.637516","Changes in Training, Lifestyle, Psychological and Demographic Factors, and Associations With Running-Related Injuries During COVID-19.","The primary purpose of this study was to examine how the type and magnitude of changes in running behavior, as a consequence of COVID-19 pandemic restrictions, influence running-related injuries. Secondarily, we aimed to examine how lifestyle and psychosocial well-being measures may influence running behavior change. An online survey was advertised to individuals over the age of 18 that currently run or have previously participated in running for exercise. The survey questions examined injury hi","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; cross-country (XC); environment; injury; intensity; surface; track and field","Monaghan","Patrick G","School of Kinesiology, Auburn University, Auburn, AL, United States",NA
"1344","34164619","10.3389/fspor.2021.637516","Changes in Training, Lifestyle, Psychological and Demographic Factors, and Associations With Running-Related Injuries During COVID-19.","The primary purpose of this study was to examine how the type and magnitude of changes in running behavior, as a consequence of COVID-19 pandemic restrictions, influence running-related injuries. Secondarily, we aimed to examine how lifestyle and psychosocial well-being measures may influence running behavior change. An online survey was advertised to individuals over the age of 18 that currently run or have previously participated in running for exercise. The survey questions examined injury hi","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; cross-country (XC); environment; injury; intensity; surface; track and field","Strunk","Kamden K","Department of Educational Foundations, Leadership and Technology, Auburn University, Auburn, AL, United States",NA
"1345","34164619","10.3389/fspor.2021.637516","Changes in Training, Lifestyle, Psychological and Demographic Factors, and Associations With Running-Related Injuries During COVID-19.","The primary purpose of this study was to examine how the type and magnitude of changes in running behavior, as a consequence of COVID-19 pandemic restrictions, influence running-related injuries. Secondarily, we aimed to examine how lifestyle and psychosocial well-being measures may influence running behavior change. An online survey was advertised to individuals over the age of 18 that currently run or have previously participated in running for exercise. The survey questions examined injury hi","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; cross-country (XC); environment; injury; intensity; surface; track and field","Paquette","Max R","College of Health Sciences, University of Memphis, Memphis, TN, United States",NA
"1346","34164619","10.3389/fspor.2021.637516","Changes in Training, Lifestyle, Psychological and Demographic Factors, and Associations With Running-Related Injuries During COVID-19.","The primary purpose of this study was to examine how the type and magnitude of changes in running behavior, as a consequence of COVID-19 pandemic restrictions, influence running-related injuries. Secondarily, we aimed to examine how lifestyle and psychosocial well-being measures may influence running behavior change. An online survey was advertised to individuals over the age of 18 that currently run or have previously participated in running for exercise. The survey questions examined injury hi","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; cross-country (XC); environment; injury; intensity; surface; track and field","Roper","Jaimie A","School of Kinesiology, Auburn University, Auburn, AL, United States",NA
"1347","34164618","10.3389/fspor.2021.589459","What Will We Do? The Action Plan From a Brazilian Professional Football Club Youth Academy Facing the COVID-19 Pandemic.","In 2020, the world was affected by the COVID-19 pandemic, which remains a major challenge for most countries today. In Brazil, football clubs' youth academies have faced a disruption of their regular activities. In order to study how the learning cultures of a Brazilian professional football club youth academy have been changed, and the alternatives created by the club's staff within this context, this perspective article aims to analyze how they have structured the Under-15 (U15) team learning ","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; action plan; football; learning cultures; social inclusion; sport career; youth academy","Morbi","Murilo Dos Reis","School of Physical Education and Sport of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil",NA
"1348","34164618","10.3389/fspor.2021.589459","What Will We Do? The Action Plan From a Brazilian Professional Football Club Youth Academy Facing the COVID-19 Pandemic.","In 2020, the world was affected by the COVID-19 pandemic, which remains a major challenge for most countries today. In Brazil, football clubs' youth academies have faced a disruption of their regular activities. In order to study how the learning cultures of a Brazilian professional football club youth academy have been changed, and the alternatives created by the club's staff within this context, this perspective article aims to analyze how they have structured the Under-15 (U15) team learning ","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; action plan; football; learning cultures; social inclusion; sport career; youth academy","Kopanakis","Annie Rangel","Pontifical Catholic University of Campinas, Campinas, Brazil",NA
"1349","34164618","10.3389/fspor.2021.589459","What Will We Do? The Action Plan From a Brazilian Professional Football Club Youth Academy Facing the COVID-19 Pandemic.","In 2020, the world was affected by the COVID-19 pandemic, which remains a major challenge for most countries today. In Brazil, football clubs' youth academies have faced a disruption of their regular activities. In order to study how the learning cultures of a Brazilian professional football club youth academy have been changed, and the alternatives created by the club's staff within this context, this perspective article aims to analyze how they have structured the Under-15 (U15) team learning ","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; action plan; football; learning cultures; social inclusion; sport career; youth academy","Mateu","Pau","Institut Nacional d'Educació Física de Catalunya, Universitat de Barcelona, Barcelona, Spain",NA
"1350","34164618","10.3389/fspor.2021.589459","What Will We Do? The Action Plan From a Brazilian Professional Football Club Youth Academy Facing the COVID-19 Pandemic.","In 2020, the world was affected by the COVID-19 pandemic, which remains a major challenge for most countries today. In Brazil, football clubs' youth academies have faced a disruption of their regular activities. In order to study how the learning cultures of a Brazilian professional football club youth academy have been changed, and the alternatives created by the club's staff within this context, this perspective article aims to analyze how they have structured the Under-15 (U15) team learning ","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; action plan; football; learning cultures; social inclusion; sport career; youth academy","Graeff","Billy","Federal University of Rio Grande, Rio Grande, Brazil",NA
"1351","34164618","10.3389/fspor.2021.589459","What Will We Do? The Action Plan From a Brazilian Professional Football Club Youth Academy Facing the COVID-19 Pandemic.","In 2020, the world was affected by the COVID-19 pandemic, which remains a major challenge for most countries today. In Brazil, football clubs' youth academies have faced a disruption of their regular activities. In order to study how the learning cultures of a Brazilian professional football club youth academy have been changed, and the alternatives created by the club's staff within this context, this perspective article aims to analyze how they have structured the Under-15 (U15) team learning ","2021","06","25","Front Sports Act Living","Frontiers in sports and active living","COVID-19; action plan; football; learning cultures; social inclusion; sport career; youth academy","Marques","Renato Francisco Rodrigues","School of Physical Education and Sport of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil",NA
"1352","34164593","10.1177/2473974X211018612","Patterns of Technology Use Among Patients With Head and Neck Cancer and Implications for Telehealth.","To describe baseline technology use within the head and neck cancer (HNC) population prior to the COVID-19 pandemic. Cross-sectional analysis of National Health Interview Survey (NHIS) data. The NHIS is a survey of population health administered in person annually to a nationally representative sample of noninstitutionalized US residents via a complex clustered sampling design. Data regarding technology use, cancer history, and demographics were extracted from the NHIS. The study population comp","2021","06","25","OTO Open","OTO open","COVID-19; coronavirus; disparities; head and neck cancer; health disparities; socioeconomic; technology; telehealth; telemedicine","Warinner","Chloe B","Harvard Medical School, Boston, Massachusetts, USA",NA
"1353","34164593","10.1177/2473974X211018612","Patterns of Technology Use Among Patients With Head and Neck Cancer and Implications for Telehealth.","To describe baseline technology use within the head and neck cancer (HNC) population prior to the COVID-19 pandemic. Cross-sectional analysis of National Health Interview Survey (NHIS) data. The NHIS is a survey of population health administered in person annually to a nationally representative sample of noninstitutionalized US residents via a complex clustered sampling design. Data regarding technology use, cancer history, and demographics were extracted from the NHIS. The study population comp","2021","06","25","OTO Open","OTO open","COVID-19; coronavirus; disparities; head and neck cancer; health disparities; socioeconomic; technology; telehealth; telemedicine","Hayirli","Tuna C","Harvard Medical School, Boston, Massachusetts, USA",NA
"1354","34164593","10.1177/2473974X211018612","Patterns of Technology Use Among Patients With Head and Neck Cancer and Implications for Telehealth.","To describe baseline technology use within the head and neck cancer (HNC) population prior to the COVID-19 pandemic. Cross-sectional analysis of National Health Interview Survey (NHIS) data. The NHIS is a survey of population health administered in person annually to a nationally representative sample of noninstitutionalized US residents via a complex clustered sampling design. Data regarding technology use, cancer history, and demographics were extracted from the NHIS. The study population comp","2021","06","25","OTO Open","OTO open","COVID-19; coronavirus; disparities; head and neck cancer; health disparities; socioeconomic; technology; telehealth; telemedicine","Bergmark","Regan W","Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA",NA
"1355","34164593","10.1177/2473974X211018612","Patterns of Technology Use Among Patients With Head and Neck Cancer and Implications for Telehealth.","To describe baseline technology use within the head and neck cancer (HNC) population prior to the COVID-19 pandemic. Cross-sectional analysis of National Health Interview Survey (NHIS) data. The NHIS is a survey of population health administered in person annually to a nationally representative sample of noninstitutionalized US residents via a complex clustered sampling design. Data regarding technology use, cancer history, and demographics were extracted from the NHIS. The study population comp","2021","06","25","OTO Open","OTO open","COVID-19; coronavirus; disparities; head and neck cancer; health disparities; socioeconomic; technology; telehealth; telemedicine","Sethi","Rosh","Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA",NA
"1356","34164593","10.1177/2473974X211018612","Patterns of Technology Use Among Patients With Head and Neck Cancer and Implications for Telehealth.","To describe baseline technology use within the head and neck cancer (HNC) population prior to the COVID-19 pandemic. Cross-sectional analysis of National Health Interview Survey (NHIS) data. The NHIS is a survey of population health administered in person annually to a nationally representative sample of noninstitutionalized US residents via a complex clustered sampling design. Data regarding technology use, cancer history, and demographics were extracted from the NHIS. The study population comp","2021","06","25","OTO Open","OTO open","COVID-19; coronavirus; disparities; head and neck cancer; health disparities; socioeconomic; technology; telehealth; telemedicine","Rettig","Eleni M","Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA",NA
"1357","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Uchiyama","Yuki","Department of Rehabilitation Medicine, Hyogo College of Medicine, Nishinomiya, Japan",NA
"1358","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Sasanuma","Naoki","Department of Rehabilitation, Hyogo College of Medicine College Hospital, Nishinomiya, Japan",NA
"1359","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Nanto","Tomoki","Department of Rehabilitation, Hyogo College of Medicine College Hospital, Nishinomiya, Japan",NA
"1360","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Fujita","Kouhei","Department of Rehabilitation, Hyogo College of Medicine College Hospital, Nishinomiya, Japan",NA
"1361","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Takahashi","Miyako","Department of Nursing, Hyogo College of Medicine College Hospital, Nishinomiya, Japan",NA
"1362","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Iwasa","Saya","Department of Rehabilitation, Hyogo College of Medicine College Hospital, Nishinomiya, Japan",NA
"1363","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Koyama","Tetsuo","Department of Rehabilitation Medicine, Hyogo College of Medicine, Nishinomiya, Japan",NA
"1364","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Kodama","Norihiko","Department of Rehabilitation Medicine, Hyogo College of Medicine, Nishinomiya, Japan",NA
"1365","34164586","10.2490/prm.20210025","COVID-19 Patient Returned to Work after Long Hospitalization and Follow-up: A Case Report.","Coronavirus disease 2019 (COVID-19) causes severe respiratory dysfunction and post-intensive care syndrome (PICS), which can significantly affect the return to work after discharge from the hospital. This report describes the first case of a patient with severe COVID-19 at our institution during the first wave of the COVID-19 pandemic (February to June 2020) who returned to work following rehabilitation management. A 48-year-old female nurse was admitted with COVID-19 and underwent mechanical ve","2021","06","25","Prog Rehabil Med","Progress in rehabilitation medicine","COVID-19; ICU-AW; post-intensive care syndrome (PICS); rehabilitation; return to work","Domen","Kazuhisa","Department of Rehabilitation Medicine, Hyogo College of Medicine, Nishinomiya, Japan",NA
"1366","34164583","10.23889/ijpds.v5i4.1402","'Leading by Science' through Covid-19: the NHS Data Store &amp; Automated Decision-Making.","The UK government announced in March 2020 that it would create an NHS Covid-19 'Data Store' from information routinely collected as part of the health service. This 'Store' would use a number of sources of population data to provide a 'single source of truth' about the spread of the coronavirus in England. The initiative illustrates the difficulty of relying on automated processing when making healthcare decisions under the General Data Protection Regulation (GDPR). The end-product of the store,","2021","06","25","Int J Popul Data Sci","International journal of population data science","Automated Decision-Making; Covid-19 Algorithms; General Data Protection Regulation","Mourby","M J","Centre for Health, Law and Emerging Technologies, University of Oxford, Ewert House, Oxford, OX2 7DD, UK",NA
"1367","34164577","10.1177/23779608211020919","Rasch Analysis of Lebanese Nurses' Responses to the Copenhagen Burnout Inventory Alternative to the Maslach Burnout Inventory.","Lebanon struggled with political and economic crises before it was affected by the COVID-19 pandemic. Executive nurses and hospital administrations need reliable open-source measures to monitor burnout and prioritize nurses for intervention as Lebanon struggles with the multiple crises compounded by rising numbers of COVID-19 cases and deaths. The study aimed to determine whether the Copenhagen Burnout Inventory scales are suitable for settings experiencing multiple crises. Its objectives were t","2021","06","25","SAGE Open Nurs","SAGE open nursing","COVID-19; Rasch analysis; burnout; crises; fatigue; measurement; nurses; nursing workforce; psychometrics; reliability.","Clinton","Michael","Hariri School of Nursing, American University of Beirut, Beirut, Lebanon",NA
"1368","34164577","10.1177/23779608211020919","Rasch Analysis of Lebanese Nurses' Responses to the Copenhagen Burnout Inventory Alternative to the Maslach Burnout Inventory.","Lebanon struggled with political and economic crises before it was affected by the COVID-19 pandemic. Executive nurses and hospital administrations need reliable open-source measures to monitor burnout and prioritize nurses for intervention as Lebanon struggles with the multiple crises compounded by rising numbers of COVID-19 cases and deaths. The study aimed to determine whether the Copenhagen Burnout Inventory scales are suitable for settings experiencing multiple crises. Its objectives were t","2021","06","25","SAGE Open Nurs","SAGE open nursing","COVID-19; Rasch analysis; burnout; crises; fatigue; measurement; nurses; nursing workforce; psychometrics; reliability.","Shehadeh Msn Rn","Roula","Hariri School of Nursing, American University of Beirut, Beirut, Lebanon",NA
"1369","34164573","10.29390/cjrt-2021-008","Implementation of point-of-care blood gas testing at a large community hospital: Cost analysis, sepsis bundle compliance, and employee engagement.","Point-of-care testing (POCT) platforms support patient-centered approaches to health care delivery and may improve patient care. We evaluated implementation of a POCT platform at a large, acute care hospital in the Midwestern United States. We used lactate testing as part of a sepsis bundle protocol to evaluate compliance and mortality outcomes. Respiratory team members were surveyed to assess perception of efficiency, ease of use, timely patient care, and overall engagement with the POCT system","2021","06","25","Can J Respir Ther","Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR","COVID-19; lab test; lactate; patient-centered care; process improvement; respiratory therapy","Chase","Robert A","Northwestern Medicine Central DuPage Hospital, Winfield, IL, USA",NA
"1370","34164573","10.29390/cjrt-2021-008","Implementation of point-of-care blood gas testing at a large community hospital: Cost analysis, sepsis bundle compliance, and employee engagement.","Point-of-care testing (POCT) platforms support patient-centered approaches to health care delivery and may improve patient care. We evaluated implementation of a POCT platform at a large, acute care hospital in the Midwestern United States. We used lactate testing as part of a sepsis bundle protocol to evaluate compliance and mortality outcomes. Respiratory team members were surveyed to assess perception of efficiency, ease of use, timely patient care, and overall engagement with the POCT system","2021","06","25","Can J Respir Ther","Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR","COVID-19; lab test; lactate; patient-centered care; process improvement; respiratory therapy","DeJuilio","Patricia A","Northwestern Medicine Central DuPage Hospital, Winfield, IL, USA",NA
"1371","34164573","10.29390/cjrt-2021-008","Implementation of point-of-care blood gas testing at a large community hospital: Cost analysis, sepsis bundle compliance, and employee engagement.","Point-of-care testing (POCT) platforms support patient-centered approaches to health care delivery and may improve patient care. We evaluated implementation of a POCT platform at a large, acute care hospital in the Midwestern United States. We used lactate testing as part of a sepsis bundle protocol to evaluate compliance and mortality outcomes. Respiratory team members were surveyed to assess perception of efficiency, ease of use, timely patient care, and overall engagement with the POCT system","2021","06","25","Can J Respir Ther","Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR","COVID-19; lab test; lactate; patient-centered care; process improvement; respiratory therapy","Huml","Jeffrey P","Northwestern Medicine Central DuPage Hospital, Winfield, IL, USA",NA
"1372","34164573","10.29390/cjrt-2021-008","Implementation of point-of-care blood gas testing at a large community hospital: Cost analysis, sepsis bundle compliance, and employee engagement.","Point-of-care testing (POCT) platforms support patient-centered approaches to health care delivery and may improve patient care. We evaluated implementation of a POCT platform at a large, acute care hospital in the Midwestern United States. We used lactate testing as part of a sepsis bundle protocol to evaluate compliance and mortality outcomes. Respiratory team members were surveyed to assess perception of efficiency, ease of use, timely patient care, and overall engagement with the POCT system","2021","06","25","Can J Respir Ther","Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR","COVID-19; lab test; lactate; patient-centered care; process improvement; respiratory therapy","Johnson","Alex P","Northwestern Medicine Central DuPage Hospital, Winfield, IL, USA",NA
"1373","34164573","10.29390/cjrt-2021-008","Implementation of point-of-care blood gas testing at a large community hospital: Cost analysis, sepsis bundle compliance, and employee engagement.","Point-of-care testing (POCT) platforms support patient-centered approaches to health care delivery and may improve patient care. We evaluated implementation of a POCT platform at a large, acute care hospital in the Midwestern United States. We used lactate testing as part of a sepsis bundle protocol to evaluate compliance and mortality outcomes. Respiratory team members were surveyed to assess perception of efficiency, ease of use, timely patient care, and overall engagement with the POCT system","2021","06","25","Can J Respir Ther","Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR","COVID-19; lab test; lactate; patient-centered care; process improvement; respiratory therapy","Kaminski","Ryan M","Northwestern Medicine Central DuPage Hospital, Winfield, IL, USA",NA
"1374","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Dugdale","Caitlin M","Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1375","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Anahtar","Melis N","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1376","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Chiosi","John J","Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1377","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Lazarus","Jacob E","Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1378","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","McCluskey","Suzanne M","Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1379","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Ciaranello","Andrea L","Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1380","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Gogakos","Tasos","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1381","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Little","Brent P","Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1382","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Branda","John A","Harvard Medical School, Boston, Massachusetts, USA",NA
"1383","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Shenoy","Erica S","Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1384","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Walensky","Rochelle P","Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1385","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Zachary","Kimon C","Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1386","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Hooper","David C","Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1387","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Turbett","Sarah E","Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1388","34164560","10.1093/ofid/ofaa559","Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.","Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection is moderate to high. However, the frequency of FNs and patient characteristics associated with FNs are poorly understood. We retrospectively reviewed test results from 15 011 adults who underwent =1 SARS-CoV-2 NAATs; 2699 had an initial negative NAAT ","2021","06","26","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 testing; coronavirus; false-negative","Hyle","Emily P","Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1389","34164551","10.1183/23120541.00292-2021","Conservative management of COVID-19 associated hypoxaemia.","Treat hypoxia, not hypoxaemia https://bit.ly/3hwPLCL.","2021","06","25","ERJ Open Res","ERJ open research",NA,"Voshaar","Thomas","Bethanien Hospital Moers, Moers, Germany",NA
"1390","34164551","10.1183/23120541.00292-2021","Conservative management of COVID-19 associated hypoxaemia.","Treat hypoxia, not hypoxaemia https://bit.ly/3hwPLCL.","2021","06","25","ERJ Open Res","ERJ open research",NA,"Stais","Patrick","Bethanien Hospital Moers, Moers, Germany",NA
"1391","34164551","10.1183/23120541.00292-2021","Conservative management of COVID-19 associated hypoxaemia.","Treat hypoxia, not hypoxaemia https://bit.ly/3hwPLCL.","2021","06","25","ERJ Open Res","ERJ open research",NA,"Köhler","Dieter","Kloster Grafschaft, Schmallenberg, Germany",NA
"1392","34164551","10.1183/23120541.00292-2021","Conservative management of COVID-19 associated hypoxaemia.","Treat hypoxia, not hypoxaemia https://bit.ly/3hwPLCL.","2021","06","25","ERJ Open Res","ERJ open research",NA,"Dellweg","Dominic","Kloster Grafschaft, Schmallenberg, Germany",NA
"1393","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Gao","Peng","Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1394","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Wu","Wei","Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1395","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Tian","Ran","Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1396","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Yan","Xiaowei","Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1397","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Qian","Hao","Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1398","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Guo","Fan","Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1399","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Li","Taisheng","Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1400","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Liu","Zhengyin","Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1401","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Wang","Jinglan","Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1402","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Zhou","Xiang","Department of Intensive Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1403","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Qin","Yan","Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1404","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Zhao","Dachun","Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1405","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Bian","Xiuwu","Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China",NA
"1406","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Lin","Xue","Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1407","34164517","10.21037/atm-21-2282","Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).","Cardiovascular involvement manifesting as arrhythmias has been confirmed in patients with coronavirus disease 2019 (COVID-19), so we aimed to explore the association between primary tachyarrhythmia and death in critically ill patients with COVID-19 in this retrospective study. A total of 79 critically ill patients with COVID-19 were included. Demographic characteristics, clinical data (past history, vital signs, therapeutic management, and outcomes), and results of laboratory findings and cardia","2021","06","25","Ann Transl Med","Annals of translational medicine","Arrhythmias; beta-blockers; coronavirus disease 2019 (COVID-19); critically ill patients; mortality","Zhang","Shuyang","Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China",NA
"1408","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Zhan","Xiao-Yong","The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China",NA
"1409","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Li","Liang","The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China",NA
"1410","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Hu","Yuhai","Department of Clinical Laboratory, Hankou Hospital, Wuhan, China",NA
"1411","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Li","Qiang","Department of Clinical Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, China",NA
"1412","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Kong","Huimin","The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China",NA
"1413","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Ng","Margaret H L","Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China",NA
"1414","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Chen","Chun","The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China",NA
"1415","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","He","Yulong","The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China",NA
"1416","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Huang","Bihui","The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China",NA
"1417","34164443","10.3389/fcvm.2021.680604","Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.","Elderly with comorbidities have shown a higher rate of fatal outcomes when suffering coronavirus disease 2019 (COVID-19). However, a delineation of clinical significances of hematologic indices and underlying comorbidities in the progression and outcome of COVID-19 remains undefined. Six hundred two COVID-19 patients with established clinical outcomes (discharged or deceased) from Hankou Hospital of Wuhan, China between January 14, 2020 and February 29, 2020 were retrospectively analyzed. Of the","2021","06","25","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; aggressive inflammatory response; cardiovascular-related comorbidities; elderly male; lymphopenia","Yang","Mo","The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China",NA
"1418","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Klassen","Stephen A","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States",NA
"1419","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Senefeld","Jonathon W","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States",NA
"1420","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Senese","Katherine A","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States",NA
"1421","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Johnson","Patrick W","Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, United States",NA
"1422","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Wiggins","Chad C","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States",NA
"1423","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Baker","Sarah E","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States",NA
"1424","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","van Helmond","Noud","Department of Anesthesiology, Cooper Medical School of Rowan University, Cooper University Health Care, Camden, NJ, United States",NA
"1425","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Bruno","Katelyn A","Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States",NA
"1426","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Pirofski","Liise-Anne","Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, United States",NA
"1427","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Shoham","Shmuel","Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"1428","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Grossman","Brenda J","Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO, United States",NA
"1429","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Henderson","Jeffrey P","Division of Infectious Diseases, Department of Medicine, Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, MO, United States",NA
"1430","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Wright","R Scott","Department of Cardiovascular Medicine, Human Research Protection Program, Mayo Clinic, Rochester, MN, United States",NA
"1431","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Fairweather","DeLisa","Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States",NA
"1432","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Paneth","Nigel S","Department of Epidemiology and Biostatistics, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI, United States",NA
"1433","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Carter","Rickey E","Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, United States",NA
"1434","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Casadevall","Arturo","Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"1435","34164419","10.3389/fmed.2021.684151","Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.","Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials (RCTs) have provided divergent evidence regarding the survival benefit of convalescent plasma. Here, we argue that during a global health emergency, the mosaic of evidence originating from multiple levels of the epistemic hierarchy should inform cont","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; KaplanMeier analysis; SARS-CoV-2; convalescent plasma therapy; passive antibody transfer","Joyner","Michael J","Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States",NA
"1436","34164415","10.3389/fmed.2021.673814","Frailty and Geriatric Medicine During the Pandemic.","The term frailty in the era of coronavirus disease 2019 (COVID-19) has a manifold implication. The vast majority of the countries worldwide being hit by the pandemic have shown the frailty of their health and social care systems. Although the surprise factor could somehow justify the unpreparedness experienced during the first wave, the second wave still led to significant difficulties almost everywhere. Looking at Italy's situation, it is evident how the stress test applied by COVID-19 o","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV2; ageism; aging; geriatrics; prevention","Crosignani","Silvia","Fellowship in Geriatrics and Gerontology, University of Milan, Milan, Italy",NA
"1437","34164415","10.3389/fmed.2021.673814","Frailty and Geriatric Medicine During the Pandemic.","The term frailty in the era of coronavirus disease 2019 (COVID-19) has a manifold implication. The vast majority of the countries worldwide being hit by the pandemic have shown the frailty of their health and social care systems. Although the surprise factor could somehow justify the unpreparedness experienced during the first wave, the second wave still led to significant difficulties almost everywhere. Looking at Italy's situation, it is evident how the stress test applied by COVID-19 o","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV2; ageism; aging; geriatrics; prevention","Fantinati","Jacopo","Fellowship in Geriatrics and Gerontology, University of Milan, Milan, Italy",NA
"1438","34164415","10.3389/fmed.2021.673814","Frailty and Geriatric Medicine During the Pandemic.","The term frailty in the era of coronavirus disease 2019 (COVID-19) has a manifold implication. The vast majority of the countries worldwide being hit by the pandemic have shown the frailty of their health and social care systems. Although the surprise factor could somehow justify the unpreparedness experienced during the first wave, the second wave still led to significant difficulties almost everywhere. Looking at Italy's situation, it is evident how the stress test applied by COVID-19 o","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV2; ageism; aging; geriatrics; prevention","Cesari","Matteo","Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy",NA
"1439","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Xiao","Yu-Feng","Department of Gastroenterology, Xinqiao Hospital, The Army Medical University, Chongqing, China",NA
"1440","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","He","Jia-Lin","Department of Gastroenterology, Xinqiao Hospital, The Army Medical University, Chongqing, China",NA
"1441","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Xu","Yu","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1442","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Liu","Xi","Department of Gastroenterology, Xinqiao Hospital, The Army Medical University, Chongqing, China",NA
"1443","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Lin","Hui","Department of Gastroenterology, Xinqiao Hospital, The Army Medical University, Chongqing, China",NA
"1444","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Li","Qi","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1445","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Xu","Zhi","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1446","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Hu","Ming-Dong","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1447","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Ren","Xiao-Bao","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1448","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Zhang","Cheng","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1449","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Zhang","Wen-Jing","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1450","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Duan","Wei","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1451","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Tian","Yong-Feng","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1452","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Li","Ping","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1453","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Wu","Hao","Taikang Tongji Hospital, Wuhan, China",NA
"1454","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Song","Cai-Ping","Huo-Shen-Shan Hospital, Wuhan, China",NA
"1455","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Liu","En","Department of Gastroenterology, Xinqiao Hospital, The Army Medical University, Chongqing, China",NA
"1456","34164413","10.3389/fmed.2021.655604","Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.","Objectives: Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. Methods: This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; diabetes; mortality; risk score; severity","Yang","Shi-Ming","Department of Gastroenterology, Xinqiao Hospital, The Army Medical University, Chongqing, China",NA
"1457","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Huang","Thomas Tao-Min","Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1458","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Chien","Ying-Chun","Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1459","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Wang","Chih-Hsien","Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1460","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Chang","Sui-Yuan","Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan",NA
"1461","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Wang","Jann-Tay","Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1462","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Hsieh","Song-Chou","Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1463","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Yeh","Yu-Chang","Department of Anesthesiology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1464","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Ku","Shih-Chi","Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1465","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Yu","Chong-Jen","Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1466","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Chiang","Bor-Luen","Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan",NA
"1467","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Chang","Shan-Chwen","Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan",NA
"1468","34164411","10.3389/fmed.2021.649583","Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.","The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COVID-19 patient with multi-organ failure, including acute respiratory failure, acute kidney injury, and fulminant cytokine release syndrome (CRS), who required mechanical ventilation and extracorporeal ","2021","06","25","Front Med (Lausanne)","Frontiers in medicine","COVID-19; continuous renal replacement therapy; cytokine release syndrome; extracorporeal membrane oxygenation; tocilizumab","Tolwani","Ashita","Division of Nephrology, University of Alabama, Birmingham, AL, United States",NA
"1469","34164375","10.3389/fpubh.2021.689870","Threshold Effect of the Government Intervention in the Relationship Between Business Cycle and Population Health: Evidence From China.","China is an emerging country, and government intervention is always considered as an important part of the solutions when people facing challenges in China. Under the impact of the coronavirus disease 2019 (COVID-19) epidemic and the global economic downturn, the Chinese government quickly brought the epidemic under control and restored the positive economic growth through strong intervention. Based on the panel data of provincial level in China and the government intervention as the threshold v","2021","06","28","Front Public Health","Frontiers in public health","business cycle; government intervention; population health; the Chinese government; threshold effect; COVID-19; China; Government; Humans; Population Health; SARS-CoV-2","Chai","Kuang-Cheng","Business School, Guilin University of Electronic Technology, Guilin, China",NA
"1470","34164375","10.3389/fpubh.2021.689870","Threshold Effect of the Government Intervention in the Relationship Between Business Cycle and Population Health: Evidence From China.","China is an emerging country, and government intervention is always considered as an important part of the solutions when people facing challenges in China. Under the impact of the coronavirus disease 2019 (COVID-19) epidemic and the global economic downturn, the Chinese government quickly brought the epidemic under control and restored the positive economic growth through strong intervention. Based on the panel data of provincial level in China and the government intervention as the threshold v","2021","06","28","Front Public Health","Frontiers in public health","business cycle; government intervention; population health; the Chinese government; threshold effect; COVID-19; China; Government; Humans; Population Health; SARS-CoV-2","Yang","Yang","Business School, Guilin University of Electronic Technology, Guilin, China",NA
"1471","34164375","10.3389/fpubh.2021.689870","Threshold Effect of the Government Intervention in the Relationship Between Business Cycle and Population Health: Evidence From China.","China is an emerging country, and government intervention is always considered as an important part of the solutions when people facing challenges in China. Under the impact of the coronavirus disease 2019 (COVID-19) epidemic and the global economic downturn, the Chinese government quickly brought the epidemic under control and restored the positive economic growth through strong intervention. Based on the panel data of provincial level in China and the government intervention as the threshold v","2021","06","28","Front Public Health","Frontiers in public health","business cycle; government intervention; population health; the Chinese government; threshold effect; COVID-19; China; Government; Humans; Population Health; SARS-CoV-2","Cui","Zhen-Xin","Business School, Guilin University of Electronic Technology, Guilin, China",NA
"1472","34164375","10.3389/fpubh.2021.689870","Threshold Effect of the Government Intervention in the Relationship Between Business Cycle and Population Health: Evidence From China.","China is an emerging country, and government intervention is always considered as an important part of the solutions when people facing challenges in China. Under the impact of the coronavirus disease 2019 (COVID-19) epidemic and the global economic downturn, the Chinese government quickly brought the epidemic under control and restored the positive economic growth through strong intervention. Based on the panel data of provincial level in China and the government intervention as the threshold v","2021","06","28","Front Public Health","Frontiers in public health","business cycle; government intervention; population health; the Chinese government; threshold effect; COVID-19; China; Government; Humans; Population Health; SARS-CoV-2","Ou","Yang-Lu","Business School, Guilin University of Electronic Technology, Guilin, China",NA
"1473","34164375","10.3389/fpubh.2021.689870","Threshold Effect of the Government Intervention in the Relationship Between Business Cycle and Population Health: Evidence From China.","China is an emerging country, and government intervention is always considered as an important part of the solutions when people facing challenges in China. Under the impact of the coronavirus disease 2019 (COVID-19) epidemic and the global economic downturn, the Chinese government quickly brought the epidemic under control and restored the positive economic growth through strong intervention. Based on the panel data of provincial level in China and the government intervention as the threshold v","2021","06","28","Front Public Health","Frontiers in public health","business cycle; government intervention; population health; the Chinese government; threshold effect; COVID-19; China; Government; Humans; Population Health; SARS-CoV-2","Chang","Ke-Chiun","School of Economics and Management, Wuhan University, Wuhan, China",NA
"1474","34164374","10.3389/fpubh.2021.683120","Innovation Model of China's High-End Equipment Industry: Do Social Capital and Dynamic Capabilities Matter for the COVID-19 Crisis?","This paper explores the different model combinations of enterprise innovation in China based on the roles of social capital and dynamic capabilities. We implement Qualitative Comparative Analysis to understand the non-linear asymmetric relationships better. We use the data of 44 Listed Companies in China's high-end equipment manufacturing industry and find that three innovation models (the market-oriented independent innovation, government-supported technological innovation and industry-supporte","2021","06","28","Front Public Health","Frontiers in public health","dynamic capabilities; innovation model; qualitative comparative analysis; social capital; the COVID-19 crisis; COVID-19; China; Humans; Pandemics; SARS-CoV-2; Social Capital","Ai","Yuhong","School of Management, Nanchang University, Nanchang, China",NA
"1475","34164374","10.3389/fpubh.2021.683120","Innovation Model of China's High-End Equipment Industry: Do Social Capital and Dynamic Capabilities Matter for the COVID-19 Crisis?","This paper explores the different model combinations of enterprise innovation in China based on the roles of social capital and dynamic capabilities. We implement Qualitative Comparative Analysis to understand the non-linear asymmetric relationships better. We use the data of 44 Listed Companies in China's high-end equipment manufacturing industry and find that three innovation models (the market-oriented independent innovation, government-supported technological innovation and industry-supporte","2021","06","28","Front Public Health","Frontiers in public health","dynamic capabilities; innovation model; qualitative comparative analysis; social capital; the COVID-19 crisis; COVID-19; China; Humans; Pandemics; SARS-CoV-2; Social Capital","Peng","Diyun","School of Economics and Management, Nanchang University, Nanchang, China",NA
"1476","34164373","10.3389/fpubh.2021.678768","Reimagining Innovation Amid the COVID-19 Pandemic: Insights From the WISH Innovation Programme.","The World Innovation Summit for Health (WISH) hosts two innovation competitions as part of its biennial healthcare conference. During the COVID-19 pandemic, WISH received more than 350 applications for both competitions, of which 31 were shortlisted to showcase at the WISH 2020 virtual summit. Of the 31 showcasing innovations, 11 (35.5%) had suggested an alternative use to their innovation as a contribution to the global fight against COVID-19. As such, this article explores the apparent and urg","2021","06","28","Front Public Health","Frontiers in public health","competition; cost efficiency; healthcare innovation; innovation; public health; COVID-19; Delivery of Health Care; Global Health; Humans; Pandemics; SARS-CoV-2","El Akoum","Maha","World Innovation Summit for Health, Qatar Foundation, Doha, Qatar",NA
"1477","34164373","10.3389/fpubh.2021.678768","Reimagining Innovation Amid the COVID-19 Pandemic: Insights From the WISH Innovation Programme.","The World Innovation Summit for Health (WISH) hosts two innovation competitions as part of its biennial healthcare conference. During the COVID-19 pandemic, WISH received more than 350 applications for both competitions, of which 31 were shortlisted to showcase at the WISH 2020 virtual summit. Of the 31 showcasing innovations, 11 (35.5%) had suggested an alternative use to their innovation as a contribution to the global fight against COVID-19. As such, this article explores the apparent and urg","2021","06","28","Front Public Health","Frontiers in public health","competition; cost efficiency; healthcare innovation; innovation; public health; COVID-19; Delivery of Health Care; Global Health; Humans; Pandemics; SARS-CoV-2","El Achi","Mahmoud","World Innovation Summit for Health, Qatar Foundation, Doha, Qatar",NA
"1478","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Liu","Shanshan","Shanghai Public Health Clinical Center, Fudan University, Shanghai, China",NA
"1479","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Li","Qiuyue","Shanghai Public Health Clinical Center, Fudan University, Shanghai, China",NA
"1480","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Chu","Xuntao","Zhuhai Livzon Diagnostics Inc., Guangdong, China",NA
"1481","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Zeng","Minxia","Zhuhai Livzon Diagnostics Inc., Guangdong, China",NA
"1482","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Liu","Mingbin","Shanghai Public Health Clinical Center, Fudan University, Shanghai, China",NA
"1483","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","He","Xiaomeng","Shanghai Public Health Clinical Center, Fudan University, Shanghai, China",NA
"1484","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Zou","Heng","Shanghai Public Health Clinical Center, Fudan University, Shanghai, China",NA
"1485","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Zheng","Jianghua","Department of Laboratory Medicine, Zhoupu Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China",NA
"1486","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Corpe","Christopher","Nutritional Science Department, King's College London, London, United Kingdom",NA
"1487","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Zhang","Xiaoyan","Shanghai Public Health Clinical Center, Fudan University, Shanghai, China",NA
"1488","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Xu","Jianqing","Shanghai Public Health Clinical Center, Fudan University, Shanghai, China",NA
"1489","34164371","10.3389/fpubh.2021.672215","Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.","Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of betacoronavirus, SARS-CoV-2 can spread across species and between populations and has a greater risk of transmission than other coronaviruses. To control the spread of SARS-CoV-2, it is vital to have a rapid and effective means of diagnosing asymptomatic SARS-CoV-2-positive individuals an","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; coronavirus; immunoassay; rRT-PCR; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; SARS-CoV-2; Sensitivity and Specificity","Wang","Jin","Shanghai Public Health Clinical Center, Fudan University, Shanghai, China",NA
"1490","34164364","10.3389/fpubh.2021.639041","The Impact of Unplanned School Closures on Adolescent Behavioral Health During the Covid-19 Pandemic in Malaysia.","School closures were implemented as a public health intervention to reduce the risk of infection from COVID-19. However, prolonged school closure is likely to impact adolescents' behavioral health due to the extreme change in routine. The current study aimed to explore adolescents' behavioral health experiences during the beginning of the outbreak of the COVID-19 pandemic. This study was done using qualitative methods to interview 15 adolescent participants (n =15) from low-income househo","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; adolescent; behavioral health; health education; unplanned school closure; Adolescent; COVID-19; Humans; Malaysia; Pandemics; SARS-CoV-2; Schools","Amran","Muhammad Syawal","Faculty of Education, National University of Malaysia, Bangi, Malaysia",NA
"1491","34164364","10.3389/fpubh.2021.639041","The Impact of Unplanned School Closures on Adolescent Behavioral Health During the Covid-19 Pandemic in Malaysia.","School closures were implemented as a public health intervention to reduce the risk of infection from COVID-19. However, prolonged school closure is likely to impact adolescents' behavioral health due to the extreme change in routine. The current study aimed to explore adolescents' behavioral health experiences during the beginning of the outbreak of the COVID-19 pandemic. This study was done using qualitative methods to interview 15 adolescent participants (n =15) from low-income househo","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; adolescent; behavioral health; health education; unplanned school closure; Adolescent; COVID-19; Humans; Malaysia; Pandemics; SARS-CoV-2; Schools","Jamaludin","Khairul Azhar","Faculty of Education, National University of Malaysia, Bangi, Malaysia",NA
"1492","34164363","10.3389/fpubh.2021.637151","Parent Perceptions of Changes in Child Physical Activity During COVID-19 Stay-At-Home Orders.","Purpose: The purpose of this study was to explore parent perceptions of changes in child physical activity during COVID-19 stay-at-home orders. Design: A cross-sectional study. Setting: The research team used social media, relevant organizations, and neighborhood groups to distribute the survey link in May and June of 2020. Subjects: A convenience sample of parents of children aged 5-12. Measures: Survey to assess parental perceptions of changes in children's p","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; barriers; children; environment; parenting; physical activity; social; Adult; COVID-19; Child; Cross-Sectional Studies; Exercise; Humans; Pandemics; Parents; Perception; SARS-CoV-2","Eyler","Amy A","Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, United States",NA
"1493","34164363","10.3389/fpubh.2021.637151","Parent Perceptions of Changes in Child Physical Activity During COVID-19 Stay-At-Home Orders.","Purpose: The purpose of this study was to explore parent perceptions of changes in child physical activity during COVID-19 stay-at-home orders. Design: A cross-sectional study. Setting: The research team used social media, relevant organizations, and neighborhood groups to distribute the survey link in May and June of 2020. Subjects: A convenience sample of parents of children aged 5-12. Measures: Survey to assess parental perceptions of changes in children's p","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; barriers; children; environment; parenting; physical activity; social; Adult; COVID-19; Child; Cross-Sectional Studies; Exercise; Humans; Pandemics; Parents; Perception; SARS-CoV-2","Schmidt","Laurel","Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, United States",NA
"1494","34164363","10.3389/fpubh.2021.637151","Parent Perceptions of Changes in Child Physical Activity During COVID-19 Stay-At-Home Orders.","Purpose: The purpose of this study was to explore parent perceptions of changes in child physical activity during COVID-19 stay-at-home orders. Design: A cross-sectional study. Setting: The research team used social media, relevant organizations, and neighborhood groups to distribute the survey link in May and June of 2020. Subjects: A convenience sample of parents of children aged 5-12. Measures: Survey to assess parental perceptions of changes in children's p","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; barriers; children; environment; parenting; physical activity; social; Adult; COVID-19; Child; Cross-Sectional Studies; Exercise; Humans; Pandemics; Parents; Perception; SARS-CoV-2","Kepper","Maura","Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, United States",NA
"1495","34164363","10.3389/fpubh.2021.637151","Parent Perceptions of Changes in Child Physical Activity During COVID-19 Stay-At-Home Orders.","Purpose: The purpose of this study was to explore parent perceptions of changes in child physical activity during COVID-19 stay-at-home orders. Design: A cross-sectional study. Setting: The research team used social media, relevant organizations, and neighborhood groups to distribute the survey link in May and June of 2020. Subjects: A convenience sample of parents of children aged 5-12. Measures: Survey to assess parental perceptions of changes in children's p","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; barriers; children; environment; parenting; physical activity; social; Adult; COVID-19; Child; Cross-Sectional Studies; Exercise; Humans; Pandemics; Parents; Perception; SARS-CoV-2","Mazzucca","Stephanie","Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, United States",NA
"1496","34164363","10.3389/fpubh.2021.637151","Parent Perceptions of Changes in Child Physical Activity During COVID-19 Stay-At-Home Orders.","Purpose: The purpose of this study was to explore parent perceptions of changes in child physical activity during COVID-19 stay-at-home orders. Design: A cross-sectional study. Setting: The research team used social media, relevant organizations, and neighborhood groups to distribute the survey link in May and June of 2020. Subjects: A convenience sample of parents of children aged 5-12. Measures: Survey to assess parental perceptions of changes in children's p","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; barriers; children; environment; parenting; physical activity; social; Adult; COVID-19; Child; Cross-Sectional Studies; Exercise; Humans; Pandemics; Parents; Perception; SARS-CoV-2","Gilbert","Amanda","Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, United States",NA
"1497","34164363","10.3389/fpubh.2021.637151","Parent Perceptions of Changes in Child Physical Activity During COVID-19 Stay-At-Home Orders.","Purpose: The purpose of this study was to explore parent perceptions of changes in child physical activity during COVID-19 stay-at-home orders. Design: A cross-sectional study. Setting: The research team used social media, relevant organizations, and neighborhood groups to distribute the survey link in May and June of 2020. Subjects: A convenience sample of parents of children aged 5-12. Measures: Survey to assess parental perceptions of changes in children's p","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; barriers; children; environment; parenting; physical activity; social; Adult; COVID-19; Child; Cross-Sectional Studies; Exercise; Humans; Pandemics; Parents; Perception; SARS-CoV-2","Beck","Alan","Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, United States",NA
"1498","34164361","10.3389/fpubh.2021.598921","Profiles of Depressive Symptoms Among Men Who Have Sex With Men and Transgender Women During the COVID-19 Outbreak in Mexico: A Latent Class Analysis.","The impact of the COVID-19 outbreak on mental health among HIV high-risk populations is not known. We assess the prevalence of depressive symptoms (DS) and explore the association with characteristics related to the COVID-19 pandemic. We conducted an online survey among 881 men who have sex with men (MSM) and transgender women (TGW) assessing the presence of DS using the Center for Epidemiological Studies Depression Scale (CESD-10); results were compared with previously self-reported DS and nati","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; Mexico; depressive symptoms; men who have sex with men; mental health; COVID-19; Depression; Female; HIV Infections; Homosexuality, Male; Humans; Latent Class Analysis; Male; Mexico; Pandemics; SARS-CoV-2; Sexual and Gender Minorities; Transgender Persons","Cerecero-Garcia","Diego","Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico",NA
"1499","34164361","10.3389/fpubh.2021.598921","Profiles of Depressive Symptoms Among Men Who Have Sex With Men and Transgender Women During the COVID-19 Outbreak in Mexico: A Latent Class Analysis.","The impact of the COVID-19 outbreak on mental health among HIV high-risk populations is not known. We assess the prevalence of depressive symptoms (DS) and explore the association with characteristics related to the COVID-19 pandemic. We conducted an online survey among 881 men who have sex with men (MSM) and transgender women (TGW) assessing the presence of DS using the Center for Epidemiological Studies Depression Scale (CESD-10); results were compared with previously self-reported DS and nati","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; Mexico; depressive symptoms; men who have sex with men; mental health; COVID-19; Depression; Female; HIV Infections; Homosexuality, Male; Humans; Latent Class Analysis; Male; Mexico; Pandemics; SARS-CoV-2; Sexual and Gender Minorities; Transgender Persons","Vermandere","Heleen","Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico",NA
"1500","34164361","10.3389/fpubh.2021.598921","Profiles of Depressive Symptoms Among Men Who Have Sex With Men and Transgender Women During the COVID-19 Outbreak in Mexico: A Latent Class Analysis.","The impact of the COVID-19 outbreak on mental health among HIV high-risk populations is not known. We assess the prevalence of depressive symptoms (DS) and explore the association with characteristics related to the COVID-19 pandemic. We conducted an online survey among 881 men who have sex with men (MSM) and transgender women (TGW) assessing the presence of DS using the Center for Epidemiological Studies Depression Scale (CESD-10); results were compared with previously self-reported DS and nati","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; Mexico; depressive symptoms; men who have sex with men; mental health; COVID-19; Depression; Female; HIV Infections; Homosexuality, Male; Humans; Latent Class Analysis; Male; Mexico; Pandemics; SARS-CoV-2; Sexual and Gender Minorities; Transgender Persons","Bojorquez","Ietza","Department of Population Studies, El Colegio de la Frontera Norte, Tijuana, Mexico",NA
"1501","34164361","10.3389/fpubh.2021.598921","Profiles of Depressive Symptoms Among Men Who Have Sex With Men and Transgender Women During the COVID-19 Outbreak in Mexico: A Latent Class Analysis.","The impact of the COVID-19 outbreak on mental health among HIV high-risk populations is not known. We assess the prevalence of depressive symptoms (DS) and explore the association with characteristics related to the COVID-19 pandemic. We conducted an online survey among 881 men who have sex with men (MSM) and transgender women (TGW) assessing the presence of DS using the Center for Epidemiological Studies Depression Scale (CESD-10); results were compared with previously self-reported DS and nati","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; Mexico; depressive symptoms; men who have sex with men; mental health; COVID-19; Depression; Female; HIV Infections; Homosexuality, Male; Humans; Latent Class Analysis; Male; Mexico; Pandemics; SARS-CoV-2; Sexual and Gender Minorities; Transgender Persons","Gómez-Castro","José","Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico",NA
"1502","34164361","10.3389/fpubh.2021.598921","Profiles of Depressive Symptoms Among Men Who Have Sex With Men and Transgender Women During the COVID-19 Outbreak in Mexico: A Latent Class Analysis.","The impact of the COVID-19 outbreak on mental health among HIV high-risk populations is not known. We assess the prevalence of depressive symptoms (DS) and explore the association with characteristics related to the COVID-19 pandemic. We conducted an online survey among 881 men who have sex with men (MSM) and transgender women (TGW) assessing the presence of DS using the Center for Epidemiological Studies Depression Scale (CESD-10); results were compared with previously self-reported DS and nati","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; Mexico; depressive symptoms; men who have sex with men; mental health; COVID-19; Depression; Female; HIV Infections; Homosexuality, Male; Humans; Latent Class Analysis; Male; Mexico; Pandemics; SARS-CoV-2; Sexual and Gender Minorities; Transgender Persons","Arturo Sánchez-Ochoa","José","Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico",NA
"1503","34164361","10.3389/fpubh.2021.598921","Profiles of Depressive Symptoms Among Men Who Have Sex With Men and Transgender Women During the COVID-19 Outbreak in Mexico: A Latent Class Analysis.","The impact of the COVID-19 outbreak on mental health among HIV high-risk populations is not known. We assess the prevalence of depressive symptoms (DS) and explore the association with characteristics related to the COVID-19 pandemic. We conducted an online survey among 881 men who have sex with men (MSM) and transgender women (TGW) assessing the presence of DS using the Center for Epidemiological Studies Depression Scale (CESD-10); results were compared with previously self-reported DS and nati","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; Mexico; depressive symptoms; men who have sex with men; mental health; COVID-19; Depression; Female; HIV Infections; Homosexuality, Male; Humans; Latent Class Analysis; Male; Mexico; Pandemics; SARS-CoV-2; Sexual and Gender Minorities; Transgender Persons","Martínez-Dávalos","Araczy","Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico",NA
"1504","34164361","10.3389/fpubh.2021.598921","Profiles of Depressive Symptoms Among Men Who Have Sex With Men and Transgender Women During the COVID-19 Outbreak in Mexico: A Latent Class Analysis.","The impact of the COVID-19 outbreak on mental health among HIV high-risk populations is not known. We assess the prevalence of depressive symptoms (DS) and explore the association with characteristics related to the COVID-19 pandemic. We conducted an online survey among 881 men who have sex with men (MSM) and transgender women (TGW) assessing the presence of DS using the Center for Epidemiological Studies Depression Scale (CESD-10); results were compared with previously self-reported DS and nati","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; Mexico; depressive symptoms; men who have sex with men; mental health; COVID-19; Depression; Female; HIV Infections; Homosexuality, Male; Humans; Latent Class Analysis; Male; Mexico; Pandemics; SARS-CoV-2; Sexual and Gender Minorities; Transgender Persons","Huerta-Icelo","Ivonne","Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico",NA
"1505","34164361","10.3389/fpubh.2021.598921","Profiles of Depressive Symptoms Among Men Who Have Sex With Men and Transgender Women During the COVID-19 Outbreak in Mexico: A Latent Class Analysis.","The impact of the COVID-19 outbreak on mental health among HIV high-risk populations is not known. We assess the prevalence of depressive symptoms (DS) and explore the association with characteristics related to the COVID-19 pandemic. We conducted an online survey among 881 men who have sex with men (MSM) and transgender women (TGW) assessing the presence of DS using the Center for Epidemiological Studies Depression Scale (CESD-10); results were compared with previously self-reported DS and nati","2021","06","28","Front Public Health","Frontiers in public health","COVID-19; Mexico; depressive symptoms; men who have sex with men; mental health; COVID-19; Depression; Female; HIV Infections; Homosexuality, Male; Humans; Latent Class Analysis; Male; Mexico; Pandemics; SARS-CoV-2; Sexual and Gender Minorities; Transgender Persons","Bautista-Arredondo","Sergio","Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico",NA
"1506","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Zhang","Cheng","College of Veterinary Medicine, Hebei Agricultural University, Baoding, China",NA
"1507","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Guo","Kangkang","College of Veterinary Medicine, Hebei Agricultural University, Baoding, China",NA
"1508","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Cui","Huan","Changchun Veterinary Research Institute, Chinese Academy of Agriculture Sciences, Changchun, China",NA
"1509","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Chen","Ligong","College of Veterinary Medicine, Hebei Agricultural University, Baoding, China",NA
"1510","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Zhang","Chunmao","Changchun Veterinary Research Institute, Chinese Academy of Agriculture Sciences, Changchun, China",NA
"1511","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Wang","Xuejing","College of Veterinary Medicine, Hebei Agricultural University, Baoding, China",NA
"1512","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Li","Jiaming","Beijing Institute of Biotechnology, Beijing, China",NA
"1513","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Fu","Yingying","Beijing Institute of Biotechnology, Beijing, China",NA
"1514","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Wang","Zhongyi","Beijing Institute of Biotechnology, Beijing, China",NA
"1515","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Guo","Zhendong","Changchun Veterinary Research Institute, Chinese Academy of Agriculture Sciences, Changchun, China",NA
"1516","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Liu","Juxiang","College of Veterinary Medicine, Hebei Agricultural University, Baoding, China",NA
"1517","34164347","10.3389/fcimb.2021.688007","Risk of Environmental Exposure to H7N9 Influenza Virus <i>via</i> Airborne and Surface Routes in a Live Poultry Market in Hebei, China.","Environmental transmission of viruses to humans has become an early warning for potential epidemic outbreaks, such as SARS-CoV-2 and influenza virus outbreaks. Recently, an H7N9 virus, A/environment/Hebei/621/2019 (H7N9), was isolated by environmental swabs from a live poultry market in Hebei, China. We found that this isolate could be transmitted by direct contact and aerosol in mammals. More importantly, after 5 passages in mice, the virus acquired two adaptive mutations, PB1-H115Q and B2-E627","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","H7N9 virus; environmental and airborne transmissibility; human exposure risk; mammalian adaption; pathogenicity; Animals; COVID-19; China; Environmental Exposure; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Mice; Poultry; SARS-CoV-2","Dong","Shishan","College of Veterinary Medicine, Hebei Agricultural University, Baoding, China",NA
"1518","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Yu","Fei","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1519","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Xie","Guoliang","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1520","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Zheng","Shufa","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1521","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Han","Dongsheng","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1522","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Bao","Jiaqi","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1523","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Zhang","Dan","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1524","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Feng","Baihuan","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1525","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Wang","Qi","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1526","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Zou","Qianda","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1527","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Wang","Ruonan","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1528","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Yang","Xianzhi","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1529","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Chen","Weizhen","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1530","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Lou","Bin","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1531","34164346","10.3389/fcimb.2021.685640","Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.","Viral nucleic acid detection is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. However, unsuitable sample types and laboratory detection kits/methods lead to misdiagnosis, which delays the prevention and control of the pandemic. We compared four nucleic acid detection methods [two kinds of reverse transcription polymerase chain reactions (RT-PCR A: ORF1ab and N testing; RT-PCRB: only ORF1ab testing), reverse transcr","2021","06","28","Front Cell Infect Microbiol","Frontiers in cellular and infection microbiology","COVID-19; RT-RAA; SARS-CoV-2; dd-RT-PCR; saliva; sample type; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Nasopharynx; Pandemics; RNA, Viral; SARS-CoV-2; Saliva; Specimen Handling","Chen","Yu","Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1532","34164296","10.5500/wjt.v11.i6.212","Medical nutritional therapy for renal transplantation in the COVID-19 pandemic.","Nutritional therapy is very important at renal transplantation. Nutrition has become more vital for transplantation patients owing to the coronavirus disease 2019 (COVID-19) pandemic. Inadequate nutrition can negatively affect the immune system. For this reason, adequate protein and energy intake should be provided to the patients. Also, overconsumption of saturated fat, sugar, and refined carbohydrates can both negatively affect the immune system and trigger chronic diseases in transplantation ","2021","06","25","World J Transplant","World journal of transplantation","COVID-19; Nutrition; Renal transplantation","Akbulut","Gamze","Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Ankara 06490, Turkey. dytgamzea@gmail","dytgamzea@gmail.com"
"1533","34164296","10.5500/wjt.v11.i6.212","Medical nutritional therapy for renal transplantation in the COVID-19 pandemic.","Nutritional therapy is very important at renal transplantation. Nutrition has become more vital for transplantation patients owing to the coronavirus disease 2019 (COVID-19) pandemic. Inadequate nutrition can negatively affect the immune system. For this reason, adequate protein and energy intake should be provided to the patients. Also, overconsumption of saturated fat, sugar, and refined carbohydrates can both negatively affect the immune system and trigger chronic diseases in transplantation ","2021","06","25","World J Transplant","World journal of transplantation","COVID-19; Nutrition; Renal transplantation","Gencer-Bingol","Feray","Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Ankara 06490, Turkey",NA
"1534","34164255","10.1016/j.gfs.2021.100524","Regional impact of COVID-19 on the production and food security of common bean smallholder farmers in Sub-Saharan Africa: Implication for SDG's.","Concerns about the implications of COVID-19 on agriculture and food security in Sub-Saharan Africa abound. Containment measures in response to the pandemic have markedly different outcomes depending on the degree of enforcement of the measures and the existing vulnerabilities pre-COVID. In this descriptive study, we document the possible impacts of the pandemic on bean production and food security using data collected from March to April 2020 in eleven countries in four sub-regions in Sub-Sahara","2021","06","25","Glob Food Sec","Global food security","Agricultural production; COVID 19; Food security; SDG'S; Sub-saharan Africa","Nchanji","Eileen Bogweh","International Center for Tropical Agriculture, Nairobi, Kenya",NA
"1535","34164255","10.1016/j.gfs.2021.100524","Regional impact of COVID-19 on the production and food security of common bean smallholder farmers in Sub-Saharan Africa: Implication for SDG's.","Concerns about the implications of COVID-19 on agriculture and food security in Sub-Saharan Africa abound. Containment measures in response to the pandemic have markedly different outcomes depending on the degree of enforcement of the measures and the existing vulnerabilities pre-COVID. In this descriptive study, we document the possible impacts of the pandemic on bean production and food security using data collected from March to April 2020 in eleven countries in four sub-regions in Sub-Sahara","2021","06","25","Glob Food Sec","Global food security","Agricultural production; COVID 19; Food security; SDG'S; Sub-saharan Africa","Lutomia","Cosmas Kweyu","Kenya Agricultural and Livestock Research Organization, Nairobi, Kenya",NA
"1536","34164236","10.7717/peerj.11584","Dental health care providers' concerns, perceived impact, and preparedness during the COVID-19 pandemic in Saudi Arabia.","Dental health care providers (DHCPs)are at high risk of cross-infection during clinical practice therefore, the aim of the study was to evaluate the DHCPs Covid-19 related concerns, its perceived impact, and their preparedness in Saudi Arabia. This cross-sectional study on DHCPs was carried out at five dental teaching hospitals/colleges in four provinces of Saudi Arabia from October to December 2020. A 35-item valid and reliable questionnaire was used to assess the concerns, perceived impact, an","2021","06","25","PeerJ","PeerJ"," COVID-19;  Dental health care providers;  Dental hospitals; Concerns; Preparedness","Javed","Muhammad Qasim","Department of Conservative Dental Sciences and Endodontics, College of Dentistry, Qassim University, Buraidah, Qassim, Saudi Arabia",NA
"1537","34164236","10.7717/peerj.11584","Dental health care providers' concerns, perceived impact, and preparedness during the COVID-19 pandemic in Saudi Arabia.","Dental health care providers (DHCPs)are at high risk of cross-infection during clinical practice therefore, the aim of the study was to evaluate the DHCPs Covid-19 related concerns, its perceived impact, and their preparedness in Saudi Arabia. This cross-sectional study on DHCPs was carried out at five dental teaching hospitals/colleges in four provinces of Saudi Arabia from October to December 2020. A 35-item valid and reliable questionnaire was used to assess the concerns, perceived impact, an","2021","06","25","PeerJ","PeerJ"," COVID-19;  Dental health care providers;  Dental hospitals; Concerns; Preparedness","Chaudhary","Farooq Ahmad","Department of Community Dentistry, School of Dentistry, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan",NA
"1538","34164236","10.7717/peerj.11584","Dental health care providers' concerns, perceived impact, and preparedness during the COVID-19 pandemic in Saudi Arabia.","Dental health care providers (DHCPs)are at high risk of cross-infection during clinical practice therefore, the aim of the study was to evaluate the DHCPs Covid-19 related concerns, its perceived impact, and their preparedness in Saudi Arabia. This cross-sectional study on DHCPs was carried out at five dental teaching hospitals/colleges in four provinces of Saudi Arabia from October to December 2020. A 35-item valid and reliable questionnaire was used to assess the concerns, perceived impact, an","2021","06","25","PeerJ","PeerJ"," COVID-19;  Dental health care providers;  Dental hospitals; Concerns; Preparedness","Mohsin","Syed Fareed","Department of Oral Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Qassim University, Ar Rass, Qassim, Saudi Arabia",NA
"1539","34164236","10.7717/peerj.11584","Dental health care providers' concerns, perceived impact, and preparedness during the COVID-19 pandemic in Saudi Arabia.","Dental health care providers (DHCPs)are at high risk of cross-infection during clinical practice therefore, the aim of the study was to evaluate the DHCPs Covid-19 related concerns, its perceived impact, and their preparedness in Saudi Arabia. This cross-sectional study on DHCPs was carried out at five dental teaching hospitals/colleges in four provinces of Saudi Arabia from October to December 2020. A 35-item valid and reliable questionnaire was used to assess the concerns, perceived impact, an","2021","06","25","PeerJ","PeerJ"," COVID-19;  Dental health care providers;  Dental hospitals; Concerns; Preparedness","AlAttas","Mustafa Hussein","Department of Conservative Dental Sciences and Endodontics, College of Dentistry, Qassim University, Buraidah, Qassim, Saudi Arabia",NA
"1540","34164236","10.7717/peerj.11584","Dental health care providers' concerns, perceived impact, and preparedness during the COVID-19 pandemic in Saudi Arabia.","Dental health care providers (DHCPs)are at high risk of cross-infection during clinical practice therefore, the aim of the study was to evaluate the DHCPs Covid-19 related concerns, its perceived impact, and their preparedness in Saudi Arabia. This cross-sectional study on DHCPs was carried out at five dental teaching hospitals/colleges in four provinces of Saudi Arabia from October to December 2020. A 35-item valid and reliable questionnaire was used to assess the concerns, perceived impact, an","2021","06","25","PeerJ","PeerJ"," COVID-19;  Dental health care providers;  Dental hospitals; Concerns; Preparedness","Edrees","Hadeel Yaseen","Endodontic Department, Faculty of Dentistry, King Abdulaziz Univeristy, Jeddah, Saudi Arabia",NA
"1541","34164236","10.7717/peerj.11584","Dental health care providers' concerns, perceived impact, and preparedness during the COVID-19 pandemic in Saudi Arabia.","Dental health care providers (DHCPs)are at high risk of cross-infection during clinical practice therefore, the aim of the study was to evaluate the DHCPs Covid-19 related concerns, its perceived impact, and their preparedness in Saudi Arabia. This cross-sectional study on DHCPs was carried out at five dental teaching hospitals/colleges in four provinces of Saudi Arabia from October to December 2020. A 35-item valid and reliable questionnaire was used to assess the concerns, perceived impact, an","2021","06","25","PeerJ","PeerJ"," COVID-19;  Dental health care providers;  Dental hospitals; Concerns; Preparedness","Habib","Syed Rashid","Department of Prosthetic Dental Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia",NA
"1542","34164236","10.7717/peerj.11584","Dental health care providers' concerns, perceived impact, and preparedness during the COVID-19 pandemic in Saudi Arabia.","Dental health care providers (DHCPs)are at high risk of cross-infection during clinical practice therefore, the aim of the study was to evaluate the DHCPs Covid-19 related concerns, its perceived impact, and their preparedness in Saudi Arabia. This cross-sectional study on DHCPs was carried out at five dental teaching hospitals/colleges in four provinces of Saudi Arabia from October to December 2020. A 35-item valid and reliable questionnaire was used to assess the concerns, perceived impact, an","2021","06","25","PeerJ","PeerJ"," COVID-19;  Dental health care providers;  Dental hospitals; Concerns; Preparedness","Riaz","Arham","Community Dentistry, Academy of Continuing Health Education and Research, Islamabad, Pakistan",NA
"1543","34164228","10.1177/21649561211020707","Sleep Disturbances in Individuals Quarantined Due to SARS-CoV-2 Pandemic in Poland: A Mixed Methods Design Study.","The study aimed to assess sleep disturbances in patients subjected to home quarantine due to suspected SARS-CoV-2 infection. The study used a mixed methods design study as a research methodology. A semi-structured interview and the scale for Insomnia Severity Index (ISI) were used to achieve the aim of the study. The survey was conducted from 16 to 20 April 2020 and 1 to 2 September 2020 in Poland, at the during of SARS-CoV-2 epidemic in this country. The data were coded and cross-processed. The","2021","06","25","Glob Adv Health Med","Global advances in health and medicine","COVID-19; anxiety; coronavirus; insomnia; pandemic; quarantine; stress","Krupa","Sabina","Institute of Health Sciences, Medical College of Rzeszow University, Rzeszow, Poland",NA
"1544","34164228","10.1177/21649561211020707","Sleep Disturbances in Individuals Quarantined Due to SARS-CoV-2 Pandemic in Poland: A Mixed Methods Design Study.","The study aimed to assess sleep disturbances in patients subjected to home quarantine due to suspected SARS-CoV-2 infection. The study used a mixed methods design study as a research methodology. A semi-structured interview and the scale for Insomnia Severity Index (ISI) were used to achieve the aim of the study. The survey was conducted from 16 to 20 April 2020 and 1 to 2 September 2020 in Poland, at the during of SARS-CoV-2 epidemic in this country. The data were coded and cross-processed. The","2021","06","25","Glob Adv Health Med","Global advances in health and medicine","COVID-19; anxiety; coronavirus; insomnia; pandemic; quarantine; stress","Pawel","Witt","Polish Association of Anaesthesiology and Intensive Care Nurses, Poznan, Poland",NA
"1545","34164228","10.1177/21649561211020707","Sleep Disturbances in Individuals Quarantined Due to SARS-CoV-2 Pandemic in Poland: A Mixed Methods Design Study.","The study aimed to assess sleep disturbances in patients subjected to home quarantine due to suspected SARS-CoV-2 infection. The study used a mixed methods design study as a research methodology. A semi-structured interview and the scale for Insomnia Severity Index (ISI) were used to achieve the aim of the study. The survey was conducted from 16 to 20 April 2020 and 1 to 2 September 2020 in Poland, at the during of SARS-CoV-2 epidemic in this country. The data were coded and cross-processed. The","2021","06","25","Glob Adv Health Med","Global advances in health and medicine","COVID-19; anxiety; coronavirus; insomnia; pandemic; quarantine; stress","Medrzycka-Dabrowska","Wioletta","Polish Association of Anaesthesiology and Intensive Care Nurses, Poznan, Poland",NA
"1546","34164228","10.1177/21649561211020707","Sleep Disturbances in Individuals Quarantined Due to SARS-CoV-2 Pandemic in Poland: A Mixed Methods Design Study.","The study aimed to assess sleep disturbances in patients subjected to home quarantine due to suspected SARS-CoV-2 infection. The study used a mixed methods design study as a research methodology. A semi-structured interview and the scale for Insomnia Severity Index (ISI) were used to achieve the aim of the study. The survey was conducted from 16 to 20 April 2020 and 1 to 2 September 2020 in Poland, at the during of SARS-CoV-2 epidemic in this country. The data were coded and cross-processed. The","2021","06","25","Glob Adv Health Med","Global advances in health and medicine","COVID-19; anxiety; coronavirus; insomnia; pandemic; quarantine; stress","Lintowska","Agnieszka","Department of Public Health, Faculty of Health Science, Wroclaw Medical University, Wroclaw, Poland",NA
"1547","34164228","10.1177/21649561211020707","Sleep Disturbances in Individuals Quarantined Due to SARS-CoV-2 Pandemic in Poland: A Mixed Methods Design Study.","The study aimed to assess sleep disturbances in patients subjected to home quarantine due to suspected SARS-CoV-2 infection. The study used a mixed methods design study as a research methodology. A semi-structured interview and the scale for Insomnia Severity Index (ISI) were used to achieve the aim of the study. The survey was conducted from 16 to 20 April 2020 and 1 to 2 September 2020 in Poland, at the during of SARS-CoV-2 epidemic in this country. The data were coded and cross-processed. The","2021","06","25","Glob Adv Health Med","Global advances in health and medicine","COVID-19; anxiety; coronavirus; insomnia; pandemic; quarantine; stress","Ozga","Dorota","Institute of Health Sciences, Medical College of Rzeszow University, Rzeszow, Poland",NA
"1548","34164210","10.21037/jtd-20-3342","Policy during coronavirus disease 2019 (COVID-19) pandemic: a protector for acute exacerbation of COPD (AECOPD) patients?",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Zeng","Yuqin","Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China",NA
"1549","34164210","10.21037/jtd-20-3342","Policy during coronavirus disease 2019 (COVID-19) pandemic: a protector for acute exacerbation of COPD (AECOPD) patients?",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Zhou","Zijing","Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China",NA
"1550","34164210","10.21037/jtd-20-3342","Policy during coronavirus disease 2019 (COVID-19) pandemic: a protector for acute exacerbation of COPD (AECOPD) patients?",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Chen","Ping","Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China",NA
"1551","34164190","10.21037/jtd-20-3011","A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study.","Given the high prevalence of coronavirus disease 2019 (COVID-19) globally, and the increased number of patients being discharged, it is necessary to understand the health consequences of COVID-19 to formulate and manage public policy concerning convalescent patients. A longitudinal follow-up investigation of 25 patients from a tertiary hospital in Henan provincial was conducted 8 weeks after discharge. Of these patients, 15 attended a second follow-up appointment 8 weeks after that. A throat swa","2021","06","25","J Thorac Dis","Journal of thoracic disease","Coronavirus disease 2019 (COVID-19); convalescent phase; follow-up","Wang","Ziqi","Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China",NA
"1552","34164190","10.21037/jtd-20-3011","A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study.","Given the high prevalence of coronavirus disease 2019 (COVID-19) globally, and the increased number of patients being discharged, it is necessary to understand the health consequences of COVID-19 to formulate and manage public policy concerning convalescent patients. A longitudinal follow-up investigation of 25 patients from a tertiary hospital in Henan provincial was conducted 8 weeks after discharge. Of these patients, 15 attended a second follow-up appointment 8 weeks after that. A throat swa","2021","06","25","J Thorac Dis","Journal of thoracic disease","Coronavirus disease 2019 (COVID-19); convalescent phase; follow-up","Yang","Li","Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China",NA
"1553","34164190","10.21037/jtd-20-3011","A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study.","Given the high prevalence of coronavirus disease 2019 (COVID-19) globally, and the increased number of patients being discharged, it is necessary to understand the health consequences of COVID-19 to formulate and manage public policy concerning convalescent patients. A longitudinal follow-up investigation of 25 patients from a tertiary hospital in Henan provincial was conducted 8 weeks after discharge. Of these patients, 15 attended a second follow-up appointment 8 weeks after that. A throat swa","2021","06","25","J Thorac Dis","Journal of thoracic disease","Coronavirus disease 2019 (COVID-19); convalescent phase; follow-up","Chen","Yi","Clinical Research Service Centre, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China",NA
"1554","34164190","10.21037/jtd-20-3011","A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study.","Given the high prevalence of coronavirus disease 2019 (COVID-19) globally, and the increased number of patients being discharged, it is necessary to understand the health consequences of COVID-19 to formulate and manage public policy concerning convalescent patients. A longitudinal follow-up investigation of 25 patients from a tertiary hospital in Henan provincial was conducted 8 weeks after discharge. Of these patients, 15 attended a second follow-up appointment 8 weeks after that. A throat swa","2021","06","25","J Thorac Dis","Journal of thoracic disease","Coronavirus disease 2019 (COVID-19); convalescent phase; follow-up","Xu","Zhiwei","Clinical Research Service Centre, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China",NA
"1555","34164190","10.21037/jtd-20-3011","A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study.","Given the high prevalence of coronavirus disease 2019 (COVID-19) globally, and the increased number of patients being discharged, it is necessary to understand the health consequences of COVID-19 to formulate and manage public policy concerning convalescent patients. A longitudinal follow-up investigation of 25 patients from a tertiary hospital in Henan provincial was conducted 8 weeks after discharge. Of these patients, 15 attended a second follow-up appointment 8 weeks after that. A throat swa","2021","06","25","J Thorac Dis","Journal of thoracic disease","Coronavirus disease 2019 (COVID-19); convalescent phase; follow-up","Wang","Hui","Xinxiang Medical School, Xinxiang, China",NA
"1556","34164190","10.21037/jtd-20-3011","A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study.","Given the high prevalence of coronavirus disease 2019 (COVID-19) globally, and the increased number of patients being discharged, it is necessary to understand the health consequences of COVID-19 to formulate and manage public policy concerning convalescent patients. A longitudinal follow-up investigation of 25 patients from a tertiary hospital in Henan provincial was conducted 8 weeks after discharge. Of these patients, 15 attended a second follow-up appointment 8 weeks after that. A throat swa","2021","06","25","J Thorac Dis","Journal of thoracic disease","Coronavirus disease 2019 (COVID-19); convalescent phase; follow-up","Zhang","Xiaoju","Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China",NA
"1557","34164162","10.21037/jtd-21-295","Lung ultrasound may improve COVID-19 safety protocols.",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Skoczynski","Szymon","Department of Pneumonology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland",NA
"1558","34164162","10.21037/jtd-21-295","Lung ultrasound may improve COVID-19 safety protocols.",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Buda","Natalia","Internal Medicine, Connective Tissue Diseases and Geriatrics Department, Medical University of Gdansk, Gdansk, Poland",NA
"1559","34164162","10.21037/jtd-21-295","Lung ultrasound may improve COVID-19 safety protocols.",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Mendrala","Konrad","Department of Anaesthesiology and Intensive Care, Medical University of Silesia, Katowice, Poland",NA
"1560","34164162","10.21037/jtd-21-295","Lung ultrasound may improve COVID-19 safety protocols.",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Górecki","Tomasz","Department of Medical Education of the Jagiellonian University Medical College, Kraków, Poland",NA
"1561","34164162","10.21037/jtd-21-295","Lung ultrasound may improve COVID-19 safety protocols.",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Kucewicz-Czech","Ewa","Department of Anaesthesiology and Intensive Care, Medical University of Silesia, Katowice, Poland",NA
"1562","34164162","10.21037/jtd-21-295","Lung ultrasound may improve COVID-19 safety protocols.",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Krzych","Lukasz","Department of Anaesthesiology and Intensive Care, Medical University of Silesia, Katowice, Poland",NA
"1563","34164162","10.21037/jtd-21-295","Lung ultrasound may improve COVID-19 safety protocols.",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Koszutski","Tomasz","Department of Pediatric Surgery and Pediatric Urology, Upper Silesian Child Health Centre, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland",NA
"1564","34164162","10.21037/jtd-21-295","Lung ultrasound may improve COVID-19 safety protocols.",NA,"2021","06","25","J Thorac Dis","Journal of thoracic disease",NA,"Darocha","Tomasz","Department of Anaesthesiology and Intensive Care, Medical University of Silesia, Katowice, Poland",NA
"1565","34164155","10.1017/cts.2021.400","Foreword to the JCTS COVID-19 special issue.",NA,"2021","06","24","J Clin Transl Sci","Journal of clinical and translational science",NA,"Austin","Christopher P","National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA",NA
"1566","34164155","10.1017/cts.2021.400","Foreword to the JCTS COVID-19 special issue.",NA,"2021","06","24","J Clin Transl Sci","Journal of clinical and translational science",NA,"Jonson","Samantha","National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA",NA
"1567","34164155","10.1017/cts.2021.400","Foreword to the JCTS COVID-19 special issue.",NA,"2021","06","24","J Clin Transl Sci","Journal of clinical and translational science",NA,"Kurilla","Michael G","National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA",NA
"1568","34164147","10.1107/S2056989021005442","Crystal structure and mol-ecular docking study of (<i>E</i>)-2-{[(<i>E</i>)-2-hy-droxy-5-methyl-benzyl-idene]hydrazinyl-idene}-1,2-di-phenyl-ethan-1-one.","The title compound, C22H18N2O2, is a Schiff base that exists in the phenol-imine tautomeric form and adopts an E configuration with respect to the C=N bond. The mol-ecular structure is stabilized by an O-H<U+22EF>N hydrogen bond, forming an S(6) ring motif. In the crystal, pairs of C-H<U+22EF>O hydrogen bonds link the mol-ecules to form inversion dimers. Weak p-p stacking inter-actions along the a-axis direction provide additional stabilization ","2021","06","25","Acta Crystallogr E Crystallogr Commun","Acta crystallographica. Section E, Crystallographic communications","COVID-19 main protease; Schiff base; crystal structure; di­phenyl­ethan; mol­ecular docking","Kansiz","Sevgi","Samsun University, Faculty of Engineering, Department of Fundamental Sciences, 55420, Samsun, Turkey",NA
"1569","34164147","10.1107/S2056989021005442","Crystal structure and mol-ecular docking study of (<i>E</i>)-2-{[(<i>E</i>)-2-hy-droxy-5-methyl-benzyl-idene]hydrazinyl-idene}-1,2-di-phenyl-ethan-1-one.","The title compound, C22H18N2O2, is a Schiff base that exists in the phenol-imine tautomeric form and adopts an E configuration with respect to the C=N bond. The mol-ecular structure is stabilized by an O-H<U+22EF>N hydrogen bond, forming an S(6) ring motif. In the crystal, pairs of C-H<U+22EF>O hydrogen bonds link the mol-ecules to form inversion dimers. Weak p-p stacking inter-actions along the a-axis direction provide additional stabilization ","2021","06","25","Acta Crystallogr E Crystallogr Commun","Acta crystallographica. Section E, Crystallographic communications","COVID-19 main protease; Schiff base; crystal structure; di­phenyl­ethan; mol­ecular docking","Tatlidil","Digdem","Ondokuz Mayis University, Faculty of Arts and Sciences, Department of Chemistry, 55139, Samsun, Turkey",NA
"1570","34164147","10.1107/S2056989021005442","Crystal structure and mol-ecular docking study of (<i>E</i>)-2-{[(<i>E</i>)-2-hy-droxy-5-methyl-benzyl-idene]hydrazinyl-idene}-1,2-di-phenyl-ethan-1-one.","The title compound, C22H18N2O2, is a Schiff base that exists in the phenol-imine tautomeric form and adopts an E configuration with respect to the C=N bond. The mol-ecular structure is stabilized by an O-H<U+22EF>N hydrogen bond, forming an S(6) ring motif. In the crystal, pairs of C-H<U+22EF>O hydrogen bonds link the mol-ecules to form inversion dimers. Weak p-p stacking inter-actions along the a-axis direction provide additional stabilization ","2021","06","25","Acta Crystallogr E Crystallogr Commun","Acta crystallographica. Section E, Crystallographic communications","COVID-19 main protease; Schiff base; crystal structure; di­phenyl­ethan; mol­ecular docking","Dege","Necmi","Ondokuz Mayis University, Faculty of Arts and Sciences, Department of Physics, 55139, Samsun, Turkey",NA
"1571","34164147","10.1107/S2056989021005442","Crystal structure and mol-ecular docking study of (<i>E</i>)-2-{[(<i>E</i>)-2-hy-droxy-5-methyl-benzyl-idene]hydrazinyl-idene}-1,2-di-phenyl-ethan-1-one.","The title compound, C22H18N2O2, is a Schiff base that exists in the phenol-imine tautomeric form and adopts an E configuration with respect to the C=N bond. The mol-ecular structure is stabilized by an O-H<U+22EF>N hydrogen bond, forming an S(6) ring motif. In the crystal, pairs of C-H<U+22EF>O hydrogen bonds link the mol-ecules to form inversion dimers. Weak p-p stacking inter-actions along the a-axis direction provide additional stabilization ","2021","06","25","Acta Crystallogr E Crystallogr Commun","Acta crystallographica. Section E, Crystallographic communications","COVID-19 main protease; Schiff base; crystal structure; di­phenyl­ethan; mol­ecular docking","Aktas","Feyzi Alkim","Samsun University, Faculty of Engineering, Biomedical Engineering, 55420, Samsun, Turkey",NA
"1572","34164147","10.1107/S2056989021005442","Crystal structure and mol-ecular docking study of (<i>E</i>)-2-{[(<i>E</i>)-2-hy-droxy-5-methyl-benzyl-idene]hydrazinyl-idene}-1,2-di-phenyl-ethan-1-one.","The title compound, C22H18N2O2, is a Schiff base that exists in the phenol-imine tautomeric form and adopts an E configuration with respect to the C=N bond. The mol-ecular structure is stabilized by an O-H<U+22EF>N hydrogen bond, forming an S(6) ring motif. In the crystal, pairs of C-H<U+22EF>O hydrogen bonds link the mol-ecules to form inversion dimers. Weak p-p stacking inter-actions along the a-axis direction provide additional stabilization ","2021","06","25","Acta Crystallogr E Crystallogr Commun","Acta crystallographica. Section E, Crystallographic communications","COVID-19 main protease; Schiff base; crystal structure; di­phenyl­ethan; mol­ecular docking","Al-Asbahy","Samir Osman Mohammed","Ibb University, Science College, Department of Physics, Ibb, Yemen",NA
"1573","34164147","10.1107/S2056989021005442","Crystal structure and mol-ecular docking study of (<i>E</i>)-2-{[(<i>E</i>)-2-hy-droxy-5-methyl-benzyl-idene]hydrazinyl-idene}-1,2-di-phenyl-ethan-1-one.","The title compound, C22H18N2O2, is a Schiff base that exists in the phenol-imine tautomeric form and adopts an E configuration with respect to the C=N bond. The mol-ecular structure is stabilized by an O-H<U+22EF>N hydrogen bond, forming an S(6) ring motif. In the crystal, pairs of C-H<U+22EF>O hydrogen bonds link the mol-ecules to form inversion dimers. Weak p-p stacking inter-actions along the a-axis direction provide additional stabilization ","2021","06","25","Acta Crystallogr E Crystallogr Commun","Acta crystallographica. Section E, Crystallographic communications","COVID-19 main protease; Schiff base; crystal structure; di­phenyl­ethan; mol­ecular docking","Alaman Agar","Aysen","Ondokuz Mayis University, Faculty of Arts and Sciences, Department of Chemistry, 55139, Samsun, Turkey",NA
"1574","34164126","10.1177/20503121211022973","Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis.","Non-pharmaceutical interventions (e.g. quarantine and isolation) are used to mitigate and control viral infectious disease, but their effectiveness has not been well studied. For COVID-19, disease control efforts will rely on non-pharmaceutical interventions until pharmaceutical interventions become widely available, while non-pharmaceutical interventions will be of continued importance thereafter. This rapid evidence-based review provides both qualitative and quantitative analyses of the effect","2021","06","25","SAGE Open Med","SAGE open medicine","COVID-19; Quarantine; incidence; influenza pandemic 19181919; mortality; non-pharmaceutical interventions; pandemics; patient isolation; transmission","Rizvi","Rubina F","IBM Watson Health , Cambridge, MA, USA",NA
"1575","34164126","10.1177/20503121211022973","Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis.","Non-pharmaceutical interventions (e.g. quarantine and isolation) are used to mitigate and control viral infectious disease, but their effectiveness has not been well studied. For COVID-19, disease control efforts will rely on non-pharmaceutical interventions until pharmaceutical interventions become widely available, while non-pharmaceutical interventions will be of continued importance thereafter. This rapid evidence-based review provides both qualitative and quantitative analyses of the effect","2021","06","25","SAGE Open Med","SAGE open medicine","COVID-19; Quarantine; incidence; influenza pandemic 19181919; mortality; non-pharmaceutical interventions; pandemics; patient isolation; transmission","Craig","Kelly J Thomas","IBM Watson Health , Cambridge, MA, USA",NA
"1576","34164126","10.1177/20503121211022973","Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis.","Non-pharmaceutical interventions (e.g. quarantine and isolation) are used to mitigate and control viral infectious disease, but their effectiveness has not been well studied. For COVID-19, disease control efforts will rely on non-pharmaceutical interventions until pharmaceutical interventions become widely available, while non-pharmaceutical interventions will be of continued importance thereafter. This rapid evidence-based review provides both qualitative and quantitative analyses of the effect","2021","06","25","SAGE Open Med","SAGE open medicine","COVID-19; Quarantine; incidence; influenza pandemic 19181919; mortality; non-pharmaceutical interventions; pandemics; patient isolation; transmission","Hekmat","Rezzan","IBM Watson Health , Cambridge, MA, USA",NA
"1577","34164126","10.1177/20503121211022973","Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis.","Non-pharmaceutical interventions (e.g. quarantine and isolation) are used to mitigate and control viral infectious disease, but their effectiveness has not been well studied. For COVID-19, disease control efforts will rely on non-pharmaceutical interventions until pharmaceutical interventions become widely available, while non-pharmaceutical interventions will be of continued importance thereafter. This rapid evidence-based review provides both qualitative and quantitative analyses of the effect","2021","06","25","SAGE Open Med","SAGE open medicine","COVID-19; Quarantine; incidence; influenza pandemic 19181919; mortality; non-pharmaceutical interventions; pandemics; patient isolation; transmission","Reyes","Fredy","IBM Watson Health , Cambridge, MA, USA",NA
"1578","34164126","10.1177/20503121211022973","Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis.","Non-pharmaceutical interventions (e.g. quarantine and isolation) are used to mitigate and control viral infectious disease, but their effectiveness has not been well studied. For COVID-19, disease control efforts will rely on non-pharmaceutical interventions until pharmaceutical interventions become widely available, while non-pharmaceutical interventions will be of continued importance thereafter. This rapid evidence-based review provides both qualitative and quantitative analyses of the effect","2021","06","25","SAGE Open Med","SAGE open medicine","COVID-19; Quarantine; incidence; influenza pandemic 19181919; mortality; non-pharmaceutical interventions; pandemics; patient isolation; transmission","South","Brett","IBM Watson Health , Cambridge, MA, USA",NA
"1579","34164126","10.1177/20503121211022973","Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis.","Non-pharmaceutical interventions (e.g. quarantine and isolation) are used to mitigate and control viral infectious disease, but their effectiveness has not been well studied. For COVID-19, disease control efforts will rely on non-pharmaceutical interventions until pharmaceutical interventions become widely available, while non-pharmaceutical interventions will be of continued importance thereafter. This rapid evidence-based review provides both qualitative and quantitative analyses of the effect","2021","06","25","SAGE Open Med","SAGE open medicine","COVID-19; Quarantine; incidence; influenza pandemic 19181919; mortality; non-pharmaceutical interventions; pandemics; patient isolation; transmission","Rosario","Bedda","IBM Watson Health , Cambridge, MA, USA",NA
"1580","34164126","10.1177/20503121211022973","Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis.","Non-pharmaceutical interventions (e.g. quarantine and isolation) are used to mitigate and control viral infectious disease, but their effectiveness has not been well studied. For COVID-19, disease control efforts will rely on non-pharmaceutical interventions until pharmaceutical interventions become widely available, while non-pharmaceutical interventions will be of continued importance thereafter. This rapid evidence-based review provides both qualitative and quantitative analyses of the effect","2021","06","25","SAGE Open Med","SAGE open medicine","COVID-19; Quarantine; incidence; influenza pandemic 19181919; mortality; non-pharmaceutical interventions; pandemics; patient isolation; transmission","Kassler","William J","IBM Watson Health , Cambridge, MA, USA",NA
"1581","34164126","10.1177/20503121211022973","Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis.","Non-pharmaceutical interventions (e.g. quarantine and isolation) are used to mitigate and control viral infectious disease, but their effectiveness has not been well studied. For COVID-19, disease control efforts will rely on non-pharmaceutical interventions until pharmaceutical interventions become widely available, while non-pharmaceutical interventions will be of continued importance thereafter. This rapid evidence-based review provides both qualitative and quantitative analyses of the effect","2021","06","25","SAGE Open Med","SAGE open medicine","COVID-19; Quarantine; incidence; influenza pandemic 19181919; mortality; non-pharmaceutical interventions; pandemics; patient isolation; transmission","Jackson","Gretchen P","IBM Watson Health , Cambridge, MA, USA",NA
"1582","34164119","10.1007/s13755-021-00152-w","New bag of deep visual words based features to classify chest x-ray images for COVID-19 diagnosis.","Because the infection by Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) causes the Pneumonia-like effect in the lung, the examination of Chest X-Rays (CXR) can help diagnose the disease. For automatic analysis of images, they are represented in machines by a set of semantic features. Deep Learning (DL) models are widely used to extract features from images. General deep features extracted from intermediate layers may not be appropriate to represent CXR images as they have a few seman","2021","06","25","Health Inf Sci Syst","Health information science and systems","Bag of deep visual words (BoDVW); Bag of visual words (BoVW); COVID-19; Chest X-ray; Deep features; SARS-CoV-2","Sitaula","Chiranjibi","School of Information Technology, Deakin University, 75 Pigdons Rd, Waurn Ponds, Melbourne, VIC 3216 Australia",NA
"1583","34164119","10.1007/s13755-021-00152-w","New bag of deep visual words based features to classify chest x-ray images for COVID-19 diagnosis.","Because the infection by Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) causes the Pneumonia-like effect in the lung, the examination of Chest X-Rays (CXR) can help diagnose the disease. For automatic analysis of images, they are represented in machines by a set of semantic features. Deep Learning (DL) models are widely used to extract features from images. General deep features extracted from intermediate layers may not be appropriate to represent CXR images as they have a few seman","2021","06","25","Health Inf Sci Syst","Health information science and systems","Bag of deep visual words (BoDVW); Bag of visual words (BoVW); COVID-19; Chest X-ray; Deep features; SARS-CoV-2","Aryal","Sunil","School of Information Technology, Deakin University, 75 Pigdons Rd, Waurn Ponds, Melbourne, VIC 3216 Australia",NA
"1584","34163908","10.1039/d0sc05330a","Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling.","Probing the conformational and functional hotspot sites within aqueous native protein complexes is still a challenging task. Herein, a mass spectrometry (MS)-based two-step isotope labeling-lysine reactivity profiling (TILLRP) strategy is developed to quantify the reactivities of lysine residues and probe the molecular details of protein-protein interactions as well as evaluate the conformational interventions by small-molecule active compounds. The hotspot lysine sites that are crucial to the S","2021","06","25","Chem Sci","Chemical science",NA,"Liu","Zheyi","CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences Dalian 116023 China wangfj@dicp.ac","wangfj@dicp.ac.cn"
"1585","34163908","10.1039/d0sc05330a","Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling.","Probing the conformational and functional hotspot sites within aqueous native protein complexes is still a challenging task. Herein, a mass spectrometry (MS)-based two-step isotope labeling-lysine reactivity profiling (TILLRP) strategy is developed to quantify the reactivities of lysine residues and probe the molecular details of protein-protein interactions as well as evaluate the conformational interventions by small-molecule active compounds. The hotspot lysine sites that are crucial to the S","2021","06","25","Chem Sci","Chemical science",NA,"Zhang","Wenxiang","CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences Dalian 116023 China wangfj@dicp.ac","wangfj@dicp.ac.cn"
"1586","34163908","10.1039/d0sc05330a","Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling.","Probing the conformational and functional hotspot sites within aqueous native protein complexes is still a challenging task. Herein, a mass spectrometry (MS)-based two-step isotope labeling-lysine reactivity profiling (TILLRP) strategy is developed to quantify the reactivities of lysine residues and probe the molecular details of protein-protein interactions as well as evaluate the conformational interventions by small-molecule active compounds. The hotspot lysine sites that are crucial to the S","2021","06","25","Chem Sci","Chemical science",NA,"Sun","Binwen","CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences Dalian 116023 China wangfj@dicp.ac","wangfj@dicp.ac.cn"
"1587","34163908","10.1039/d0sc05330a","Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling.","Probing the conformational and functional hotspot sites within aqueous native protein complexes is still a challenging task. Herein, a mass spectrometry (MS)-based two-step isotope labeling-lysine reactivity profiling (TILLRP) strategy is developed to quantify the reactivities of lysine residues and probe the molecular details of protein-protein interactions as well as evaluate the conformational interventions by small-molecule active compounds. The hotspot lysine sites that are crucial to the S","2021","06","25","Chem Sci","Chemical science",NA,"Ma","Yaolu","CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences Dalian 116023 China wangfj@dicp.ac","wangfj@dicp.ac.cn"
"1588","34163908","10.1039/d0sc05330a","Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling.","Probing the conformational and functional hotspot sites within aqueous native protein complexes is still a challenging task. Herein, a mass spectrometry (MS)-based two-step isotope labeling-lysine reactivity profiling (TILLRP) strategy is developed to quantify the reactivities of lysine residues and probe the molecular details of protein-protein interactions as well as evaluate the conformational interventions by small-molecule active compounds. The hotspot lysine sites that are crucial to the S","2021","06","25","Chem Sci","Chemical science",NA,"He","Min","CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences Dalian 116023 China wangfj@dicp.ac","wangfj@dicp.ac.cn"
"1589","34163908","10.1039/d0sc05330a","Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling.","Probing the conformational and functional hotspot sites within aqueous native protein complexes is still a challenging task. Herein, a mass spectrometry (MS)-based two-step isotope labeling-lysine reactivity profiling (TILLRP) strategy is developed to quantify the reactivities of lysine residues and probe the molecular details of protein-protein interactions as well as evaluate the conformational interventions by small-molecule active compounds. The hotspot lysine sites that are crucial to the S","2021","06","25","Chem Sci","Chemical science",NA,"Pan","Yuanjiang","Department of Chemistry, Zhejiang University Hangzhou 310027 China",NA
"1590","34163908","10.1039/d0sc05330a","Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling.","Probing the conformational and functional hotspot sites within aqueous native protein complexes is still a challenging task. Herein, a mass spectrometry (MS)-based two-step isotope labeling-lysine reactivity profiling (TILLRP) strategy is developed to quantify the reactivities of lysine residues and probe the molecular details of protein-protein interactions as well as evaluate the conformational interventions by small-molecule active compounds. The hotspot lysine sites that are crucial to the S","2021","06","25","Chem Sci","Chemical science",NA,"Wang","Fangjun","CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences Dalian 116023 China wangfj@dicp.ac","wangfj@dicp.ac.cn"
"1591","34163906","10.1039/d0sc06195f","Mechanism of inhibition of SARS-CoV-2 M<sup>pro</sup> by <b>N3</b> peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.","The SARS-CoV-2 main protease (M<sup>pro</sup>) is essential for replication of the virus responsible for the COVID-19 pandemic, and one of the main targets for drug design. Here, we simulate the inhibition process of SARS-CoV-2 M<sup>pro</sup> with a known Michael acceptor (peptidyl) inhibitor, N3. The free energy landscape for the mechanism of the formation of the covalent enzyme-inhibitor product is computed with QM/MM molecular dynamics methods. The simulations show a two-step mechanis","2021","06","25","Chem Sci","Chemical science",NA,"Arafet","Kemel","Departament de Química Física i Analítica, Universitat Jaume I 12071 Castelló Spain swiderek@uji.es moliner@uji","swiderek@uji.es"
"1592","34163906","10.1039/d0sc06195f","Mechanism of inhibition of SARS-CoV-2 M<sup>pro</sup> by <b>N3</b> peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.","The SARS-CoV-2 main protease (M<sup>pro</sup>) is essential for replication of the virus responsible for the COVID-19 pandemic, and one of the main targets for drug design. Here, we simulate the inhibition process of SARS-CoV-2 M<sup>pro</sup> with a known Michael acceptor (peptidyl) inhibitor, N3. The free energy landscape for the mechanism of the formation of the covalent enzyme-inhibitor product is computed with QM/MM molecular dynamics methods. The simulations show a two-step mechanis","2021","06","25","Chem Sci","Chemical science",NA,"Serrano-Aparicio","Natalia","Departament de Química Física i Analítica, Universitat Jaume I 12071 Castelló Spain swiderek@uji.es moliner@uji","swiderek@uji.es"
"1593","34163906","10.1039/d0sc06195f","Mechanism of inhibition of SARS-CoV-2 M<sup>pro</sup> by <b>N3</b> peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.","The SARS-CoV-2 main protease (M<sup>pro</sup>) is essential for replication of the virus responsible for the COVID-19 pandemic, and one of the main targets for drug design. Here, we simulate the inhibition process of SARS-CoV-2 M<sup>pro</sup> with a known Michael acceptor (peptidyl) inhibitor, N3. The free energy landscape for the mechanism of the formation of the covalent enzyme-inhibitor product is computed with QM/MM molecular dynamics methods. The simulations show a two-step mechanis","2021","06","25","Chem Sci","Chemical science",NA,"Lodola","Alessio","Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma Italy",NA
"1594","34163906","10.1039/d0sc06195f","Mechanism of inhibition of SARS-CoV-2 M<sup>pro</sup> by <b>N3</b> peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.","The SARS-CoV-2 main protease (M<sup>pro</sup>) is essential for replication of the virus responsible for the COVID-19 pandemic, and one of the main targets for drug design. Here, we simulate the inhibition process of SARS-CoV-2 M<sup>pro</sup> with a known Michael acceptor (peptidyl) inhibitor, N3. The free energy landscape for the mechanism of the formation of the covalent enzyme-inhibitor product is computed with QM/MM molecular dynamics methods. The simulations show a two-step mechanis","2021","06","25","Chem Sci","Chemical science",NA,"Mulholland","Adrian J","Centre for Computational Chemistry, School of Chemistry, University of Bristol UK",NA
"1595","34163906","10.1039/d0sc06195f","Mechanism of inhibition of SARS-CoV-2 M<sup>pro</sup> by <b>N3</b> peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.","The SARS-CoV-2 main protease (M<sup>pro</sup>) is essential for replication of the virus responsible for the COVID-19 pandemic, and one of the main targets for drug design. Here, we simulate the inhibition process of SARS-CoV-2 M<sup>pro</sup> with a known Michael acceptor (peptidyl) inhibitor, N3. The free energy landscape for the mechanism of the formation of the covalent enzyme-inhibitor product is computed with QM/MM molecular dynamics methods. The simulations show a two-step mechanis","2021","06","25","Chem Sci","Chemical science",NA,"González","Florenci V","Departament de Química Inorgànica i Orgànica, Universitat Jaume I 12071 Castelló Spain",NA
"1596","34163906","10.1039/d0sc06195f","Mechanism of inhibition of SARS-CoV-2 M<sup>pro</sup> by <b>N3</b> peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.","The SARS-CoV-2 main protease (M<sup>pro</sup>) is essential for replication of the virus responsible for the COVID-19 pandemic, and one of the main targets for drug design. Here, we simulate the inhibition process of SARS-CoV-2 M<sup>pro</sup> with a known Michael acceptor (peptidyl) inhibitor, N3. The free energy landscape for the mechanism of the formation of the covalent enzyme-inhibitor product is computed with QM/MM molecular dynamics methods. The simulations show a two-step mechanis","2021","06","25","Chem Sci","Chemical science",NA,"Swiderek","Katarzyna","Departament de Química Física i Analítica, Universitat Jaume I 12071 Castelló Spain swiderek@uji.es moliner@uji","swiderek@uji.es"
"1597","34163906","10.1039/d0sc06195f","Mechanism of inhibition of SARS-CoV-2 M<sup>pro</sup> by <b>N3</b> peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.","The SARS-CoV-2 main protease (M<sup>pro</sup>) is essential for replication of the virus responsible for the COVID-19 pandemic, and one of the main targets for drug design. Here, we simulate the inhibition process of SARS-CoV-2 M<sup>pro</sup> with a known Michael acceptor (peptidyl) inhibitor, N3. The free energy landscape for the mechanism of the formation of the covalent enzyme-inhibitor product is computed with QM/MM molecular dynamics methods. The simulations show a two-step mechanis","2021","06","25","Chem Sci","Chemical science",NA,"Moliner","Vicent","Departament de Química Física i Analítica, Universitat Jaume I 12071 Castelló Spain swiderek@uji.es moliner@uji","swiderek@uji.es"
"1598","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"Cheng","Yangyang","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1599","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"Pham","Anh-Tuan","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1600","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"Kato","Takehiro","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1601","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"Lim","Bumhee","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1602","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"Moreau","Dimitri","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1603","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"López-Andarias","Javier","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1604","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"Zong","Lili","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1605","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"Sakai","Naomi","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1606","34163793","10.1039/d0sc05447j","Inhibitors of thiol-mediated uptake.","Ellman's reagent has caused substantial confusion and concern as a probe for thiol-mediated uptake because it is the only established inhibitor available but works neither efficiently nor reliably. Here we use fluorescent cyclic oligochalcogenides that enter cells by thiol-mediated uptake to systematically screen for more potent inhibitors, including epidithiodiketopiperazines, benzopolysulfanes, disulfide-bridged <U+03B3>-turned peptides, heteroaromatic sulfones and cyclic thiosulfonates, thiosulfinat","2021","06","25","Chem Sci","Chemical science",NA,"Matile","Stefan","Department of Organic Chemistry, University of Geneva Geneva Switzerland stefan.matile@unige.ch http://www.unige.ch/sciences/chiorg/matile/ +41 22 379 6523","stefan.matile@unige.ch"
"1607","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Feng","Wei","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1608","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Newbigging","Ashley M","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1609","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Tao","Jeffrey","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1610","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Cao","Yiren","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1611","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Peng","Hanyong","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1612","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Le","Connie","Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2E1 Canada",NA
"1613","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Wu","Jinjun","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1614","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Pang","Bo","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1615","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Li","Juan","School of Public Health, Jilin University 1163 Xinmin Street Changchun Jilin 130021 China",NA
"1616","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Tyrrell","D Lorne","Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2E1 Canada",NA
"1617","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Zhang","Hongquan","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1618","34163728","10.1039/d0sc06973f","CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.","Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have transformed the field of genome editing and transcriptional modulation. Progress in CRISPR-Cas technology has also advanced molecular detection of diverse targets, ranging from nucleic acids to proteins. Incorporating CRISPR-Cas systems with various nucleic acid amplification strategies enables the generation of amplified detection signals, enrichment of low-abundance molecular tar","2021","06","25","Chem Sci","Chemical science",NA,"Le","X Chris","Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada xc.le@ualberta.ca hongquan@ualberta.ca +1-780-492-7800 +1-780-492-6416","xc.le@ualberta.ca"
"1619","34163622","10.1039/d0sc04978f","A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.","The irreversible inhibition of the main protease of SARS-CoV-2 by a Michael acceptor known as N3 has been investigated using multiscale methods. The noncovalent enzyme-inhibitor complex was simulated using classical molecular dynamics techniques and the pose of the inhibitor in the active site was compared to that of the natural substrate, a peptide containing the Gln-Ser scissile bond. The formation of the covalent enzyme-inhibitor complex was then simulated using hybrid QM/MM free energy metho","2021","06","25","Chem Sci","Chemical science",NA,"Ramos-Guzmán","Carlos A","Departamento de Química Física, Universidad de Valencia 46100 Burjassot Spain ignacio.tunon@uv.es j.javier.ruiz@uv",NA
"1620","34163622","10.1039/d0sc04978f","A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.","The irreversible inhibition of the main protease of SARS-CoV-2 by a Michael acceptor known as N3 has been investigated using multiscale methods. The noncovalent enzyme-inhibitor complex was simulated using classical molecular dynamics techniques and the pose of the inhibitor in the active site was compared to that of the natural substrate, a peptide containing the Gln-Ser scissile bond. The formation of the covalent enzyme-inhibitor complex was then simulated using hybrid QM/MM free energy metho","2021","06","25","Chem Sci","Chemical science",NA,"Ruiz-Pernía","J Javier","Departamento de Química Física, Universidad de Valencia 46100 Burjassot Spain ignacio.tunon@uv.es j.javier.ruiz@uv",NA
"1621","34163622","10.1039/d0sc04978f","A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.","The irreversible inhibition of the main protease of SARS-CoV-2 by a Michael acceptor known as N3 has been investigated using multiscale methods. The noncovalent enzyme-inhibitor complex was simulated using classical molecular dynamics techniques and the pose of the inhibitor in the active site was compared to that of the natural substrate, a peptide containing the Gln-Ser scissile bond. The formation of the covalent enzyme-inhibitor complex was then simulated using hybrid QM/MM free energy metho","2021","06","25","Chem Sci","Chemical science",NA,"Tuñón","Iñaki","Departamento de Química Física, Universidad de Valencia 46100 Burjassot Spain ignacio.tunon@uv.es j.javier.ruiz@uv",NA
"1622","34163551","10.1177/1941874420977308","Partial Recanalization of a Large Vessel Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator, Followed by Systemic Anticoagulation, in the Setting of COVID-19-Induced Hypercoagulability: A Case Report.","We report on the use of systemic heparinization following thrombolysis with intravenous tissue plasminogen activator (t-PA) for acute ischemic large vessel stroke, in the setting of COVID-19-induced hypercoagulability, with partial recanalization of the internal carotid artery. Off-label systemic heparinization was used within 12 hours of t-PA administration, after extensive multidisciplinary collaboration and family discussion, given evidence of severe hypercoagulability. We conclude that throm","2021","06","25","Neurohospitalist","The Neurohospitalist","COVID-19; anticoagulation; case report; ischemic stroke; tissue plasminogen activator","LaBarbera","Vincent A","Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA",NA
"1623","34163551","10.1177/1941874420977308","Partial Recanalization of a Large Vessel Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator, Followed by Systemic Anticoagulation, in the Setting of COVID-19-Induced Hypercoagulability: A Case Report.","We report on the use of systemic heparinization following thrombolysis with intravenous tissue plasminogen activator (t-PA) for acute ischemic large vessel stroke, in the setting of COVID-19-induced hypercoagulability, with partial recanalization of the internal carotid artery. Off-label systemic heparinization was used within 12 hours of t-PA administration, after extensive multidisciplinary collaboration and family discussion, given evidence of severe hypercoagulability. We conclude that throm","2021","06","25","Neurohospitalist","The Neurohospitalist","COVID-19; anticoagulation; case report; ischemic stroke; tissue plasminogen activator","Azher","Aidan","Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA",NA
"1624","34163551","10.1177/1941874420977308","Partial Recanalization of a Large Vessel Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator, Followed by Systemic Anticoagulation, in the Setting of COVID-19-Induced Hypercoagulability: A Case Report.","We report on the use of systemic heparinization following thrombolysis with intravenous tissue plasminogen activator (t-PA) for acute ischemic large vessel stroke, in the setting of COVID-19-induced hypercoagulability, with partial recanalization of the internal carotid artery. Off-label systemic heparinization was used within 12 hours of t-PA administration, after extensive multidisciplinary collaboration and family discussion, given evidence of severe hypercoagulability. We conclude that throm","2021","06","25","Neurohospitalist","The Neurohospitalist","COVID-19; anticoagulation; case report; ischemic stroke; tissue plasminogen activator","Jayaraman","Mahesh V","Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA",NA
"1625","34163551","10.1177/1941874420977308","Partial Recanalization of a Large Vessel Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator, Followed by Systemic Anticoagulation, in the Setting of COVID-19-Induced Hypercoagulability: A Case Report.","We report on the use of systemic heparinization following thrombolysis with intravenous tissue plasminogen activator (t-PA) for acute ischemic large vessel stroke, in the setting of COVID-19-induced hypercoagulability, with partial recanalization of the internal carotid artery. Off-label systemic heparinization was used within 12 hours of t-PA administration, after extensive multidisciplinary collaboration and family discussion, given evidence of severe hypercoagulability. We conclude that throm","2021","06","25","Neurohospitalist","The Neurohospitalist","COVID-19; anticoagulation; case report; ischemic stroke; tissue plasminogen activator","Wendell","Linda C","Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA",NA
"1626","34163551","10.1177/1941874420977308","Partial Recanalization of a Large Vessel Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator, Followed by Systemic Anticoagulation, in the Setting of COVID-19-Induced Hypercoagulability: A Case Report.","We report on the use of systemic heparinization following thrombolysis with intravenous tissue plasminogen activator (t-PA) for acute ischemic large vessel stroke, in the setting of COVID-19-induced hypercoagulability, with partial recanalization of the internal carotid artery. Off-label systemic heparinization was used within 12 hours of t-PA administration, after extensive multidisciplinary collaboration and family discussion, given evidence of severe hypercoagulability. We conclude that throm","2021","06","25","Neurohospitalist","The Neurohospitalist","COVID-19; anticoagulation; case report; ischemic stroke; tissue plasminogen activator","Sacchetti","Daniel C","Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA",NA
"1627","34163551","10.1177/1941874420977308","Partial Recanalization of a Large Vessel Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator, Followed by Systemic Anticoagulation, in the Setting of COVID-19-Induced Hypercoagulability: A Case Report.","We report on the use of systemic heparinization following thrombolysis with intravenous tissue plasminogen activator (t-PA) for acute ischemic large vessel stroke, in the setting of COVID-19-induced hypercoagulability, with partial recanalization of the internal carotid artery. Off-label systemic heparinization was used within 12 hours of t-PA administration, after extensive multidisciplinary collaboration and family discussion, given evidence of severe hypercoagulability. We conclude that throm","2021","06","25","Neurohospitalist","The Neurohospitalist","COVID-19; anticoagulation; case report; ischemic stroke; tissue plasminogen activator","Thompson","Bradford","Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA",NA
"1628","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Ayub","Neishay","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1629","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Cohen","Joseph","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1630","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Jing","Jin","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1631","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Jain","Aayushee","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1632","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Tesh","Ryan","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1633","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Mukerji","Shibani S","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1634","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Zafar","Sahar F","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1635","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Westover","M Brandon","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1636","34163546","10.1177/1941874420972237","Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.","Reports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology. We studied a consecu","2021","06","25","Neurohospitalist","The Neurohospitalist","SARS-CoV-2; coronavirus; electroencephalography; sedation; seizure","Kimchi","Eyal Y","Department of Neurology, Massachusetts General Hospital, Boston, MA, USA",NA
"1637","34163545","10.1177/1941874420976517","Impact of Covid-19 on Stroke Code Activations, Process Metrics, and Diagnostic Error.","In a comprehensive stroke center, we analyzed the stroke code activations (SCA), assessed the impact of Covid-19, and the measures taken by the local government to lessen the spread of the disease. We retrospectively reviewed SCA and classified them into 2 groups: pre-pandemic activations (February 15 to March 10) and Covid-19 pandemic activations (March 11 to April 30). The primary outcome was the ratio of true positive diagnoses of stroke relative to the total number of SCA in the 2 time perio","2021","06","25","Neurohospitalist","The Neurohospitalist","Covid-19; acute stroke; pandemic; stroke code; stroke mimics","Velez","Faddi G Saleh","Department of Neurology, University of Chicago Medical Center, University of Chicago, Chicago, IL, USA",NA
"1638","34163545","10.1177/1941874420976517","Impact of Covid-19 on Stroke Code Activations, Process Metrics, and Diagnostic Error.","In a comprehensive stroke center, we analyzed the stroke code activations (SCA), assessed the impact of Covid-19, and the measures taken by the local government to lessen the spread of the disease. We retrospectively reviewed SCA and classified them into 2 groups: pre-pandemic activations (February 15 to March 10) and Covid-19 pandemic activations (March 11 to April 30). The primary outcome was the ratio of true positive diagnoses of stroke relative to the total number of SCA in the 2 time perio","2021","06","25","Neurohospitalist","The Neurohospitalist","Covid-19; acute stroke; pandemic; stroke code; stroke mimics","Alvarado-Dyer","Ronald","Department of Neurology, University of Chicago Medical Center, University of Chicago, Chicago, IL, USA",NA
"1639","34163545","10.1177/1941874420976517","Impact of Covid-19 on Stroke Code Activations, Process Metrics, and Diagnostic Error.","In a comprehensive stroke center, we analyzed the stroke code activations (SCA), assessed the impact of Covid-19, and the measures taken by the local government to lessen the spread of the disease. We retrospectively reviewed SCA and classified them into 2 groups: pre-pandemic activations (February 15 to March 10) and Covid-19 pandemic activations (March 11 to April 30). The primary outcome was the ratio of true positive diagnoses of stroke relative to the total number of SCA in the 2 time perio","2021","06","25","Neurohospitalist","The Neurohospitalist","Covid-19; acute stroke; pandemic; stroke code; stroke mimics","Brutto","Victor J Del","Department of Neurology, University of Miami Miller School of Medicine, University of Miami, Miami, FL, USA",NA
"1640","34163545","10.1177/1941874420976517","Impact of Covid-19 on Stroke Code Activations, Process Metrics, and Diagnostic Error.","In a comprehensive stroke center, we analyzed the stroke code activations (SCA), assessed the impact of Covid-19, and the measures taken by the local government to lessen the spread of the disease. We retrospectively reviewed SCA and classified them into 2 groups: pre-pandemic activations (February 15 to March 10) and Covid-19 pandemic activations (March 11 to April 30). The primary outcome was the ratio of true positive diagnoses of stroke relative to the total number of SCA in the 2 time perio","2021","06","25","Neurohospitalist","The Neurohospitalist","Covid-19; acute stroke; pandemic; stroke code; stroke mimics","Carrión-Penagos","Julián","Department of Neurology, University of Chicago Medical Center, University of Chicago, Chicago, IL, USA",NA
"1641","34163545","10.1177/1941874420976517","Impact of Covid-19 on Stroke Code Activations, Process Metrics, and Diagnostic Error.","In a comprehensive stroke center, we analyzed the stroke code activations (SCA), assessed the impact of Covid-19, and the measures taken by the local government to lessen the spread of the disease. We retrospectively reviewed SCA and classified them into 2 groups: pre-pandemic activations (February 15 to March 10) and Covid-19 pandemic activations (March 11 to April 30). The primary outcome was the ratio of true positive diagnoses of stroke relative to the total number of SCA in the 2 time perio","2021","06","25","Neurohospitalist","The Neurohospitalist","Covid-19; acute stroke; pandemic; stroke code; stroke mimics","Bulwa","Zachary","Department of Neurology, University of Chicago Medical Center, University of Chicago, Chicago, IL, USA",NA
"1642","34163545","10.1177/1941874420976517","Impact of Covid-19 on Stroke Code Activations, Process Metrics, and Diagnostic Error.","In a comprehensive stroke center, we analyzed the stroke code activations (SCA), assessed the impact of Covid-19, and the measures taken by the local government to lessen the spread of the disease. We retrospectively reviewed SCA and classified them into 2 groups: pre-pandemic activations (February 15 to March 10) and Covid-19 pandemic activations (March 11 to April 30). The primary outcome was the ratio of true positive diagnoses of stroke relative to the total number of SCA in the 2 time perio","2021","06","25","Neurohospitalist","The Neurohospitalist","Covid-19; acute stroke; pandemic; stroke code; stroke mimics","Prabhakaran","Shyam","Department of Neurology, University of Chicago Medical Center, University of Chicago, Chicago, IL, USA",NA
"1643","34163532","10.3389/fgene.2021.680646","Circulating Cytokines and Coronavirus Disease: A Bi-Directional Mendelian Randomization Study.","Immune system functioning is relevant to vulnerability to coronavirus disease (COVID-19). Cytokines are important to immunity. To further elucidate the role of the immune system in COVID-19, we used Mendelian randomization (MR) to assess comprehensively and bi-directionally the role of cytokines in COVID-19. We assessed primarily whether genetically different levels of 41 cytokines affected risk of any COVID-19 (laboratory confirmed, physician confirmed or self-reported, 36,590 cases, 1,668,938 ","2021","06","25","Front Genet","Frontiers in genetics","Mendelian randomization; coronavirus disease; cytokine; genetics; immune system","Li","Mengyu","School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"1644","34163532","10.3389/fgene.2021.680646","Circulating Cytokines and Coronavirus Disease: A Bi-Directional Mendelian Randomization Study.","Immune system functioning is relevant to vulnerability to coronavirus disease (COVID-19). Cytokines are important to immunity. To further elucidate the role of the immune system in COVID-19, we used Mendelian randomization (MR) to assess comprehensively and bi-directionally the role of cytokines in COVID-19. We assessed primarily whether genetically different levels of 41 cytokines affected risk of any COVID-19 (laboratory confirmed, physician confirmed or self-reported, 36,590 cases, 1,668,938 ","2021","06","25","Front Genet","Frontiers in genetics","Mendelian randomization; coronavirus disease; cytokine; genetics; immune system","Yeung","Chris Ho Ching","School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"1645","34163532","10.3389/fgene.2021.680646","Circulating Cytokines and Coronavirus Disease: A Bi-Directional Mendelian Randomization Study.","Immune system functioning is relevant to vulnerability to coronavirus disease (COVID-19). Cytokines are important to immunity. To further elucidate the role of the immune system in COVID-19, we used Mendelian randomization (MR) to assess comprehensively and bi-directionally the role of cytokines in COVID-19. We assessed primarily whether genetically different levels of 41 cytokines affected risk of any COVID-19 (laboratory confirmed, physician confirmed or self-reported, 36,590 cases, 1,668,938 ","2021","06","25","Front Genet","Frontiers in genetics","Mendelian randomization; coronavirus disease; cytokine; genetics; immune system","Schooling","C Mary","School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China",NA
"1646","34163530","10.3389/fgene.2021.678994","Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel RNA virus affecting humans, causing a form of acute pulmonary respiratory disorder named COVID-19, declared a pandemic by the World Health Organization. MicroRNAs (miRNA) play an emerging and important role in the interplay between viruses and host cells. Although the impact of host miRNAs on SARS-CoV-2 infection has been predicted, experimental data are still missing. This study started by a bioinformatics prediction of cel","2021","06","25","Front Genet","Frontiers in genetics","COVID-19; RNA virus; SARS-CoV-2; anti-viral; microRNA; non-coding RNA","Siniscalchi","Chiara","Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"1647","34163530","10.3389/fgene.2021.678994","Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel RNA virus affecting humans, causing a form of acute pulmonary respiratory disorder named COVID-19, declared a pandemic by the World Health Organization. MicroRNAs (miRNA) play an emerging and important role in the interplay between viruses and host cells. Although the impact of host miRNAs on SARS-CoV-2 infection has been predicted, experimental data are still missing. This study started by a bioinformatics prediction of cel","2021","06","25","Front Genet","Frontiers in genetics","COVID-19; RNA virus; SARS-CoV-2; anti-viral; microRNA; non-coding RNA","Di Palo","Armando","Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"1648","34163530","10.3389/fgene.2021.678994","Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel RNA virus affecting humans, causing a form of acute pulmonary respiratory disorder named COVID-19, declared a pandemic by the World Health Organization. MicroRNAs (miRNA) play an emerging and important role in the interplay between viruses and host cells. Although the impact of host miRNAs on SARS-CoV-2 infection has been predicted, experimental data are still missing. This study started by a bioinformatics prediction of cel","2021","06","25","Front Genet","Frontiers in genetics","COVID-19; RNA virus; SARS-CoV-2; anti-viral; microRNA; non-coding RNA","Russo","Aniello","Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"1649","34163530","10.3389/fgene.2021.678994","Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel RNA virus affecting humans, causing a form of acute pulmonary respiratory disorder named COVID-19, declared a pandemic by the World Health Organization. MicroRNAs (miRNA) play an emerging and important role in the interplay between viruses and host cells. Although the impact of host miRNAs on SARS-CoV-2 infection has been predicted, experimental data are still missing. This study started by a bioinformatics prediction of cel","2021","06","25","Front Genet","Frontiers in genetics","COVID-19; RNA virus; SARS-CoV-2; anti-viral; microRNA; non-coding RNA","Potenza","Nicoletta","Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"1650","34163491","10.3389/fimmu.2021.696085","Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.","Activation of the complement system has been observed in coronavirus disease 19 (COVID-19). We conducted a systematic review and meta-analysis with meta-regression to investigate possible differences in the serum concentrations of two routinely measured complement components, C3 and C4, in COVID-19 patients with different severity and survival status. We searched PubMed, Web of Science and Scopus, between January 2020 and February 2021, for studies reporting serum complement C3 and C4, measures ","2021","07","05","Front Immunol","Frontiers in immunology","C3; C4; COVID-19 severity; complement system; mortality; Biomarkers; COVID-19; Complement Activation; Complement C3; Complement C4; Humans; SARS-CoV-2; Severity of Illness Index","Zinellu","Angelo","Department of Biomedical Sciences, University of Sassari, Sassari, Italy",NA
"1651","34163491","10.3389/fimmu.2021.696085","Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.","Activation of the complement system has been observed in coronavirus disease 19 (COVID-19). We conducted a systematic review and meta-analysis with meta-regression to investigate possible differences in the serum concentrations of two routinely measured complement components, C3 and C4, in COVID-19 patients with different severity and survival status. We searched PubMed, Web of Science and Scopus, between January 2020 and February 2021, for studies reporting serum complement C3 and C4, measures ","2021","07","05","Front Immunol","Frontiers in immunology","C3; C4; COVID-19 severity; complement system; mortality; Biomarkers; COVID-19; Complement Activation; Complement C3; Complement C4; Humans; SARS-CoV-2; Severity of Illness Index","Mangoni","Arduino A","Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia",NA
"1652","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Sabbatino","Francesco","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1653","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Conti","Valeria","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1654","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Franci","Gianluigi","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1655","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Sellitto","Carmine","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1656","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Manzo","Valentina","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1657","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Pagliano","Pasquale","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1658","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","De Bellis","Emanuela","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1659","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Masullo","Alfonso","Infectious Disease Unit, San Giovanni di Dio e Ruggi D'Aragona University Hospital, Salerno, Italy",NA
"1660","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Salzano","Francesco Antonio","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1661","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Caputo","Alessandro","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1662","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Peluso","Ilaria","Hematology Unit, AORN Cardarelli Hospital, Naples, Italy",NA
"1663","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Zeppa","Pio","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1664","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Scognamiglio","Giosuè","Pathology Unit, Istituto Nazionale Tumori, IRCSS, ""Fondazione G Pascale"", Naples, Italy",NA
"1665","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Greco","Giuseppe","Section of Microbiology and Virology, University Hospital ""Luigi Vanvitelli"", Naples, Italy",NA
"1666","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Zannella","Carla","Department of Experimental Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"1667","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Ciccarelli","Michele","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1668","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Cicala","Claudia","Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States",NA
"1669","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Vecchione","Carmine","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1670","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Filippelli","Amelia","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1671","34163490","10.3389/fimmu.2021.695242","PD-L1 Dysregulation in COVID-19 Patients.","The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i","2021","07","05","Front Immunol","Frontiers in immunology","ARDS; COVID-19; PD-L1; SARS-CoV-2; adaptive immune response; immune checkpoint molecules; innate immune response; prognosis; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; COVID-19; Epithelial Cells; Female; Humans; Leukocytes, Mononuclear; Lung; Male; Middle Aged; Prognosis; SARS-CoV-2; Up-Regulation","Pepe","Stefano","Department of Medicine, Surgery and Dentistry, ""Scuola Medica Salernitana"", University of Salerno, Baronissi (SA), Italy",NA
"1672","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Li","Jin","School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China",NA
"1673","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Wei","Jinli","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"1674","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Xu","Zhixiang","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"1675","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Jiang","Chunmei","Department of Infectious Disease, The People's Hospital of Longhua, Shenzhen, China",NA
"1676","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Li","Mianhuan","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"1677","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Chen","Jie","Research and Development Department, Guangzhou Sagene Biotech Co., Ltd., Guangzhou, China",NA
"1678","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Li","Yanjie","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"1679","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Yang","Minghui","School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China",NA
"1680","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Gu","Yuchen","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"1681","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Wang","Fuxiang","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"1682","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Shu","Yuelong","School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China",NA
"1683","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Yang","Yang","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"1684","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Sun","Litao","School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China",NA
"1685","34163488","10.3389/fimmu.2021.691879","Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.","Increasing human Adenovirus (HAdV) infections complicated with acute respiratory distress syndrome (ARDS) even fatal outcome were reported in immunocompetent adolescent and adult patients. Here, we characterized the cytokine/chemokine expression profiles of immunocompetent patients complicated with ARDS during HAdV infection and identified biomarkers for disease severity/progression. Forty-eight cytokines/chemokines in the plasma samples from 19 HAdV-infected immunocompetent adolescent and adult","2021","07","05","Front Immunol","Frontiers in immunology","cytokine storm; disease progression; human adenoviruses; immunocompetent adults; prediction; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Bacteria; Bacterial Infections; Biomarkers; COVID-19; Cytokines; Disease Progression; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Viremia; Young Adult","Liu","Yingxia","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"1686","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Jacque","Emilie","LFB Biotechnologies, Les Ulis, France",NA
"1687","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Chottin","Claire","Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France",NA
"1688","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Laubreton","Daphné","Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France",NA
"1689","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Nogre","Michel","LFB Biotechnologies, Les Ulis, France",NA
"1690","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Ferret","Cécile","Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France",NA
"1691","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","de Marcos","Sandrine","LFB Biotechnologies, Les Ulis, France",NA
"1692","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Baptista","Linda","LFB Biotechnologies, Les Ulis, France",NA
"1693","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Drajac","Carole","Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France",NA
"1694","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Mondon","Philippe","LFB Biotechnologies, Les Ulis, France",NA
"1695","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","De Romeuf","Christophe","LFB Biotechnologies, Les Ulis, France",NA
"1696","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Rameix-Welti","Marie-Anne","Université Paris-Saclay, UVSQ, Inserm, Infection et inflammation, U1173, Montigny-Le-Bretonneux, France",NA
"1697","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Eléouët","Jean-François","Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France",NA
"1698","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Chtourou","Sami","LFB Biotechnologies, Les Ulis, France",NA
"1699","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Riffault","Sabine","Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France",NA
"1700","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Perret","Gérald","LFB Biotechnologies, Les Ulis, France",NA
"1701","34163482","10.3389/fimmu.2021.683902","Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.","Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibody (Synagis<sup>®</sup>). Polyclonal human anti-RSV hyper-immune immunoglobulins (Igs) have also been used but were superseded by Synagis<sup>®</sup> owing to their low titer and large infused volume. ","2021","07","05","Front Immunol","Frontiers in immunology","bioprocess; concentration; human plasma; hyper-immune immunoglobulins; nasal administration; neutralization; prophylactic strategy; viral infection; Administration, Intranasal; Animals; Antibodies, Viral; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Lung; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Turbinates; Viral Fusion Proteins; Virus Replication","Descamps","Delphyne","Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France",NA
"1702","34163462","10.3389/fimmu.2021.612807","Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?","Since being identified as a key receptor for SARS-CoV-2, Angiotensin converting enzyme 2 (ACE2) has been studied as one of the potential targets for the development of preventative and/or treatment options. Tissue expression of ACE2 and the amino acids interacting with the spike protein of SARS-CoV-2 have been mapped. Furthermore, the recombinant soluble extracellular domain of ACE2 is already in phase 2 trials as a treatment for SARS-CoV-2 infection. Most studies have continued to focus on the ","2021","07","05","Front Immunol","Frontiers in immunology","ACE2; COVID-19; SARS-CoV-2; ectodomain shedding; endodomain cleavage; regulated intramembrane proteolysis; Angiotensin-Converting Enzyme 2; COVID-19; Cell Membrane; Humans; Immunomodulation; Protein Structure, Tertiary; Proteolysis; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Gonzalez","Sandra M","Department of Medical Microbiology and Infectious Diseases, University of Manitobag, Winnipe, MB, Canada",NA
"1703","34163462","10.3389/fimmu.2021.612807","Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?","Since being identified as a key receptor for SARS-CoV-2, Angiotensin converting enzyme 2 (ACE2) has been studied as one of the potential targets for the development of preventative and/or treatment options. Tissue expression of ACE2 and the amino acids interacting with the spike protein of SARS-CoV-2 have been mapped. Furthermore, the recombinant soluble extracellular domain of ACE2 is already in phase 2 trials as a treatment for SARS-CoV-2 infection. Most studies have continued to focus on the ","2021","07","05","Front Immunol","Frontiers in immunology","ACE2; COVID-19; SARS-CoV-2; ectodomain shedding; endodomain cleavage; regulated intramembrane proteolysis; Angiotensin-Converting Enzyme 2; COVID-19; Cell Membrane; Humans; Immunomodulation; Protein Structure, Tertiary; Proteolysis; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Siddik","Abu Bakar","Department of Medical Microbiology and Infectious Diseases, University of Manitobag, Winnipe, MB, Canada",NA
"1704","34163462","10.3389/fimmu.2021.612807","Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?","Since being identified as a key receptor for SARS-CoV-2, Angiotensin converting enzyme 2 (ACE2) has been studied as one of the potential targets for the development of preventative and/or treatment options. Tissue expression of ACE2 and the amino acids interacting with the spike protein of SARS-CoV-2 have been mapped. Furthermore, the recombinant soluble extracellular domain of ACE2 is already in phase 2 trials as a treatment for SARS-CoV-2 infection. Most studies have continued to focus on the ","2021","07","05","Front Immunol","Frontiers in immunology","ACE2; COVID-19; SARS-CoV-2; ectodomain shedding; endodomain cleavage; regulated intramembrane proteolysis; Angiotensin-Converting Enzyme 2; COVID-19; Cell Membrane; Humans; Immunomodulation; Protein Structure, Tertiary; Proteolysis; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Su","Ruey-Chyi","Department of Medical Microbiology and Infectious Diseases, University of Manitobag, Winnipe, MB, Canada",NA
"1705","34163427","10.3389/fneur.2021.672524","Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.","Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We present herewith a COVID-19 case manifesting as opsoclonus-myoclonus syndrome (OMS), a rare neurological disorder. Case Presentation: A 63-year-old male diagnosed with COVID-19 infection developed behavioral changes, confusion, and insomn","2021","06","25","Front Neurol","Frontiers in neurology","COVID-19; ataxia; autoimmue disease; movement disorder; neurological disorder; opsoclonus myoclonus syndrome","Ishaq","Hira","Department of Neurology, Lady Reading Hospital, Peshawar, Pakistan",NA
"1706","34163427","10.3389/fneur.2021.672524","Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.","Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We present herewith a COVID-19 case manifesting as opsoclonus-myoclonus syndrome (OMS), a rare neurological disorder. Case Presentation: A 63-year-old male diagnosed with COVID-19 infection developed behavioral changes, confusion, and insomn","2021","06","25","Front Neurol","Frontiers in neurology","COVID-19; ataxia; autoimmue disease; movement disorder; neurological disorder; opsoclonus myoclonus syndrome","Durrani","Talha","Department of Neurology, Lady Reading Hospital, Peshawar, Pakistan",NA
"1707","34163427","10.3389/fneur.2021.672524","Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.","Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We present herewith a COVID-19 case manifesting as opsoclonus-myoclonus syndrome (OMS), a rare neurological disorder. Case Presentation: A 63-year-old male diagnosed with COVID-19 infection developed behavioral changes, confusion, and insomn","2021","06","25","Front Neurol","Frontiers in neurology","COVID-19; ataxia; autoimmue disease; movement disorder; neurological disorder; opsoclonus myoclonus syndrome","Umar","Zainab","Department of Accident and Emergency, Hayatabad Medical Complex, Peshawar, Pakistan",NA
"1708","34163427","10.3389/fneur.2021.672524","Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.","Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We present herewith a COVID-19 case manifesting as opsoclonus-myoclonus syndrome (OMS), a rare neurological disorder. Case Presentation: A 63-year-old male diagnosed with COVID-19 infection developed behavioral changes, confusion, and insomn","2021","06","25","Front Neurol","Frontiers in neurology","COVID-19; ataxia; autoimmue disease; movement disorder; neurological disorder; opsoclonus myoclonus syndrome","Khan","Nemat","School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia",NA
"1709","34163427","10.3389/fneur.2021.672524","Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.","Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We present herewith a COVID-19 case manifesting as opsoclonus-myoclonus syndrome (OMS), a rare neurological disorder. Case Presentation: A 63-year-old male diagnosed with COVID-19 infection developed behavioral changes, confusion, and insomn","2021","06","25","Front Neurol","Frontiers in neurology","COVID-19; ataxia; autoimmue disease; movement disorder; neurological disorder; opsoclonus myoclonus syndrome","McCombe","Pamela","UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, The University of Queensland, Brisbane, QLD, Australia",NA
"1710","34163427","10.3389/fneur.2021.672524","Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.","Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We present herewith a COVID-19 case manifesting as opsoclonus-myoclonus syndrome (OMS), a rare neurological disorder. Case Presentation: A 63-year-old male diagnosed with COVID-19 infection developed behavioral changes, confusion, and insomn","2021","06","25","Front Neurol","Frontiers in neurology","COVID-19; ataxia; autoimmue disease; movement disorder; neurological disorder; opsoclonus myoclonus syndrome","Ul Haq","Mian Ayaz","Department of Neurology, Lady Reading Hospital, Peshawar, Pakistan",NA
"1711","34163416","10.3389/fpsyg.2021.691492","Preschool Teachers' Technology Acceptance During the COVID-19: An Adapted Technology Acceptance Model.","Online education has become a major reaction to the COVID-19 epidemic, which requires preschool teachers to quickly adapt to online education and accept educational technology. In this emergency background, research on the preschool teachers' technology acceptance provides clues to improve preschool teachers' intention to use educational technology. The Technology Acceptance Model (TAM) is widely used to examine the process of individuals' technology acceptance in the previous literature. Theref","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; behavioral intention; determinant factors; preschool teachers; technology acceptance model","Hong","Xiumin","Institute of Early Childhood Education, Faculty of Education, Beijing Normal University, Beijing, China",NA
"1712","34163416","10.3389/fpsyg.2021.691492","Preschool Teachers' Technology Acceptance During the COVID-19: An Adapted Technology Acceptance Model.","Online education has become a major reaction to the COVID-19 epidemic, which requires preschool teachers to quickly adapt to online education and accept educational technology. In this emergency background, research on the preschool teachers' technology acceptance provides clues to improve preschool teachers' intention to use educational technology. The Technology Acceptance Model (TAM) is widely used to examine the process of individuals' technology acceptance in the previous literature. Theref","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; behavioral intention; determinant factors; preschool teachers; technology acceptance model","Zhang","Mingzhu","Institute of Early Childhood Education, Faculty of Education, Beijing Normal University, Beijing, China",NA
"1713","34163416","10.3389/fpsyg.2021.691492","Preschool Teachers' Technology Acceptance During the COVID-19: An Adapted Technology Acceptance Model.","Online education has become a major reaction to the COVID-19 epidemic, which requires preschool teachers to quickly adapt to online education and accept educational technology. In this emergency background, research on the preschool teachers' technology acceptance provides clues to improve preschool teachers' intention to use educational technology. The Technology Acceptance Model (TAM) is widely used to examine the process of individuals' technology acceptance in the previous literature. Theref","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; behavioral intention; determinant factors; preschool teachers; technology acceptance model","Liu","Qianqian","Institute of Early Childhood Education, Faculty of Education, Beijing Normal University, Beijing, China",NA
"1714","34163414","10.3389/fpsyg.2021.689251","Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak.","At the beginning of the coronavirus disease 2019 (COVID-19) outbreak, college students returning home from Wuhan, Hubei Province, experienced various degrees of discrimination. This study first investigates perceived discrimination among college students returning home from Wuhan. Then, an experimental method is used to investigate the effectiveness of an intervention designed to reduce the perceived discrimination among those who returned to towns outside of Hubei Province. A total of 63 colleg","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; mental health; perceived discrimination; perceived social support; wise intervention","Lu","Ting","Department of Psychology, Faculty of Education, Hubei University, Wuhan, China",NA
"1715","34163414","10.3389/fpsyg.2021.689251","Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak.","At the beginning of the coronavirus disease 2019 (COVID-19) outbreak, college students returning home from Wuhan, Hubei Province, experienced various degrees of discrimination. This study first investigates perceived discrimination among college students returning home from Wuhan. Then, an experimental method is used to investigate the effectiveness of an intervention designed to reduce the perceived discrimination among those who returned to towns outside of Hubei Province. A total of 63 colleg","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; mental health; perceived discrimination; perceived social support; wise intervention","Guo","Zihan","Department of Psychology, Faculty of Education, Hubei University, Wuhan, China",NA
"1716","34163414","10.3389/fpsyg.2021.689251","Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak.","At the beginning of the coronavirus disease 2019 (COVID-19) outbreak, college students returning home from Wuhan, Hubei Province, experienced various degrees of discrimination. This study first investigates perceived discrimination among college students returning home from Wuhan. Then, an experimental method is used to investigate the effectiveness of an intervention designed to reduce the perceived discrimination among those who returned to towns outside of Hubei Province. A total of 63 colleg","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; mental health; perceived discrimination; perceived social support; wise intervention","Li","Hao","Department of Psychology, Faculty of Education, Hubei University, Wuhan, China",NA
"1717","34163414","10.3389/fpsyg.2021.689251","Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak.","At the beginning of the coronavirus disease 2019 (COVID-19) outbreak, college students returning home from Wuhan, Hubei Province, experienced various degrees of discrimination. This study first investigates perceived discrimination among college students returning home from Wuhan. Then, an experimental method is used to investigate the effectiveness of an intervention designed to reduce the perceived discrimination among those who returned to towns outside of Hubei Province. A total of 63 colleg","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; mental health; perceived discrimination; perceived social support; wise intervention","Zhang","Xinyu","Department of Psychology, Faculty of Education, Hubei University, Wuhan, China",NA
"1718","34163414","10.3389/fpsyg.2021.689251","Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak.","At the beginning of the coronavirus disease 2019 (COVID-19) outbreak, college students returning home from Wuhan, Hubei Province, experienced various degrees of discrimination. This study first investigates perceived discrimination among college students returning home from Wuhan. Then, an experimental method is used to investigate the effectiveness of an intervention designed to reduce the perceived discrimination among those who returned to towns outside of Hubei Province. A total of 63 colleg","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; mental health; perceived discrimination; perceived social support; wise intervention","Ren","Zhihong","Key Laboratory of Adolescent Cyberpsychology and Behavior, Key Laboratory of Human Development and Mental Health of Hubei Province, Ministry of Education, School of Psychology at Central China Normal University, Wuhan, China",NA
"1719","34163414","10.3389/fpsyg.2021.689251","Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak.","At the beginning of the coronavirus disease 2019 (COVID-19) outbreak, college students returning home from Wuhan, Hubei Province, experienced various degrees of discrimination. This study first investigates perceived discrimination among college students returning home from Wuhan. Then, an experimental method is used to investigate the effectiveness of an intervention designed to reduce the perceived discrimination among those who returned to towns outside of Hubei Province. A total of 63 colleg","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; mental health; perceived discrimination; perceived social support; wise intervention","Yang","Weiping","Department of Psychology, Faculty of Education, Hubei University, Wuhan, China",NA
"1720","34163414","10.3389/fpsyg.2021.689251","Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak.","At the beginning of the coronavirus disease 2019 (COVID-19) outbreak, college students returning home from Wuhan, Hubei Province, experienced various degrees of discrimination. This study first investigates perceived discrimination among college students returning home from Wuhan. Then, an experimental method is used to investigate the effectiveness of an intervention designed to reduce the perceived discrimination among those who returned to towns outside of Hubei Province. A total of 63 colleg","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; mental health; perceived discrimination; perceived social support; wise intervention","Wei","Liuqing","Department of Psychology, Faculty of Education, Hubei University, Wuhan, China",NA
"1721","34163414","10.3389/fpsyg.2021.689251","Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak.","At the beginning of the coronavirus disease 2019 (COVID-19) outbreak, college students returning home from Wuhan, Hubei Province, experienced various degrees of discrimination. This study first investigates perceived discrimination among college students returning home from Wuhan. Then, an experimental method is used to investigate the effectiveness of an intervention designed to reduce the perceived discrimination among those who returned to towns outside of Hubei Province. A total of 63 colleg","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; mental health; perceived discrimination; perceived social support; wise intervention","Huang","Ling","Department of Psychology, Faculty of Education, Hubei University, Wuhan, China",NA
"1722","34163404","10.3389/fpsyg.2021.659218","A Norm-Based Conditional Process Model of the Negative Impact of Optimistic Bias on Self-Protection Behaviors During the COVID-19 Pandemic in Three Chinese Cities.","Data were collected from 896 participants in three Chinese cities affected by the COVID-19 pandemic to varying degrees through an online survey platform. A conditional process model was then proposed for the impact of optimistic bias on self-protection behaviors during the COVID-19 pandemic from the perspective of social norms. Statistical analysis demonstrates that optimistic bias has a negative impact on self-protection behaviors through message acceptance. Perceived social norms moderate this","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; message acceptance; optimistic bias; self-protection behavior; social norms","Chen","Sijing","School of Economics and Management, Zhejiang University of Science and Technology, Hangzhou, China",NA
"1723","34163404","10.3389/fpsyg.2021.659218","A Norm-Based Conditional Process Model of the Negative Impact of Optimistic Bias on Self-Protection Behaviors During the COVID-19 Pandemic in Three Chinese Cities.","Data were collected from 896 participants in three Chinese cities affected by the COVID-19 pandemic to varying degrees through an online survey platform. A conditional process model was then proposed for the impact of optimistic bias on self-protection behaviors during the COVID-19 pandemic from the perspective of social norms. Statistical analysis demonstrates that optimistic bias has a negative impact on self-protection behaviors through message acceptance. Perceived social norms moderate this","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; message acceptance; optimistic bias; self-protection behavior; social norms","Liu","Jianwei","School of Economics and Management, Zhejiang University of Science and Technology, Hangzhou, China",NA
"1724","34163404","10.3389/fpsyg.2021.659218","A Norm-Based Conditional Process Model of the Negative Impact of Optimistic Bias on Self-Protection Behaviors During the COVID-19 Pandemic in Three Chinese Cities.","Data were collected from 896 participants in three Chinese cities affected by the COVID-19 pandemic to varying degrees through an online survey platform. A conditional process model was then proposed for the impact of optimistic bias on self-protection behaviors during the COVID-19 pandemic from the perspective of social norms. Statistical analysis demonstrates that optimistic bias has a negative impact on self-protection behaviors through message acceptance. Perceived social norms moderate this","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; message acceptance; optimistic bias; self-protection behavior; social norms","Hu","Huamin","School of Economics and Management, Zhejiang University of Science and Technology, Hangzhou, China",NA
"1725","34163399","10.3389/fpsyg.2021.644106","Associations Between Depressive Symptoms and Physical Activity Intensity in an Older Adult Population During COVID-19 Lockdown.","The COVID-19 pandemic led to the implementation of physical-social distancing measures-including self-isolation, home confinement, and quarantine around the world, with psychological consequences such as depression. Older adults are especially likely to develop depressive symptomatology. This study aims to investigate the association between physical activity intensities and sedentary behavior with depression levels among previously active older adults during the COVID-19 lockdown. A total of 1,","2021","06","25","Front Psychol","Frontiers in psychology","association; depression; intensity; lockdown; pandemic; physical activity","Lage","Ana","Research Center in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sports, University of Porto (FADEUP), Portugal Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal",NA
"1726","34163399","10.3389/fpsyg.2021.644106","Associations Between Depressive Symptoms and Physical Activity Intensity in an Older Adult Population During COVID-19 Lockdown.","The COVID-19 pandemic led to the implementation of physical-social distancing measures-including self-isolation, home confinement, and quarantine around the world, with psychological consequences such as depression. Older adults are especially likely to develop depressive symptomatology. This study aims to investigate the association between physical activity intensities and sedentary behavior with depression levels among previously active older adults during the COVID-19 lockdown. A total of 1,","2021","06","25","Front Psychol","Frontiers in psychology","association; depression; intensity; lockdown; pandemic; physical activity","Carrapatoso","Susana","Research Center in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sports, University of Porto (FADEUP), Portugal Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal",NA
"1727","34163399","10.3389/fpsyg.2021.644106","Associations Between Depressive Symptoms and Physical Activity Intensity in an Older Adult Population During COVID-19 Lockdown.","The COVID-19 pandemic led to the implementation of physical-social distancing measures-including self-isolation, home confinement, and quarantine around the world, with psychological consequences such as depression. Older adults are especially likely to develop depressive symptomatology. This study aims to investigate the association between physical activity intensities and sedentary behavior with depression levels among previously active older adults during the COVID-19 lockdown. A total of 1,","2021","06","25","Front Psychol","Frontiers in psychology","association; depression; intensity; lockdown; pandemic; physical activity","Sampaio de Queiroz Neto","Elzier","Research Center in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sports, University of Porto (FADEUP), Portugal Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal",NA
"1728","34163399","10.3389/fpsyg.2021.644106","Associations Between Depressive Symptoms and Physical Activity Intensity in an Older Adult Population During COVID-19 Lockdown.","The COVID-19 pandemic led to the implementation of physical-social distancing measures-including self-isolation, home confinement, and quarantine around the world, with psychological consequences such as depression. Older adults are especially likely to develop depressive symptomatology. This study aims to investigate the association between physical activity intensities and sedentary behavior with depression levels among previously active older adults during the COVID-19 lockdown. A total of 1,","2021","06","25","Front Psychol","Frontiers in psychology","association; depression; intensity; lockdown; pandemic; physical activity","Gomes","Sérgio","Prefeitura Municipal de Fortaleza, Coordenadoria do Idoso, Fortaleza, Brazil",NA
"1729","34163399","10.3389/fpsyg.2021.644106","Associations Between Depressive Symptoms and Physical Activity Intensity in an Older Adult Population During COVID-19 Lockdown.","The COVID-19 pandemic led to the implementation of physical-social distancing measures-including self-isolation, home confinement, and quarantine around the world, with psychological consequences such as depression. Older adults are especially likely to develop depressive symptomatology. This study aims to investigate the association between physical activity intensities and sedentary behavior with depression levels among previously active older adults during the COVID-19 lockdown. A total of 1,","2021","06","25","Front Psychol","Frontiers in psychology","association; depression; intensity; lockdown; pandemic; physical activity","Soares-Miranda","Luísa","Research Center in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sports, University of Porto (FADEUP), Portugal Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal",NA
"1730","34163399","10.3389/fpsyg.2021.644106","Associations Between Depressive Symptoms and Physical Activity Intensity in an Older Adult Population During COVID-19 Lockdown.","The COVID-19 pandemic led to the implementation of physical-social distancing measures-including self-isolation, home confinement, and quarantine around the world, with psychological consequences such as depression. Older adults are especially likely to develop depressive symptomatology. This study aims to investigate the association between physical activity intensities and sedentary behavior with depression levels among previously active older adults during the COVID-19 lockdown. A total of 1,","2021","06","25","Front Psychol","Frontiers in psychology","association; depression; intensity; lockdown; pandemic; physical activity","Bohn","Lucimere","Research Center in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sports, University of Porto (FADEUP), Portugal Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal",NA
"1731","34163395","10.3389/fpsyg.2021.635110","Cross-Cultural Bayesian Network Analysis of Factors Affecting Residents' Concerns About the Spread of an Infectious Disease Caused by Tourism.","COVID-19 has had a severe impact globally, and the recovery can be characterized as a tug of war between fast economic recovery and firm control of further virus-spread. To be prepared for future pandemics, public health policy makers should put effort into fully understanding any complex psychological tensions that inherently arise between opposing human factors such as free enjoyment versus self-restriction. As the COVID-19 crisis is an unusual and complex problem, combinations of diverse fact","2021","06","25","Front Psychol","Frontiers in psychology","Bayesian network; COVID-19; Probabilistic Structural Equation Modeling; cultural sensitivity; experience economy; health risk perception; human values; international tourism","Glückstad","Fumiko Kano","Department of Management, Society and Communication, Copenhagen Business School, Frederiksberg, Denmark",NA
"1732","34163395","10.3389/fpsyg.2021.635110","Cross-Cultural Bayesian Network Analysis of Factors Affecting Residents' Concerns About the Spread of an Infectious Disease Caused by Tourism.","COVID-19 has had a severe impact globally, and the recovery can be characterized as a tug of war between fast economic recovery and firm control of further virus-spread. To be prepared for future pandemics, public health policy makers should put effort into fully understanding any complex psychological tensions that inherently arise between opposing human factors such as free enjoyment versus self-restriction. As the COVID-19 crisis is an unusual and complex problem, combinations of diverse fact","2021","06","25","Front Psychol","Frontiers in psychology","Bayesian network; COVID-19; Probabilistic Structural Equation Modeling; cultural sensitivity; experience economy; health risk perception; human values; international tourism","Wiil","Uffe Kock","Center of Health Informatics and Technology, Maersk Mc-Kinney Moller Institute, University of Southern Denmark, Odense, Denmark",NA
"1733","34163395","10.3389/fpsyg.2021.635110","Cross-Cultural Bayesian Network Analysis of Factors Affecting Residents' Concerns About the Spread of an Infectious Disease Caused by Tourism.","COVID-19 has had a severe impact globally, and the recovery can be characterized as a tug of war between fast economic recovery and firm control of further virus-spread. To be prepared for future pandemics, public health policy makers should put effort into fully understanding any complex psychological tensions that inherently arise between opposing human factors such as free enjoyment versus self-restriction. As the COVID-19 crisis is an unusual and complex problem, combinations of diverse fact","2021","06","25","Front Psychol","Frontiers in psychology","Bayesian network; COVID-19; Probabilistic Structural Equation Modeling; cultural sensitivity; experience economy; health risk perception; human values; international tourism","Mansourvar","Marjan","Center of Health Informatics and Technology, Maersk Mc-Kinney Moller Institute, University of Southern Denmark, Odense, Denmark",NA
"1734","34163395","10.3389/fpsyg.2021.635110","Cross-Cultural Bayesian Network Analysis of Factors Affecting Residents' Concerns About the Spread of an Infectious Disease Caused by Tourism.","COVID-19 has had a severe impact globally, and the recovery can be characterized as a tug of war between fast economic recovery and firm control of further virus-spread. To be prepared for future pandemics, public health policy makers should put effort into fully understanding any complex psychological tensions that inherently arise between opposing human factors such as free enjoyment versus self-restriction. As the COVID-19 crisis is an unusual and complex problem, combinations of diverse fact","2021","06","25","Front Psychol","Frontiers in psychology","Bayesian network; COVID-19; Probabilistic Structural Equation Modeling; cultural sensitivity; experience economy; health risk perception; human values; international tourism","Andersen","Pernille Tanggaard","Department of Public Health, University of Southern Denmark, Esbjerg, Denmark",NA
"1735","34163393","10.3389/fpsyg.2021.615909","Gender Differences in Anxiety, Depression, and Nursing Needs Among Isolated Coronavirus Disease 2019 Patients.","This study explored gender differences in anxiety, depression, and nursing needs among isolated Coronavirus Disease 2019 (COVID-19) patients, with a particular focus on the influencing factors. The main goal was to elucidate breakthrough points and intervention targets for psychological counseling aimed at the promotion of overall health during isolation treatment. A survey was conducted to obtain information about the nursing needs of COVID-19 patients, with mental health assessed via the Hospi","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; coronavirus disease 2019; gender; hospital anxiety and depression scale; isolated patients; nursing needs","Li","Yifei","Nursing Psychology Research Center, Xiangya School of Nursing, Central South University, Changsha, China",NA
"1736","34163393","10.3389/fpsyg.2021.615909","Gender Differences in Anxiety, Depression, and Nursing Needs Among Isolated Coronavirus Disease 2019 Patients.","This study explored gender differences in anxiety, depression, and nursing needs among isolated Coronavirus Disease 2019 (COVID-19) patients, with a particular focus on the influencing factors. The main goal was to elucidate breakthrough points and intervention targets for psychological counseling aimed at the promotion of overall health during isolation treatment. A survey was conducted to obtain information about the nursing needs of COVID-19 patients, with mental health assessed via the Hospi","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; coronavirus disease 2019; gender; hospital anxiety and depression scale; isolated patients; nursing needs","Li","Juan","Nursing Psychology Research Center, Xiangya School of Nursing, Central South University, Changsha, China",NA
"1737","34163393","10.3389/fpsyg.2021.615909","Gender Differences in Anxiety, Depression, and Nursing Needs Among Isolated Coronavirus Disease 2019 Patients.","This study explored gender differences in anxiety, depression, and nursing needs among isolated Coronavirus Disease 2019 (COVID-19) patients, with a particular focus on the influencing factors. The main goal was to elucidate breakthrough points and intervention targets for psychological counseling aimed at the promotion of overall health during isolation treatment. A survey was conducted to obtain information about the nursing needs of COVID-19 patients, with mental health assessed via the Hospi","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; coronavirus disease 2019; gender; hospital anxiety and depression scale; isolated patients; nursing needs","Yang","Zhen","The Second Affiliated Hospital of Shantou University Medical College, Shantou, China",NA
"1738","34163393","10.3389/fpsyg.2021.615909","Gender Differences in Anxiety, Depression, and Nursing Needs Among Isolated Coronavirus Disease 2019 Patients.","This study explored gender differences in anxiety, depression, and nursing needs among isolated Coronavirus Disease 2019 (COVID-19) patients, with a particular focus on the influencing factors. The main goal was to elucidate breakthrough points and intervention targets for psychological counseling aimed at the promotion of overall health during isolation treatment. A survey was conducted to obtain information about the nursing needs of COVID-19 patients, with mental health assessed via the Hospi","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; coronavirus disease 2019; gender; hospital anxiety and depression scale; isolated patients; nursing needs","Zhang","Jie","Nursing Psychology Research Center, Xiangya School of Nursing, Central South University, Changsha, China",NA
"1739","34163393","10.3389/fpsyg.2021.615909","Gender Differences in Anxiety, Depression, and Nursing Needs Among Isolated Coronavirus Disease 2019 Patients.","This study explored gender differences in anxiety, depression, and nursing needs among isolated Coronavirus Disease 2019 (COVID-19) patients, with a particular focus on the influencing factors. The main goal was to elucidate breakthrough points and intervention targets for psychological counseling aimed at the promotion of overall health during isolation treatment. A survey was conducted to obtain information about the nursing needs of COVID-19 patients, with mental health assessed via the Hospi","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; coronavirus disease 2019; gender; hospital anxiety and depression scale; isolated patients; nursing needs","Dong","Lili","The Second Affiliated Hospital of Shantou University Medical College, Shantou, China",NA
"1740","34163393","10.3389/fpsyg.2021.615909","Gender Differences in Anxiety, Depression, and Nursing Needs Among Isolated Coronavirus Disease 2019 Patients.","This study explored gender differences in anxiety, depression, and nursing needs among isolated Coronavirus Disease 2019 (COVID-19) patients, with a particular focus on the influencing factors. The main goal was to elucidate breakthrough points and intervention targets for psychological counseling aimed at the promotion of overall health during isolation treatment. A survey was conducted to obtain information about the nursing needs of COVID-19 patients, with mental health assessed via the Hospi","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; coronavirus disease 2019; gender; hospital anxiety and depression scale; isolated patients; nursing needs","Wang","Fusheng","The Second Affiliated Hospital of Shantou University Medical College, Shantou, China",NA
"1741","34163393","10.3389/fpsyg.2021.615909","Gender Differences in Anxiety, Depression, and Nursing Needs Among Isolated Coronavirus Disease 2019 Patients.","This study explored gender differences in anxiety, depression, and nursing needs among isolated Coronavirus Disease 2019 (COVID-19) patients, with a particular focus on the influencing factors. The main goal was to elucidate breakthrough points and intervention targets for psychological counseling aimed at the promotion of overall health during isolation treatment. A survey was conducted to obtain information about the nursing needs of COVID-19 patients, with mental health assessed via the Hospi","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; coronavirus disease 2019; gender; hospital anxiety and depression scale; isolated patients; nursing needs","Zhang","Jingping","Nursing Psychology Research Center, Xiangya School of Nursing, Central South University, Changsha, China",NA
"1742","34163389","10.3389/fpsyg.2021.558437","Accepting Restrictions and Compliance With Recommended Preventive Behaviors for COVID-19: A Discussion Based on the Key Approaches and Current Research on Fear Appeals.","COVID-19 (Coronavirus disease 2019) is a novel coronavirus which was first detected in late December 2019 in the Wuhan Province of China. This novel coronavirus, caused by a zoonotic beta-coronavirus (SARS-CoV-), is described as highly infectious. The World Health Organization (WHO) named the novel coronavirus as COVID-19 on February 11, 2020, and declared it as a ""pandemic."" Almost all countries have undertaken wide-scale precautions so as to prevent or limit the spread of the virus, with most ","2021","06","25","Front Psychol","Frontiers in psychology","COVID-19; extended parallel process model; fear appeals; fear-drive theory; health behavior; health psychology; pandemic; protection-motivation theory","Demirtas-Madran","H Andaç","Faculty of Communication, Baskent University, Ankara, Turkey",NA
"1743","34163379","10.3389/fpsyt.2021.617397","Factors Associated With Mental Health Symptoms During the COVID-19 Pandemic in Hong Kong.","Background: The COVID-19 pandemic has led to an increasing mental health burden. We examined the factors associated with mental health symptoms in Chinese general adults in Hong Kong. Methods: We conducted a dual-frame (landline and mobile) survey on Chinese adults aged 18 years or older in April 2020. Shortage of preventive materials, perceptions of the outbreak (each item range 1-5), and reduction in income were assessed. Mental health symptoms measured included stress (Perceived","2021","06","25","Front Psychiatry","Frontiers in psychiatry","COVID-19; mental health; public health; risk factors; unemployment","Zhao","Sheng Zhi","School of Nursing, University of Hong Kong, Hong Kong, China",NA
"1744","34163379","10.3389/fpsyt.2021.617397","Factors Associated With Mental Health Symptoms During the COVID-19 Pandemic in Hong Kong.","Background: The COVID-19 pandemic has led to an increasing mental health burden. We examined the factors associated with mental health symptoms in Chinese general adults in Hong Kong. Methods: We conducted a dual-frame (landline and mobile) survey on Chinese adults aged 18 years or older in April 2020. Shortage of preventive materials, perceptions of the outbreak (each item range 1-5), and reduction in income were assessed. Mental health symptoms measured included stress (Perceived","2021","06","25","Front Psychiatry","Frontiers in psychiatry","COVID-19; mental health; public health; risk factors; unemployment","Luk","Tzu Tsun","School of Nursing, University of Hong Kong, Hong Kong, China",NA
"1745","34163379","10.3389/fpsyt.2021.617397","Factors Associated With Mental Health Symptoms During the COVID-19 Pandemic in Hong Kong.","Background: The COVID-19 pandemic has led to an increasing mental health burden. We examined the factors associated with mental health symptoms in Chinese general adults in Hong Kong. Methods: We conducted a dual-frame (landline and mobile) survey on Chinese adults aged 18 years or older in April 2020. Shortage of preventive materials, perceptions of the outbreak (each item range 1-5), and reduction in income were assessed. Mental health symptoms measured included stress (Perceived","2021","06","25","Front Psychiatry","Frontiers in psychiatry","COVID-19; mental health; public health; risk factors; unemployment","Wu","Yongda","School of Nursing, University of Hong Kong, Hong Kong, China",NA
"1746","34163379","10.3389/fpsyt.2021.617397","Factors Associated With Mental Health Symptoms During the COVID-19 Pandemic in Hong Kong.","Background: The COVID-19 pandemic has led to an increasing mental health burden. We examined the factors associated with mental health symptoms in Chinese general adults in Hong Kong. Methods: We conducted a dual-frame (landline and mobile) survey on Chinese adults aged 18 years or older in April 2020. Shortage of preventive materials, perceptions of the outbreak (each item range 1-5), and reduction in income were assessed. Mental health symptoms measured included stress (Perceived","2021","06","25","Front Psychiatry","Frontiers in psychiatry","COVID-19; mental health; public health; risk factors; unemployment","Weng","Xue","School of Nursing, University of Hong Kong, Hong Kong, China",NA
"1747","34163379","10.3389/fpsyt.2021.617397","Factors Associated With Mental Health Symptoms During the COVID-19 Pandemic in Hong Kong.","Background: The COVID-19 pandemic has led to an increasing mental health burden. We examined the factors associated with mental health symptoms in Chinese general adults in Hong Kong. Methods: We conducted a dual-frame (landline and mobile) survey on Chinese adults aged 18 years or older in April 2020. Shortage of preventive materials, perceptions of the outbreak (each item range 1-5), and reduction in income were assessed. Mental health symptoms measured included stress (Perceived","2021","06","25","Front Psychiatry","Frontiers in psychiatry","COVID-19; mental health; public health; risk factors; unemployment","Wong","Janet Yuen Ha","School of Nursing, University of Hong Kong, Hong Kong, China",NA
"1748","34163379","10.3389/fpsyt.2021.617397","Factors Associated With Mental Health Symptoms During the COVID-19 Pandemic in Hong Kong.","Background: The COVID-19 pandemic has led to an increasing mental health burden. We examined the factors associated with mental health symptoms in Chinese general adults in Hong Kong. Methods: We conducted a dual-frame (landline and mobile) survey on Chinese adults aged 18 years or older in April 2020. Shortage of preventive materials, perceptions of the outbreak (each item range 1-5), and reduction in income were assessed. Mental health symptoms measured included stress (Perceived","2021","06","25","Front Psychiatry","Frontiers in psychiatry","COVID-19; mental health; public health; risk factors; unemployment","Wang","Man Ping","School of Nursing, University of Hong Kong, Hong Kong, China",NA
"1749","34163379","10.3389/fpsyt.2021.617397","Factors Associated With Mental Health Symptoms During the COVID-19 Pandemic in Hong Kong.","Background: The COVID-19 pandemic has led to an increasing mental health burden. We examined the factors associated with mental health symptoms in Chinese general adults in Hong Kong. Methods: We conducted a dual-frame (landline and mobile) survey on Chinese adults aged 18 years or older in April 2020. Shortage of preventive materials, perceptions of the outbreak (each item range 1-5), and reduction in income were assessed. Mental health symptoms measured included stress (Perceived","2021","06","25","Front Psychiatry","Frontiers in psychiatry","COVID-19; mental health; public health; risk factors; unemployment","Lam","Tai Hing","School of Public Health, University of Hong Kong, Hong Kong, China",NA
"1750","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Sekowski","Marcin","Department of Psychology, The Maria Grzegorzewska University, Warsaw, Poland",NA
"1751","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Gambin","Malgorzata","Faculty of Psychology, University of Warsaw, Warsaw, Poland",NA
"1752","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Hansen","Karolina","Faculty of Psychology, University of Warsaw, Warsaw, Poland",NA
"1753","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Holas","Pawel","Faculty of Psychology, University of Warsaw, Warsaw, Poland",NA
"1754","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Hyniewska","Sylwia","Department of Experimental Psychology, University College London, London, United Kingdom",NA
"1755","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Wyszomirska","Julia","Department of Psychology, Medical University of Silesia, Katowice, Poland",NA
"1756","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Pluta","Agnieszka","Faculty of Psychology, University of Warsaw, Warsaw, Poland",NA
"1757","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Sobanska","Marta","Faculty of Psychology, University of Warsaw, Warsaw, Poland",NA
"1758","34163377","10.3389/fpsyt.2021.562899","Risk of Developing Post-traumatic Stress Disorder in Severe COVID-19 Survivors, Their Families and Frontline Healthcare Workers: What Should Mental Health Specialists Prepare For?","Given the high mortality of the coronavirus disease 2019 (COVID-19), having severe COVID-19 may be a life-threatening event, especially for individuals at high risk of complications. Therefore, in the article we try to answer two questions that are relevant to public mental health: Can we define groups who are at higher risk of developing pandemic-related PTSD? How can health specialists prepare for it? Given the results of previous research on PTSD in epidemic (e.g., SARS) survivors, we suggest","2021","06","25","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; family; healthcare worker; post-traumatic stress disorder; prolonged grief disorder; severe acute respiratory syndrome","Lojek","Emilia","Faculty of Psychology, University of Warsaw, Warsaw, Poland",NA
"1759","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Ágh","Tamás","Syreon Research Institute, Budapest, Hungary",NA
"1760","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","van Boven","Job Fm","Department of Clinical Pharmacy and Pharmacology, Medication Adherence Expertise Center of the Northern Netherlands, University Medical Center Groningen, University of Groningen, Groningen, Netherlands",NA
"1761","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Wettermark","Björn","Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden",NA
"1762","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Menditto","Enrica","Department of Pharmacy, CIRFF, Center of Pharmacoeconomics and Drug Utilization Research, University of Naples Federico II, Naples, Italy",NA
"1763","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Pinnock","Hilary","Usher Institute, University of Edinburgh, Edinburgh, United Kingdom",NA
"1764","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Tsiligianni","Ioanna","Department of Social Medicine, School of Medicine, University of Crete, Crete, Greece",NA
"1765","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Petrova","Guenka","Departement of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria",NA
"1766","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Potocnjak","Ines","Institute for Clinical Medical Research and Education, University Hospital Centre Sisters of Charity, Zagreb, Croatia",NA
"1767","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Kamberi","Fatjona","Faculty of Health, Research Center of Public Health, University of Vlore ""Ismail Qemali"", Vlore, Albania",NA
"1768","34163364","10.3389/fphar.2021.685696","A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.","Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices &amp; technoLogy on medication adherencE (ENABLE) ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug therapy; healthcare system; medication adherence; medication management; noncommunicable diseases; pandemic; persistence","Kardas","Przemyslaw","Medication Adherence Research Centre, Department of Family Medicine, Medical University of Lodz, Lodz, Poland",NA
"1769","34163359","10.3389/fphar.2021.673485","Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.","Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for therapeutic targeting using approved drugs. We integrated a resource of TF-cytokine gene interactions with single-cell RNA-seq expression data from bronchoalveolar lavage fluid cells of COVID-19 patients. ","2021","06","29","Front Pharmacol","Frontiers in pharmacology","COVID-19; SARS-CoV2; cytokine release syndrome; cytokine storm; drug repurposing; gene regulatory networks; transcriptional regulators","Santoso","Clarissa S","Department of Biology, Boston University, Boston, MA, United States",NA
"1770","34163359","10.3389/fphar.2021.673485","Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.","Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for therapeutic targeting using approved drugs. We integrated a resource of TF-cytokine gene interactions with single-cell RNA-seq expression data from bronchoalveolar lavage fluid cells of COVID-19 patients. ","2021","06","29","Front Pharmacol","Frontiers in pharmacology","COVID-19; SARS-CoV2; cytokine release syndrome; cytokine storm; drug repurposing; gene regulatory networks; transcriptional regulators","Li","Zhaorong","Bioinformatics Program, Boston University, Boston, MA, United States",NA
"1771","34163359","10.3389/fphar.2021.673485","Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.","Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for therapeutic targeting using approved drugs. We integrated a resource of TF-cytokine gene interactions with single-cell RNA-seq expression data from bronchoalveolar lavage fluid cells of COVID-19 patients. ","2021","06","29","Front Pharmacol","Frontiers in pharmacology","COVID-19; SARS-CoV2; cytokine release syndrome; cytokine storm; drug repurposing; gene regulatory networks; transcriptional regulators","Rottenberg","Jaice T","Department of Biology, Boston University, Boston, MA, United States",NA
"1772","34163359","10.3389/fphar.2021.673485","Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.","Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for therapeutic targeting using approved drugs. We integrated a resource of TF-cytokine gene interactions with single-cell RNA-seq expression data from bronchoalveolar lavage fluid cells of COVID-19 patients. ","2021","06","29","Front Pharmacol","Frontiers in pharmacology","COVID-19; SARS-CoV2; cytokine release syndrome; cytokine storm; drug repurposing; gene regulatory networks; transcriptional regulators","Liu","Xing","Department of Biology, Boston University, Boston, MA, United States",NA
"1773","34163359","10.3389/fphar.2021.673485","Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.","Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for therapeutic targeting using approved drugs. We integrated a resource of TF-cytokine gene interactions with single-cell RNA-seq expression data from bronchoalveolar lavage fluid cells of COVID-19 patients. ","2021","06","29","Front Pharmacol","Frontiers in pharmacology","COVID-19; SARS-CoV2; cytokine release syndrome; cytokine storm; drug repurposing; gene regulatory networks; transcriptional regulators","Shen","Vivian X","Department of Biology, Boston University, Boston, MA, United States",NA
"1774","34163359","10.3389/fphar.2021.673485","Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.","Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for therapeutic targeting using approved drugs. We integrated a resource of TF-cytokine gene interactions with single-cell RNA-seq expression data from bronchoalveolar lavage fluid cells of COVID-19 patients. ","2021","06","29","Front Pharmacol","Frontiers in pharmacology","COVID-19; SARS-CoV2; cytokine release syndrome; cytokine storm; drug repurposing; gene regulatory networks; transcriptional regulators","Fuxman Bass","Juan I","Department of Biology, Boston University, Boston, MA, United States",NA
"1775","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Cui","Xinyu","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1776","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Chen","Wuyue","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1777","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Zhou","Haoyan","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1778","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Gong","Yuan","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1779","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Zhu","Bowen","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1780","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Lv","Xiang","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1781","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Guo","Hongbo","Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada",NA
"1782","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Duan","Jinao","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1783","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Zhou","Jing","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1784","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Marcon","Edyta","Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada",NA
"1785","34163357","10.3389/fphar.2021.664349","Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.","COVID-19 mortality is primarily driven by abnormal alveolar fluid metabolism of the lung, leading to fluid accumulation in the alveolar airspace. This condition is generally referred to as pulmonary edema and is a direct consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are multiple potential mechanisms leading to pulmonary edema in severe Coronavirus Disease (COVID-19) patients and understanding of those mechanisms may enable proper management of this ","2021","06","25","Front Pharmacol","Frontiers in pharmacology","COVID-19; abnormal lung humoral metabolism; drug; pulmonary edema; syndrome coronavirus 2; traditional Chinese medicine","Ma","Hongyue","Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China",NA
"1786","34163314","10.18332/tid/136040","Perceived health risks associated with the use of tobacco and nicotine products during the COVID-19 pandemic.","The perceived health risks of tobacco products may change during the ongoing COVID-19 pandemic. This study aimed to examine the perceived risks of tobacco use on COVID-19 infection and severity, and possible COVID-related changes in perceptions of tobacco use and overall health. We conducted an online survey of adults in the United States in June 2020 (n=2097). The survey covered cigarettes, cigars, e-cigarettes, and hookah. We also assessed changes in the use of any of the four tobacco products","2021","06","25","Tob Induc Dis","Tobacco induced diseases","COVID-19; perceived risk; tobacco/nicotine products","Yang","Yong","School of Public Health, The University of Memphis, Memphis, United States",NA
"1787","34163314","10.18332/tid/136040","Perceived health risks associated with the use of tobacco and nicotine products during the COVID-19 pandemic.","The perceived health risks of tobacco products may change during the ongoing COVID-19 pandemic. This study aimed to examine the perceived risks of tobacco use on COVID-19 infection and severity, and possible COVID-related changes in perceptions of tobacco use and overall health. We conducted an online survey of adults in the United States in June 2020 (n=2097). The survey covered cigarettes, cigars, e-cigarettes, and hookah. We also assessed changes in the use of any of the four tobacco products","2021","06","25","Tob Induc Dis","Tobacco induced diseases","COVID-19; perceived risk; tobacco/nicotine products","Lindblom","Eric N","O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, United States",NA
"1788","34163314","10.18332/tid/136040","Perceived health risks associated with the use of tobacco and nicotine products during the COVID-19 pandemic.","The perceived health risks of tobacco products may change during the ongoing COVID-19 pandemic. This study aimed to examine the perceived risks of tobacco use on COVID-19 infection and severity, and possible COVID-related changes in perceptions of tobacco use and overall health. We conducted an online survey of adults in the United States in June 2020 (n=2097). The survey covered cigarettes, cigars, e-cigarettes, and hookah. We also assessed changes in the use of any of the four tobacco products","2021","06","25","Tob Induc Dis","Tobacco induced diseases","COVID-19; perceived risk; tobacco/nicotine products","Salloum","Ramzi G","Department of Health Outcomes and Policy, University of Florida, Gainesville, United States",NA
"1789","34163314","10.18332/tid/136040","Perceived health risks associated with the use of tobacco and nicotine products during the COVID-19 pandemic.","The perceived health risks of tobacco products may change during the ongoing COVID-19 pandemic. This study aimed to examine the perceived risks of tobacco use on COVID-19 infection and severity, and possible COVID-related changes in perceptions of tobacco use and overall health. We conducted an online survey of adults in the United States in June 2020 (n=2097). The survey covered cigarettes, cigars, e-cigarettes, and hookah. We also assessed changes in the use of any of the four tobacco products","2021","06","25","Tob Induc Dis","Tobacco induced diseases","COVID-19; perceived risk; tobacco/nicotine products","Ward","Kenneth D","School of Public Health, The University of Memphis, Memphis, United States",NA
"1790","34163313","10.18332/tid/137086","Tackling illicit tobacco during COVID-19 pandemic.",NA,"2021","06","25","Tob Induc Dis","Tobacco induced diseases","COVID-19; illicit trade; tobacco","Ross","Hana","Research Unit on the Economics of Excisable Products, University of Cape Town, Cape Town, South Africa",NA
"1791","34163313","10.18332/tid/137086","Tackling illicit tobacco during COVID-19 pandemic.",NA,"2021","06","25","Tob Induc Dis","Tobacco induced diseases","COVID-19; illicit trade; tobacco","Joossens","Luk","Illicit Tobacco Trade Expert, Leuven, Belgium",NA
"1792","34163282","10.2147/AMEP.S314509","E-Learning for Undergraduate Medical Students.","Disruption of education can lead to drastic changes and therefore, we need to maximize the benefits of e-technology. We aimed to explore changes in knowledge, attitudes, and challenges regarding e-learning during the COVID-19 pandemic and determine how e-learning has influenced academic performance. We conducted a self-administrated electronic survey to collect information on undergraduate medical students' e-learning. We evaluated its validity, reliability and pilot tested the instrument. Betwe","2021","06","25","Adv Med Educ Pract","Advances in medical education and practice","COVID-19; e-assessment; e-learning; medical education; mobile-learning","Tashkandi","Emad","Umm AlQura University, College of Medicine, Makkah, Saudi Arabia",NA
"1793","34163281","10.2147/AMEP.S302728","The Development of an Educational Video on Blood Pressure Measurement for Pharmacy Students.","High blood pressure is an important worldwide health issue. Pharmacists can perform multifaceted tasks in hypertension management such as measuring blood pressure. In a time where the use of educational videos in health professions education has increased, an educational video might be an option for teaching blood pressure measurement skills to pharmacy students. This project aimed to develop an educational video tailored to pharmacy students on oscillometric blood pressure measurement in a comm","2021","06","25","Adv Med Educ Pract","Advances in medical education and practice","blood pressure measurement; educational video; pharmacy; pharmacy education; pharmacy students; self-instruction video","Farahani","Samieh","Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University Duesseldorf, Duesseldorf, Germany",NA
"1794","34163281","10.2147/AMEP.S302728","The Development of an Educational Video on Blood Pressure Measurement for Pharmacy Students.","High blood pressure is an important worldwide health issue. Pharmacists can perform multifaceted tasks in hypertension management such as measuring blood pressure. In a time where the use of educational videos in health professions education has increased, an educational video might be an option for teaching blood pressure measurement skills to pharmacy students. This project aimed to develop an educational video tailored to pharmacy students on oscillometric blood pressure measurement in a comm","2021","06","25","Adv Med Educ Pract","Advances in medical education and practice","blood pressure measurement; educational video; pharmacy; pharmacy education; pharmacy students; self-instruction video","Farahani","Imaneh","Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University Duesseldorf, Duesseldorf, Germany",NA
"1795","34163281","10.2147/AMEP.S302728","The Development of an Educational Video on Blood Pressure Measurement for Pharmacy Students.","High blood pressure is an important worldwide health issue. Pharmacists can perform multifaceted tasks in hypertension management such as measuring blood pressure. In a time where the use of educational videos in health professions education has increased, an educational video might be an option for teaching blood pressure measurement skills to pharmacy students. This project aimed to develop an educational video tailored to pharmacy students on oscillometric blood pressure measurement in a comm","2021","06","25","Adv Med Educ Pract","Advances in medical education and practice","blood pressure measurement; educational video; pharmacy; pharmacy education; pharmacy students; self-instruction video","Burckhardt","Bjoern B","Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University Duesseldorf, Duesseldorf, Germany",NA
"1796","34163281","10.2147/AMEP.S302728","The Development of an Educational Video on Blood Pressure Measurement for Pharmacy Students.","High blood pressure is an important worldwide health issue. Pharmacists can perform multifaceted tasks in hypertension management such as measuring blood pressure. In a time where the use of educational videos in health professions education has increased, an educational video might be an option for teaching blood pressure measurement skills to pharmacy students. This project aimed to develop an educational video tailored to pharmacy students on oscillometric blood pressure measurement in a comm","2021","06","25","Adv Med Educ Pract","Advances in medical education and practice","blood pressure measurement; educational video; pharmacy; pharmacy education; pharmacy students; self-instruction video","Monser","Karin","Multimedia Center, Heinrich Heine University Duesseldorf, Duesseldorf, Germany",NA
"1797","34163281","10.2147/AMEP.S302728","The Development of an Educational Video on Blood Pressure Measurement for Pharmacy Students.","High blood pressure is an important worldwide health issue. Pharmacists can perform multifaceted tasks in hypertension management such as measuring blood pressure. In a time where the use of educational videos in health professions education has increased, an educational video might be an option for teaching blood pressure measurement skills to pharmacy students. This project aimed to develop an educational video tailored to pharmacy students on oscillometric blood pressure measurement in a comm","2021","06","25","Adv Med Educ Pract","Advances in medical education and practice","blood pressure measurement; educational video; pharmacy; pharmacy education; pharmacy students; self-instruction video","Laeer","Stephanie","Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University Duesseldorf, Duesseldorf, Germany",NA
"1798","34163271","10.2147/RMHP.S301645","Development and Psychometric Properties of the Health Belief Scales Toward COVID-19 Vaccine in Ho Chi Minh City, Vietnam.","Beliefs of an individual about health conditions can play an important role in contributing to their behavior concerning good and bad health practices. The aim of this study was to develop and assess a set of vaccination belief scales in relation to COVID-19 vaccines. A cross-sectional study was conducted between July 2020 and January 2021 using a systematic random sampling of 425 adult outpatients at two hospitals in Ho Chi Minh City, Vietnam. An instrument was designed based on the dimensional","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; COVID-19 vaccine; Vietnam; health belief model; psychometric","Huynh","Giao","Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam",NA
"1799","34163271","10.2147/RMHP.S301645","Development and Psychometric Properties of the Health Belief Scales Toward COVID-19 Vaccine in Ho Chi Minh City, Vietnam.","Beliefs of an individual about health conditions can play an important role in contributing to their behavior concerning good and bad health practices. The aim of this study was to develop and assess a set of vaccination belief scales in relation to COVID-19 vaccines. A cross-sectional study was conducted between July 2020 and January 2021 using a systematic random sampling of 425 adult outpatients at two hospitals in Ho Chi Minh City, Vietnam. An instrument was designed based on the dimensional","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; COVID-19 vaccine; Vietnam; health belief model; psychometric","Nguyen","Han Thi Ngoc","Infection Control Department, University Medical Center Ho Chi Minh City, Ho Chi Minh City, Vietnam",NA
"1800","34163271","10.2147/RMHP.S301645","Development and Psychometric Properties of the Health Belief Scales Toward COVID-19 Vaccine in Ho Chi Minh City, Vietnam.","Beliefs of an individual about health conditions can play an important role in contributing to their behavior concerning good and bad health practices. The aim of this study was to develop and assess a set of vaccination belief scales in relation to COVID-19 vaccines. A cross-sectional study was conducted between July 2020 and January 2021 using a systematic random sampling of 425 adult outpatients at two hospitals in Ho Chi Minh City, Vietnam. An instrument was designed based on the dimensional","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; COVID-19 vaccine; Vietnam; health belief model; psychometric","Nguyen","Vien Truong","Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam",NA
"1801","34163271","10.2147/RMHP.S301645","Development and Psychometric Properties of the Health Belief Scales Toward COVID-19 Vaccine in Ho Chi Minh City, Vietnam.","Beliefs of an individual about health conditions can play an important role in contributing to their behavior concerning good and bad health practices. The aim of this study was to develop and assess a set of vaccination belief scales in relation to COVID-19 vaccines. A cross-sectional study was conducted between July 2020 and January 2021 using a systematic random sampling of 425 adult outpatients at two hospitals in Ho Chi Minh City, Vietnam. An instrument was designed based on the dimensional","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; COVID-19 vaccine; Vietnam; health belief model; psychometric","Pham","An Le","Family Medicine Training Center, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam",NA
"1802","34163266","10.2147/RMHP.S311830","Intention to Care for COVID-19 Patients Among Nurses Working at Health Care Institutions of Debre Tabor Town, North Central Ethiopia.","Coronavirus disease 2019 (COVID-19) has caused many challenges for health care providers. Nurses meet patients with coronavirus disease and offer care for newly communicable diseases. Despite global and national efforts to prevent the spread, the outbreak is still on a rise, and studies on the health care behaviors of nurses were scarce in the study setting. Therefore, this study was intended in addressing nurses' intention to care for coronavirus disease 19 patients and its determinants among n","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","Ethiopia; coronavirus; intention to care; nurse; theory of planned behavior","Minuye","Binyam","College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1803","34163266","10.2147/RMHP.S311830","Intention to Care for COVID-19 Patients Among Nurses Working at Health Care Institutions of Debre Tabor Town, North Central Ethiopia.","Coronavirus disease 2019 (COVID-19) has caused many challenges for health care providers. Nurses meet patients with coronavirus disease and offer care for newly communicable diseases. Despite global and national efforts to prevent the spread, the outbreak is still on a rise, and studies on the health care behaviors of nurses were scarce in the study setting. Therefore, this study was intended in addressing nurses' intention to care for coronavirus disease 19 patients and its determinants among n","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","Ethiopia; coronavirus; intention to care; nurse; theory of planned behavior","Alebachew","Wubet","College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1804","34163266","10.2147/RMHP.S311830","Intention to Care for COVID-19 Patients Among Nurses Working at Health Care Institutions of Debre Tabor Town, North Central Ethiopia.","Coronavirus disease 2019 (COVID-19) has caused many challenges for health care providers. Nurses meet patients with coronavirus disease and offer care for newly communicable diseases. Despite global and national efforts to prevent the spread, the outbreak is still on a rise, and studies on the health care behaviors of nurses were scarce in the study setting. Therefore, this study was intended in addressing nurses' intention to care for coronavirus disease 19 patients and its determinants among n","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","Ethiopia; coronavirus; intention to care; nurse; theory of planned behavior","Kebede","Melese","College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1805","34163266","10.2147/RMHP.S311830","Intention to Care for COVID-19 Patients Among Nurses Working at Health Care Institutions of Debre Tabor Town, North Central Ethiopia.","Coronavirus disease 2019 (COVID-19) has caused many challenges for health care providers. Nurses meet patients with coronavirus disease and offer care for newly communicable diseases. Despite global and national efforts to prevent the spread, the outbreak is still on a rise, and studies on the health care behaviors of nurses were scarce in the study setting. Therefore, this study was intended in addressing nurses' intention to care for coronavirus disease 19 patients and its determinants among n","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","Ethiopia; coronavirus; intention to care; nurse; theory of planned behavior","Asnakew","Sintayehu","College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1806","34163266","10.2147/RMHP.S311830","Intention to Care for COVID-19 Patients Among Nurses Working at Health Care Institutions of Debre Tabor Town, North Central Ethiopia.","Coronavirus disease 2019 (COVID-19) has caused many challenges for health care providers. Nurses meet patients with coronavirus disease and offer care for newly communicable diseases. Despite global and national efforts to prevent the spread, the outbreak is still on a rise, and studies on the health care behaviors of nurses were scarce in the study setting. Therefore, this study was intended in addressing nurses' intention to care for coronavirus disease 19 patients and its determinants among n","2021","06","25","Risk Manag Healthc Policy","Risk management and healthcare policy","Ethiopia; coronavirus; intention to care; nurse; theory of planned behavior","Mesfin Belay","Demeke","College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1807","34163257","10.2147/IMCRJ.S306830","Arterial Thrombosis in an Asymptomatic COVID-19 Complicated by Malignant Middle Cerebral Artery Syndrome: A Case Report and Literature Review.","Coronavirus disease 2019 (COVID-19) is a severe infectious respiratory disease caused by the novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Multiple studies in the literature highlight the association between COVID-19 and stroke. We report a case of acute ischemic stroke in a COVID-19 patient without displaying symptoms of active COVID-19 infection or risk factors for stroke with further review of the literature. The patient's recovery was complicated by","2021","06","25","Int Med Case Rep J","International medical case reports journal","COVID-19; SARS-CoV-2; carotid artery thrombosis; case report; infection; ischemic stroke","Alzahrani","Ali A","College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"1808","34163257","10.2147/IMCRJ.S306830","Arterial Thrombosis in an Asymptomatic COVID-19 Complicated by Malignant Middle Cerebral Artery Syndrome: A Case Report and Literature Review.","Coronavirus disease 2019 (COVID-19) is a severe infectious respiratory disease caused by the novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Multiple studies in the literature highlight the association between COVID-19 and stroke. We report a case of acute ischemic stroke in a COVID-19 patient without displaying symptoms of active COVID-19 infection or risk factors for stroke with further review of the literature. The patient's recovery was complicated by","2021","06","25","Int Med Case Rep J","International medical case reports journal","COVID-19; SARS-CoV-2; carotid artery thrombosis; case report; infection; ischemic stroke","Al Abdulsalam","Hissah","Division of Neurosurgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"1809","34163257","10.2147/IMCRJ.S306830","Arterial Thrombosis in an Asymptomatic COVID-19 Complicated by Malignant Middle Cerebral Artery Syndrome: A Case Report and Literature Review.","Coronavirus disease 2019 (COVID-19) is a severe infectious respiratory disease caused by the novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Multiple studies in the literature highlight the association between COVID-19 and stroke. We report a case of acute ischemic stroke in a COVID-19 patient without displaying symptoms of active COVID-19 infection or risk factors for stroke with further review of the literature. The patient's recovery was complicated by","2021","06","25","Int Med Case Rep J","International medical case reports journal","COVID-19; SARS-CoV-2; carotid artery thrombosis; case report; infection; ischemic stroke","Al-Sakkaf","Hussein","Department of Radiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"1810","34163257","10.2147/IMCRJ.S306830","Arterial Thrombosis in an Asymptomatic COVID-19 Complicated by Malignant Middle Cerebral Artery Syndrome: A Case Report and Literature Review.","Coronavirus disease 2019 (COVID-19) is a severe infectious respiratory disease caused by the novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Multiple studies in the literature highlight the association between COVID-19 and stroke. We report a case of acute ischemic stroke in a COVID-19 patient without displaying symptoms of active COVID-19 infection or risk factors for stroke with further review of the literature. The patient's recovery was complicated by","2021","06","25","Int Med Case Rep J","International medical case reports journal","COVID-19; SARS-CoV-2; carotid artery thrombosis; case report; infection; ischemic stroke","Yousef","Ayat","Department of Radiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"1811","34163257","10.2147/IMCRJ.S306830","Arterial Thrombosis in an Asymptomatic COVID-19 Complicated by Malignant Middle Cerebral Artery Syndrome: A Case Report and Literature Review.","Coronavirus disease 2019 (COVID-19) is a severe infectious respiratory disease caused by the novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Multiple studies in the literature highlight the association between COVID-19 and stroke. We report a case of acute ischemic stroke in a COVID-19 patient without displaying symptoms of active COVID-19 infection or risk factors for stroke with further review of the literature. The patient's recovery was complicated by","2021","06","25","Int Med Case Rep J","International medical case reports journal","COVID-19; SARS-CoV-2; carotid artery thrombosis; case report; infection; ischemic stroke","Albadr","Fahad B","Department of Radiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"1812","34163220","10.2147/IJGM.S309003","Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India - A Hospital-Based Study.","The world is facing the most challenging pandemic in the 21st century. The developed and developing countries are facing the burden equally and no proven treatment options available. Recent studies suggest the plausibility of vitamin D therapy and prophylaxis for COVID-19, in the setting where the deficiency is more prevalent. Though evaluation of vitamin D status is not a routine in India, the present study focuses on the level of Vitamin d among COVID-19 patients. The study was a hospital-base","2021","06","25","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; Vitamin D; low level of Vitamin D","Singh","Shruti","Department of Pharmacology, AIIMS, Patna, Bihar, India",NA
"1813","34163220","10.2147/IJGM.S309003","Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India - A Hospital-Based Study.","The world is facing the most challenging pandemic in the 21st century. The developed and developing countries are facing the burden equally and no proven treatment options available. Recent studies suggest the plausibility of vitamin D therapy and prophylaxis for COVID-19, in the setting where the deficiency is more prevalent. Though evaluation of vitamin D status is not a routine in India, the present study focuses on the level of Vitamin d among COVID-19 patients. The study was a hospital-base","2021","06","25","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; Vitamin D; low level of Vitamin D","Nimavat","Nirav","Department of Community Medicine, SBKS MIRC, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India",NA
"1814","34163220","10.2147/IJGM.S309003","Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India - A Hospital-Based Study.","The world is facing the most challenging pandemic in the 21st century. The developed and developing countries are facing the burden equally and no proven treatment options available. Recent studies suggest the plausibility of vitamin D therapy and prophylaxis for COVID-19, in the setting where the deficiency is more prevalent. Though evaluation of vitamin D status is not a routine in India, the present study focuses on the level of Vitamin d among COVID-19 patients. The study was a hospital-base","2021","06","25","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; Vitamin D; low level of Vitamin D","Kumar Singh","Amarjeet","Department of Anaesthesia, AIIMS, Patna, Bihar, India",NA
"1815","34163220","10.2147/IJGM.S309003","Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India - A Hospital-Based Study.","The world is facing the most challenging pandemic in the 21st century. The developed and developing countries are facing the burden equally and no proven treatment options available. Recent studies suggest the plausibility of vitamin D therapy and prophylaxis for COVID-19, in the setting where the deficiency is more prevalent. Though evaluation of vitamin D status is not a routine in India, the present study focuses on the level of Vitamin d among COVID-19 patients. The study was a hospital-base","2021","06","25","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; Vitamin D; low level of Vitamin D","Ahmad","Shamshad","Department of Community and Family Medicine, AIIMS, Patna, Bihar, India",NA
"1816","34163220","10.2147/IJGM.S309003","Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India - A Hospital-Based Study.","The world is facing the most challenging pandemic in the 21st century. The developed and developing countries are facing the burden equally and no proven treatment options available. Recent studies suggest the plausibility of vitamin D therapy and prophylaxis for COVID-19, in the setting where the deficiency is more prevalent. Though evaluation of vitamin D status is not a routine in India, the present study focuses on the level of Vitamin d among COVID-19 patients. The study was a hospital-base","2021","06","25","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; Vitamin D; low level of Vitamin D","Sinha","Nishi","Department of Community Medicine, SBKS MIRC, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India",NA
"1817","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Garg","Mandeep","Department of Radiodiagnosis &amp",NA
"1818","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Maralakunte","Muniraju","Department of Radiodiagnosis &amp",NA
"1819","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Garg","Suruchi","Department of Dermatology, Aura Skin Institute, Chandigarh, India",NA
"1820","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Dhooria","Sahajal","Department of Pulmonary Medicine, PGIMER, Chandigarh, India",NA
"1821","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Sehgal","Inderpaul","Department of Pulmonary Medicine, PGIMER, Chandigarh, India",NA
"1822","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Bhalla","Ashu Seith","Department of Radiodiagnosis, AIIMS, New Delhi, India",NA
"1823","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Vijayvergiya","Rajesh","Department of Cardiology, PGIMER, Chandigarh, India",NA
"1824","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Grover","Sandeep","Department of Psychiatry, PGIMER, Chandigarh, India",NA
"1825","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Bhatia","Vikas","Department of Radiodiagnosis &amp",NA
"1826","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Jagia","Priya","Department of Cardiovascular Imaging &amp",NA
"1827","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Bhalla","Ashish","Department of Internal Medicine, PGIMER, Chandigarh, India",NA
"1828","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Suri","Vikas","Department of Internal Medicine, PGIMER, Chandigarh, India",NA
"1829","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Goyal","Manoj","Department of Neurology, PGIMER, Chandigarh, India",NA
"1830","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Agarwal","Ritesh","Department of Pulmonary Medicine, PGIMER, Chandigarh, India",NA
"1831","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Puri","Goverdhan Dutt","Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh, India",NA
"1832","34163217","10.2147/IJGM.S316708","The Conundrum of 'Long-COVID-19': A Narrative Review.","COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common sy","2021","06","25","Int J Gen Med","International journal of general medicine","Long-COVID; Long-COVID-19; chronic COVID; ongoing symptomatic COVID-19; post-COVID; post-COVID-19 syndrome","Sandhu","Manavjit Singh","Department of Radiodiagnosis &amp",NA
"1833","34163216","10.2147/IJGM.S312416","KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.","SARS-CoV-2 proteins binding human mRNAs (SPBRs) have been proven to regulate a variety of tumor-related functions in different types of cancer. However, their biological roles and potential mechanisms in clear cell renal cell carcinoma (ccRCC) are still elusive. Herein, we investigate the expression and prognostic value of SPBRs in ccRCC through bioinformatics methods. Data downloaded from the Cancer Genome Atlas (TCGA) database was used to screen differentially expressed SPBRs (DE-SPBRs) betwee","2021","06","25","Int J Gen Med","International journal of general medicine","SARS-CoV-2 proteins binding human mRNAs; bioinformatics; clear cell renal cell carcinoma","Li","Canxuan","Department of Urology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People's Republic of China",NA
"1834","34163216","10.2147/IJGM.S312416","KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.","SARS-CoV-2 proteins binding human mRNAs (SPBRs) have been proven to regulate a variety of tumor-related functions in different types of cancer. However, their biological roles and potential mechanisms in clear cell renal cell carcinoma (ccRCC) are still elusive. Herein, we investigate the expression and prognostic value of SPBRs in ccRCC through bioinformatics methods. Data downloaded from the Cancer Genome Atlas (TCGA) database was used to screen differentially expressed SPBRs (DE-SPBRs) betwee","2021","06","25","Int J Gen Med","International journal of general medicine","SARS-CoV-2 proteins binding human mRNAs; bioinformatics; clear cell renal cell carcinoma","Yao","Yuzhi","Department of Breast Surgery and General Surgery, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, People's Republic of China",NA
"1835","34163216","10.2147/IJGM.S312416","KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.","SARS-CoV-2 proteins binding human mRNAs (SPBRs) have been proven to regulate a variety of tumor-related functions in different types of cancer. However, their biological roles and potential mechanisms in clear cell renal cell carcinoma (ccRCC) are still elusive. Herein, we investigate the expression and prognostic value of SPBRs in ccRCC through bioinformatics methods. Data downloaded from the Cancer Genome Atlas (TCGA) database was used to screen differentially expressed SPBRs (DE-SPBRs) betwee","2021","06","25","Int J Gen Med","International journal of general medicine","SARS-CoV-2 proteins binding human mRNAs; bioinformatics; clear cell renal cell carcinoma","Long","Dan","Respiratory medicine, Shenshan Central Hospital, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Shanwei, Guangdong, People's Republic of China",NA
"1836","34163216","10.2147/IJGM.S312416","KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.","SARS-CoV-2 proteins binding human mRNAs (SPBRs) have been proven to regulate a variety of tumor-related functions in different types of cancer. However, their biological roles and potential mechanisms in clear cell renal cell carcinoma (ccRCC) are still elusive. Herein, we investigate the expression and prognostic value of SPBRs in ccRCC through bioinformatics methods. Data downloaded from the Cancer Genome Atlas (TCGA) database was used to screen differentially expressed SPBRs (DE-SPBRs) betwee","2021","06","25","Int J Gen Med","International journal of general medicine","SARS-CoV-2 proteins binding human mRNAs; bioinformatics; clear cell renal cell carcinoma","Lin","Xiaobin","Department of Breast Surgery and General Surgery, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, People's Republic of China",NA
"1837","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Jamiruddin","Mohd Raeed","Department of Pharmacy, BRAC University, Dhaka, 1212, Bangladesh",NA
"1838","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Haq","Md Ahsanul","Gonoshasthaya-RNA Molecular Diagnostic &amp",NA
"1839","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Tomizawa","Kazuhito","Department of Molecular Physiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 860-0811, Japan",NA
"1840","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Kobatake","Eiry","School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, 226-8502, Japan",NA
"1841","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Mie","Masayasu","School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, 226-8502, Japan",NA
"1842","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Ahmed","Sohel","Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh",NA
"1843","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Khandker","Shahad Saif","Gonoshasthaya-RNA Molecular Diagnostic &amp",NA
"1844","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Ali","Tamanna","Gonoshasthaya-RNA Molecular Diagnostic &amp",NA
"1845","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Jahan","Nowshin","Gonoshasthaya-RNA Molecular Diagnostic &amp",NA
"1846","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Oishee","Mumtarin Jannat","Gonoshasthaya-RNA Molecular Diagnostic &amp",NA
"1847","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Khondoker","Mohib Ullah","Gonoshasthaya-RNA Molecular Diagnostic &amp",NA
"1848","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Sil","Bijon Kumar","Gonoshasthaya-RNA Molecular Diagnostic &amp",NA
"1849","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Haque","Mainul","The Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000, Malaysia",NA
"1850","34163208","10.2147/JIR.S313188","Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.","Dynamics and persistence of neutralizing and non-neutralizing antibodies can give us the knowledge required for serodiagnosis, disease management, and successful vaccine design and development. The disappearance of antibodies, absence of humoral immunity activation, and sporadic reinfection cases emphasize the importance of longitudinal antibody dynamics against variable structural antigens. In this study, twenty-five healthy subjects working in a SARS-COV-2 serodiagnostic assay development proj","2021","06","25","J Inflamm Res","Journal of inflammation research","COVID-19; SARS-CoV-2; antibody dynamics; reinfection; vaccination","Adnan","Nihad","Department of Microbiology, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh",NA
"1851","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Torre","Enrico","Endocrinology Diabetology and Metabolic Diseases Unit - ASL3, Genoa, Italy",NA
"1852","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Colombo","Giorgio Lorenzo","Department of Drug Sciences, University of Pavia, Pavia, Italy",NA
"1853","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Di Matteo","Sergio","S.A.V.E. Studi Analisi Valutazioni Economiche S.r.l., Health Economics &amp",NA
"1854","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Martinotti","Chiara","S.A.V.E. Studi Analisi Valutazioni Economiche S.r.l., Health Economics &amp",NA
"1855","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Valentino","Maria Chiara","S.A.V.E. Studi Analisi Valutazioni Economiche S.r.l., Health Economics &amp",NA
"1856","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Rebora","Alberto","Endocrinology Diabetology and Metabolic Diseases Unit - ASL3, Genoa, Italy",NA
"1857","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Cecoli","Francesca","Endocrinology Diabetology and Metabolic Diseases Unit - ASL3, Genoa, Italy",NA
"1858","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Monti","Eleonora","Endocrinology Diabetology and Metabolic Diseases Unit - ASL3, Genoa, Italy",NA
"1859","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Galimberti","Marco","DP Trade SA, Lugano, Switzerland",NA
"1860","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Di Bartolo","Paolo","Diabetes Center of Ravenna, Romagna Diabetes Clinical Network, Romagna Local Health Authority, Ravenna, Italy",NA
"1861","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Gaggioli","Germano","Cardiology Unit Villascassi Hospital - ASL3, Genoa, Italy",NA
"1862","34163191","10.2147/CEOR.S313577","Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.","In Italy, the adoption of a total lockdown has generated almost total suspension of outpatient visits except for emergencies. Even after lockdown, the pandemic fear created additional barriers to access the health services. The aim of our study is to evaluate the economic impact of the lockdown for COVID-19 on public health in Italy, focusing on its effects on diabetic population. We analyzed the impact of the lockdown on excess mortality and morbidity in the Italian diabetic population during 2","2021","06","25","Clinicoecon Outcomes Res","ClinicoEconomics and outcomes research : CEOR","COVID-19; diabetes type II; diabetic complications; economic impact; quality of life","Bruno","Giacomo Matteo","Department of Drug Sciences, University of Pavia, Pavia, Italy",NA
"1863","34163190","10.2147/IDR.S306441","Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review.","Coronaviruses are named after the crown-like spike proteins on their surface. In the 21st century, three coronaviruses, namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), SARS-CoV, and Middle East respiratory syndrome related coronavirus (MERS-CoV), have emerged in the human population, presumably evolving from pathogens infecting other animals. Coronaviruses are enveloped viruses responsible for 15-30% of the atypical pneumonia cases in humans worldwide. The current coronaviru","2021","06","25","Infect Drug Resist","Infection and drug resistance","ACE2; coronavirus; mechanism; spike protein; vaccine pandemic","Alsobaie","Sarah","Department of Clinical Laboratory Science, King Saud University, Riyadh, 11451, Saudi Arabia",NA
"1864","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Bhardwaj","Pankaj","Community Medicine &amp",NA
"1865","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Joshi","Nitin Kumar","Community Medicine &amp",NA
"1866","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Gupta","Manoj Kumar","Community Medicine &amp",NA
"1867","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Goel","Akhil Dhanesh","Community Medicine &amp",NA
"1868","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Saurabh","Suman","Community Medicine &amp",NA
"1869","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Charan","Jaykaran","Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India",NA
"1870","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Rajpurohit","Prakash","District Collector Office, Jodhpur, India",NA
"1871","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Ola","Suresh","Jodhpur Municipal Corporation, Jodhpur, India",NA
"1872","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Singh","Pritam","Medical &amp",NA
"1873","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Bisht","Sunil","Medical &amp",NA
"1874","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Bishnoi","N R","Administrative Office, All India Institute of Medical Sciences, Jodhpur, India",NA
"1875","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Manda","Balwant","Medical &amp",NA
"1876","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Singh","Kuldeep","Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India",NA
"1877","34163188","10.2147/IDR.S309909","Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India.","Jodhpur administration directed its efforts to control and mitigate COVID 19 infection by implementing and monitoring facility isolation (FI) and home isolation (HI) measures. This study is conducted with a hypothesis that there is no difference in the quality of life and cost-effectiveness of mildly symptomatic or asymptomatic patients in HI and FI. A mixed-method study was conducted in Jodhpur in September 2020. The purposive sampling technique was used and data from 120 individuals admitted i","2021","07","09","Infect Drug Resist","Infection and drug resistance","COVID 19; cost savings; patient isolation; public health; quality of life","Misra","Sanjeev","Department of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India",NA
"1878","34163184","10.2147/IDR.S316461","Awareness and Attitude Towards COVID-19 Vaccination and Associated Factors in Ethiopia: Cross-Sectional Study.","Coronavirus disease (COVID-19) is a deadly virus that continues to afflict many countries worldwide. The development of a COVID-19 vaccine to combat the disease's spread and devastating effects is still ongoing, and as the pandemic progresses, new, more effective vaccines are likely to be created. The aim of this study was to assess awareness and attitude towards COVID-19 vaccination in Ethiopia. A population-based cross-sectional e-survey was conducted among 425 participants from March 13, 2021","2021","07","15","Infect Drug Resist","Infection and drug resistance","COVID-19; Ethiopia; attitude; awareness; vaccination","Mesesle","Molalegn","School of Midwifery, College of Health Science and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia",NA
"1879","34163183","10.2147/IDR.S307374","Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).","The COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It is one of the RNA coronaviruses which share the highest mutation rates of RNA viruses when compared with that of their hosts. The collective mutation rate of RNA viruses is up to a million times higher than their hosts and is correlated with enhanced virulence of viruses. The RNA, genomic material of SARS-CoV-2, has the capacity of showing amplified fast changes as the infection spreads. These cha","2021","06","25","Infect Drug Resist","Infection and drug resistance","RdRp; SARS COV-2; amino acid sequence mutations; genomic mutations; spike proteins; therapeutic target; virulence","Kelta Wabalo","Endriyas","Department of Biomedical Sciences, Faculty of Medical Sciences, Institute of Health, Jimma University, Jimma, Ethiopia",NA
"1880","34163183","10.2147/IDR.S307374","Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).","The COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It is one of the RNA coronaviruses which share the highest mutation rates of RNA viruses when compared with that of their hosts. The collective mutation rate of RNA viruses is up to a million times higher than their hosts and is correlated with enhanced virulence of viruses. The RNA, genomic material of SARS-CoV-2, has the capacity of showing amplified fast changes as the infection spreads. These cha","2021","06","25","Infect Drug Resist","Infection and drug resistance","RdRp; SARS COV-2; amino acid sequence mutations; genomic mutations; spike proteins; therapeutic target; virulence","Dukessa Dubiwak","Abebe","Department of Biomedical Sciences, Faculty of Medical Sciences, Institute of Health, Jimma University, Jimma, Ethiopia",NA
"1881","34163183","10.2147/IDR.S307374","Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).","The COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It is one of the RNA coronaviruses which share the highest mutation rates of RNA viruses when compared with that of their hosts. The collective mutation rate of RNA viruses is up to a million times higher than their hosts and is correlated with enhanced virulence of viruses. The RNA, genomic material of SARS-CoV-2, has the capacity of showing amplified fast changes as the infection spreads. These cha","2021","06","25","Infect Drug Resist","Infection and drug resistance","RdRp; SARS COV-2; amino acid sequence mutations; genomic mutations; spike proteins; therapeutic target; virulence","Welde Senbetu","Mengistu","Department of Biomedical Sciences, Faculty of Medical Sciences, Institute of Health, Jimma University, Jimma, Ethiopia",NA
"1882","34163183","10.2147/IDR.S307374","Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).","The COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It is one of the RNA coronaviruses which share the highest mutation rates of RNA viruses when compared with that of their hosts. The collective mutation rate of RNA viruses is up to a million times higher than their hosts and is correlated with enhanced virulence of viruses. The RNA, genomic material of SARS-CoV-2, has the capacity of showing amplified fast changes as the infection spreads. These cha","2021","06","25","Infect Drug Resist","Infection and drug resistance","RdRp; SARS COV-2; amino acid sequence mutations; genomic mutations; spike proteins; therapeutic target; virulence","Sime Gizaw","Tariku","Department of Biomedical Sciences, Faculty of Medical Sciences, Institute of Health, Jimma University, Jimma, Ethiopia",NA
"1883","34163172","10.2147/JMDH.S304419","Structural Zero Data of COVID-19 Discovers Exodus Probabilities.","Challenges to manage, mitigate, or prevent the COVID-19's pandemics are felt by medical, healthcare professionals and governing agencies. Health researchers conduct survey among the citizens to capture their opinion on COVID-19. In such surveys like in Hanafiah and Wan (2020), structural-zero (different from sampling zero) category occurs as they question about perception, knowledge, and communication regarding COVID-19. The data were collected in a survey conducted among Malaysians by Hanafiah ","2021","06","25","J Multidiscip Healthc","Journal of multidisciplinary healthcare","Venn layout; communication; dependent probabilities; odds; odds ratio; perception; public knowledge; sample space; survey outcomes","Shanmugam","Ramalingam","School of Health Administration, Texas State University, San Marcos, TX, 78666, USA",NA
"1884","34163172","10.2147/JMDH.S304419","Structural Zero Data of COVID-19 Discovers Exodus Probabilities.","Challenges to manage, mitigate, or prevent the COVID-19's pandemics are felt by medical, healthcare professionals and governing agencies. Health researchers conduct survey among the citizens to capture their opinion on COVID-19. In such surveys like in Hanafiah and Wan (2020), structural-zero (different from sampling zero) category occurs as they question about perception, knowledge, and communication regarding COVID-19. The data were collected in a survey conducted among Malaysians by Hanafiah ","2021","06","25","J Multidiscip Healthc","Journal of multidisciplinary healthcare","Venn layout; communication; dependent probabilities; odds; odds ratio; perception; public knowledge; sample space; survey outcomes","Singh","Karan P","Department of Epidemiology and Biostatistics, School of Community and Rural Health, The University of Texas Health Sciences Center at Tyler, Tyler, TX, 75708, USA",NA
"1885","34163169","10.2147/JMDH.S311535","The COVID-19 Pandemic and Its Impact on Knowledge, Perception and Attitudes of Dentistry Students in Austria: A Cross-Sectional Survey.","Universities with dental schools are faced with complex problems during the COVID-19 pandemic. Dentistry students are at a higher risk of contracting infections, specifically COVID-19, due to direct contact with patients. The aim of this study was to assess the knowledge, perception and attitude regarding COVID-19 among dentistry students in Austria. During the first lockdown in Austria, an online survey was distributed among 165 dentistry students in their clinical term at the Medical Universit","2021","06","25","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; dentistry students; infection; infection control; pandemic","Boukhobza","Sarra","Department of Pediatric Dentistry, University Clinic of Dentistry, Medical University Vienna, Vienna, Austria",NA
"1886","34163169","10.2147/JMDH.S311535","The COVID-19 Pandemic and Its Impact on Knowledge, Perception and Attitudes of Dentistry Students in Austria: A Cross-Sectional Survey.","Universities with dental schools are faced with complex problems during the COVID-19 pandemic. Dentistry students are at a higher risk of contracting infections, specifically COVID-19, due to direct contact with patients. The aim of this study was to assess the knowledge, perception and attitude regarding COVID-19 among dentistry students in Austria. During the first lockdown in Austria, an online survey was distributed among 165 dentistry students in their clinical term at the Medical Universit","2021","06","25","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; dentistry students; infection; infection control; pandemic","Ritschl","Valentin","Center for Medical Statistics, Informatics, and Intelligent Systems, Section for Outcomes Research, Medical University Vienna, Vienna, Austria",NA
"1887","34163169","10.2147/JMDH.S311535","The COVID-19 Pandemic and Its Impact on Knowledge, Perception and Attitudes of Dentistry Students in Austria: A Cross-Sectional Survey.","Universities with dental schools are faced with complex problems during the COVID-19 pandemic. Dentistry students are at a higher risk of contracting infections, specifically COVID-19, due to direct contact with patients. The aim of this study was to assess the knowledge, perception and attitude regarding COVID-19 among dentistry students in Austria. During the first lockdown in Austria, an online survey was distributed among 165 dentistry students in their clinical term at the Medical Universit","2021","06","25","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; dentistry students; infection; infection control; pandemic","Stamm","Tanja","Center for Medical Statistics, Informatics, and Intelligent Systems, Section for Outcomes Research, Medical University Vienna, Vienna, Austria",NA
"1888","34163169","10.2147/JMDH.S311535","The COVID-19 Pandemic and Its Impact on Knowledge, Perception and Attitudes of Dentistry Students in Austria: A Cross-Sectional Survey.","Universities with dental schools are faced with complex problems during the COVID-19 pandemic. Dentistry students are at a higher risk of contracting infections, specifically COVID-19, due to direct contact with patients. The aim of this study was to assess the knowledge, perception and attitude regarding COVID-19 among dentistry students in Austria. During the first lockdown in Austria, an online survey was distributed among 165 dentistry students in their clinical term at the Medical Universit","2021","06","25","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; dentistry students; infection; infection control; pandemic","Bekes","Katrin","Department of Pediatric Dentistry, University Clinic of Dentistry, Medical University Vienna, Vienna, Austria",NA
"1889","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Huang","Yuanyuan","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1890","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Zhou","Yongjie","Department of Psychiatry, Shenzhen Kangning Hospital, Shenzhen, People's Republic of China",NA
"1891","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Wei","Yi","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1892","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Zeng","Lingyun","Department of Psychiatry, Shenzhen Kangning Hospital, Shenzhen, People's Republic of China",NA
"1893","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Yang","Jiezhi","Department of Psychiatry, Shenzhen Health Development Research Center, Shenzhen, People's Republic of China",NA
"1894","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Li","Yi","Department of Psychiatry, Shenzhen Kangning Hospital, Shenzhen, People's Republic of China",NA
"1895","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Song","Xiuli","Clinical Psychology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, People's Republic of China",NA
"1896","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Li","Hehua","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1897","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","He","Hongbo","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1898","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Li","Ting","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1899","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Wu","Kai","Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology (scUT), Guangzhou, People's Republic of China",NA
"1900","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Yang","Mingzhe","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1901","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Wu","Fengchun","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1902","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Ning","Yuping","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1903","34163164","10.2147/NDT.S300719","Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19.","During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. A total of 605 medical staff and 1091 public","2021","06","25","Neuropsychiatr Dis Treat","Neuropsychiatric disease and treatment","COVID-19; anxiety; insomnia; medical staff; somatic symptom","Zhang","Xiangyang","Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People's Republic of China",NA
"1904","34163159","10.2147/IJN.S313093","Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.","Ivermectin is an FDA-approved broad-spectrum anti-parasitic agent that has been shown to inhibit SARS-CoV-2 replication in vitro. We aimed to assess the therapeutic efficacy of ivermectin mucoadhesive nanosuspension intranasal spray in treatment of patients with mild COVID-19. This clinical trial included 114 patients diagnosed as mild COVID-19. Patients were divided randomly into two age and sex-matched groups; group A comprising 57 patients received ivermectin nanosuspension nasal spray twice ","2021","06","30","Int J Nanomedicine","International journal of nanomedicine","COVID-19; biochemical and molecular; ivermectin nanosuspension; nasal spray; Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Cough; Egypt; Female; Fever; Humans; Ivermectin; Male; Middle Aged; Nanostructures; Nasal Sprays; Nasopharynx; Prospective Studies; Respiratory Tract Diseases; Treatment Outcome","Aref","Zaki F","ENT Department, Faculty of Medicine, South Valley University, Qena, Egypt",NA
"1905","34163159","10.2147/IJN.S313093","Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.","Ivermectin is an FDA-approved broad-spectrum anti-parasitic agent that has been shown to inhibit SARS-CoV-2 replication in vitro. We aimed to assess the therapeutic efficacy of ivermectin mucoadhesive nanosuspension intranasal spray in treatment of patients with mild COVID-19. This clinical trial included 114 patients diagnosed as mild COVID-19. Patients were divided randomly into two age and sex-matched groups; group A comprising 57 patients received ivermectin nanosuspension nasal spray twice ","2021","06","30","Int J Nanomedicine","International journal of nanomedicine","COVID-19; biochemical and molecular; ivermectin nanosuspension; nasal spray; Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Cough; Egypt; Female; Fever; Humans; Ivermectin; Male; Middle Aged; Nanostructures; Nasal Sprays; Nasopharynx; Prospective Studies; Respiratory Tract Diseases; Treatment Outcome","Bazeed","Shamardan Ezz Eldin S","Tropical Medicine and Gastroenterology Department, Faculty of Medicine, South Valley University, Qena, Egypt",NA
"1906","34163159","10.2147/IJN.S313093","Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.","Ivermectin is an FDA-approved broad-spectrum anti-parasitic agent that has been shown to inhibit SARS-CoV-2 replication in vitro. We aimed to assess the therapeutic efficacy of ivermectin mucoadhesive nanosuspension intranasal spray in treatment of patients with mild COVID-19. This clinical trial included 114 patients diagnosed as mild COVID-19. Patients were divided randomly into two age and sex-matched groups; group A comprising 57 patients received ivermectin nanosuspension nasal spray twice ","2021","06","30","Int J Nanomedicine","International journal of nanomedicine","COVID-19; biochemical and molecular; ivermectin nanosuspension; nasal spray; Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Cough; Egypt; Female; Fever; Humans; Ivermectin; Male; Middle Aged; Nanostructures; Nasal Sprays; Nasopharynx; Prospective Studies; Respiratory Tract Diseases; Treatment Outcome","Hassan","Mohammed H","Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt",NA
"1907","34163159","10.2147/IJN.S313093","Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.","Ivermectin is an FDA-approved broad-spectrum anti-parasitic agent that has been shown to inhibit SARS-CoV-2 replication in vitro. We aimed to assess the therapeutic efficacy of ivermectin mucoadhesive nanosuspension intranasal spray in treatment of patients with mild COVID-19. This clinical trial included 114 patients diagnosed as mild COVID-19. Patients were divided randomly into two age and sex-matched groups; group A comprising 57 patients received ivermectin nanosuspension nasal spray twice ","2021","06","30","Int J Nanomedicine","International journal of nanomedicine","COVID-19; biochemical and molecular; ivermectin nanosuspension; nasal spray; Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Cough; Egypt; Female; Fever; Humans; Ivermectin; Male; Middle Aged; Nanostructures; Nasal Sprays; Nasopharynx; Prospective Studies; Respiratory Tract Diseases; Treatment Outcome","Hassan","Abeer S","Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena, Egypt",NA
"1908","34163159","10.2147/IJN.S313093","Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.","Ivermectin is an FDA-approved broad-spectrum anti-parasitic agent that has been shown to inhibit SARS-CoV-2 replication in vitro. We aimed to assess the therapeutic efficacy of ivermectin mucoadhesive nanosuspension intranasal spray in treatment of patients with mild COVID-19. This clinical trial included 114 patients diagnosed as mild COVID-19. Patients were divided randomly into two age and sex-matched groups; group A comprising 57 patients received ivermectin nanosuspension nasal spray twice ","2021","06","30","Int J Nanomedicine","International journal of nanomedicine","COVID-19; biochemical and molecular; ivermectin nanosuspension; nasal spray; Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Cough; Egypt; Female; Fever; Humans; Ivermectin; Male; Middle Aged; Nanostructures; Nasal Sprays; Nasopharynx; Prospective Studies; Respiratory Tract Diseases; Treatment Outcome","Rashad","Alaa","Department of Chest Diseases and Tuberculosis, Faculty of Medicine, South Vally University, Qena, Egypt",NA
"1909","34163159","10.2147/IJN.S313093","Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.","Ivermectin is an FDA-approved broad-spectrum anti-parasitic agent that has been shown to inhibit SARS-CoV-2 replication in vitro. We aimed to assess the therapeutic efficacy of ivermectin mucoadhesive nanosuspension intranasal spray in treatment of patients with mild COVID-19. This clinical trial included 114 patients diagnosed as mild COVID-19. Patients were divided randomly into two age and sex-matched groups; group A comprising 57 patients received ivermectin nanosuspension nasal spray twice ","2021","06","30","Int J Nanomedicine","International journal of nanomedicine","COVID-19; biochemical and molecular; ivermectin nanosuspension; nasal spray; Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Cough; Egypt; Female; Fever; Humans; Ivermectin; Male; Middle Aged; Nanostructures; Nasal Sprays; Nasopharynx; Prospective Studies; Respiratory Tract Diseases; Treatment Outcome","Hassan","Rehab G","Department of Public Health and Community Medicine, Faculty of Medicine, South Valley University, Qena, Egypt",NA
"1910","34163159","10.2147/IJN.S313093","Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.","Ivermectin is an FDA-approved broad-spectrum anti-parasitic agent that has been shown to inhibit SARS-CoV-2 replication in vitro. We aimed to assess the therapeutic efficacy of ivermectin mucoadhesive nanosuspension intranasal spray in treatment of patients with mild COVID-19. This clinical trial included 114 patients diagnosed as mild COVID-19. Patients were divided randomly into two age and sex-matched groups; group A comprising 57 patients received ivermectin nanosuspension nasal spray twice ","2021","06","30","Int J Nanomedicine","International journal of nanomedicine","COVID-19; biochemical and molecular; ivermectin nanosuspension; nasal spray; Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Cough; Egypt; Female; Fever; Humans; Ivermectin; Male; Middle Aged; Nanostructures; Nasal Sprays; Nasopharynx; Prospective Studies; Respiratory Tract Diseases; Treatment Outcome","Abdelmaksoud","Aida A","ENT Department, Faculty of Medicine, South Valley University, Qena, Egypt",NA
"1911","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Malik","Arif","Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore (UOL), Lahore, Pakistan",NA
"1912","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Naz","Anam","Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore (UOL), Lahore, Pakistan",NA
"1913","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Ahmad","Sajjad","Foundation University Medical College, Foundation University Islamabad, Islamabad, Pakistan",NA
"1914","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Hafeez","Mansoor","Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore (UOL), Lahore, Pakistan",NA
"1915","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Awan","Faryal Mehwish","Department of Medical Lab Technology, The University of Haripur (UOH), Haripur, Pakistan",NA
"1916","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Jafar","Tassadaq Hussain","Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore (UOL), Lahore, Pakistan",NA
"1917","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Zahid","Ayesha","Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore (UOL), Lahore, Pakistan",NA
"1918","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Ikram","Aqsa","Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore (UOL), Lahore, Pakistan",NA
"1919","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Rauff","Bisma","Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore (UOL), Lahore, Pakistan",NA
"1920","34163151","10.1177/11779322211021430","Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.","A recent COVID-19 pandemic has resulted in a large death toll rate globally and even no cure or vaccine has been successfully employed to combat this disease. Patients have been reported with multi-organ dysfunction along with acute respiratory distress syndrome which implies a critical situation for patients and made them difficult to breathe and survive. Moreover, pathology of COVID-19 is also related to cytokine storm which indicates the elevated levels of interleukin (IL)-1, IL-6, IL-12, and","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","COVID-19; drug designing; interleukin-6; molecular docking; phytocompounds","Hassan","Mubashir","Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore (UOL), Lahore, Pakistan",NA
"1921","34163149","10.1177/11779322211020316","DGraph Clusters Flaviviruses and ß-Coronaviruses According to Their Hosts, Disease Type, and Human Cell Receptors.","There is a need for rapid and easy-to-use, alignment-free methods to cluster large groups of protein sequence data. Commonly used phylogenetic trees based on alignments can be used to visualize only a limited number of protein sequences. DGraph, introduced here, is an application developed to generate 2-dimensional (2D) maps based on similarity scores for sequences. The program automatically calculates and graphically displays property distance (PD) scores based on physico-chemical property (PCP","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","Alignment free clustering; Enterovirus classification; Physical-chemical property (PCP) consensus; Property distances (PD) of viral sequences; SARS origin","Braun","Benjamin A","Department of Computer Science, Stanford University, Stanford, CA, USA",NA
"1922","34163149","10.1177/11779322211020316","DGraph Clusters Flaviviruses and ß-Coronaviruses According to Their Hosts, Disease Type, and Human Cell Receptors.","There is a need for rapid and easy-to-use, alignment-free methods to cluster large groups of protein sequence data. Commonly used phylogenetic trees based on alignments can be used to visualize only a limited number of protein sequences. DGraph, introduced here, is an application developed to generate 2-dimensional (2D) maps based on similarity scores for sequences. The program automatically calculates and graphically displays property distance (PD) scores based on physico-chemical property (PCP","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","Alignment free clustering; Enterovirus classification; Physical-chemical property (PCP) consensus; Property distances (PD) of viral sequences; SARS origin","Schein","Catherine H","Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA",NA
"1923","34163149","10.1177/11779322211020316","DGraph Clusters Flaviviruses and ß-Coronaviruses According to Their Hosts, Disease Type, and Human Cell Receptors.","There is a need for rapid and easy-to-use, alignment-free methods to cluster large groups of protein sequence data. Commonly used phylogenetic trees based on alignments can be used to visualize only a limited number of protein sequences. DGraph, introduced here, is an application developed to generate 2-dimensional (2D) maps based on similarity scores for sequences. The program automatically calculates and graphically displays property distance (PD) scores based on physico-chemical property (PCP","2021","06","25","Bioinform Biol Insights","Bioinformatics and biology insights","Alignment free clustering; Enterovirus classification; Physical-chemical property (PCP) consensus; Property distances (PD) of viral sequences; SARS origin","Braun","Werner","Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA",NA
"1924","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Hadrawi","Manal","Department of Ophthalmology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia",NA
"1925","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Malak","Mohammad","Department of Ophthalmology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia",NA
"1926","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Almahmoudi","Faeeqah","Department of Ophthalmology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia",NA
"1927","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Mogharbel","Ahmed","Faculty of Medicine, King Abdulalziz University, Jeddah, Saudi Arabia",NA
"1928","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Rozy","Omar","Department of Ophthalmology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia",NA
"1929","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Hanafi","Somaya","Department of Ophthalmology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia",NA
"1930","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Ali","Batool","Department of Infectious Diseases, East Jeddah Hospital, Ministry of Health, Jeddah, Saudi Arabia",NA
"1931","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Nabeel","Sanaa","Department of Infectious Diseases, East Jeddah Hospital, Ministry of Health, Jeddah, Saudi Arabia",NA
"1932","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Faqieha","Fatimah","Department of Public Health, Ministry of Health, Jeddah, Saudi Arabia",NA
"1933","34163132","10.2147/OPTH.S313721","Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients.","To investigate the incidence of COVID-19 viral RNA in the conjunctiva of patients priorly confirmed to have COVID-19, using a conjunctival swab and to determine swab sensitivity. This cross-sectional study enrolled patients who tested positive for COVID-19 with PCR via nasopharyngeal swabs. Conjunctival swabs were collected for each patient and subjected to RT-PCR assay. Demographic data and clinical history of patients were investigated and analysed. In this study, 4.9% of the patients tested p","2021","06","25","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19; RNA; conjunctival swab; sensitivity; specificity","Alzahrani","Khaled","Department of Ophthalmology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia",NA
"1934","34163125","10.1109/lsp.2021.3068072","Quickest Detection of COVID-19 Pandemic Onset.","This paper develops an easily-implementable version of Page's CUSUM quickest-detection test, designed to work in certain composite hypothesis scenarios with time-varying data statistics. The decision statistic can be cast in a recursive form and is particularly suited for on-line analysis. By back-testing our approach on publicly-available COVID-19 data we find reliable early warning of infection flare-ups, in fact sufficiently early that the tool may be of use to decision-makers on the timing o","2021","06","26","IEEE Signal Process Lett","IEEE signal processing letters","COVID-19 pandemic; MAST; Quickest detection; pandemic waves","Braca","P","NATO STO CMRE, Research Department, La Spezia, 19126, Italy",NA
"1935","34163125","10.1109/lsp.2021.3068072","Quickest Detection of COVID-19 Pandemic Onset.","This paper develops an easily-implementable version of Page's CUSUM quickest-detection test, designed to work in certain composite hypothesis scenarios with time-varying data statistics. The decision statistic can be cast in a recursive form and is particularly suited for on-line analysis. By back-testing our approach on publicly-available COVID-19 data we find reliable early warning of infection flare-ups, in fact sufficiently early that the tool may be of use to decision-makers on the timing o","2021","06","26","IEEE Signal Process Lett","IEEE signal processing letters","COVID-19 pandemic; MAST; Quickest detection; pandemic waves","Gaglione","D","NATO STO CMRE, Research Department, La Spezia, 19126, Italy",NA
"1936","34163125","10.1109/lsp.2021.3068072","Quickest Detection of COVID-19 Pandemic Onset.","This paper develops an easily-implementable version of Page's CUSUM quickest-detection test, designed to work in certain composite hypothesis scenarios with time-varying data statistics. The decision statistic can be cast in a recursive form and is particularly suited for on-line analysis. By back-testing our approach on publicly-available COVID-19 data we find reliable early warning of infection flare-ups, in fact sufficiently early that the tool may be of use to decision-makers on the timing o","2021","06","26","IEEE Signal Process Lett","IEEE signal processing letters","COVID-19 pandemic; MAST; Quickest detection; pandemic waves","Marano","S","DIEM, University of Salerno, Italy",NA
"1937","34163125","10.1109/lsp.2021.3068072","Quickest Detection of COVID-19 Pandemic Onset.","This paper develops an easily-implementable version of Page's CUSUM quickest-detection test, designed to work in certain composite hypothesis scenarios with time-varying data statistics. The decision statistic can be cast in a recursive form and is particularly suited for on-line analysis. By back-testing our approach on publicly-available COVID-19 data we find reliable early warning of infection flare-ups, in fact sufficiently early that the tool may be of use to decision-makers on the timing o","2021","06","26","IEEE Signal Process Lett","IEEE signal processing letters","COVID-19 pandemic; MAST; Quickest detection; pandemic waves","Millefiori","L M","NATO STO CMRE, Research Department, La Spezia, 19126, Italy",NA
"1938","34163125","10.1109/lsp.2021.3068072","Quickest Detection of COVID-19 Pandemic Onset.","This paper develops an easily-implementable version of Page's CUSUM quickest-detection test, designed to work in certain composite hypothesis scenarios with time-varying data statistics. The decision statistic can be cast in a recursive form and is particularly suited for on-line analysis. By back-testing our approach on publicly-available COVID-19 data we find reliable early warning of infection flare-ups, in fact sufficiently early that the tool may be of use to decision-makers on the timing o","2021","06","26","IEEE Signal Process Lett","IEEE signal processing letters","COVID-19 pandemic; MAST; Quickest detection; pandemic waves","Willett","P","ECE Dept., University of Connecticut, Storrs, 06269, USA",NA
"1939","34163125","10.1109/lsp.2021.3068072","Quickest Detection of COVID-19 Pandemic Onset.","This paper develops an easily-implementable version of Page's CUSUM quickest-detection test, designed to work in certain composite hypothesis scenarios with time-varying data statistics. The decision statistic can be cast in a recursive form and is particularly suited for on-line analysis. By back-testing our approach on publicly-available COVID-19 data we find reliable early warning of infection flare-ups, in fact sufficiently early that the tool may be of use to decision-makers on the timing o","2021","06","26","IEEE Signal Process Lett","IEEE signal processing letters","COVID-19 pandemic; MAST; Quickest detection; pandemic waves","Pattipati","K","ECE Dept., University of Connecticut, Storrs, 06269, USA",NA
"1940","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Calitri","Carmelina","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy. carmelina_calitri@libero","calitri@libero.it"
"1941","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Fumi","Ilaria","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy",NA
"1942","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Ignaccolo","Maria Giovanna","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy",NA
"1943","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Banino","Elena","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy",NA
"1944","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Benetti","Stefania","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy",NA
"1945","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Lupica","Maria Maddalena","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy",NA
"1946","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Fantone","Francesca","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy",NA
"1947","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Pace","Mariella","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy",NA
"1948","34163113","10.3748/wjg.v27.i23.3303","Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is responsible for the first pandemic of the 21<sup>st</sup> century. As found in adults, signs and symptoms related to the disease mainly involve the respiratory tract in the paediatric population. However, a considerable number of children present with gastrointestinal symptoms such as vomiting, abdominal pain, and diarrhea. The purpose of this review is an accurate descrip","2021","06","25","World J Gastroenterol","World journal of gastroenterology","COVID-19; Diarrhea; Gastrointestinal; Hydration; Paediatric; SARS-CoV-2; Adult; COVID-19; Child; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Garofalo","Franco","Department of Paediatrics, Infermi Hospital, ASLTO3, Rivoli 10098, Italy",NA
"1949","34163106","10.3748/wjg.v27.i23.3208","COVID-19-associated diarrhea.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged as a highly virulent respiratory pathogen that is known as the causative agent of coronavirus disease 2019 (COVID-19). Diarrhea is a common early symptom in a significant proportion of patients with SARS-CoV-2 infection. SARS-CoV-2 can infect and replicate in esophageal cells and enterocytes, leading to direct damage to the intestinal epithelium. The infection decreases the level of angiotensin-converting enzyme 2 rece","2021","06","25","World J Gastroenterol","World journal of gastroenterology","Angiotensin-converting enzyme type 2; COVID-19; Diarrhea; Ionic imbalance; Leaky gut; Viroporin; COVID-19; Diarrhea; Dysbiosis; Gastrointestinal Tract; Humans; SARS-CoV-2","Megyeri","Klara","Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged 6720, Csongrad, Hungary. megyeri.klara@med.u-szeged",NA
"1950","34163106","10.3748/wjg.v27.i23.3208","COVID-19-associated diarrhea.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged as a highly virulent respiratory pathogen that is known as the causative agent of coronavirus disease 2019 (COVID-19). Diarrhea is a common early symptom in a significant proportion of patients with SARS-CoV-2 infection. SARS-CoV-2 can infect and replicate in esophageal cells and enterocytes, leading to direct damage to the intestinal epithelium. The infection decreases the level of angiotensin-converting enzyme 2 rece","2021","06","25","World J Gastroenterol","World journal of gastroenterology","Angiotensin-converting enzyme type 2; COVID-19; Diarrhea; Ionic imbalance; Leaky gut; Viroporin; COVID-19; Diarrhea; Dysbiosis; Gastrointestinal Tract; Humans; SARS-CoV-2","Dernovics","Áron","Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged 6720, Csongrad, Hungary",NA
"1951","34163106","10.3748/wjg.v27.i23.3208","COVID-19-associated diarrhea.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged as a highly virulent respiratory pathogen that is known as the causative agent of coronavirus disease 2019 (COVID-19). Diarrhea is a common early symptom in a significant proportion of patients with SARS-CoV-2 infection. SARS-CoV-2 can infect and replicate in esophageal cells and enterocytes, leading to direct damage to the intestinal epithelium. The infection decreases the level of angiotensin-converting enzyme 2 rece","2021","06","25","World J Gastroenterol","World journal of gastroenterology","Angiotensin-converting enzyme type 2; COVID-19; Diarrhea; Ionic imbalance; Leaky gut; Viroporin; COVID-19; Diarrhea; Dysbiosis; Gastrointestinal Tract; Humans; SARS-CoV-2","Al-Luhaibi","Zaid I I","Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged 6720, Csongrad, Hungary",NA
"1952","34163106","10.3748/wjg.v27.i23.3208","COVID-19-associated diarrhea.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged as a highly virulent respiratory pathogen that is known as the causative agent of coronavirus disease 2019 (COVID-19). Diarrhea is a common early symptom in a significant proportion of patients with SARS-CoV-2 infection. SARS-CoV-2 can infect and replicate in esophageal cells and enterocytes, leading to direct damage to the intestinal epithelium. The infection decreases the level of angiotensin-converting enzyme 2 rece","2021","06","25","World J Gastroenterol","World journal of gastroenterology","Angiotensin-converting enzyme type 2; COVID-19; Diarrhea; Ionic imbalance; Leaky gut; Viroporin; COVID-19; Diarrhea; Dysbiosis; Gastrointestinal Tract; Humans; SARS-CoV-2","Rosztóczy","András","Division of Gastroenterology, Department of Internal Medicine, University of Szeged, Szeged 6720, Csongrad, Hungary",NA
"1953","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Blomberg","Bjørn","Department of Clinical Science, University of Bergen, Bergen, Norway. bjorn.blomberg@uib","bjorn.blomberg@uib.no"
"1954","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Mohn","Kristin Greve-Isdahl","Department of Medicine, Haukeland University Hospital, Bergen, Norway",NA
"1955","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Brokstad","Karl Albert","Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway",NA
"1956","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Zhou","Fan","Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway",NA
"1957","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Linchausen","Dagrun Waag","Bergen Municipality Emergency Clinic, Bergen, Norway",NA
"1958","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Hansen","Bent-Are","Department of Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway",NA
"1959","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Lartey","Sarah","Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway",NA
"1960","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Onyango","Therese Bredholt","Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway",NA
"1961","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Kuwelker","Kanika","Department of Clinical Science, University of Bergen, Bergen, Norway",NA
"1962","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Sævik","Marianne","Department of Medicine, Haukeland University Hospital, Bergen, Norway",NA
"1963","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Bartsch","Hauke","Mohn Medical Imaging and Visualization Centre, Department of Radiology, Haukeland University Hospital, Bergen, Norway",NA
"1964","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Tøndel","Camilla","Department of Paediatrics, Haukeland University Hospital, Bergen, Norway",NA
"1965","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Kittang","Bård Reiakvam","Department of Clinical Science, University of Bergen, Bergen, Norway",NA
"1966","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Cox","Rebecca Jane","Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway. rebecca.cox@uib","rebecca.cox@uib.no"
"1967","34163090","10.1038/s41591-021-01433-3","Long COVID in a prospective cohort of home-isolated patients.","Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of i","2021","06","24","Nat Med","Nature medicine",NA,"Langeland","Nina","Department of Clinical Science, University of Bergen, Bergen, Norway. nina.langeland@uib","nina.langeland@uib.no"
"1968","34163079","10.1038/d41586-020-01928-y","Daily briefing: Why protests haven't lead to a surge in COVID-19.",NA,"2021","06","24","Nature","Nature",NA,"Graham","Flora",NA,NA
"1969","34163077","10.1038/d41586-020-01896-3","Organizing a virtual conference changed the way we think about academic exchange.",NA,"2021","06","24","Nature","Nature","Careers; Conferences and meetings; SARS-CoV-2","Bidmon","Christina",NA,NA
"1970","34163077","10.1038/d41586-020-01896-3","Organizing a virtual conference changed the way we think about academic exchange.",NA,"2021","06","24","Nature","Nature","Careers; Conferences and meetings; SARS-CoV-2","Meath","Cristyn",NA,NA
"1971","34163077","10.1038/d41586-020-01896-3","Organizing a virtual conference changed the way we think about academic exchange.",NA,"2021","06","24","Nature","Nature","Careers; Conferences and meetings; SARS-CoV-2","Bohnsack","René",NA,NA
"1972","34163051","10.1038/d41586-021-01680-x","COVID vaccines and breastfeeding: what the data say.",NA,"2021","06","30","Nature","Nature","Epidemiology; Infection; SARS-CoV-2; Vaccines; Breast Feeding; COVID-19; COVID-19 Vaccines; Female; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactation; Mothers; Patient Safety; Pregnant Women; SARS-CoV-2; Time Factors","Hall","Shannon",NA,NA
"1973","34163044","10.1038/s41569-021-00591-8","Social disparities in COVID-19 prevention.",NA,"2021","07","20","Nat Rev Cardiol","Nature reviews. Cardiology","COVID-19; Health Status Disparities; Humans; SARS-CoV-2; Social Determinants of Health","Fitzpatrick","Ciarán Martin","BMC Series, . nrcardio@nature","nrcardio@nature.com"
"1974","34163043","10.1038/s41684-021-00810-2","Nonhuman primate models for SARS-CoV-2 Research: Managing demand for specific-pathogen-free (SPF) animals.",NA,"2021","06","24","Lab Anim (NY)","Lab animal",NA,"Contreras","Miguel A","Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA. miguel.contreras@nih","miguel.contreras@nih.gov"
"1975","34163043","10.1038/s41684-021-00810-2","Nonhuman primate models for SARS-CoV-2 Research: Managing demand for specific-pathogen-free (SPF) animals.",NA,"2021","06","24","Lab Anim (NY)","Lab animal",NA,"Arnegard","Matthew E","Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA",NA
"1976","34163043","10.1038/s41684-021-00810-2","Nonhuman primate models for SARS-CoV-2 Research: Managing demand for specific-pathogen-free (SPF) animals.",NA,"2021","06","24","Lab Anim (NY)","Lab animal",NA,"Chang","Michael C","Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA",NA
"1977","34163043","10.1038/s41684-021-00810-2","Nonhuman primate models for SARS-CoV-2 Research: Managing demand for specific-pathogen-free (SPF) animals.",NA,"2021","06","24","Lab Anim (NY)","Lab animal",NA,"Hild","Sheri","Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA",NA
"1978","34163043","10.1038/s41684-021-00810-2","Nonhuman primate models for SARS-CoV-2 Research: Managing demand for specific-pathogen-free (SPF) animals.",NA,"2021","06","24","Lab Anim (NY)","Lab animal",NA,"Grieder","Franziska","Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA",NA
"1979","34163043","10.1038/s41684-021-00810-2","Nonhuman primate models for SARS-CoV-2 Research: Managing demand for specific-pathogen-free (SPF) animals.",NA,"2021","06","24","Lab Anim (NY)","Lab animal",NA,"Murphy","Stephanie J","Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA",NA
"1980","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Bugembe","Daniel Lule","Medical Research Council/Uganda Virus Research Institute, London School of Hygiene &amp",NA
"1981","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Phan","My V T","Medical Research Council/Uganda Virus Research Institute, London School of Hygiene &amp",NA
"1982","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Ssewanyana","Isaac","Central Public Health Laboratories of the Republic of Uganda, Kampala, Uganda",NA
"1983","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Semanda","Patrick","Central Public Health Laboratories of the Republic of Uganda, Kampala, Uganda",NA
"1984","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Nansumba","Hellen","Central Public Health Laboratories of the Republic of Uganda, Kampala, Uganda",NA
"1985","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Dhaala","Beatrice","Medical Research Council/Uganda Virus Research Institute, London School of Hygiene &amp",NA
"1986","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Nabadda","Susan","Central Public Health Laboratories of the Republic of Uganda, Kampala, Uganda",NA
"1987","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"O'Toole","Áine Niamh","Institute for Evolutionary Biology, University of Edinburgh, Edinburgh, UK",NA
"1988","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Rambaut","Andrew","Institute for Evolutionary Biology, University of Edinburgh, Edinburgh, UK",NA
"1989","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Kaleebu","Pontiano","Medical Research Council/Uganda Virus Research Institute, London School of Hygiene &amp",NA
"1990","34163035","10.1038/s41564-021-00933-9","Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.","Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the","2021","06","24","Nat Microbiol","Nature microbiology",NA,"Cotten","Matthew","Medical Research Council/Uganda Virus Research Institute, London School of Hygiene &amp","Matthew.Cotten@lshtm.ac.uk"
"1991","34163019","10.1038/s41430-021-00961-y","Diabetes and COVID19: a bidirectional relationship.","The advent and rapid spread of the coronavirus disease-2019 (COVID19) pandemic across the world has focused attention on the relationship of commonly occurring comorbidities such as diabetes on the course and outcomes of this infection. While diabetes does not seem to be associated with an increased risk of COVID19 infection per se, it has been clearly demonstrated that the presence of hyperglycemia of any degree predisposes to worse outcomes, such as more severe respiratory involvement, ICU adm","2021","06","26","Eur J Clin Nutr","European journal of clinical nutrition",NA,"Unnikrishnan","Ranjit","Department of Diabetology, Dr. Mohan's Diabetes Specialities Centre &amp","drranjit@drmohans.com"
"1992","34163019","10.1038/s41430-021-00961-y","Diabetes and COVID19: a bidirectional relationship.","The advent and rapid spread of the coronavirus disease-2019 (COVID19) pandemic across the world has focused attention on the relationship of commonly occurring comorbidities such as diabetes on the course and outcomes of this infection. While diabetes does not seem to be associated with an increased risk of COVID19 infection per se, it has been clearly demonstrated that the presence of hyperglycemia of any degree predisposes to worse outcomes, such as more severe respiratory involvement, ICU adm","2021","06","26","Eur J Clin Nutr","European journal of clinical nutrition",NA,"Misra","Anoop","Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India",NA
"1993","34163017","10.1038/s41430-021-00949-8","Nutrition and immunity: lessons for COVID-19.","The role of the immune system is to protect the individual against pathogenic organisms. Nutrition is one of multiple factors that determines the immune response and good nutrition is important in supporting the immune response. Immunity can be impaired in older people, particularly those who are frail, in those living with obesity, in those who are malnourished and in those with low intakes of micronutrients. The immune impairments associated with nutritional inadequacy increase susceptibility ","2021","06","26","Eur J Clin Nutr","European journal of clinical nutrition",NA,"Calder","Philip C","School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. pcc@soton.ac","pcc@soton.ac.uk"
"1994","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Dave","Rajiv V","The Nightingale Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK. rajiv.dave@nhs","rajiv.dave@nhs.net"
"1995","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Kim","Baek","Department of Breast Surgery, St. James's University Hospital, Leeds, LS9 7TF, UK",NA
"1996","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Courtney","Alona","Department of Surgery and Cancer, Imperial College, London, UK",NA
"1997","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"O'Connell","Rachel","Department of Breast Surgery, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT, UK",NA
"1998","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Rattay","Tim","Leicester Cancer Research Centre, Clinical Sciences Building, University of Leicester, Leicester, LE2 2LX, UK",NA
"1999","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Taxiarchi","Vicky P","Division of Population Health, Health Services Research, and Primary Care, School of Health Sciences, University of Manchester, Manchester, M13 9PL, UK",NA
"2000","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Kirkham","Jamie J","Division of Population Health, Health Services Research, and Primary Care, School of Health Sciences, University of Manchester, Manchester, M13 9PL, UK",NA
"2001","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Camacho","Elizabeth M","Division of Population Health, Health Services Research, and Primary Care, School of Health Sciences, University of Manchester, Manchester, M13 9PL, UK",NA
"2002","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Fairbrother","Patricia","Trustee, Independent Cancer Patients Voice, Manchester, UK",NA
"2003","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Sharma","Nisha","Breast unit, Level 1 Chancellor wing, St James's Hospital, Leeds, LS9 7TF, UK",NA
"2004","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Cartlidge","Christopher W J","Queen Margaret Hospital, Dunfermline, Whitefield Rd, Dunfermline, KY12 0SU, UK",NA
"2005","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Horgan","Kieran","Department of Breast Surgery, St. James's University Hospital, Leeds, LS9 7TF, UK",NA
"2006","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"McIntosh","Stuart A","Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7AE, UK",NA
"2007","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Leff","Daniel R","Department of Surgery and Cancer, Imperial College, London, UK",NA
"2008","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Vidya","Raghavan","The Royal Wolverhampton NHS Trust, Wolverhampton Road, Wolverhampton, WV10 0QP, UK",NA
"2009","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Potter","Shelley","Bristol Centre for Surgical Research, Population Health Sciences, Bristol Medical School, Canynge Hall, Whatley Road, Bristol, BS8 2PS, UK",NA
"2010","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Holcombe","Chris","Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospital, Prescot Street, Liverpool, L7 8XP, UK",NA
"2011","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Copson","Ellen","Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton, Tremona Road, Southampton, SO16 6YD, UK",NA
"2012","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Coles","Charlotte E","Department of Oncology, University of Cambridge, Cambridge, UK",NA
"2013","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Cutress","Ramsey I","Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton, Tremona Road, Southampton, SO16 6YD, UK",NA
"2014","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Gandhi","Ashu","The Nightingale Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK",NA
"2015","34163004","10.1038/s41416-021-01465-z","Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.",NA,"2021","06","26","Br J Cancer","British journal of cancer",NA,"Kirwan","Cliona C","The Nightingale Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK. cliona.kirwan@manchester.ac","cliona.kirwan@manchester.ac.uk"
"2016","34163002","10.1038/s41375-021-01332-z","An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.",NA,"2021","06","26","Leukemia","Leukemia",NA,"Kucia","Magdalena","Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA. magdalena.kucia@wum.edu","magdalena.kucia@wum.edu.pl"
"2017","34163002","10.1038/s41375-021-01332-z","An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.",NA,"2021","06","26","Leukemia","Leukemia",NA,"Ratajczak","Janina","Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA",NA
"2018","34163002","10.1038/s41375-021-01332-z","An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.",NA,"2021","06","26","Leukemia","Leukemia",NA,"Bujko","Kamila","Department of Regenerative Medicine, Warsaw Medical University, Warsaw, Poland",NA
"2019","34163002","10.1038/s41375-021-01332-z","An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.",NA,"2021","06","26","Leukemia","Leukemia",NA,"Adamiak","Mateusz","Department of Regenerative Medicine, Warsaw Medical University, Warsaw, Poland",NA
"2020","34163002","10.1038/s41375-021-01332-z","An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.",NA,"2021","06","26","Leukemia","Leukemia",NA,"Ciechanowicz","Andrzej","Department of Regenerative Medicine, Warsaw Medical University, Warsaw, Poland",NA
"2021","34163002","10.1038/s41375-021-01332-z","An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.",NA,"2021","06","26","Leukemia","Leukemia",NA,"Chumak","Vira","Department of Regenerative Medicine, Warsaw Medical University, Warsaw, Poland",NA
"2022","34163002","10.1038/s41375-021-01332-z","An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.",NA,"2021","06","26","Leukemia","Leukemia",NA,"Brzezniakiewicz-Janus","Katarzyna","Department of Hematology, University of Zielona Gora, Hospital Gorzow Wlkp., Gorzów Wielkopolski, Poland",NA
"2023","34163002","10.1038/s41375-021-01332-z","An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.",NA,"2021","06","26","Leukemia","Leukemia",NA,"Ratajczak","Mariusz Z","Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA. mzrata01@louisville","mzrata01@louisville.edu"
"2024","34162970","10.1038/s41598-021-92641-x","Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.","In December 2019, a novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of pneumonia with severe respiratory distress and outbreaks in Wuhan, China. The rapid and global spread of SARS-CoV-2 resulted in the coronavirus 2019 (COVID-19) pandemic. Earlier during the pandemic, there were limited genetic viral variations. As millions of people became infected, multiple single amino acid substitutions emerged. Many of these substitutions ","2021","07","06","Sci Rep","Scientific reports","Amino Acid Substitution; Furin; Genetic Variation; Glycosylation; Humans; Models, Molecular; Pre-Exposure Prophylaxis; Spike Glycoprotein, Coronavirus","Pokhrel","Suman","Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA",NA
"2025","34162970","10.1038/s41598-021-92641-x","Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.","In December 2019, a novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of pneumonia with severe respiratory distress and outbreaks in Wuhan, China. The rapid and global spread of SARS-CoV-2 resulted in the coronavirus 2019 (COVID-19) pandemic. Earlier during the pandemic, there were limited genetic viral variations. As millions of people became infected, multiple single amino acid substitutions emerged. Many of these substitutions ","2021","07","06","Sci Rep","Scientific reports","Amino Acid Substitution; Furin; Genetic Variation; Glycosylation; Humans; Models, Molecular; Pre-Exposure Prophylaxis; Spike Glycoprotein, Coronavirus","Kraemer","Benjamin R","Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA",NA
"2026","34162970","10.1038/s41598-021-92641-x","Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.","In December 2019, a novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of pneumonia with severe respiratory distress and outbreaks in Wuhan, China. The rapid and global spread of SARS-CoV-2 resulted in the coronavirus 2019 (COVID-19) pandemic. Earlier during the pandemic, there were limited genetic viral variations. As millions of people became infected, multiple single amino acid substitutions emerged. Many of these substitutions ","2021","07","06","Sci Rep","Scientific reports","Amino Acid Substitution; Furin; Genetic Variation; Glycosylation; Humans; Models, Molecular; Pre-Exposure Prophylaxis; Spike Glycoprotein, Coronavirus","Burkholz","Scott","Flow Pharma, Inc., Pleasant Hill, CA, USA",NA
"2027","34162970","10.1038/s41598-021-92641-x","Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.","In December 2019, a novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of pneumonia with severe respiratory distress and outbreaks in Wuhan, China. The rapid and global spread of SARS-CoV-2 resulted in the coronavirus 2019 (COVID-19) pandemic. Earlier during the pandemic, there were limited genetic viral variations. As millions of people became infected, multiple single amino acid substitutions emerged. Many of these substitutions ","2021","07","06","Sci Rep","Scientific reports","Amino Acid Substitution; Furin; Genetic Variation; Glycosylation; Humans; Models, Molecular; Pre-Exposure Prophylaxis; Spike Glycoprotein, Coronavirus","Mochly-Rosen","Daria","Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA. mochly@stanford","mochly@stanford.edu"
"2028","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Rodríguez-Serrano","Diego A","Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain. cancabrilla@hotmail","cancabrilla@hotmail.com"
"2029","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Roy-Vallejo","Emilia","Internal Medicine Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2030","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Zurita Cruz","Nelly D","Microbiology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2031","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Martín Ramírez","Alexandra","Microbiology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2032","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Rodríguez-García","Sebastián C","Rheumatology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2033","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Arevalillo-Fernández","Nuria","Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain",NA
"2034","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Galván-Román","José María","Internal Medicine Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2035","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Fontán García-Rodrigo","Leticia","Microbiology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2036","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Vega-Piris","Lorena","Methodology Unit, Biomedical Research Institute, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2037","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Chicot Llano","Marta","Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain",NA
"2038","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Arribas Méndez","David","Anaesthesiology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2039","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","González de Marcos","Begoña","Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain",NA
"2040","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Hernando Santos","Julia","Anaesthesiology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2041","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Sánchez Azofra","Ana","Pneumology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2042","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Ávalos Pérez-Urria","Elena","Pneumology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2043","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Rodriguez-Cortes","Pablo","Internal Medicine Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2044","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Esparcia","Laura","Immunology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2045","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Marcos-Jimenez","Ana","Immunology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2046","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Sánchez-Alonso","Santiago","Immunology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2047","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Llorente","Irene","Rheumatology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2048","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Soriano","Joan","Pneumology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2049","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Suárez Fernández","Carmen","Internal Medicine Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2050","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","García-Vicuña","Rosario","Rheumatology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2051","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Ancochea","Julio","Pneumology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2052","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Sanz","Jesús","Internal Medicine Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2053","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Muñoz-Calleja","Cecilia","Immunology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2054","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","de la Cámara","Rafael","Hematology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2055","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Canabal Berlanga","Alfonso","Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain",NA
"2056","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","González-Álvaro","Isidoro","Rheumatology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2057","34162948","10.1038/s41598-021-92497-1","Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.","COVID-19 has overloaded national health services worldwide. Thus, early identification of patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19. Retrospective observational study including 193 patients admitted for COVID-19. Detection of SARS-CoV-2 RNA in serum (viremia) was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS). Main outc","2021","07","06","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Critical Care; Female; Hospitalization; Humans; Interleukin-6; Male; Middle Aged; Patient Acuity; RNA, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; SARS-CoV-2; Spain; Viremia","Cardeñoso","Laura","Microbiology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain",NA
"2058","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Mahajan","Swapnil","MedGenome, Bangalore, India",NA
"2059","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Kode","Vasumathi","MedGenome, Foster City, USA",NA
"2060","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Bhojak","Keshav","MedGenome, Bangalore, India",NA
"2061","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Karunakaran","Coral","MedGenome, Bangalore, India",NA
"2062","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Lee","Kayla","MedGenome, Foster City, USA",NA
"2063","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Manoharan","Malini","MedGenome, Bangalore, India",NA
"2064","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Ramesh","Athulya","MedGenome, Bangalore, India",NA
"2065","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Hv","Sudheendra","MedGenome, Bangalore, India",NA
"2066","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Srivastava","Ankita","MedGenome, Bangalore, India",NA
"2067","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Sathian","Rekha","MedGenome, Bangalore, India",NA
"2068","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Khan","Tahira","MedGenome, Foster City, USA",NA
"2069","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Kumar","Prasanna","MedGenome, Bangalore, India",NA
"2070","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Gupta","Ravi","MedGenome, Bangalore, India",NA
"2071","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Chakraborty","Papia","MedGenome, Foster City, USA. pchakra1@gmail","pchakra1@gmail.com"
"2072","34162945","10.1038/s41598-021-92521-4","Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.","The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-ce","2021","07","06","Sci Rep","Scientific reports","Algorithms; CD8-Positive T-Lymphocytes; COVID-19; Clone Cells; Epitopes, T-Lymphocyte; Gene Expression; Humans; Immunodominant Epitopes; Lymphocyte Activation; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Chaudhuri","Amitabha","MedGenome, Foster City, USA. amitc@medgenome","amitc@medgenome.com"
"2073","34162933","10.1038/s41598-021-92399-2","Human mobility in response to COVID-19 in France, Italy and UK.","The COVID-19 pandemic is one of the defining events of our time. National Governments responded to the global crisis by implementing mobility restrictions to slow down the spread of the virus. To assess the impact of those policies on human mobility, we perform a massive comparative analysis on geolocalized data from 13 M Facebook users in France, Italy, and the UK. We find that lockdown generally affects national mobility efficiency and smallworldness-i.e., a substantial reduction of long-range","2021","07","06","Sci Rep","Scientific reports","COVID-19; France; Humans; Italy; Pandemics; Travel","Galeazzi","Alessandro","University of Brescia, Via Branze, 59, 25123, Brescia, Italy. a.galeazzi002@unibs","a.galeazzi002@unibs.it"
"2074","34162933","10.1038/s41598-021-92399-2","Human mobility in response to COVID-19 in France, Italy and UK.","The COVID-19 pandemic is one of the defining events of our time. National Governments responded to the global crisis by implementing mobility restrictions to slow down the spread of the virus. To assess the impact of those policies on human mobility, we perform a massive comparative analysis on geolocalized data from 13 M Facebook users in France, Italy, and the UK. We find that lockdown generally affects national mobility efficiency and smallworldness-i.e., a substantial reduction of long-range","2021","07","06","Sci Rep","Scientific reports","COVID-19; France; Humans; Italy; Pandemics; Travel","Cinelli","Matteo","Ca'Foscari University of Venice, via Torino 155, 30172, Venezia, Italy",NA
"2075","34162933","10.1038/s41598-021-92399-2","Human mobility in response to COVID-19 in France, Italy and UK.","The COVID-19 pandemic is one of the defining events of our time. National Governments responded to the global crisis by implementing mobility restrictions to slow down the spread of the virus. To assess the impact of those policies on human mobility, we perform a massive comparative analysis on geolocalized data from 13 M Facebook users in France, Italy, and the UK. We find that lockdown generally affects national mobility efficiency and smallworldness-i.e., a substantial reduction of long-range","2021","07","06","Sci Rep","Scientific reports","COVID-19; France; Humans; Italy; Pandemics; Travel","Bonaccorsi","Giovanni","Impact, Department of Management, Economics and Industrial Engineering, Politecnico di Milano, Milan, Italy",NA
"2076","34162933","10.1038/s41598-021-92399-2","Human mobility in response to COVID-19 in France, Italy and UK.","The COVID-19 pandemic is one of the defining events of our time. National Governments responded to the global crisis by implementing mobility restrictions to slow down the spread of the virus. To assess the impact of those policies on human mobility, we perform a massive comparative analysis on geolocalized data from 13 M Facebook users in France, Italy, and the UK. We find that lockdown generally affects national mobility efficiency and smallworldness-i.e., a substantial reduction of long-range","2021","07","06","Sci Rep","Scientific reports","COVID-19; France; Humans; Italy; Pandemics; Travel","Pierri","Francesco","Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy",NA
"2077","34162933","10.1038/s41598-021-92399-2","Human mobility in response to COVID-19 in France, Italy and UK.","The COVID-19 pandemic is one of the defining events of our time. National Governments responded to the global crisis by implementing mobility restrictions to slow down the spread of the virus. To assess the impact of those policies on human mobility, we perform a massive comparative analysis on geolocalized data from 13 M Facebook users in France, Italy, and the UK. We find that lockdown generally affects national mobility efficiency and smallworldness-i.e., a substantial reduction of long-range","2021","07","06","Sci Rep","Scientific reports","COVID-19; France; Humans; Italy; Pandemics; Travel","Schmidt","Ana Lucia","Ca'Foscari University of Venice, via Torino 155, 30172, Venezia, Italy",NA
"2078","34162933","10.1038/s41598-021-92399-2","Human mobility in response to COVID-19 in France, Italy and UK.","The COVID-19 pandemic is one of the defining events of our time. National Governments responded to the global crisis by implementing mobility restrictions to slow down the spread of the virus. To assess the impact of those policies on human mobility, we perform a massive comparative analysis on geolocalized data from 13 M Facebook users in France, Italy, and the UK. We find that lockdown generally affects national mobility efficiency and smallworldness-i.e., a substantial reduction of long-range","2021","07","06","Sci Rep","Scientific reports","COVID-19; France; Humans; Italy; Pandemics; Travel","Scala","Antonio","Applico Lab-ISC CNR, Via dei Taurini 19, 00185, Rome, Italy",NA
"2079","34162933","10.1038/s41598-021-92399-2","Human mobility in response to COVID-19 in France, Italy and UK.","The COVID-19 pandemic is one of the defining events of our time. National Governments responded to the global crisis by implementing mobility restrictions to slow down the spread of the virus. To assess the impact of those policies on human mobility, we perform a massive comparative analysis on geolocalized data from 13 M Facebook users in France, Italy, and the UK. We find that lockdown generally affects national mobility efficiency and smallworldness-i.e., a substantial reduction of long-range","2021","07","06","Sci Rep","Scientific reports","COVID-19; France; Humans; Italy; Pandemics; Travel","Pammolli","Fabio","Impact, Department of Management, Economics and Industrial Engineering, Politecnico di Milano, Milan, Italy",NA
"2080","34162933","10.1038/s41598-021-92399-2","Human mobility in response to COVID-19 in France, Italy and UK.","The COVID-19 pandemic is one of the defining events of our time. National Governments responded to the global crisis by implementing mobility restrictions to slow down the spread of the virus. To assess the impact of those policies on human mobility, we perform a massive comparative analysis on geolocalized data from 13 M Facebook users in France, Italy, and the UK. We find that lockdown generally affects national mobility efficiency and smallworldness-i.e., a substantial reduction of long-range","2021","07","06","Sci Rep","Scientific reports","COVID-19; France; Humans; Italy; Pandemics; Travel","Quattrociocchi","Walter","Ca'Foscari University of Venice, via Torino 155, 30172, Venezia, Italy",NA
"2081","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Bliddal","Sofie","Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark",NA
"2082","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Banasik","Karina","Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2083","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Pedersen","Ole Birger","Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark",NA
"2084","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Nissen","Janna","Department of Clinical Immunology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark",NA
"2085","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Cantwell","Lisa","Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2086","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Schwinn","Michael","Department of Clinical Immunology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark",NA
"2087","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Tulstrup","Morten","Department of Hematology, Rigshospitalet, Copenhagen, Denmark",NA
"2088","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Westergaard","David","Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2089","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Ullum","Henrik","Management Section, Statens Serum Institut, Copenhagen, Denmark",NA
"2090","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Brunak","Søren","Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2091","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Tommerup","Niels","Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark",NA
"2092","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Feenstra","Bjarke","Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark",NA
"2093","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Geller","Frank","Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark",NA
"2094","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Ostrowski","Sisse Rye","Department of Clinical Immunology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark",NA
"2095","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Grønbæk","Kirsten","Department of Hematology, Rigshospitalet, Copenhagen, Denmark",NA
"2096","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Nielsen","Claus Henrik","Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark",NA
"2097","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Nielsen","Susanne Dam","Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark",NA
"2098","34162913","10.1038/s41598-021-92045-x","Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.","Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a ""long COVID"" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants recei","2021","07","06","Sci Rep","Scientific reports","Acute Disease; Adult; Body Mass Index; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Sex Factors; Surveys and Questionnaires","Feldt-Rasmussen","Ulla","Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark. ufeldt@rh",NA
"2099","34162894","10.1038/s41598-021-91392-z","Assessing inequality, irregularity, and severity regarding road traffic safety during COVID-19.","COVID-19 has affected every sector of our society, among which human mobility is taking a dramatic change due to quarantine and social distancing. We investigate the impact of the pandemic and subsequent mobility changes on road traffic safety. Using traffic accident data from the city of Los Angeles and New York City, we find that the impact is not merely a blunt reduction in traffic and accidents; rather, (1) the proportion of accidents unexpectedly increases for ""Hispanic"" and ""Male"" groups; ","2021","07","06","Sci Rep","Scientific reports","Accidents, Traffic; COVID-19; Female; Humans; Los Angeles; Male; New York City; Safety","Lin","Lei","Goergen Institute for Data Science, University of Rochester, Rochester, USA",NA
"2100","34162894","10.1038/s41598-021-91392-z","Assessing inequality, irregularity, and severity regarding road traffic safety during COVID-19.","COVID-19 has affected every sector of our society, among which human mobility is taking a dramatic change due to quarantine and social distancing. We investigate the impact of the pandemic and subsequent mobility changes on road traffic safety. Using traffic accident data from the city of Los Angeles and New York City, we find that the impact is not merely a blunt reduction in traffic and accidents; rather, (1) the proportion of accidents unexpectedly increases for ""Hispanic"" and ""Male"" groups; ","2021","07","06","Sci Rep","Scientific reports","Accidents, Traffic; COVID-19; Female; Humans; Los Angeles; Male; New York City; Safety","Shi","Feng","Odum Institute for Research in Social Science, University of North Carolina at Chapel Hill, Chapel Hill, USA",NA
"2101","34162894","10.1038/s41598-021-91392-z","Assessing inequality, irregularity, and severity regarding road traffic safety during COVID-19.","COVID-19 has affected every sector of our society, among which human mobility is taking a dramatic change due to quarantine and social distancing. We investigate the impact of the pandemic and subsequent mobility changes on road traffic safety. Using traffic accident data from the city of Los Angeles and New York City, we find that the impact is not merely a blunt reduction in traffic and accidents; rather, (1) the proportion of accidents unexpectedly increases for ""Hispanic"" and ""Male"" groups; ","2021","07","06","Sci Rep","Scientific reports","Accidents, Traffic; COVID-19; Female; Humans; Los Angeles; Male; New York City; Safety","Li","Weizi","Department of Computer Science, University of Memphis, Memphis, USA. wli@memphis","wli@memphis.edu"
"2102","34162883","10.1038/s41597-021-00937-4","The COUGHVID crowdsourcing dataset, a corpus for the study of large-scale cough analysis algorithms.","Cough audio signal classification has been successfully used to diagnose a variety of respiratory conditions, and there has been significant interest in leveraging Machine Learning (ML) to provide widespread COVID-19 screening. The COUGHVID dataset provides over 25,000 crowdsourced cough recordings representing a wide range of participant ages, genders, geographic locations, and COVID-19 statuses. First, we contribute our open-sourced cough detection algorithm to the research community to assist","2021","07","10","Sci Data","Scientific data",NA,"Orlandic","Lara","Embedded Systems Laboratory (ESL), EPFL, Lausanne, 1015, Switzerland. lara.orlandic@epfl","lara.orlandic@epfl.ch"
"2103","34162883","10.1038/s41597-021-00937-4","The COUGHVID crowdsourcing dataset, a corpus for the study of large-scale cough analysis algorithms.","Cough audio signal classification has been successfully used to diagnose a variety of respiratory conditions, and there has been significant interest in leveraging Machine Learning (ML) to provide widespread COVID-19 screening. The COUGHVID dataset provides over 25,000 crowdsourced cough recordings representing a wide range of participant ages, genders, geographic locations, and COVID-19 statuses. First, we contribute our open-sourced cough detection algorithm to the research community to assist","2021","07","10","Sci Data","Scientific data",NA,"Teijeiro","Tomas","Embedded Systems Laboratory (ESL), EPFL, Lausanne, 1015, Switzerland",NA
"2104","34162883","10.1038/s41597-021-00937-4","The COUGHVID crowdsourcing dataset, a corpus for the study of large-scale cough analysis algorithms.","Cough audio signal classification has been successfully used to diagnose a variety of respiratory conditions, and there has been significant interest in leveraging Machine Learning (ML) to provide widespread COVID-19 screening. The COUGHVID dataset provides over 25,000 crowdsourced cough recordings representing a wide range of participant ages, genders, geographic locations, and COVID-19 statuses. First, we contribute our open-sourced cough detection algorithm to the research community to assist","2021","07","10","Sci Data","Scientific data",NA,"Atienza","David","Embedded Systems Laboratory (ESL), EPFL, Lausanne, 1015, Switzerland",NA
"2105","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Simonetti","Michele","Bienko-Crosetto Lab for Quantitative Genome Biology, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden",NA
"2106","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Zhang","Ning","Bienko-Crosetto Lab for Quantitative Genome Biology, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden",NA
"2107","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Harbers","Luuk","Bienko-Crosetto Lab for Quantitative Genome Biology, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden",NA
"2108","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Milia","Maria Grazia","Laboratory of Microbiology and Virology, Ospedale 'Amedeo di Savoia', Turin, Italy",NA
"2109","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Brossa","Silvia","Instituto di Candiolo FPO-IRCCS, Candiolo, Turin, Italy",NA
"2110","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Huong Nguyen","Thi Thu","Bienko-Crosetto Lab for Quantitative Genome Biology, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden",NA
"2111","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Cerutti","Francesco","Laboratory of Microbiology and Virology, Ospedale 'Amedeo di Savoia', Turin, Italy",NA
"2112","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Berrino","Enrico","Instituto di Candiolo FPO-IRCCS, Candiolo, Turin, Italy",NA
"2113","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Sapino","Anna","Instituto di Candiolo FPO-IRCCS, Candiolo, Turin, Italy",NA
"2114","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Bienko","Magda","Bienko-Crosetto Lab for Quantitative Genome Biology, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden",NA
"2115","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Sottile","Antonino","Instituto di Candiolo FPO-IRCCS, Candiolo, Turin, Italy",NA
"2116","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Ghisetti","Valeria","Laboratory of Microbiology and Virology, Ospedale 'Amedeo di Savoia', Turin, Italy. valeria.ghisetti@gmail","valeria.ghisetti@gmail.com"
"2117","34162869","10.1038/s41467-021-24078-9","COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.","While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid and cost-effective manner. We benchmark COVseq aga","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Cost-Benefit Analysis; Epidemiological Monitoring; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; SARS-CoV-2; Workflow","Crosetto","Nicola","Bienko-Crosetto Lab for Quantitative Genome Biology, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. nicola.crosetto@ki",NA
"2118","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Chen","Yanwen","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2119","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Lear","Travis B","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2120","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Evankovich","John W","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2121","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Larsen","Mads B","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2122","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Lin","Bo","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2123","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Alfaras","Irene","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2124","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Kennerdell","Jason R","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2125","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Salminen","Laura","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2126","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Camarco","Daniel P","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2127","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Lockwood","Karina C","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2128","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Tuncer","Ferhan","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2129","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Liu","Jie","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA",NA
"2130","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Myerburg","Michael M","Department of Medicine, Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA, USA",NA
"2131","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","McDyer","John F","Department of Medicine, Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA, USA",NA
"2132","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Liu","Yuan","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA. liuy13@upmc","liuy13@upmc.edu"
"2133","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Finkel","Toren","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA. finkelt@pitt","finkelt@pitt.edu"
"2134","34162861","10.1038/s41467-021-24156-y","A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.","SARS-CoV-2 (2019-nCoV) is the pathogenic coronavirus responsible for the global pandemic of COVID-19 disease. The Spike (S) protein of SARS-CoV-2 attaches to host lung epithelial cells through the cell surface receptor ACE2, a process dependent on host proteases including TMPRSS2. Here, we identify small molecules that reduce surface expression of TMPRSS2 using a library of 2,560 FDA-approved or current clinical trial compounds. We identify homoharringtonine and halofuginone as the most attracti","2021","07","19","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; High-Throughput Screening Assays; Homoharringtonine; Humans; Lung; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization","Chen","Bill B","Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, USA. chenb@upmc","chenb@upmc.edu"
"2135","34162794","10.1097/NMC.0000000000000742","Narrative Analysis of Childbearing Experiences During the COVID-19 Pandemic.","Purpose: The COVID-19 pandemic has disrupted health care delivery and services around the world causing rapid changes to maternity care protocols and pregnant women to give birth with tight restrictions and significant uncertainties. There is a gap in evidence about expectant and new mothers' experiences with birthing during the pandemic. We sought to describe and understand pregnant and new mothers' lived experiences during the COVID-19 pandemic using authentic birth stories.Study Design and Me","2021","06","24","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing",NA,"Ajayi","Kobi V","Kobi V. Ajayi is a PhD student, Department of Health and Kinesiology, Laboratory for Community Health Evaluation and Systems Science (CHESS), Texas A&amp","rpage@tamu.edu"
"2136","34162794","10.1097/NMC.0000000000000742","Narrative Analysis of Childbearing Experiences During the COVID-19 Pandemic.","Purpose: The COVID-19 pandemic has disrupted health care delivery and services around the world causing rapid changes to maternity care protocols and pregnant women to give birth with tight restrictions and significant uncertainties. There is a gap in evidence about expectant and new mothers' experiences with birthing during the pandemic. We sought to describe and understand pregnant and new mothers' lived experiences during the COVID-19 pandemic using authentic birth stories.Study Design and Me","2021","06","24","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing",NA,"Harvey","Idethia S","Kobi V. Ajayi is a PhD student, Department of Health and Kinesiology, Laboratory for Community Health Evaluation and Systems Science (CHESS), Texas A&amp",NA
"2137","34162794","10.1097/NMC.0000000000000742","Narrative Analysis of Childbearing Experiences During the COVID-19 Pandemic.","Purpose: The COVID-19 pandemic has disrupted health care delivery and services around the world causing rapid changes to maternity care protocols and pregnant women to give birth with tight restrictions and significant uncertainties. There is a gap in evidence about expectant and new mothers' experiences with birthing during the pandemic. We sought to describe and understand pregnant and new mothers' lived experiences during the COVID-19 pandemic using authentic birth stories.Study Design and Me","2021","06","24","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing",NA,"Panjwani","Sonya","Kobi V. Ajayi is a PhD student, Department of Health and Kinesiology, Laboratory for Community Health Evaluation and Systems Science (CHESS), Texas A&amp",NA
"2138","34162794","10.1097/NMC.0000000000000742","Narrative Analysis of Childbearing Experiences During the COVID-19 Pandemic.","Purpose: The COVID-19 pandemic has disrupted health care delivery and services around the world causing rapid changes to maternity care protocols and pregnant women to give birth with tight restrictions and significant uncertainties. There is a gap in evidence about expectant and new mothers' experiences with birthing during the pandemic. We sought to describe and understand pregnant and new mothers' lived experiences during the COVID-19 pandemic using authentic birth stories.Study Design and Me","2021","06","24","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing",NA,"Uwak","Inyang","Kobi V. Ajayi is a PhD student, Department of Health and Kinesiology, Laboratory for Community Health Evaluation and Systems Science (CHESS), Texas A&amp",NA
"2139","34162794","10.1097/NMC.0000000000000742","Narrative Analysis of Childbearing Experiences During the COVID-19 Pandemic.","Purpose: The COVID-19 pandemic has disrupted health care delivery and services around the world causing rapid changes to maternity care protocols and pregnant women to give birth with tight restrictions and significant uncertainties. There is a gap in evidence about expectant and new mothers' experiences with birthing during the pandemic. We sought to describe and understand pregnant and new mothers' lived experiences during the COVID-19 pandemic using authentic birth stories.Study Design and Me","2021","06","24","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing",NA,"Garney","Whitney","Kobi V. Ajayi is a PhD student, Department of Health and Kinesiology, Laboratory for Community Health Evaluation and Systems Science (CHESS), Texas A&amp",NA
"2140","34162794","10.1097/NMC.0000000000000742","Narrative Analysis of Childbearing Experiences During the COVID-19 Pandemic.","Purpose: The COVID-19 pandemic has disrupted health care delivery and services around the world causing rapid changes to maternity care protocols and pregnant women to give birth with tight restrictions and significant uncertainties. There is a gap in evidence about expectant and new mothers' experiences with birthing during the pandemic. We sought to describe and understand pregnant and new mothers' lived experiences during the COVID-19 pandemic using authentic birth stories.Study Design and Me","2021","06","24","MCN Am J Matern Child Nurs","MCN. The American journal of maternal child nursing",NA,"Page","Robin L","Kobi V. Ajayi is a PhD student, Department of Health and Kinesiology, Laboratory for Community Health Evaluation and Systems Science (CHESS), Texas A&amp",NA
"2141","34162790","10.1097/NJH.0000000000000780","Facing the Inevitable: Preparing Nurses to Deliver End-of-Life Care.","Health care providers have an ethical obligation to reduce suffering during a patient's end of life (EOL), but few receive formal education on EOL care principles. The objective of this project was to determine the feasibility and potential benefits of an education initiative in which the principles of EOL care were taught to senior-level nursing students and practicing nurses. To assess feasibility, data regarding recruitment rates, retention rates, and implementation issues were collected. Wor","2021","06","24","J Hosp Palliat Nurs","Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association",NA,"Orr","Shelly","Shelly Orr, PhD, RN, CNE, is nurse clinician, Clinical Research Unit, Virginia Commonwealth University Health System, Richmond. Mary Falk, MSN, RN, CCRN, is clinical assistant professor, Virginia Commonwealth University School of Nursing, Richmond. R.K. Elswick, PhD, is professor, Virginia Commonwealth University School of Nursing, Richmond",NA
"2142","34162790","10.1097/NJH.0000000000000780","Facing the Inevitable: Preparing Nurses to Deliver End-of-Life Care.","Health care providers have an ethical obligation to reduce suffering during a patient's end of life (EOL), but few receive formal education on EOL care principles. The objective of this project was to determine the feasibility and potential benefits of an education initiative in which the principles of EOL care were taught to senior-level nursing students and practicing nurses. To assess feasibility, data regarding recruitment rates, retention rates, and implementation issues were collected. Wor","2021","06","24","J Hosp Palliat Nurs","Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association",NA,"Falk","Mary","Shelly Orr, PhD, RN, CNE, is nurse clinician, Clinical Research Unit, Virginia Commonwealth University Health System, Richmond. Mary Falk, MSN, RN, CCRN, is clinical assistant professor, Virginia Commonwealth University School of Nursing, Richmond. R.K. Elswick, PhD, is professor, Virginia Commonwealth University School of Nursing, Richmond",NA
"2143","34162790","10.1097/NJH.0000000000000780","Facing the Inevitable: Preparing Nurses to Deliver End-of-Life Care.","Health care providers have an ethical obligation to reduce suffering during a patient's end of life (EOL), but few receive formal education on EOL care principles. The objective of this project was to determine the feasibility and potential benefits of an education initiative in which the principles of EOL care were taught to senior-level nursing students and practicing nurses. To assess feasibility, data regarding recruitment rates, retention rates, and implementation issues were collected. Wor","2021","06","24","J Hosp Palliat Nurs","Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association",NA,"Elswick","R K","Shelly Orr, PhD, RN, CNE, is nurse clinician, Clinical Research Unit, Virginia Commonwealth University Health System, Richmond. Mary Falk, MSN, RN, CCRN, is clinical assistant professor, Virginia Commonwealth University School of Nursing, Richmond. R.K. Elswick, PhD, is professor, Virginia Commonwealth University School of Nursing, Richmond",NA
"2144","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Ishii","Tadashi","Department of Education and Support for Regional Medicine, Tohoku University Hospital",NA
"2145","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Kushimoto","Shigeki","Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine",NA
"2146","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Katori","Yukio","Department of Otolaryngology-Head and Neck Surgery, Tohoku University Graduate School of Medicine",NA
"2147","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Kure","Shigeo","Department of Pediatrics, Tohoku University Graduate School of Medicine",NA
"2148","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Igarashi","Kaoru","Division of Craniofacial Anomalies, Tohoku University Graduate School of Dentistry",NA
"2149","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Fujita","Motoo","Department of Emergency and Critical Care Medicine, Tohoku University Hospital",NA
"2150","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Sugawara","Noriko","Department of Pediatrics, Tohoku University Graduate School of Medicine",NA
"2151","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Takayama","Shin","Department of Education and Support for Regional Medicine, Tohoku University Hospital",NA
"2152","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Abe","Michiaki","Department of Education and Support for Regional Medicine, Tohoku University Hospital",NA
"2153","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Tanaka","Junichi","Department of Education and Support for Regional Medicine, Tohoku University Hospital",NA
"2154","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Kikuchi","Akiko","Department of Education and Support for Regional Medicine, Tohoku University Hospital",NA
"2155","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Abe","Yoshiko","Department of Education and Support for Regional Medicine, Tohoku University Hospital",NA
"2156","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Imai","Hiroyuki","Clinical Skills Laboratory, Tohoku University School of Medicine",NA
"2157","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Inaba","Yohei","Department of Radiation Disaster Medicine, International Research Institute of Disaster Science, Tohoku University",NA
"2158","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Iwamatsu-Kobayashi","Yoko","Department of Dental Infection Control, Tohoku University Hospital",NA
"2159","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Nishioka","Takashi","Liaison Center for Innovative Dentistry, Tohoku University Graduate School of Dentistry",NA
"2160","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Onodera","Ko","Department of General Practitioner Development, Tohoku University Graduate School of Medicine",NA
"2161","34162780","10.1620/tjem.254.89","Impacts of Natural Environmental Factors and Prevalence of Airway Symptoms on the Local Spread of COVID-19: A Time-Series Analysis in Regional COVID-19 Epidemics.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the world's largest public health concern in 2021. This study evaluated the associations of the prevalence of airway symptoms among the tested individuals and data regarding the natural environmental factors with the weekly number of newly diagnosed COVID-19 patients in Sendai City (Nt). For the derivatives of the screening test results, data from individuals with a contact ","2021","06","30","Tohoku J Exp Med","The Tohoku journal of experimental medicine","atmospheric humidity; coronavirus disease 2019 (COVID-19); cough symptoms; local epidemics; time-series analysis; Adolescent; Adult; COVID-19; Child; Contact Tracing; Environment; Epidemics; Female; Humans; Japan; Male; Prevalence; Regression Analysis; SARS-CoV-2; Time Factors; Young Adult","Akaishi","Tetsuya","Department of Education and Support for Regional Medicine, Tohoku University Hospital",NA
"2162","34162772","10.1539/sangyoeisei.2021-004-E","[Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].","Owing to the spread of COVID-19, many companies are likely to experience a significant impact on not only the safety and health of employees, but also on their businesses. The impact may be more severe for small and medium-sized enterprises (SMEs) than large enterprises, given their limited management resources. This study aims to clarify the good practices of institutional measures, the challenges in implementing these measures, and the required supports among SMEs. The authors conducted an int","2021","06","24","Sangyo Eiseigaku Zasshi","Sangyo eiseigaku zasshi = Journal of occupational health","COVID-19; interview study; occupational health; small and medium enterprises","Imai","Teppei","The Working Group for Safety and Health among Small and Medium Enterprises",NA
"2163","34162772","10.1539/sangyoeisei.2021-004-E","[Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].","Owing to the spread of COVID-19, many companies are likely to experience a significant impact on not only the safety and health of employees, but also on their businesses. The impact may be more severe for small and medium-sized enterprises (SMEs) than large enterprises, given their limited management resources. This study aims to clarify the good practices of institutional measures, the challenges in implementing these measures, and the required supports among SMEs. The authors conducted an int","2021","06","24","Sangyo Eiseigaku Zasshi","Sangyo eiseigaku zasshi = Journal of occupational health","COVID-19; interview study; occupational health; small and medium enterprises","Moriguchi","Jiro","The Working Group for Safety and Health among Small and Medium Enterprises",NA
"2164","34162772","10.1539/sangyoeisei.2021-004-E","[Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].","Owing to the spread of COVID-19, many companies are likely to experience a significant impact on not only the safety and health of employees, but also on their businesses. The impact may be more severe for small and medium-sized enterprises (SMEs) than large enterprises, given their limited management resources. This study aims to clarify the good practices of institutional measures, the challenges in implementing these measures, and the required supports among SMEs. The authors conducted an int","2021","06","24","Sangyo Eiseigaku Zasshi","Sangyo eiseigaku zasshi = Journal of occupational health","COVID-19; interview study; occupational health; small and medium enterprises","Abe","Hitomi","The Working Group for Safety and Health among Small and Medium Enterprises",NA
"2165","34162772","10.1539/sangyoeisei.2021-004-E","[Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].","Owing to the spread of COVID-19, many companies are likely to experience a significant impact on not only the safety and health of employees, but also on their businesses. The impact may be more severe for small and medium-sized enterprises (SMEs) than large enterprises, given their limited management resources. This study aims to clarify the good practices of institutional measures, the challenges in implementing these measures, and the required supports among SMEs. The authors conducted an int","2021","06","24","Sangyo Eiseigaku Zasshi","Sangyo eiseigaku zasshi = Journal of occupational health","COVID-19; interview study; occupational health; small and medium enterprises","Maeda","Kisaki","The Working Group for Safety and Health among Small and Medium Enterprises",NA
"2166","34162772","10.1539/sangyoeisei.2021-004-E","[Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].","Owing to the spread of COVID-19, many companies are likely to experience a significant impact on not only the safety and health of employees, but also on their businesses. The impact may be more severe for small and medium-sized enterprises (SMEs) than large enterprises, given their limited management resources. This study aims to clarify the good practices of institutional measures, the challenges in implementing these measures, and the required supports among SMEs. The authors conducted an int","2021","06","24","Sangyo Eiseigaku Zasshi","Sangyo eiseigaku zasshi = Journal of occupational health","COVID-19; interview study; occupational health; small and medium enterprises","Sukegawa","Mayumi","The Working Group for Safety and Health among Small and Medium Enterprises",NA
"2167","34162772","10.1539/sangyoeisei.2021-004-E","[Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].","Owing to the spread of COVID-19, many companies are likely to experience a significant impact on not only the safety and health of employees, but also on their businesses. The impact may be more severe for small and medium-sized enterprises (SMEs) than large enterprises, given their limited management resources. This study aims to clarify the good practices of institutional measures, the challenges in implementing these measures, and the required supports among SMEs. The authors conducted an int","2021","06","24","Sangyo Eiseigaku Zasshi","Sangyo eiseigaku zasshi = Journal of occupational health","COVID-19; interview study; occupational health; small and medium enterprises","Shibata","Eiji","The Working Group for Safety and Health among Small and Medium Enterprises",NA
"2168","34162772","10.1539/sangyoeisei.2021-004-E","[Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].","Owing to the spread of COVID-19, many companies are likely to experience a significant impact on not only the safety and health of employees, but also on their businesses. The impact may be more severe for small and medium-sized enterprises (SMEs) than large enterprises, given their limited management resources. This study aims to clarify the good practices of institutional measures, the challenges in implementing these measures, and the required supports among SMEs. The authors conducted an int","2021","06","24","Sangyo Eiseigaku Zasshi","Sangyo eiseigaku zasshi = Journal of occupational health","COVID-19; interview study; occupational health; small and medium enterprises","Nishikido","Noriko","The Working Group for Safety and Health among Small and Medium Enterprises",NA
"2169","34162747","10.1523/JNEUROSCI.3188-20.2021","SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.","Clinical reports suggest that the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS)-coronavirus-2 (CoV-2) has not only taken millions of lives, but has also created a major crisis of neurologic complications that persist even after recovery from the disease. Autopsies of patients confirm the presence of the coronaviruses in the CNS, especially in the brain. The invasion and transmission of SARS-CoV-2 in the CNS is not clearly defined, but, because the ","2021","07","01","J Neurosci","The Journal of neuroscience : the official journal of the Society for Neuroscience","ACE2; COVID-19; SARS-CoV-2; autophagy; coronavirus; hyperinflammation; lysosome; mTOR; mitochondria; Animals; COVID-19; Humans; Mitochondria; Nervous System Diseases; Neurons; SARS-CoV-2; TOR Serine-Threonine Kinases","Swain","Olivia","Neuroscience Department, Krieger School of Arts and Sciences, The Johns Hopkins University, Baltimore, Maryland 21205",NA
"2170","34162747","10.1523/JNEUROSCI.3188-20.2021","SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.","Clinical reports suggest that the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS)-coronavirus-2 (CoV-2) has not only taken millions of lives, but has also created a major crisis of neurologic complications that persist even after recovery from the disease. Autopsies of patients confirm the presence of the coronaviruses in the CNS, especially in the brain. The invasion and transmission of SARS-CoV-2 in the CNS is not clearly defined, but, because the ","2021","07","01","J Neurosci","The Journal of neuroscience : the official journal of the Society for Neuroscience","ACE2; COVID-19; SARS-CoV-2; autophagy; coronavirus; hyperinflammation; lysosome; mTOR; mitochondria; Animals; COVID-19; Humans; Mitochondria; Nervous System Diseases; Neurons; SARS-CoV-2; TOR Serine-Threonine Kinases","Romano","Sofia K","Neuroscience Department, Krieger School of Arts and Sciences, The Johns Hopkins University, Baltimore, Maryland 21205",NA
"2171","34162747","10.1523/JNEUROSCI.3188-20.2021","SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.","Clinical reports suggest that the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS)-coronavirus-2 (CoV-2) has not only taken millions of lives, but has also created a major crisis of neurologic complications that persist even after recovery from the disease. Autopsies of patients confirm the presence of the coronaviruses in the CNS, especially in the brain. The invasion and transmission of SARS-CoV-2 in the CNS is not clearly defined, but, because the ","2021","07","01","J Neurosci","The Journal of neuroscience : the official journal of the Society for Neuroscience","ACE2; COVID-19; SARS-CoV-2; autophagy; coronavirus; hyperinflammation; lysosome; mTOR; mitochondria; Animals; COVID-19; Humans; Mitochondria; Nervous System Diseases; Neurons; SARS-CoV-2; TOR Serine-Threonine Kinases","Miryala","Ritika","Neuroscience Department, Krieger School of Arts and Sciences, The Johns Hopkins University, Baltimore, Maryland 21205",NA
"2172","34162747","10.1523/JNEUROSCI.3188-20.2021","SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.","Clinical reports suggest that the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS)-coronavirus-2 (CoV-2) has not only taken millions of lives, but has also created a major crisis of neurologic complications that persist even after recovery from the disease. Autopsies of patients confirm the presence of the coronaviruses in the CNS, especially in the brain. The invasion and transmission of SARS-CoV-2 in the CNS is not clearly defined, but, because the ","2021","07","01","J Neurosci","The Journal of neuroscience : the official journal of the Society for Neuroscience","ACE2; COVID-19; SARS-CoV-2; autophagy; coronavirus; hyperinflammation; lysosome; mTOR; mitochondria; Animals; COVID-19; Humans; Mitochondria; Nervous System Diseases; Neurons; SARS-CoV-2; TOR Serine-Threonine Kinases","Tsai","Jocelyn","Neuroscience Department, Krieger School of Arts and Sciences, The Johns Hopkins University, Baltimore, Maryland 21205",NA
"2173","34162747","10.1523/JNEUROSCI.3188-20.2021","SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.","Clinical reports suggest that the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS)-coronavirus-2 (CoV-2) has not only taken millions of lives, but has also created a major crisis of neurologic complications that persist even after recovery from the disease. Autopsies of patients confirm the presence of the coronaviruses in the CNS, especially in the brain. The invasion and transmission of SARS-CoV-2 in the CNS is not clearly defined, but, because the ","2021","07","01","J Neurosci","The Journal of neuroscience : the official journal of the Society for Neuroscience","ACE2; COVID-19; SARS-CoV-2; autophagy; coronavirus; hyperinflammation; lysosome; mTOR; mitochondria; Animals; COVID-19; Humans; Mitochondria; Nervous System Diseases; Neurons; SARS-CoV-2; TOR Serine-Threonine Kinases","Parikh","Vinnie","Neuroscience Department, Krieger School of Arts and Sciences, The Johns Hopkins University, Baltimore, Maryland 21205",NA
"2174","34162747","10.1523/JNEUROSCI.3188-20.2021","SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.","Clinical reports suggest that the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS)-coronavirus-2 (CoV-2) has not only taken millions of lives, but has also created a major crisis of neurologic complications that persist even after recovery from the disease. Autopsies of patients confirm the presence of the coronaviruses in the CNS, especially in the brain. The invasion and transmission of SARS-CoV-2 in the CNS is not clearly defined, but, because the ","2021","07","01","J Neurosci","The Journal of neuroscience : the official journal of the Society for Neuroscience","ACE2; COVID-19; SARS-CoV-2; autophagy; coronavirus; hyperinflammation; lysosome; mTOR; mitochondria; Animals; COVID-19; Humans; Mitochondria; Nervous System Diseases; Neurons; SARS-CoV-2; TOR Serine-Threonine Kinases","Umanah","George K E","Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 gumanah1@jhmi","gumanah1@jhmi.edu"
"2175","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Tscherne","Alina","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2176","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Schwarz","Jan Hendrik","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2177","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Rohde","Cornelius","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2178","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Kupke","Alexandra","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2179","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Kalodimou","Georgia","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2180","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Limpinsel","Leonard","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2181","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Okba","Nisreen M A","Department of Viroscience, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands",NA
"2182","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Bonjak","Berislav","Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany",NA
"2183","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Sandrock","Inga","Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany",NA
"2184","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Odak","Ivan","Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany",NA
"2185","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Halwe","Sandro","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2186","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Sauerhering","Lucie","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2187","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Brosinski","Katrin","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2188","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Liangliang","Nan","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2189","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Duell","Elke","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2190","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Jany","Sylvia","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2191","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Freudenstein","Astrid","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2192","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Schmidt","Jörg","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2193","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Werner","Anke","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2194","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Gellhorn Serra","Michelle","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2195","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Klüver","Michael","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2196","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Guggemos","Wolfgang","Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians-Universität München, 80804 Munich, Germany",NA
"2197","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Seilmaier","Michael","Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians-Universität München, 80804 Munich, Germany",NA
"2198","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Wendtner","Clemens-Martin","Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians-Universität München, 80804 Munich, Germany",NA
"2199","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Förster","Reinhold","Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany",NA
"2200","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Haagmans","Bart L","Department of Viroscience, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands",NA
"2201","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Becker","Stephan","Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany",NA
"2202","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Sutter","Gerd","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany","gerd.sutter@lmu.de"
"2203","34162739","10.1073/pnas.2026207118","Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.","Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavirus disease 2019 (COVID-19) with dramatic consequences for global human health and economics. Previously, we reached clinical evaluation with our vector vaccine based on modified vaccinia virus Ankara (MVA) against the Middle East respiratory syndrome coronavirus (MERS-CoV), which causes an infection in humans similar to SARS and COVID-19. Here, we describe the con","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","nonclinical testing; poxvirus; vaccine vector; vaccinia virus; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Humans; Mice; Mice, Inbred BALB C; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Vaccination; Vaccinia virus","Volz","Asisa","Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany",NA
"2204","34162732","10.1542/peds.2021-050636","Sharing Stories Through Art: Promoting Resident Connection During and After the COVID-19 Pandemic.",NA,"2021","06","24","Pediatrics","Pediatrics",NA,"Korus","Rachel E","Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts",NA
"2205","34162732","10.1542/peds.2021-050636","Sharing Stories Through Art: Promoting Resident Connection During and After the COVID-19 Pandemic.",NA,"2021","06","24","Pediatrics","Pediatrics",NA,"Rabinowitz","Danielle G","Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts","danielle.rabinowitz@childrens.harvard.edu"
"2206","34162708","10.1073/pnas.2100664118","Monitoring the COVID-19 epidemic with nationwide telecommunication data.","In response to the novel coronavirus disease (COVID-19), governments have introduced severe policy measures with substantial effects on human behavior. Here, we perform a large-scale, spatiotemporal analysis of human mobility during the COVID-19 epidemic. We derive human mobility from anonymized, aggregated telecommunication data in a nationwide setting (Switzerland; 10 February to 26 April 2020), consisting of ~1.5 billion trips. In comparison to the same time period from 2019, human movement i","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","Bayesian modeling; COVID-19; epidemiology; human mobility; telecommunication data; COVID-19; Health Policy; Humans; Population Surveillance; Public Health; SARS-CoV-2; Switzerland; Telecommunications; Travel","Persson","Joel","Department of Management, Technology, and Economics, ETH Zurich (Swiss Federal Institute of Technology), 8092 Zurich, Switzerland jpersson@ethz","jpersson@ethz.ch"
"2207","34162708","10.1073/pnas.2100664118","Monitoring the COVID-19 epidemic with nationwide telecommunication data.","In response to the novel coronavirus disease (COVID-19), governments have introduced severe policy measures with substantial effects on human behavior. Here, we perform a large-scale, spatiotemporal analysis of human mobility during the COVID-19 epidemic. We derive human mobility from anonymized, aggregated telecommunication data in a nationwide setting (Switzerland; 10 February to 26 April 2020), consisting of ~1.5 billion trips. In comparison to the same time period from 2019, human movement i","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","Bayesian modeling; COVID-19; epidemiology; human mobility; telecommunication data; COVID-19; Health Policy; Humans; Population Surveillance; Public Health; SARS-CoV-2; Switzerland; Telecommunications; Travel","Parie","Jurriaan F","Department of Management, Technology, and Economics, ETH Zurich (Swiss Federal Institute of Technology), 8092 Zurich, Switzerland",NA
"2208","34162708","10.1073/pnas.2100664118","Monitoring the COVID-19 epidemic with nationwide telecommunication data.","In response to the novel coronavirus disease (COVID-19), governments have introduced severe policy measures with substantial effects on human behavior. Here, we perform a large-scale, spatiotemporal analysis of human mobility during the COVID-19 epidemic. We derive human mobility from anonymized, aggregated telecommunication data in a nationwide setting (Switzerland; 10 February to 26 April 2020), consisting of ~1.5 billion trips. In comparison to the same time period from 2019, human movement i","2021","06","30","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","Bayesian modeling; COVID-19; epidemiology; human mobility; telecommunication data; COVID-19; Health Policy; Humans; Population Surveillance; Public Health; SARS-CoV-2; Switzerland; Telecommunications; Travel","Feuerriegel","Stefan","Department of Management, Technology, and Economics, ETH Zurich (Swiss Federal Institute of Technology), 8092 Zurich, Switzerland",NA
"2209","34162652","10.1136/bmjopen-2021-048660","Prevalence and risk factors of depression symptoms among Chinese seafarers during the COVID-19 pandemic: a cross-sectional study.","To curb the spread of COVID-19, most countries have adopted measures such as banning shore leave at ports and placed restrictions on crew change. Seafarers may bear an excess pressure during the COVID-19 pandemic. This study aimed to investigate the prevalence and risk factors associated with depression symptoms among Chinese seafarers during the COVID-19 pandemic. Cross-sectional study. This field survey-based study was conducted at Rongcheng Port, Shandong Province, China, from 10 June 2020 to","2021","06","28","BMJ Open","BMJ open","COVID-19; depression &amp; mood disorders; epidemiology; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Humans; Male; Pandemics; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Qin","Wenzhe","Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"2210","34162652","10.1136/bmjopen-2021-048660","Prevalence and risk factors of depression symptoms among Chinese seafarers during the COVID-19 pandemic: a cross-sectional study.","To curb the spread of COVID-19, most countries have adopted measures such as banning shore leave at ports and placed restrictions on crew change. Seafarers may bear an excess pressure during the COVID-19 pandemic. This study aimed to investigate the prevalence and risk factors associated with depression symptoms among Chinese seafarers during the COVID-19 pandemic. Cross-sectional study. This field survey-based study was conducted at Rongcheng Port, Shandong Province, China, from 10 June 2020 to","2021","06","28","BMJ Open","BMJ open","COVID-19; depression &amp; mood disorders; epidemiology; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Humans; Male; Pandemics; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Li","Lei","Department of Health Quarantine, Jinan Airport Customs, Jinan, China",NA
"2211","34162652","10.1136/bmjopen-2021-048660","Prevalence and risk factors of depression symptoms among Chinese seafarers during the COVID-19 pandemic: a cross-sectional study.","To curb the spread of COVID-19, most countries have adopted measures such as banning shore leave at ports and placed restrictions on crew change. Seafarers may bear an excess pressure during the COVID-19 pandemic. This study aimed to investigate the prevalence and risk factors associated with depression symptoms among Chinese seafarers during the COVID-19 pandemic. Cross-sectional study. This field survey-based study was conducted at Rongcheng Port, Shandong Province, China, from 10 June 2020 to","2021","06","28","BMJ Open","BMJ open","COVID-19; depression &amp; mood disorders; epidemiology; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Humans; Male; Pandemics; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Zhu","Dongshan","Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"2212","34162652","10.1136/bmjopen-2021-048660","Prevalence and risk factors of depression symptoms among Chinese seafarers during the COVID-19 pandemic: a cross-sectional study.","To curb the spread of COVID-19, most countries have adopted measures such as banning shore leave at ports and placed restrictions on crew change. Seafarers may bear an excess pressure during the COVID-19 pandemic. This study aimed to investigate the prevalence and risk factors associated with depression symptoms among Chinese seafarers during the COVID-19 pandemic. Cross-sectional study. This field survey-based study was conducted at Rongcheng Port, Shandong Province, China, from 10 June 2020 to","2021","06","28","BMJ Open","BMJ open","COVID-19; depression &amp; mood disorders; epidemiology; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Humans; Male; Pandemics; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Ju","Chengfei","Department of Health Quarantine, Rongcheng Customs, Rongcheng, China",NA
"2213","34162652","10.1136/bmjopen-2021-048660","Prevalence and risk factors of depression symptoms among Chinese seafarers during the COVID-19 pandemic: a cross-sectional study.","To curb the spread of COVID-19, most countries have adopted measures such as banning shore leave at ports and placed restrictions on crew change. Seafarers may bear an excess pressure during the COVID-19 pandemic. This study aimed to investigate the prevalence and risk factors associated with depression symptoms among Chinese seafarers during the COVID-19 pandemic. Cross-sectional study. This field survey-based study was conducted at Rongcheng Port, Shandong Province, China, from 10 June 2020 to","2021","06","28","BMJ Open","BMJ open","COVID-19; depression &amp; mood disorders; epidemiology; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Humans; Male; Pandemics; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Bi","Pengfei","Department of Health Quarantine, Rongcheng Customs, Rongcheng, China",NA
"2214","34162652","10.1136/bmjopen-2021-048660","Prevalence and risk factors of depression symptoms among Chinese seafarers during the COVID-19 pandemic: a cross-sectional study.","To curb the spread of COVID-19, most countries have adopted measures such as banning shore leave at ports and placed restrictions on crew change. Seafarers may bear an excess pressure during the COVID-19 pandemic. This study aimed to investigate the prevalence and risk factors associated with depression symptoms among Chinese seafarers during the COVID-19 pandemic. Cross-sectional study. This field survey-based study was conducted at Rongcheng Port, Shandong Province, China, from 10 June 2020 to","2021","06","28","BMJ Open","BMJ open","COVID-19; depression &amp; mood disorders; epidemiology; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Humans; Male; Pandemics; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Li","Shixue","Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China shixueli@sdu.edu","shixueli@sdu.edu.cn"
"2215","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Hayward","Andrew","Institute of Epidemiology and Health Care, University College London, London, UK a.hayward@ucl.ac","a.hayward@ucl.ac.uk"
"2216","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Fragaszy","Ellen","Centre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK",NA
"2217","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Kovar","Jana","Institute of Epidemiology and Health Care, University College London, London, UK",NA
"2218","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Nguyen","Vincent","Institute of Epidemiology and Health Care, University College London, London, UK",NA
"2219","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Beale","Sarah","Institute of Epidemiology and Health Care, University College London, London, UK",NA
"2220","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Byrne","Thomas","Centre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK",NA
"2221","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Aryee","Anna","Centre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK",NA
"2222","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Hardelid","Pia","Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College London, London, UK",NA
"2223","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Wijlaars","Linda","Population, Policy and Practice, University College London, London, UK",NA
"2224","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Fong","Wing Lam Erica","Centre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK",NA
"2225","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Geismar","Cyril","Institute of Epidemiology and Health Care, University College London, London, UK",NA
"2226","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Patel","Parth","Centre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK",NA
"2227","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Shrotri","Madhumita","Centre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK",NA
"2228","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Navaratnam","Annalan M D","Institute of Epidemiology and Health Care, University College London, London, UK",NA
"2229","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Nastouli","Eleni","Population, Policy and Practice, University College London, London, UK",NA
"2230","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Spyer","Moira","Population, Policy and Practice, University College London, London, UK",NA
"2231","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Killingley","Ben","University of Nottingham School of Medicine, Nottingham, UK",NA
"2232","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Cox","Ingemar","Department of Computer Science, University College London, London, UK",NA
"2233","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Lampos","Vasileios","Department of Computer Science, University College London, London, UK",NA
"2234","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","McKendry","Rachel A","London Centre for Nanotechnology and Division of Medicine, University College London, London, UK",NA
"2235","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Liu","Yunzhe","SpaceTimeLab, Department of Civil, Environmental and Geomatic Engineering, University College London, London, UK",NA
"2236","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Cheng","Tao","SpaceTimeLab, Department of Civil, Environmental and Geomatic Engineering, University College London, London, UK",NA
"2237","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Johnson","Anne M","Institute for Global Health, University College London, London, UK",NA
"2238","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Michie","Susan","Centre for Behaviour Change, University College London, London, UK",NA
"2239","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Gibbs","Jo","Institute for Global Health, University College London, London, UK",NA
"2240","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Gilson","Richard","Institute for Global Health, University College London, London, UK",NA
"2241","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Rodger","Alison","Institute for Global Health, University College London, London, UK",NA
"2242","34162651","10.1136/bmjopen-2020-048042","Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study.","The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. Virus Watch is a household community cohort study of acute respiratory infections in England an","2021","06","28","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Cohort Studies; England; Humans; Patient Acceptance of Health Care; Prospective Studies; Public Health; Risk Factors; SARS-CoV-2; State Medicine; Wales","Aldridge","Robert W","Centre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK",NA
"2243","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Luntamo","Terhi","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2244","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Korpilahti-Leino","Tarja","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2245","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Ristkari","Terja","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2246","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Hinkka-Yli-Salomäki","Sanna","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2247","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Kurki","Marjo","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2248","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Sinokki","Atte","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2249","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Lamminen","Kaisa","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2250","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Saanakorpi","Kristiina","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2251","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Saarinen","Susanna","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2252","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Maunuksela","Marjukka","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2253","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Sourander","Saana","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2254","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Toivonen","Katja","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2255","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Zadkova","Anna","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2256","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Suilamo","Miia","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2257","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Casagrande","Linda","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2258","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Palmroth","Johanna","Department of Child Psychiatry, University of Turku and Turku University Hospital",NA
"2259","34162641","10.1136/bmjopen-2020-045474","Internet-assisted cognitive behavioural therapy with telephone coaching for anxious Finnish children aged 10-13 years: study protocol for a randomised controlled trial.","Childhood anxiety is common, causes significant functional impairment and may lead to psychosocial problems by adulthood. Although cognitive behavioural therapy (CBT) is effective for treating anxiety, its availability is limited by the lack of trained CBT therapists and easily accessible local services. To address the challenges in both recognition and treatment, this study combines systematic anxiety screening in the general population with a randomised controlled trial (RCT) on internet-assis","2021","06","28","BMJ Open","BMJ open","anxiety disorders; child &amp; adolescent psychiatry; clinical trials; preventive medicine; Adult; Anxiety; COVID-19; Child; Cognitive Behavioral Therapy; Finland; Humans; Internet; Mentoring; Randomized Controlled Trials as Topic; SARS-CoV-2; Telephone; Treatment Outcome","Sourander","A","Department of Child Psychiatry, University of Turku and Turku University Hospital","andsou@utu.fi"
"2260","34162630","10.1136/emermed-2020-210586","Clinical benefits of prone positioning in the treatment of non-intubated patients with acute hypoxic respiratory failure: a rapid systematic review.","The COVID-19 pandemic has led to a surge in critically unwell patients with type 1 respiratory failure. In an attempt to reduce the number of patients requiring mechanical ventilation, prone positioning (PP) of non-intubated patients has been added to many hospital guidelines around the world. We set out to conduct a systematic review of the evidence relating to PP in the non-intubated patient with type 1 respiratory failure secondary to COVID-19 and other causes. The review was conducted in acc","2021","06","24","Emerg Med J","Emergency medicine journal : EMJ","pneumonia/infections; respiratory","Richards","Hayden","Emergency Medicine, University Hospital Geelong, Geelong, Victoria, Australia haydenr@barwonhealth.org","haydenr@barwonhealth.org.au"
"2261","34162630","10.1136/emermed-2020-210586","Clinical benefits of prone positioning in the treatment of non-intubated patients with acute hypoxic respiratory failure: a rapid systematic review.","The COVID-19 pandemic has led to a surge in critically unwell patients with type 1 respiratory failure. In an attempt to reduce the number of patients requiring mechanical ventilation, prone positioning (PP) of non-intubated patients has been added to many hospital guidelines around the world. We set out to conduct a systematic review of the evidence relating to PP in the non-intubated patient with type 1 respiratory failure secondary to COVID-19 and other causes. The review was conducted in acc","2021","06","24","Emerg Med J","Emergency medicine journal : EMJ","pneumonia/infections; respiratory","Robins-Browne","Karen","Emergency Medicine, University Hospital Geelong, Geelong, Victoria, Australia",NA
"2262","34162630","10.1136/emermed-2020-210586","Clinical benefits of prone positioning in the treatment of non-intubated patients with acute hypoxic respiratory failure: a rapid systematic review.","The COVID-19 pandemic has led to a surge in critically unwell patients with type 1 respiratory failure. In an attempt to reduce the number of patients requiring mechanical ventilation, prone positioning (PP) of non-intubated patients has been added to many hospital guidelines around the world. We set out to conduct a systematic review of the evidence relating to PP in the non-intubated patient with type 1 respiratory failure secondary to COVID-19 and other causes. The review was conducted in acc","2021","06","24","Emerg Med J","Emergency medicine journal : EMJ","pneumonia/infections; respiratory","O'Brien","Troy","Emergency Medicine, University Hospital Geelong, Geelong, Victoria, Australia",NA
"2263","34162630","10.1136/emermed-2020-210586","Clinical benefits of prone positioning in the treatment of non-intubated patients with acute hypoxic respiratory failure: a rapid systematic review.","The COVID-19 pandemic has led to a surge in critically unwell patients with type 1 respiratory failure. In an attempt to reduce the number of patients requiring mechanical ventilation, prone positioning (PP) of non-intubated patients has been added to many hospital guidelines around the world. We set out to conduct a systematic review of the evidence relating to PP in the non-intubated patient with type 1 respiratory failure secondary to COVID-19 and other causes. The review was conducted in acc","2021","06","24","Emerg Med J","Emergency medicine journal : EMJ","pneumonia/infections; respiratory","Wilson","Greer","Emergency Medicine, University Hospital Geelong, Geelong, Victoria, Australia",NA
"2264","34162630","10.1136/emermed-2020-210586","Clinical benefits of prone positioning in the treatment of non-intubated patients with acute hypoxic respiratory failure: a rapid systematic review.","The COVID-19 pandemic has led to a surge in critically unwell patients with type 1 respiratory failure. In an attempt to reduce the number of patients requiring mechanical ventilation, prone positioning (PP) of non-intubated patients has been added to many hospital guidelines around the world. We set out to conduct a systematic review of the evidence relating to PP in the non-intubated patient with type 1 respiratory failure secondary to COVID-19 and other causes. The review was conducted in acc","2021","06","24","Emerg Med J","Emergency medicine journal : EMJ","pneumonia/infections; respiratory","Furyk","Jeremy","Emergency Medicine, University Hospital Geelong, Geelong, Victoria, Australia",NA
"2265","34162628","10.1136/bmj.n1617","Covid-19: Israel advises against foreign travel after recording 125 new cases.",NA,"2021","06","28","BMJ","BMJ (Clinical research ed.)",NA,"Day","Michael","London",NA
"2266","34162623","10.1136/bcr-2021-244024","Multiple arterial thrombosis in a patient with COVID-19.",NA,"2021","06","29","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; haematology (incl blood transfusion); COVID-19; Humans; SARS-CoV-2; Thrombosis","Monteiro Dias","Luís","Department of Internal Medicine, Hospital de Braga, Braga, Portugal Lfmsd13@gmail","Lfmsd13@gmail.com"
"2267","34162623","10.1136/bcr-2021-244024","Multiple arterial thrombosis in a patient with COVID-19.",NA,"2021","06","29","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; haematology (incl blood transfusion); COVID-19; Humans; SARS-CoV-2; Thrombosis","Martins","José","Intensive Care Unit, Hospital de Braga, Braga, Portugal",NA
"2268","34162623","10.1136/bcr-2021-244024","Multiple arterial thrombosis in a patient with COVID-19.",NA,"2021","06","29","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; haematology (incl blood transfusion); COVID-19; Humans; SARS-CoV-2; Thrombosis","Castro","Rui","Intensive Care Unit, Hospital de Braga, Braga, Portugal",NA
"2269","34162623","10.1136/bcr-2021-244024","Multiple arterial thrombosis in a patient with COVID-19.",NA,"2021","06","29","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; haematology (incl blood transfusion); COVID-19; Humans; SARS-CoV-2; Thrombosis","Mesquita","Anabela","Intensive Care Unit, Hospital de Braga, Braga, Portugal",NA
"2270","34162616","10.1136/bcr-2021-242651","Appendicitis with concurrent COVID-19 infection in a patient during the third trimester of pregnancy.","This article presents an unusual case of appendicitis in pregnancy complicated by the novel coronavirus (SARS-CoV-2). The novel coronavirus has affected the way medicine is practised across most parts of the world with over 160 000 000 global cases to date. Tackling management of these cases is more complex when other pathological processes are ongoing. Appendicitis is a common occurrence in pregnancy, with most obstetric centres seeing about one or two cases a year. Though maternal morbidity an","2021","06","25","BMJ Case Rep","BMJ case reports","COVID-19; general surgery; pregnancy; Adult; Appendectomy; Appendicitis; COVID-19; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Third; SARS-CoV-2","Sanders-Davis","Laura Jane","Obstetrics and Gynaecology, Shrewsbury and Telford Hospital NHS Trust, Telford, UK lauradavis@doctors.org","lauradavis@doctors.org.uk"
"2271","34162616","10.1136/bcr-2021-242651","Appendicitis with concurrent COVID-19 infection in a patient during the third trimester of pregnancy.","This article presents an unusual case of appendicitis in pregnancy complicated by the novel coronavirus (SARS-CoV-2). The novel coronavirus has affected the way medicine is practised across most parts of the world with over 160 000 000 global cases to date. Tackling management of these cases is more complex when other pathological processes are ongoing. Appendicitis is a common occurrence in pregnancy, with most obstetric centres seeing about one or two cases a year. Though maternal morbidity an","2021","06","25","BMJ Case Rep","BMJ case reports","COVID-19; general surgery; pregnancy; Adult; Appendectomy; Appendicitis; COVID-19; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Third; SARS-CoV-2","Ritchie","Joanne","Obstetrics and Gynaecology, Shrewsbury and Telford Hospital NHS Trust Maternity Services, Telford, UK",NA
"2272","34162603","10.1136/bcr-2020-241052","Dermographism in COVID-19.",NA,"2021","06","29","BMJ Case Rep","BMJ case reports","COVID-19; dermatology; COVID-19; Humans; SARS-CoV-2; Skin; Urticaria","Valladares","Daniel","Department of Medicine, University of Florida Health, Gainesville, Florida, USA",NA
"2273","34162603","10.1136/bcr-2020-241052","Dermographism in COVID-19.",NA,"2021","06","29","BMJ Case Rep","BMJ case reports","COVID-19; dermatology; COVID-19; Humans; SARS-CoV-2; Skin; Urticaria","Kattan","Juan Nicolas","Department of Medicine, University of Florida Health, Gainesville, Florida, USA",NA
"2274","34162603","10.1136/bcr-2020-241052","Dermographism in COVID-19.",NA,"2021","06","29","BMJ Case Rep","BMJ case reports","COVID-19; dermatology; COVID-19; Humans; SARS-CoV-2; Skin; Urticaria","Radhakrishnan","Nila","Department of Medicine, University of Florida Health, Gainesville, Florida, USA",NA
"2275","34162603","10.1136/bcr-2020-241052","Dermographism in COVID-19.",NA,"2021","06","29","BMJ Case Rep","BMJ case reports","COVID-19; dermatology; COVID-19; Humans; SARS-CoV-2; Skin; Urticaria","Jones","Riley G","Department of Medicine, University of Florida Health, Gainesville, Florida, USA riley.jones@medicine.ufl","riley.jones@medicine.ufl.edu"
"2276","34162598","10.1136/bmj.n1343","Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data.","To estimate changes in life expectancy in 2010-18 and during the covid-19 pandemic in 2020 across population groups in the United States and to compare outcomes with peer nations. Simulations of provisional mortality data. US and 16 other high income countries in 2010-18 and 2020, by sex, including an analysis of US outcomes by race and ethnicity. Data for the US and for 16 other high income countries from the National Center for Health Statistics and the Human Mortality Database, respectively. ","2021","07","01","BMJ","BMJ (Clinical research ed.)","Aged; Aged, 80 and over; COVID-19; Developed Countries; Female; Humans; Life Expectancy; Life Tables; Male; Pandemics; SARS-CoV-2; United States","Woolf","Steven H","Center on Society and Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA steven.woolf@vcuhealth","steven.woolf@vcuhealth.org"
"2277","34162598","10.1136/bmj.n1343","Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data.","To estimate changes in life expectancy in 2010-18 and during the covid-19 pandemic in 2020 across population groups in the United States and to compare outcomes with peer nations. Simulations of provisional mortality data. US and 16 other high income countries in 2010-18 and 2020, by sex, including an analysis of US outcomes by race and ethnicity. Data for the US and for 16 other high income countries from the National Center for Health Statistics and the Human Mortality Database, respectively. ","2021","07","01","BMJ","BMJ (Clinical research ed.)","Aged; Aged, 80 and over; COVID-19; Developed Countries; Female; Humans; Life Expectancy; Life Tables; Male; Pandemics; SARS-CoV-2; United States","Masters","Ryan K","Department of Sociology, Health and Society Program and Population Program, Institute of Behavioral Science, University of Colorado Population Center, University of Colorado Boulder, CO, USA",NA
"2278","34162598","10.1136/bmj.n1343","Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data.","To estimate changes in life expectancy in 2010-18 and during the covid-19 pandemic in 2020 across population groups in the United States and to compare outcomes with peer nations. Simulations of provisional mortality data. US and 16 other high income countries in 2010-18 and 2020, by sex, including an analysis of US outcomes by race and ethnicity. Data for the US and for 16 other high income countries from the National Center for Health Statistics and the Human Mortality Database, respectively. ","2021","07","01","BMJ","BMJ (Clinical research ed.)","Aged; Aged, 80 and over; COVID-19; Developed Countries; Female; Humans; Life Expectancy; Life Tables; Male; Pandemics; SARS-CoV-2; United States","Aron","Laudan Y","Urban Institute, Washington, DC, USA",NA
"2279","34162596","10.1136/annrheumdis-2021-220787","Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein <i>et al</i>.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; epidemiology","Landewé","Robert Bm","Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands landewe@rlandewe","landewe@rlandewe.nl"
"2280","34162596","10.1136/annrheumdis-2021-220787","Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein <i>et al</i>.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; epidemiology","Ramiro","Sofia","Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands",NA
"2281","34162596","10.1136/annrheumdis-2021-220787","Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein <i>et al</i>.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; epidemiology","Mostard","Rémy L M","Department of Pulmonology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands",NA
"2282","34162593","10.1136/annrheumdis-2021-220771","Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; anti-inflammatory agents; antirheumatic agents; non-steroidal","Klopfenstein","Timothée","Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France timothee.klopfenstein@hnfc","timothee.klopfenstein@hnfc.fr"
"2283","34162593","10.1136/annrheumdis-2021-220771","Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; anti-inflammatory agents; antirheumatic agents; non-steroidal","Gendrin","Vincent","Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France",NA
"2284","34162593","10.1136/annrheumdis-2021-220771","Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; anti-inflammatory agents; antirheumatic agents; non-steroidal","Conrozier","Thierry","Rheumatology Department, North Franche-Comté Hospital, Montbeliard, France",NA
"2285","34162593","10.1136/annrheumdis-2021-220771","Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; anti-inflammatory agents; antirheumatic agents; non-steroidal","Gerazime","Aurélie","Methodology unit, Clinical Investigation Center INSERM 1431, CHU Besancon, Besancon, France",NA
"2286","34162593","10.1136/annrheumdis-2021-220771","Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; anti-inflammatory agents; antirheumatic agents; non-steroidal","Puyraveau","Marc","Methodology unit, Clinical Investigation Center INSERM 1431, CHU Besancon, Besancon, France",NA
"2287","34162593","10.1136/annrheumdis-2021-220771","Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.",NA,"2021","06","24","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; anti-inflammatory agents; antirheumatic agents; non-steroidal","Zayet","Souheil","Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France",NA
"2288","34162590","10.1136/bmj.n1530","Covid-19 and the growing disadvantage in US life expectancy.",NA,"2021","07","02","BMJ","BMJ (Clinical research ed.)","COVID-19; Humans; Life Expectancy; SARS-CoV-2","Barbieri","Magali","Department of Demography, University of California, Berkeley, CA, USA",NA
"2289","34162584","10.1136/bmjspcare-2021-002987","Telehealth: rapid adoption in community palliative care due to COVID-19: patient and professional evaluation.","The COVID-19 pandemic has brought the use of telehealth to the fore, as many people have been unable to interact directly with healthcare professionals (HCP). For community palliative care (CPC) services, this has meant a sudden change from a predominantly face-to-face model of care to one that incorporates telehealth. Understanding patient and HCP experiences with telehealth and how telehealth compares to 'usual' care will be crucial in planning future CPC services. All patients of the Barwon H","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; home care; service evaluation","Eastman","Peter","Department of Palliative Care, Barwon Health, Geelong, Victoria, Australia eastman@gmp.usyd.edu","eastman@gmp.usyd.edu.au"
"2290","34162584","10.1136/bmjspcare-2021-002987","Telehealth: rapid adoption in community palliative care due to COVID-19: patient and professional evaluation.","The COVID-19 pandemic has brought the use of telehealth to the fore, as many people have been unable to interact directly with healthcare professionals (HCP). For community palliative care (CPC) services, this has meant a sudden change from a predominantly face-to-face model of care to one that incorporates telehealth. Understanding patient and HCP experiences with telehealth and how telehealth compares to 'usual' care will be crucial in planning future CPC services. All patients of the Barwon H","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; home care; service evaluation","Dowd","Anna","Department of Palliative Care, Barwon Health, Geelong, Victoria, Australia",NA
"2291","34162584","10.1136/bmjspcare-2021-002987","Telehealth: rapid adoption in community palliative care due to COVID-19: patient and professional evaluation.","The COVID-19 pandemic has brought the use of telehealth to the fore, as many people have been unable to interact directly with healthcare professionals (HCP). For community palliative care (CPC) services, this has meant a sudden change from a predominantly face-to-face model of care to one that incorporates telehealth. Understanding patient and HCP experiences with telehealth and how telehealth compares to 'usual' care will be crucial in planning future CPC services. All patients of the Barwon H","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; home care; service evaluation","White","Jacqui","Department of Palliative Care, Barwon Health, Geelong, Victoria, Australia",NA
"2292","34162584","10.1136/bmjspcare-2021-002987","Telehealth: rapid adoption in community palliative care due to COVID-19: patient and professional evaluation.","The COVID-19 pandemic has brought the use of telehealth to the fore, as many people have been unable to interact directly with healthcare professionals (HCP). For community palliative care (CPC) services, this has meant a sudden change from a predominantly face-to-face model of care to one that incorporates telehealth. Understanding patient and HCP experiences with telehealth and how telehealth compares to 'usual' care will be crucial in planning future CPC services. All patients of the Barwon H","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; home care; service evaluation","Carter","Jill","Department of Palliative Care, Barwon Health, Geelong, Victoria, Australia",NA
"2293","34162584","10.1136/bmjspcare-2021-002987","Telehealth: rapid adoption in community palliative care due to COVID-19: patient and professional evaluation.","The COVID-19 pandemic has brought the use of telehealth to the fore, as many people have been unable to interact directly with healthcare professionals (HCP). For community palliative care (CPC) services, this has meant a sudden change from a predominantly face-to-face model of care to one that incorporates telehealth. Understanding patient and HCP experiences with telehealth and how telehealth compares to 'usual' care will be crucial in planning future CPC services. All patients of the Barwon H","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; home care; service evaluation","Ely","Matthew","Department of Palliative Care, Barwon Health, Geelong, Victoria, Australia",NA
"2294","34162580","10.1136/bmjspcare-2020-002861","Video hospice consultation in COVID-19: professional and patient evaluations.","Providing care for our patients during the COVID-19 pandemic required a rapid shift to video consultations (VCs). A service evaluation was performed to capture hospice professionals' (HPs) and patients' experiences of VC. Online or postal surveys were sent to HPs and patients, who had participated in VC between March and July 2020, focusing on their experience and satisfaction with the service. 31 responses from HPs were received. 19 (61.3%) rated their experience of VC as good, despite 29 (93.5","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; hospice care; service evaluation; supportive care","Milne","Shannon","Education and Research, Princess Alice Hospice, Esher, UK shannonmilne@pah.org","shannonmilne@pah.org.uk"
"2295","34162580","10.1136/bmjspcare-2020-002861","Video hospice consultation in COVID-19: professional and patient evaluations.","Providing care for our patients during the COVID-19 pandemic required a rapid shift to video consultations (VCs). A service evaluation was performed to capture hospice professionals' (HPs) and patients' experiences of VC. Online or postal surveys were sent to HPs and patients, who had participated in VC between March and July 2020, focusing on their experience and satisfaction with the service. 31 responses from HPs were received. 19 (61.3%) rated their experience of VC as good, despite 29 (93.5","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; hospice care; service evaluation; supportive care","Palfrey","Jennifer","Palliative Medicine, Princess Alice Hospice, Esher, UK",NA
"2296","34162580","10.1136/bmjspcare-2020-002861","Video hospice consultation in COVID-19: professional and patient evaluations.","Providing care for our patients during the COVID-19 pandemic required a rapid shift to video consultations (VCs). A service evaluation was performed to capture hospice professionals' (HPs) and patients' experiences of VC. Online or postal surveys were sent to HPs and patients, who had participated in VC between March and July 2020, focusing on their experience and satisfaction with the service. 31 responses from HPs were received. 19 (61.3%) rated their experience of VC as good, despite 29 (93.5","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; hospice care; service evaluation; supportive care","Berg","Jane","Education and Research, Princess Alice Hospice, Esher, UK",NA
"2297","34162580","10.1136/bmjspcare-2020-002861","Video hospice consultation in COVID-19: professional and patient evaluations.","Providing care for our patients during the COVID-19 pandemic required a rapid shift to video consultations (VCs). A service evaluation was performed to capture hospice professionals' (HPs) and patients' experiences of VC. Online or postal surveys were sent to HPs and patients, who had participated in VC between March and July 2020, focusing on their experience and satisfaction with the service. 31 responses from HPs were received. 19 (61.3%) rated their experience of VC as good, despite 29 (93.5","2021","06","24","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; hospice care; service evaluation; supportive care","Todd","Jennifer","Palliative Medicine, Princess Alice Hospice, Esher, UK",NA
"2298","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Hammer","Melanie S","Department of Energy, Environmental, and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA. melanie.hammer@wustl","melanie.hammer@wustl.edu"
"2299","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"van Donkelaar","Aaron","Department of Physics and Atmospheric Science, Dalhousie University, Halifax, NS, Canada",NA
"2300","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Martin","Randall V","Department of Energy, Environmental, and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA",NA
"2301","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"McDuffie","Erin E","Department of Energy, Environmental, and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA",NA
"2302","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Lyapustin","Alexei","Earth Sciences Division, NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA",NA
"2303","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Sayer","Andrew M","Earth Sciences Division, NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA",NA
"2304","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Hsu","N Christina","Earth Sciences Division, NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA",NA
"2305","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Levy","Robert C","Earth Sciences Division, NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA",NA
"2306","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Garay","Michael J","Jet Propulsion Laboratory, California Institute of Technology, Pasadena, CA 91109, USA",NA
"2307","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Kalashnikova","Olga V","Jet Propulsion Laboratory, California Institute of Technology, Pasadena, CA 91109, USA",NA
"2308","34162552","10.1126/sciadv.abg7670","Effects of COVID-19 lockdowns on fine particulate matter concentrations.","Lockdowns during the COVID-19 pandemic provide an unprecedented opportunity to examine the effects of human activity on air quality. The effects on fine particulate matter (PM2.5) are of particular interest, as PM2.5 is the leading environmental risk factor for mortality globally. We map global PM2.5 concentrations for January to April 2020 with a focus on China, Europe, and North America using a combination of satellite data, simulation, and ground-based observa","2021","07","02","Sci Adv","Science advances",NA,"Kahn","Ralph A","Earth Sciences Division, NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA",NA
"2309","34162550","10.1126/sciadv.abg4511","Mitigation strategies for airborne disease transmission in orchestras using computational fluid dynamics.","The COVID-19 pandemic forced performing arts groups to cancel shows and entire seasons due to safety concerns for the audience and performers. It is unclear to what extent aerosols generated by wind instruments contribute to exposure because their fate is dependent on the airflow onstage. We use transient, second-order accurate computational fluid dynamics (CFD) simulations and quantitative microbial risk assessment to estimate aerosol concentrations and the associated risk and assess strategies","2021","07","02","Sci Adv","Science advances",NA,"Hedworth","Hayden A","Department of Chemical Engineering, University of Utah Salt Lake City, UT 84112, USA",NA
"2310","34162550","10.1126/sciadv.abg4511","Mitigation strategies for airborne disease transmission in orchestras using computational fluid dynamics.","The COVID-19 pandemic forced performing arts groups to cancel shows and entire seasons due to safety concerns for the audience and performers. It is unclear to what extent aerosols generated by wind instruments contribute to exposure because their fate is dependent on the airflow onstage. We use transient, second-order accurate computational fluid dynamics (CFD) simulations and quantitative microbial risk assessment to estimate aerosol concentrations and the associated risk and assess strategies","2021","07","02","Sci Adv","Science advances",NA,"Karam","Mokbel","Department of Chemical Engineering, University of Utah Salt Lake City, UT 84112, USA",NA
"2311","34162550","10.1126/sciadv.abg4511","Mitigation strategies for airborne disease transmission in orchestras using computational fluid dynamics.","The COVID-19 pandemic forced performing arts groups to cancel shows and entire seasons due to safety concerns for the audience and performers. It is unclear to what extent aerosols generated by wind instruments contribute to exposure because their fate is dependent on the airflow onstage. We use transient, second-order accurate computational fluid dynamics (CFD) simulations and quantitative microbial risk assessment to estimate aerosol concentrations and the associated risk and assess strategies","2021","07","02","Sci Adv","Science advances",NA,"McConnell","Josh","Department of Chemical Engineering, University of Utah Salt Lake City, UT 84112, USA",NA
"2312","34162550","10.1126/sciadv.abg4511","Mitigation strategies for airborne disease transmission in orchestras using computational fluid dynamics.","The COVID-19 pandemic forced performing arts groups to cancel shows and entire seasons due to safety concerns for the audience and performers. It is unclear to what extent aerosols generated by wind instruments contribute to exposure because their fate is dependent on the airflow onstage. We use transient, second-order accurate computational fluid dynamics (CFD) simulations and quantitative microbial risk assessment to estimate aerosol concentrations and the associated risk and assess strategies","2021","07","02","Sci Adv","Science advances",NA,"Sutherland","James C","Department of Chemical Engineering, University of Utah Salt Lake City, UT 84112, USA",NA
"2313","34162550","10.1126/sciadv.abg4511","Mitigation strategies for airborne disease transmission in orchestras using computational fluid dynamics.","The COVID-19 pandemic forced performing arts groups to cancel shows and entire seasons due to safety concerns for the audience and performers. It is unclear to what extent aerosols generated by wind instruments contribute to exposure because their fate is dependent on the airflow onstage. We use transient, second-order accurate computational fluid dynamics (CFD) simulations and quantitative microbial risk assessment to estimate aerosol concentrations and the associated risk and assess strategies","2021","07","02","Sci Adv","Science advances",NA,"Saad","Tony","Department of Chemical Engineering, University of Utah Salt Lake City, UT 84112, USA. tony.saad@chemeng.utah","tony.saad@chemeng.utah.edu"
"2314","34162526","10.1016/j.resinv.2021.05.009","Increased usage of the high flow nasal cannula in COVID-19 cases in Japan -from the online questionnaire survey by the Japanese Respiratory Society.","An online questionnaire survey was used to assess the application of noninvasive strategies in the management of COVID-19 patients. We found a marked increase in the proportion of facilities using high flow nasal cannula (HFNC) oxygen therapy successfully in the 3rd epidemic wave as compared to the 1st wave (49% vs. 12%) and rare reports of associated nosocomial infection in the medical personnel. Furthermore, the proportion of facilities using HFNC as first-line therapy for half or more than ha","2021","06","26","Respir Investig","Respiratory investigation","COVID-19; COVID-19 management; CPAP; High flow nasal cannula (HFNC); NPPV","Tomii","Keisuke","Japanese Respiratory Society Scientific Assembly of Respiratory Care, Nichinai Building., 7F, 3-28-8, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan","ktomii@kcho.jp"
"2315","34162526","10.1016/j.resinv.2021.05.009","Increased usage of the high flow nasal cannula in COVID-19 cases in Japan -from the online questionnaire survey by the Japanese Respiratory Society.","An online questionnaire survey was used to assess the application of noninvasive strategies in the management of COVID-19 patients. We found a marked increase in the proportion of facilities using high flow nasal cannula (HFNC) oxygen therapy successfully in the 3rd epidemic wave as compared to the 1st wave (49% vs. 12%) and rare reports of associated nosocomial infection in the medical personnel. Furthermore, the proportion of facilities using HFNC as first-line therapy for half or more than ha","2021","06","26","Respir Investig","Respiratory investigation","COVID-19; COVID-19 management; CPAP; High flow nasal cannula (HFNC); NPPV","Terada","Jiro","Japanese Respiratory Society Scientific Assembly of Respiratory Care, Nichinai Building., 7F, 3-28-8, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan",NA
"2316","34162526","10.1016/j.resinv.2021.05.009","Increased usage of the high flow nasal cannula in COVID-19 cases in Japan -from the online questionnaire survey by the Japanese Respiratory Society.","An online questionnaire survey was used to assess the application of noninvasive strategies in the management of COVID-19 patients. We found a marked increase in the proportion of facilities using high flow nasal cannula (HFNC) oxygen therapy successfully in the 3rd epidemic wave as compared to the 1st wave (49% vs. 12%) and rare reports of associated nosocomial infection in the medical personnel. Furthermore, the proportion of facilities using HFNC as first-line therapy for half or more than ha","2021","06","26","Respir Investig","Respiratory investigation","COVID-19; COVID-19 management; CPAP; High flow nasal cannula (HFNC); NPPV","Chin","Kazuo","Japanese Respiratory Society Scientific Assembly of Respiratory Care, Nichinai Building., 7F, 3-28-8, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan",NA
"2317","34162525","10.1016/j.jaip.2021.05.030","""COVID Toes"" After mRNA COVID-19 Vaccines.",NA,"2021","06","26","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Kelso","John M","Division of Allergy, Asthma and Immunology, Scripps Clinic, San Diego, Calif. Electronic address: kelso.john@scrippshealth","kelso.john@scrippshealth.org"
"2318","34162525","10.1016/j.jaip.2021.05.030","""COVID Toes"" After mRNA COVID-19 Vaccines.",NA,"2021","06","26","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Coda","Alvin B","Department of Dermatology, Scripps Clinic, San Diego, Calif",NA
"2319","34162525","10.1016/j.jaip.2021.05.030","""COVID Toes"" After mRNA COVID-19 Vaccines.",NA,"2021","06","26","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Keating","Richard M","Division of Rheumatology, Scripps Clinic, San Diego, Calif",NA
"2320","34162525","10.1016/j.jaip.2021.05.030","""COVID Toes"" After mRNA COVID-19 Vaccines.",NA,"2021","06","26","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Vaccari","Dana M","Department of Internal Medicine, Scripps Clinic, San Diego, Calif",NA
"2321","34162515","10.1016/j.jneb.2021.04.005","Differing Experiences of Boredom During the Pandemic and Associations With Dietary Behaviors.","To examine how changes in feeling bored and eating because of boredom during the coronavirus disease 2019 (COVID-19) pandemic relate to intuitive eating, diet quality, and snacking. A representative sample of 360 US adults completed an online survey including changes in feeling bored and eating because of boredom since the COVID-19 pandemic. An ANCOVA and multivariate analysis of covariance were used to examine relationships between intuitive eating, diet quality, and snacking in individuals who","2021","06","24","J Nutr Educ Behav","Journal of nutrition education and behavior","COVID-19 pandemic; boredom; diet quality; intuitive eating; snacking","Jackson","Alexandra","Department of Human Development, Washington State University, Vancouver, WA. Electronic address: Alexandra.m.jackson@wsu","Alexandra.m.jackson@wsu.edu"
"2322","34162515","10.1016/j.jneb.2021.04.005","Differing Experiences of Boredom During the Pandemic and Associations With Dietary Behaviors.","To examine how changes in feeling bored and eating because of boredom during the coronavirus disease 2019 (COVID-19) pandemic relate to intuitive eating, diet quality, and snacking. A representative sample of 360 US adults completed an online survey including changes in feeling bored and eating because of boredom since the COVID-19 pandemic. An ANCOVA and multivariate analysis of covariance were used to examine relationships between intuitive eating, diet quality, and snacking in individuals who","2021","06","24","J Nutr Educ Behav","Journal of nutrition education and behavior","COVID-19 pandemic; boredom; diet quality; intuitive eating; snacking","Anderson","Alana","Department of Human Development, Washington State University, Pullman, WA",NA
"2323","34162515","10.1016/j.jneb.2021.04.005","Differing Experiences of Boredom During the Pandemic and Associations With Dietary Behaviors.","To examine how changes in feeling bored and eating because of boredom during the coronavirus disease 2019 (COVID-19) pandemic relate to intuitive eating, diet quality, and snacking. A representative sample of 360 US adults completed an online survey including changes in feeling bored and eating because of boredom since the COVID-19 pandemic. An ANCOVA and multivariate analysis of covariance were used to examine relationships between intuitive eating, diet quality, and snacking in individuals who","2021","06","24","J Nutr Educ Behav","Journal of nutrition education and behavior","COVID-19 pandemic; boredom; diet quality; intuitive eating; snacking","Weybright","Elizabeth","Department of Human Development, Washington State University, Pullman, WA",NA
"2324","34162515","10.1016/j.jneb.2021.04.005","Differing Experiences of Boredom During the Pandemic and Associations With Dietary Behaviors.","To examine how changes in feeling bored and eating because of boredom during the coronavirus disease 2019 (COVID-19) pandemic relate to intuitive eating, diet quality, and snacking. A representative sample of 360 US adults completed an online survey including changes in feeling bored and eating because of boredom since the COVID-19 pandemic. An ANCOVA and multivariate analysis of covariance were used to examine relationships between intuitive eating, diet quality, and snacking in individuals who","2021","06","24","J Nutr Educ Behav","Journal of nutrition education and behavior","COVID-19 pandemic; boredom; diet quality; intuitive eating; snacking","Lanigan","Jane","Department of Human Development, Washington State University, Vancouver, WA",NA
"2325","34162507","10.1016/j.dld.2021.05.037","No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience.",NA,"2021","06","26","Dig Liver Dis","Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver",NA,"De Biasio","Fabiola","IBD Unit, S Filippo Neri Hospital, Rome, Italy",NA
"2326","34162507","10.1016/j.dld.2021.05.037","No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience.",NA,"2021","06","26","Dig Liver Dis","Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver",NA,"Aratari","Annalisa","IBD Unit, S Filippo Neri Hospital, Rome, Italy",NA
"2327","34162507","10.1016/j.dld.2021.05.037","No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience.",NA,"2021","06","26","Dig Liver Dis","Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver",NA,"Festa","Stefano","IBD Unit, S Filippo Neri Hospital, Rome, Italy",NA
"2328","34162507","10.1016/j.dld.2021.05.037","No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience.",NA,"2021","06","26","Dig Liver Dis","Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver",NA,"Lorenzetti","Roberto","IBD Unit, S Filippo Neri Hospital, Rome, Italy",NA
"2329","34162507","10.1016/j.dld.2021.05.037","No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience.",NA,"2021","06","26","Dig Liver Dis","Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver",NA,"Papi","Claudio","IBD Unit, S Filippo Neri Hospital, Rome, Italy. Electronic address: claudio.papi@aslroma1","claudio.papi@aslroma1.it"
"2330","34162455","10.1017/ice.2021.289","Strategy to limit multidrug-resistant <i>Acinetobacter baumannii</i> transmission in a cohort coronavirus disease 2019 (COVID-19) critical care unit.",NA,"2021","07","11","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Apisarnthanarak","Anucha","Division of Infectious Diseases, Thammasat University Hospital, Pathum Thani, Thailand",NA
"2331","34162455","10.1017/ice.2021.289","Strategy to limit multidrug-resistant <i>Acinetobacter baumannii</i> transmission in a cohort coronavirus disease 2019 (COVID-19) critical care unit.",NA,"2021","07","11","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Weber","David J","Gillings School of Global Public Health, Chapel Hill, North Carolina, United States",NA
"2332","34162451","10.1017/ice.2021.282","Predicting asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection rates of inpatients: A time-series analysis.","Asymptomatic SARS-CoV-2 infections are often difficult to identify because widespread surveillance has not been the norm. Using time-series analyses, we examined whether COVID-19 rates at the county level could predict positivity rates among asymptomatic patients in a large health system. Asymptomatic positivity rates at the system level and county-level COVID-19 rates were not associated.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Rivera","Frida","Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin",NA
"2333","34162451","10.1017/ice.2021.282","Predicting asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection rates of inpatients: A time-series analysis.","Asymptomatic SARS-CoV-2 infections are often difficult to identify because widespread surveillance has not been the norm. Using time-series analyses, we examined whether COVID-19 rates at the county level could predict positivity rates among asymptomatic patients in a large health system. Asymptomatic positivity rates at the system level and county-level COVID-19 rates were not associated.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Ahn","Kwang Woo","Department of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin",NA
"2334","34162451","10.1017/ice.2021.282","Predicting asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection rates of inpatients: A time-series analysis.","Asymptomatic SARS-CoV-2 infections are often difficult to identify because widespread surveillance has not been the norm. Using time-series analyses, we examined whether COVID-19 rates at the county level could predict positivity rates among asymptomatic patients in a large health system. Asymptomatic positivity rates at the system level and county-level COVID-19 rates were not associated.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Munoz-Price","L Silvia","Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin",NA
"2335","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Smith","Richard D","University of Maryland School of Medicine, Baltimore, MD, USA",NA
"2336","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Johnson","J Kristie","University of Maryland School of Medicine, Baltimore, MD, USA",NA
"2337","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Clay","Colleen","Upper Chesapeake Medical Center, Bel Air, MD, USA",NA
"2338","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Girio-Herrera","Leo","Upper Chesapeake Medical Center, Bel Air, MD, USA",NA
"2339","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Stevens","Diane","Upper Chesapeake Medical Center, Bel Air, MD, USA",NA
"2340","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Abraham","Michael","University of Maryland School of Medicine, Baltimore, MD, USA",NA
"2341","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Zimand","Paul","Upper Chesapeake Medical Center, Bel Air, MD, USA",NA
"2342","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Ahlman","Mark","Upper Chesapeake Medical Center, Bel Air, MD, USA",NA
"2343","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Gimigliano","Sheri","Upper Chesapeake Medical Center, Bel Air, MD, USA",NA
"2344","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Zhao","Richard","University of Maryland School of Medicine, Baltimore, MD, USA",NA
"2345","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Hildenbrand","Cynthia","University of Maryland School of Medicine, Baltimore, MD, USA",NA
"2346","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Barrueto","Fermin","University of Maryland School of Medicine, Baltimore, MD, USA",NA
"2347","34162449","10.1017/ice.2021.281","Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions.","To determine the utility of the Sofia® SARS rapid antigen fluorescent immunoassay (FIA) to guide hospital bed placement of patients being admitted through the emergency department (ED). Cross-sectional analysis of a clinical quality improvement study. Two community hospitals in Maryland. From 9/21/2020 to 12/3/2020, 2887 patients simultaneously received the Sofia® SARS rapid antigen FIA and SARS-CoV-2 RT-PCR assays on admission through the ED. Rapid antigen results and symptom assessment guided ","2021","06","24","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Leekha","Surbhi","University of Maryland School of Medicine, Baltimore, MD, USA",NA
"2348","34162448","10.1017/cjn.2021.148","COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES.",NA,"2021","06","24","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques",NA,"Chu","Joseph Y",NA,NA
"2349","34162448","10.1017/cjn.2021.148","COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES.",NA,"2021","06","24","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques",NA,"Kaliwal","Yosuf",NA,NA
"2350","34162448","10.1017/cjn.2021.148","COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES.",NA,"2021","06","24","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques",NA,"Koh","Maria",NA,NA
"2351","34162448","10.1017/cjn.2021.148","COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES.",NA,"2021","06","24","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques",NA,"Chen","Robert",NA,NA
"2352","34162448","10.1017/cjn.2021.148","COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES.",NA,"2021","06","24","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques",NA,"Chow","Chi-Ming",NA,NA
"2353","34162448","10.1017/cjn.2021.148","COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES.",NA,"2021","06","24","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques",NA,"Ko","Dennis T",NA,NA
"2354","34162448","10.1017/cjn.2021.148","COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES.",NA,"2021","06","24","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques",NA,"Liu","Peter P",NA,NA
"2355","34162448","10.1017/cjn.2021.148","COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES.",NA,"2021","06","24","Can J Neurol Sci","The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques",NA,"Moe","Gordon W",NA,NA
"2356","34162445","10.1186/s41182-021-00344-w","The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries.","Antimicrobial resistance is a hidden threat lurking behind the COVID-19 pandemic which has claimed thousands of lives prior to the emergence of the global outbreak. With a pandemic on the scale of COVID-19, antimicrobial resistance has the potential to become a double-edged sword with the overuse of antibiotics having the potential of taking us back to the pre-antibiotic era. Antimicrobial resistance is majorly attributed to widespread and unnecessary use of antibiotics, among other causes, whic","2021","06","27","Trop Med Health","Tropical medicine and health","Africa; Antibiotic resistance; Antimicrobial resistance; COVID-19; Clinical case management; Pandemic","Adebisi","Yusuff Adebayo","Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria",NA
"2357","34162445","10.1186/s41182-021-00344-w","The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries.","Antimicrobial resistance is a hidden threat lurking behind the COVID-19 pandemic which has claimed thousands of lives prior to the emergence of the global outbreak. With a pandemic on the scale of COVID-19, antimicrobial resistance has the potential to become a double-edged sword with the overuse of antibiotics having the potential of taking us back to the pre-antibiotic era. Antimicrobial resistance is majorly attributed to widespread and unnecessary use of antibiotics, among other causes, whic","2021","06","27","Trop Med Health","Tropical medicine and health","Africa; Antibiotic resistance; Antimicrobial resistance; COVID-19; Clinical case management; Pandemic","Jimoh","Nafisat Dasola","Federal University of Technology Minna, Minna, Nigeria",NA
"2358","34162445","10.1186/s41182-021-00344-w","The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries.","Antimicrobial resistance is a hidden threat lurking behind the COVID-19 pandemic which has claimed thousands of lives prior to the emergence of the global outbreak. With a pandemic on the scale of COVID-19, antimicrobial resistance has the potential to become a double-edged sword with the overuse of antibiotics having the potential of taking us back to the pre-antibiotic era. Antimicrobial resistance is majorly attributed to widespread and unnecessary use of antibiotics, among other causes, whic","2021","06","27","Trop Med Health","Tropical medicine and health","Africa; Antibiotic resistance; Antimicrobial resistance; COVID-19; Clinical case management; Pandemic","Ogunkola","Isaac Olushola","Department of Public Health, University of Calabar, Calabar, Nigeria",NA
"2359","34162445","10.1186/s41182-021-00344-w","The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries.","Antimicrobial resistance is a hidden threat lurking behind the COVID-19 pandemic which has claimed thousands of lives prior to the emergence of the global outbreak. With a pandemic on the scale of COVID-19, antimicrobial resistance has the potential to become a double-edged sword with the overuse of antibiotics having the potential of taking us back to the pre-antibiotic era. Antimicrobial resistance is majorly attributed to widespread and unnecessary use of antibiotics, among other causes, whic","2021","06","27","Trop Med Health","Tropical medicine and health","Africa; Antibiotic resistance; Antimicrobial resistance; COVID-19; Clinical case management; Pandemic","Uwizeyimana","Theogene","Department of Public Health, Mount Kenya University Rwanda, Kigali, Rwanda. uwizeyimanatheogene@gmail","uwizeyimanatheogene@gmail.com"
"2360","34162445","10.1186/s41182-021-00344-w","The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries.","Antimicrobial resistance is a hidden threat lurking behind the COVID-19 pandemic which has claimed thousands of lives prior to the emergence of the global outbreak. With a pandemic on the scale of COVID-19, antimicrobial resistance has the potential to become a double-edged sword with the overuse of antibiotics having the potential of taking us back to the pre-antibiotic era. Antimicrobial resistance is majorly attributed to widespread and unnecessary use of antibiotics, among other causes, whic","2021","06","27","Trop Med Health","Tropical medicine and health","Africa; Antibiotic resistance; Antimicrobial resistance; COVID-19; Clinical case management; Pandemic","Olayemi","Alaka Hassan","Department of Microbiology, Obafemi Awolowo University, Ile-Ife, Nigeria",NA
"2361","34162445","10.1186/s41182-021-00344-w","The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries.","Antimicrobial resistance is a hidden threat lurking behind the COVID-19 pandemic which has claimed thousands of lives prior to the emergence of the global outbreak. With a pandemic on the scale of COVID-19, antimicrobial resistance has the potential to become a double-edged sword with the overuse of antibiotics having the potential of taking us back to the pre-antibiotic era. Antimicrobial resistance is majorly attributed to widespread and unnecessary use of antibiotics, among other causes, whic","2021","06","27","Trop Med Health","Tropical medicine and health","Africa; Antibiotic resistance; Antimicrobial resistance; COVID-19; Clinical case management; Pandemic","Ukor","Nelson Ashinedu","Faculty of Pharmacy, University of Port Harcourt, Choba, Nigeria",NA
"2362","34162445","10.1186/s41182-021-00344-w","The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries.","Antimicrobial resistance is a hidden threat lurking behind the COVID-19 pandemic which has claimed thousands of lives prior to the emergence of the global outbreak. With a pandemic on the scale of COVID-19, antimicrobial resistance has the potential to become a double-edged sword with the overuse of antibiotics having the potential of taking us back to the pre-antibiotic era. Antimicrobial resistance is majorly attributed to widespread and unnecessary use of antibiotics, among other causes, whic","2021","06","27","Trop Med Health","Tropical medicine and health","Africa; Antibiotic resistance; Antimicrobial resistance; COVID-19; Clinical case management; Pandemic","Lucero-Prisno","Don Eliseo","Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK",NA
"2363","34162440","10.1186/s13578-021-00626-0","Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.","The novel SARS-CoV-2 has quickly become a global pandemic since the first reported case in December 2019, with the virus infecting millions of people to date. The spike (S) protein of the SARS-CoV-2 virus plays a key role in binding to angiotensin-converting enzyme 2 (ACE2), a host cell receptor for SARS-CoV-2. S proteins that are expressed on the cell membrane can initiate receptor-dependent syncytia formation that is associated with extensive tissue damage. Formation of syncytia have been prev","2021","06","29","Cell Biosci","Cell &amp; bioscience","ACE2; COVID-19; Cell fusion; Cell hybrid; SARS-CoV-2; Spike protein; Syncytia","Wang","Xuening","Department of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers University-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, USA",NA
"2364","34162440","10.1186/s13578-021-00626-0","Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.","The novel SARS-CoV-2 has quickly become a global pandemic since the first reported case in December 2019, with the virus infecting millions of people to date. The spike (S) protein of the SARS-CoV-2 virus plays a key role in binding to angiotensin-converting enzyme 2 (ACE2), a host cell receptor for SARS-CoV-2. S proteins that are expressed on the cell membrane can initiate receptor-dependent syncytia formation that is associated with extensive tissue damage. Formation of syncytia have been prev","2021","06","29","Cell Biosci","Cell &amp; bioscience","ACE2; COVID-19; Cell fusion; Cell hybrid; SARS-CoV-2; Spike protein; Syncytia","Chen","Chih-Hsiung","Department of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers University-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, USA",NA
"2365","34162440","10.1186/s13578-021-00626-0","Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.","The novel SARS-CoV-2 has quickly become a global pandemic since the first reported case in December 2019, with the virus infecting millions of people to date. The spike (S) protein of the SARS-CoV-2 virus plays a key role in binding to angiotensin-converting enzyme 2 (ACE2), a host cell receptor for SARS-CoV-2. S proteins that are expressed on the cell membrane can initiate receptor-dependent syncytia formation that is associated with extensive tissue damage. Formation of syncytia have been prev","2021","06","29","Cell Biosci","Cell &amp; bioscience","ACE2; COVID-19; Cell fusion; Cell hybrid; SARS-CoV-2; Spike protein; Syncytia","Badeti","Saiaditya","Department of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers University-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, USA",NA
"2366","34162440","10.1186/s13578-021-00626-0","Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.","The novel SARS-CoV-2 has quickly become a global pandemic since the first reported case in December 2019, with the virus infecting millions of people to date. The spike (S) protein of the SARS-CoV-2 virus plays a key role in binding to angiotensin-converting enzyme 2 (ACE2), a host cell receptor for SARS-CoV-2. S proteins that are expressed on the cell membrane can initiate receptor-dependent syncytia formation that is associated with extensive tissue damage. Formation of syncytia have been prev","2021","06","29","Cell Biosci","Cell &amp; bioscience","ACE2; COVID-19; Cell fusion; Cell hybrid; SARS-CoV-2; Spike protein; Syncytia","Cho","Jong Hyun","School of Graduate Studies, Rutgers Biomedical and Health Sciences, Newark, NJ, 07103, USA",NA
"2367","34162440","10.1186/s13578-021-00626-0","Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.","The novel SARS-CoV-2 has quickly become a global pandemic since the first reported case in December 2019, with the virus infecting millions of people to date. The spike (S) protein of the SARS-CoV-2 virus plays a key role in binding to angiotensin-converting enzyme 2 (ACE2), a host cell receptor for SARS-CoV-2. S proteins that are expressed on the cell membrane can initiate receptor-dependent syncytia formation that is associated with extensive tissue damage. Formation of syncytia have been prev","2021","06","29","Cell Biosci","Cell &amp; bioscience","ACE2; COVID-19; Cell fusion; Cell hybrid; SARS-CoV-2; Spike protein; Syncytia","Naghizadeh","Alireza","Department of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers University-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, USA",NA
"2368","34162440","10.1186/s13578-021-00626-0","Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.","The novel SARS-CoV-2 has quickly become a global pandemic since the first reported case in December 2019, with the virus infecting millions of people to date. The spike (S) protein of the SARS-CoV-2 virus plays a key role in binding to angiotensin-converting enzyme 2 (ACE2), a host cell receptor for SARS-CoV-2. S proteins that are expressed on the cell membrane can initiate receptor-dependent syncytia formation that is associated with extensive tissue damage. Formation of syncytia have been prev","2021","06","29","Cell Biosci","Cell &amp; bioscience","ACE2; COVID-19; Cell fusion; Cell hybrid; SARS-CoV-2; Spike protein; Syncytia","Wang","Ziren","School of Graduate Studies, Rutgers Biomedical and Health Sciences, Newark, NJ, 07103, USA",NA
"2369","34162440","10.1186/s13578-021-00626-0","Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.","The novel SARS-CoV-2 has quickly become a global pandemic since the first reported case in December 2019, with the virus infecting millions of people to date. The spike (S) protein of the SARS-CoV-2 virus plays a key role in binding to angiotensin-converting enzyme 2 (ACE2), a host cell receptor for SARS-CoV-2. S proteins that are expressed on the cell membrane can initiate receptor-dependent syncytia formation that is associated with extensive tissue damage. Formation of syncytia have been prev","2021","06","29","Cell Biosci","Cell &amp; bioscience","ACE2; COVID-19; Cell fusion; Cell hybrid; SARS-CoV-2; Spike protein; Syncytia","Liu","Dongfang","Department of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers University-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, USA. dongfang.liu@rutgers","dongfang.liu@rutgers.edu"
"2370","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Dassieu","Lise","Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Saint- Antoine Building, 850 Saint Denis St, H2X 0A9, Montreal, Quebec, Canada. lise.dassieu@umontreal","lise.dassieu@umontreal.ca"
"2371","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Pagé","M Gabrielle","Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Saint- Antoine Building, 850 Saint Denis St, H2X 0A9, Montreal, Quebec, Canada",NA
"2372","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Lacasse","Anaïs","Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue (UQAT), Rouyn-Noranda, Quebec, Canada",NA
"2373","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Laflamme","Maude","Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Saint- Antoine Building, 850 Saint Denis St, H2X 0A9, Montreal, Quebec, Canada",NA
"2374","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Perron","Vickie","Pain BC Society, Vancouver, British Columbia, Canada",NA
"2375","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Janelle-Montcalm","Audrée","Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Saint- Antoine Building, 850 Saint Denis St, H2X 0A9, Montreal, Quebec, Canada",NA
"2376","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Hudspith","Maria","Pain BC Society, Vancouver, British Columbia, Canada",NA
"2377","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Moor","Gregg","Pain BC Society, Vancouver, British Columbia, Canada",NA
"2378","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Sutton","Kathryn","Pain BC Society, Vancouver, British Columbia, Canada",NA
"2379","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Thompson","James M","Department of Public Health Sciences, Queens University, Kingston, Ontario, Canada",NA
"2380","34162393","10.1186/s12939-021-01496-1","Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID-19 pan-Canadian study.","Chronic pain affects about 20 % of the Canadian population and can lead to physical, psychological and social vulnerabilities. However, this condition remains poorly recognized and undertreated. During 2020, as the COVID-19 pandemic disrupted daily living and health care systems, the situation of people with chronic pain has drawn little public attention. This qualitative study was part of a pan-Canadian mixed-methods project and aimed to understand the experiences and challenges of people livin","2021","07","05","Int J Equity Health","International journal for equity in health","COVID-19; Canada; Chronic pain; Illness experience; Qualitative research; Social inequities; Activities of Daily Living; Adult; COVID-19; Canada; Chronic Pain; Humans; Male; Mental Disorders; Middle Aged; Qualitative Research; Quality of Life; Social Support; Stress, Psychological; Young Adult","Choinière","Manon","Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Saint- Antoine Building, 850 Saint Denis St, H2X 0A9, Montreal, Quebec, Canada",NA
"2381","34162385","10.1186/s12913-021-06575-1","Factors impacting hospital avoidance program utilisation in the care of acutely unwell residential aged care facility residents.","An existing hospital avoidance program, the Aged Care Rapid Response Team (ARRT), rapidly delivers geriatric outreach services to acutely unwell or older people with declining health at risk of hospitalisation. The aim of the current study was to explore health professionals' perspectives on the factors impacting ARRT utilisation in the care of acutely unwell residential aged care facility residents. Semi-structured interviews were conducted with two Geriatricians, two ARRT Clinical Nurse Consul","2021","06","25","BMC Health Serv Res","BMC health services research","Aged; Aged, 80 and over; COVID-19; Health Services for the Aged; Nursing homes; Patient care team; Patient transfer; Referral and consultation; Aged; COVID-19; Homes for the Aged; Hospitals; Humans; Middle Aged; Pandemics; SARS-CoV-2","Testa","Luke","Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Sydney, NSW, 2109, Australia. luke.testa@mq.edu","luke.testa@mq.edu.au"
"2382","34162385","10.1186/s12913-021-06575-1","Factors impacting hospital avoidance program utilisation in the care of acutely unwell residential aged care facility residents.","An existing hospital avoidance program, the Aged Care Rapid Response Team (ARRT), rapidly delivers geriatric outreach services to acutely unwell or older people with declining health at risk of hospitalisation. The aim of the current study was to explore health professionals' perspectives on the factors impacting ARRT utilisation in the care of acutely unwell residential aged care facility residents. Semi-structured interviews were conducted with two Geriatricians, two ARRT Clinical Nurse Consul","2021","06","25","BMC Health Serv Res","BMC health services research","Aged; Aged, 80 and over; COVID-19; Health Services for the Aged; Nursing homes; Patient care team; Patient transfer; Referral and consultation; Aged; COVID-19; Homes for the Aged; Hospitals; Humans; Middle Aged; Pandemics; SARS-CoV-2","Ryder","Tayhla","Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Sydney, NSW, 2109, Australia",NA
"2383","34162385","10.1186/s12913-021-06575-1","Factors impacting hospital avoidance program utilisation in the care of acutely unwell residential aged care facility residents.","An existing hospital avoidance program, the Aged Care Rapid Response Team (ARRT), rapidly delivers geriatric outreach services to acutely unwell or older people with declining health at risk of hospitalisation. The aim of the current study was to explore health professionals' perspectives on the factors impacting ARRT utilisation in the care of acutely unwell residential aged care facility residents. Semi-structured interviews were conducted with two Geriatricians, two ARRT Clinical Nurse Consul","2021","06","25","BMC Health Serv Res","BMC health services research","Aged; Aged, 80 and over; COVID-19; Health Services for the Aged; Nursing homes; Patient care team; Patient transfer; Referral and consultation; Aged; COVID-19; Homes for the Aged; Hospitals; Humans; Middle Aged; Pandemics; SARS-CoV-2","Braithwaite","Jeffrey","Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Sydney, NSW, 2109, Australia",NA
"2384","34162385","10.1186/s12913-021-06575-1","Factors impacting hospital avoidance program utilisation in the care of acutely unwell residential aged care facility residents.","An existing hospital avoidance program, the Aged Care Rapid Response Team (ARRT), rapidly delivers geriatric outreach services to acutely unwell or older people with declining health at risk of hospitalisation. The aim of the current study was to explore health professionals' perspectives on the factors impacting ARRT utilisation in the care of acutely unwell residential aged care facility residents. Semi-structured interviews were conducted with two Geriatricians, two ARRT Clinical Nurse Consul","2021","06","25","BMC Health Serv Res","BMC health services research","Aged; Aged, 80 and over; COVID-19; Health Services for the Aged; Nursing homes; Patient care team; Patient transfer; Referral and consultation; Aged; COVID-19; Homes for the Aged; Hospitals; Humans; Middle Aged; Pandemics; SARS-CoV-2","Mitchell","Rebecca J","Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Sydney, NSW, 2109, Australia",NA
"2385","34162364","10.1186/s12889-021-11166-0","Behavioural responses to Covid-19 health certification: a rapid review.","Covid-status certification - certificates for those who test negative for the SARS-CoV-2 virus, test positive for antibodies, or who have been vaccinated against SARS-CoV-2 - has been proposed to enable safer access to a range of activities. Realising these benefits will depend in part upon the behavioural and social impacts of certification. The aim of this rapid review was to describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protecti","2021","06","30","BMC Public Health","BMC public health","Covid-19; Covid-status certification; Health certification; Health passport; Immunity certificate; Immunity passport; Mandatory vaccination; SARS-CoV-2; Vaccination certificate; Vaccine passport; Bias; COVID-19; Certification; Humans; SARS-CoV-2; Vaccination","Drury","John","School of Psychology, University of Sussex, Brighton, UK. j.drury@sussex.ac","j.drury@sussex.ac.uk"
"2386","34162364","10.1186/s12889-021-11166-0","Behavioural responses to Covid-19 health certification: a rapid review.","Covid-status certification - certificates for those who test negative for the SARS-CoV-2 virus, test positive for antibodies, or who have been vaccinated against SARS-CoV-2 - has been proposed to enable safer access to a range of activities. Realising these benefits will depend in part upon the behavioural and social impacts of certification. The aim of this rapid review was to describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protecti","2021","06","30","BMC Public Health","BMC public health","Covid-19; Covid-status certification; Health certification; Health passport; Immunity certificate; Immunity passport; Mandatory vaccination; SARS-CoV-2; Vaccination certificate; Vaccine passport; Bias; COVID-19; Certification; Humans; SARS-CoV-2; Vaccination","Mao","Guanlan","School of Psychology, University of Sussex, Brighton, UK",NA
"2387","34162364","10.1186/s12889-021-11166-0","Behavioural responses to Covid-19 health certification: a rapid review.","Covid-status certification - certificates for those who test negative for the SARS-CoV-2 virus, test positive for antibodies, or who have been vaccinated against SARS-CoV-2 - has been proposed to enable safer access to a range of activities. Realising these benefits will depend in part upon the behavioural and social impacts of certification. The aim of this rapid review was to describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protecti","2021","06","30","BMC Public Health","BMC public health","Covid-19; Covid-status certification; Health certification; Health passport; Immunity certificate; Immunity passport; Mandatory vaccination; SARS-CoV-2; Vaccination certificate; Vaccine passport; Bias; COVID-19; Certification; Humans; SARS-CoV-2; Vaccination","John","Ann","Swansea University, Population Data Science, Swansea, UK",NA
"2388","34162364","10.1186/s12889-021-11166-0","Behavioural responses to Covid-19 health certification: a rapid review.","Covid-status certification - certificates for those who test negative for the SARS-CoV-2 virus, test positive for antibodies, or who have been vaccinated against SARS-CoV-2 - has been proposed to enable safer access to a range of activities. Realising these benefits will depend in part upon the behavioural and social impacts of certification. The aim of this rapid review was to describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protecti","2021","06","30","BMC Public Health","BMC public health","Covid-19; Covid-status certification; Health certification; Health passport; Immunity certificate; Immunity passport; Mandatory vaccination; SARS-CoV-2; Vaccination certificate; Vaccine passport; Bias; COVID-19; Certification; Humans; SARS-CoV-2; Vaccination","Kamal","Atiya","Department of Psychology, Birmingham City University, Birmingham, UK",NA
"2389","34162364","10.1186/s12889-021-11166-0","Behavioural responses to Covid-19 health certification: a rapid review.","Covid-status certification - certificates for those who test negative for the SARS-CoV-2 virus, test positive for antibodies, or who have been vaccinated against SARS-CoV-2 - has been proposed to enable safer access to a range of activities. Realising these benefits will depend in part upon the behavioural and social impacts of certification. The aim of this rapid review was to describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protecti","2021","06","30","BMC Public Health","BMC public health","Covid-19; Covid-status certification; Health certification; Health passport; Immunity certificate; Immunity passport; Mandatory vaccination; SARS-CoV-2; Vaccination certificate; Vaccine passport; Bias; COVID-19; Certification; Humans; SARS-CoV-2; Vaccination","Rubin","G James","Department of Psychological Medicine, King's College London, London, UK",NA
"2390","34162364","10.1186/s12889-021-11166-0","Behavioural responses to Covid-19 health certification: a rapid review.","Covid-status certification - certificates for those who test negative for the SARS-CoV-2 virus, test positive for antibodies, or who have been vaccinated against SARS-CoV-2 - has been proposed to enable safer access to a range of activities. Realising these benefits will depend in part upon the behavioural and social impacts of certification. The aim of this rapid review was to describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protecti","2021","06","30","BMC Public Health","BMC public health","Covid-19; Covid-status certification; Health certification; Health passport; Immunity certificate; Immunity passport; Mandatory vaccination; SARS-CoV-2; Vaccination certificate; Vaccine passport; Bias; COVID-19; Certification; Humans; SARS-CoV-2; Vaccination","Stott","Clifford","School of Psychology, Keele University, Keele, UK",NA
"2391","34162364","10.1186/s12889-021-11166-0","Behavioural responses to Covid-19 health certification: a rapid review.","Covid-status certification - certificates for those who test negative for the SARS-CoV-2 virus, test positive for antibodies, or who have been vaccinated against SARS-CoV-2 - has been proposed to enable safer access to a range of activities. Realising these benefits will depend in part upon the behavioural and social impacts of certification. The aim of this rapid review was to describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protecti","2021","06","30","BMC Public Health","BMC public health","Covid-19; Covid-status certification; Health certification; Health passport; Immunity certificate; Immunity passport; Mandatory vaccination; SARS-CoV-2; Vaccination certificate; Vaccine passport; Bias; COVID-19; Certification; Humans; SARS-CoV-2; Vaccination","Vandrevala","Tushna","Department of Psychology, Kingston University, Kingston upon Thames, UK",NA
"2392","34162364","10.1186/s12889-021-11166-0","Behavioural responses to Covid-19 health certification: a rapid review.","Covid-status certification - certificates for those who test negative for the SARS-CoV-2 virus, test positive for antibodies, or who have been vaccinated against SARS-CoV-2 - has been proposed to enable safer access to a range of activities. Realising these benefits will depend in part upon the behavioural and social impacts of certification. The aim of this rapid review was to describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protecti","2021","06","30","BMC Public Health","BMC public health","Covid-19; Covid-status certification; Health certification; Health passport; Immunity certificate; Immunity passport; Mandatory vaccination; SARS-CoV-2; Vaccination certificate; Vaccine passport; Bias; COVID-19; Certification; Humans; SARS-CoV-2; Vaccination","Marteau","Theresa M","Behaviour and Health Research Unit, University of Cambridge, Cambridge, UK",NA
"2393","34162358","10.1186/s12889-021-11202-z","Pregnant women's experiences of social distancing behavioural guidelines during the Covid-19 pandemic 'lockdown' in the UK, a qualitative interview study.","Covid-19 triggered the rapid roll-out of mass social distancing behavioural measures for infection control. Pregnant women were categorised as 'at risk' requiring extra vigilance with behavioural guidelines. Their understanding and ability to adhere to recommendations was unknown. To complete a behavioural analysis of the determinants of recommended social distancing behaviour in pregnant women, according to the 'capability, opportunity, motivation and behaviour' ('COM-B') model to inform the de","2021","06","30","BMC Public Health","BMC public health","Behavioral research; Coronavirus; Covid-19; Health-related behavior; Infection control; Maternal health services; Pandemics; Pregnant women; Qualitative research; Social distance; COVID-19; Communicable Disease Control; Female; Humans; Maternal Health Services; Pandemics; Physical Distancing; Pregnancy; Pregnant Women; Qualitative Research; SARS-CoV-2; United Kingdom","Anderson","Emma","Centre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK. emma.anderson@bristol.ac","emma.anderson@bristol.ac.uk"
"2394","34162358","10.1186/s12889-021-11202-z","Pregnant women's experiences of social distancing behavioural guidelines during the Covid-19 pandemic 'lockdown' in the UK, a qualitative interview study.","Covid-19 triggered the rapid roll-out of mass social distancing behavioural measures for infection control. Pregnant women were categorised as 'at risk' requiring extra vigilance with behavioural guidelines. Their understanding and ability to adhere to recommendations was unknown. To complete a behavioural analysis of the determinants of recommended social distancing behaviour in pregnant women, according to the 'capability, opportunity, motivation and behaviour' ('COM-B') model to inform the de","2021","06","30","BMC Public Health","BMC public health","Behavioral research; Coronavirus; Covid-19; Health-related behavior; Infection control; Maternal health services; Pandemics; Pregnant women; Qualitative research; Social distance; COVID-19; Communicable Disease Control; Female; Humans; Maternal Health Services; Pandemics; Physical Distancing; Pregnancy; Pregnant Women; Qualitative Research; SARS-CoV-2; United Kingdom","Brigden","Amberly","Centre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK",NA
"2395","34162358","10.1186/s12889-021-11202-z","Pregnant women's experiences of social distancing behavioural guidelines during the Covid-19 pandemic 'lockdown' in the UK, a qualitative interview study.","Covid-19 triggered the rapid roll-out of mass social distancing behavioural measures for infection control. Pregnant women were categorised as 'at risk' requiring extra vigilance with behavioural guidelines. Their understanding and ability to adhere to recommendations was unknown. To complete a behavioural analysis of the determinants of recommended social distancing behaviour in pregnant women, according to the 'capability, opportunity, motivation and behaviour' ('COM-B') model to inform the de","2021","06","30","BMC Public Health","BMC public health","Behavioral research; Coronavirus; Covid-19; Health-related behavior; Infection control; Maternal health services; Pandemics; Pregnant women; Qualitative research; Social distance; COVID-19; Communicable Disease Control; Female; Humans; Maternal Health Services; Pandemics; Physical Distancing; Pregnancy; Pregnant Women; Qualitative Research; SARS-CoV-2; United Kingdom","Davies","Anna","Centre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK",NA
"2396","34162358","10.1186/s12889-021-11202-z","Pregnant women's experiences of social distancing behavioural guidelines during the Covid-19 pandemic 'lockdown' in the UK, a qualitative interview study.","Covid-19 triggered the rapid roll-out of mass social distancing behavioural measures for infection control. Pregnant women were categorised as 'at risk' requiring extra vigilance with behavioural guidelines. Their understanding and ability to adhere to recommendations was unknown. To complete a behavioural analysis of the determinants of recommended social distancing behaviour in pregnant women, according to the 'capability, opportunity, motivation and behaviour' ('COM-B') model to inform the de","2021","06","30","BMC Public Health","BMC public health","Behavioral research; Coronavirus; Covid-19; Health-related behavior; Infection control; Maternal health services; Pandemics; Pregnant women; Qualitative research; Social distance; COVID-19; Communicable Disease Control; Female; Humans; Maternal Health Services; Pandemics; Physical Distancing; Pregnancy; Pregnant Women; Qualitative Research; SARS-CoV-2; United Kingdom","Shepherd","Emily","Centre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK",NA
"2397","34162358","10.1186/s12889-021-11202-z","Pregnant women's experiences of social distancing behavioural guidelines during the Covid-19 pandemic 'lockdown' in the UK, a qualitative interview study.","Covid-19 triggered the rapid roll-out of mass social distancing behavioural measures for infection control. Pregnant women were categorised as 'at risk' requiring extra vigilance with behavioural guidelines. Their understanding and ability to adhere to recommendations was unknown. To complete a behavioural analysis of the determinants of recommended social distancing behaviour in pregnant women, according to the 'capability, opportunity, motivation and behaviour' ('COM-B') model to inform the de","2021","06","30","BMC Public Health","BMC public health","Behavioral research; Coronavirus; Covid-19; Health-related behavior; Infection control; Maternal health services; Pandemics; Pregnant women; Qualitative research; Social distance; COVID-19; Communicable Disease Control; Female; Humans; Maternal Health Services; Pandemics; Physical Distancing; Pregnancy; Pregnant Women; Qualitative Research; SARS-CoV-2; United Kingdom","Ingram","Jenny","Centre for Academic Child Health, Bristol Medical School: Population Health Sciences, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK",NA
"2398","34162357","10.1186/s12889-021-11165-1","Misinformation on social networks during the novel coronavirus pandemic: a quali-quantitative case study of Brazil.","One of the challenges posed by the novel coronavirus pandemic is the infodemic risk, that is, a huge amount of information being published on the topic, along with misinformation and rumours; with social media, this phenomenon is amplified, and it goes faster and further. Around 100 million people in Brazil (50% of the inhabitants) are users of social media networks - almost half of the country's population. Most of the information on the Internet is unregulated, and its quality remains question","2021","06","30","BMC Public Health","BMC public health","Brazil; COVID-19; Coronavirus; Fact check; Misinformation; Pandemic; Politics; Social media; Brazil; COVID-19; Communication; Humans; Pandemics; SARS-CoV-2; Social Media; Social Networking","Biancovilli","Priscila","Doctoral School of Health Sciences, University of Pécs, Pécs, Hungary. biancovilli.priscila@etk.pte","biancovilli.priscila@etk.pte.hu"
"2399","34162357","10.1186/s12889-021-11165-1","Misinformation on social networks during the novel coronavirus pandemic: a quali-quantitative case study of Brazil.","One of the challenges posed by the novel coronavirus pandemic is the infodemic risk, that is, a huge amount of information being published on the topic, along with misinformation and rumours; with social media, this phenomenon is amplified, and it goes faster and further. Around 100 million people in Brazil (50% of the inhabitants) are users of social media networks - almost half of the country's population. Most of the information on the Internet is unregulated, and its quality remains question","2021","06","30","BMC Public Health","BMC public health","Brazil; COVID-19; Coronavirus; Fact check; Misinformation; Pandemic; Politics; Social media; Brazil; COVID-19; Communication; Humans; Pandemics; SARS-CoV-2; Social Media; Social Networking","Makszin","Lilla","Institute of Bioanalysis, Medical School, University of Pécs, Pécs, Hungary",NA
"2400","34162357","10.1186/s12889-021-11165-1","Misinformation on social networks during the novel coronavirus pandemic: a quali-quantitative case study of Brazil.","One of the challenges posed by the novel coronavirus pandemic is the infodemic risk, that is, a huge amount of information being published on the topic, along with misinformation and rumours; with social media, this phenomenon is amplified, and it goes faster and further. Around 100 million people in Brazil (50% of the inhabitants) are users of social media networks - almost half of the country's population. Most of the information on the Internet is unregulated, and its quality remains question","2021","06","30","BMC Public Health","BMC public health","Brazil; COVID-19; Coronavirus; Fact check; Misinformation; Pandemic; Politics; Social media; Brazil; COVID-19; Communication; Humans; Pandemics; SARS-CoV-2; Social Media; Social Networking","Jurberg","Claudia","Federal University of Rio de Janeiro, Oncobiology Program, Institute of Medical Biochemistry Leopoldo de Meis, Rio de Janeiro, Brazil",NA
"2401","34162343","10.1186/s12875-021-01471-3","The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study.","The aims of our study were to describe the effect of the COVID-19 pandemic and lockdown on primary care in Germany regarding the number of consultations, the prevalence of specific reasons for consultation presented by the patients, and the frequency of specific services performed by the GP. We conducted a longitudinal observational study based on standardised GP interviews in a quota sampling design comparing the time before the COVID-19 pandemic (12 June 2015 to 27 April 2017) with the time du","2021","07","01","BMC Fam Pract","BMC family practice","Covid-19; Health care utilisation; Primary care; COVID-19; Communicable Disease Control; Female; General Practitioners; Germany; Health Services; House Calls; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nursing Homes; Primary Health Care; Public Policy; Referral and Consultation; SARS-CoV-2","Schäfer","Ingmar","Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. in.schaefer@uke","in.schaefer@uke.de"
"2402","34162343","10.1186/s12875-021-01471-3","The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study.","The aims of our study were to describe the effect of the COVID-19 pandemic and lockdown on primary care in Germany regarding the number of consultations, the prevalence of specific reasons for consultation presented by the patients, and the frequency of specific services performed by the GP. We conducted a longitudinal observational study based on standardised GP interviews in a quota sampling design comparing the time before the COVID-19 pandemic (12 June 2015 to 27 April 2017) with the time du","2021","07","01","BMC Fam Pract","BMC family practice","Covid-19; Health care utilisation; Primary care; COVID-19; Communicable Disease Control; Female; General Practitioners; Germany; Health Services; House Calls; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nursing Homes; Primary Health Care; Public Policy; Referral and Consultation; SARS-CoV-2","Hansen","Heike","Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany",NA
"2403","34162343","10.1186/s12875-021-01471-3","The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study.","The aims of our study were to describe the effect of the COVID-19 pandemic and lockdown on primary care in Germany regarding the number of consultations, the prevalence of specific reasons for consultation presented by the patients, and the frequency of specific services performed by the GP. We conducted a longitudinal observational study based on standardised GP interviews in a quota sampling design comparing the time before the COVID-19 pandemic (12 June 2015 to 27 April 2017) with the time du","2021","07","01","BMC Fam Pract","BMC family practice","Covid-19; Health care utilisation; Primary care; COVID-19; Communicable Disease Control; Female; General Practitioners; Germany; Health Services; House Calls; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nursing Homes; Primary Health Care; Public Policy; Referral and Consultation; SARS-CoV-2","Menzel","Agata","Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany",NA
"2404","34162343","10.1186/s12875-021-01471-3","The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study.","The aims of our study were to describe the effect of the COVID-19 pandemic and lockdown on primary care in Germany regarding the number of consultations, the prevalence of specific reasons for consultation presented by the patients, and the frequency of specific services performed by the GP. We conducted a longitudinal observational study based on standardised GP interviews in a quota sampling design comparing the time before the COVID-19 pandemic (12 June 2015 to 27 April 2017) with the time du","2021","07","01","BMC Fam Pract","BMC family practice","Covid-19; Health care utilisation; Primary care; COVID-19; Communicable Disease Control; Female; General Practitioners; Germany; Health Services; House Calls; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nursing Homes; Primary Health Care; Public Policy; Referral and Consultation; SARS-CoV-2","Eisele","Marion","Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany",NA
"2405","34162343","10.1186/s12875-021-01471-3","The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study.","The aims of our study were to describe the effect of the COVID-19 pandemic and lockdown on primary care in Germany regarding the number of consultations, the prevalence of specific reasons for consultation presented by the patients, and the frequency of specific services performed by the GP. We conducted a longitudinal observational study based on standardised GP interviews in a quota sampling design comparing the time before the COVID-19 pandemic (12 June 2015 to 27 April 2017) with the time du","2021","07","01","BMC Fam Pract","BMC family practice","Covid-19; Health care utilisation; Primary care; COVID-19; Communicable Disease Control; Female; General Practitioners; Germany; Health Services; House Calls; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nursing Homes; Primary Health Care; Public Policy; Referral and Consultation; SARS-CoV-2","Tajdar","Daniel","Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany",NA
"2406","34162343","10.1186/s12875-021-01471-3","The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study.","The aims of our study were to describe the effect of the COVID-19 pandemic and lockdown on primary care in Germany regarding the number of consultations, the prevalence of specific reasons for consultation presented by the patients, and the frequency of specific services performed by the GP. We conducted a longitudinal observational study based on standardised GP interviews in a quota sampling design comparing the time before the COVID-19 pandemic (12 June 2015 to 27 April 2017) with the time du","2021","07","01","BMC Fam Pract","BMC family practice","Covid-19; Health care utilisation; Primary care; COVID-19; Communicable Disease Control; Female; General Practitioners; Germany; Health Services; House Calls; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nursing Homes; Primary Health Care; Public Policy; Referral and Consultation; SARS-CoV-2","Lühmann","Dagmar","Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany",NA
"2407","34162343","10.1186/s12875-021-01471-3","The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study.","The aims of our study were to describe the effect of the COVID-19 pandemic and lockdown on primary care in Germany regarding the number of consultations, the prevalence of specific reasons for consultation presented by the patients, and the frequency of specific services performed by the GP. We conducted a longitudinal observational study based on standardised GP interviews in a quota sampling design comparing the time before the COVID-19 pandemic (12 June 2015 to 27 April 2017) with the time du","2021","07","01","BMC Fam Pract","BMC family practice","Covid-19; Health care utilisation; Primary care; COVID-19; Communicable Disease Control; Female; General Practitioners; Germany; Health Services; House Calls; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nursing Homes; Primary Health Care; Public Policy; Referral and Consultation; SARS-CoV-2","Scherer","Martin","Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany",NA
"2408","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Camilleri","Marquita","Haematology Department, University College Hospitals, , London, UK",NA
"2409","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"McGrath","Thomas","Haematology Department, University College Hospitals, , London, UK",NA
"2410","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Wilson","William","Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK",NA
"2411","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Ings","Stuart J","Wolfson Cellular Therapy Unit, University College London Hospitals NHS Foundation Trust, London, UK",NA
"2412","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Horder","Jacqueline","Haematology Department, University College Hospitals, , London, UK",NA
"2413","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Newrick","Fiona","Haematology Department, University College Hospitals, , London, UK",NA
"2414","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Sive","Jonathan","Haematology Department, University College Hospitals, , London, UK",NA
"2415","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Papanikolaou","Xenofon","Haematology Department, University College Hospitals, , London, UK",NA
"2416","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Popat","Rakesh","Haematology Department, University College Hospitals, , London, UK",NA
"2417","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Kyriakou","Charalampia","Haematology Department, University College Hospitals, , London, UK",NA
"2418","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Yong","Kwee","Haematology Department, University College Hospitals, , London, UK",NA
"2419","34162310","10.1080/10428194.2021.1941930","Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.",NA,"2021","06","24","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Rabin","Neil","Haematology Department, University College Hospitals, , London, UK",NA
"2420","34162301","10.1080/03630269.2021.1926278","Association between Hb A<sub>1c</sub> and Severity of COVID-19 Patients.","This study aimed to examine the relationship between Hb A1c levels and the clinical course of coronavirus-19 (COVID-19) patients. Sixty-six COVID-19(+) patients with high Hb A1c and 46 with average Hb A1c and 30 COVID-19(-) patients with average Hb A1c were included. Hb A1c levels and parameters examined in COVID-19(+) patients were compared between groups, and correlation analysis was performed between these parameters and Hb A1c","2021","07","09","Hemoglobin","Hemoglobin","Coronavirus-19 (COVID-19); Hb A1c; diabetes mellitus (DM); mortality; Adult; Aged; Blood Sedimentation; C-Reactive Protein; COVID-19; Critical Care; Diabetes Complications; Diabetes Mellitus; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Glycated Hemoglobin A; Humans; Hyperglycemia; L-Lactate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Neutrophils; Oxygen; Partial Pressure; Procalcitonin; Prognosis; Risk; SARS-CoV-2; Severity of Illness Index; Thrombophilia","Unluguzel Ustun","Goksenin","Department of Biochemistry, University of Health Sciences, Samsun, Turkey",NA
"2421","34162301","10.1080/03630269.2021.1926278","Association between Hb A<sub>1c</sub> and Severity of COVID-19 Patients.","This study aimed to examine the relationship between Hb A1c levels and the clinical course of coronavirus-19 (COVID-19) patients. Sixty-six COVID-19(+) patients with high Hb A1c and 46 with average Hb A1c and 30 COVID-19(-) patients with average Hb A1c were included. Hb A1c levels and parameters examined in COVID-19(+) patients were compared between groups, and correlation analysis was performed between these parameters and Hb A1c","2021","07","09","Hemoglobin","Hemoglobin","Coronavirus-19 (COVID-19); Hb A1c; diabetes mellitus (DM); mortality; Adult; Aged; Blood Sedimentation; C-Reactive Protein; COVID-19; Critical Care; Diabetes Complications; Diabetes Mellitus; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Glycated Hemoglobin A; Humans; Hyperglycemia; L-Lactate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Neutrophils; Oxygen; Partial Pressure; Procalcitonin; Prognosis; Risk; SARS-CoV-2; Severity of Illness Index; Thrombophilia","Keskin","Adem","Department of Medicine Biochemistry, Aydin Adnan Menderes University Institute of Health Sciences, Aydin, Turkey",NA
"2422","34162301","10.1080/03630269.2021.1926278","Association between Hb A<sub>1c</sub> and Severity of COVID-19 Patients.","This study aimed to examine the relationship between Hb A1c levels and the clinical course of coronavirus-19 (COVID-19) patients. Sixty-six COVID-19(+) patients with high Hb A1c and 46 with average Hb A1c and 30 COVID-19(-) patients with average Hb A1c were included. Hb A1c levels and parameters examined in COVID-19(+) patients were compared between groups, and correlation analysis was performed between these parameters and Hb A1c","2021","07","09","Hemoglobin","Hemoglobin","Coronavirus-19 (COVID-19); Hb A1c; diabetes mellitus (DM); mortality; Adult; Aged; Blood Sedimentation; C-Reactive Protein; COVID-19; Critical Care; Diabetes Complications; Diabetes Mellitus; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Glycated Hemoglobin A; Humans; Hyperglycemia; L-Lactate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Neutrophils; Oxygen; Partial Pressure; Procalcitonin; Prognosis; Risk; SARS-CoV-2; Severity of Illness Index; Thrombophilia","Aci","Recai","Department of Biochemistry, University of Health Sciences, Samsun, Turkey",NA
"2423","34162301","10.1080/03630269.2021.1926278","Association between Hb A<sub>1c</sub> and Severity of COVID-19 Patients.","This study aimed to examine the relationship between Hb A1c levels and the clinical course of coronavirus-19 (COVID-19) patients. Sixty-six COVID-19(+) patients with high Hb A1c and 46 with average Hb A1c and 30 COVID-19(-) patients with average Hb A1c were included. Hb A1c levels and parameters examined in COVID-19(+) patients were compared between groups, and correlation analysis was performed between these parameters and Hb A1c","2021","07","09","Hemoglobin","Hemoglobin","Coronavirus-19 (COVID-19); Hb A1c; diabetes mellitus (DM); mortality; Adult; Aged; Blood Sedimentation; C-Reactive Protein; COVID-19; Critical Care; Diabetes Complications; Diabetes Mellitus; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Glycated Hemoglobin A; Humans; Hyperglycemia; L-Lactate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Neutrophils; Oxygen; Partial Pressure; Procalcitonin; Prognosis; Risk; SARS-CoV-2; Severity of Illness Index; Thrombophilia","Arslanbek Erdem","Mukadder","Department of Biochemistry, University of Health Sciences, Samsun, Turkey",NA
"2424","34162301","10.1080/03630269.2021.1926278","Association between Hb A<sub>1c</sub> and Severity of COVID-19 Patients.","This study aimed to examine the relationship between Hb A1c levels and the clinical course of coronavirus-19 (COVID-19) patients. Sixty-six COVID-19(+) patients with high Hb A1c and 46 with average Hb A1c and 30 COVID-19(-) patients with average Hb A1c were included. Hb A1c levels and parameters examined in COVID-19(+) patients were compared between groups, and correlation analysis was performed between these parameters and Hb A1c","2021","07","09","Hemoglobin","Hemoglobin","Coronavirus-19 (COVID-19); Hb A1c; diabetes mellitus (DM); mortality; Adult; Aged; Blood Sedimentation; C-Reactive Protein; COVID-19; Critical Care; Diabetes Complications; Diabetes Mellitus; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Glycated Hemoglobin A; Humans; Hyperglycemia; L-Lactate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Neutrophils; Oxygen; Partial Pressure; Procalcitonin; Prognosis; Risk; SARS-CoV-2; Severity of Illness Index; Thrombophilia","Ari","Murat","Department of Medicine Biochemistry, Aydin Adnan Menderes University Institute of Health Sciences, Aydin, Turkey",NA
"2425","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Charan","Jaykaran","Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India",NA
"2426","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Dutta","Siddhartha","Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India",NA
"2427","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Kaur","Rimplejeet","Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India",NA
"2428","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Bhardwaj","Pankaj","Department of Community and Family Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India",NA
"2429","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Sharma","Praveen","Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India",NA
"2430","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Ambwani","Sneha","Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India",NA
"2431","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Jahan","Iffat","Department of Physiology, Eastern Medical College, Cumilla, Bangladesh",NA
"2432","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Abubakar","Abdullahi Rabiu","Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano, Nigeria",NA
"2433","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Islam","Salequl","Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"2434","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Hardcastle","Timothy Craig","Department of Surgery, Nelson R Mandela School of Clinical Medicine, University of KwaZulu-Natal, Umbel, Berea, South Africa",NA
"2435","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Rahman","Nor Azlina A","Department of Physical Rehabilitation Sciences, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, Kuantan, Malaysia",NA
"2436","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Lugova","Halyna","Unit of Community Medicine. Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, Kuala Lumpur, Malaysia",NA
"2437","34162299","10.1080/14740338.2021.1946513","Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.","Elevated inflammatory cytokines in Coronavirus disease 2019 (COVID-19) affect the lungs leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacovigilance database. All suspected ADEs associated with tocilizumab between April to August 2020 were analyzed bas","2021","07","22","Expert Opin Drug Saf","Expert opinion on drug safety","COVID-19; Tocilizumab; WHO; adverse drug event; interleukin-6; monoclonal antibody; pharmacovigilance","Haque","Mainul","Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, Kuala Lumpur, Malaysia",NA
"2438","34162297","10.1177/14034948211027086","COVID-19: systematic learning across boundaries requires a conceptual agreement.","The COVID-19 epidemic has revealed a shortage of basic knowledge and understanding of pandemics, especially regarding their dynamics and how to contain them. The results are a host of governments' decrees and instructions, one replacing the other, often within the same week. It has further, in a truly short time, resulted in an overwhelming number of publications, many of them prioritising early publication over quality. This commentary addresses the concept of structured research related to dis","2021","06","24","Scand J Public Health","Scandinavian journal of public health","COVID-19; Utstein-template; learning; research","Sundnes","Knut Ole","The Intervention Centre, Oslo University Hospital, Norway",NA
"2439","34162297","10.1177/14034948211027086","COVID-19: systematic learning across boundaries requires a conceptual agreement.","The COVID-19 epidemic has revealed a shortage of basic knowledge and understanding of pandemics, especially regarding their dynamics and how to contain them. The results are a host of governments' decrees and instructions, one replacing the other, often within the same week. It has further, in a truly short time, resulted in an overwhelming number of publications, many of them prioritising early publication over quality. This commentary addresses the concept of structured research related to dis","2021","06","24","Scand J Public Health","Scandinavian journal of public health","COVID-19; Utstein-template; learning; research","Braut","Geir Sverre","Research Department, Stavanger University Hospital, Norway",NA
"2440","34162289","10.1177/14034948211022429","The Danish Health and Wellbeing Survey: Study design, response proportion and respondent characteristics.","This study aimed to describe the study design and respondent characteristics (including non-response analyses) of the Danish Health and Wellbeing Surveys in 2015 and 2019 and a follow-up survey that was carried out during the COVID-19 pandemic in 2020. The Danish Health and Wellbeing Survey is the Danish part of the European Health Interview Survey (EHIS). The samples in 2015 (N=12,000) and 2019 (N=14,000) were both based on a simple random selection of individuals aged <U+2A7E>15 years from the Danish","2021","06","24","Scand J Public Health","Scandinavian journal of public health","COVID-19; Cross-sectional studies; data collection; follow-up-studies; health surveys; participation rate; public health surveillance; survey and questionnaires","Rosendahl Jensen","Heidi Amalie","National Institute of Public Health, University of Southern Denmark, Denmark",NA
"2441","34162289","10.1177/14034948211022429","The Danish Health and Wellbeing Survey: Study design, response proportion and respondent characteristics.","This study aimed to describe the study design and respondent characteristics (including non-response analyses) of the Danish Health and Wellbeing Surveys in 2015 and 2019 and a follow-up survey that was carried out during the COVID-19 pandemic in 2020. The Danish Health and Wellbeing Survey is the Danish part of the European Health Interview Survey (EHIS). The samples in 2015 (N=12,000) and 2019 (N=14,000) were both based on a simple random selection of individuals aged <U+2A7E>15 years from the Danish","2021","06","24","Scand J Public Health","Scandinavian journal of public health","COVID-19; Cross-sectional studies; data collection; follow-up-studies; health surveys; participation rate; public health surveillance; survey and questionnaires","Thygesen","Lau Caspar","National Institute of Public Health, University of Southern Denmark, Denmark",NA
"2442","34162289","10.1177/14034948211022429","The Danish Health and Wellbeing Survey: Study design, response proportion and respondent characteristics.","This study aimed to describe the study design and respondent characteristics (including non-response analyses) of the Danish Health and Wellbeing Surveys in 2015 and 2019 and a follow-up survey that was carried out during the COVID-19 pandemic in 2020. The Danish Health and Wellbeing Survey is the Danish part of the European Health Interview Survey (EHIS). The samples in 2015 (N=12,000) and 2019 (N=14,000) were both based on a simple random selection of individuals aged <U+2A7E>15 years from the Danish","2021","06","24","Scand J Public Health","Scandinavian journal of public health","COVID-19; Cross-sectional studies; data collection; follow-up-studies; health surveys; participation rate; public health surveillance; survey and questionnaires","Møller","Sanne Pagh","National Institute of Public Health, University of Southern Denmark, Denmark",NA
"2443","34162289","10.1177/14034948211022429","The Danish Health and Wellbeing Survey: Study design, response proportion and respondent characteristics.","This study aimed to describe the study design and respondent characteristics (including non-response analyses) of the Danish Health and Wellbeing Surveys in 2015 and 2019 and a follow-up survey that was carried out during the COVID-19 pandemic in 2020. The Danish Health and Wellbeing Survey is the Danish part of the European Health Interview Survey (EHIS). The samples in 2015 (N=12,000) and 2019 (N=14,000) were both based on a simple random selection of individuals aged <U+2A7E>15 years from the Danish","2021","06","24","Scand J Public Health","Scandinavian journal of public health","COVID-19; Cross-sectional studies; data collection; follow-up-studies; health surveys; participation rate; public health surveillance; survey and questionnaires","Dahl Nielsen","Maj Britt","National Institute of Public Health, University of Southern Denmark, Denmark",NA
"2444","34162289","10.1177/14034948211022429","The Danish Health and Wellbeing Survey: Study design, response proportion and respondent characteristics.","This study aimed to describe the study design and respondent characteristics (including non-response analyses) of the Danish Health and Wellbeing Surveys in 2015 and 2019 and a follow-up survey that was carried out during the COVID-19 pandemic in 2020. The Danish Health and Wellbeing Survey is the Danish part of the European Health Interview Survey (EHIS). The samples in 2015 (N=12,000) and 2019 (N=14,000) were both based on a simple random selection of individuals aged <U+2A7E>15 years from the Danish","2021","06","24","Scand J Public Health","Scandinavian journal of public health","COVID-19; Cross-sectional studies; data collection; follow-up-studies; health surveys; participation rate; public health surveillance; survey and questionnaires","Ersbøll","Annette Kjær","National Institute of Public Health, University of Southern Denmark, Denmark",NA
"2445","34162289","10.1177/14034948211022429","The Danish Health and Wellbeing Survey: Study design, response proportion and respondent characteristics.","This study aimed to describe the study design and respondent characteristics (including non-response analyses) of the Danish Health and Wellbeing Surveys in 2015 and 2019 and a follow-up survey that was carried out during the COVID-19 pandemic in 2020. The Danish Health and Wellbeing Survey is the Danish part of the European Health Interview Survey (EHIS). The samples in 2015 (N=12,000) and 2019 (N=14,000) were both based on a simple random selection of individuals aged <U+2A7E>15 years from the Danish","2021","06","24","Scand J Public Health","Scandinavian journal of public health","COVID-19; Cross-sectional studies; data collection; follow-up-studies; health surveys; participation rate; public health surveillance; survey and questionnaires","Ekholm","Ola","National Institute of Public Health, University of Southern Denmark, Denmark",NA
"2446","34162276","10.1177/11297298211027014","Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.","The COVID 19 pandemic adversely impacted delivery of preventive, routine, urgent, and essential care worldwide. Dialysis access care was particularly affected due to the lack of specific guidelines regarding procedures for its creation and maintenance. Early guidance by Centers for Medicare and Medicaid was inadvertently interpreted as guidance to stop dialysis access procedures. Prompt action by professional societies was needed to furnish detailed guidance to establish essential nature of thes","2021","06","24","J Vasc Access","The journal of vascular access","ASDIN; COVID 19; Dialysis access; maintaining lifelines; pandemic; procedure guidance; telemedicine","Agarwal","Anil K","University of California San Francisco, Fresno, California, USA",NA
"2447","34162276","10.1177/11297298211027014","Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.","The COVID 19 pandemic adversely impacted delivery of preventive, routine, urgent, and essential care worldwide. Dialysis access care was particularly affected due to the lack of specific guidelines regarding procedures for its creation and maintenance. Early guidance by Centers for Medicare and Medicaid was inadvertently interpreted as guidance to stop dialysis access procedures. Prompt action by professional societies was needed to furnish detailed guidance to establish essential nature of thes","2021","06","24","J Vasc Access","The journal of vascular access","ASDIN; COVID 19; Dialysis access; maintaining lifelines; pandemic; procedure guidance; telemedicine","Sequeira","Adrian","Louisiana State University, Shreveport, LA, USA",NA
"2448","34162276","10.1177/11297298211027014","Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.","The COVID 19 pandemic adversely impacted delivery of preventive, routine, urgent, and essential care worldwide. Dialysis access care was particularly affected due to the lack of specific guidelines regarding procedures for its creation and maintenance. Early guidance by Centers for Medicare and Medicaid was inadvertently interpreted as guidance to stop dialysis access procedures. Prompt action by professional societies was needed to furnish detailed guidance to establish essential nature of thes","2021","06","24","J Vasc Access","The journal of vascular access","ASDIN; COVID 19; Dialysis access; maintaining lifelines; pandemic; procedure guidance; telemedicine","Oza-Gajera","Bharvi P","University of Cincinnati, Cincinnati, OH, USA",NA
"2449","34162276","10.1177/11297298211027014","Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.","The COVID 19 pandemic adversely impacted delivery of preventive, routine, urgent, and essential care worldwide. Dialysis access care was particularly affected due to the lack of specific guidelines regarding procedures for its creation and maintenance. Early guidance by Centers for Medicare and Medicaid was inadvertently interpreted as guidance to stop dialysis access procedures. Prompt action by professional societies was needed to furnish detailed guidance to establish essential nature of thes","2021","06","24","J Vasc Access","The journal of vascular access","ASDIN; COVID 19; Dialysis access; maintaining lifelines; pandemic; procedure guidance; telemedicine","Ramani","Karthik","University of Michigan, Ann Arbor, MI, USA",NA
"2450","34162276","10.1177/11297298211027014","Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.","The COVID 19 pandemic adversely impacted delivery of preventive, routine, urgent, and essential care worldwide. Dialysis access care was particularly affected due to the lack of specific guidelines regarding procedures for its creation and maintenance. Early guidance by Centers for Medicare and Medicaid was inadvertently interpreted as guidance to stop dialysis access procedures. Prompt action by professional societies was needed to furnish detailed guidance to establish essential nature of thes","2021","06","24","J Vasc Access","The journal of vascular access","ASDIN; COVID 19; Dialysis access; maintaining lifelines; pandemic; procedure guidance; telemedicine","Packer","Jeffrey","University of Arizona College of Medicine, Phoenix, AZ, USA",NA
"2451","34162276","10.1177/11297298211027014","Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.","The COVID 19 pandemic adversely impacted delivery of preventive, routine, urgent, and essential care worldwide. Dialysis access care was particularly affected due to the lack of specific guidelines regarding procedures for its creation and maintenance. Early guidance by Centers for Medicare and Medicaid was inadvertently interpreted as guidance to stop dialysis access procedures. Prompt action by professional societies was needed to furnish detailed guidance to establish essential nature of thes","2021","06","24","J Vasc Access","The journal of vascular access","ASDIN; COVID 19; Dialysis access; maintaining lifelines; pandemic; procedure guidance; telemedicine","Litchfield","Terry","Access Solutions, Blanchardville, WI, USA",NA
"2452","34162276","10.1177/11297298211027014","Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.","The COVID 19 pandemic adversely impacted delivery of preventive, routine, urgent, and essential care worldwide. Dialysis access care was particularly affected due to the lack of specific guidelines regarding procedures for its creation and maintenance. Early guidance by Centers for Medicare and Medicaid was inadvertently interpreted as guidance to stop dialysis access procedures. Prompt action by professional societies was needed to furnish detailed guidance to establish essential nature of thes","2021","06","24","J Vasc Access","The journal of vascular access","ASDIN; COVID 19; Dialysis access; maintaining lifelines; pandemic; procedure guidance; telemedicine","Nations","Mary Lea","American Society of Diagnostic and Interventional Nephrology, Clinton, MS, USA",NA
"2453","34162276","10.1177/11297298211027014","Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.","The COVID 19 pandemic adversely impacted delivery of preventive, routine, urgent, and essential care worldwide. Dialysis access care was particularly affected due to the lack of specific guidelines regarding procedures for its creation and maintenance. Early guidance by Centers for Medicare and Medicaid was inadvertently interpreted as guidance to stop dialysis access procedures. Prompt action by professional societies was needed to furnish detailed guidance to establish essential nature of thes","2021","06","24","J Vasc Access","The journal of vascular access","ASDIN; COVID 19; Dialysis access; maintaining lifelines; pandemic; procedure guidance; telemedicine","Lerma","Edgar V","University of Illinois at Chicago/Advocate Christ Medical Center, Oak Lawn, IL, USA",NA
"2454","34162269","10.1177/20587384211027679","Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review.","Coronavirus disease 2019 (COVID-19) was declared a global pandemic in March 2020. Since then, several studies have found COVID-19 patients with recurrent viral polymerase chain reaction (PCR) positivity. On May 6, 2021, an exhaustive literature search of the Web of Science, PubMed, Cochrane Library, Chinese National Knowledge Infrastructure databases, Embase, Wan Fang Data, VIP database, Sinomed database, BioRxiv, MedRxiv, and Research Square was conducted to find describing the laboratory indic","2021","06","29","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; clinical features; immune function status; meta-analysis; recurrent viral positivity; COVID-19; COVID-19 Testing; Humans; Immunity, Cellular; Polymerase Chain Reaction; Recurrence","Ren","Xingxiang","Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China",NA
"2455","34162269","10.1177/20587384211027679","Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review.","Coronavirus disease 2019 (COVID-19) was declared a global pandemic in March 2020. Since then, several studies have found COVID-19 patients with recurrent viral polymerase chain reaction (PCR) positivity. On May 6, 2021, an exhaustive literature search of the Web of Science, PubMed, Cochrane Library, Chinese National Knowledge Infrastructure databases, Embase, Wan Fang Data, VIP database, Sinomed database, BioRxiv, MedRxiv, and Research Square was conducted to find describing the laboratory indic","2021","06","29","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; clinical features; immune function status; meta-analysis; recurrent viral positivity; COVID-19; COVID-19 Testing; Humans; Immunity, Cellular; Polymerase Chain Reaction; Recurrence","Wang","Xiankun","Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China",NA
"2456","34162269","10.1177/20587384211027679","Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review.","Coronavirus disease 2019 (COVID-19) was declared a global pandemic in March 2020. Since then, several studies have found COVID-19 patients with recurrent viral polymerase chain reaction (PCR) positivity. On May 6, 2021, an exhaustive literature search of the Web of Science, PubMed, Cochrane Library, Chinese National Knowledge Infrastructure databases, Embase, Wan Fang Data, VIP database, Sinomed database, BioRxiv, MedRxiv, and Research Square was conducted to find describing the laboratory indic","2021","06","29","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; clinical features; immune function status; meta-analysis; recurrent viral positivity; COVID-19; COVID-19 Testing; Humans; Immunity, Cellular; Polymerase Chain Reaction; Recurrence","Ge","Ziruo","Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China",NA
"2457","34162269","10.1177/20587384211027679","Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review.","Coronavirus disease 2019 (COVID-19) was declared a global pandemic in March 2020. Since then, several studies have found COVID-19 patients with recurrent viral polymerase chain reaction (PCR) positivity. On May 6, 2021, an exhaustive literature search of the Web of Science, PubMed, Cochrane Library, Chinese National Knowledge Infrastructure databases, Embase, Wan Fang Data, VIP database, Sinomed database, BioRxiv, MedRxiv, and Research Square was conducted to find describing the laboratory indic","2021","06","29","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; clinical features; immune function status; meta-analysis; recurrent viral positivity; COVID-19; COVID-19 Testing; Humans; Immunity, Cellular; Polymerase Chain Reaction; Recurrence","Cui","Shuping","Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China",NA
"2458","34162269","10.1177/20587384211027679","Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review.","Coronavirus disease 2019 (COVID-19) was declared a global pandemic in March 2020. Since then, several studies have found COVID-19 patients with recurrent viral polymerase chain reaction (PCR) positivity. On May 6, 2021, an exhaustive literature search of the Web of Science, PubMed, Cochrane Library, Chinese National Knowledge Infrastructure databases, Embase, Wan Fang Data, VIP database, Sinomed database, BioRxiv, MedRxiv, and Research Square was conducted to find describing the laboratory indic","2021","06","29","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; clinical features; immune function status; meta-analysis; recurrent viral positivity; COVID-19; COVID-19 Testing; Humans; Immunity, Cellular; Polymerase Chain Reaction; Recurrence","Chen","Zhihai","Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China",NA
"2459","34162233","10.1177/00302228211027461","College Student Experiences of Grief and Loss Amid the COVID-19 Global Pandemic.","This study examined types of and reactions to loss experienced by a sample of 162 undergraduate and graduate students in the United States amid the COVID-19 global pandemic. Results indicated students reported an average of 6.33 losses with loss of normalcy being the most prominent. The number of losses experienced was a significant predictor of loss of control and avoidance. A significant positive relationship was revealed between spirituality and positive reappraisal whereas a significant nega","2021","07","01","Omega (Westport)","Omega","COVID-19; college students; grief; loss; pandemic","Sirrine","Erica H","Department of Social Work, St. Jude Children's Research Hospital, Memphis, Tennessee, United States",NA
"2460","34162233","10.1177/00302228211027461","College Student Experiences of Grief and Loss Amid the COVID-19 Global Pandemic.","This study examined types of and reactions to loss experienced by a sample of 162 undergraduate and graduate students in the United States amid the COVID-19 global pandemic. Results indicated students reported an average of 6.33 losses with loss of normalcy being the most prominent. The number of losses experienced was a significant predictor of loss of control and avoidance. A significant positive relationship was revealed between spirituality and positive reappraisal whereas a significant nega","2021","07","01","Omega (Westport)","Omega","COVID-19; college students; grief; loss; pandemic","Kliner","Olivia","Southeastern University, Lakeland, Florida, United States",NA
"2461","34162233","10.1177/00302228211027461","College Student Experiences of Grief and Loss Amid the COVID-19 Global Pandemic.","This study examined types of and reactions to loss experienced by a sample of 162 undergraduate and graduate students in the United States amid the COVID-19 global pandemic. Results indicated students reported an average of 6.33 losses with loss of normalcy being the most prominent. The number of losses experienced was a significant predictor of loss of control and avoidance. A significant positive relationship was revealed between spirituality and positive reappraisal whereas a significant nega","2021","07","01","Omega (Westport)","Omega","COVID-19; college students; grief; loss; pandemic","Gollery","Thomas J","Southeastern University, Lakeland, Florida, United States",NA
"2462","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Lyu","Jinglu","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2463","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Bao","Lirong","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2464","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Shen","Xin","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2465","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Yan","Caixia","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2466","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Zhang","Cheng","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2467","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Wei","Wei","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2468","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Yang","Yutao","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2469","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Li","Jia","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2470","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Dong","Jiajia","Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China",NA
"2471","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Xiao","Liying","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China",NA
"2472","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Zhou","Xuedong","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address: zhouxd@scu.edu","zhouxd@scu.edu.cn"
"2473","34162159","10.1016/j.intimp.2021.107797","The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-<U+03B3> production in vitro.","Specific antibodies against SARS-CoV-2 structural protein have a wide range of effects in the diagnose, prevention and treatment of the COVID-19 epidemic. Among them, egg yolk immunoglobulin Y (IgY), which has high safety, high yield, and without inducing antibody-dependent enhancement, is an important biological candidate. In this study, specific IgY against the conservative nucleocapsid protein (NP) of SARS-CoV-2 was obtained by immunizing hens. Through a series of optimized precipitation and ","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Conservative; Egg yolk immunoglobulin Y (IgY); Immunomodulatory; Nucleocapsid protein (NP); Animals; Antibodies; Antiviral Agents; COVID-19; Chickens; Drug Development; Egg Yolk; Humans; Immunity; Immunoglobulins; Immunologic Factors; Immunomodulation; In Vitro Techniques; Interferon-gamma; Nucleocapsid Proteins; SARS-CoV-2","Li","Yan","State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address: feifeiliyan@163","feifeiliyan@163.com"
"2474","34162156","10.1016/j.intimp.2021.107794","Characteristics of patients with kidney injury associated with COVID-19.","To explore the characteristics of COVID-19 infection related kidney injury, we retrospectively collected cases of COVID-19 patients with definite clinical outcomes (discharge or death) and relevant laboratory results from Jan 3 to Mar 30, 2020 in Tongji hospital, Wuhan, China. 1509 patients were included, 1393 cases with normal baseline serum creatinine, and 116 cases with elevated baseline serum creatinine (EBSC). On admission, the prevalence of elevated serum creatinine, elevated blood urea ni","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Inflammatory factors; Kidney injury; Lymphocyte; Prognosis; SARS-CoV-2; Acute Kidney Injury; Aged; COVID-19; Cardiovascular Diseases; China; Comorbidity; Creatinine; Female; Hospital Mortality; Humans; Inflammation; Leukocytes; Lymphocytes; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Ke","Chunjin","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China",NA
"2475","34162156","10.1016/j.intimp.2021.107794","Characteristics of patients with kidney injury associated with COVID-19.","To explore the characteristics of COVID-19 infection related kidney injury, we retrospectively collected cases of COVID-19 patients with definite clinical outcomes (discharge or death) and relevant laboratory results from Jan 3 to Mar 30, 2020 in Tongji hospital, Wuhan, China. 1509 patients were included, 1393 cases with normal baseline serum creatinine, and 116 cases with elevated baseline serum creatinine (EBSC). On admission, the prevalence of elevated serum creatinine, elevated blood urea ni","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Inflammatory factors; Kidney injury; Lymphocyte; Prognosis; SARS-CoV-2; Acute Kidney Injury; Aged; COVID-19; Cardiovascular Diseases; China; Comorbidity; Creatinine; Female; Hospital Mortality; Humans; Inflammation; Leukocytes; Lymphocytes; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Xiao","Jun","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China",NA
"2476","34162156","10.1016/j.intimp.2021.107794","Characteristics of patients with kidney injury associated with COVID-19.","To explore the characteristics of COVID-19 infection related kidney injury, we retrospectively collected cases of COVID-19 patients with definite clinical outcomes (discharge or death) and relevant laboratory results from Jan 3 to Mar 30, 2020 in Tongji hospital, Wuhan, China. 1509 patients were included, 1393 cases with normal baseline serum creatinine, and 116 cases with elevated baseline serum creatinine (EBSC). On admission, the prevalence of elevated serum creatinine, elevated blood urea ni","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Inflammatory factors; Kidney injury; Lymphocyte; Prognosis; SARS-CoV-2; Acute Kidney Injury; Aged; COVID-19; Cardiovascular Diseases; China; Comorbidity; Creatinine; Female; Hospital Mortality; Humans; Inflammation; Leukocytes; Lymphocytes; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Wang","Zhihua","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China",NA
"2477","34162156","10.1016/j.intimp.2021.107794","Characteristics of patients with kidney injury associated with COVID-19.","To explore the characteristics of COVID-19 infection related kidney injury, we retrospectively collected cases of COVID-19 patients with definite clinical outcomes (discharge or death) and relevant laboratory results from Jan 3 to Mar 30, 2020 in Tongji hospital, Wuhan, China. 1509 patients were included, 1393 cases with normal baseline serum creatinine, and 116 cases with elevated baseline serum creatinine (EBSC). On admission, the prevalence of elevated serum creatinine, elevated blood urea ni","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Inflammatory factors; Kidney injury; Lymphocyte; Prognosis; SARS-CoV-2; Acute Kidney Injury; Aged; COVID-19; Cardiovascular Diseases; China; Comorbidity; Creatinine; Female; Hospital Mortality; Humans; Inflammation; Leukocytes; Lymphocytes; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Yu","Chong","Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China",NA
"2478","34162156","10.1016/j.intimp.2021.107794","Characteristics of patients with kidney injury associated with COVID-19.","To explore the characteristics of COVID-19 infection related kidney injury, we retrospectively collected cases of COVID-19 patients with definite clinical outcomes (discharge or death) and relevant laboratory results from Jan 3 to Mar 30, 2020 in Tongji hospital, Wuhan, China. 1509 patients were included, 1393 cases with normal baseline serum creatinine, and 116 cases with elevated baseline serum creatinine (EBSC). On admission, the prevalence of elevated serum creatinine, elevated blood urea ni","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Inflammatory factors; Kidney injury; Lymphocyte; Prognosis; SARS-CoV-2; Acute Kidney Injury; Aged; COVID-19; Cardiovascular Diseases; China; Comorbidity; Creatinine; Female; Hospital Mortality; Humans; Inflammation; Leukocytes; Lymphocytes; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Yang","Chunguang","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China. Electronic address: cgyang-hust@hotmail","hust@hotmail.com"
"2479","34162156","10.1016/j.intimp.2021.107794","Characteristics of patients with kidney injury associated with COVID-19.","To explore the characteristics of COVID-19 infection related kidney injury, we retrospectively collected cases of COVID-19 patients with definite clinical outcomes (discharge or death) and relevant laboratory results from Jan 3 to Mar 30, 2020 in Tongji hospital, Wuhan, China. 1509 patients were included, 1393 cases with normal baseline serum creatinine, and 116 cases with elevated baseline serum creatinine (EBSC). On admission, the prevalence of elevated serum creatinine, elevated blood urea ni","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Inflammatory factors; Kidney injury; Lymphocyte; Prognosis; SARS-CoV-2; Acute Kidney Injury; Aged; COVID-19; Cardiovascular Diseases; China; Comorbidity; Creatinine; Female; Hospital Mortality; Humans; Inflammation; Leukocytes; Lymphocytes; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Hu","Zhiquan","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China. Electronic address: huzhiquan2000@163","huzhiquan2000@163.com"
"2480","34162141","10.1016/j.intimp.2021.107763","An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; SARS-CoV-2; Vaccines; Adolescent; Adult; Aged; Aged, 80 and over; Animals; BCG Vaccine; COVID-19; COVID-19 Vaccines; Drug Evaluation, Preclinical; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; SARS-CoV-2; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Subunit; Vaccines, Virus-Like Particle; Viral Vaccines","Motamedi","Hamid","Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran",NA
"2481","34162141","10.1016/j.intimp.2021.107763","An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; SARS-CoV-2; Vaccines; Adolescent; Adult; Aged; Aged, 80 and over; Animals; BCG Vaccine; COVID-19; COVID-19 Vaccines; Drug Evaluation, Preclinical; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; SARS-CoV-2; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Subunit; Vaccines, Virus-Like Particle; Viral Vaccines","Ari","Marzie Mahdizade","Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran",NA
"2482","34162141","10.1016/j.intimp.2021.107763","An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; SARS-CoV-2; Vaccines; Adolescent; Adult; Aged; Aged, 80 and over; Animals; BCG Vaccine; COVID-19; COVID-19 Vaccines; Drug Evaluation, Preclinical; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; SARS-CoV-2; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Subunit; Vaccines, Virus-Like Particle; Viral Vaccines","Dashtbin","Shirin","Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran",NA
"2483","34162141","10.1016/j.intimp.2021.107763","An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; SARS-CoV-2; Vaccines; Adolescent; Adult; Aged; Aged, 80 and over; Animals; BCG Vaccine; COVID-19; COVID-19 Vaccines; Drug Evaluation, Preclinical; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; SARS-CoV-2; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Subunit; Vaccines, Virus-Like Particle; Viral Vaccines","Fathollahi","Matin","Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran",NA
"2484","34162141","10.1016/j.intimp.2021.107763","An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; SARS-CoV-2; Vaccines; Adolescent; Adult; Aged; Aged, 80 and over; Animals; BCG Vaccine; COVID-19; COVID-19 Vaccines; Drug Evaluation, Preclinical; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; SARS-CoV-2; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Subunit; Vaccines, Virus-Like Particle; Viral Vaccines","Hossainpour","Hadi","Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran",NA
"2485","34162141","10.1016/j.intimp.2021.107763","An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; SARS-CoV-2; Vaccines; Adolescent; Adult; Aged; Aged, 80 and over; Animals; BCG Vaccine; COVID-19; COVID-19 Vaccines; Drug Evaluation, Preclinical; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; SARS-CoV-2; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Subunit; Vaccines, Virus-Like Particle; Viral Vaccines","Alvandi","Amirhoushang","Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran",NA
"2486","34162141","10.1016/j.intimp.2021.107763","An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; SARS-CoV-2; Vaccines; Adolescent; Adult; Aged; Aged, 80 and over; Animals; BCG Vaccine; COVID-19; COVID-19 Vaccines; Drug Evaluation, Preclinical; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; SARS-CoV-2; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Subunit; Vaccines, Virus-Like Particle; Viral Vaccines","Moradi","Jale","Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran",NA
"2487","34162141","10.1016/j.intimp.2021.107763","An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; SARS-CoV-2; Vaccines; Adolescent; Adult; Aged; Aged, 80 and over; Animals; BCG Vaccine; COVID-19; COVID-19 Vaccines; Drug Evaluation, Preclinical; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; SARS-CoV-2; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Subunit; Vaccines, Virus-Like Particle; Viral Vaccines","Abiri","Ramin","Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran","rabiri@kums.ac.ir"
"2488","34162139","10.1016/j.intimp.2021.107761","Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects.","Since the discovery of lymphocytes with immunosuppressive activity, increasing interest has arisen in their possible influence on the immune response induced by vaccines. Regulatory T cells (Tregs) are essential for maintaining peripheral tolerance, preventing autoimmune diseases, and limiting chronic inflammatory diseases. However, they also limit beneficial immune responses by suppressing anti-infectious and anti-tumor immunity. Mounting evidence suggests that Tregs are involved, at least in p","2021","07","07","Int Immunopharmacol","International immunopharmacology","Adjuvants; Immune response; Immunosenescense; Older adults; Regulatory T cells; SARS-CoV-2; Vaccine; Age Factors; Aged; Aged, 80 and over; Animals; Autoimmune Diseases; Chronic Disease; Humans; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Inflammation; Membrane Proteins; Middle Aged; T-Lymphocytes, Regulatory; Vaccination; Vaccines","Batista-Duharte","Alexander","Department of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rod. Araraquara-Jaú - Km 1, 14800-903 Araraquara, SP, Brazil. Electronic address: batista.duharte@unesp","batista.duharte@unesp.br"
"2489","34162139","10.1016/j.intimp.2021.107761","Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects.","Since the discovery of lymphocytes with immunosuppressive activity, increasing interest has arisen in their possible influence on the immune response induced by vaccines. Regulatory T cells (Tregs) are essential for maintaining peripheral tolerance, preventing autoimmune diseases, and limiting chronic inflammatory diseases. However, they also limit beneficial immune responses by suppressing anti-infectious and anti-tumor immunity. Mounting evidence suggests that Tregs are involved, at least in p","2021","07","07","Int Immunopharmacol","International immunopharmacology","Adjuvants; Immune response; Immunosenescense; Older adults; Regulatory T cells; SARS-CoV-2; Vaccine; Age Factors; Aged; Aged, 80 and over; Animals; Autoimmune Diseases; Chronic Disease; Humans; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Inflammation; Membrane Proteins; Middle Aged; T-Lymphocytes, Regulatory; Vaccination; Vaccines","Pera","Alejandra","Immunology and Allergy Group, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain","alejandra.pera@imibic.org"
"2490","34162139","10.1016/j.intimp.2021.107761","Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects.","Since the discovery of lymphocytes with immunosuppressive activity, increasing interest has arisen in their possible influence on the immune response induced by vaccines. Regulatory T cells (Tregs) are essential for maintaining peripheral tolerance, preventing autoimmune diseases, and limiting chronic inflammatory diseases. However, they also limit beneficial immune responses by suppressing anti-infectious and anti-tumor immunity. Mounting evidence suggests that Tregs are involved, at least in p","2021","07","07","Int Immunopharmacol","International immunopharmacology","Adjuvants; Immune response; Immunosenescense; Older adults; Regulatory T cells; SARS-CoV-2; Vaccine; Age Factors; Aged; Aged, 80 and over; Animals; Autoimmune Diseases; Chronic Disease; Humans; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Inflammation; Membrane Proteins; Middle Aged; T-Lymphocytes, Regulatory; Vaccination; Vaccines","Aliño","Salvador F","Department of Pharmacology, Medicine Faculty, University of Valencia, Valencia, Spain",NA
"2491","34162139","10.1016/j.intimp.2021.107761","Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects.","Since the discovery of lymphocytes with immunosuppressive activity, increasing interest has arisen in their possible influence on the immune response induced by vaccines. Regulatory T cells (Tregs) are essential for maintaining peripheral tolerance, preventing autoimmune diseases, and limiting chronic inflammatory diseases. However, they also limit beneficial immune responses by suppressing anti-infectious and anti-tumor immunity. Mounting evidence suggests that Tregs are involved, at least in p","2021","07","07","Int Immunopharmacol","International immunopharmacology","Adjuvants; Immune response; Immunosenescense; Older adults; Regulatory T cells; SARS-CoV-2; Vaccine; Age Factors; Aged; Aged, 80 and over; Animals; Autoimmune Diseases; Chronic Disease; Humans; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Inflammation; Membrane Proteins; Middle Aged; T-Lymphocytes, Regulatory; Vaccination; Vaccines","Solana","Rafael","Immunology and Allergy Group, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain",NA
"2492","34162133","10.1016/j.intimp.2021.107732","Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis.","The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. We searched articles from Web of Science, PubMed, Embase, the Cochrane Library, MedRxiv between 1 January 2020 and February 17, 2021. We selected randomized clinical trials and observational studies with a control group to assess the efficiency of IVIG in treating patients with COVID-19. Subjects were di","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Efficacy; IVIG; Meta-analysis; COVID-19; Databases, Factual; Humans; Immunoglobulins, Intravenous; Mortality; Outcome Assessment, Health Care; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Xiang","Huai-Rong","Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China",NA
"2493","34162133","10.1016/j.intimp.2021.107732","Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis.","The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. We searched articles from Web of Science, PubMed, Embase, the Cochrane Library, MedRxiv between 1 January 2020 and February 17, 2021. We selected randomized clinical trials and observational studies with a control group to assess the efficiency of IVIG in treating patients with COVID-19. Subjects were di","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Efficacy; IVIG; Meta-analysis; COVID-19; Databases, Factual; Humans; Immunoglobulins, Intravenous; Mortality; Outcome Assessment, Health Care; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Cheng","Xuan","Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China",NA
"2494","34162133","10.1016/j.intimp.2021.107732","Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis.","The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. We searched articles from Web of Science, PubMed, Embase, the Cochrane Library, MedRxiv between 1 January 2020 and February 17, 2021. We selected randomized clinical trials and observational studies with a control group to assess the efficiency of IVIG in treating patients with COVID-19. Subjects were di","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Efficacy; IVIG; Meta-analysis; COVID-19; Databases, Factual; Humans; Immunoglobulins, Intravenous; Mortality; Outcome Assessment, Health Care; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Li","Yun","Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China",NA
"2495","34162133","10.1016/j.intimp.2021.107732","Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis.","The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. We searched articles from Web of Science, PubMed, Embase, the Cochrane Library, MedRxiv between 1 January 2020 and February 17, 2021. We selected randomized clinical trials and observational studies with a control group to assess the efficiency of IVIG in treating patients with COVID-19. Subjects were di","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Efficacy; IVIG; Meta-analysis; COVID-19; Databases, Factual; Humans; Immunoglobulins, Intravenous; Mortality; Outcome Assessment, Health Care; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Luo","Wen-Wen","Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China",NA
"2496","34162133","10.1016/j.intimp.2021.107732","Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis.","The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. We searched articles from Web of Science, PubMed, Embase, the Cochrane Library, MedRxiv between 1 January 2020 and February 17, 2021. We selected randomized clinical trials and observational studies with a control group to assess the efficiency of IVIG in treating patients with COVID-19. Subjects were di","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Efficacy; IVIG; Meta-analysis; COVID-19; Databases, Factual; Humans; Immunoglobulins, Intravenous; Mortality; Outcome Assessment, Health Care; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Zhang","Qi-Zhi","Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China",NA
"2497","34162133","10.1016/j.intimp.2021.107732","Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis.","The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. We searched articles from Web of Science, PubMed, Embase, the Cochrane Library, MedRxiv between 1 January 2020 and February 17, 2021. We selected randomized clinical trials and observational studies with a control group to assess the efficiency of IVIG in treating patients with COVID-19. Subjects were di","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Efficacy; IVIG; Meta-analysis; COVID-19; Databases, Factual; Humans; Immunoglobulins, Intravenous; Mortality; Outcome Assessment, Health Care; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome","Peng","Wen-Xing","Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China","pwx.csu@csu.edu.cn"
"2498","34162130","10.1016/j.intimp.2021.107723","Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.","This systematic review, with meta-analysis and meta-regression aims to evaluate the effect of colchicine administration on mortality in patients with coronavirus disease 2019 (COVID-19) and factors affecting the association. A systematic literature search using the PubMed, Scopus, and Embase databases were performed from inception of databases up until 3 March 2021. We included studies that fulfill all of the following criteria: 1) observational studies or randomized controlled trials (RCTs) tha","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Colchicine; Coronavirus; Outcome; Treatment; Age Factors; COVID-19; Colchicine; Diabetes Complications; Diabetes Mellitus; Female; Gender Identity; Humans; Hypertension; Male; Mortality; Odds Ratio; Regression Analysis; SARS-CoV-2","Nawangsih","Eka Noneng","Department of Microbiology, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, Indonesia. Electronic address: eka.noneng@lecture.unjani.ac","eka.noneng@lecture.unjani.ac.id"
"2499","34162130","10.1016/j.intimp.2021.107723","Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.","This systematic review, with meta-analysis and meta-regression aims to evaluate the effect of colchicine administration on mortality in patients with coronavirus disease 2019 (COVID-19) and factors affecting the association. A systematic literature search using the PubMed, Scopus, and Embase databases were performed from inception of databases up until 3 March 2021. We included studies that fulfill all of the following criteria: 1) observational studies or randomized controlled trials (RCTs) tha","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Colchicine; Coronavirus; Outcome; Treatment; Age Factors; COVID-19; Colchicine; Diabetes Complications; Diabetes Mellitus; Female; Gender Identity; Humans; Hypertension; Male; Mortality; Odds Ratio; Regression Analysis; SARS-CoV-2","Kusmala","Yudith Yunia","Department of Internal Medicine, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, Indonesia. Electronic address: yudith.yunia@lecture.unjani.ac","yudith.yunia@lecture.unjani.ac.id"
"2500","34162130","10.1016/j.intimp.2021.107723","Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.","This systematic review, with meta-analysis and meta-regression aims to evaluate the effect of colchicine administration on mortality in patients with coronavirus disease 2019 (COVID-19) and factors affecting the association. A systematic literature search using the PubMed, Scopus, and Embase databases were performed from inception of databases up until 3 March 2021. We included studies that fulfill all of the following criteria: 1) observational studies or randomized controlled trials (RCTs) tha","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Colchicine; Coronavirus; Outcome; Treatment; Age Factors; COVID-19; Colchicine; Diabetes Complications; Diabetes Mellitus; Female; Gender Identity; Humans; Hypertension; Male; Mortality; Odds Ratio; Regression Analysis; SARS-CoV-2","Rakhmat","Iis Inayati","Department of Biochemistry, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, Indonesia. Electronic address: iis.inayati@lecture.unjani.ac","iis.inayati@lecture.unjani.ac.id"
"2501","34162130","10.1016/j.intimp.2021.107723","Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.","This systematic review, with meta-analysis and meta-regression aims to evaluate the effect of colchicine administration on mortality in patients with coronavirus disease 2019 (COVID-19) and factors affecting the association. A systematic literature search using the PubMed, Scopus, and Embase databases were performed from inception of databases up until 3 March 2021. We included studies that fulfill all of the following criteria: 1) observational studies or randomized controlled trials (RCTs) tha","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Colchicine; Coronavirus; Outcome; Treatment; Age Factors; COVID-19; Colchicine; Diabetes Complications; Diabetes Mellitus; Female; Gender Identity; Humans; Hypertension; Male; Mortality; Odds Ratio; Regression Analysis; SARS-CoV-2","Handayani","Dewi Ratih","Department of Biochemistry, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, Indonesia. Electronic address: dewi.ratih@lecture.unjani.ac","dewi.ratih@lecture.unjani.ac.id"
"2502","34162130","10.1016/j.intimp.2021.107723","Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.","This systematic review, with meta-analysis and meta-regression aims to evaluate the effect of colchicine administration on mortality in patients with coronavirus disease 2019 (COVID-19) and factors affecting the association. A systematic literature search using the PubMed, Scopus, and Embase databases were performed from inception of databases up until 3 March 2021. We included studies that fulfill all of the following criteria: 1) observational studies or randomized controlled trials (RCTs) tha","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Colchicine; Coronavirus; Outcome; Treatment; Age Factors; COVID-19; Colchicine; Diabetes Complications; Diabetes Mellitus; Female; Gender Identity; Humans; Hypertension; Male; Mortality; Odds Ratio; Regression Analysis; SARS-CoV-2","Juliastuti","Henny","Department of Biochemistry, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, Indonesia",NA
"2503","34162130","10.1016/j.intimp.2021.107723","Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.","This systematic review, with meta-analysis and meta-regression aims to evaluate the effect of colchicine administration on mortality in patients with coronavirus disease 2019 (COVID-19) and factors affecting the association. A systematic literature search using the PubMed, Scopus, and Embase databases were performed from inception of databases up until 3 March 2021. We included studies that fulfill all of the following criteria: 1) observational studies or randomized controlled trials (RCTs) tha","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Colchicine; Coronavirus; Outcome; Treatment; Age Factors; COVID-19; Colchicine; Diabetes Complications; Diabetes Mellitus; Female; Gender Identity; Humans; Hypertension; Male; Mortality; Odds Ratio; Regression Analysis; SARS-CoV-2","Wibowo","Arief","Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"2504","34162130","10.1016/j.intimp.2021.107723","Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.","This systematic review, with meta-analysis and meta-regression aims to evaluate the effect of colchicine administration on mortality in patients with coronavirus disease 2019 (COVID-19) and factors affecting the association. A systematic literature search using the PubMed, Scopus, and Embase databases were performed from inception of databases up until 3 March 2021. We included studies that fulfill all of the following criteria: 1) observational studies or randomized controlled trials (RCTs) tha","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Colchicine; Coronavirus; Outcome; Treatment; Age Factors; COVID-19; Colchicine; Diabetes Complications; Diabetes Mellitus; Female; Gender Identity; Humans; Hypertension; Male; Mortality; Odds Ratio; Regression Analysis; SARS-CoV-2","Lim","Michael Anthonius","Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia",NA
"2505","34162130","10.1016/j.intimp.2021.107723","Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.","This systematic review, with meta-analysis and meta-regression aims to evaluate the effect of colchicine administration on mortality in patients with coronavirus disease 2019 (COVID-19) and factors affecting the association. A systematic literature search using the PubMed, Scopus, and Embase databases were performed from inception of databases up until 3 March 2021. We included studies that fulfill all of the following criteria: 1) observational studies or randomized controlled trials (RCTs) tha","2021","07","07","Int Immunopharmacol","International immunopharmacology","COVID-19; Colchicine; Coronavirus; Outcome; Treatment; Age Factors; COVID-19; Colchicine; Diabetes Complications; Diabetes Mellitus; Female; Gender Identity; Humans; Hypertension; Male; Mortality; Odds Ratio; Regression Analysis; SARS-CoV-2","Pranata","Raymond","Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"2506","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Alfano","Gaetano","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2507","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Ferrari","Annachiara","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2508","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Fontana","Francesco","Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy",NA
"2509","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Mori","Giacomo","Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy",NA
"2510","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Ligabue","Giulia","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2511","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Giovanella","Silvia","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2512","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Magistroni","Riccardo","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2513","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Meschiari","Marianna","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2514","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Franceschini","Erica","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2515","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Menozzi","Marianna","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2516","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Cuomo","Gianluca","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2517","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Orlando","Gabriella","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2518","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Santoro","Antonella","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2519","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Di Gaetano","Margherita","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2520","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Puzzolante","Cinzia","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2521","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Carli","Federica","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2522","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Bedini","Andrea","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2523","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Milic","Jovana","Clinical and Experimental Medicine Ph.D. Program, University of Modena and Reggio Emilia, Modena, Italy",NA
"2524","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Mussini","Cristina","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2525","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Cappelli","Gianni","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2526","34162049","10.23876/j.krcp.20.177","Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.","The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour","2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice","Acute kidney injury; Biomarkers; Coronavirus; Creatinine; Kidney; Mortality","Guaraldi","Giovanni","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2527","34162046","10.23876/j.krcp.21.108","Does a slight change in serum creatinine matter in coronavirus disease 2019 (COVID-19) patients?",NA,"2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice",NA,"Komaru","Yohei","Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan",NA
"2528","34162046","10.23876/j.krcp.21.108","Does a slight change in serum creatinine matter in coronavirus disease 2019 (COVID-19) patients?",NA,"2021","07","08","Kidney Res Clin Pract","Kidney research and clinical practice",NA,"Doi","Kent","Department of Acute Medicine, The University of Tokyo Hospital, Tokyo, Japan",NA
"2529","34158927","10.12688/f1000research.26368.2","A multidimensional quality model: an opportunity for patients, their kin, healthcare providers and professionals to coproduce health.","Background: It is twenty years since the US Institute of Medicine (IOM) defined quality in healthcare, as comprising six domains: person-centredness, timeliness, efficiency, effectiveness, safety and equity. Since then, a new quality movement has emerged, with the development of numerous interventions aimed at improving quality, with a focus on accessibility, safety and effectiveness of care. Further gains in equity and timeliness have proven even more challenging. The challenge: W","2021","06","30","F1000Res","F1000Research","covid19; kin centered; person centered care; quality; safety; COVID-19; Health Personnel; Humans; SARS-CoV-2","Lachman","Peter","International Society for Quality in Health Care (ISQua), Dublin, D02 NY63, Ireland",NA
"2530","34158927","10.12688/f1000research.26368.2","A multidimensional quality model: an opportunity for patients, their kin, healthcare providers and professionals to coproduce health.","Background: It is twenty years since the US Institute of Medicine (IOM) defined quality in healthcare, as comprising six domains: person-centredness, timeliness, efficiency, effectiveness, safety and equity. Since then, a new quality movement has emerged, with the development of numerous interventions aimed at improving quality, with a focus on accessibility, safety and effectiveness of care. Further gains in equity and timeliness have proven even more challenging. The challenge: W","2021","06","30","F1000Res","F1000Research","covid19; kin centered; person centered care; quality; safety; COVID-19; Health Personnel; Humans; SARS-CoV-2","Batalden","Paul","Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH, USA",NA
"2531","34158927","10.12688/f1000research.26368.2","A multidimensional quality model: an opportunity for patients, their kin, healthcare providers and professionals to coproduce health.","Background: It is twenty years since the US Institute of Medicine (IOM) defined quality in healthcare, as comprising six domains: person-centredness, timeliness, efficiency, effectiveness, safety and equity. Since then, a new quality movement has emerged, with the development of numerous interventions aimed at improving quality, with a focus on accessibility, safety and effectiveness of care. Further gains in equity and timeliness have proven even more challenging. The challenge: W","2021","06","30","F1000Res","F1000Research","covid19; kin centered; person centered care; quality; safety; COVID-19; Health Personnel; Humans; SARS-CoV-2","Vanhaecht","Kris","KU Leuven Institute for Healthcare Policy, KU Leuven, Leuven, 3000, Belgium",NA
"2532","34162043","10.52586/4931","A detailed review of the outbreak of COVID-19.","The disease COVID-19 caused by SARS-CoV-2 is the third highly infectious human Coronavirus epidemic in the 21<sup>s<U+2062>t</sup> century due to its high transmission rate and quick evolution of its pathogenicity. Genomic studies indicate that it is zoonotic from bats. The COVID-19 has led to significant loss of lives and a tremendous economic decline in the world. Generally, the population at risk of a fatal outcome are the elderly and those who are debilitated or are immune compromised. The fatality","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","COVID-19; Phronetic needs for COVID-19; SARS-CoV-2; Socio-economic impacts; Therapeutics; Vaccine development; Antiviral Agents; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disease Outbreaks; Hand Disinfection; Humans; Physical Distancing; Public Health; SARS-CoV-2","Das","Kabita","Department of Philosophy, Utkal University, Bhubaneswar, 751004 Odisha, India",NA
"2533","34162043","10.52586/4931","A detailed review of the outbreak of COVID-19.","The disease COVID-19 caused by SARS-CoV-2 is the third highly infectious human Coronavirus epidemic in the 21<sup>s<U+2062>t</sup> century due to its high transmission rate and quick evolution of its pathogenicity. Genomic studies indicate that it is zoonotic from bats. The COVID-19 has led to significant loss of lives and a tremendous economic decline in the world. Generally, the population at risk of a fatal outcome are the elderly and those who are debilitated or are immune compromised. The fatality","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","COVID-19; Phronetic needs for COVID-19; SARS-CoV-2; Socio-economic impacts; Therapeutics; Vaccine development; Antiviral Agents; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disease Outbreaks; Hand Disinfection; Humans; Physical Distancing; Public Health; SARS-CoV-2","Pingali","M Shivapriya","Department of Applied Sciences, Indian Institute of Information Technology Allahabad, 211012 Allahabad, India",NA
"2534","34162043","10.52586/4931","A detailed review of the outbreak of COVID-19.","The disease COVID-19 caused by SARS-CoV-2 is the third highly infectious human Coronavirus epidemic in the 21<sup>s<U+2062>t</sup> century due to its high transmission rate and quick evolution of its pathogenicity. Genomic studies indicate that it is zoonotic from bats. The COVID-19 has led to significant loss of lives and a tremendous economic decline in the world. Generally, the population at risk of a fatal outcome are the elderly and those who are debilitated or are immune compromised. The fatality","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","COVID-19; Phronetic needs for COVID-19; SARS-CoV-2; Socio-economic impacts; Therapeutics; Vaccine development; Antiviral Agents; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disease Outbreaks; Hand Disinfection; Humans; Physical Distancing; Public Health; SARS-CoV-2","Paital","Biswaranjan","Reodx Regulation Laboratory, Department of Zoology, Odisha University of Agriculture and Technology, College of Basic Science and Humanities, Bhubaneswar, 751003 Odisha, India",NA
"2535","34162043","10.52586/4931","A detailed review of the outbreak of COVID-19.","The disease COVID-19 caused by SARS-CoV-2 is the third highly infectious human Coronavirus epidemic in the 21<sup>s<U+2062>t</sup> century due to its high transmission rate and quick evolution of its pathogenicity. Genomic studies indicate that it is zoonotic from bats. The COVID-19 has led to significant loss of lives and a tremendous economic decline in the world. Generally, the population at risk of a fatal outcome are the elderly and those who are debilitated or are immune compromised. The fatality","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","COVID-19; Phronetic needs for COVID-19; SARS-CoV-2; Socio-economic impacts; Therapeutics; Vaccine development; Antiviral Agents; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disease Outbreaks; Hand Disinfection; Humans; Physical Distancing; Public Health; SARS-CoV-2","Panda","Falguni","Reodx Regulation Laboratory, Department of Zoology, Odisha University of Agriculture and Technology, College of Basic Science and Humanities, Bhubaneswar, 751003 Odisha, India",NA
"2536","34162043","10.52586/4931","A detailed review of the outbreak of COVID-19.","The disease COVID-19 caused by SARS-CoV-2 is the third highly infectious human Coronavirus epidemic in the 21<sup>s<U+2062>t</sup> century due to its high transmission rate and quick evolution of its pathogenicity. Genomic studies indicate that it is zoonotic from bats. The COVID-19 has led to significant loss of lives and a tremendous economic decline in the world. Generally, the population at risk of a fatal outcome are the elderly and those who are debilitated or are immune compromised. The fatality","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","COVID-19; Phronetic needs for COVID-19; SARS-CoV-2; Socio-economic impacts; Therapeutics; Vaccine development; Antiviral Agents; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disease Outbreaks; Hand Disinfection; Humans; Physical Distancing; Public Health; SARS-CoV-2","Pati","Samar Gourav","Reodx Regulation Laboratory, Department of Zoology, Odisha University of Agriculture and Technology, College of Basic Science and Humanities, Bhubaneswar, 751003 Odisha, India",NA
"2537","34162043","10.52586/4931","A detailed review of the outbreak of COVID-19.","The disease COVID-19 caused by SARS-CoV-2 is the third highly infectious human Coronavirus epidemic in the 21<sup>s<U+2062>t</sup> century due to its high transmission rate and quick evolution of its pathogenicity. Genomic studies indicate that it is zoonotic from bats. The COVID-19 has led to significant loss of lives and a tremendous economic decline in the world. Generally, the population at risk of a fatal outcome are the elderly and those who are debilitated or are immune compromised. The fatality","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","COVID-19; Phronetic needs for COVID-19; SARS-CoV-2; Socio-economic impacts; Therapeutics; Vaccine development; Antiviral Agents; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disease Outbreaks; Hand Disinfection; Humans; Physical Distancing; Public Health; SARS-CoV-2","Singh","Anirudh","Department of Applied Sciences, Indian Institute of Information Technology Allahabad, 211012 Allahabad, India",NA
"2538","34162043","10.52586/4931","A detailed review of the outbreak of COVID-19.","The disease COVID-19 caused by SARS-CoV-2 is the third highly infectious human Coronavirus epidemic in the 21<sup>s<U+2062>t</sup> century due to its high transmission rate and quick evolution of its pathogenicity. Genomic studies indicate that it is zoonotic from bats. The COVID-19 has led to significant loss of lives and a tremendous economic decline in the world. Generally, the population at risk of a fatal outcome are the elderly and those who are debilitated or are immune compromised. The fatality","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","COVID-19; Phronetic needs for COVID-19; SARS-CoV-2; Socio-economic impacts; Therapeutics; Vaccine development; Antiviral Agents; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disease Outbreaks; Hand Disinfection; Humans; Physical Distancing; Public Health; SARS-CoV-2","Varadwaj","Pritish Kumar","Department of Applied Sciences, Indian Institute of Information Technology Allahabad, 211012 Allahabad, India",NA
"2539","34162043","10.52586/4931","A detailed review of the outbreak of COVID-19.","The disease COVID-19 caused by SARS-CoV-2 is the third highly infectious human Coronavirus epidemic in the 21<sup>s<U+2062>t</sup> century due to its high transmission rate and quick evolution of its pathogenicity. Genomic studies indicate that it is zoonotic from bats. The COVID-19 has led to significant loss of lives and a tremendous economic decline in the world. Generally, the population at risk of a fatal outcome are the elderly and those who are debilitated or are immune compromised. The fatality","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","COVID-19; Phronetic needs for COVID-19; SARS-CoV-2; Socio-economic impacts; Therapeutics; Vaccine development; Antiviral Agents; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disease Outbreaks; Hand Disinfection; Humans; Physical Distancing; Public Health; SARS-CoV-2","Samanta","Sintu Kumar","Department of Applied Sciences, Indian Institute of Information Technology Allahabad, 211012 Allahabad, India",NA
"2540","34162042","10.52586/4930","Current knowledge about the connection between health status and gut microbiota from birth to elderly. A narrative review.","The human body is colonized from the birth by a large number of microorganisms. This will constitute a real ""functional microbial organ"" that is fundamental for homeostasis and therefore for health in humans. Those microorganisms. The microbial populations that colonize humans creating a specific ecosystem they have been collectively referred to as ""human microbiota"" or ""human normal microflora"". The microbiota play an important pathophysiological role in the various locations of the human body.","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","Colon cancer; Dysbiosis; Gut microbiota; Gut-brain axis; Gut-lung axis; Gut-skin axis; Human microbiota; Idiopathic inflammatory bowel disease (IBD); Immune modulation; Irritable bowel syndrome (IBS); Metabolic diseases; Microbiology; SARS-CoV-2; Bacteria; Brain; Cytokines; Gastrointestinal Microbiome; Gastrointestinal Tract; Health Status; Homeostasis; Humans; Lung; Population Dynamics","Santacroce","Luigi","Department of Interdisciplinary Medicine, Microbiology and Virology Unit, University of Bari ""Aldo Moro"", 70100 Bari, Italy",NA
"2541","34162042","10.52586/4930","Current knowledge about the connection between health status and gut microbiota from birth to elderly. A narrative review.","The human body is colonized from the birth by a large number of microorganisms. This will constitute a real ""functional microbial organ"" that is fundamental for homeostasis and therefore for health in humans. Those microorganisms. The microbial populations that colonize humans creating a specific ecosystem they have been collectively referred to as ""human microbiota"" or ""human normal microflora"". The microbiota play an important pathophysiological role in the various locations of the human body.","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","Colon cancer; Dysbiosis; Gut microbiota; Gut-brain axis; Gut-lung axis; Gut-skin axis; Human microbiota; Idiopathic inflammatory bowel disease (IBD); Immune modulation; Irritable bowel syndrome (IBS); Metabolic diseases; Microbiology; SARS-CoV-2; Bacteria; Brain; Cytokines; Gastrointestinal Microbiome; Gastrointestinal Tract; Health Status; Homeostasis; Humans; Lung; Population Dynamics","Man","Adrian","Department of Microbiology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mure<U+0219>, 540003 Târgu Mure<U+0219>, Romania",NA
"2542","34162042","10.52586/4930","Current knowledge about the connection between health status and gut microbiota from birth to elderly. A narrative review.","The human body is colonized from the birth by a large number of microorganisms. This will constitute a real ""functional microbial organ"" that is fundamental for homeostasis and therefore for health in humans. Those microorganisms. The microbial populations that colonize humans creating a specific ecosystem they have been collectively referred to as ""human microbiota"" or ""human normal microflora"". The microbiota play an important pathophysiological role in the various locations of the human body.","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","Colon cancer; Dysbiosis; Gut microbiota; Gut-brain axis; Gut-lung axis; Gut-skin axis; Human microbiota; Idiopathic inflammatory bowel disease (IBD); Immune modulation; Irritable bowel syndrome (IBS); Metabolic diseases; Microbiology; SARS-CoV-2; Bacteria; Brain; Cytokines; Gastrointestinal Microbiome; Gastrointestinal Tract; Health Status; Homeostasis; Humans; Lung; Population Dynamics","Charitos","Ioannis Alexandros","Emergency/Urgent Department - National Poisoning Center, Riuniti University Hospital of Foggia, 85025 Foggia, Italy",NA
"2543","34162042","10.52586/4930","Current knowledge about the connection between health status and gut microbiota from birth to elderly. A narrative review.","The human body is colonized from the birth by a large number of microorganisms. This will constitute a real ""functional microbial organ"" that is fundamental for homeostasis and therefore for health in humans. Those microorganisms. The microbial populations that colonize humans creating a specific ecosystem they have been collectively referred to as ""human microbiota"" or ""human normal microflora"". The microbiota play an important pathophysiological role in the various locations of the human body.","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","Colon cancer; Dysbiosis; Gut microbiota; Gut-brain axis; Gut-lung axis; Gut-skin axis; Human microbiota; Idiopathic inflammatory bowel disease (IBD); Immune modulation; Irritable bowel syndrome (IBS); Metabolic diseases; Microbiology; SARS-CoV-2; Bacteria; Brain; Cytokines; Gastrointestinal Microbiome; Gastrointestinal Tract; Health Status; Homeostasis; Humans; Lung; Population Dynamics","Haxhirexha","Kastriot","Medical Faculty, Clinical Hospital of Tetovo, University of Tetovo, 1230 Tetovo, North Macedonia",NA
"2544","34162042","10.52586/4930","Current knowledge about the connection between health status and gut microbiota from birth to elderly. A narrative review.","The human body is colonized from the birth by a large number of microorganisms. This will constitute a real ""functional microbial organ"" that is fundamental for homeostasis and therefore for health in humans. Those microorganisms. The microbial populations that colonize humans creating a specific ecosystem they have been collectively referred to as ""human microbiota"" or ""human normal microflora"". The microbiota play an important pathophysiological role in the various locations of the human body.","2021","07","19","Front Biosci (Landmark Ed)","Frontiers in bioscience (Landmark edition)","Colon cancer; Dysbiosis; Gut microbiota; Gut-brain axis; Gut-lung axis; Gut-skin axis; Human microbiota; Idiopathic inflammatory bowel disease (IBD); Immune modulation; Irritable bowel syndrome (IBS); Metabolic diseases; Microbiology; SARS-CoV-2; Bacteria; Brain; Cytokines; Gastrointestinal Microbiome; Gastrointestinal Tract; Health Status; Homeostasis; Humans; Lung; Population Dynamics","Topi","Skender","School of Technical Medical Sciences, ""Alexander Xhuvani"" University of Elbasan, 3001-3006 Elbasan, Albania",NA
"2545","34162025","10.1515/cclm-2021-0687","Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.",NA,"2021","06","23","Clin Chem Lab Med","Clinical chemistry and laboratory medicine","COVID-19; SARS-CoV-2; antibodies; immune response; vaccination","Salvagno","Gian Luca","Section of Clinical Biochemistry, University of Verona, Verona, Italy",NA
"2546","34162025","10.1515/cclm-2021-0687","Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.",NA,"2021","06","23","Clin Chem Lab Med","Clinical chemistry and laboratory medicine","COVID-19; SARS-CoV-2; antibodies; immune response; vaccination","Henry","Brandon M","The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA",NA
"2547","34162025","10.1515/cclm-2021-0687","Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.",NA,"2021","06","23","Clin Chem Lab Med","Clinical chemistry and laboratory medicine","COVID-19; SARS-CoV-2; antibodies; immune response; vaccination","Pighi","Laura","Section of Clinical Biochemistry, University of Verona, Verona, Italy",NA
"2548","34162025","10.1515/cclm-2021-0687","Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.",NA,"2021","06","23","Clin Chem Lab Med","Clinical chemistry and laboratory medicine","COVID-19; SARS-CoV-2; antibodies; immune response; vaccination","De Nitto","Simone","Section of Clinical Biochemistry, University of Verona, Verona, Italy",NA
"2549","34162025","10.1515/cclm-2021-0687","Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.",NA,"2021","06","23","Clin Chem Lab Med","Clinical chemistry and laboratory medicine","COVID-19; SARS-CoV-2; antibodies; immune response; vaccination","Gianfilippi","Gian Luca","Medical Direction, Pederzoli Hospital, Peschiera del Garda, Italy",NA
"2550","34162025","10.1515/cclm-2021-0687","Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.",NA,"2021","06","23","Clin Chem Lab Med","Clinical chemistry and laboratory medicine","COVID-19; SARS-CoV-2; antibodies; immune response; vaccination","Lippi","Giuseppe","Section of Clinical Biochemistry, University of Verona, Verona, Italy",NA
"2551","34161995","10.1055/a-1468-4296","Diabetes Mellitus as the Major Factor of Prolonged Hospitalisation in Mild or Moderate COVID-19 Pneumonia.",NA,"2021","06","23","Exp Clin Endocrinol Diabetes","Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association",NA,"Petrakis","Vasileios","Department of Infectious Diseases, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece",NA
"2552","34161995","10.1055/a-1468-4296","Diabetes Mellitus as the Major Factor of Prolonged Hospitalisation in Mild or Moderate COVID-19 Pneumonia.",NA,"2021","06","23","Exp Clin Endocrinol Diabetes","Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association",NA,"Trypsianis","Grigorios","Department of Medical Statistics, Medical School, Democritus University of Thrace, Greece",NA
"2553","34161995","10.1055/a-1468-4296","Diabetes Mellitus as the Major Factor of Prolonged Hospitalisation in Mild or Moderate COVID-19 Pneumonia.",NA,"2021","06","23","Exp Clin Endocrinol Diabetes","Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association",NA,"Panagopoulos","Periklis","Department of Infectious Diseases, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece",NA
"2554","34161995","10.1055/a-1468-4296","Diabetes Mellitus as the Major Factor of Prolonged Hospitalisation in Mild or Moderate COVID-19 Pneumonia.",NA,"2021","06","23","Exp Clin Endocrinol Diabetes","Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association",NA,"Papazoglou","Dimitrios","Department of Infectious Diseases, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece",NA
"2555","34161995","10.1055/a-1468-4296","Diabetes Mellitus as the Major Factor of Prolonged Hospitalisation in Mild or Moderate COVID-19 Pneumonia.",NA,"2021","06","23","Exp Clin Endocrinol Diabetes","Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association",NA,"Papanas","Nikolaos","Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece",NA
"2556","34161984","10.1055/s-0041-1731294","The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.","The novel coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), continues to be a major health concern. In search for novel treatment strategies against COVID-19, exosomes have attracted the attention of scientists and pharmaceutical companies worldwide. Exosomes are small extracellular vesicles, secreted by all types of cells, and considered as key mediators of intercellular communication and stem-cell paracrine signaling. Here","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; COVID-19 Vaccines; Drug Carriers; Exosomes; Humans; Immunization, Passive; Mesenchymal Stem Cells","Zani-Ruttenstock","Elke","Division of General and Thoracic Surgery, Hospital for Sick Children, Toronto, Ontario, Canada",NA
"2557","34161984","10.1055/s-0041-1731294","The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.","The novel coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), continues to be a major health concern. In search for novel treatment strategies against COVID-19, exosomes have attracted the attention of scientists and pharmaceutical companies worldwide. Exosomes are small extracellular vesicles, secreted by all types of cells, and considered as key mediators of intercellular communication and stem-cell paracrine signaling. Here","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; COVID-19 Vaccines; Drug Carriers; Exosomes; Humans; Immunization, Passive; Mesenchymal Stem Cells","Antounians","Lina","Division of General and Thoracic Surgery, Hospital for Sick Children, Toronto, Ontario, Canada",NA
"2558","34161984","10.1055/s-0041-1731294","The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.","The novel coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), continues to be a major health concern. In search for novel treatment strategies against COVID-19, exosomes have attracted the attention of scientists and pharmaceutical companies worldwide. Exosomes are small extracellular vesicles, secreted by all types of cells, and considered as key mediators of intercellular communication and stem-cell paracrine signaling. Here","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; COVID-19 Vaccines; Drug Carriers; Exosomes; Humans; Immunization, Passive; Mesenchymal Stem Cells","Khalaj","Kasra","Division of General and Thoracic Surgery, Hospital for Sick Children, Toronto, Ontario, Canada",NA
"2559","34161984","10.1055/s-0041-1731294","The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.","The novel coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), continues to be a major health concern. In search for novel treatment strategies against COVID-19, exosomes have attracted the attention of scientists and pharmaceutical companies worldwide. Exosomes are small extracellular vesicles, secreted by all types of cells, and considered as key mediators of intercellular communication and stem-cell paracrine signaling. Here","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; COVID-19 Vaccines; Drug Carriers; Exosomes; Humans; Immunization, Passive; Mesenchymal Stem Cells","Figueira","Rebeca L","Division of General and Thoracic Surgery, Hospital for Sick Children, Toronto, Ontario, Canada",NA
"2560","34161984","10.1055/s-0041-1731294","The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.","The novel coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), continues to be a major health concern. In search for novel treatment strategies against COVID-19, exosomes have attracted the attention of scientists and pharmaceutical companies worldwide. Exosomes are small extracellular vesicles, secreted by all types of cells, and considered as key mediators of intercellular communication and stem-cell paracrine signaling. Here","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; COVID-19 Vaccines; Drug Carriers; Exosomes; Humans; Immunization, Passive; Mesenchymal Stem Cells","Zani","Augusto","Division of General and Thoracic Surgery, Hospital for Sick Children, Toronto, Ontario, Canada",NA
"2561","34161983","10.1055/s-0041-1731295","Impact of the Global COVID-19 Pandemic on the Incidence, Presentation, and Management of Pediatric Appendicitis: Lessons Learned from the First Wave.","The fast-evolving nature of the coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented clinical, logistical, and socioeconomical challenges for health-care systems worldwide. While several studies have analyzed the impact on the presentation and management of acute appendicitis (AA) in the adult population, there is a relative paucity of similar research in pediatric patients with AA. To date, there is some evidence that the incidence of simple AA in children may have decreased du","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","Abdominal Pain; Appendicitis; COVID-19; Child; Diagnosis, Differential; Diarrhea; Humans; Incidence; Length of Stay; Pandemics; Postoperative Complications; Symptom Assessment; Systemic Inflammatory Response Syndrome; Vomiting","Saalabian","Kerstin","Department of Pediatric Surgery, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt (Main), Germany",NA
"2562","34161983","10.1055/s-0041-1731295","Impact of the Global COVID-19 Pandemic on the Incidence, Presentation, and Management of Pediatric Appendicitis: Lessons Learned from the First Wave.","The fast-evolving nature of the coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented clinical, logistical, and socioeconomical challenges for health-care systems worldwide. While several studies have analyzed the impact on the presentation and management of acute appendicitis (AA) in the adult population, there is a relative paucity of similar research in pediatric patients with AA. To date, there is some evidence that the incidence of simple AA in children may have decreased du","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","Abdominal Pain; Appendicitis; COVID-19; Child; Diagnosis, Differential; Diarrhea; Humans; Incidence; Length of Stay; Pandemics; Postoperative Complications; Symptom Assessment; Systemic Inflammatory Response Syndrome; Vomiting","Rolle","Udo","Department of Pediatric Surgery, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt (Main), Germany",NA
"2563","34161983","10.1055/s-0041-1731295","Impact of the Global COVID-19 Pandemic on the Incidence, Presentation, and Management of Pediatric Appendicitis: Lessons Learned from the First Wave.","The fast-evolving nature of the coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented clinical, logistical, and socioeconomical challenges for health-care systems worldwide. While several studies have analyzed the impact on the presentation and management of acute appendicitis (AA) in the adult population, there is a relative paucity of similar research in pediatric patients with AA. To date, there is some evidence that the incidence of simple AA in children may have decreased du","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","Abdominal Pain; Appendicitis; COVID-19; Child; Diagnosis, Differential; Diarrhea; Humans; Incidence; Length of Stay; Pandemics; Postoperative Complications; Symptom Assessment; Systemic Inflammatory Response Syndrome; Vomiting","Friedmacher","Florian","Department of Pediatric Surgery, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt (Main), Germany",NA
"2564","34161967","10.4037/aacnacc2021948","COVID-19 Technology-Enabled Living Systematic Reviews to Enhance Knowledge Translation.",NA,"2021","07","05","AACN Adv Crit Care","AACN advanced critical care","COVID-19; Critical Care; Data Collection; Evidence-Based Medicine; Humans; Information Dissemination; Inventions; SARS-CoV-2; Systematic Reviews as Topic; Translational Medical Research","Harrington","Linda","Linda Harrington is an Independent Consultant, Health Informatics and Digital Strategy, and Adjunct Faculty at Texas Christian University, 2800 South University Drive, Fort Worth, TX 76109 (linda.harrington@gmail","linda.harrington@gmail.com"
"2565","34161963","10.4037/aacnacc2021636","Understanding the Impact of COVID-19: Now and for the Future.",NA,"2021","07","05","AACN Adv Crit Care","AACN advanced critical care","Adult; COVID-19; Critical Care; Female; Forecasting; Health Impact Assessment; Health Personnel; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; United States","Tracy","Mary Fran","Mary Fran Tracy is Associate Professor, University of Minnesota School of Nursing, 5-140 Weaver-Densford Hall, 308 Harvard St SE, Minneapolis, MN 55455 (tracy005@umn","tracy005@umn.edu"
"2566","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Yu","Jingyou","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2567","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Tostanoski","Lisa H","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2568","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Mercado","Noe B","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2569","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"McMahan","Katherine","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2570","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Liu","Jinyan","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2571","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Jacob-Dolan","Catherine","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2572","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Chandrashekar","Abishek","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2573","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Atyeo","Caroline","Harvard Medical School, Boston, MA, USA",NA
"2574","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Martinez","David R","University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2575","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Anioke","Tochi","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2576","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Bondzie","Esther A","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2577","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Chang","Aiquan","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2578","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Gardner","Sarah","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2579","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Giffin","Victoria M","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2580","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Hope","David L","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2581","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Nampanya","Felix","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2582","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Nkolola","Joseph","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2583","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Patel","Shivani","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2584","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Sanborn","Owen","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2585","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Sellers","Daniel","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2586","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Wan","Huahua","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"2587","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Hayes","Tammy","Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA",NA
"2588","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Bauer","Katherine","Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA",NA
"2589","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Pessaint","Laurent","Bioqual, Rockville, MD, USA",NA
"2590","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Valentin","Daniel","Bioqual, Rockville, MD, USA",NA
"2591","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Flinchbaugh","Zack","Bioqual, Rockville, MD, USA",NA
"2592","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Brown","Renita","Bioqual, Rockville, MD, USA",NA
"2593","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Cook","Anthony","Bioqual, Rockville, MD, USA",NA
"2594","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Bueno-Wilkerson","Deandre","Bioqual, Rockville, MD, USA",NA
"2595","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Teow","Elyse","Bioqual, Rockville, MD, USA",NA
"2596","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Andersen","Hanne","Bioqual, Rockville, MD, USA",NA
"2597","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Lewis","Mark G","Bioqual, Rockville, MD, USA",NA
"2598","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Martinot","Amanda J","Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA",NA
"2599","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Baric","Ralph S","University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2600","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Alter","Galit","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA",NA
"2601","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Wegmann","Frank","Janssen Vaccines &amp",NA
"2602","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Zahn","Roland","Janssen Vaccines &amp",NA
"2603","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Schuitemaker","Hanneke","Janssen Vaccines &amp",NA
"2604","34161961","10.1038/s41586-021-03732-8","Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.","The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines<sup>1,2</sup>. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and has recently demonstrated protective efficacy against symptomatic COVID-19 in humans in several geographical regions-including in South Africa, where 95% of sequenced viruses in cases of COVID-19 were the B.1.351 variant<sup>3</sup>. Here","2021","07","15","Nature","Nature",NA,"Barouch","Dan H","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard","dbarouch@bidmc.harvard.edu"
"2605","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Zhang","Nan","Beijing Key Laboratory of Green Built Environment and Energy Efficient Technology, Beijing University of Technology, Beijing, China",NA
"2606","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Jack Chan","Pak-To","Department of Mechanical Engineering, The University of Hong Kong, Hong Kong SAR, China",NA
"2607","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Jia","Wei","Department of Mechanical Engineering, The University of Hong Kong, Hong Kong SAR, China",NA
"2608","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Dung","Chung-Hin","Department of Mechanical Engineering, The University of Hong Kong, Hong Kong SAR, China",NA
"2609","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Zhao","Pengcheng","Department of Mechanical Engineering, The University of Hong Kong, Hong Kong SAR, China",NA
"2610","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Lei","Hao","School of Public Health, Zhejiang University, Hangzhou, China",NA
"2611","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Su","Boni","China Electric Power Planning &amp",NA
"2612","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Xue","Peng","Beijing Key Laboratory of Green Built Environment and Energy Efficient Technology, Beijing University of Technology, Beijing, China",NA
"2613","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Zhang","Weirong","Beijing Key Laboratory of Green Built Environment and Energy Efficient Technology, Beijing University of Technology, Beijing, China",NA
"2614","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Xie","Jingchao","Beijing Key Laboratory of Green Built Environment and Energy Efficient Technology, Beijing University of Technology, Beijing, China",NA
"2615","34161908","10.1016/j.envint.2021.106723","Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.","By the end of February 2021, COVID-19 had spread to over 230 countries, with more than 100 million confirmed cases and 2.5 million deaths. To control infection spread with the least disruption to economic and societal activities, it is crucial to implement the various interventions effectively. In this study, we developed an agent-based SEIR model, using real demographic and geographic data from Hong Kong, to analyse the efficiency of various intervention strategies in preventing infection by th","2021","07","21","Environ Int","Environment international","COVID-19; Close contact; Mask; SEIR model; Temperature screening; Vaccine","Li","Yuguo","Department of Mechanical Engineering, The University of Hong Kong, Hong Kong SAR, China. Electronic address: liyg@hku","liyg@hku.hk"
"2616","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Bergmans","Barbara J M","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2617","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Reusken","Chantal B E M","Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands",NA
"2618","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","van Oudheusden","Anne J G","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2619","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Godeke","Gert-Jan","Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands",NA
"2620","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Bonacic Marinovic","Axel A","Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands",NA
"2621","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","de Vries","Esther","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2622","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Kluiters-de Hingh","Yvette C M","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2623","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Vingerhoets","Ralf","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2624","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Berrevoets","Marvin A H","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2625","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Verweij","Jaco J","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2626","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Nieman","An-Emmie","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2627","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Reimerink","Johan","Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands",NA
"2628","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Murk","Jean-Luc","Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands",NA
"2629","34161880","10.1016/j.diagmicrobio.2021.115392","Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort.","Real-time reverse transcription-polymerase chain reaction (RT-PCR) on upper respiratory tract (URT) samples is the primary method to diagnose SARS-CoV-2 infections and guide public health measures, with a supportive role for serology. We reinforce previous findings on limited sensitivity of PCR testing, and solidify this fact by statistically utilizing a firm basis of multiple tests per individual. We integrate stratifications with respect to several patient characteristics such as severity of d","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","RT-PCR; SARS-CoV-2; public health; sensitivity; serology","Swart","Arno","Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Electronic address: arno.swart@rivm","arno.swart@rivm.nl"
"2630","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Gradin","A","Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden. Electronic address: anna.gradin@surgsci.uu","anna.gradin@surgsci.uu.se"
"2631","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Andersson","H","Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden",NA
"2632","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Luther","T","Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden",NA
"2633","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Anderberg","S Bülow","Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden",NA
"2634","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Rubertsson","S","Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden",NA
"2635","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Lipcsey","M","Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden",NA
"2636","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Åberg","M","Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden",NA
"2637","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Larsson","A","Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden",NA
"2638","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Frithiof","R","Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden",NA
"2639","34161857","10.1016/j.cyto.2021.155589","Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients.","Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary cytokines are not fully investigated. The current study aimed to assess urinary cytokine levels in COVID-19 patients. Urine was collected from COVID-19 patients (n = 29) in intensive care and compared to a preoperative group of patients (n = 9) with no critical illness. 92 urinary cytokines were analyzed in multiplex using the Olink Targe","2021","07","24","Cytokine","Cytokine","Acute kidney injury; Biomarkers; COVID-19; Inflammation; Intensive care; Urine","Hultström","M","Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden",NA
"2640","34161852","10.1016/j.coph.2021.05.002","Repairing damaged lungs using regenerative therapy.","There is an urgent need for better treatment of lung diseases that are a major cause of morbidity and mortality worldwide. This urgency is illustrated by the current COVID-19 health crisis. Moderate-to-extensive lung injury characterizes several lung diseases, and not only therapies that reduce such lung injury are needed but also those that regenerate lung tissue and repair existing lung injury. At present, such therapies are not available, but as a result of a rapid increase in our understandi","2021","07","23","Curr Opin Pharmacol","Current opinion in pharmacology",NA,"Khedoe","P Padmini P S J","Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands",NA
"2641","34161852","10.1016/j.coph.2021.05.002","Repairing damaged lungs using regenerative therapy.","There is an urgent need for better treatment of lung diseases that are a major cause of morbidity and mortality worldwide. This urgency is illustrated by the current COVID-19 health crisis. Moderate-to-extensive lung injury characterizes several lung diseases, and not only therapies that reduce such lung injury are needed but also those that regenerate lung tissue and repair existing lung injury. At present, such therapies are not available, but as a result of a rapid increase in our understandi","2021","07","23","Curr Opin Pharmacol","Current opinion in pharmacology",NA,"Wu","Xinhui","Department of Molecular Pharmacology, Faculty of Science and Engineering, University of Groningen, Groningen, the Netherlands",NA
"2642","34161852","10.1016/j.coph.2021.05.002","Repairing damaged lungs using regenerative therapy.","There is an urgent need for better treatment of lung diseases that are a major cause of morbidity and mortality worldwide. This urgency is illustrated by the current COVID-19 health crisis. Moderate-to-extensive lung injury characterizes several lung diseases, and not only therapies that reduce such lung injury are needed but also those that regenerate lung tissue and repair existing lung injury. At present, such therapies are not available, but as a result of a rapid increase in our understandi","2021","07","23","Curr Opin Pharmacol","Current opinion in pharmacology",NA,"Gosens","Reinoud","Department of Molecular Pharmacology, Faculty of Science and Engineering, University of Groningen, Groningen, the Netherlands",NA
"2643","34161852","10.1016/j.coph.2021.05.002","Repairing damaged lungs using regenerative therapy.","There is an urgent need for better treatment of lung diseases that are a major cause of morbidity and mortality worldwide. This urgency is illustrated by the current COVID-19 health crisis. Moderate-to-extensive lung injury characterizes several lung diseases, and not only therapies that reduce such lung injury are needed but also those that regenerate lung tissue and repair existing lung injury. At present, such therapies are not available, but as a result of a rapid increase in our understandi","2021","07","23","Curr Opin Pharmacol","Current opinion in pharmacology",NA,"Hiemstra","Pieter S","Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: p.s.hiemstra@lumc","p.s.hiemstra@lumc.nl"
"2644","34161830","10.1016/j.anai.2021.06.013","Telemedicine during the coronavirus disease 2019 pandemic for pediatric patients with eosinophilic esophagitis.",NA,"2021","07","12","Ann Allergy Asthma Immunol","Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology",NA,"Kewalramani","Anupama","Division of Pediatric Pulmonology and Allergy, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: akewal@som.umaryland","akewal@som.umaryland.edu"
"2645","34161830","10.1016/j.anai.2021.06.013","Telemedicine during the coronavirus disease 2019 pandemic for pediatric patients with eosinophilic esophagitis.",NA,"2021","07","12","Ann Allergy Asthma Immunol","Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology",NA,"Waddell","Jaylyn","Division of Neonatology, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland",NA
"2646","34161830","10.1016/j.anai.2021.06.013","Telemedicine during the coronavirus disease 2019 pandemic for pediatric patients with eosinophilic esophagitis.",NA,"2021","07","12","Ann Allergy Asthma Immunol","Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology",NA,"Puppa","Elaine Leonard","Division of Gastroenterology, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland",NA
"2647","34161825","10.1016/j.amjms.2021.06.007","Splenic Infarction with Aortic Thrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic","2021","06","25","Am J Med Sci","The American journal of the medical sciences","Aorta; Covid-19; Spleen; Splenic infarction; Thrombosis","Sztajnbok","Jaques","Intensive Care Unit, Emílio Ribas Institute of Infectious Diseases, São Paulo, Brazil. Electronic address: jaques.sztajnbok@gmail","jaques.sztajnbok@gmail.com"
"2648","34161825","10.1016/j.amjms.2021.06.007","Splenic Infarction with Aortic Thrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic","2021","06","25","Am J Med Sci","The American journal of the medical sciences","Aorta; Covid-19; Spleen; Splenic infarction; Thrombosis","Brasil","Lucas Mendes Cunha de Resende","Intensive Care Unit, Emílio Ribas Institute of Infectious Diseases, São Paulo, Brazil. Electronic address: lucasmcrbrasil@hotmail","lucasmcrbrasil@hotmail.com"
"2649","34161825","10.1016/j.amjms.2021.06.007","Splenic Infarction with Aortic Thrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic","2021","06","25","Am J Med Sci","The American journal of the medical sciences","Aorta; Covid-19; Spleen; Splenic infarction; Thrombosis","Romero","Luis Arancibia","Intensive Care Unit, Emílio Ribas Institute of Infectious Diseases, São Paulo, Brazil. Electronic address: luisarancibiaromero@gmail","luisarancibiaromero@gmail.com"
"2650","34161825","10.1016/j.amjms.2021.06.007","Splenic Infarction with Aortic Thrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic","2021","06","25","Am J Med Sci","The American journal of the medical sciences","Aorta; Covid-19; Spleen; Splenic infarction; Thrombosis","Ribeiro","Ana Freitas","Intensive Care Unit, Emílio Ribas Institute of Infectious Diseases, São Paulo, Brazil. Electronic address: anafribeiro1@gmail","anafribeiro1@gmail.com"
"2651","34161825","10.1016/j.amjms.2021.06.007","Splenic Infarction with Aortic Thrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic","2021","06","25","Am J Med Sci","The American journal of the medical sciences","Aorta; Covid-19; Spleen; Splenic infarction; Thrombosis","Vidal","Jose Ernesto","Intensive Care Unit, Emílio Ribas Institute of Infectious Diseases, São Paulo, Brazil. Electronic address: josevibe@gmail","josevibe@gmail.com"
"2652","34161825","10.1016/j.amjms.2021.06.007","Splenic Infarction with Aortic Thrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic","2021","06","25","Am J Med Sci","The American journal of the medical sciences","Aorta; Covid-19; Spleen; Splenic infarction; Thrombosis","Figueiredo-Melo","Claudia","Intensive Care Unit, Emílio Ribas Institute of Infectious Diseases, São Paulo, Brazil. Electronic address: claudia7mello@gmail","claudia7mello@gmail.com"
"2653","34161825","10.1016/j.amjms.2021.06.007","Splenic Infarction with Aortic Thrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic","2021","06","25","Am J Med Sci","The American journal of the medical sciences","Aorta; Covid-19; Spleen; Splenic infarction; Thrombosis","Sant'Ana Malaque","Ceila Maria","Intensive Care Unit, Emílio Ribas Institute of Infectious Diseases, São Paulo, Brazil. Electronic address: cmalaque@uol.com","cmalaque@uol.com.br"
"2654","34161818","10.1016/j.jinf.2021.06.018","Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.","To evaluate which non-pharmaceutical interventions (NPIs) have been more and less effective in controlling the COVID-19 pandemic. We performed a systematic review of published and unpublished empirical studies, either observational or interventional, analysing the comparative effectiveness of NPIs against the COVID-19 pandemic. We searched Embase/Medline and medRxiv to identify the relevant literature. We identified 34 studies. During the first wave of the COVID-19 pandemic, school closing was t","2021","06","25","J Infect","The Journal of infection","COVID-19; SARS-CoV-2; Systematic review; epidemic; non-pharmaceutical interventions","Mendez-Brito","Alba","Evidence-Based Public Health Unit, Centre for International Health Protection, Robert Koch Institute. Nordufer 20, 13353 Berlin, Germany",NA
"2655","34161818","10.1016/j.jinf.2021.06.018","Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.","To evaluate which non-pharmaceutical interventions (NPIs) have been more and less effective in controlling the COVID-19 pandemic. We performed a systematic review of published and unpublished empirical studies, either observational or interventional, analysing the comparative effectiveness of NPIs against the COVID-19 pandemic. We searched Embase/Medline and medRxiv to identify the relevant literature. We identified 34 studies. During the first wave of the COVID-19 pandemic, school closing was t","2021","06","25","J Infect","The Journal of infection","COVID-19; SARS-CoV-2; Systematic review; epidemic; non-pharmaceutical interventions","Bcheraoui","Charbel El","Evidence-Based Public Health Unit, Centre for International Health Protection, Robert Koch Institute. Nordufer 20, 13353 Berlin, Germany",NA
"2656","34161818","10.1016/j.jinf.2021.06.018","Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.","To evaluate which non-pharmaceutical interventions (NPIs) have been more and less effective in controlling the COVID-19 pandemic. We performed a systematic review of published and unpublished empirical studies, either observational or interventional, analysing the comparative effectiveness of NPIs against the COVID-19 pandemic. We searched Embase/Medline and medRxiv to identify the relevant literature. We identified 34 studies. During the first wave of the COVID-19 pandemic, school closing was t","2021","06","25","J Infect","The Journal of infection","COVID-19; SARS-CoV-2; Systematic review; epidemic; non-pharmaceutical interventions","Pozo-Martin","Francisco","Evidence-Based Public Health Unit, Centre for International Health Protection, Robert Koch Institute. Nordufer 20, 13353 Berlin, Germany. Electronic address: Pozo-MartinF@rki","MartinF@rki.de"
"2657","34161817","10.1016/j.jinf.2021.06.017","Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.",NA,"2021","07","07","J Infect","The Journal of infection","Covid-19; Efficacy; Immunogenicity; SARS-CoV-2; mRNA-1273 vaccine","Tré-Hardy","Marie","Department of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium",NA
"2658","34161817","10.1016/j.jinf.2021.06.017","Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.",NA,"2021","07","07","J Infect","The Journal of infection","Covid-19; Efficacy; Immunogenicity; SARS-CoV-2; mRNA-1273 vaccine","Cupaiolo","Roberto","Department of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium",NA
"2659","34161817","10.1016/j.jinf.2021.06.017","Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.",NA,"2021","07","07","J Infect","The Journal of infection","Covid-19; Efficacy; Immunogenicity; SARS-CoV-2; mRNA-1273 vaccine","Wilmet","Alain","Department of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium",NA
"2660","34161817","10.1016/j.jinf.2021.06.017","Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.",NA,"2021","07","07","J Infect","The Journal of infection","Covid-19; Efficacy; Immunogenicity; SARS-CoV-2; mRNA-1273 vaccine","Beukinga","Ingrid","Department of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium",NA
"2661","34161817","10.1016/j.jinf.2021.06.017","Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.",NA,"2021","07","07","J Infect","The Journal of infection","Covid-19; Efficacy; Immunogenicity; SARS-CoV-2; mRNA-1273 vaccine","Blairon","Laurent","Department of Laboratory Medicine, Iris Hospitals South, rue Jean Paquot 63, Brussels 1050, Belgium",NA
"2662","34161811","10.1016/j.jpainsymman.2021.06.017","Transitioning to Remote Recruitment and Intervention: A Tale of Two Palliative Care Research Studies Enrolling Underserved Populations During COVID-19.","During the COVID-19 pandemic, community-based research studies experienced prolonged shutdowns unless able to pivot to remote study procedures. To describe the revision of two National Institutes of Health funded community-based palliative-focused clinical trials serving underserved populations to accommodate remote subject enrollment and examine its impact. Transitioning to remote processes required multiple protocol and procedural changes including: altering informed consent processes; reducin","2021","07","23","J Pain Symptom Manage","Journal of pain and symptom management","Palliative care; dementia; lay navigator; recruitment; underserved population; virtual enrollment","Brody","Abraham A","Division of Geriatric Medicine and Palliative Care, NYU Grossman School of Medicine, Hartford Institute for Geriatric Nursing, NYU Rory Meyers College of Nursing, Aurora, Colorado, USA",NA
"2663","34161811","10.1016/j.jpainsymman.2021.06.017","Transitioning to Remote Recruitment and Intervention: A Tale of Two Palliative Care Research Studies Enrolling Underserved Populations During COVID-19.","During the COVID-19 pandemic, community-based research studies experienced prolonged shutdowns unless able to pivot to remote study procedures. To describe the revision of two National Institutes of Health funded community-based palliative-focused clinical trials serving underserved populations to accommodate remote subject enrollment and examine its impact. Transitioning to remote processes required multiple protocol and procedural changes including: altering informed consent processes; reducin","2021","07","23","J Pain Symptom Manage","Journal of pain and symptom management","Palliative care; dementia; lay navigator; recruitment; underserved population; virtual enrollment","Convery","Kimberly A","Division of Geriatric Medicine and Palliative Care, NYU Grossman School of Medicine, Hartford Institute for Geriatric Nursing, NYU Rory Meyers College of Nursing, Aurora, Colorado, USA",NA
"2664","34161811","10.1016/j.jpainsymman.2021.06.017","Transitioning to Remote Recruitment and Intervention: A Tale of Two Palliative Care Research Studies Enrolling Underserved Populations During COVID-19.","During the COVID-19 pandemic, community-based research studies experienced prolonged shutdowns unless able to pivot to remote study procedures. To describe the revision of two National Institutes of Health funded community-based palliative-focused clinical trials serving underserved populations to accommodate remote subject enrollment and examine its impact. Transitioning to remote processes required multiple protocol and procedural changes including: altering informed consent processes; reducin","2021","07","23","J Pain Symptom Manage","Journal of pain and symptom management","Palliative care; dementia; lay navigator; recruitment; underserved population; virtual enrollment","Kline","Danielle M","Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA",NA
"2665","34161811","10.1016/j.jpainsymman.2021.06.017","Transitioning to Remote Recruitment and Intervention: A Tale of Two Palliative Care Research Studies Enrolling Underserved Populations During COVID-19.","During the COVID-19 pandemic, community-based research studies experienced prolonged shutdowns unless able to pivot to remote study procedures. To describe the revision of two National Institutes of Health funded community-based palliative-focused clinical trials serving underserved populations to accommodate remote subject enrollment and examine its impact. Transitioning to remote processes required multiple protocol and procedural changes including: altering informed consent processes; reducin","2021","07","23","J Pain Symptom Manage","Journal of pain and symptom management","Palliative care; dementia; lay navigator; recruitment; underserved population; virtual enrollment","Fink","Regina M","Division of General Internal Medicine, University of Colorado Anschutz Medical Campus, School of Medicine and College of Nursing, Aurora, Colorado, USA. Electronic address: regina.fink@cuanschutz","regina.fink@cuanschutz.edu"
"2666","34161811","10.1016/j.jpainsymman.2021.06.017","Transitioning to Remote Recruitment and Intervention: A Tale of Two Palliative Care Research Studies Enrolling Underserved Populations During COVID-19.","During the COVID-19 pandemic, community-based research studies experienced prolonged shutdowns unless able to pivot to remote study procedures. To describe the revision of two National Institutes of Health funded community-based palliative-focused clinical trials serving underserved populations to accommodate remote subject enrollment and examine its impact. Transitioning to remote processes required multiple protocol and procedural changes including: altering informed consent processes; reducin","2021","07","23","J Pain Symptom Manage","Journal of pain and symptom management","Palliative care; dementia; lay navigator; recruitment; underserved population; virtual enrollment","Fischer","Stacy M","Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA",NA
"2667","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Kamaladasa","Achala","AICBU, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka",NA
"2668","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Gunasekara","Banuri","AICBU, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka",NA
"2669","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Jeewandara","Chandima","AICBU, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka",NA
"2670","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Jayathilaka","Deshni","AICBU, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka",NA
"2671","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Wijewickrama","Ananda","National Institute of Infectious Diseases, Angoda, Sri Lanka",NA
"2672","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Guruge","Dinuka","Colombo Municipality Council, Sri Lanka",NA
"2673","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Wijayamuni","Ruwan","Colombo Municipality Council, Sri Lanka",NA
"2674","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Tan","T K","MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom",NA
"2675","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Ogg","Graham S","AICBU, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka",NA
"2676","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Townsend","Alain","MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom",NA
"2677","34161801","10.1016/j.ijid.2021.06.031","Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.","Neutralizing antibodies (NAbs) are important for protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection. In this study, two assays that are correlated with NAbs were compared: the haemagglutination test (HAT) and the surrogate virus neutralization test (sVNT). The specificity of the HAT was compared with the sVNT, and the sensitivity and persistence of antibodies in patients with varying severity of illness was assessed in a cohort of 71 patients at 4-6 weeks","2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Disease severity; Haemagglutination assay; Neutralizing antibodies; Surrogate neutralization assay","Malavige","Gathsaurie Neelika","AICBU, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka","gathsaurie.malavige@ndm.ox.ac.uk"
"2678","34161794","10.1016/j.annepidem.2021.06.003","Trends in the distribution of COVID-19 deaths by age and race/ethnicity - United States, April 4-December 26, 2020.",NA,"2021","06","25","Ann Epidemiol","Annals of epidemiology","Coronavirus 2019; Disparities; Mortality; National Vital Statistics System; SARS-CoV-2","Rossen","Lauren M","National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD. Electronic address: LRossen@cdc","LRossen@cdc.gov"
"2679","34161794","10.1016/j.annepidem.2021.06.003","Trends in the distribution of COVID-19 deaths by age and race/ethnicity - United States, April 4-December 26, 2020.",NA,"2021","06","25","Ann Epidemiol","Annals of epidemiology","Coronavirus 2019; Disparities; Mortality; National Vital Statistics System; SARS-CoV-2","Gold","Jeremy A W","Epidemic Intelligence Service, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, GA",NA
"2680","34161794","10.1016/j.annepidem.2021.06.003","Trends in the distribution of COVID-19 deaths by age and race/ethnicity - United States, April 4-December 26, 2020.",NA,"2021","06","25","Ann Epidemiol","Annals of epidemiology","Coronavirus 2019; Disparities; Mortality; National Vital Statistics System; SARS-CoV-2","Ahmad","Farida B","National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD",NA
"2681","34161794","10.1016/j.annepidem.2021.06.003","Trends in the distribution of COVID-19 deaths by age and race/ethnicity - United States, April 4-December 26, 2020.",NA,"2021","06","25","Ann Epidemiol","Annals of epidemiology","Coronavirus 2019; Disparities; Mortality; National Vital Statistics System; SARS-CoV-2","Sutton","Paul D","National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD",NA
"2682","34161794","10.1016/j.annepidem.2021.06.003","Trends in the distribution of COVID-19 deaths by age and race/ethnicity - United States, April 4-December 26, 2020.",NA,"2021","06","25","Ann Epidemiol","Annals of epidemiology","Coronavirus 2019; Disparities; Mortality; National Vital Statistics System; SARS-CoV-2","Branum","Amy M","National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD",NA
"2683","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Redzic","Jasmina S","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States",NA
"2684","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Lee","Eunjeong","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States",NA
"2685","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Born","Alexandra","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States",NA
"2686","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Issaian","Aaron","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States",NA
"2687","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Henen","Morkos A","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States",NA
"2688","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Nichols","Parker J","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States",NA
"2689","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Blue","Ashley","National High Magnetic Field Laboratory, Tallahassee, FL 32310, United States",NA
"2690","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Hansen","Kirk C","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States",NA
"2691","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","D'Alessandro","Angelo","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States",NA
"2692","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Vögeli","Beat","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States. Electronic address: beat.vogeli@cuanschutz","beat.vogeli@cuanschutz.edu"
"2693","34161778","10.1016/j.jmb.2021.167108","The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.","The nucleocapsid protein is one of four structural proteins encoded by SARS-CoV-2 and plays a central role in packaging viral RNA and manipulating the host cell machinery, yet its dynamic behavior and promiscuity in nucleotide binding has made standard structural methods to address its atomic-resolution details difficult. To begin addressing the SARS-CoV-2 nucleocapsid protein interactions with both RNA and the host cell along with its dynamic behavior, we have specifically focused on the folded","2021","07","21","J Mol Biol","Journal of molecular biology","RNA; SARS-CoV; cyclophilin-A; dynamics; nucleocapsid; Angiotensin-Converting Enzyme 2; Binding Sites; Evolution, Molecular; HEK293 Cells; Humans; Immune Evasion; Models, Molecular; Mutation; Protein Conformation; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Eisenmesser","Elan Zohar","Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States. Electronic address: Elan.Eisenmesser@ucdenver","Elan.Eisenmesser@ucdenver.edu"
"2694","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Copin","Richard","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2695","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Baum","Alina","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2696","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Wloga","Elzbieta","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2697","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Pascal","Kristen E","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2698","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Giordano","Stephanie","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2699","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Fulton","Benjamin O","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2700","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Zhou","Anbo","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2701","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Negron","Nicole","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2702","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Lanza","Kathryn","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2703","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Chan","Newton","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2704","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Coppola","Angel","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2705","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Chiu","Joyce","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2706","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Ni","Min","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2707","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Wei","Yi","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2708","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Atwal","Gurinder S","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2709","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Hernandez","Annabel Romero","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2710","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Saotome","Kei","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2711","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Zhou","Yi","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2712","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Franklin","Matthew C","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2713","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Hooper","Andrea T","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2714","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","McCarthy","Shane","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2715","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Hamon","Sara","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2716","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Hamilton","Jennifer D","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2717","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Staples","Hilary M","Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245, USA",NA
"2718","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Alfson","Kendra","Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245, USA",NA
"2719","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Carrion","Ricardo","Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245, USA",NA
"2720","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Ali","Shazia","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2721","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Norton","Thomas","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2722","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Somersan-Karakaya","Selin","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2723","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Sivapalasingam","Sumathi","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2724","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Herman","Gary A","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2725","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Weinreich","David M","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2726","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Lipsich","Leah","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2727","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Stahl","Neil","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2728","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Murphy","Andrew J","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2729","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Yancopoulos","George D","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA",NA
"2730","34161776","10.1016/j.cell.2021.06.002","The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.","Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option against COVID-19. Because rapidly emerging virus mutants are becoming the next major concern in the fight against the global pandemic, it is imperative that these therapeutic treatments provide coverage against circulating variants and do not contribute to development of treatment-induced emergent resistance. To this end, we investigated the sequence diversity of the spike protein and monitored emergence of vi","2021","07","23","Cell","Cell","COVID-19; REGEN-COV; SARS-CoV-2; escape; monoclonal antibodies","Kyratsous","Christos A","Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA. Electronic address: christos.kyratsous@regeneron","christos.kyratsous@regeneron.com"
"2731","34161756","10.1016/j.str.2021.06.002","Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.","There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M<sup>pro</sup>) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors described thus far are peptidomimetic and bind to the active-site cysteine via a covalent adduct, which is generally pharmacokinetically unfavorable. We have reported the optimization of an ","2021","06","25","Structure","Structure (London, England : 1993)","3CL M(pro); 3CL main protease; SARS-CoV-2; X-ray crystallography; drug design; enzyme kinetics; protease inhibitor","Deshmukh","Maya G","Medical Scientist Training Program (MD-PhD), Yale School of Medicine, New Haven, CT, USA",NA
"2732","34161756","10.1016/j.str.2021.06.002","Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.","There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M<sup>pro</sup>) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors described thus far are peptidomimetic and bind to the active-site cysteine via a covalent adduct, which is generally pharmacokinetically unfavorable. We have reported the optimization of an ","2021","06","25","Structure","Structure (London, England : 1993)","3CL M(pro); 3CL main protease; SARS-CoV-2; X-ray crystallography; drug design; enzyme kinetics; protease inhibitor","Ippolito","Joseph A","Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA",NA
"2733","34161756","10.1016/j.str.2021.06.002","Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.","There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M<sup>pro</sup>) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors described thus far are peptidomimetic and bind to the active-site cysteine via a covalent adduct, which is generally pharmacokinetically unfavorable. We have reported the optimization of an ","2021","06","25","Structure","Structure (London, England : 1993)","3CL M(pro); 3CL main protease; SARS-CoV-2; X-ray crystallography; drug design; enzyme kinetics; protease inhibitor","Zhang","Chun-Hui","Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA",NA
"2734","34161756","10.1016/j.str.2021.06.002","Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.","There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M<sup>pro</sup>) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors described thus far are peptidomimetic and bind to the active-site cysteine via a covalent adduct, which is generally pharmacokinetically unfavorable. We have reported the optimization of an ","2021","06","25","Structure","Structure (London, England : 1993)","3CL M(pro); 3CL main protease; SARS-CoV-2; X-ray crystallography; drug design; enzyme kinetics; protease inhibitor","Stone","Elizabeth A","Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA",NA
"2735","34161756","10.1016/j.str.2021.06.002","Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.","There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M<sup>pro</sup>) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors described thus far are peptidomimetic and bind to the active-site cysteine via a covalent adduct, which is generally pharmacokinetically unfavorable. We have reported the optimization of an ","2021","06","25","Structure","Structure (London, England : 1993)","3CL M(pro); 3CL main protease; SARS-CoV-2; X-ray crystallography; drug design; enzyme kinetics; protease inhibitor","Reilly","Raquel A","Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066, USA",NA
"2736","34161756","10.1016/j.str.2021.06.002","Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.","There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M<sup>pro</sup>) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors described thus far are peptidomimetic and bind to the active-site cysteine via a covalent adduct, which is generally pharmacokinetically unfavorable. We have reported the optimization of an ","2021","06","25","Structure","Structure (London, England : 1993)","3CL M(pro); 3CL main protease; SARS-CoV-2; X-ray crystallography; drug design; enzyme kinetics; protease inhibitor","Miller","Scott J","Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA",NA
"2737","34161756","10.1016/j.str.2021.06.002","Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.","There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M<sup>pro</sup>) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors described thus far are peptidomimetic and bind to the active-site cysteine via a covalent adduct, which is generally pharmacokinetically unfavorable. We have reported the optimization of an ","2021","06","25","Structure","Structure (London, England : 1993)","3CL M(pro); 3CL main protease; SARS-CoV-2; X-ray crystallography; drug design; enzyme kinetics; protease inhibitor","Jorgensen","William L","Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA",NA
"2738","34161756","10.1016/j.str.2021.06.002","Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.","There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M<sup>pro</sup>) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors described thus far are peptidomimetic and bind to the active-site cysteine via a covalent adduct, which is generally pharmacokinetically unfavorable. We have reported the optimization of an ","2021","06","25","Structure","Structure (London, England : 1993)","3CL M(pro); 3CL main protease; SARS-CoV-2; X-ray crystallography; drug design; enzyme kinetics; protease inhibitor","Anderson","Karen S","Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066, USA","karen.anderson@yale.edu"
"2739","34161754","10.1071/AH20233","Innovative preclinic triage system to guide Australians to the right mental health care first time.","This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the h","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Davenport","Tracey A",NA,NA
"2740","34161754","10.1071/AH20233","Innovative preclinic triage system to guide Australians to the right mental health care first time.","This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the h","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"LaMonica","Haley M",NA,NA
"2741","34161754","10.1071/AH20233","Innovative preclinic triage system to guide Australians to the right mental health care first time.","This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the h","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Rowe","Shelley",NA,NA
"2742","34161754","10.1071/AH20233","Innovative preclinic triage system to guide Australians to the right mental health care first time.","This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the h","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Sturgess","Julie",NA,NA
"2743","34161754","10.1071/AH20233","Innovative preclinic triage system to guide Australians to the right mental health care first time.","This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the h","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Scott","Elizabeth M",NA,NA
"2744","34161754","10.1071/AH20233","Innovative preclinic triage system to guide Australians to the right mental health care first time.","This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the h","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Lee","Grace",NA,NA
"2745","34161754","10.1071/AH20233","Innovative preclinic triage system to guide Australians to the right mental health care first time.","This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the h","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Cheng","Vanessa Wan Sze",NA,NA
"2746","34161754","10.1071/AH20233","Innovative preclinic triage system to guide Australians to the right mental health care first time.","This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the h","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Hickie","Ian B",NA,NA
"2747","34161753","10.1071/AH20307","It.","ObjectiveMindStep is an Australian low-intensity cognitive behaviour therapy (LICBT) program for individuals with mild-to-moderate symptoms of anxiety and depression. UK-produced LICBT guided self-help (GSH) materials were originally used in the MindStep program. In 2017, Australian LICBT GSH materials were developed to better suit Australian users. This study explored whether the Australian-produced materials continued to achieve the benchmark recovery rates established in the UK and maintain","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Venning","Anthony",NA,NA
"2748","34161753","10.1071/AH20307","It.","ObjectiveMindStep is an Australian low-intensity cognitive behaviour therapy (LICBT) program for individuals with mild-to-moderate symptoms of anxiety and depression. UK-produced LICBT guided self-help (GSH) materials were originally used in the MindStep program. In 2017, Australian LICBT GSH materials were developed to better suit Australian users. This study explored whether the Australian-produced materials continued to achieve the benchmark recovery rates established in the UK and maintain","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Oswald","Tassia K",NA,NA
"2749","34161753","10.1071/AH20307","It.","ObjectiveMindStep is an Australian low-intensity cognitive behaviour therapy (LICBT) program for individuals with mild-to-moderate symptoms of anxiety and depression. UK-produced LICBT guided self-help (GSH) materials were originally used in the MindStep program. In 2017, Australian LICBT GSH materials were developed to better suit Australian users. This study explored whether the Australian-produced materials continued to achieve the benchmark recovery rates established in the UK and maintain","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Barnes","Mary",NA,NA
"2750","34161753","10.1071/AH20307","It.","ObjectiveMindStep is an Australian low-intensity cognitive behaviour therapy (LICBT) program for individuals with mild-to-moderate symptoms of anxiety and depression. UK-produced LICBT guided self-help (GSH) materials were originally used in the MindStep program. In 2017, Australian LICBT GSH materials were developed to better suit Australian users. This study explored whether the Australian-produced materials continued to achieve the benchmark recovery rates established in the UK and maintain","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Glover","Fiona",NA,NA
"2751","34161753","10.1071/AH20307","It.","ObjectiveMindStep is an Australian low-intensity cognitive behaviour therapy (LICBT) program for individuals with mild-to-moderate symptoms of anxiety and depression. UK-produced LICBT guided self-help (GSH) materials were originally used in the MindStep program. In 2017, Australian LICBT GSH materials were developed to better suit Australian users. This study explored whether the Australian-produced materials continued to achieve the benchmark recovery rates established in the UK and maintain","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Lawn","Sharon",NA,NA
"2752","34161753","10.1071/AH20307","It.","ObjectiveMindStep is an Australian low-intensity cognitive behaviour therapy (LICBT) program for individuals with mild-to-moderate symptoms of anxiety and depression. UK-produced LICBT guided self-help (GSH) materials were originally used in the MindStep program. In 2017, Australian LICBT GSH materials were developed to better suit Australian users. This study explored whether the Australian-produced materials continued to achieve the benchmark recovery rates established in the UK and maintain","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Azadi","Leva",NA,NA
"2753","34161753","10.1071/AH20307","It.","ObjectiveMindStep is an Australian low-intensity cognitive behaviour therapy (LICBT) program for individuals with mild-to-moderate symptoms of anxiety and depression. UK-produced LICBT guided self-help (GSH) materials were originally used in the MindStep program. In 2017, Australian LICBT GSH materials were developed to better suit Australian users. This study explored whether the Australian-produced materials continued to achieve the benchmark recovery rates established in the UK and maintain","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Tepper","Nicci",NA,NA
"2754","34161753","10.1071/AH20307","It.","ObjectiveMindStep is an Australian low-intensity cognitive behaviour therapy (LICBT) program for individuals with mild-to-moderate symptoms of anxiety and depression. UK-produced LICBT guided self-help (GSH) materials were originally used in the MindStep program. In 2017, Australian LICBT GSH materials were developed to better suit Australian users. This study explored whether the Australian-produced materials continued to achieve the benchmark recovery rates established in the UK and maintain","2021","06","23","Aust Health Rev","Australian health review : a publication of the Australian Hospital Association",NA,"Redpath","Paula",NA,NA
"2755","34161739","10.1044/2021_AJSLP-20-00325","The Impact of COVID-19 on Speech-Language Pathologists Engaged in Clinical Practices With Elevated Coronavirus Transmission Risk.","Purpose This study assessed and described potential clinical practice changes secondary to COVID-19 that emerged as an early response to the pandemic for speech-language pathologists (SLPs) engaged in voice, alaryngeal, and swallowing activities that may increase the risk of virus transmission. Method SLPs from the United States and Canada (n = 665) who were engaged in clinical activities that might elevate the risk of COVID-19 exposure completed an online survey regarding their clinical ","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Attitude of Health Personnel; COVID-19; COVID-19 Testing; Humans; Pathologists; SARS-CoV-2; Speech; Speech-Language Pathology; Surveys and Questionnaires; United States","Kearney","Ann","Department of Otolaryngology - Head and Neck Surgery, Division of Laryngology, Stanford University School of Medicine, CA",NA
"2756","34161739","10.1044/2021_AJSLP-20-00325","The Impact of COVID-19 on Speech-Language Pathologists Engaged in Clinical Practices With Elevated Coronavirus Transmission Risk.","Purpose This study assessed and described potential clinical practice changes secondary to COVID-19 that emerged as an early response to the pandemic for speech-language pathologists (SLPs) engaged in voice, alaryngeal, and swallowing activities that may increase the risk of virus transmission. Method SLPs from the United States and Canada (n = 665) who were engaged in clinical activities that might elevate the risk of COVID-19 exposure completed an online survey regarding their clinical ","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Attitude of Health Personnel; COVID-19; COVID-19 Testing; Humans; Pathologists; SARS-CoV-2; Speech; Speech-Language Pathology; Surveys and Questionnaires; United States","Searl","Jeff","Department of Communicative Sciences and Disorders, Michigan State University, East Lansing",NA
"2757","34161739","10.1044/2021_AJSLP-20-00325","The Impact of COVID-19 on Speech-Language Pathologists Engaged in Clinical Practices With Elevated Coronavirus Transmission Risk.","Purpose This study assessed and described potential clinical practice changes secondary to COVID-19 that emerged as an early response to the pandemic for speech-language pathologists (SLPs) engaged in voice, alaryngeal, and swallowing activities that may increase the risk of virus transmission. Method SLPs from the United States and Canada (n = 665) who were engaged in clinical activities that might elevate the risk of COVID-19 exposure completed an online survey regarding their clinical ","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Attitude of Health Personnel; COVID-19; COVID-19 Testing; Humans; Pathologists; SARS-CoV-2; Speech; Speech-Language Pathology; Surveys and Questionnaires; United States","Erickson-DiRenzo","Elizabeth","Department of Otolaryngology - Head and Neck Surgery, Division of Laryngology, Stanford University School of Medicine, CA",NA
"2758","34161739","10.1044/2021_AJSLP-20-00325","The Impact of COVID-19 on Speech-Language Pathologists Engaged in Clinical Practices With Elevated Coronavirus Transmission Risk.","Purpose This study assessed and described potential clinical practice changes secondary to COVID-19 that emerged as an early response to the pandemic for speech-language pathologists (SLPs) engaged in voice, alaryngeal, and swallowing activities that may increase the risk of virus transmission. Method SLPs from the United States and Canada (n = 665) who were engaged in clinical activities that might elevate the risk of COVID-19 exposure completed an online survey regarding their clinical ","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Attitude of Health Personnel; COVID-19; COVID-19 Testing; Humans; Pathologists; SARS-CoV-2; Speech; Speech-Language Pathology; Surveys and Questionnaires; United States","Doyle","Philip C","Department of Otolaryngology - Head and Neck Surgery, Division of Laryngology, Stanford University School of Medicine, CA",NA
"2759","34161714","10.1056/NEJMe2110531","Audio Interview: A New mRNA Vaccine.",NA,"2021","07","07","N Engl J Med","The New England journal of medicine","Adenoviridae; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Disease Transmission, Infectious; Genetic Vectors; Humans; Immunocompromised Host; Immunogenicity, Vaccine; Time Factors; Vaccines, Inactivated; Vaccines, Synthetic","Rubin","Eric J",NA,NA
"2760","34161714","10.1056/NEJMe2110531","Audio Interview: A New mRNA Vaccine.",NA,"2021","07","07","N Engl J Med","The New England journal of medicine","Adenoviridae; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Disease Transmission, Infectious; Genetic Vectors; Humans; Immunocompromised Host; Immunogenicity, Vaccine; Time Factors; Vaccines, Inactivated; Vaccines, Synthetic","Baden","Lindsey R",NA,NA
"2761","34161714","10.1056/NEJMe2110531","Audio Interview: A New mRNA Vaccine.",NA,"2021","07","07","N Engl J Med","The New England journal of medicine","Adenoviridae; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Disease Transmission, Infectious; Genetic Vectors; Humans; Immunocompromised Host; Immunogenicity, Vaccine; Time Factors; Vaccines, Inactivated; Vaccines, Synthetic","Morrissey","Stephen",NA,NA
"2762","34161702","10.1056/NEJMc2107717","Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Harris","Ross J","Public Health England, London, United Kingdom feedback.c19epi@phe.gov","feedback.c19epi@phe.gov.uk"
"2763","34161702","10.1056/NEJMc2107717","Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Hall","Jennifer A","University College London Institute for Women's Health, London, United Kingdom",NA
"2764","34161702","10.1056/NEJMc2107717","Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Zaidi","Asad","Public Health England, London, United Kingdom",NA
"2765","34161702","10.1056/NEJMc2107717","Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Andrews","Nick J","Public Health England, London, United Kingdom",NA
"2766","34161702","10.1056/NEJMc2107717","Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Dunbar","J Kevin","Public Health England, London, United Kingdom",NA
"2767","34161702","10.1056/NEJMc2107717","Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Dabrera","Gavin","Public Health England, London, United Kingdom",NA
"2768","34161700","10.1056/NEJMc2108861","Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Kamar","Nassim","Toulouse University Hospital, Toulouse, France kamar.n@chu-toulouse",NA
"2769","34161700","10.1056/NEJMc2108861","Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Abravanel","Florence","Toulouse University Hospital, Toulouse, France kamar.n@chu-toulouse",NA
"2770","34161700","10.1056/NEJMc2108861","Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Marion","Olivier","Toulouse University Hospital, Toulouse, France kamar.n@chu-toulouse",NA
"2771","34161700","10.1056/NEJMc2108861","Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Couat","Chloé","Toulouse University Hospital, Toulouse, France kamar.n@chu-toulouse",NA
"2772","34161700","10.1056/NEJMc2108861","Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Izopet","Jacques","Toulouse University Hospital, Toulouse, France kamar.n@chu-toulouse",NA
"2773","34161700","10.1056/NEJMc2108861","Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.",NA,"2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Del Bello","Arnaud","Toulouse University Hospital, Toulouse, France kamar.n@chu-toulouse",NA
"2774","34161693","10.1515/znc-2020-0291","Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends.","The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals proc","2021","06","23","Z Naturforsch C J Biosci","Zeitschrift fur Naturforschung. C, Journal of biosciences","COVID19; Pakistan; SARS-CoV-2; epidemiology; seroprevalence","Waqar","Muhammad","Department of Biotechnology, Quaid Azam University Islamabad, Islamabad, Pakistan",NA
"2775","34161693","10.1515/znc-2020-0291","Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends.","The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals proc","2021","06","23","Z Naturforsch C J Biosci","Zeitschrift fur Naturforschung. C, Journal of biosciences","COVID19; Pakistan; SARS-CoV-2; epidemiology; seroprevalence","Wahid","Braira","Monash Biomedicine Discovery Institute, Monash University, Melbourne, Australia",NA
"2776","34161693","10.1515/znc-2020-0291","Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends.","The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals proc","2021","06","23","Z Naturforsch C J Biosci","Zeitschrift fur Naturforschung. C, Journal of biosciences","COVID19; Pakistan; SARS-CoV-2; epidemiology; seroprevalence","Idrees","Muhammad","Center for Excellence in Molecular Biology, University of Punjab, Lahore, Pakistan",NA
"2777","34161693","10.1515/znc-2020-0291","Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends.","The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals proc","2021","06","23","Z Naturforsch C J Biosci","Zeitschrift fur Naturforschung. C, Journal of biosciences","COVID19; Pakistan; SARS-CoV-2; epidemiology; seroprevalence","Ali","Muhammad","Department of Biotechnology, Quaid Azam University Islamabad, Islamabad, Pakistan",NA
"2778","34161693","10.1515/znc-2020-0291","Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends.","The emergence of the pandemic in 2020 is a huge threat to global public health. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China in December 2019 and later spread to almost all parts of the world in four months and declared as a pandemic in March 2020. SARS-CoV-2 has infected 15.8 million people worldwide while 641,000 died of it. This study aims to report the seroprevalence of SARS-CoV-2 in Pakistan. Of total of 635 samples of symptomatic individuals proc","2021","06","23","Z Naturforsch C J Biosci","Zeitschrift fur Naturforschung. C, Journal of biosciences","COVID19; Pakistan; SARS-CoV-2; epidemiology; seroprevalence","Rehman","Zobaria","Genome Center for Molecular Based Diagnostic &amp",NA
"2779","34161688","","Adolescent Vaping and COVID-19: When an Epidemic Meets a Pandemic.","National epidemiological studies indicate that vaping or e-cigarette use has increased in alarming proportions among American adolescents. In vaping, a battery-powered device heats up a liquid into an aerosol which is inhaled by the user. The aerosol, commonly referred to as vapor, usually contains nicotine, flavoring, marijuana along with other chemicals and substances. This article highlights serious yet avoidable health risks from vaping amidst the coronavirus disease 2019 (COVID-19) pandemic","2021","06","25","S D Med","South Dakota medicine : the journal of the South Dakota State Medical Association","Adolescent; COVID-19; Electronic Nicotine Delivery Systems; Humans; Pandemics; SARS-CoV-2; South Dakota; United States; Vaping","Waligoske","Kate","University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota",NA
"2780","34161688","","Adolescent Vaping and COVID-19: When an Epidemic Meets a Pandemic.","National epidemiological studies indicate that vaping or e-cigarette use has increased in alarming proportions among American adolescents. In vaping, a battery-powered device heats up a liquid into an aerosol which is inhaled by the user. The aerosol, commonly referred to as vapor, usually contains nicotine, flavoring, marijuana along with other chemicals and substances. This article highlights serious yet avoidable health risks from vaping amidst the coronavirus disease 2019 (COVID-19) pandemic","2021","06","25","S D Med","South Dakota medicine : the journal of the South Dakota State Medical Association","Adolescent; COVID-19; Electronic Nicotine Delivery Systems; Humans; Pandemics; SARS-CoV-2; South Dakota; United States; Vaping","Anand","Vivek","Avera Medical Group, University Psychiatry Associates, Sioux Falls, South Dakota",NA
"2781","34161684","","COVID-19 Isolation and Quarantine Guidelines for Older Adults in Nursing Homes.","The COVID-19 pandemic poses an ever-increasing threat to older Americans, especially those in nursing homes. The compact nature of these facilities and the morbidities shared by this population make them susceptible to the virus and its symptoms. Because of this, the CDC has published guidelines directed at isolation and quarantine measures specifically created to protect this patient population. These measures are comprehensive and provide examples and management of situations, such as admissio","2021","06","25","S D Med","South Dakota medicine : the journal of the South Dakota State Medical Association","Aged; COVID-19; Humans; Nursing Homes; Pandemics; Quarantine; SARS-CoV-2; United States","Esper","Jacob J","Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania",NA
"2782","34161684","","COVID-19 Isolation and Quarantine Guidelines for Older Adults in Nursing Homes.","The COVID-19 pandemic poses an ever-increasing threat to older Americans, especially those in nursing homes. The compact nature of these facilities and the morbidities shared by this population make them susceptible to the virus and its symptoms. Because of this, the CDC has published guidelines directed at isolation and quarantine measures specifically created to protect this patient population. These measures are comprehensive and provide examples and management of situations, such as admissio","2021","06","25","S D Med","South Dakota medicine : the journal of the South Dakota State Medical Association","Aged; COVID-19; Humans; Nursing Homes; Pandemics; Quarantine; SARS-CoV-2; United States","Garg","Divya","University College of Medical Sciences, Delhi, India",NA
"2783","34161684","","COVID-19 Isolation and Quarantine Guidelines for Older Adults in Nursing Homes.","The COVID-19 pandemic poses an ever-increasing threat to older Americans, especially those in nursing homes. The compact nature of these facilities and the morbidities shared by this population make them susceptible to the virus and its symptoms. Because of this, the CDC has published guidelines directed at isolation and quarantine measures specifically created to protect this patient population. These measures are comprehensive and provide examples and management of situations, such as admissio","2021","06","25","S D Med","South Dakota medicine : the journal of the South Dakota State Medical Association","Aged; COVID-19; Humans; Nursing Homes; Pandemics; Quarantine; SARS-CoV-2; United States","McClafferty","Brendan R","Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania",NA
"2784","34161684","","COVID-19 Isolation and Quarantine Guidelines for Older Adults in Nursing Homes.","The COVID-19 pandemic poses an ever-increasing threat to older Americans, especially those in nursing homes. The compact nature of these facilities and the morbidities shared by this population make them susceptible to the virus and its symptoms. Because of this, the CDC has published guidelines directed at isolation and quarantine measures specifically created to protect this patient population. These measures are comprehensive and provide examples and management of situations, such as admissio","2021","06","25","S D Med","South Dakota medicine : the journal of the South Dakota State Medical Association","Aged; COVID-19; Humans; Nursing Homes; Pandemics; Quarantine; SARS-CoV-2; United States","Golamari","Reshma","Division of Hospital Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania",NA
"2785","34161684","","COVID-19 Isolation and Quarantine Guidelines for Older Adults in Nursing Homes.","The COVID-19 pandemic poses an ever-increasing threat to older Americans, especially those in nursing homes. The compact nature of these facilities and the morbidities shared by this population make them susceptible to the virus and its symptoms. Because of this, the CDC has published guidelines directed at isolation and quarantine measures specifically created to protect this patient population. These measures are comprehensive and provide examples and management of situations, such as admissio","2021","06","25","S D Med","South Dakota medicine : the journal of the South Dakota State Medical Association","Aged; COVID-19; Humans; Nursing Homes; Pandemics; Quarantine; SARS-CoV-2; United States","Jain","Rohit","Division of Hospital Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania",NA
"2786","34161659","10.1002/nop2.957","COVID-19-The impact of variable and ""low normal"" pulse oximetry scores on Oximetry@Home services and clinical pathways: Confounding variables?","COVID-19 Oximetry@Home services have been commissioned nationally. This allows higher-risk patients with mild COVID-19 symptoms to remain at home, being supplied with a Pulse Oximeter to measure their oxygen saturation (SpO2 ) two to three times daily for two weeks. Patients record their readings manually or electronically which are monitored by a clinical team. Clinical decisions, using an algorithm, are based on SpO2 readings in a narrow range with 1-2 point changes poten","2021","06","23","Nurs Open","Nursing open","COVID-19; oximetry@home; oxygen saturation; pulse oximeter","Harland","Nicholas","Faculty of Health Science and Wellbeing, Helen McArdle Nursing and Care Research Institute, University of Sunderland, Sunderland, UK",NA
"2787","34161659","10.1002/nop2.957","COVID-19-The impact of variable and ""low normal"" pulse oximetry scores on Oximetry@Home services and clinical pathways: Confounding variables?","COVID-19 Oximetry@Home services have been commissioned nationally. This allows higher-risk patients with mild COVID-19 symptoms to remain at home, being supplied with a Pulse Oximeter to measure their oxygen saturation (SpO2 ) two to three times daily for two weeks. Patients record their readings manually or electronically which are monitored by a clinical team. Clinical decisions, using an algorithm, are based on SpO2 readings in a narrow range with 1-2 point changes poten","2021","06","23","Nurs Open","Nursing open","COVID-19; oximetry@home; oxygen saturation; pulse oximeter","Greaves","Jane","Northumbria University, Newcastle upon Tyne, UK",NA
"2788","34161659","10.1002/nop2.957","COVID-19-The impact of variable and ""low normal"" pulse oximetry scores on Oximetry@Home services and clinical pathways: Confounding variables?","COVID-19 Oximetry@Home services have been commissioned nationally. This allows higher-risk patients with mild COVID-19 symptoms to remain at home, being supplied with a Pulse Oximeter to measure their oxygen saturation (SpO2 ) two to three times daily for two weeks. Patients record their readings manually or electronically which are monitored by a clinical team. Clinical decisions, using an algorithm, are based on SpO2 readings in a narrow range with 1-2 point changes poten","2021","06","23","Nurs Open","Nursing open","COVID-19; oximetry@home; oxygen saturation; pulse oximeter","Fuller","Elizabeth","South Tyneside NHS Foundation Trust, South Shields, UK",NA
"2790","34161635","10.1111/1468-0009.12530","The Structure and Financing of Health Care Systems Affected How Providers Coped With COVID-19.","Policy Points We compared the structure of health care systems and the financial effects of the COVID-19 pandemic on health care providers in the United States, England, Germany, and Israel: systems incorporating both public and private insurers and providers. The negative financial effects on health care providers have been more severe in the United States than elsewhere, owing to the prevalence of activity-based payment systems, limited direct governmental control over available provider capac","2021","07","07","Milbank Q","The Milbank quarterly","COVID-19; Delivery of Health Care; England; Germany; Humans; Insurance, Health; Israel; Pandemics; Reimbursement Mechanisms; SARS-CoV-2; United States","Waitzberg","Ruth","Smokler Center for Health Policy Research, Myers-JDC-Brookdale Institute, Jerusalem",NA
"2791","34161635","10.1111/1468-0009.12530","The Structure and Financing of Health Care Systems Affected How Providers Coped With COVID-19.","Policy Points We compared the structure of health care systems and the financial effects of the COVID-19 pandemic on health care providers in the United States, England, Germany, and Israel: systems incorporating both public and private insurers and providers. The negative financial effects on health care providers have been more severe in the United States than elsewhere, owing to the prevalence of activity-based payment systems, limited direct governmental control over available provider capac","2021","07","07","Milbank Q","The Milbank quarterly","COVID-19; Delivery of Health Care; England; Germany; Humans; Insurance, Health; Israel; Pandemics; Reimbursement Mechanisms; SARS-CoV-2; United States","Quentin","Wilm","Technical University Berlin",NA
"2792","34161635","10.1111/1468-0009.12530","The Structure and Financing of Health Care Systems Affected How Providers Coped With COVID-19.","Policy Points We compared the structure of health care systems and the financial effects of the COVID-19 pandemic on health care providers in the United States, England, Germany, and Israel: systems incorporating both public and private insurers and providers. The negative financial effects on health care providers have been more severe in the United States than elsewhere, owing to the prevalence of activity-based payment systems, limited direct governmental control over available provider capac","2021","07","07","Milbank Q","The Milbank quarterly","COVID-19; Delivery of Health Care; England; Germany; Humans; Insurance, Health; Israel; Pandemics; Reimbursement Mechanisms; SARS-CoV-2; United States","Webb","Erin","Technical University Berlin",NA
"2793","34161635","10.1111/1468-0009.12530","The Structure and Financing of Health Care Systems Affected How Providers Coped With COVID-19.","Policy Points We compared the structure of health care systems and the financial effects of the COVID-19 pandemic on health care providers in the United States, England, Germany, and Israel: systems incorporating both public and private insurers and providers. The negative financial effects on health care providers have been more severe in the United States than elsewhere, owing to the prevalence of activity-based payment systems, limited direct governmental control over available provider capac","2021","07","07","Milbank Q","The Milbank quarterly","COVID-19; Delivery of Health Care; England; Germany; Humans; Insurance, Health; Israel; Pandemics; Reimbursement Mechanisms; SARS-CoV-2; United States","Glied","Sherry","Robert F. Wagner Graduate School of Public Service, New York University",NA
"2794","34161626","10.1002/ncp.10731","Sarcopenic dysphagia following COVID-19 infection: A new danger.","Oropharyngeal dysphagia is one of the complications of endotracheal intubation. As expected, cases of dysphagia following coronavirus disease 2019 (COVID-19) reported to date have all been intubated. We here report a case of sarcopenic dysphagia following severe COVID-19 pneumonia in a nonintubated older adult. The patient was an 85-year-old male who was readmitted to the hospital with dysphagia and subsequent aspiration pneumonia in the first week after his discharge from the COVID-19 unit. On ","2021","06","23","Nutr Clin Pract","Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition","COVID-19; aspiration pneumonia; dysphagia; sarcopenia","Can","Büsra","Division of Geriatrics, Department of Internal Medicine, Marmara University Faculty of Medicine, Istanbul, Turkey",NA
"2795","34161626","10.1002/ncp.10731","Sarcopenic dysphagia following COVID-19 infection: A new danger.","Oropharyngeal dysphagia is one of the complications of endotracheal intubation. As expected, cases of dysphagia following coronavirus disease 2019 (COVID-19) reported to date have all been intubated. We here report a case of sarcopenic dysphagia following severe COVID-19 pneumonia in a nonintubated older adult. The patient was an 85-year-old male who was readmitted to the hospital with dysphagia and subsequent aspiration pneumonia in the first week after his discharge from the COVID-19 unit. On ","2021","06","23","Nutr Clin Pract","Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition","COVID-19; aspiration pneumonia; dysphagia; sarcopenia","Ismagulova","Narkiza","Department of Infectious Diseases, Marmara University Faculty of Medicine, Istanbul, Turkey",NA
"2796","34161626","10.1002/ncp.10731","Sarcopenic dysphagia following COVID-19 infection: A new danger.","Oropharyngeal dysphagia is one of the complications of endotracheal intubation. As expected, cases of dysphagia following coronavirus disease 2019 (COVID-19) reported to date have all been intubated. We here report a case of sarcopenic dysphagia following severe COVID-19 pneumonia in a nonintubated older adult. The patient was an 85-year-old male who was readmitted to the hospital with dysphagia and subsequent aspiration pneumonia in the first week after his discharge from the COVID-19 unit. On ","2021","06","23","Nutr Clin Pract","Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition","COVID-19; aspiration pneumonia; dysphagia; sarcopenia","Enver","Necati","Department of Otorhinolaryngology, Marmara University Faculty of Medicine, Istanbul, Turkey",NA
"2797","34161626","10.1002/ncp.10731","Sarcopenic dysphagia following COVID-19 infection: A new danger.","Oropharyngeal dysphagia is one of the complications of endotracheal intubation. As expected, cases of dysphagia following coronavirus disease 2019 (COVID-19) reported to date have all been intubated. We here report a case of sarcopenic dysphagia following severe COVID-19 pneumonia in a nonintubated older adult. The patient was an 85-year-old male who was readmitted to the hospital with dysphagia and subsequent aspiration pneumonia in the first week after his discharge from the COVID-19 unit. On ","2021","06","23","Nutr Clin Pract","Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition","COVID-19; aspiration pneumonia; dysphagia; sarcopenia","Tufan","Asli","Division of Geriatrics, Department of Internal Medicine, Marmara University Faculty of Medicine, Istanbul, Turkey",NA
"2798","34161626","10.1002/ncp.10731","Sarcopenic dysphagia following COVID-19 infection: A new danger.","Oropharyngeal dysphagia is one of the complications of endotracheal intubation. As expected, cases of dysphagia following coronavirus disease 2019 (COVID-19) reported to date have all been intubated. We here report a case of sarcopenic dysphagia following severe COVID-19 pneumonia in a nonintubated older adult. The patient was an 85-year-old male who was readmitted to the hospital with dysphagia and subsequent aspiration pneumonia in the first week after his discharge from the COVID-19 unit. On ","2021","06","23","Nutr Clin Pract","Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition","COVID-19; aspiration pneumonia; dysphagia; sarcopenia","Cinel","Ismail","Department of Anesthesiology, Marmara University Faculty of Medicine, Istanbul, Turkey",NA
"2799","34161625","10.1002/hpm.3263","COVID-19 and progress towards achieving universal health coverage in Africa: A case of Nigeria.","Universal Health Coverage (UHC) 2030 is a global health target, and countries are making efforts to convert plans into tangible results. Nigeria, the most populated country in Africa, has made commitments towards UHC2030 target but is underperforming across many building blocks of health and progress has been slow. The arrival of COVID-19 poses additional pressure on the already feeble health system causing the government to direct focus towards containing the pandemic. However, existing gaps in","2021","06","23","Int J Health Plann Manage","The International journal of health planning and management","Africa; COVID-19; Nigeria; Universal Health Coverage; health system strengthening","Amos","Oladunni Abimbola","Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria",NA
"2800","34161625","10.1002/hpm.3263","COVID-19 and progress towards achieving universal health coverage in Africa: A case of Nigeria.","Universal Health Coverage (UHC) 2030 is a global health target, and countries are making efforts to convert plans into tangible results. Nigeria, the most populated country in Africa, has made commitments towards UHC2030 target but is underperforming across many building blocks of health and progress has been slow. The arrival of COVID-19 poses additional pressure on the already feeble health system causing the government to direct focus towards containing the pandemic. However, existing gaps in","2021","06","23","Int J Health Plann Manage","The International journal of health planning and management","Africa; COVID-19; Nigeria; Universal Health Coverage; health system strengthening","Adebisi","Yusuff Adebayo","Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria",NA
"2801","34161625","10.1002/hpm.3263","COVID-19 and progress towards achieving universal health coverage in Africa: A case of Nigeria.","Universal Health Coverage (UHC) 2030 is a global health target, and countries are making efforts to convert plans into tangible results. Nigeria, the most populated country in Africa, has made commitments towards UHC2030 target but is underperforming across many building blocks of health and progress has been slow. The arrival of COVID-19 poses additional pressure on the already feeble health system causing the government to direct focus towards containing the pandemic. However, existing gaps in","2021","06","23","Int J Health Plann Manage","The International journal of health planning and management","Africa; COVID-19; Nigeria; Universal Health Coverage; health system strengthening","Bamisaiye","Adeola","Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria",NA
"2802","34161625","10.1002/hpm.3263","COVID-19 and progress towards achieving universal health coverage in Africa: A case of Nigeria.","Universal Health Coverage (UHC) 2030 is a global health target, and countries are making efforts to convert plans into tangible results. Nigeria, the most populated country in Africa, has made commitments towards UHC2030 target but is underperforming across many building blocks of health and progress has been slow. The arrival of COVID-19 poses additional pressure on the already feeble health system causing the government to direct focus towards containing the pandemic. However, existing gaps in","2021","06","23","Int J Health Plann Manage","The International journal of health planning and management","Africa; COVID-19; Nigeria; Universal Health Coverage; health system strengthening","Olayemi","Alaka Hassan","Department of Microbiology, Obafemi Awolowo University, Ile-Ife, Nigeria",NA
"2803","34161625","10.1002/hpm.3263","COVID-19 and progress towards achieving universal health coverage in Africa: A case of Nigeria.","Universal Health Coverage (UHC) 2030 is a global health target, and countries are making efforts to convert plans into tangible results. Nigeria, the most populated country in Africa, has made commitments towards UHC2030 target but is underperforming across many building blocks of health and progress has been slow. The arrival of COVID-19 poses additional pressure on the already feeble health system causing the government to direct focus towards containing the pandemic. However, existing gaps in","2021","06","23","Int J Health Plann Manage","The International journal of health planning and management","Africa; COVID-19; Nigeria; Universal Health Coverage; health system strengthening","Ilesanmi","Esther Bosede","Faculty of Nursing Science, Ladoke Akintola University of Technology, Ogbomoso, Nigeria",NA
"2804","34161625","10.1002/hpm.3263","COVID-19 and progress towards achieving universal health coverage in Africa: A case of Nigeria.","Universal Health Coverage (UHC) 2030 is a global health target, and countries are making efforts to convert plans into tangible results. Nigeria, the most populated country in Africa, has made commitments towards UHC2030 target but is underperforming across many building blocks of health and progress has been slow. The arrival of COVID-19 poses additional pressure on the already feeble health system causing the government to direct focus towards containing the pandemic. However, existing gaps in","2021","06","23","Int J Health Plann Manage","The International journal of health planning and management","Africa; COVID-19; Nigeria; Universal Health Coverage; health system strengthening","Micheal","Alumuku Iordepuun","School of Medicine, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine",NA
"2805","34161625","10.1002/hpm.3263","COVID-19 and progress towards achieving universal health coverage in Africa: A case of Nigeria.","Universal Health Coverage (UHC) 2030 is a global health target, and countries are making efforts to convert plans into tangible results. Nigeria, the most populated country in Africa, has made commitments towards UHC2030 target but is underperforming across many building blocks of health and progress has been slow. The arrival of COVID-19 poses additional pressure on the already feeble health system causing the government to direct focus towards containing the pandemic. However, existing gaps in","2021","06","23","Int J Health Plann Manage","The International journal of health planning and management","Africa; COVID-19; Nigeria; Universal Health Coverage; health system strengthening","Ekpenyong","Aniekan","Global Health Focus, London, UK",NA
"2806","34161625","10.1002/hpm.3263","COVID-19 and progress towards achieving universal health coverage in Africa: A case of Nigeria.","Universal Health Coverage (UHC) 2030 is a global health target, and countries are making efforts to convert plans into tangible results. Nigeria, the most populated country in Africa, has made commitments towards UHC2030 target but is underperforming across many building blocks of health and progress has been slow. The arrival of COVID-19 poses additional pressure on the already feeble health system causing the government to direct focus towards containing the pandemic. However, existing gaps in","2021","06","23","Int J Health Plann Manage","The International journal of health planning and management","Africa; COVID-19; Nigeria; Universal Health Coverage; health system strengthening","Lucero-Prisno","Don Eliseo","Global Health Focus, London, UK",NA
"2807","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Rentscher","Kelly E","Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California",NA
"2808","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Zhao","Xingtao","Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia",NA
"2809","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Small","Brent J","School of Aging Studies, University of South Florida, Tampa, Florida",NA
"2810","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Cohen","Harvey J","Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina",NA
"2811","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Dilawari","Asma A","Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia",NA
"2812","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Patel","Sunita K","Outcomes Division, Population Sciences, City of Hope National Medical Center, Los Angeles, California",NA
"2813","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Bethea","Traci N","Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia",NA
"2814","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Van Dyk","Kathleen M","Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California",NA
"2815","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Nakamura","Zev M","Department of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina",NA
"2816","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Ahn","Jaeil","Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, District of Columbia",NA
"2817","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Zhai","Wanting","Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia",NA
"2818","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Ahles","Tim A","Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York",NA
"2819","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Jim","Heather S L","Moffitt Cancer Center, Tampa, Florida",NA
"2820","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","McDonald","Brenna C","Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana",NA
"2821","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Saykin","Andrew J","Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana",NA
"2822","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Root","James C","Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York",NA
"2823","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Graham","Deena M A","John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey",NA
"2824","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Carroll","Judith E","Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California",NA
"2825","34161601","10.1002/cncr.33687","Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.","The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at pare","2021","07","04","Cancer","Cancer","anxiety; breast cancer; cancer survivorship; coronavirus disease 2019 (COVID-19); depression; loneliness; older adults; psychological stress","Mandelblatt","Jeanne S","Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia",NA
"2826","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Wacker","Anna","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2827","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Weigand","Julia E","Department of Biology, Technical University of Darmstadt, Schnittspahnstrasse 10, 64287 Darmstadt, Germany",NA
"2828","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Akabayov","Sabine R","Faculty of Chemistry, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"2829","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Altincekic","Nadide","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2830","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Bains","Jasleen Kaur","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2831","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Banijamali","Elnaz","Department of Medical Biochemistry and Biophysics, Karolinska Institute, Biomedicum 9B, Solnavägen 9, 17177 Stockholm, Sweden",NA
"2832","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Binas","Oliver","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2833","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Castillo-Martinez","Jesus","School of Medicine, Catholic University of Valencia, C/Quevedo 2, 46001 Valencia, Spain",NA
"2834","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Cetiner","Erhan","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2835","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Ceylan","Betül","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2836","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Chiu","Liang-Yuan","Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA",NA
"2837","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Davila-Calderon","Jesse","Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA",NA
"2838","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Dhamotharan","Karthikeyan","Institute for Molecular Biosciences",NA
"2839","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Duchardt-Ferner","Elke","Institute for Molecular Biosciences",NA
"2840","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Ferner","Jan","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2841","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Frydman","Lucio","Faculty of Chemistry, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"2842","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Fürtig","Boris","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2843","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Gallego","José","School of Medicine, Catholic University of Valencia, C/Quevedo 2, 46001 Valencia, Spain",NA
"2844","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Grün","J Tassilo","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2845","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Hacker","Carolin","Signals GmbH &amp",NA
"2846","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Haddad","Christina","Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA",NA
"2847","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Hähnke","Martin","Signals GmbH &amp",NA
"2848","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Hengesbach","Martin","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2849","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Hiller","Fabian","Signals GmbH &amp",NA
"2850","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Hohmann","Katharina F","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2851","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Hymon","Daniel","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2852","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"de Jesus","Vanessa","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2853","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Jonker","Henry","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2854","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Keller","Heiko","Institute for Molecular Biosciences",NA
"2855","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Knezic","Bozana","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2856","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Landgraf","Tom","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2857","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Löhr","Frank","Institute of Biophysical Chemistry, Center for Biomolecular Magnetic Resonance (BMRZ), Johann Wolfgang Goethe-University Frankfurt, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2858","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Luo","Le","Department of Medical Biochemistry and Biophysics, Karolinska Institute, Biomedicum 9B, Solnavägen 9, 17177 Stockholm, Sweden",NA
"2859","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Mertinkus","Klara R","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2860","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Muhs","Christina","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2861","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Novakovic","Mihajlo","Faculty of Chemistry, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"2862","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Oxenfarth","Andreas","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2863","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Palomino-Schätzlein","Martina","School of Medicine, Catholic University of Valencia, C/Quevedo 2, 46001 Valencia, Spain",NA
"2864","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Petzold","Katja","Department of Medical Biochemistry and Biophysics, Karolinska Institute, Biomedicum 9B, Solnavägen 9, 17177 Stockholm, Sweden",NA
"2865","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Peter","Stephen A","Department of Biology, Technical University of Darmstadt, Schnittspahnstrasse 10, 64287 Darmstadt, Germany",NA
"2866","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Pyper","Dennis J","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2867","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Qureshi","Nusrat S","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2868","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Riad","Magdalena","Department of Medical Biochemistry and Biophysics, Karolinska Institute, Biomedicum 9B, Solnavägen 9, 17177 Stockholm, Sweden",NA
"2869","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Richter","Christian","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2870","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Saxena","Krishna","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2871","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Schamber","Tatjana","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2872","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Scherf","Tali","Faculty of Chemistry, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"2873","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Schlagnitweit","Judith","Department of Medical Biochemistry and Biophysics, Karolinska Institute, Biomedicum 9B, Solnavägen 9, 17177 Stockholm, Sweden",NA
"2874","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Schlundt","Andreas","Institute for Molecular Biosciences",NA
"2875","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Schnieders","Robbin","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2876","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Schwalbe","Harald","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2877","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Simba-Lahuasi","Alvaro","School of Medicine, Catholic University of Valencia, C/Quevedo 2, 46001 Valencia, Spain",NA
"2878","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Sreeramulu","Sridhar","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2879","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Stirnal","Elke","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2880","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Sudakov","Alexey","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2881","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Tants","Jan-Niklas","Institute for Molecular Biosciences",NA
"2882","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Tolbert","Blanton S","Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA",NA
"2883","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Vögele","Jennifer","Institute for Molecular Biosciences",NA
"2884","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Weiß","Lena","Institute for Molecular Biosciences",NA
"2885","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Wirmer-Bartoschek","Julia","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2886","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Wirtz Martin","Maria A","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2887","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Wöhnert","Jens","Institute for Molecular Biosciences",NA
"2888","34161581","10.1093/nar/gkab568","Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy'.",NA,"2021","07","11","Nucleic Acids Res","Nucleic acids research",NA,"Zetzsche","Heidi","Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Strasse 7, 60438 Frankfurt/M., Germany",NA
"2889","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Sharwani","Khalid","Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, veterinary and Ecological Sciences, University of Liverpool, UK",NA
"2890","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Sharma","Ravi","ENT Departments, Alder Hey Children's Hospital, UK",NA
"2891","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Krishnan","Madhan","ENT Departments, Alder Hey Children's Hospital, UK",NA
"2892","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Jones","Terry","Liverpool Head and Neck Centre, University of Liverpool, UK",NA
"2893","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Mayora-Neto","Martin","Viral Pseudotype Unit Medway School of Pharmacy, University of Kent, UK",NA
"2894","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Cantoni","Diego","Viral Pseudotype Unit Medway School of Pharmacy, University of Kent, UK",NA
"2895","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Temperton","Nigel A","Viral Pseudotype Unit Medway School of Pharmacy, University of Kent, UK",NA
"2896","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Dobson","Susan L","Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, veterinary and Ecological Sciences, University of Liverpool, UK",NA
"2897","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Subramaniam","Krishanthi","Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, veterinary and Ecological Sciences, University of Liverpool, UK",NA
"2898","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","McNamara","Paul S","Institute of Child Health, Alder Hey Children's Hospital, UK",NA
"2899","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Cunliffe","Nigel A","Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, veterinary and Ecological Sciences, University of Liverpool, UK",NA
"2900","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Turtle","Lance","Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, veterinary and Ecological Sciences, University of Liverpool, UK",NA
"2901","34161567","10.1093/infdis/jiab333","Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples.","A notable feature of COVID-19 is that children are less susceptible to severe disease. Children are known to experience more infections with endemic human coronaviruses (HCoVs) compared to adults. Little is known whether HCoV infections lead to cross-reactive anti-SARS-CoV-2 antibodies. We investigated the presence of cross-reactive anti-SARS-CoV-2 IgG antibodies (to spike(S)1, S1-receptor-binding receptor (S1-RBD) and nucleocapsid protein(NP)), by enzyme-linked immunosorbent assays, and neutral","2021","06","23","J Infect Dis","The Journal of infectious diseases","COVID-19; HCoV-NL63; SARS-CoV-2; common human coronavirus (HCoV)-HKU1; cross-reactive immunity; immunological memory; serum antibody","Zhang","Qibo","Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, veterinary and Ecological Sciences, University of Liverpool, UK",NA
"2902","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Yu","Ana Lucia Frugis","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Centro de Vigilância Epidemiológica ""Prof. Alexandre Vranjac"", Divisão de Doenças de Transmissão Respiratória, São Paulo, São Paulo, Brazil",NA
"2903","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Liphaus","Bernadete L","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Centro de Vigilância Epidemiológica ""Prof. Alexandre Vranjac"", Divisão de Doenças de Transmissão Respiratória, São Paulo, São Paulo, Brazil",NA
"2904","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Ferreira","Patrícia Marques","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Centro de Vigilância Epidemiológica ""Prof. Alexandre Vranjac"", Divisão de Doenças de Transmissão Respiratória, São Paulo, São Paulo, Brazil",NA
"2905","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Tanamachi","Angela Tiemi","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Centro de Vigilância Epidemiológica ""Prof. Alexandre Vranjac"", Divisão de Doenças de Transmissão Respiratória, São Paulo, São Paulo, Brazil",NA
"2906","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Masuda","Eliana Tiemi","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Centro de Vigilância Epidemiológica ""Prof. Alexandre Vranjac"", Divisão de Doenças de Transmissão Respiratória, São Paulo, São Paulo, Brazil",NA
"2907","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Trevisan","Camila Martins","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Centro de Vigilância Epidemiológica ""Prof. Alexandre Vranjac"", Divisão de Doenças de Transmissão Respiratória, São Paulo, São Paulo, Brazil",NA
"2908","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Lucas","Pamella Cristina de Carvalho","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Centro de Vigilância Epidemiológica ""Prof. Alexandre Vranjac"", Divisão de Doenças de Transmissão Respiratória, São Paulo, São Paulo, Brazil",NA
"2909","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Bugno","Adriana","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Instituto Adolfo Lutz, São Paulo, São Paulo, Brazil",NA
"2910","34161556","10.1590/S1678-9946202163050","SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.","From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have been described since December 2020 in Brazil. This report","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Pandemics; Reinfection; SARS-CoV-2","Carvalhanas","Telma Regina Marques Pinto","Secretaria de Estado da Saúde de São Paulo, Coordenadoria de Controle de Doenças, Centro de Vigilância Epidemiológica ""Prof. Alexandre Vranjac"", Divisão de Doenças de Transmissão Respiratória, São Paulo, São Paulo, Brazil",NA
"2911","34161551","10.1590/S1678-9946202163045","An approximate analytical formula for estimating the weight of factors affecting the spread of COVID-19: a case study of the first wave.","COVID-19 pandemic has changed the way we live our lives for the foreseen future. To date, there have been over 113 million reported cases and 2.5 million deaths worldwide. Many studies investigated the factors affecting the number of daily cases such as weather conditions, lockdown duration and other factors. In this study, we propose a COVID-19 analytical formula for factors contributing to the number of the new coronavirus daily cases. We have also calculated values of relative weights of thos","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","COVID-19; Communicable Disease Control; Humans; Pandemics; SARS-CoV-2; Spain","Abdeen","Mohammad A R","Islamic University of Madinah, Madinah, Saudi Arabia",NA
"2912","34161551","10.1590/S1678-9946202163045","An approximate analytical formula for estimating the weight of factors affecting the spread of COVID-19: a case study of the first wave.","COVID-19 pandemic has changed the way we live our lives for the foreseen future. To date, there have been over 113 million reported cases and 2.5 million deaths worldwide. Many studies investigated the factors affecting the number of daily cases such as weather conditions, lockdown duration and other factors. In this study, we propose a COVID-19 analytical formula for factors contributing to the number of the new coronavirus daily cases. We have also calculated values of relative weights of thos","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","COVID-19; Communicable Disease Control; Humans; Pandemics; SARS-CoV-2; Spain","Sheltami","Tarek R","King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia",NA
"2913","34161551","10.1590/S1678-9946202163045","An approximate analytical formula for estimating the weight of factors affecting the spread of COVID-19: a case study of the first wave.","COVID-19 pandemic has changed the way we live our lives for the foreseen future. To date, there have been over 113 million reported cases and 2.5 million deaths worldwide. Many studies investigated the factors affecting the number of daily cases such as weather conditions, lockdown duration and other factors. In this study, we propose a COVID-19 analytical formula for factors contributing to the number of the new coronavirus daily cases. We have also calculated values of relative weights of thos","2021","06","25","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","COVID-19; Communicable Disease Control; Humans; Pandemics; SARS-CoV-2; Spain","Nemer","Ibrahim A","King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia",NA
"2914","34161547","10.1590/1983-1447.2021.20200391","Bundle to care for newborn children of mothers with suspected or confirmed diagnosis of COVID-19.","To build and validate the contents of a bundle for the care of newborn children of mothers with suspected or confirmed diagnosis of COVID-19 in the delivery room and in the rooming-in care. Methodological research, developed in 2020 in three stages: bibliographic survey, construction of the instrument in Google Forms® and content validation by seven judges. The initial instrument consisted of seven nursing care. The content validity index above 80% was used to assess the agreement between the ju","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","COVID-19; Female; Humans; Infant Care; Infant, Newborn; Mothers; Nursing Care; Parturition; Patient Care Bundles; Pregnancy; Pregnancy Complications, Infectious","Silva","Maria Paula Custódio","Universidade Federal do Triângulo Mineiro (UFTM). Uberaba, Minas Gerais, Brasil",NA
"2915","34161547","10.1590/1983-1447.2021.20200391","Bundle to care for newborn children of mothers with suspected or confirmed diagnosis of COVID-19.","To build and validate the contents of a bundle for the care of newborn children of mothers with suspected or confirmed diagnosis of COVID-19 in the delivery room and in the rooming-in care. Methodological research, developed in 2020 in three stages: bibliographic survey, construction of the instrument in Google Forms® and content validation by seven judges. The initial instrument consisted of seven nursing care. The content validity index above 80% was used to assess the agreement between the ju","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","COVID-19; Female; Humans; Infant Care; Infant, Newborn; Mothers; Nursing Care; Parturition; Patient Care Bundles; Pregnancy; Pregnancy Complications, Infectious","Rocha","Nylze Helena Guillarducci","Universidade Federal do Triângulo Mineiro (UFTM). Uberaba, Minas Gerais, Brasil",NA
"2916","34161547","10.1590/1983-1447.2021.20200391","Bundle to care for newborn children of mothers with suspected or confirmed diagnosis of COVID-19.","To build and validate the contents of a bundle for the care of newborn children of mothers with suspected or confirmed diagnosis of COVID-19 in the delivery room and in the rooming-in care. Methodological research, developed in 2020 in three stages: bibliographic survey, construction of the instrument in Google Forms® and content validation by seven judges. The initial instrument consisted of seven nursing care. The content validity index above 80% was used to assess the agreement between the ju","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","COVID-19; Female; Humans; Infant Care; Infant, Newborn; Mothers; Nursing Care; Parturition; Patient Care Bundles; Pregnancy; Pregnancy Complications, Infectious","Teixeira","Cinthia Lorena Silva Barbosa","Universidade Federal do Triângulo Mineiro (UFTM). Uberaba, Minas Gerais, Brasil",NA
"2917","34161547","10.1590/1983-1447.2021.20200391","Bundle to care for newborn children of mothers with suspected or confirmed diagnosis of COVID-19.","To build and validate the contents of a bundle for the care of newborn children of mothers with suspected or confirmed diagnosis of COVID-19 in the delivery room and in the rooming-in care. Methodological research, developed in 2020 in three stages: bibliographic survey, construction of the instrument in Google Forms® and content validation by seven judges. The initial instrument consisted of seven nursing care. The content validity index above 80% was used to assess the agreement between the ju","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","COVID-19; Female; Humans; Infant Care; Infant, Newborn; Mothers; Nursing Care; Parturition; Patient Care Bundles; Pregnancy; Pregnancy Complications, Infectious","Ued","Flávia da Veiga","Universidade Federal do Triângulo Mineiro (UFTM). Uberaba, Minas Gerais, Brasil",NA
"2918","34161547","10.1590/1983-1447.2021.20200391","Bundle to care for newborn children of mothers with suspected or confirmed diagnosis of COVID-19.","To build and validate the contents of a bundle for the care of newborn children of mothers with suspected or confirmed diagnosis of COVID-19 in the delivery room and in the rooming-in care. Methodological research, developed in 2020 in three stages: bibliographic survey, construction of the instrument in Google Forms® and content validation by seven judges. The initial instrument consisted of seven nursing care. The content validity index above 80% was used to assess the agreement between the ju","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","COVID-19; Female; Humans; Infant Care; Infant, Newborn; Mothers; Nursing Care; Parturition; Patient Care Bundles; Pregnancy; Pregnancy Complications, Infectious","Ruiz","Mariana Torreglosa","Universidade Federal do Triângulo Mineiro (UFTM). Uberaba, Minas Gerais, Brasil",NA
"2919","34161547","10.1590/1983-1447.2021.20200391","Bundle to care for newborn children of mothers with suspected or confirmed diagnosis of COVID-19.","To build and validate the contents of a bundle for the care of newborn children of mothers with suspected or confirmed diagnosis of COVID-19 in the delivery room and in the rooming-in care. Methodological research, developed in 2020 in three stages: bibliographic survey, construction of the instrument in Google Forms® and content validation by seven judges. The initial instrument consisted of seven nursing care. The content validity index above 80% was used to assess the agreement between the ju","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","COVID-19; Female; Humans; Infant Care; Infant, Newborn; Mothers; Nursing Care; Parturition; Patient Care Bundles; Pregnancy; Pregnancy Complications, Infectious","Contim","Divanice","Universidade Federal do Triângulo Mineiro (UFTM). Uberaba, Minas Gerais, Brasil",NA
"2920","34161546","10.1590/1983-1447.2021.20200383","Nursing and ""being with"" in a world with COVID-19: an existentialist look.","To reflect on nursing from an existentialist perspective, in which ""being-with"" has been shown to be the best type of care in a world with Covid-19. Reflective theoretical study on nursing in the context of a pandemic using an existentialist philosophical theoretical framework. Nursing is now perceived by society as a profession whose practices are beyond the clinical conditions that affect individuals who live with this pandemic, as taking care of others is not only performing technical actions","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Existentialism; Humans; Pandemics; Philosophy, Nursing","Silva","Carolina Giordani da","Universidade Federal do Rio Grande do Sul (UFRGS), Escola de Enfermagem, Programam de Pós-Graduação em Enfermagem. Porto Alegre, Rio Grande do Sul, Brasil",NA
"2921","34161546","10.1590/1983-1447.2021.20200383","Nursing and ""being with"" in a world with COVID-19: an existentialist look.","To reflect on nursing from an existentialist perspective, in which ""being-with"" has been shown to be the best type of care in a world with Covid-19. Reflective theoretical study on nursing in the context of a pandemic using an existentialist philosophical theoretical framework. Nursing is now perceived by society as a profession whose practices are beyond the clinical conditions that affect individuals who live with this pandemic, as taking care of others is not only performing technical actions","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Existentialism; Humans; Pandemics; Philosophy, Nursing","Crossetti","Maria da Graça Oliveira","Universidade Federal do Rio Grande do Sul (UFRGS), Escola de Enfermagem, Programam de Pós-Graduação em Enfermagem. Porto Alegre, Rio Grande do Sul, Brasil",NA
"2922","34161546","10.1590/1983-1447.2021.20200383","Nursing and ""being with"" in a world with COVID-19: an existentialist look.","To reflect on nursing from an existentialist perspective, in which ""being-with"" has been shown to be the best type of care in a world with Covid-19. Reflective theoretical study on nursing in the context of a pandemic using an existentialist philosophical theoretical framework. Nursing is now perceived by society as a profession whose practices are beyond the clinical conditions that affect individuals who live with this pandemic, as taking care of others is not only performing technical actions","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Existentialism; Humans; Pandemics; Philosophy, Nursing","Giménez-Fernández","Maravilla","Universidad Católica San Antonio de Murcia (UCAM). Murcia, Murcia, España",NA
"2923","34161545","10.1590/1983-1447.2021.20200339","Working conditions of Nursing professionals in coping with the Covid-19 pandemic.","To trigger a reflection on the current working conditions of Nursing professionals in coping with the Covid-19 pandemic. A theoretical-reflective study supported by studies from the Marxist perspective, national and international scientific articles, and official documents from the World Health Organization and the Federal Nursing Council. The daily work of Nursing professionals in the face of the Covid-19 pandemic presents unfavorable working conditions in Brazil and worldwide, with emphasis on","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Humans; Nursing Staff; Nursing Theory; Pandemics; Personal Protective Equipment; Salaries and Fringe Benefits; Workload; Workplace","Backes","Marli Terezinha Stein","Universidade Federal de Santa Catarina (UFSC). Florianópolis, Santa Catarina, Brasil",NA
"2924","34161545","10.1590/1983-1447.2021.20200339","Working conditions of Nursing professionals in coping with the Covid-19 pandemic.","To trigger a reflection on the current working conditions of Nursing professionals in coping with the Covid-19 pandemic. A theoretical-reflective study supported by studies from the Marxist perspective, national and international scientific articles, and official documents from the World Health Organization and the Federal Nursing Council. The daily work of Nursing professionals in the face of the Covid-19 pandemic presents unfavorable working conditions in Brazil and worldwide, with emphasis on","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Humans; Nursing Staff; Nursing Theory; Pandemics; Personal Protective Equipment; Salaries and Fringe Benefits; Workload; Workplace","Higashi","Giovana Dorneles Callegaro","Universidade Federal de Santa Maria (UFSM). Santa Maria, Rio Grande do Sul, Brasil",NA
"2925","34161545","10.1590/1983-1447.2021.20200339","Working conditions of Nursing professionals in coping with the Covid-19 pandemic.","To trigger a reflection on the current working conditions of Nursing professionals in coping with the Covid-19 pandemic. A theoretical-reflective study supported by studies from the Marxist perspective, national and international scientific articles, and official documents from the World Health Organization and the Federal Nursing Council. The daily work of Nursing professionals in the face of the Covid-19 pandemic presents unfavorable working conditions in Brazil and worldwide, with emphasis on","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Humans; Nursing Staff; Nursing Theory; Pandemics; Personal Protective Equipment; Salaries and Fringe Benefits; Workload; Workplace","Damiani","Pattrícia da Rosa","Universidade Federal de Santa Catarina (UFSC). Florianópolis, Santa Catarina, Brasil",NA
"2926","34161545","10.1590/1983-1447.2021.20200339","Working conditions of Nursing professionals in coping with the Covid-19 pandemic.","To trigger a reflection on the current working conditions of Nursing professionals in coping with the Covid-19 pandemic. A theoretical-reflective study supported by studies from the Marxist perspective, national and international scientific articles, and official documents from the World Health Organization and the Federal Nursing Council. The daily work of Nursing professionals in the face of the Covid-19 pandemic presents unfavorable working conditions in Brazil and worldwide, with emphasis on","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Humans; Nursing Staff; Nursing Theory; Pandemics; Personal Protective Equipment; Salaries and Fringe Benefits; Workload; Workplace","Mendes","Janifer Souza","Universidade Federal de Santa Catarina (UFSC). Florianópolis, Santa Catarina, Brasil",NA
"2927","34161545","10.1590/1983-1447.2021.20200339","Working conditions of Nursing professionals in coping with the Covid-19 pandemic.","To trigger a reflection on the current working conditions of Nursing professionals in coping with the Covid-19 pandemic. A theoretical-reflective study supported by studies from the Marxist perspective, national and international scientific articles, and official documents from the World Health Organization and the Federal Nursing Council. The daily work of Nursing professionals in the face of the Covid-19 pandemic presents unfavorable working conditions in Brazil and worldwide, with emphasis on","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Humans; Nursing Staff; Nursing Theory; Pandemics; Personal Protective Equipment; Salaries and Fringe Benefits; Workload; Workplace","Sampaio","Lucimar de Souza","Universidade Federal de Santa Catarina (UFSC). Florianópolis, Santa Catarina, Brasil",NA
"2928","34161545","10.1590/1983-1447.2021.20200339","Working conditions of Nursing professionals in coping with the Covid-19 pandemic.","To trigger a reflection on the current working conditions of Nursing professionals in coping with the Covid-19 pandemic. A theoretical-reflective study supported by studies from the Marxist perspective, national and international scientific articles, and official documents from the World Health Organization and the Federal Nursing Council. The daily work of Nursing professionals in the face of the Covid-19 pandemic presents unfavorable working conditions in Brazil and worldwide, with emphasis on","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Brazil; COVID-19; Humans; Nursing Staff; Nursing Theory; Pandemics; Personal Protective Equipment; Salaries and Fringe Benefits; Workload; Workplace","Soares","Gustavo Lopes","Universidade Federal de Santa Catarina (UFSC). Florianópolis, Santa Catarina, Brasil",NA
"2929","34161544","10.1590/1983-1447.2021.20200312","Construction and validation of checklist for disinfecting ambulances to transport Covid-19 patients.","To build and validate a checklist for disinfecting ambulances transporting patients with Covid-19. Methodological study composed by the construction of a checklist and validation by 42 professionals, of which 35 professionals had expertise in patient transport/transfer and seven in hospital infection control. The item with a minimum agreement of 80% was considered valid, based on the Content Validation Index and binomial test. The checklist had the steps performed for terminal disinfection of am","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Ambulances; COVID-19; Checklist; Disinfection; Humans; Personal Protective Equipment; SARS-CoV-2; Transportation of Patients","Alexandre","Ana Carla Silva","Instituto Federal de Educação Ciência e Tecnologia de Pernambuco (IFPE), Campus Pesqueira, Departamento de Enfermagem. Recife, Pernambuco, Brasil",NA
"2930","34161544","10.1590/1983-1447.2021.20200312","Construction and validation of checklist for disinfecting ambulances to transport Covid-19 patients.","To build and validate a checklist for disinfecting ambulances transporting patients with Covid-19. Methodological study composed by the construction of a checklist and validation by 42 professionals, of which 35 professionals had expertise in patient transport/transfer and seven in hospital infection control. The item with a minimum agreement of 80% was considered valid, based on the Content Validation Index and binomial test. The checklist had the steps performed for terminal disinfection of am","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Ambulances; COVID-19; Checklist; Disinfection; Humans; Personal Protective Equipment; SARS-CoV-2; Transportation of Patients","Galindo Neto","Nelson Miguel","Instituto Federal de Educação Ciência e Tecnologia de Pernambuco (IFPE), Campus Pesqueira, Departamento de Enfermagem. Recife, Pernambuco, Brasil",NA
"2931","34161544","10.1590/1983-1447.2021.20200312","Construction and validation of checklist for disinfecting ambulances to transport Covid-19 patients.","To build and validate a checklist for disinfecting ambulances transporting patients with Covid-19. Methodological study composed by the construction of a checklist and validation by 42 professionals, of which 35 professionals had expertise in patient transport/transfer and seven in hospital infection control. The item with a minimum agreement of 80% was considered valid, based on the Content Validation Index and binomial test. The checklist had the steps performed for terminal disinfection of am","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Ambulances; COVID-19; Checklist; Disinfection; Humans; Personal Protective Equipment; SARS-CoV-2; Transportation of Patients","Souza Silva","Maria Aparecida de","Instituto Federal de Educação Ciência e Tecnologia de Pernambuco (IFPE), Campus Pesqueira, Departamento de Enfermagem. Recife, Pernambuco, Brasil",NA
"2932","34161544","10.1590/1983-1447.2021.20200312","Construction and validation of checklist for disinfecting ambulances to transport Covid-19 patients.","To build and validate a checklist for disinfecting ambulances transporting patients with Covid-19. Methodological study composed by the construction of a checklist and validation by 42 professionals, of which 35 professionals had expertise in patient transport/transfer and seven in hospital infection control. The item with a minimum agreement of 80% was considered valid, based on the Content Validation Index and binomial test. The checklist had the steps performed for terminal disinfection of am","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Ambulances; COVID-19; Checklist; Disinfection; Humans; Personal Protective Equipment; SARS-CoV-2; Transportation of Patients","Silva Santos","Dária Catarina","Instituto Federal de Educação Ciência e Tecnologia de Pernambuco (IFPE), Campus Pesqueira, Departamento de Enfermagem. Recife, Pernambuco, Brasil",NA
"2933","34161544","10.1590/1983-1447.2021.20200312","Construction and validation of checklist for disinfecting ambulances to transport Covid-19 patients.","To build and validate a checklist for disinfecting ambulances transporting patients with Covid-19. Methodological study composed by the construction of a checklist and validation by 42 professionals, of which 35 professionals had expertise in patient transport/transfer and seven in hospital infection control. The item with a minimum agreement of 80% was considered valid, based on the Content Validation Index and binomial test. The checklist had the steps performed for terminal disinfection of am","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Ambulances; COVID-19; Checklist; Disinfection; Humans; Personal Protective Equipment; SARS-CoV-2; Transportation of Patients","Alcoforado","Josicleide Montenegro da Silva Guedes","Instituto Federal de Educação Ciência e Tecnologia de Pernambuco (IFPE), Campus Pesqueira, Departamento de Enfermagem. Recife, Pernambuco, Brasil",NA
"2934","34161544","10.1590/1983-1447.2021.20200312","Construction and validation of checklist for disinfecting ambulances to transport Covid-19 patients.","To build and validate a checklist for disinfecting ambulances transporting patients with Covid-19. Methodological study composed by the construction of a checklist and validation by 42 professionals, of which 35 professionals had expertise in patient transport/transfer and seven in hospital infection control. The item with a minimum agreement of 80% was considered valid, based on the Content Validation Index and binomial test. The checklist had the steps performed for terminal disinfection of am","2021","07","05","Rev Gaucha Enferm","Revista gaucha de enfermagem","Ambulances; COVID-19; Checklist; Disinfection; Humans; Personal Protective Equipment; SARS-CoV-2; Transportation of Patients","Melo","Daniela Bezerra de","Instituto Federal de Educação Ciência e Tecnologia de Pernambuco (IFPE), Campus Pesqueira, Departamento de Enfermagem. Recife, Pernambuco, Brasil",NA
"2935","34161520","10.1590/0034-7167-2021-0023","Psychological distress in the COVID-19 pandemic: prevalence and associated factors at a nursing college.","to analyze the prevalence and factors associated with psychological distress in students and workers at a public nursing college during the COVID-19 pandemic. this is a cross-sectional study, carried out by a structured survey based on the internet with a sample of 477 students and workers. Prevalence ratios were calculated and adjusted Prevalence Ratios were obtained by Poisson Regression, with robust variance control and stepwise backward technique. the prevalence of psychological distress was","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Cross-Sectional Studies; Humans; Pandemics; Prevalence; Psychological Distress; SARS-CoV-2","Rafael","Ricardo de Mattos Russo","Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2936","34161520","10.1590/0034-7167-2021-0023","Psychological distress in the COVID-19 pandemic: prevalence and associated factors at a nursing college.","to analyze the prevalence and factors associated with psychological distress in students and workers at a public nursing college during the COVID-19 pandemic. this is a cross-sectional study, carried out by a structured survey based on the internet with a sample of 477 students and workers. Prevalence ratios were calculated and adjusted Prevalence Ratios were obtained by Poisson Regression, with robust variance control and stepwise backward technique. the prevalence of psychological distress was","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Cross-Sectional Studies; Humans; Pandemics; Prevalence; Psychological Distress; SARS-CoV-2","Correia","Luiza Mara","Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2937","34161520","10.1590/0034-7167-2021-0023","Psychological distress in the COVID-19 pandemic: prevalence and associated factors at a nursing college.","to analyze the prevalence and factors associated with psychological distress in students and workers at a public nursing college during the COVID-19 pandemic. this is a cross-sectional study, carried out by a structured survey based on the internet with a sample of 477 students and workers. Prevalence ratios were calculated and adjusted Prevalence Ratios were obtained by Poisson Regression, with robust variance control and stepwise backward technique. the prevalence of psychological distress was","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Cross-Sectional Studies; Humans; Pandemics; Prevalence; Psychological Distress; SARS-CoV-2","Mello","Alex Simões de","Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2938","34161520","10.1590/0034-7167-2021-0023","Psychological distress in the COVID-19 pandemic: prevalence and associated factors at a nursing college.","to analyze the prevalence and factors associated with psychological distress in students and workers at a public nursing college during the COVID-19 pandemic. this is a cross-sectional study, carried out by a structured survey based on the internet with a sample of 477 students and workers. Prevalence ratios were calculated and adjusted Prevalence Ratios were obtained by Poisson Regression, with robust variance control and stepwise backward technique. the prevalence of psychological distress was","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Cross-Sectional Studies; Humans; Pandemics; Prevalence; Psychological Distress; SARS-CoV-2","Prata","Juliana Amaral","Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2939","34161520","10.1590/0034-7167-2021-0023","Psychological distress in the COVID-19 pandemic: prevalence and associated factors at a nursing college.","to analyze the prevalence and factors associated with psychological distress in students and workers at a public nursing college during the COVID-19 pandemic. this is a cross-sectional study, carried out by a structured survey based on the internet with a sample of 477 students and workers. Prevalence ratios were calculated and adjusted Prevalence Ratios were obtained by Poisson Regression, with robust variance control and stepwise backward technique. the prevalence of psychological distress was","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Cross-Sectional Studies; Humans; Pandemics; Prevalence; Psychological Distress; SARS-CoV-2","Depret","Davi Gomes","Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2940","34161520","10.1590/0034-7167-2021-0023","Psychological distress in the COVID-19 pandemic: prevalence and associated factors at a nursing college.","to analyze the prevalence and factors associated with psychological distress in students and workers at a public nursing college during the COVID-19 pandemic. this is a cross-sectional study, carried out by a structured survey based on the internet with a sample of 477 students and workers. Prevalence ratios were calculated and adjusted Prevalence Ratios were obtained by Poisson Regression, with robust variance control and stepwise backward technique. the prevalence of psychological distress was","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Cross-Sectional Studies; Humans; Pandemics; Prevalence; Psychological Distress; SARS-CoV-2","Espírito Santo","Tiago Braga do","Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2941","34161520","10.1590/0034-7167-2021-0023","Psychological distress in the COVID-19 pandemic: prevalence and associated factors at a nursing college.","to analyze the prevalence and factors associated with psychological distress in students and workers at a public nursing college during the COVID-19 pandemic. this is a cross-sectional study, carried out by a structured survey based on the internet with a sample of 477 students and workers. Prevalence ratios were calculated and adjusted Prevalence Ratios were obtained by Poisson Regression, with robust variance control and stepwise backward technique. the prevalence of psychological distress was","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Cross-Sectional Studies; Humans; Pandemics; Prevalence; Psychological Distress; SARS-CoV-2","Silva","Frances Valéria Costa E","Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2942","34161520","10.1590/0034-7167-2021-0023","Psychological distress in the COVID-19 pandemic: prevalence and associated factors at a nursing college.","to analyze the prevalence and factors associated with psychological distress in students and workers at a public nursing college during the COVID-19 pandemic. this is a cross-sectional study, carried out by a structured survey based on the internet with a sample of 477 students and workers. Prevalence ratios were calculated and adjusted Prevalence Ratios were obtained by Poisson Regression, with robust variance control and stepwise backward technique. the prevalence of psychological distress was","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Cross-Sectional Studies; Humans; Pandemics; Prevalence; Psychological Distress; SARS-CoV-2","Acioli","Sonia","Universidade do Estado do Rio de Janeiro. Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2943","34161519","10.1590/0034-7167-2020-1154","Coronavirus infection has reached Brazil, what now? Nurses' emotions.","To investigate the nurse's emotions about coronavirus infection (COVID-19). We conducted a qualitative study with 58 nurses, students of the postgraduate course in Nursing of a higher education institution in Fortaleza, State of Ceará, Brazil. We obtained data through questionnaires with a sociodemographic approach and reflections on the emotions/perceptions of nurses, as well as a synchronous meeting to discuss strategies for worker health during the pandemic. We organized the results on the IR","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Brazil; COVID-19; Emotions; Humans; Nurses; SARS-CoV-2","Eleres","Fabrício Bezerra","Faculdade dos Carajás. Marabá, Pará, Brazil",NA
"2944","34161519","10.1590/0034-7167-2020-1154","Coronavirus infection has reached Brazil, what now? Nurses' emotions.","To investigate the nurse's emotions about coronavirus infection (COVID-19). We conducted a qualitative study with 58 nurses, students of the postgraduate course in Nursing of a higher education institution in Fortaleza, State of Ceará, Brazil. We obtained data through questionnaires with a sociodemographic approach and reflections on the emotions/perceptions of nurses, as well as a synchronous meeting to discuss strategies for worker health during the pandemic. We organized the results on the IR","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Brazil; COVID-19; Emotions; Humans; Nurses; SARS-CoV-2","Abreu","Rita Neuma Dantas Cavalcante de","Universidade de Fortaleza. Fortaleza, Ceará, Brazil",NA
"2945","34161519","10.1590/0034-7167-2020-1154","Coronavirus infection has reached Brazil, what now? Nurses' emotions.","To investigate the nurse's emotions about coronavirus infection (COVID-19). We conducted a qualitative study with 58 nurses, students of the postgraduate course in Nursing of a higher education institution in Fortaleza, State of Ceará, Brazil. We obtained data through questionnaires with a sociodemographic approach and reflections on the emotions/perceptions of nurses, as well as a synchronous meeting to discuss strategies for worker health during the pandemic. We organized the results on the IR","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Brazil; COVID-19; Emotions; Humans; Nurses; SARS-CoV-2","Magalhães","Fernanda Jorge","Universidade de Pernambuco. Recife, Pernambuco, Brazil",NA
"2946","34161519","10.1590/0034-7167-2020-1154","Coronavirus infection has reached Brazil, what now? Nurses' emotions.","To investigate the nurse's emotions about coronavirus infection (COVID-19). We conducted a qualitative study with 58 nurses, students of the postgraduate course in Nursing of a higher education institution in Fortaleza, State of Ceará, Brazil. We obtained data through questionnaires with a sociodemographic approach and reflections on the emotions/perceptions of nurses, as well as a synchronous meeting to discuss strategies for worker health during the pandemic. We organized the results on the IR","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Brazil; COVID-19; Emotions; Humans; Nurses; SARS-CoV-2","Rolim","Karla Maria Carneiro","Universidade de Fortaleza. Fortaleza, Ceará, Brazil",NA
"2947","34161519","10.1590/0034-7167-2020-1154","Coronavirus infection has reached Brazil, what now? Nurses' emotions.","To investigate the nurse's emotions about coronavirus infection (COVID-19). We conducted a qualitative study with 58 nurses, students of the postgraduate course in Nursing of a higher education institution in Fortaleza, State of Ceará, Brazil. We obtained data through questionnaires with a sociodemographic approach and reflections on the emotions/perceptions of nurses, as well as a synchronous meeting to discuss strategies for worker health during the pandemic. We organized the results on the IR","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Brazil; COVID-19; Emotions; Humans; Nurses; SARS-CoV-2","Cestari","Virna Ribeiro Feitosa","Universidade Estadual do Ceará. Fortaleza, Ceará, Brazil",NA
"2948","34161519","10.1590/0034-7167-2020-1154","Coronavirus infection has reached Brazil, what now? Nurses' emotions.","To investigate the nurse's emotions about coronavirus infection (COVID-19). We conducted a qualitative study with 58 nurses, students of the postgraduate course in Nursing of a higher education institution in Fortaleza, State of Ceará, Brazil. We obtained data through questionnaires with a sociodemographic approach and reflections on the emotions/perceptions of nurses, as well as a synchronous meeting to discuss strategies for worker health during the pandemic. We organized the results on the IR","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Brazil; COVID-19; Emotions; Humans; Nurses; SARS-CoV-2","Moreira","Thereza Maria Magalhães","Universidade Estadual do Ceará. Fortaleza, Ceará, Brazil",NA
"2949","34161518","10.1590/0034-7167-2020-1088","COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients.","to describe the experience of building the technology ""Care for the prevention of COVID-19 in post-hematopoietic stem cell transplant patients"". experience report conducted in a hematopoietic stem cell transplant outpatient clinic that supported the construction of an educational technology in the form of a booklet for the prevention of COVID-19. In May 2020, a literature review in scientific databases and guidelines of health organizations were used for its development. printed booklet with inf","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Educational Technology; Hematopoietic Stem Cell Transplantation; Humans; Pandemics; SARS-CoV-2","Piubello","Simone Martins Nascimento","Universidade Federal do Paraná. Curitiba, Paraná, Brazil",NA
"2950","34161518","10.1590/0034-7167-2020-1088","COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients.","to describe the experience of building the technology ""Care for the prevention of COVID-19 in post-hematopoietic stem cell transplant patients"". experience report conducted in a hematopoietic stem cell transplant outpatient clinic that supported the construction of an educational technology in the form of a booklet for the prevention of COVID-19. In May 2020, a literature review in scientific databases and guidelines of health organizations were used for its development. printed booklet with inf","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Educational Technology; Hematopoietic Stem Cell Transplantation; Humans; Pandemics; SARS-CoV-2","Reichembach","Mitzy Tannia","Universidade Federal do Paraná. Curitiba, Paraná, Brazil",NA
"2951","34161518","10.1590/0034-7167-2020-1088","COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients.","to describe the experience of building the technology ""Care for the prevention of COVID-19 in post-hematopoietic stem cell transplant patients"". experience report conducted in a hematopoietic stem cell transplant outpatient clinic that supported the construction of an educational technology in the form of a booklet for the prevention of COVID-19. In May 2020, a literature review in scientific databases and guidelines of health organizations were used for its development. printed booklet with inf","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Educational Technology; Hematopoietic Stem Cell Transplantation; Humans; Pandemics; SARS-CoV-2","Pontes","Leticia","Universidade Federal do Paraná. Curitiba, Paraná, Brazil",NA
"2952","34161518","10.1590/0034-7167-2020-1088","COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients.","to describe the experience of building the technology ""Care for the prevention of COVID-19 in post-hematopoietic stem cell transplant patients"". experience report conducted in a hematopoietic stem cell transplant outpatient clinic that supported the construction of an educational technology in the form of a booklet for the prevention of COVID-19. In May 2020, a literature review in scientific databases and guidelines of health organizations were used for its development. printed booklet with inf","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Educational Technology; Hematopoietic Stem Cell Transplantation; Humans; Pandemics; SARS-CoV-2","Boller","Shirley","Universidade Federal do Paraná. Curitiba, Paraná, Brazil",NA
"2953","34161517","10.1590/0034-7167-2020-0710","Perceptions of adults with obesity about multiprofessional remote monitoring at the beginning of the COVID-19 pandemic.","To understand the perception of adults with obesity about remote monitoring at the beginning of the pandemic of COVID-19. A descriptive-exploratory, qualitative study with participants in remote monitoring of a multi-professional treatment program in southern Brazil. Data was collected through digital platforms with interviews in written or audio-recorded records. The results were submitted to content analysis, thematic modality. 26 women participated, emerging the thematic category ""Difficultie","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Adult; Brazil; COVID-19; Female; Humans; Obesity; Pandemics; Perception; SARS-CoV-2","Christinelli","Heloá Costa Borim","Universidade Estadual de Maringá. Maringá, Paraná, Brazil",NA
"2954","34161517","10.1590/0034-7167-2020-0710","Perceptions of adults with obesity about multiprofessional remote monitoring at the beginning of the COVID-19 pandemic.","To understand the perception of adults with obesity about remote monitoring at the beginning of the pandemic of COVID-19. A descriptive-exploratory, qualitative study with participants in remote monitoring of a multi-professional treatment program in southern Brazil. Data was collected through digital platforms with interviews in written or audio-recorded records. The results were submitted to content analysis, thematic modality. 26 women participated, emerging the thematic category ""Difficultie","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Adult; Brazil; COVID-19; Female; Humans; Obesity; Pandemics; Perception; SARS-CoV-2","Spigolon","Dandara Novakowski","Universidade Estadual do Paraná. Paranavaí, Paraná, Brazil",NA
"2955","34161517","10.1590/0034-7167-2020-0710","Perceptions of adults with obesity about multiprofessional remote monitoring at the beginning of the COVID-19 pandemic.","To understand the perception of adults with obesity about remote monitoring at the beginning of the pandemic of COVID-19. A descriptive-exploratory, qualitative study with participants in remote monitoring of a multi-professional treatment program in southern Brazil. Data was collected through digital platforms with interviews in written or audio-recorded records. The results were submitted to content analysis, thematic modality. 26 women participated, emerging the thematic category ""Difficultie","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Adult; Brazil; COVID-19; Female; Humans; Obesity; Pandemics; Perception; SARS-CoV-2","Teston","Élen Ferraz","Universidade Federal de Mato Grosso do Sul. Campo Grande, Mato Grosso do Sul, Brazil",NA
"2956","34161517","10.1590/0034-7167-2020-0710","Perceptions of adults with obesity about multiprofessional remote monitoring at the beginning of the COVID-19 pandemic.","To understand the perception of adults with obesity about remote monitoring at the beginning of the pandemic of COVID-19. A descriptive-exploratory, qualitative study with participants in remote monitoring of a multi-professional treatment program in southern Brazil. Data was collected through digital platforms with interviews in written or audio-recorded records. The results were submitted to content analysis, thematic modality. 26 women participated, emerging the thematic category ""Difficultie","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Adult; Brazil; COVID-19; Female; Humans; Obesity; Pandemics; Perception; SARS-CoV-2","Costa","Maria Antonia Ramos","Universidade Estadual do Paraná. Paranavaí, Paraná, Brazil",NA
"2957","34161517","10.1590/0034-7167-2020-0710","Perceptions of adults with obesity about multiprofessional remote monitoring at the beginning of the COVID-19 pandemic.","To understand the perception of adults with obesity about remote monitoring at the beginning of the pandemic of COVID-19. A descriptive-exploratory, qualitative study with participants in remote monitoring of a multi-professional treatment program in southern Brazil. Data was collected through digital platforms with interviews in written or audio-recorded records. The results were submitted to content analysis, thematic modality. 26 women participated, emerging the thematic category ""Difficultie","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Adult; Brazil; COVID-19; Female; Humans; Obesity; Pandemics; Perception; SARS-CoV-2","Westphal","Greice","Universidade Estadual de Maringá. Maringá, Paraná, Brazil",NA
"2958","34161517","10.1590/0034-7167-2020-0710","Perceptions of adults with obesity about multiprofessional remote monitoring at the beginning of the COVID-19 pandemic.","To understand the perception of adults with obesity about remote monitoring at the beginning of the pandemic of COVID-19. A descriptive-exploratory, qualitative study with participants in remote monitoring of a multi-professional treatment program in southern Brazil. Data was collected through digital platforms with interviews in written or audio-recorded records. The results were submitted to content analysis, thematic modality. 26 women participated, emerging the thematic category ""Difficultie","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Adult; Brazil; COVID-19; Female; Humans; Obesity; Pandemics; Perception; SARS-CoV-2","Nardo Junior","Nelson","Universidade Estadual de Maringá. Maringá, Paraná, Brazil",NA
"2959","34161517","10.1590/0034-7167-2020-0710","Perceptions of adults with obesity about multiprofessional remote monitoring at the beginning of the COVID-19 pandemic.","To understand the perception of adults with obesity about remote monitoring at the beginning of the pandemic of COVID-19. A descriptive-exploratory, qualitative study with participants in remote monitoring of a multi-professional treatment program in southern Brazil. Data was collected through digital platforms with interviews in written or audio-recorded records. The results were submitted to content analysis, thematic modality. 26 women participated, emerging the thematic category ""Difficultie","2021","06","25","Rev Bras Enferm","Revista brasileira de enfermagem","Adult; Brazil; COVID-19; Female; Humans; Obesity; Pandemics; Perception; SARS-CoV-2","Fernandes","Carlos Alexandre Molena","Universidade Estadual de Maringá. Maringá, Paraná, Brazil",NA
"2960","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Kant","Aydin","Trabzon Vakfikebir State Hospital, Department of Chest Diseases - Trabzon, Turkey",NA
"2961","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Kostakoglu","Ugur","Recep Tayyip Erdogan University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology - Rize, Turkey",NA
"2962","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Saral","Özlem Bayraktar","Health Sciences University Trabzon Kanuni Training And Research Hospital, Department of Infectious Diseases and Clinical Microbiology - Trabzon, Turkey",NA
"2963","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Çomoglu","Senol","University of Health Sciences Istanbul Ümraniye Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology - Istanbul, Turkey",NA
"2964","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Arslan","Mustafa","Amasya University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology - Amasya, Turkey",NA
"2965","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Karakoç","Hanife Nur","Tatvan State Hospital, Department of Infectious Diseases and Clinical Microbiology - Bitlis, Turkey",NA
"2966","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Erkan","Gönül","University of Health Sciences, Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Education and Research Hospital, Department of Anesthesiology and Reanimation - Trabzon, Turkey",NA
"2967","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Ertunç","Baris","Akçaabat Haçkali Baba State Hospital, Department of Infectious Diseases and Clinical Microbiology - Trabzon, Turkey",NA
"2968","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Demir","Hanzade Duygu","Trabzon Vakfikebir State Hospital, Department of Internal Medicine - Trabzon, Turkey",NA
"2969","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Aydin","Murat","Karadeniz Technical University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology - Trabzon, Turkey",NA
"2970","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Öztürk","Sinan","University of Health Sciences Istanbul Ümraniye Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology - Istanbul, Turkey",NA
"2971","34161484","10.1590/1806-9282.67.01.20200584","Comparison of two pandemics: H1N1 and SARS-CoV-2.","We aimed to compare the clinical, epidemiological, and prognostic features of the H1N1 pandemic in 2009 and the severe acute respiratory syndrome coronavirus 2 pandemic in 2020. This retrospective study involved subjects from seven centers that were admitted and found to be positive for H1N1 or COVID-19 real-time polymerase chain reaction test. A total of 143 patients with H1N1 and 309 patients with COVID-19 were involved in the study. H1N1 patients were younger than COVID-19 ones. While 58.7% o","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Female; Humans; Influenza A Virus, H1N1 Subtype; Male; Pandemics; Retrospective Studies; SARS-CoV-2","Yilmaz","Gürdal","Karadeniz Technical University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology - Trabzon, Turkey",NA
"2972","34161477","10.1590/1806-9282.67.01.20200512","A beacon for the COVID-19 epidemic control in Brasil: seroepidemiological population-based surveys.",NA,"2021","06","28","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","Brazil; COVID-19; China; Demography; Epidemics; Humans; Italy; SARS-CoV-2","Donalisio","Maria Rita","Universidade Estadual de Campinas, Faculdade de Ciências Médicas - Campinas (SP), Brasil",NA
"2973","34161476","10.1590/1806-9282.67.01.20200982","COVID-19-induced de novo nephritic syndrome.",NA,"2021","06","28","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Glomerulonephritis; Hematuria; Humans; Proteinuria; SARS-CoV-2","Yasri","Sora","Private Academic Consultant - Bangkok, Thailand",NA
"2974","34161476","10.1590/1806-9282.67.01.20200982","COVID-19-induced de novo nephritic syndrome.",NA,"2021","06","28","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Glomerulonephritis; Hematuria; Humans; Proteinuria; SARS-CoV-2","Wiwanitkit","Viroj","Patil University - Pune, India",NA
"2975","34161475","10.1590/1806-9282.67.01.20200671","Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue.","The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcran","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Fatigue; Humans; Pain; SARS-CoV-2; Transcranial Direct Current Stimulation","Silva Filho","Edson","UniversidadeFederal da Paraíba, Departamento de Educação Física, Laboratório de Estudos do Treinamento Físico Aplicado ao Desempenho e a Saúde - João Pessoa (PB), Brasil",NA
"2976","34161475","10.1590/1806-9282.67.01.20200671","Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue.","The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcran","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Fatigue; Humans; Pain; SARS-CoV-2; Transcranial Direct Current Stimulation","Moura","Stephanney","UniversidadeFederal da Paraíba, Departamento de Educação Física, Laboratório de Estudos do Treinamento Físico Aplicado ao Desempenho e a Saúde - João Pessoa (PB), Brasil",NA
"2977","34161475","10.1590/1806-9282.67.01.20200671","Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue.","The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcran","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Fatigue; Humans; Pain; SARS-CoV-2; Transcranial Direct Current Stimulation","Santos","Amilton da Cruz","UniversidadeFederal da Paraíba, Departamento de Educação Física, Laboratório de Estudos do Treinamento Físico Aplicado ao Desempenho e a Saúde - João Pessoa (PB), Brasil",NA
"2978","34161475","10.1590/1806-9282.67.01.20200671","Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue.","The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcran","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Fatigue; Humans; Pain; SARS-CoV-2; Transcranial Direct Current Stimulation","Brasileiro-Santos","Maria do Socorro","UniversidadeFederal da Paraíba, Departamento de Educação Física, Laboratório de Estudos do Treinamento Físico Aplicado ao Desempenho e a Saúde - João Pessoa (PB), Brasil",NA
"2979","34161475","10.1590/1806-9282.67.01.20200671","Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue.","The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcran","2021","06","25","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)","COVID-19; Fatigue; Humans; Pain; SARS-CoV-2; Transcranial Direct Current Stimulation","Albuquerque","Jéssica Andrade de","UniversidadeFederal da Paraíba, Programa de Pós-Graduação em Psicologia Social - João Pessoa, Brasil",NA
